Document:

<![CDATA[Credit & Guaranty Agreement]]>

 Exhibit 10.1 
 CONFIDENTIAL TREATMENT REQUESTED: Certain portions of this document have been omitted pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk
(“[***]”) to denote where omissions have been made. The confidential material has been filed separately with the U.S. Securities and Exchange Commission. 
 Execution Copy 
 Tranche A Term Loan CUSIP: 43644AAP4 

Tranche B Term Loan CUSIP: 43644AAQ2 
 Revolving Loan CUSIP: 43644AAR0 
 CREDIT AND GUARANTY AGREEMENT 

dated as of August 1, 2012 
 among 
 HOLOGIC, INC., 

CERTAIN SUBSIDIARIES OF HOLOGIC, INC., 
 as Guarantors, 
 VARIOUS LENDERS, 

GOLDMAN SACHS BANK USA, 
 J.P. MORGAN SECURITIES LLC and 
 CITIGROUP GLOBAL MARKETS INC. 

as Joint Lead Arrangers and Joint Lead Bookrunners, 
 J.P. MORGAN SECURITIES LLC and 
 CITIGROUP GLOBAL MARKETS INC. 

as Co-Syndication Agents, 
 GOLDMAN SACHS BANK USA 
 as Administrative Agent and Collateral Agent, 

and 
 DNB BANK
ASA, 
 THE BANK OF TOKYO-MITSUBISHI UFJ LTD. and 
 FIFTH THIRD BANK 
 as Co-Documentation Agents 

 
  

$2,800,000,000 Senior Secured Credit Facilities 
  

 

 TABLE OF CONTENTS 

 
  

 

							
	 	 	 	  	PAGE	 
		
	 ARTICLE 1
 DEFINITIONS AND INTERPRETATION
	  			
			
	 Section 1.01.
	 	 Definitions
	  	 	2	  
	 Section 1.02.
	 	 Accounting Terms
	  	 	64	  
	 Section 1.03.
	 	 Interpretation, Etc.
	  	 	65	  
	 Section 1.04.
	 	 Letter of Credit Amounts
	  	 	65	  
	 Section 1.05.
	 	 Pro forma Calculations
	  	 	66	  
		
	 ARTICLE 2
 LOANS AND LETTERS OF CREDIT
	  			
	 Section 2.01.
	 	 Term Loans
	  	 	67	  
	 Section 2.02.
	 	 Revolving Loans
	  	 	68	  
	 Section 2.03.
	 	 Swing Line Loans
	  	 	69	  
	 Section 2.04.
	 	 Issuance of Letters of Credit and Purchase of Participations Therein
	  	 	72	  
	 Section 2.05.
	 	 Pro Rata Shares; Availability of Funds
	  	 	79	  
	 Section 2.06.
	 	 Use of Proceeds
	  	 	80	  
	 Section 2.07.
	 	 Evidence of Debt; Register; Notes
	  	 	80	  
	 Section 2.08.
	 	 Interest on Loans
	  	 	82	  
	 Section 2.09.
	 	 Conversion/Continuation
	  	 	84	  
	 Section 2.10.
	 	 Default Interest
	  	 	85	  
	 Section 2.11.
	 	 Fees
	  	 	85	  
	 Section 2.12.
	 	 Scheduled Payments/Commitment Reductions
	  	 	86	  
	 Section 2.13.
	 	 Voluntary Prepayments/Commitment Reductions
	  	 	88	  
	 Section 2.14.
	 	 Mandatory Prepayments/Commitment Reductions
	  	 	90	  
	 Section 2.15.
	 	 Application of Prepayments/Reductions
	  	 	92	  
	 Section 2.16.
	 	 General Provisions Regarding Payments
	  	 	94	  
	 Section 2.17.
	 	 Ratable Sharing
	  	 	96	  
	 Section 2.18.
	 	 Making or Maintaining Eurodollar Rate Loans
	  	 	97	  
	 Section 2.19.
	 	 Increased Costs; Capital Adequacy
	  	 	100	  
	 Section 2.20.
	 	 Taxes; Withholding, etc.
	  	 	101	  
	 Section 2.21.
	 	 Obligation to Mitigate
	  	 	106	  
	 Section 2.22.
	 	 Defaulting Lenders
	  	 	107	  
	 Section 2.23.
	 	 Removal or Replacement of a Lender
	  	 	111	  
	 Section 2.24.
	 	 Incremental Facilities
	  	 	112	  
	 Section 2.25.
	 	 Extensions of Loans
	  	 	115	  
	 Section 2.26.
	 	 Refinancing Amendments
	  	 	119	  

  
 i 

							
	 ARTICLE 3
 CONDITIONS PRECEDENT
	   

  

			
	 Section 3.01.
	 	 Closing Date
	  	 	122	  
	 Section 3.02.
	 	 Conditions to Each Credit Extension
	  	 	128	  
	
	 ARTICLE 4
 REPRESENTATIONS AND WARRANTIES
	   

  

			
	 Section 4.01.
	 	 Organization; Requisite Power and Authority; Qualification
	  	 	130	  
	 Section 4.02.
	 	 Equity Interests and Ownership
	  	 	131	  
	 Section 4.03.
	 	 Due Authorization
	  	 	131	  
	 Section 4.04.
	 	 No Conflict
	  	 	131	  
	 Section 4.05.
	 	 Governmental Consents
	  	 	132	  
	 Section 4.06.
	 	 Binding Obligation
	  	 	132	  
	 Section 4.07.
	 	 Historical Financial Statements
	  	 	132	  
	 Section 4.08.
	 	 Projections
	  	 	132	  
	 Section 4.09.
	 	 No Material Adverse Change
	  	 	133	  
	 Section 4.10.
	 	 No Restricted Junior Payments
	  	 	133	  
	 Section 4.11.
	 	 Adverse Proceedings, etc.
	  	 	133	  
	 Section 4.12.
	 	 Payment of Taxes
	  	 	133	  
	 Section 4.13.
	 	 Properties
	  	 	134	  
	 Section 4.14.
	 	 Environmental Matters
	  	 	135	  
	 Section 4.15.
	 	 No Defaults
	  	 	136	  
	 Section 4.16.
	 	 Material Contracts
	  	 	136	  
	 Section 4.17.
	 	 Governmental Regulation
	  	 	136	  
	 Section 4.18.
	 	 Margin Stock
	  	 	136	  
	 Section 4.19.
	 	 Employee Matters
	  	 	136	  
	 Section 4.20.
	 	 Employee Benefit Plans
	  	 	137	  
	 Section 4.21.
	 	 Certain Fees
	  	 	138	  
	 Section 4.22.
	 	 Solvency
	  	 	138	  
	 Section 4.23.
	 	 Related Agreements
	  	 	138	  
	 Section 4.24.
	 	 Compliance with Statutes, etc.
	  	 	138	  
	 Section 4.25.
	 	 Disclosure
	  	 	138	  
	 Section 4.26.
	 	 Senior Indebtedness
	  	 	139	  
	 Section 4.27.
	 	 PATRIOT Act; Sanctioned Persons
	  	 	139	  
	 Section 4.28.
	 	 Use of Proceeds
	  	 	140	  
	 Section 4.29.
	 	 Security Documents
	  	 	140	  
	
	 ARTICLE 5
 AFFIRMATIVE COVENANTS
	   

  

			
	 Section 5.01.
	 	 Financial Statements and Other Reports
	  	 	141	  
	 Section 5.02.
	 	 Existence
	  	 	146	  
	 Section 5.03.
	 	 Payment of Taxes and Claims
	  	 	146	  

  
 ii 

							
	 Section 5.04.
	 	 Maintenance of Properties
	  	 	147	  
	 Section 5.05.
	 	 Insurance
	  	 	147	  
	 Section 5.06.
	 	 Books and Records; Inspections
	  	 	148	  
	 Section 5.07.
	 	 Lenders Meetings
	  	 	148	  
	 Section 5.08.
	 	 Compliance with Laws
	  	 	148	  
	 Section 5.09.
	 	 Environmental Matters
	  	 	148	  
	 Section 5.10.
	 	 Subsidiaries
	  	 	150	  
	 Section 5.11.
	 	 Additional Material Real Estate Assets
	  	 	151	  
	 Section 5.12.
	 	 Further Assurances
	  	 	152	  
	 Section 5.13.
	 	 Miscellaneous Covenants
	  	 	153	  
	
	 ARTICLE 6
 NEGATIVE COVENANTS
	   

  

			
	 Section 6.01.
	 	 Indebtedness
	  	 	153	  
	 Section 6.02.
	 	 Liens
	  	 	158	  
	 Section 6.03.
	 	 No Further Negative Pledges
	  	 	161	  
	 Section 6.04.
	 	 Restricted Junior Payments
	  	 	162	  
	 Section 6.05.
	 	 Restrictions on Subsidiary Distributions
	  	 	163	  
	 Section 6.06.
	 	 Investments
	  	 	164	  
	 Section 6.07.
	 	 Financial Covenants
	  	 	167	  
	 Section 6.08.
	 	 Fundamental Changes; Disposition of Assets; Acquisitions
	  	 	168	  
	 Section 6.09.
	 	 Sales and Leasebacks
	  	 	171	  
	 Section 6.10.
	 	 Transactions with Shareholders and Affiliates
	  	 	172	  
	 Section 6.11.
	 	 Conduct of Business
	  	 	174	  
	 Section 6.12.
	 	 Amendments or Waivers of Organizational Documents and Certain Related Agreements
	  	 	174	  
	 Section 6.13.
	 	 Amendments or Waivers with Respect to Junior Financing
	  	 	174	  
	 Section 6.14.
	 	 Fiscal Year
	  	 	175	  
	 Section 6.15.
	 	 Massachusetts Securities Corporation
	  	 	175	  
	
	 ARTICLE 7
 GUARANTY
	   

  

			
	 Section 7.01.
	 	 Guaranty of the Obligations
	  	 	175	  
	 Section 7.02.
	 	 Contribution by Guarantors
	  	 	175	  
	 Section 7.03.
	 	 Payment by Guarantors
	  	 	176	  
	 Section 7.04.
	 	 Liability of Guarantors Absolute
	  	 	177	  
	 Section 7.05.
	 	 Waivers by Guarantors
	  	 	179	  
	 Section 7.06.
	 	 Guarantors’ Rights of Subrogation, Contribution, etc
	  	 	180	  
	 Section 7.07.
	 	 Subordination of Other Obligations
	  	 	181	  
	 Section 7.08.
	 	 Continuing Guaranty
	  	 	181	  
	 Section 7.09.
	 	 Authority of Guarantors or Borrower
	  	 	181	  
	 Section 7.10.
	 	 Financial Condition of Borrower
	  	 	181	  
	 Section 7.11.
	 	 Bankruptcy, etc.
	  	 	182	  

  
 iii

							
	 Section 7.12.
	 	 Discharge of Guaranty Upon Sale of Guarantor
	  	 	182	  
	
	 ARTICLE 8
 EVENTS OF DEFAULT
	   

  

			
	 Section 8.01.
	 	 Events of Default
	  	 	183	  
	
	 ARTICLE 9
 AGENTS
	   

  

			
	 Section 9.01.
	 	 Appointment of Agents
	  	 	187	  
	 Section 9.02.
	 	 Powers and Duties
	  	 	187	  
	 Section 9.03.
	 	 General Immunity
	  	 	188	  
	 Section 9.04.
	 	 Agents Entitled to Act as Lender
	  	 	189	  
	 Section 9.05.
	 	 Lenders’ Representations, Warranties and Acknowledgment
	  	 	190	  
	 Section 9.06.
	 	 Right to Indemnity
	  	 	190	  
	 Section 9.07.
	 	 Successor Administrative Agent, Collateral Agent and Swing Line Lender
	  	 	191	  
	 Section 9.08.
	 	 Collateral Documents and Guaranty
	  	 	193	  
	 Section 9.09.
	 	 Withholding Taxes
	  	 	195	  
	 Section 9.10.
	 	 Administrative Agent May File Bankruptcy Disclosure and Proofs of Claim
	  	 	195	  
	
	 ARTICLE 10
 MISCELLANEOUS
	   

  

			
	 Section 10.01.
	 	 Notices
	  	 	197	  
	 Section 10.02.
	 	 Expenses
	  	 	199	  
	 Section 10.03.
	 	 Indemnity
	  	 	200	  
	 Section 10.04.
	 	 Set-off
	  	 	201	  
	 Section 10.05.
	 	 Amendments and Waivers
	  	 	202	  
	 Section 10.06.
	 	 Successors and Assigns; Participations
	  	 	205	  
	 Section 10.07.
	 	 Independence of Covenants
	  	 	211	  
	 Section 10.08.
	 	 Survival of Representations, Warranties and Agreements
	  	 	211	  
	 Section 10.09.
	 	 No Waiver; Remedies Cumulative
	  	 	212	  
	 Section 10.10.
	 	 Marshalling; Payments Set Aside
	  	 	212	  
	 Section 10.11.
	 	 Severability
	  	 	212	  
	 Section 10.12.
	 	 Obligations Several; Independent Nature of Lenders’ Rights
	  	 	212	  
	 Section 10.13.
	 	 Headings
	  	 	213	  
	 Section 10.14.
	 	 APPLICABLE LAW
	  	 	213	  
	 Section 10.15.
	 	 CONSENT TO JURISDICTION
	  	 	213	  
	 Section 10.16.
	 	 WAIVER OF JURY TRIAL
	  	 	214	  
	 Section 10.17.
	 	 Confidentiality
	  	 	215	  
	 Section 10.18.
	 	 Usury Savings Clause
	  	 	216	  
	 Section 10.19.
	 	 Counterparts
	  	 	216	  

  
 iv 

							
	 Section 10.20.
	 	 Effectiveness; Entire Agreement
	  	 	216	  
	 Section 10.21.
	 	 PATRIOT Act
	  	 	217	  
	 Section 10.22.
	 	 Electronic Execution of Assignments
	  	 	217	  
	 Section 10.23.
	 	 No Fiduciary Duty
	  	 	217	  

  

			
	APPENDICES
	 A-1
	 	 Tranche A Term Loan Commitments

	 A-2
	 	 Tranche B Term Loan Commitments

	 A-3
	 	 Revolving Commitments

	 B
	 	 Notice Addresses

	
	SCHEDULES
		
	 1.1A
	 	 Asset Sales

	 1.1B
	 	 Closing Date Mortgaged Properties

	 1.1C
	 	 Immaterial Domestic Subsidiaries

	 1.1D
	 	 Existing Letters of Credit

	 1.1E
	 	 Acquired Business Non-Core Assets

	 4.01
	 	 Jurisdictions of Organization and Qualification, Capital Structure

	 4.02
	 	 Equity Interests and Ownership

	 4.11
	 	 Adverse Proceedings

	 4.13(b)
	 	 Real Estate Assets

	 4.13(c)
	 	 Intellectual Property Litigation

	 4.16
	 	 Material Contracts

	 4.24
	 	 Compliance with Statutes

	 5.12(c)
	 	 Post-Closing Actions

	 6.01
	 	 Certain Indebtedness

	 6.02
	 	 Certain Liens

	 6.03
	 	 Negative Pledges

	 6.04
	 	 Certain Restricted Payments

	 6.05
	 	 Certain Restrictions on Subsidiary Distributions

	 6.06(k)
	 	 Certain Investments

	 6.09
	 	 Sale and Leasebacks

	 6.10
	 	 Certain Affiliate Transactions

	
	EXHIBITS
		
	 A-1
	 	 Funding Notice

	 A-2
	 	 Conversion/Continuation Notice

	 B-1
	 	 Tranche A Term Loan Note

	 B-2
	 	 Tranche B Term Loan Note

	 B-3
	 	 Revolving Loan Note

  
 v 

			
	 B-4
	 	 Swing Line Note

	 C
	 	 Compliance Certificate

	 D-1
	 	 Opinion of Brown Rudnick LLP

	 D-2
	 	 Opinion of Richards, Layton & Finger, P.A.

	 D-3
	 	 Opinion of Newmeyer & Dillion, LLP

	 D-4
	 	 Opinion of Brownstein Hyatt Farber Schreck, LLP

	 D-5
	 	 Opinion of Whyte Hirschboeck Dudek S.C.

	 E
	 	 Assignment Agreement

	 F
	 	 Certificate re Non-Bank Status

	 G-1
	 	 Closing Date Certificate

	 G-2
	 	 Solvency Certificate

	 H
	 	 Counterpart Agreement

	 I
	 	 Pledge and Security Agreement

	 J
	 	 Joinder Agreement

	 K
	 	 Modified Dutch Auction Procedures

	 L
	 	 Incumbency Certificate

  
 vi 

 CREDIT AND GUARANTY AGREEMENT 

This CREDIT AND GUARANTY AGREEMENT dated as of August 1, 2012, is entered into by and among HOLOGIC, INC., a Delaware corporation
(the “Borrower”), certain Subsidiaries of the Borrower, as Guarantors, the Lenders party hereto from time to time, GOLDMAN SACHS BANK USA (“Goldman Sachs”), J.P. MORGAN SECURITIES LLC (“JPMS”) and
CITIGROUP GLOBAL MARKETS INC. (“Citi”), as joint lead arrangers and joint lead bookrunners (in such capacities, the “Lead Arrangers”), JPMS and Citi, as co-syndication agents (in such capacities, the
“Co-Syndication Agents”), DNB Bank ASA, The Bank of Tokyo-Mitsubishi UFJ Ltd. and Fifth Third Bank, as co-documentation agents (in such capacities, the “Co-Documentation Agents”) and Goldman Sachs, as administrative
agent (together with its permitted successors in such capacity, the “Administrative Agent”) and as collateral agent (together with its permitted successors in such capacity, the “Collateral Agent”). 

RECITALS: 

WHEREAS, capitalized terms used and not defined in these Recitals shall have the respective meanings set forth for such terms in Section
1.01 hereof; 
 WHEREAS, Lenders have agreed to extend certain credit facilities to the Borrower, in an aggregate principal
amount not to exceed $2,800,000,000, consisting of (i) $1,000,000,000 aggregate principal amount of Tranche A Term Loans and $1,500,000,000 aggregate principal amount of Tranche B Term Loans the proceeds of which (a) will be used to fund
the Acquisition (including the Refinancing and paying fees, commissions and expenses in connection with the Acquisition) and (b) may be used to repurchase or redeem the Convertible Notes and (ii) $300,000,000 aggregate principal amount of
Revolving Commitments, the proceeds of which may be used (a) to repurchase or redeem the Convertible Notes, (b) for capital expenditures permitted hereunder and Permitted Acquisitions, (c) to provide for the ongoing working capital
requirements of the Borrower following the Acquisition and (d) for general corporate purposes; 
 WHEREAS, the Borrower has
agreed to secure all of its Obligations by granting to the Collateral Agent, for the benefit of the Secured Parties, a First Priority Lien on substantially all of its assets, including a pledge of all of the Equity Interests of certain of its
Domestic Subsidiaries and 65% of all the Equity Interests of certain of its First-Tier Foreign Subsidiaries and all of its intercompany Indebtedness; 
 WHEREAS, Guarantors have agreed to guarantee the obligations of the Borrower hereunder and to secure their respective Obligations by granting to the Collateral Agent, for the benefit of the Secured
Parties, a First Priority Lien on substantially all of their respective assets, including a pledge of all of the Equity 

 
Interests of certain of their respective Domestic Subsidiaries and 65% of all the Equity Interests of certain of their respective First-Tier Foreign Subsidiaries and all of their intercompany
Indebtedness; and 
 NOW, THEREFORE, in consideration of the premises and the agreements, provisions and covenants herein
contained, the parties hereto agree as follows: 
 ARTICLE 1 

DEFINITIONS AND INTERPRETATION 

Section 1.01. Definitions. (a) The following terms used herein, including in the preamble, recitals, exhibits and
schedules hereto, shall have the following meanings: 
 “2007 Notes” as defined in the definition of
“Convertible Notes.” 
 “Acquired Business” means Gen-Probe Incorporated, a Delaware corporation.

 “Acquired Business Material Adverse Effect” means any event, state of facts, circumstance, development,
change, effect or occurrence that is or could reasonably be expected to be materially adverse (i) to the business, financial condition or results of operations of the Acquired Business and its Subsidiaries, taken as a whole or (ii) to the
ability of the Acquired Business to timely perform any of its obligations under the Acquisition Agreement, other than in the case of clause (i) or (ii) above, any event, state of facts, circumstance, development, change, effect or
occurrence resulting from (A) changes in general economic, regulatory or political conditions or in the securities, credit or financial markets in general, (B) general changes or developments in the business in which the Acquired Business
and its Subsidiaries operate, including any changes in applicable law affecting such business, including generally applicable rules, regulations and administrative policies of the FDA, or published interpretations thereof, (C) the negotiation,
execution, announcement, existence or performance of the Acquisition Agreement or the transactions contemplated thereby, including (x) any fees or expenses incurred in connection therewith and (y) the impact of the foregoing on
relationships with customers, suppliers, employees and regulators, (D) the identity of the Borrower or any of its Affiliates as the acquiror of the Acquired Business, (E) compliance with the terms of, or the taking of any action expressly
required to be taken by the Acquired Business pursuant to the Acquisition Agreement or any other action consented to by the Borrower and the Lead Arrangers after April 29, 2012, (F) any acts of terrorism or war or any natural disaster or
weather-related event, (G) changes in generally accepted 

  
 2 

 
accounting principles or the interpretation thereof, (H) changes in the price or trading volume of the common stock of the Acquired Business (provided that this clause (H) shall
not be construed as providing that the change, event, circumstance, development, occurrence or state of facts giving rise to such change in price or trading volume does not constitute or contribute to an Acquired Business Material Adverse Effect),
(I) any failure to meet internal or published projections, forecasts or revenue or earning predictions or any downward revisions for any period (provided that this clause (I) shall not be construed as providing that the change,
event, circumstance, development, occurrence or state of facts giving rise to such failure does not constitute or contribute to an Acquired Business Material Adverse Effect), (J) any action, suit, investigation or proceeding made, brought or
threatened by any holder of Company Securities (as defined in the Acquisition Agreement in effect on April 29, 2012, and without giving effect to any amendments thereunder), on the holder’s own behalf or on behalf of the Acquired Business
on a derivative basis (other than any actions, suits, investigations or proceedings made, brought or threatened by any of the Acquired Business’s officers or directors), arising out of or related to any of the transactions contemplated hereby,
including the Acquisition, or (K) any determination by, or the delay of a determination by, the FDA or any panel or advisory body empowered or appointed thereby, after April 29, 2012, with respect to the approval or non-approval of new
Medical Products (as defined in the Acquisition Agreement in effect on April 29, 2012, and without giving effect to any amendments thereunder) or new uses of existing Medical Products, in each case of the Acquired Business or its Subsidiaries,
as of April 29, 2012, except, in the case of the foregoing clause (A), (B) or (F), to the extent such changes or developments referred to therein could reasonably be expected to have a materially disproportionate negative impact on the
Acquired Business and its subsidiaries, taken as a whole, compared to other comparable participants in the Acquired Business’s industries. 
 “Acquired Business Non-Core Assets” means the assets of the Acquired Business and its Subsidiaries set forth on Schedule 1.1E. 

“Acquired Non-Investment-Grade Securities” means any and all investment securities (including equity securities listed
on a national securities exchange) owned by any Subsidiary acquired in the Acquisition or any Permitted Acquisition, which are not Investment Grade Securities or securities issued by an Affiliate of such Subsidiary, to the extent that such
investment securities were owned by such Subsidiary at the time of the Acquisition or such Permitted Acquisition, as applicable, and were not acquired in contemplation thereof. 

“Acquisition” means the acquisition by the Borrower of 100% of the Equity Interests of the Acquired Business through the
merger of Merger Sub with and into the Acquired Business with the Acquired Business continuing as the surviving corporation in accordance with the Acquisition Agreement. 

  
 3 

 “Acquisition Agreement” means the Agreement and Plan of Merger (together
with all exhibits and schedules thereto) dated as of April 29, 2012, among the Borrower, the Acquired Business and Merger Sub to consummate the Acquisition and the other transactions described therein or related thereto. 

“Acquisition Agreement Representations” means such of the representations made by or with respect to the Acquired
Business in the Acquisition Agreement as are material to the interests of the Lenders and the Commitment Parties (but only to the extent that the Borrower or its Affiliates have the right not to consummate the Acquisition, or to terminate their
obligations (or otherwise do not have an obligation to close), under the Acquisition Agreement as a result of a failure of such representations in the Acquisition Agreement to be true and correct). 

“Additional Lender” as defined in Section 2.26. 

“Adjusted Consolidated Cash Interest Expense” means for any period, the Adjusted Consolidated Interest Expense for such
period, excluding any amount not payable in Cash, original issue discount and other imputed non-cash interest charges relating to the Convertible Notes or any other Indebtedness now or hereafter outstanding. 

“Adjusted Consolidated Interest Expense” means for any period, total interest expense in accordance with GAAP (including
that portion attributable to Capital Leases in accordance with GAAP, capitalized interest, amortization of deferred financing fees and amortization in relation to terminated Hedge Agreements) of the Borrower and its Subsidiaries on a consolidated
basis with respect to all outstanding Indebtedness of the Borrower and its Subsidiaries, including all commissions, discounts and other fees and charges owed with respect to letters of credit, net costs under Interest Rate Agreements, capitalized
interest and the interest component of all Attributable Receivables Indebtedness. 
 “Adjusted Eurodollar Rate”
means, for any Interest Rate Determination Date with respect to an Interest Period for a Eurodollar Rate Loan, the rate per annum obtained by dividing (i) (a) the rate per annum equal to the rate determined by the Administrative Agent to
be the offered rate which appears on the page of the Reuters Screen which displays an average British Bankers Association Interest Settlement Rate (such page currently being LIBOR01 page) for deposits (for delivery on the first day of such period)
with a term equivalent to such period in Dollars, determined as of approximately 11:00 a.m. (London, England, time) on such Interest Rate Determination Date, (b) in the event the rate referenced in the preceding clause (a) does not appear
on such page or service or if such page or service shall cease to be available, the rate per annum equal to the rate determined by the Administrative Agent to be the offered rate on such other page or other service which displays an average British
Bankers Association Interest Settlement 

  
 4 

 
Rate for deposits (for delivery on the first day of such period) with a term equivalent to such period in Dollars, determined as of approximately 11:00 a.m. (London, England, time) on such
Interest Rate Determination Date or (c) in the event the rates referenced in the preceding clauses (a) and (b) are not available, the rate per annum equal to the offered quotation rate to first class banks in the London interbank
market by JPMorgan Chase Bank N.A. for deposits (for delivery on the first day of the relevant period) in Dollars of amounts in same day funds comparable to the principal amount of the applicable Loan of the Administrative Agent, in its capacity as
a Lender, for which the Adjusted Eurodollar Rate is then being determined with maturities comparable to such period as of approximately 11:00 a.m. (London, England, time) on such Interest Rate Determination Date by (ii) an amount equal to
(a) one minus (b) the Applicable Reserve Requirement; provided that with respect to the Tranche B Term Loans, the Adjusted Eurodollar Rate shall not be less than 1.00% per annum. 

“Administrative Agent” as defined in the preamble hereto. 

“Adverse Proceeding” means any action, suit, proceeding, hearing (in each case, whether administrative, judicial or
otherwise), governmental investigation or arbitration (whether or not purportedly on behalf of the Borrower or any of its Subsidiaries) at law or in equity, or before or by any Governmental Authority, domestic or foreign (including any Environmental
Claims), whether pending or, to the knowledge of any Authorized Officer of the Borrower or any of its Subsidiaries, threatened against or affecting the Borrower or any of its Subsidiaries or any property of the Borrower or any of its Subsidiaries.

 “Affected Lender” as defined in Section 2.18(b). 

“Affected Loans” as defined in Section 2.18(b). 

“Affiliate” means, with respect to any specified Person, any other Person directly or indirectly controlling or
controlled by or under direct or indirect common control with such specified Person. For the purposes of this definition, “control” when used with respect to any specified Person means the power to direct the management and policies of
such Person, directly or indirectly, whether through ownership of voting securities, by contract or otherwise; and the terms “controlling” and “controlled” have meanings correlative to the foregoing. For the avoidance of doubt,
none of the Agents or their respective lending affiliates (in each case in their capacity as such) shall be deemed to be an Affiliate of the Borrower or any of its Subsidiaries. 

“Affiliate Assignment Agreement” means an Assignment and Assumption Agreement substantially in the form of Annex C to
Exhibit K, with such amendments or modifications as may be approved by the Administrative Agent. 

  
 5 

 “Agent” means each of the Administrative Agent, the Co-Syndication Agents,
the Collateral Agent, the Lead Arrangers, the Co-Documentation Agents and any other Person appointed under the Credit Documents to serve in an agent or similar capacity, including, without limitation, any Auction Manager. 

“Agent Affiliates” as defined in Section 10.01(b)(iii). 

“Aggregate Amounts Due” as defined in Section 2.17. 

“Aggregate Payments” as defined in Section 7.02. 

“Agreed Currency” means Dollars, Euro, Pounds Sterling and such other currencies as are acceptable to the Issuing Bank
and Administrative Agent in their sole discretion. 
 “Agreement” means this Credit and Guaranty Agreement
dated as of August 1, 2012, as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time. 
 “Applicable Date” as defined in Section 2.18(b). 

“Applicable Margin” and “Applicable Revolving Commitment Fee Percentage” mean (i) with respect to
Revolving Loans and Tranche A Term Loans that are Eurodollar Rate Loans and the Applicable Revolving Commitment Fee Percentage, (a) from the Closing Date until the date of delivery of the Compliance Certificate and the financial statements for
the second full Fiscal Quarter after the Closing Date, a percentage, per annum, determined by reference to Tier 1 in the following table and (b) thereafter, a percentage, per annum, determined by reference to the Total Net Leverage Ratio in
effect from time to time as set forth below: 
  

											
	 Tier
	  	Total Net
Leverage Ratio	  	Applicable
Margin	 	 	Applicable
Revolving
Commitment Fee
Percentage	 
	 Tier 1
	  	>4.00:1.00	  	 	3.00	% 	 	 	0.500	% 
	 Tier 2
	  	£4.00:1.00

>3.00:1.00
	  	 	2.75	% 	 	 	0.500	% 
	 Tier 3
	  	£3.00:1.00	  	 	2.50	% 	 	 	0.375	% 

 ; and (ii) with respect to Swing Line Loans, Revolving Loans and Tranche A Term Loans that are Base Rate Loans, an
amount equal to (a) the Applicable 

  
 6 

 
Margin for Eurodollar Rate Loans as set forth in clause (i)(a) or (i)(b) above, as applicable, minus (b) 1.00% per annum. No change in the Applicable Margin or the Applicable Revolving
Commitment Fee Percentage shall be effective until three (3) Business Days after the date on which the Administrative Agent shall have received the applicable financial statements and a Compliance Certificate pursuant to Section 5.01(c)
calculating the Total Net Leverage Ratio. At any time the Borrower has not submitted to the Administrative Agent the applicable information as and when required under Section 5.01(c), the Applicable Margin and the Applicable Revolving Commitment Fee
Percentage shall be determined by reference to Tier 1 in the above table. Within one (1) Business Day after receipt of the applicable information under Section 5.01(c), Administrative Agent shall give each Lender telefacsimile or telephonic
notice (confirmed in writing) of the Applicable Margin and the Applicable Revolving Commitment Fee Percentage in effect from such date. In the event that any financial statement or certificate delivered pursuant to Section 5.01 is shown to be
inaccurate (at a time when this Agreement is in effect and unpaid Obligations under this Agreement are outstanding (other than indemnities and other contingent obligations not yet due and payable)), and such inaccuracy, if corrected, would have led
to the application of a higher Applicable Margin for any period (an “Applicable Period”) than the Applicable Margin applied for such Applicable Period, then (i) the Borrower shall immediately deliver to Administrative Agent a
correct certificate required by Section 5.01 for such Applicable Period, (ii) the Applicable Margin shall be determined by reference to the applicable Tier in the above table for such Applicable Period based on the corrected certificate and
(iii) the Borrower shall immediately pay to the Administrative Agent the accrued additional interest owing as a result of such increased Applicable Margin for such Applicable Period. Nothing in this paragraph shall limit the right of the
Administrative Agent or any Lender under Section 2.10 or Article 8. 
 “Applicable Period” as defined in
the definition of “Applicable Margin.” 
 “Applicable Reserve Requirement” means, at any time, for
any Eurodollar Rate Loan, the maximum rate, expressed as a decimal, at which reserves (including any basic marginal, special, supplemental, emergency or other reserves) are required to be maintained with respect thereto against “Eurocurrency
liabilities” (as such term is defined in Regulation D) under regulations issued from time to time by the Board of Governors or other applicable banking regulator. Without limiting the effect of the foregoing, the Applicable Reserve
Requirement shall reflect any other reserves required to be maintained by member banks with respect to (i) any category of liabilities which includes deposits by reference to which the applicable Adjusted Eurodollar Rate or any other interest
rate of a Loan is to be determined or (ii) any category of extensions of credit or other assets which include Eurodollar Rate Loans. A Eurodollar Rate Loan shall be deemed to constitute Eurocurrency liabilities and as such shall be deemed
subject to reserve requirements without benefits of credit for 

  
 7 

 
proration, exceptions or offsets that may be available from time to time to the applicable Lender. The rate of interest on Eurodollar Rate Loans shall be adjusted automatically on and as of the
effective date of any change in the Applicable Reserve Requirement. 
 “Applicable Time” means (i) with
respect to any payment in Dollars, as set forth in Section 2.16 and (ii) with respect to any payment in any Agreed Currency other than Dollars, the local time in the place of settlement for such Agreed Currency as may be determined by the
Administrative Agent to be necessary for timely settlement on the relevant date in accordance with normal banking procedures in such place of settlement. 
 “Approved Electronic Communications” means any notice, demand, communication, information, document or other material that any Credit Party provides to the Administrative Agent pursuant
to any Credit Document or the transactions contemplated therein which is distributed to the Agents, the Lenders or the Issuing Bank by means of electronic communications pursuant to Section 10.01(b). 

“Asset Sale” means a sale or lease (as lessor), sale and leaseback, assignment, conveyance, exclusive license (as
licensor), transfer or other Disposition to, or any exchange of property with, any Person (other than the Borrower or any Guarantor), in one transaction or a series of transactions, of all or any part of the Borrower’s or any of its
Subsidiaries’ businesses, assets or properties of any kind, whether real, personal, or mixed and whether tangible or intangible, whether now owned or hereafter acquired, created, leased or licensed, including the Equity Interests of any of the
Borrower’s Subsidiaries, other than (i) inventory (or other tangible or intangible assets) sold, assigned, leased or licensed out in the ordinary course of business (excluding any such sales, assignments, leases or licenses out by
operations or divisions discontinued or to be discontinued), (ii) sales of other assets the proceeds of which are (x) less than $25,000,000 with respect to any transaction or series of related transactions and (y) when aggregated with
the proceeds of all other such sales during the same Fiscal Year, less than the sum of (A) $50,000,000 and (B) an amount equal to the lesser of (1) any unused portion of the basket provided for in this clause (y) from the
immediately prior Fiscal Year and (2) $50,000,000, (iii) the transactions listed on Schedule 1.1A, (iv) the Borrower’s or a Subsidiary’s exercise of its rights and remedies with respect to, and/or the sale, assignment,
license or other Disposition (including following the exercise of such rights and remedies) of, any Makena Products and Interests, (v) Permitted Licenses, (vi) the sale or other Disposition of Acquired Non-Investment-Grade Securities owned
by the Acquired Business or any of its Subsidiaries at the time of the Acquisition, Investment Grade Securities and Cash Equivalents in exchange for Cash; provided that with respect to such Acquired Non-Investment-Grade Securities, such sale
or other Disposition occurs not later than one year following the Closing Date, (vii) the sale, assignment, 

  
 8 

 
lease or license of any Discontinued Real Property, (viii) the surrender or waiver of contract rights on the settlement, release or surrender of contract, tort or other claims and
(ix) the sale or other Disposition of Acquired Business Non-Core Assets, the proceeds of which are applied to fund the Convertible Note Payment Reserve (to the extent permitted under the definition thereof). 

“Assignment Agreement” means an Assignment and Assumption Agreement substantially in the form of Exhibit E, with such
amendments or modifications as may be approved by the Administrative Agent. 
 “Assignment Effective Date” as
defined in Section 10.06(b). 
 “Attributable Receivables Indebtedness” at any time means the principal amount
of Indebtedness which (i) if a Qualified Receivables Transaction is structured as a secured lending agreement, constitutes the principal amount of such Indebtedness or (ii) if a Qualified Receivables Transaction is structured as a purchase
agreement, would be outstanding at such time under the Qualified Receivables Transaction if the same were structured as a secured lending agreement rather than a purchase agreement. 

“Auction” as defined in Section 10.06(i)(i). 

“Auction Manager” means the Administrative Agent. 

“Auction Procedures” means the Modified Dutch Auction Procedures set forth on Exhibit K. 

“Authorized Officer” means, as applied to any Person, any individual holding the position of chief executive officer, or
president, and such Person’s chief financial officer, chief accounting officer, corporate controller or treasurer (or, in each such case, the equivalent position however titled). 

“Available ECF Amount” means, on any date, an amount determined on a cumulative basis equal to Consolidated Excess Cash
Flow for each Fiscal Year of the Borrower commencing with the Fiscal Year ending in 2013 to the extent Not Otherwise Applied. 

“Bankruptcy Code” means Title 11 of the United States Code entitled “Bankruptcy,” as now and hereafter in
effect, or any successor statute. 
 “Base Indenture” means that certain Indenture dated as of
December 10, 2007 by and between Wilmington Trust Company, as trustee, and the Borrower. 

“Base Rate” means, for any day, a rate per annum equal to the greatest of (i) the Prime Rate in
effect on such day, (ii) the Federal Funds Effective Rate in effect on such day plus  1/2 of 1% and (iii) the sum of (a) the Adjusted Eurodollar

  
 9 

 
Rate (after giving effect to any Adjusted Eurodollar Rate “floor”) that would be applicable on such day for a Eurodollar Rate Loan with a one-month Interest Period (assuming such date
was the Interest Rate Determination Date with respect to such Interest Period) plus (b) 1.00%; provided that with respect to the Tranche B Term Loans, the Base Rate shall not be less than 2.00% per annum. Any change in the
Base Rate due to a change in the Prime Rate, Adjusted Eurodollar Rate or the Federal Funds Effective Rate shall be effective on the effective day of such change in the Prime Rate, Adjusted Eurodollar Rate or the Federal Funds Effective Rate,
respectively. 
 “Base Rate Loan” means a Loan bearing interest at a rate determined by reference to the Base
Rate. 
 “Beneficiary” means each Agent, the Issuing Bank, each Lender and each Lender Counterparty.

 “Board of Governors” means the Board of Governors of the Federal Reserve System of the United States, or any
successor thereto. 
 “Bookrunner” as defined in Section 9.01. 

“Borrower” as defined in the preamble hereto. 
 “Business Day” means (i) if such day relates to any dealings in Dollars to be carried out pursuant to this Agreement, (x) any day excluding Saturday, Sunday and any day which is
a legal holiday under the laws of the State of New York or is a day on which banking institutions located in such state are authorized or required by law or other governmental action to close and (y) with respect to all notices, determinations,
fundings and payments in connection with the Adjusted Eurodollar Rate or any Eurodollar Rate Loans, the term “Business Day” means any day which is a Business Day described in clause (x) and which is also a day for trading by
and between banks in Dollar deposits in the London interbank market, (ii) if such day relates to any dealings in Euros to be carried out pursuant to this Agreement, any such day which is a TARGET Day and (iii) if such day relates to any
dealings in any Agreed Currency other than Dollars or Euros to be carried out pursuant to this Agreement, any such day on which banks are open for foreign exchange business in the principal financial center of the country of such Agreed Currency.

 “Capital Lease” means, as applied to any Person, any lease of any property (whether real, personal or mixed)
by that Person as lessee that, in conformity with GAAP, is or should be accounted for as a capital lease on the balance sheet of that Person. 

  
 10 

 “Cash” means money, currency or a credit balance in any demand or Deposit
Account. 
 “Cash Collateralize” means, in respect of an Obligation, to provide and pledge (as a First Priority
security interest) cash collateral in Dollars, at a location and pursuant to documentation in form and substance reasonably satisfactory to the Administrative Agent and the Issuing Bank (and “Cash Collateralization” has a
corresponding meaning). “Cash Collateral” shall have a meaning correlative to the foregoing and shall include the proceeds of such cash collateral and other credit support. 

“Cash Equivalents” means, as at any date of determination, any of the following: (i) marketable securities
(a) issued or directly and unconditionally guaranteed as to interest and principal by the United States government or (b) issued by any agency of the United States the obligations of which are backed by the full faith and credit of the
United States, in each case maturing within one year after such date; (ii) marketable direct obligations issued by any state of the United States of America or any political subdivision of any such state or any public instrumentality thereof,
in each case maturing within one year after such date and having, at the time of the acquisition thereof, a rating of at least A 1 from S&P or at least P-1 from Moody’s; (iii) commercial paper maturing no more than one year from the
date of creation thereof and having, at the time of the acquisition thereof, a rating of at least A-1 from S&P or at least P-1 from Moody’s; (iv) certificates of deposit or bankers’ acceptances maturing within one year after such
date and issued or accepted by any Lender or by any commercial bank organized under the laws of the United States of America or any state thereof or the District of Columbia that (a) is at least “adequately capitalized” (as defined in
the regulations of its primary federal banking regulator) and (b) has Tier 1 capital (as defined in such regulations) of not less than $1,000,000,000; (v) shares of any money market mutual fund that (a) has substantially all of its
assets invested continuously in the types of investments referred to in clauses (i) through (iv) above, (b) has net assets of not less than $5,000,000,000 and (c) has the highest rating obtainable from either S&P or
Moody’s; and (vi) instruments equivalent to those referred to in clauses (i) to (v) above denominated in Euros or Pounds Sterling comparable in credit quality and tenor to those referred to above and customarily used by
corporations for cash management purposes in any jurisdiction outside the United States to the extent required or advisable in connection with any business conducted by the Borrower or any Subsidiary organized or operating in such jurisdiction.

 “Cash Management Agreements” means those agreements entered into from time to time by the Borrower or its
Subsidiaries with a Cash Management Provider in connection with the obtaining of any Cash Management Services that have been designated by the Borrower and such Cash Management Provider by notice to the Administrative Agent as a Cash Management
Agreement. 

  
 11 

 “Cash Management Obligations” means all obligations, liabilities,
contingent reimbursement obligations, fees and expenses owing by the Borrower or any of its Subsidiaries to any Cash Management Provider pursuant to or evidenced by the Cash Management Agreements and irrespective of whether for the payment of money,
whether direct or indirect, absolute or contingent, due or to become due, now existing or hereafter arising. 
 “Cash
Management Provider” means any Lender or Affiliate of a Lender which provides Cash Management Services to the Borrower or its Subsidiaries; provided that each such Affiliate shall appoint the Collateral Agent as its agent and agree
to be bound by the Credit Documents as a Secured Party, subject to Section 9.08(c). 
 “Cash Management
Services” means any cash management, including controlled disbursement, accounts or related services (including the Automated Clearing House processing of electronic funds transfers through the direct Federal Reserve Fedline system)
provided to the Borrower or any of its Subsidiaries by a Cash Management Provider. 
 “Certificate re Non-Bank
Status” means a certificate substantially in the form of Exhibit F. 
 “Change in Law” means the
occurrence, after the Closing Date, of any of the following: (a) the adoption or taking effect of any law, rule, regulation, treaty or order; (b) any change in any law, rule, regulation, treaty or order or in the administration,
interpretation, implementation or application thereof by any Governmental Authority; or (c) the making or issuance of any request, rule, guideline or directive (whether or not having the force of law) by any Governmental Authority;
provided that, notwithstanding anything herein to the contrary, (x) the Dodd-Frank Wall Street Reform and Consumer Protection Act and all requests, rules, guidelines or directives thereunder or issued in connection therewith and
(y) all requests, rules, guidelines or directives promulgated by the Bank for International Settlements, the Basel Committee on Banking Supervision (or any successor or similar authority) or the United States or foreign regulatory authorities,
in each case pursuant to Basel III, shall in each case be deemed to be a “Change in Law,” regardless of the date enacted, adopted or issued. 
 “Change of Control” means, at any time, (i) any Person or “group” (within the meaning of Rules 13d 3 and 13d 5 under the Exchange Act) (a) shall have acquired
beneficial ownership of 35% or more on a fully diluted basis of the total outstanding voting interest in the Equity Interests of the Borrower or (b) shall have obtained the power (whether or not exercised) to elect a majority of the members of
the board of directors (or similar governing body) of the Borrower; (ii) the majority of the seats (other than vacant seats) on the board of directors (or similar governing body) of the Borrower ceases to be occupied by Persons who

  
 12 

 
either (a) were members of the board of directors of the Borrower on the Closing Date or (b) were nominated for election by the board of directors of the Borrower or a nominating
committee thereof, a majority of whom were directors on the Closing Date or whose election or nomination for election was previously approved by a majority of such directors; or (iii) the occurrence of a “Change of Control” (or any
comparable term) under, and as defined in, the documents evidencing any Indebtedness permitted under Section 6.01(h), (j), (k), (o) or (p). 
 “Citi” as defined in the preamble hereto. 

“Class” means (i) with respect to Lenders, each of the following classes of Lenders: (a) Lenders having
Tranche A Term Loan Exposure, (b) Lenders having Tranche B Term Loan Exposure, (c) Lenders having Revolving Exposure (including the Swing Line Lender) and (d) Lenders having New Term Loan Exposure; and (ii) with respect to Loans,
each of the following classes of Loans: (a) Tranche A Term Loans, (b) Tranche B Term Loans, (c) Revolving Loans (including Swing Line Loans) and (d) each Series of New Term Loans. 

“Closing Date” means the date on which the conditions precedent set forth in Section 3.01 are satisfied or waived
in accordance with the terms hereof. 
 “Closing Date Certificate” means a Closing Date Certificate
substantially in the form of Exhibit G-1. 
 “Closing Date Mortgaged Property” as defined in
Section 3.01(h)(i). 
 “Co-Development Agreement” means an agreement between the Borrower or any
Subsidiary and a third party (excluding, for the avoidance of doubt, any joint venture or Subsidiary) which primarily relates to the co-development or joint development of Intellectual Property, and which does not materially interfere with the
conduct of the Borrower’s or any of its Subsidiaries’ business as conducted on the Closing Date (or as permitted by Section 6.11) or materially detract from the value thereof. 

“Co-Documentation Agents” as defined in the preamble hereto. 

“Co-Syndication Agents” as defined in the preamble hereto. 

“Collateral” means, collectively, all of the real, personal and mixed property (including Equity Interests) in which
Liens are purported to be granted pursuant to the Collateral Documents as security for the Obligations. 
 “Collateral
Agent” as defined in the preamble hereto. 
 “Collateral Documents” means the Pledge and Security
Agreement, the Mortgages, the Intellectual Property Security Agreements, and all other 

  
 13 

 
instruments, documents and agreements delivered by any Credit Party pursuant to this Agreement or any of the other Credit Documents in order to grant to, or perfect in favor of, the Collateral
Agent, for the benefit of the Secured Parties, a Lien on any real, personal or mixed property of that Credit Party as security for the Obligations. 
 “Collateral Questionnaire” means a certificate in form reasonably satisfactory to the Collateral Agent that provides information with respect to the real, personal or mixed property of
each Credit Party. 
 “Commitment” means any Revolving Commitment or Term Loan Commitment. 

“Commitment Letter” as defined in Section 10.20. 

“Commitment Party” means each of Goldman Sachs, Goldman Sachs Lending Partners LLC, JPMS, JPMorgan Chase Bank N.A. and
Citi, each in its capacity as a party to the Commitment Letter. 
 “Commodity Price Protection Agreement” means
any forward contract, commodity swap, commodity option or other similar financial agreement or arrangement relating to, or the value of which is dependent upon, fluctuations in commodity prices. 

“Compliance Certificate” means a Compliance Certificate substantially in the form of Exhibit C. 

“Connection Income Taxes” means Other Connection Taxes that are imposed on or measured by net income (however
denominated) or that are franchise Taxes or branch profits Taxes. 
 “Consolidated Adjusted EBITDA” means, for
any period, the Consolidated Net Income of the Borrower and its Subsidiaries for such period plus, without duplication and (except with respect to paragraph (k) below) to the extent reducing net income (and not excluded in determining
Consolidated Net Income) for such period, the sum of: 
 (a) any expense and provision for taxes, paid or accrued, 

(b) Adjusted Consolidated Interest Expense milestone payments in connection with any investment or series of related investments and
costs of surety bonds in connection with financing activities, 
 (c) Consolidated Depreciation and Amortization Expense,

  
 14 

 (d) any non-cash charges and non-cash revenue loss recorded in respect of purchase
accounting (including, but not limited, to revenue not recognized as a result of the write-up of accounts receivable), and non-cash exchange, translation or performance losses relating to any foreign currency hedging transactions or currency
fluctuations, 
 (e) any other non-cash charges (including, without limitation, incurred pursuant to any equity incentive plan
or award or arising from any impairment of intangible assets or goodwill, but excluding any such non-cash charge to the extent that it represents an accrual or reserve for cash expenses in any future period, an amortization of a prepaid cash expense
that was paid in a prior period or a write-off, writedown or reserve with respect to current assets) for such period, 
 (f) any
unusual expenses or charges, including without limitation, any restructuring, integration, transition and similar charges accrued during such period, including any charges to establish accruals and reserves or to make payments associated with the
reassessment or realignment of the business and operations of the Borrower and its Subsidiaries, including, without limitation, the sale or closing of facilities, severance and curtailments or modifications to pension and post-retirement employee
benefit plans, retention payments in connection therewith, asset write-downs or asset disposals, write-downs for purchase and lease commitments, write-downs of excess, obsolete or unbalanced inventories, relocation costs which are not otherwise
capitalized and any related costs of existing products or product lines; provided that (x) subject to clause (y), the aggregate amount added back pursuant to this paragraph (f), together with the amount of projected synergies and cost
savings added back pursuant to Section 1.05(c), shall not exceed 10% of Consolidated Adjusted EBITDA for such period, calculated without giving effect to any adjustment pursuant to this paragraph (f), paragraph (k) or Section 1.05(c)
as it relates to projected synergies and cost savings and (y) in addition to the amount set forth in clause (x) above, there may also be added back pursuant to this paragraph (f) such expenses and charges incurred in connection with
the Acquisition during the period commencing on the Closing Date and ending on September 26, 2015, in an aggregate amount not to exceed $50,000,000, 
 (g) charges with respect to casualty events, 
 (h) to the extent actually
reimbursed, expenses incurred to the extent covered by indemnification provisions in any agreement in connection with any acquisition permitted hereunder, 
 (i) any contingent or deferred payments (including, but not limited to, severance, retention, earn-out payments, non-compete payments and consulting payments but excluding ongoing royalty payments) made
in connection with the Acquisition, any Prior Acquisition or any Permitted Acquisition, 

  
 15 

 (j) non-cash charges pursuant to Statement of Financial Accounting Standards No. 158
(codified within Accounting Standards Codifications 715-20, Defined Benefit Plans—General and 715-30, Defined Benefit Plans—Pension) and 
 (k) in addition to synergies and cost savings permitted to be added back in connection with a Pro Forma Transaction pursuant to Section 1.05(c), the amount of synergies and cost savings projected by
the Borrower in good faith to result from actions taken or expected to be taken in connection with the Acquisition, in the period commencing on the Closing Date and ending on September 26, 2015, net of the amount of actual benefits during such
period realized from such actions or otherwise added back pursuant to this definition; provided that (A) such amounts are reasonably identifiable, quantifiable and factually supportable in the good faith judgment of the Borrower and
(B) the aggregate amount added back pursuant to this paragraph (k) shall not exceed $75,000,000; 
 minus, to
the extent increasing net income (and not excluded in determining Consolidated Net Income) for such period, (i) any cash payments made during such period on account of non-cash charges added to Consolidated Net Income pursuant to clause
(e) above in such period or any prior period, (ii) all non-cash income or gains (but excluding any such amount (x) in respect of which cash or other assets were received in a prior period or will be received or (y) which
represents the reversal of an accrual or cash reserve for anticipated cash charges in any prior period) and non-cash exchange, translation or performance gains relating to any foreign currency hedging transactions or currency fluctuations and
(iii) any unusual income or gains, all calculated for the Borrower and its Subsidiaries in accordance with GAAP on a consolidated basis; 

provided that, without duplication and to the extent included in Consolidated Net Income, any adjustments resulting from the application of
Accounting Standards Codification 815 shall be excluded in determining Consolidated Adjusted EBITDA. For purposes of calculating the Total Net Leverage Ratio and Net Senior Secured Leverage Ratio, Consolidated Adjusted EBITDA will be deemed to be
equal to (1) for the fiscal quarter ended September 24, 2011, $239,780,000, (2) for the fiscal quarter ended December 24, 2011, $248,894,000 and (3) for the fiscal quarter ended March 24, 2012, $234,588,000 (it being
understood and agreed that the foregoing Consolidated Adjusted EBITDA amounts set forth in clauses (1), (2) and (3) each reflect the inclusion of synergies of $18,750,000 (which accordingly utilizes a portion of the basket set forth in
clause (k) above) and each other adjustment contemplated by this definition for the applicable period but is without limitation of the pro forma adjustment contemplated by Section 1.05). 

  
 16 

 “Consolidated Capital Expenditures” means, for any period, the aggregate of
all expenditures of the Borrower and its Subsidiaries during such period determined on a consolidated basis that, in accordance with GAAP, are or should be included in “purchase of property and equipment,” “construction
in-process,” “purchase or capitalized development of intellectual property” or similar items reflected in the consolidated statement of cash flows of the Borrower and its Subsidiaries. 

“Consolidated Current Assets” means, as at any date of determination, the total assets of a Person and its Subsidiaries
on a consolidated basis that may properly be classified as current assets in conformity with GAAP, excluding Cash and Cash Equivalents. 
 “Consolidated Current Liabilities” means, as at any date of determination, the total liabilities of a Person and its Subsidiaries on a consolidated basis that may properly be classified
as current liabilities in conformity with GAAP, excluding the current portion of long-term debt. 
 “Consolidated
Depreciation and Amortization Expense” means with respect to any Person for any period, the total amount of depreciation and amortization expense, including any amortization of intangibles, including, without limitation, goodwill, of such
Person and its Subsidiaries for such period on a consolidated basis and otherwise determined in accordance with GAAP. 

“Consolidated Excess Cash Flow” means, for any period, an amount (if positive) equal to: 

(a) the sum, without duplication (including, without limitation, duplication of the effects of adjustments or exclusions provided for in
the definitions of Consolidated Adjusted EBITDA and Consolidated Net Income), of (i) Consolidated Adjusted EBITDA, (ii) the Consolidated Working Capital Adjustment (which may be a negative amount) and (iii) the amount related to items
that were deducted or excluded (with the result that Consolidated Adjusted EBITDA was reduced) hereunder in calculating Consolidated Adjusted EBITDA to the extent either (A) such items represent cash received by the Borrower or any Subsidiary,
including, without limitation, cash gains excluded from Consolidated Net Income pursuant to clause (h) of the definition thereof or (B) such items do not represent cash paid by the Borrower or any Subsidiary; minus 

(b) the sum, without duplication (including, without limitation, duplication of the effects of adjustments or exclusions provided for in
the definitions of Consolidated Adjusted EBITDA and Consolidated Net Income), of the amounts for such period paid in cash (or, in the case of clause (I) below, held in reserve) from operating cash flow of (A) payments relating to expenses
or provision for taxes with respect to such period, (B) Adjusted Consolidated Cash 

  
 17 

 
Interest Expense, milestone payments in connection with any investment or series of related investments, costs of surety bonds in connection with financing activities and scheduled repayments of
Indebtedness for borrowed money and scheduled repayments of obligations under Capital Leases, (C) consideration in respect of any Consolidated Capital Expenditure, (D) consideration in respect of the Acquisition, any Prior Acquisition or
any Permitted Acquisition, (E) the aggregate amount of principal prepayments of long-term Indebtedness of the Borrower and its Subsidiaries, excluding (w) all prepayments of Term Loans (other than, for the avoidance of doubt, scheduled
payments of Term Loans referred to in clause (b)(B) above), (x) all prepayments of Swing Line Loans and Revolving Loans, (y) all prepayments in respect of any revolving credit facility, except to the extent there is an equivalent permanent
reduction in commitments thereunder and (z) all prepayments of Junior Financing, (F) the amount related to items that were added back or excluded (with the result that Consolidated Adjusted EBITDA was increased) hereunder in calculating
Consolidated Adjusted EBITDA to the extent either (1) such items represent cash payments made by the Borrower or any Subsidiary (which had not reduced Consolidated Excess Cash Flow upon the accrual thereof in a prior fiscal year), including,
without limitation cash losses excluded from Consolidated Net Income pursuant to clause (h) of the definition thereof or (2) such items do not represent cash received by the Borrower or any Subsidiary, (G) to the extent not expensed
during such period, the aggregate amount of costs, fees and expenses in connection with the consummation of the Acquisition, or any Prior Acquisition, Permitted Acquisition, permitted Investment, Asset Sale, issuance or repayment of Indebtedness,
issuance of Equity Interests, refinancing transaction or amendment or other modification of any Indebtedness (in each case, including any such transaction consummated prior to the Closing Date and any such transaction undertaken but not completed),
(H) payments made with respect to Adverse Proceedings listed on Schedule 4.11, (I) amounts used to fund the Convertible Note Repayment Reserve to the extent permitted under the definition thereof and (J) without duplication of amounts
deducted pursuant to clause (b)(I) above in a prior period that were applied to Convertible Note Repayment Obligations, the aggregate amount applied to Convertible Note Repayment Obligations in such period; plus 

(c) amounts deducted pursuant to clause (b)(I) above in a prior period to the extent not applied to the Convertible Note Repayment
Obligations within the applicable time period specified in the definition of Convertible Note Repayment Reserve; 
 provided that, for
the purpose of calculating Consolidated Net Income or Consolidated Adjusted EBITDA included in the definition of Consolidated Excess Cash Flow in connection with any Pro Forma Transaction or the Acquisition, the income (or loss) of any Person or
business accrued prior to the date it becomes a Subsidiary of the Borrower shall not be included. 

  
 18 

 “Consolidated Net Debt” means, as of any date of determination,
(a) Consolidated Total Debt less (b) the aggregate amount (not to exceed $250,000,000) of Qualified Cash as of such date. 
 “Consolidated Net Income” means, for any period, the consolidated net income (or loss) of the Borrower and its Subsidiaries for such period, determined on a consolidated basis in
accordance with GAAP; provided that, in calculating the Consolidated Net Income of the Borrower and its Subsidiaries for any period, there shall be excluded: 
 (a) the income (or deficit) of any Person accrued prior to the date it becomes a Subsidiary of the Borrower or is merged into or consolidated with the Borrower or any of its Subsidiaries (except as
contemplated by Section 1.05); 
 (b) the income (or deficit) of any Person in which the Borrower or any of its
Subsidiaries has an ownership interest that is either (x) not a Subsidiary or (y) accounted for by the equity method of accounting, except to the extent that any such income is actually received by the Borrower or such Subsidiary in the
form of dividends or similar distributions; 
 (c) the undistributed earnings of any Subsidiary of the Borrower to the extent
that the declaration or payment of dividends or similar distributions by such Subsidiary is not at the time permitted by the terms of any agreement, instrument, contract or other undertaking to which such Subsidiary is a party or by which any of its
property is bound or any law, treaty, rule, regulation or determination of an arbitrator or a court of competent jurisdiction or other Governmental Authority, in each case, applicable or binding upon such Subsidiary or any of its property or to
which such Subsidiary or any of its property is subject; 
 (d) any fees and expenses recognized during such period, or any
amortization thereof for such period, in connection with the consummation of the Acquisition, any Prior Acquisition, Permitted Acquisition, Investment, asset disposition, issuance or repayment of Indebtedness, issuance of Equity Interests,
refinancing transaction or amendment or other modification of any Indebtedness (in each case, including any such transaction consummated prior to the Closing Date and any such transaction undertaken but not completed) and any charges or
non-recurring costs recognized during such period as a result of any such transaction; 
 (e) any amortization of deferred
charges resulting from the application of Accounting Standards Codification 470-20, Debt (but only to the extent of the information therein that was codified from Financial Accounting Standards Board Staff Position No. APB
14-1—Accounting for Convertible Debt Instruments That May Be Settled in Cash upon Conversion (Including Partial Cash Settlement) or 

  
 19 

 
related interpretations or guidance) (including, for the avoidance of doubt, as a result of its application to Convertible Notes issued in exchange for other Convertible Notes); 

(f) any extraordinary gain or loss (including, without limitation, any gains or losses arising out of the settlement of any Adverse
Proceeding listed on Schedule 4.11); 
 (g) any income (loss) for such period attributable to the exchange or early
extinguishment of Indebtedness, together with any related provision for taxes on any such income; and 
 (h) any net after-tax
gains or losses attributable to asset dispositions other than in the ordinary course of business, as determined in good faith by the Borrower. 
 “Consolidated Senior Secured Debt” means, as of any date of determination, Consolidated Total Debt that is secured by a Lien on the assets of the Credit Parties. 

“Consolidated Senior Secured Net Debt” means, as of any date of determination, (a) Consolidated Senior Secured Debt
less (b) the aggregate amount (not to exceed $250,000,000) of Qualified Cash as of such date. 

“Consolidated Total Debt” means, as at any date of determination, the aggregate stated balance sheet amount of all
Indebtedness of the Borrower and its Subsidiaries determined on a consolidated basis in accordance with GAAP. 

“Consolidated Working Capital” means, as at any date of determination, the excess of Consolidated Current Assets of the
Borrower and its Subsidiaries over Consolidated Current Liabilities of the Borrower and its Subsidiaries. 

“Consolidated Working Capital Adjustment” means, for any period on a consolidated basis, the amount (which may be a
negative number) by which Consolidated Working Capital as of the beginning of such period exceeds (or is less than) Consolidated Working Capital as of the end of such period. In calculating the Consolidated Working Capital Adjustment, there shall be
excluded the effect of reclassification during such period of current assets to long-term assets and current liabilities to long-term liabilities and the effect of any Permitted Acquisition during such period; provided that there shall be
included with respect to any Permitted Acquisition during such period, an amount (which may be a negative number) by which the Consolidated Working Capital acquired in such Permitted Acquisition as at the time of such acquisition exceeds (or is less
than) Consolidated Working Capital at the end of such period. 

  
 20 

 “Contractual Obligation” means, as applied to any Person, any provision of
any Security issued by that Person or of any indenture, mortgage, deed of trust, contract, undertaking, agreement or other instrument to which that Person is a party or by which it or any of its properties is bound or to which it or any of its
properties is subject. 
 “Contributing Guarantors” as defined in Section 7.02. 

“Conversion/Continuation Date” means the effective date of a continuation or conversion, as the case may be, as set
forth in the applicable Conversion/Continuation Notice. 
 “Conversion/Continuation Notice” means a
Conversion/Continuation Notice substantially in the form of Exhibit A-2. 
 “Convertible Note Put Date” means
with respect to each series of Convertible Notes, a date on which holders thereof may require the Borrower to repurchase such Convertible Notes under the terms thereof. 
 “Convertible Note Repayment Event” means (i) the repurchase of Convertible Notes by the Borrower upon the exercise of the holder’s right to require the Borrower to repurchase
its Convertible Notes, (ii) the redemption of Convertible Notes by the Borrower upon the exercise of the Borrower’s option to call or otherwise redeem such Convertible Notes from the holder thereof, (iii) the election by the Borrower
to make a net share settlement payment in cash (rather than Equity Interests) following the conversion of any Convertible Notes into Equity Interests by the holder thereof or (iv) the exchange of Convertible Notes by the Borrower in connection
with a Permitted Refinancing, in each case in accordance with the terms of the applicable Convertible Notes. 

“Convertible Note Repayment Obligations” means any cash payment paid by the Borrower or any of its Subsidiaries
(i) to a holder of a Convertible Note upon the occurrence of a Convertible Note Repayment Event other than an event set forth in clause (iv) of the definition thereof or (ii) on account of any recapture taxes (or any other applicable
taxes) due by the Borrower or any of its Subsidiaries in respect thereto, in each case, in connection with the redemption, repayment, repurchase, conversion or exchange thereof upon a Convertible Note Repayment Event. 

“Convertible Note Repayment Reserve” means, with respect to each series of Convertible Notes, cash reserves established
by the Borrower, in its discretion, to fund future Convertible Note Repayment Obligations in an amount not to exceed the Convertible Note Repayment Obligation which the Borrower in its good faith, reasonable judgment believes it will incur in
connection with the next scheduled Convertible Note Put Date, which reserve the Borrower may begin 

  
 21 

 
to fund (x) on the Closing Date, with respect to the 2007 Convertible Notes and (y) twelve (12) months immediately preceding the next scheduled Convertible Note Put Date in respect
of each other series of Convertible Notes. The Convertible Note Repayment Reserve shall be invested in Cash or Cash Equivalents held in a general (i.e., non-escrow) deposit account of the Borrower. 

“Convertible Notes” means (i) the 2.00% Convertible Senior Notes due 2037 issued by the Borrower pursuant to the
Base Indenture and that certain First Supplemental Indenture dated as of December 10, 2007, by and between Wilmington Trust Company, as trustee, and the Borrower (the “2007 Notes”), (ii) the 2.00% Convertible Exchange
Senior Notes due 2037, issued by the Borrower pursuant to the Base Indenture and that certain Second Supplemental Indenture dated as of November 23, 2010, by and between Wilmington Trust Company, as trustee, and the Borrower, (iii) the
2.00% Convertible Senior Notes due 2042, issued by the Borrower pursuant to the Base Indenture and that certain Third Supplemental Indenture dated as of March 5, 2012, by and between Wilmington Trust Company, as trustee, and the Borrower and
(iv) any other series of convertible notes which may be issued in a Permitted Refinancing of such Convertible Notes (including an exchange therefor). 
 “Counterpart Agreement” means a Counterpart Agreement substantially in the form of Exhibit H delivered by a Credit Party pursuant to Section 5.10. 

“Credit Agreement Refinancing Indebtedness” as defined in Section 2.26(a). 

“Credit Date” means the date of a Credit Extension. 

“Credit Document” means any of this Agreement, the Notes, if any, the Collateral Documents, any documents or
certificates executed by the Borrower in favor of the Issuing Bank relating to Letters of Credit, and all other documents, certificates, instruments or agreements executed and delivered by or on behalf of a Credit Party for the benefit of any Agent,
the Issuing Bank or any Lender in connection herewith on or after the Closing Date. 
 “Credit Extension” means
the making of a Loan or the issuing of a Letter of Credit. 
 “Credit Party” means each Person (other than any
Agent, the Issuing Bank or any Lender or any other representative thereof) from time to time party to a Credit Document. 

“Currency Agreement” means any foreign exchange contract, currency swap agreement, futures contract, option contract,
synthetic cap or other similar agreement or arrangement, each of which is for the purpose of hedging the foreign currency risk associated with the Borrower’s and its Subsidiaries’ operations and not for speculative purposes. 

  
 22 

 “Debtor Relief Laws” means the Bankruptcy Code, and all other liquidation,
conservatorship, bankruptcy, assignment for the benefit of creditors, moratorium, rearrangement, receivership, insolvency, reorganization, or similar debtor relief laws of the United States or other applicable jurisdictions from time to time in
effect. 
 “Declining Lender” as defined in Section 2.15(c). 

“Default” means a condition or event that, after notice or lapse of time or both, would constitute an Event of Default.

 “Defaulting Lender” means, subject to Section 2.22(b), any Lender that (a) has failed to
(i) fund all or any portion of its Loans within two (2) Business Days of the date such Loans were required to be funded hereunder, unless such Lender notifies the Administrative Agent and the Borrower in writing that such failure is the
result of such Lender’s good faith determination that one or more conditions precedent to funding (which conditions precedent, together with the applicable default, if any, shall be specifically identified in such writing) have not been
satisfied or (ii) pay to the Administrative Agent, the Issuing Bank, the Swing Line Lender or any other Lender any other amount required to be paid by it hereunder (including in respect of its participation in Letters of Credit or Swing Line
Loans) within two (2) Business Days of the date when due, (b) has notified the Borrower, the Administrative Agent, the Issuing Bank or the Swing Line Lender in writing that it does not intend to comply with its funding obligations
hereunder, or has made a public statement to that effect (unless such writing or public statement relates to such Lender’s obligation to fund a Loan hereunder and states that such position is based on such Lender’s good faith determination
that a condition precedent to funding (which condition precedent, together with the applicable default, if any, shall be specifically identified in such writing or public statement) cannot be satisfied), (c) has failed, within three
(3) Business Days after written request by the Administrative Agent or the Borrower, to confirm in writing to the Administrative Agent and the Borrower that it will comply with its prospective funding obligations hereunder (provided that
such Lender shall cease to be a Defaulting Lender pursuant to this clause (c) upon receipt of such written confirmation by the Administrative Agent and the Borrower) or (d) the Administrative Agent has received notification that such
Lender is, or has a direct or indirect parent company that is, (i) insolvent, or is generally unable to pay its debts as they become due, or admits in writing its inability to pay its debts as they become due, or makes a general assignment for
the benefit of its creditors or (ii) the subject of a bankruptcy, insolvency, reorganization, liquidation or similar proceeding, or a receiver, trustee, conservator, intervenor or sequestrator or the like has been appointed for such Lender or
its direct or indirect parent company, 

  
 23 

 
or such Lender or its direct or indirect parent company has taken any action in furtherance of or indicating its consent to or acquiescence in any such proceeding or appointment; provided
that, unless an event or condition described in clauses (d)(i) or (d)(ii) of this definition otherwise has occurred or then exists, a Lender shall not be a Defaulting Lender solely by virtue of the ownership or acquisition of any Equity Interest in
that Lender or any direct or indirect parent company thereof by a Governmental Authority so long as such ownership interest does not result in or provide such Lender with immunity from the jurisdiction of courts within the United States or from the
enforcement of judgments or writs of attachment on its assets or permit such Lender (or such Governmental Authority or instrumentality) to reject, repudiate, disavow or disaffirm any contracts or agreements made with such Lender. 

“Deposit Account” means a demand, time, savings, passbook or like account with a bank, savings and loan association,
credit union or like organization, other than an account evidenced by a negotiable certificate of deposit. 

“Designated Non-Cash Consideration” means non-cash consideration (including any purchase price holdbacks) received by
the Borrower or a Subsidiary in connection with an Asset Sale pursuant to Section 6.08(c) that is designated as Designated Non-Cash Consideration pursuant to a certificate of an Authorized Officer setting forth the fair market value thereof and
the basis of such valuation (which amount will be reduced by the fair market value of the portion of such non-cash consideration converted to Cash within 270 days following the consummation of the applicable Asset Sale). 

“Discontinued Real Property” means all or any portion of real property owned or leased by the Borrower or a Subsidiary
which is no longer used or useful in the business of the Borrower and its Subsidiaries; provided that no Material Real Estate Asset shall constitute Discontinued Real Property. 

“Disposition” or “Dispose” means the sale, transfer, license, lease or other disposition (including any
sale and leaseback transaction) of any property by any Person, including any sale, assignment, transfer or other disposal, with or without recourse, of any notes or accounts receivable or any rights and claims associated therewith. 

“Disqualified Equity Interests” means any Equity Interest which, by its terms (or by the terms of any security or other
Equity Interests into which it is convertible or for which it is exchangeable), or upon the happening of any event or condition (i) matures or is mandatorily redeemable (other than solely for Equity Interests which are not otherwise
Disqualified Equity Interests), pursuant to a sinking fund obligation or otherwise, (ii) is redeemable at the option of the holder thereof (other than solely for Equity Interests which are not otherwise

  
 24 

 
Disqualified Equity Interests), in whole or in part, (iii) requires the scheduled payments or dividends in cash or (iv) is or becomes convertible into or exchangeable for Indebtedness
or any other Equity Interests that would constitute Disqualified Equity Interests, in each case, prior to the date that is 91 days after the Latest Maturity Date, except, in the case of clauses (i) and (ii), if as a result of a change of
control or asset sale, so long as any rights of the holders thereof upon the occurrence of such a change of control or asset sale event are subject to the prior payment in full of all Obligations, the cancellation or expiration of all Letters of
Credit and the termination of the Commitments. 
 “Dollar Equivalent” means, at any time, (a) with respect
to any amount denominated in Dollars, such amount and (b) with respect to any amount denominated in any Agreed Currency other than Dollars, the equivalent amount thereof in Dollars as determined by the Issuing Bank on the basis of the Spot Rate
(determined in respect of the most recent Revaluation Date or other relevant date of determination) for the purchase of Dollars with such currency. 
 “Dollars” and the sign “$” mean the lawful money of the United States of America. 
 “Domestic Subsidiary” means any Subsidiary of the Borrower organized under the laws of the United States of America, any State thereof or the District of Columbia. 

“ECF Percentage” as defined in Section 2.14(e). 

“Eligible Assignee” means any Person other than a natural Person that is (i) a Lender, an Affiliate of any Lender
or a Related Fund of any Lender (any two (2) or more Related Funds being treated as a single Eligible Assignee for all purposes hereof) or (ii) any commercial bank, insurance company, investment or mutual fund, financial institution or
other entity that is an “accredited investor” (as defined in Regulation D under the Securities Act) and which extends credit or buys loans in the ordinary course of business; provided no Defaulting Lender, Credit Party or Affiliate
of a Credit Party shall be an Eligible Assignee. 
 “Employee Benefit Plan” means any “employee benefit
plan” as defined in Section 3(3) of ERISA which is or was sponsored within the prior six (6) years, maintained or contributed to by, or required to be contributed by, the Borrower, any of its Subsidiaries or any of their respective
ERISA Affiliates. 
 “EMU Legislation” means the legislative measures of the European Council for the
introduction of, changeover to or operation of a single or unified European currency. 

  
 25 

 “Environmental Claim” means any investigation, notice, notice of violation,
claim, action, suit, proceeding, demand, abatement order or other order (conditional or otherwise), by any Governmental Authority or any other Person, arising (i) pursuant to or in connection with any actual or alleged violation of, or
liability under, any Environmental Law; (ii) in connection with any Hazardous Material or any actual or alleged Hazardous Materials Activity; or (iii) in connection with any actual or alleged damage, injury, threat or harm to health,
safety, natural resources or the environment. 
 “Environmental Laws” means any and all foreign, domestic or
transnational, federal or state (or any subdivision of either of them) statutes, ordinances, orders, rules, regulations, judgments, Governmental Authorizations or any other requirements of or agreements with Governmental Authorities as any of the
foregoing may be amended relating to (i) environmental matters, including those relating to any Hazardous Materials Activity; (ii) the generation, use, storage, transportation or disposal of Hazardous Materials; or (iii) occupational
and human safety and health, industrial hygiene or land use, in any manner applicable to the Borrower or any of its Subsidiaries or any Facility. 
 “Equity Interests” of any Person means any and all shares, interests, participations, rights in or other equivalents (however designated) of such Person’s capital stock, other equity
interests whether now outstanding or issued after the Closing Date, partnership interests (whether general or limited), limited liability company interests, any other interest or participation that confers on a Person the right to receive a share of
the profits and losses of, or distributions of assets of, the issuing Person, including any preferred stock, and any rights (other than debt securities convertible into, or exchangeable for or valued by reference to, Equity Interests until and
unless any such debt security is converted into Equity Interests), warrants or options exchangeable for or convertible into such Equity Interest or any other rights to subscribe to or otherwise acquire such Equity Interests. 

“Equity Percentage” as defined in Section 2.14(c). 

“ERISA” means the Employee Retirement Income Security Act of 1974, as amended from time to time, and any successor
thereto. 
 “ERISA Affiliate” means, as applied to any Person, (i) any corporation which is a member of a
controlled group of corporations within the meaning of Section 414(b) of the Internal Revenue Code of which that Person is a member; (ii) any trade or business (whether or not incorporated) which is a member of a group of trades or
businesses under common control within the meaning of Section 414(c) of the Internal Revenue Code of which that Person is a member; and (iii) any member of an affiliated service group within the meaning of Section 414(m) or
(o) of the Internal Revenue Code of which that Person, any corporation 

  
 26 

 
described in clause (i) above or any trade or business described in clause (ii) above is a member. Any former ERISA Affiliate of the Borrower or any of its Subsidiaries shall continue
to be considered an ERISA Affiliate of the Borrower or any such Subsidiary within the meaning of this definition with respect to the period such entity was an ERISA Affiliate of the Borrower or such Subsidiary and with respect to liabilities arising
after such period for which the Borrower or such Subsidiary could be liable under the Internal Revenue Code or ERISA. 

“ERISA Event” means (i) a “reportable event” within the meaning of Section 4043 of ERISA and the
regulations issued thereunder with respect to any Pension Plan (excluding those for which the provision for 30-day notice to the PBGC has been waived by regulation); (ii) the failure to meet the minimum funding standard of Section 412 of
the Internal Revenue Code with respect to any Pension Plan (whether or not waived in accordance with Section 412(c) of the Internal Revenue Code), or the failure to make by its due date a required installment under Section 430(j) of the
Internal Revenue Code with respect to any Pension Plan, or the failure to make any required contribution to a Multiemployer Plan; (iii) the provision by the administrator of any Pension Plan pursuant to Section 4041(a)(2) of ERISA of a
notice of intent to terminate such plan in a distress termination described in Section 4041(c) of ERISA; (iv) the withdrawal by the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates from any Pension Plan with
two (2) or more contributing sponsors or the termination of any such Pension Plan resulting in liability to the Borrower, any of its Subsidiaries or any of their respective Affiliates pursuant to Section 4063 or Section 4064 of ERISA;
(v) the institution by the PBGC of proceedings to terminate any Pension Plan, or the occurrence of any event or condition which would reasonably be expected to constitute grounds under ERISA for the termination of, or the appointment of a
trustee to administer, any Pension Plan; (vi) the imposition of liability on the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates pursuant to Section 4062(e) or Section 4069 of ERISA or by reason of the
application of Section 4212(c) of ERISA; (vii) the withdrawal of the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates in a complete or partial withdrawal (within the meaning of Section 4203 and
Section 4205 of ERISA) from any Multiemployer Plan if there is any potential liability therefore, or the receipt by the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates of notice from any Multiemployer Plan that it
is in reorganization or insolvency pursuant to Section 4241 or Section 4245 of ERISA, or that it intends to terminate or has terminated under Section 4041A or Section 4042 of ERISA; (viii) the occurrence of an act or
omission which would reasonably be expected to give rise to the imposition on the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates of fines, penalties, taxes or related charges under Chapter 43 of the Internal Revenue
Code or under Section 409, Section 502(c), (i) or (l) or Section 4071 of ERISA in respect of any Employee Benefit Plan; (ix) the assertion of a material 

  
 27 

 
claim (other than routine claims for benefits) against any Employee Benefit Plan other than a Multiemployer Plan or the assets thereof, or against the Borrower, any of its Subsidiaries or any of
their respective ERISA Affiliates in connection with any Employee Benefit Plan; (x) receipt from the Internal Revenue Service of notice of the failure of any Pension Plan (or any other Employee Benefit Plan intended to be qualified under
Section 401(a) of the Internal Revenue Code) to qualify under Section 401(a) of the Internal Revenue Code, or the failure of any trust forming part of any Pension Plan to qualify for exemption from taxation under Section 501(a) of the
Internal Revenue Code; (xi) the imposition of a Lien pursuant to Section 430(k) of the Internal Revenue Code or ERISA or a violation of Section 436 of the Internal Revenue Code; or (xii) the occurrence of a Foreign Benefit Event.

 “Euro” means the lawful currency of the Participating Member States introduced in accordance with the EMU
Legislation. 
 “Eurodollar Rate Loan” means a Loan bearing interest at a rate determined by reference to the
Adjusted Eurodollar Rate. 
 “Event of Default” means each of the conditions or events set forth in Section
8.01. 
 “Exchange Act” means the Securities Exchange Act of 1934, as amended from time to time, and any
successor statute. 
 “Excluded Subsidiary” means (i) any Subsidiary of the Borrower that is a
Massachusetts securities corporation or a Receivables Entity, (ii) any Foreign Subsidiary and (iii) any Immaterial Domestic Subsidiary. 
 “Excluded Taxes” means any of the following Taxes imposed on or with respect to a Recipient or required to be withheld or deducted from a payment to a Recipient: (a) Taxes imposed on
or measured by net income (however denominated), franchise Taxes and branch profits Taxes, in each case, (i) imposed as a result of such Recipient being organized under the laws of, or having its principal office or, in the case of any Lender,
its applicable lending office, located in the jurisdiction imposing such Tax (or any political subdivision thereof) or (ii) that are Other Connection Taxes, (b) in the case of a Lender, U.S. federal withholding Taxes imposed on amounts
payable to or for the account of such Lender with respect to an applicable interest in a Loan or Commitment pursuant to a law in effect on the date on which (i) such Lender acquires such interest in the Loan (other than pursuant to an
assignment request by the Borrower under Section 2.23) or Commitment or (ii) such Lender changes its lending office, except in each case to the extent that, pursuant to Section 2.20, amounts with respect to such Taxes were payable
either to such Lender’s assignor immediately before such Lender became a party hereto or to such Lender immediately before it 

  
 28 

 
changed its lending office, (c) Taxes attributable to such Recipient’s failure to comply with Section 2.20(c) and (d) any U.S. federal withholding Taxes imposed under FATCA.

 “Existing Acquired Business Credit Agreement” means the Credit Agreement dated as of February 27, 2009,
as amended on March 23, 2009, and as further amended on each of February 11, 2010, February 10, 2011, June 24, 2011, September 30, 2011, and February 10, 2012, and including any replacement, renewal,
extension, refinancing or refunding thereof, by and between the Acquired Business, as borrower, and Bank of America, N.A., as lender. 
 “Existing Class” as defined in Section 2.25(a). 

“Existing Letters of Credit” means each letter of credit previously issued by the Issuing Bank that is
(a) outstanding on the Closing Date and (b) listed on Schedule 1.1D. 
 “Existing Revolving
Commitments” as defined in Section 2.25(c). 
 “Existing Term Loans” as defined in
Section 2.25(c). 
 “Exposure” means Tranche A Term Loan Exposure, Tranche B Term Loan Exposure, New Term
Loan Exposure and/or Revolving Exposure, as applicable. 
 “Extended Maturity Date” as defined in
Section 2.25(a). 
 “Extended Revolving Commitments” as defined in Section 2.25(c). 

“Extended Term Loans” as defined in Section 2.25(c). 

“Extension” as defined in Section 2.25(a). 

“Extension Amendment” as defined in Section 2.25(f). 

“Extension Offer” as defined in Section 2.25(a). 

“Facility” means any real property (including all buildings, fixtures or other improvements located thereon) now,
hereafter or heretofore owned, leased, operated or used by the Borrower or any of its Subsidiaries or any of their respective predecessors or Affiliates. 
 “Fair Share” as defined in Section 7.02. 

“FATCA” means Sections 1471 through 1474 of the Internal Revenue Code, as of the date of this Agreement (or any amended
or successor version that is substantively comparable and not materially more onerous to comply with) and any current or future regulations or official interpretations thereof. 

  
 29 

 “FDA” means the United States Food and Drug Administration. 

“Federal Funds Effective Rate” means for any day, the rate per annum (expressed as a decimal, rounded upwards if
necessary, to the next higher 1/100 of 1%) equal to the weighted average of the rates on overnight federal funds transactions with members of the Federal Reserve System arranged by federal funds brokers on such day, as published by the Federal
Reserve Bank of New York on the Business Day next succeeding such day; provided (i) if such day is not a Business Day, the Federal Funds Rate for such day shall be such rate on such transactions on the next preceding Business Day as so
published on the next succeeding Business Day and (ii) if no such rate is so published on such next succeeding Business Day, the Federal Funds Rate for such day shall be the average rate charged to the Administrative Agent, in its capacity as a
Lender, on such day for such transactions as determined by the Administrative Agent. 
 “Financial Officer
Certification” means, with respect to the financial statements for which such certification is required, the certification of the chief financial officer of the Borrower that such financial statements fairly present, in all material
respects, the financial condition of the Borrower and its Subsidiaries as at the dates indicated and the results of their operations and their cash flows for the periods indicated, subject to changes resulting from audit and normal year-end
adjustments, and, with respect to quarterly financial statements, absence of footnotes. 
 “First Priority”
means, with respect to any Lien purported to be created in any Collateral pursuant to any Collateral Document, that such Lien is the only Lien to which such Collateral is subject, other than any Permitted Lien. 

“First-Tier Foreign Subsidiary” means a Foreign Subsidiary, the Equity Interests of which are directly owned by a
Domestic Subsidiary that is not a Subsidiary of a Foreign Subsidiary. 
 “Fiscal Quarter” means a fiscal
quarter of any Fiscal Year. 
 “Fiscal Year” means the fiscal year of the Borrower and its Subsidiaries ending
on the last Saturday of September of each calendar year. 
 “Flood Certificate” means a “Standard Flood
Hazard Determination Form” of the Federal Emergency Management Agency and any successor Governmental Authority performing a similar function. 

  
 30 

 “Flood Hazard Property” means any Real Estate Asset subject to a mortgage
in favor of the Collateral Agent, for the benefit of the Secured Parties, and located in an area designated by the Federal Emergency Management Agency as having special flood or mud slide hazards. 

“Flood Program” means the National Flood Insurance Program created by the U.S. Congress pursuant to the National Flood
Insurance Act of 1968, the Flood Disaster Protection Act of 1973, the National Flood Insurance Reform Act of 1994 and the Flood Insurance Reform Act of 2004, in each case as amended from time to time, and any successor statutes. 

“Flood Zone” means areas having special flood hazards as described in the National Flood Insurance Act of 1968, as
amended from time to time, and any successor statute. 
 “Foreign Benefit Event” means, with respect to any
Foreign Pension Plan, (a) the existence of unfunded liabilities in excess of the amount permitted under any applicable law or in excess of the amount that would be permitted absent a waiver from a governmental authority, (b) the failure to
make the required contributions or payments, under any applicable law, on or before the due date for such contributions or payments, (c) the receipt of a notice by a governmental authority relating to the intention to terminate any such Foreign
Pension Plan or to appoint a trustee or similar official to administer any such Foreign Pension Plan, or alleging the insolvency of any such Foreign Pension Plan, (d) the incurrence of any liability in excess of $10,000,000 by the Borrower or
any Subsidiary under applicable law on account of the complete or partial termination of such Foreign Pension Plan or the complete or partial withdrawal of any participating employer therein or (e) the occurrence of any transaction that is
prohibited under any applicable law and that could reasonably be expected to result in the incurrence of any liability by the Borrower or any Subsidiary, or the imposition on the Borrower or any Subsidiary of any fine, excise tax or penalty
resulting from any noncompliance with any applicable law, in each case in excess of $10,000,000. 
 “Foreign
Jurisdiction” means any jurisdiction other than the United States of America, any State thereof or the District of Columbia. 
 “Foreign Pension Plan” means any benefit plan that under applicable law, other than the laws of the United States or any political subdivision thereof, is required to be funded through a
trust or other funding vehicle other than a trust or funding vehicle maintained exclusively by a governmental authority. 

“Foreign Subsidiary” means any Subsidiary of the Borrower that is not a Domestic Subsidiary. 

  
 31 

 “Fronting Exposure” means, at any time there is a Defaulting Lender, with
respect to (x) the Issuing Bank, such Defaulting Lender’s Pro Rata Share of the outstanding Obligations with respect to Letters of Credit issued by the Issuing Bank other than such Obligations as to which such Defaulting Lender’s
participation obligation has been reallocated to other Lenders or Cash Collateralized in accordance with the terms hereof and (y) with respect to the Swing Line Lender, such Defaulting Lender’s Pro Rata Share of outstanding Swing Line
Loans made by the Swing Line Lender other than Swing Line Loans as to which such Defaulting Lender’s participation obligation has been reallocated to other Lenders. 
 “Funding Guarantors” as defined in Section 7.02. 

“Funding Notice” means a notice substantially in the form of Exhibit A-1. 

“GAAP” means, subject to the limitations on the application thereof set forth in Section 1.02, United States generally
accepted accounting principles in effect as of the date of determination thereof. 
 “Goldman Sachs” as defined
in the preamble hereto. 
 “Governmental Acts” means any act or omission, whether rightful or wrongful, of any
present or future de jure or de facto government or Governmental Authority. 
 “Governmental Authority” means
any federal, state, municipal, foreign, transnational, national or other government, governmental department, commission, board, bureau, court, agency or instrumentality or political subdivision thereof or any entity, officer or examiner exercising
executive, legislative, judicial, regulatory or administrative functions of or pertaining to any government or any court, in each case whether associated with a state of the United States, the United States, or a foreign entity or government.

 “Governmental Authorization” means any permit, license, authorization, plan, directive, consent order or
consent decree of or from any Governmental Authority. 
 “Grantor” has the meaning assigned to that term in the
Pledge and Security Agreement. 
 “Guaranteed Obligations” as defined in Section 7.01. 

“Guarantor” means each Domestic Subsidiary of the Borrower (including, without limitation, the Acquired Business) that
has in effect an enforceable Guaranty made pursuant to Article 7; provided, however, that no Excluded Subsidiary shall be required to furnish a Guaranty. 

  
 32 

 “Guaranty” means the guaranty of each Guarantor set forth in Article 7.

 “Hazardous Materials” means any chemical, material, waste or substance, which is prohibited, limited or
regulated by any Governmental Authority or Environmental Law or which may or could pose a hazard to the health and safety of any Persons or to the indoor or outdoor environment pursuant to any Governmental Authority or Environmental Law. 

“Hazardous Materials Activity” means any past, current, proposed or threatened activity, event or occurrence involving
any Hazardous Materials, including the use, manufacture, possession, storage, holding, presence, existence, location, Release, threatened Release, discharge, placement, generation, transportation, processing, construction, treatment, abatement,
removal, remediation, disposal, disposition or handling of any Hazardous Materials, and any corrective action or response action with respect to any of the foregoing. 
 “Hedge Agreement” means an Interest Rate Agreement, Commodity Price Protection Agreement or a Currency Agreement entered into with a Lender Counterparty. 

“Highest Lawful Rate” means the maximum lawful interest rate, if any, that at any time or from time to time may be
contracted for, charged or received under the laws applicable to any Lender which are presently in effect or, to the extent allowed by law, under such applicable laws which may hereafter be in effect and which allow a higher maximum non-usurious
interest rate than applicable laws now allow. 
 “Historical Financial Statements” means, as of the Closing
Date, (i) the audited financial statements of the Borrower and its Subsidiaries for the immediately preceding three (3) Fiscal Years ended at least 60 days prior to the Closing Date, consisting of balance sheets and the related
consolidated statements of income, stockholders’ equity and cash flows for such Fiscal Years, and (ii) the unaudited financial statements of the Borrower and its Subsidiaries for each subsequent Fiscal Quarter ended after the date of the
most recent audited financial statements and at least 45 days prior to the Closing Date, consisting of a balance sheet and the related consolidated statements of income, stockholders’ equity and cash flows for the three (3), six (6) or
nine (9) month period, as applicable, ending on such date and, in the case of clauses (i) and (ii), certified by the chief financial officer of the Borrower that they fairly present, in all material respects, the financial condition of the
Borrower and its Subsidiaries as at the dates indicated and the results of their operations and their cash flows for the periods indicated, subject to changes resulting from audit and normal year-end adjustments; provided that, solely for
purposes of Section 3.01(j) and the first sentence of Section 4.07, “Historical Financial Statements” includes, as of the Closing Date, (i) the audited financial statements of the Acquired Business and its Subsidiaries

  
 33 

 
for the immediately preceding three (3) fiscal years of the Acquired Business ended at least sixty (60) days prior to the Closing Date, consisting of balance sheets and the related
consolidated statements of income, stockholders’ equity and cash flows for such fiscal years, and (ii) the unaudited financial statements of the Acquired Business and its Subsidiaries for each subsequent fiscal quarter ended after the date
of the most recent audited financial statements and at least 45 days prior to the Closing Date, consisting of a balance sheet and the related consolidated statements of income, stockholders’ equity and cash flows for the three (3), six
(6) or nine (9) month period, as applicable, ending on such date and, in the case of clauses (i) and (ii) of this proviso, certified by the chief financial officer of the Acquired Business that they fairly present, in all
material respects, the financial condition of the Acquired Business and its Subsidiaries as at the dates indicated and the results of their operations and their cash flows for the periods indicated, subject to changes resulting from audit and normal
year-end adjustments. 
 “Immaterial Domestic Subsidiary” means, at any date of determination, any Domestic
Subsidiary of the Borrower that, together with all other Immaterial Domestic Subsidiaries, (i) had consolidated assets comprising in the aggregate less than 2% of Total Assets on the last day of the most recent Fiscal Quarter for which
financial statements are available and (ii) contributed in the aggregate less than 2% of Consolidated Adjusted EBITDA for the period of four (4) Fiscal Quarters most recently ended for which financial statements are available. The
Immaterial Domestic Subsidiaries as of the Closing Date are listed on Schedule 1.1C. 
 “Increased Amount Date”
as defined in Section 2.24. 
 “Increased Cost Lender” as defined in Section 2.23. 

“Incremental Cap” as defined in Section 2.24. 

“Incremental Facility” means the facility under which New Term Loans or New Revolving Loans are made available, as
applicable. 
 “Indebtedness” means, as applied to any Person, without duplication, (i) all indebtedness
for borrowed money; (ii) that portion of obligations with respect to Capital Leases that is properly classified as a liability on a balance sheet in conformity with GAAP; (iii) notes payable, bonds, debentures or other similar instruments
and drafts accepted representing extensions of credit, whether or not representing obligations for borrowed money; (iv) any obligation owed for all or any part of the deferred purchase price of property or services, which purchase price is
(a) due more than six (6) months from the date of incurrence of the obligation in respect thereof or (b) evidenced by a note or similar written instrument, and all conditional sale obligations of such Person and all obligations

  
 34 

 
of such Person under a title retention agreement, excluding (A) trade accounts (including intercompany accounts receivable) or accrued expenses payable in the ordinary course of business and
(B) obligations incurred under ERISA or deferred employee or director compensation and accruals for employee expenses in the ordinary course of business; (v) all obligations of others that constitute Indebtedness (other than pursuant to
this clause (v)) of others secured by any Lien on any property or asset owned or held by such Person regardless of whether the Indebtedness secured thereby shall have been assumed by that Person or is nonrecourse to the credit of that Person;
(vi) the face amount of any letter of credit issued for the account of that Person or as to which that Person is otherwise liable for reimbursement of drawings; (vii) Disqualified Equity Interests; (viii) the direct or indirect
guaranty, endorsement (otherwise than for collection or deposit in the ordinary course of business), co-making, discounting with recourse or sale with recourse by such Person of the obligation of another; (ix) any obligation of such Person the
primary purpose or intent of which is to provide assurance to an obligee that the obligation of the obligor thereof will be paid or discharged, or any agreement relating thereto will be complied with, or the holders thereof will be protected (in
whole or in part) against loss in respect thereof; (x) any liability of such Person for an obligation of another through any agreement (contingent or otherwise) (a) to purchase, repurchase or otherwise acquire such obligation or any
security therefor, or to provide funds for the payment or discharge of such obligation (whether in the form of loans, advances, stock purchases, capital contributions or otherwise) or (b) to maintain the solvency or any balance sheet item,
level of income or financial condition of another if, in the case of any agreement described under subclauses (a) or (b) of this clause (x), the primary purpose or intent thereof is as described in clause (ix) above; (xi) all
obligations of such Person in respect of any exchange traded or over-the-counter derivative transaction, including any Interest Rate Agreement, any Commodity Price Protection Agreement and any Currency Agreement, in each case, whether entered into
for hedging or speculative purposes; provided, in no event shall obligations under any derivative transaction (including, without limitation, any transaction evidenced by any Interest Rate Agreement, any Commodity Price Protection Agreement
and/or any Currency Agreement) be deemed “Indebtedness” for any purpose under Section 6.07; and (xii) all Attributable Receivables Indebtedness. Notwithstanding the foregoing, in connection with the purchase by the Borrower or any
Subsidiary of any business or assets, the term “Indebtedness” will exclude indemnification, purchase price adjustment, earn-outs, holdbacks and contingent payment obligations to which the seller thereof may become entitled; provided
that, to the extent such payment is fixed and determinable (and not otherwise contingent), the amount is paid within 60 days after the date such payment becomes fixed and determinable (and not otherwise contingent) (and to the extent not so
paid, such amount shall become Indebtedness for all purposes hereunder). 

  
 35 

 “Indemnified Liabilities” means, collectively, any and all liabilities,
obligations, losses, damages (including natural resource damages), penalties, claims (including Environmental Claims), actions, judgments, suits, costs (including the costs of any investigation, study, sampling, testing, abatement, cleanup, removal,
remediation or other response action necessary to remove, remediate, clean up or abate any Hazardous Materials Activity), expenses and disbursements of any kind or nature whatsoever (including the reasonable fees and disbursements of counsel for
Indemnitees in connection with any investigative, administrative or judicial proceeding or hearing commenced or threatened by any Person, whether or not any such Indemnitee shall be designated as a party or a potential party thereto, and any fees or
expenses incurred by Indemnitees in enforcing this indemnity, but only to the extent recoverable under Section 10.02 of this Agreement), whether direct, indirect, special or consequential and whether based on any federal, state, foreign or
transnational laws, statutes, rules or regulations (including securities and commercial laws, statutes, rules or regulations and Environmental Laws), on common law or equitable cause or on contract or otherwise, that may be imposed on, incurred by
or asserted against any such Indemnitee, in any manner relating to or arising out of (i) this Agreement or the other Credit Documents or the transactions contemplated hereby or thereby (including the Lenders’ agreement to make Credit
Extensions, the syndication of the credit facilities provided for herein or the use or intended use of the proceeds thereof, any amendments, waivers or consents with respect to any provision of this Agreement or any of the other Credit Documents, or
any enforcement of any of the Credit Documents (including any sale of, collection from or other realization upon any of the Collateral or the enforcement of the Guaranty)); (ii) the Commitment Letter (and any related fee or engagement letter
delivered by any Agent or any Lender to the Borrower with respect to the transactions contemplated by this Agreement); or (iii) any Environmental Claim, Environmental Law, Hazardous Material or any Hazardous Materials Activity relating to or
arising from, directly or indirectly, the Borrower, any of its Subsidiaries or any of their respective predecessors or any past or present activity, operation, property or practice of the Borrower, any of its Subsidiaries or any of their respective
predecessors. 
 “Indemnified Taxes” means (a) Taxes, other than Excluded Taxes, imposed on or with
respect to any payment made by or on account of any obligation of the Borrower under any Credit Document and (b) to the extent not otherwise described in (a), Other Taxes. 

“Indemnitee” as defined in Section 10.03. 
 “Installment” means a Tranche A Installment, a Tranche B Installment or a scheduled repayment of principal of New Term Loans, if any, pursuant to the proviso to Section 2.12(b), as the
case may be. 

  
 36 

 “Institutional Incremental Term Facility” means a term Incremental Facility
that is an Institutional Term Facility. 
 “Institutional Term Facility” means a term loan facility of the type
marketed primarily to institutional term loan lenders (as opposed to commercial banks) in the primary syndication thereof (including, for the avoidance of doubt, the Tranche B Term Facility). 

“Intellectual Property” has the meaning assigned to that term in the Pledge and Security Agreement. 

“Intellectual Property Asset” means, at the time of determination, any interest (fee, license or otherwise) then owned
by any Credit Party in any Intellectual Property. 
 “Intellectual Property Security Agreements” means the
Trademark Security Agreement, the Copyright Security Agreement and the Patent Security Agreement as such terms are defined in the Pledge and Security Agreement. 
 “Intercompany Note” means that certain Intercompany Subordinated Demand Promissory Note, dated as of the Closing Date, by and among the Borrower and each of the Credit Parties and their
respective Subsidiaries, each as a Payor and as a Payee, as it may be amended, supplemented or otherwise modified in accordance with the terms thereof from time to time. 
 “Interest Coverage Ratio” means the ratio as of the last day of (A) the first full Fiscal Quarter ending after the Closing Date of (i) Consolidated Adjusted EBITDA for the prior
four (4)-Fiscal Quarter period ending on such date to (ii) Adjusted Consolidated Cash Interest Expense for such Fiscal Quarter period multiplied by four (4), (B) the second full Fiscal Quarter ending after the Closing Date of
(i) Consolidated Adjusted EBITDA for the prior four (4)-Fiscal Quarter period ending on such date to (ii) Adjusted Consolidated Cash Interest Expense for such two(2)-Fiscal Quarter period multiplied by two (2), (C) the third full
Fiscal Quarter ending after the Closing Date of (i) Consolidated Adjusted EBITDA for the prior four (4)-Fiscal Quarter period ending on such date to (ii) Adjusted Consolidated Cash Interest Expense for such three (3)-Fiscal Quarter period
multiplied by four thirds (4/3)-and (D) any other Fiscal Quarter of (i) Consolidated Adjusted EBITDA for the prior four (4)-Fiscal Quarter period then ending to (ii) Adjusted Consolidated Cash Interest Expense for such four (4)-Fiscal
Quarter period. Prior to the last day of the first full Fiscal Quarter ending after the Closing Date, the ratio as of the last day of the most recently ended Fiscal Quarter of (i) Consolidated Adjusted EBITDA for the four (4)-Fiscal Quarter
period ending on such date to (ii) Adjusted Consolidated Cash Interest Expense for such four (4)-Fiscal Quarter period shall be determined on a pro forma basis for the Acquisition and related transactions, assuming such transactions occurred on
the first day of such period. 

  
 37 

 “Interest Payment Date” means with respect to (i) any Loan that is a
Base Rate Loan, the last Business Day of each Fiscal Quarter, commencing on the first such date to occur after the Closing Date, and the final maturity date of such Loan; and (ii) any Loan that is a Eurodollar Rate Loan, the last day of each
Interest Period applicable to such Loan; provided, in the case of each Interest Period of longer than three (3) months, “Interest Payment Date” shall also include each date that is three (3) months, or an integral multiple
thereof, after the commencement of such Interest Period. 
 “Interest Period” means, in connection with a
Eurodollar Rate Loan, an interest period of one, two, three or six months, as selected by the Borrower in the applicable Funding Notice or Conversion/Continuation Notice, (i) initially commencing on the Credit Date or Conversion/Continuation
Date thereof, as the case may be; and (ii) thereafter, commencing on the day on which the immediately preceding Interest Period expires; provided, (a) if an Interest Period would otherwise expire on a day that is not a Business Day,
such Interest Period shall expire on the next succeeding Business Day unless no further Business Day occurs in such month, in which case such Interest Period shall expire on the immediately preceding Business Day; (b) any Interest Period that
begins on the last Business Day of a calendar month (or on a day for which there is no numerically corresponding day in the calendar month at the end of such Interest Period) shall, subject to clauses (c) and (d) of this definition, end on
the last Business Day of a calendar month; (c) no Interest Period with respect to any portion of any Class of Term Loans shall extend beyond the applicable Term Loan Maturity Date for such Class; and (d) no Interest Period with respect to
any portion of the Revolving Loans shall extend beyond the Revolving Commitment Termination Date. 
 “Interest Rate
Agreement” means any interest rate swap agreement, interest rate cap agreement, interest rate collar agreement, interest rate hedging agreement or other similar agreement or arrangement, entered into (A) to hedge or mitigate risks to
which the Borrower or any Subsidiary has actual or anticipated exposure, and not for speculative purposes, (B) in order to effectively cap, collar or exchange interest rates (from fixed to floating rates, from floating to fixed rates or from
one floating rate to another floating rate or otherwise), and not for speculative purposes, with respect to any interest-bearing liability or investment of the Borrower or any Subsidiary. 

“Interest Rate Determination Date” means, with respect to any Interest Period, the date that is two (2) Business
Days prior to the first day of such Interest Period. 

  
 38 

 “Internal Revenue Code” means the Internal Revenue Code of 1986, as amended
to the Closing Date and from time to time hereafter, and any successor statute. 
 “Investment” means
(i) any direct or indirect purchase or other acquisition by the Borrower or any of its Subsidiaries of, or of a beneficial interest in, any of the Securities of any other Person; (ii) any direct or indirect redemption, retirement, purchase
or other acquisition for value, by any Subsidiary of the Borrower from any Person, of any Equity Interests of such Person; (iii) any direct or indirect loan, advance (other than advances to employees, officers, directors or consultants for
payroll, fees and other compensation, moving, entertainment and travel expenses, drawing accounts and similar expenditures, in each case, in the ordinary course of business) or capital contributions by the Borrower or any of its Subsidiaries to any
other Person, including all indebtedness and accounts receivable from that other Person that are not current assets or did not arise from sales to that other Person in the ordinary course of business (excluding, in the case of the Borrower and its
Subsidiaries, intercompany loans, receivables, advances, balances or Indebtedness having a term not exceeding 90 days (inclusive of all rollover or extension of terms) and entered into in the ordinary course of business); (iv) all investments
consisting of any exchange-traded or over-the-counter derivative transaction, including any Interest Rate Agreement, Commodity Price Protection Agreement or Currency Agreement, whether entered into for hedging or speculative purposes; and
(v) the acquisition whether by purchase, merger or otherwise of all or substantially all of the assets of, or a business line, unit or division of, any Person. The amount of any Investment shall be the original cost of such Investment of the
type described in clauses (i), (ii) and (iii) plus the cost of all additions thereto, without any adjustments for increases or decreases in value, or write-ups, write-downs or write-offs with respect to such Investment. 

“Investment Grade Securities” means each of the following investment securities (excluding, for the avoidance of doubt,
securities issued by an Affiliate of the Borrower) purchased in the ordinary course of the Borrower’s cash management operations consistent with its past practice: 
 (a) securities issued or directly and fully guaranteed or insured by the U.S. government or any agency or instrumentality thereof (other than Cash Equivalents); 

(b) investments in any fund that invests exclusively in investments of the type described in clause (a) of this definition, which
fund may also hold immaterial amounts of cash pending investment and/or distribution; 
 (c) corresponding instruments in
countries other than the United States customarily utilized for high-quality investments and, in each case, with maturities not exceeding two (2) years from the date of acquisition; and 

  
 39 

 (d) securities that have a Moody’s rating of Baa3 or better and an S&P rating of
BBB- or better and, in each case, with maturities not exceeding one (1) year from the date of acquisition. 

“Issuer Documents” means, with respect to any Letter of Credit, the Letter of Credit Application and any other document,
agreement and instrument entered into by the Issuing Bank and the Borrower (or any Subsidiary) or in favor of the Issuing Bank and relating to such Letter of Credit. 
 “Issuing Bank” means (a) JPMorgan Chase Bank N.A., in its capacity as issuer of Letters of Credit hereunder and (b) any other Lender that may become an Issuing Bank pursuant to
Section 2.04(h), with respect to Letters of Credit issued by such Lender. 
 “Joinder Agreement” means an
agreement substantially in the form of Exhibit J. 
 “JPMS” as defined in the preamble hereto. 

“Junior Financing” means any unsecured indebtedness issued pursuant to and in accordance with Section 6.01(k), the
Convertible Notes, the Senior Notes, Permitted Second Priority Refinancing Debt, Permitted Unsecured Refinancing Debt and any Permitted Incremental Equivalent Debt (other than Indebtedness secured as contemplated by clause (i)(A) of the proviso to
the definition thereof). 
 “KV” means KV Pharmaceutical Company. 

“Latest Maturity Date” means, at any date of determination, the latest maturity or expiration date applicable to any
Loan or Commitment hereunder at such time, including the latest maturity or expiration date of any New Revolving Loan Commitments, New Term Loan Commitments, New Revolving Loans or New Term Loans, in each case as extended in accordance with this
Agreement from time to time. 
 “Lead Arrangers” as defined in the preamble hereto. 

“Lender” means each financial institution listed on the signature pages hereto as a Lender and any other Person that
becomes a party hereto pursuant to an Assignment Agreement or a Joinder Agreement. For the avoidance of doubt, the “Swing Line Lender” shall be a “Lender” for purposes of this Agreement. 

“Lender Counterparty” means each Lender, each Agent and each of their respective Affiliates counterparty to a Hedge
Agreement (including any Person who is an Agent or a Lender (and any Affiliate thereof) as of the Closing Date but subsequently, whether before or after entering into a Hedge Agreement, ceases to be an Agent or a Lender, as the case may be).

  
 40 

 “Letter of Credit” means (i) a commercial or standby letter of credit
issued or to be issued by the Issuing Bank pursuant to this Agreement and (ii) the Existing Letters of Credit. 

“Letter of Credit Application” means an application and agreement for the issuance or amendment of a Letter of Credit in
the form from time to time in use by the Issuing Bank. 
 “Letter of Credit Sublimit” means the lesser of
(i) $80,000,000 and (ii) the aggregate unused amount of the Revolving Commitments then in effect. 
 “Letter
of Credit Usage” means, as at any date of determination, the sum of (i) the maximum aggregate Stated Amount which is, or at any time thereafter may become, available for drawing under all Letters of Credit then outstanding and
(ii) the aggregate Dollar Equivalent of the amount of all drawings under Letters of Credit honored by the Issuing Bank and not theretofore reimbursed by or on behalf of the Borrower. 

“Lien” means (i) any lien, mortgage, pledge, assignment, security interest, charge or encumbrance of any kind
(including any agreement to give any of the foregoing, any conditional sale or other title retention agreement, and any lease or license in the nature thereof) and any option, trust or other preferential arrangement having the practical effect of
any of the foregoing and (ii) in the case of Securities, any purchase option, call or similar right of a third party with respect to such Securities. 
 “Loan” means (i) a Tranche A Term Loan, (ii) a Tranche B Term Loan, (iii) a Revolving Loan, (iv) a Swing Line Loan or (v) a New Term Loan, as applicable.

 “Makena” means the drug currently known as Makena. 

“Makena Products and Interests” means Makena and shall also include (i) any contract rights, licensing rights or
other Intellectual Property owned by the Borrower and/or its Subsidiaries in connection therewith, (ii) any other contractual obligations owed to the Borrower and/or its Subsidiaries by KV in connection with the foregoing, (iii) any Liens
of the Borrower and/or its Subsidiaries on KV’s rights under such license agreement, and the Intellectual Property underlying Makena and other assets of KV securing such contractual obligations and (iv) any other rights and interests that
the Borrower and/or its Subsidiaries may acquire in respect of Makena, including as a result of exercising its rights and remedies with respect to such Liens, licenses and contractual obligations. 

“Margin Stock” as defined in Regulation U. 

  
 41 

 “Material Adverse Effect” means a material adverse effect on and/or
material adverse developments with respect to (i) the business, operations, properties, assets or condition (financial or otherwise) of the Borrower and its Subsidiaries taken as a whole; (ii) the ability of any Credit Party to fully and
timely perform its Obligations; (iii) the legality, validity, binding effect or enforceability against a Credit Party of a Credit Document to which it is a party; or (iv) the rights, remedies and benefits available to, or conferred upon,
any Agent and any Lender or any Secured Party under any Credit Document. 
 “Material Contract” means any
contract or other arrangement to which the Borrower or any of its Subsidiaries is a party (other than the Credit Documents) for which breach, nonperformance, cancellation or failure to renew would reasonably be expected to have a Material Adverse
Effect. 
 “Material Real Estate Asset” means any fee-owned Real Estate Asset having a book value in excess of
$10,000,000 as of the date of (x) the acquisition thereof by a Credit Party or (y) the substantial completion of any improvements thereon by a Credit Party. 
 “Merger Sub” means Gold Acquisition Corp., a Delaware corporation. 
 “Minimum Collateral Amount” means, at any time, (i) with respect to Cash Collateral consisting of Cash or Deposit Account balances, an amount equal to 101% of the Fronting Exposure
of the Issuing Bank with respect to Letters of Credit issued and outstanding at such time and (ii) with respect to all other forms of collateral, an amount determined by the Administrative Agent and the Issuing Bank in their sole discretion
(such amount not to be less than 100% of such Fronting Exposure). 
 “Moody’s” means Moody’s
Investors Service, Inc. 
 “Mortgage” means (i) each of those certain mortgages in respect of each Closing
Date Mortgaged Property and (ii) each mortgage (which shall be substantially in the form of the Mortgages delivered in connection with clause (i) above), delivered subsequent to the Closing Date pursuant to and in accordance with
Section 5.11, as any such mortgage may be amended, restated, amended and restated, supplemented or otherwise modified from time to time. 
 “Net Asset Sale Proceeds” means, with respect to any Asset Sale, an amount equal to: (i) Cash payments actually received (including any Cash received by way of deferred payment
pursuant to, or by monetization of, a note receivable or pursuant to a purchase price adjustment, earn-out or any contingent payment obligation to which the applicable seller is entitled or otherwise, but only as and when such deferred Cash payment
is so received or when released from an escrow or holdback) by the Borrower or any of its Subsidiaries from such Asset 

  
 42 

 
Sale, minus (ii) any bona fide direct costs incurred in connection with such Asset Sale, including (a) any applicable transfer taxes or recording charges and any income or gains
taxes payable by the seller as a result of any gain recognized in connection with such Asset Sale, (b) payment of the outstanding principal amount of, premium or penalty, if any, and interest on any Indebtedness (other than the Loans, Credit
Agreement Refinancing Indebtedness, Permitted First Priority Refinancing Debt, Permitted Second Priority Refinancing Debt or any Permitted Incremental Equivalent Debt to the extent secured) that is secured by a Lien on the stock or assets in
question and that is required to be repaid under the terms thereof as a result of such Asset Sale, (c) any professional fees actually incurred in connection therewith, including, without limitation, advisers, brokers, investment bankers,
attorneys and accountants fees, (d) a reasonable reserve for any indemnification payments (fixed or contingent) attributable to seller’s indemnities and representations and warranties to purchaser undertaken by the Borrower or any of its
Subsidiaries in connection with such Asset Sale or any purchase price adjustment, deferred payment obligation, earn-out, contingent payment obligation of the Borrower or any Subsidiary in respect of any such Asset Sale and (e) reasonable
reserves under GAAP for any facilities closings, severance or other restructuring expenses in connection with such Asset Sale; provided that the amount of any subsequent release or reduction of the reserves specified in clauses (d) and
(e) above (other than in connection with a payment in respect of the applicable obligation or expense) shall be deemed to be Net Asset Sale Proceeds on the date of such release or reduction). 

“Net Equity Proceeds” means an amount equal to any Cash proceeds from a capital contribution to, or the issuance of any
Equity Interests of, the Borrower or any of its Subsidiaries other than (i) pursuant to any employee, director or consultant stock or stock option compensation plan, (ii) pursuant to the Spread Overlay Agreements or (iii) Cash
proceeds applied to Convertible Note Repayment Obligations or to fund a Convertible Note Repayment Reserve as permitted hereunder, in each case net of underwriting discounts and commissions and other reasonable costs and expenses associated
therewith, including reasonable legal fees and expenses and underwriter, arranger and placement agent fees and expenses. 

“Net Insurance/Condemnation Proceeds” means an amount equal to: (i) any Cash payments or proceeds received by the
Borrower or any of its Subsidiaries (a) under any casualty insurance policy in respect of a covered loss thereunder or (b) as a result of the taking of any assets of the Borrower or any of its Subsidiaries by any Person pursuant to the
power of eminent domain, condemnation or otherwise, or pursuant to a sale of any such assets to a purchaser with such power under threat of such a taking, minus (ii) (a) any actual and reasonable costs incurred by the Borrower or
any of its Subsidiaries in connection with the adjustment or settlement of any claims of the Borrower or such Subsidiary in respect thereof, (b) any professional fees actually incurred in

  
 43 

 
connection therewith, including, without limitation, advisers, brokers, investment bankers, attorneys and accountants, (c) any bona fide direct costs incurred in connection with any sale of
such assets as referred to in clause (i)(b) of this definition, including income taxes payable as a result of any gain recognized in connection therewith and (d) reasonable reserves under GAAP for any facilities closings, severance or other
restructuring expenses in connection with any such sale or insurance claim; provided that the amount of any subsequent release or reduction of the reserves specified in clause (d) above (other than in connection with a payment in respect
of the applicable obligation or expense) shall be deemed to be Net Insurance/Condemnation Proceeds on the date of such release or reduction. 
 “Net Mark-to-Market Exposure” of a Person means, as of any date of determination, the excess (if any) of all unrealized losses over all unrealized profits of such Person arising from
Hedge Agreements or other Indebtedness of the type described in clause (xi) of the definition thereof. As used in this definition, “unrealized losses” means the fair market value of the cost to such Person of replacing such
Hedge Agreement or such other Indebtedness as of the date of determination (assuming the Hedge Agreement or such other Indebtedness were to be terminated as of that date), and “unrealized profits” means the fair market value of the
gain to such Person of replacing such Hedge Agreement or such other Indebtedness as of the date of determination (assuming such Hedge Agreement or such other Indebtedness were to be terminated as of that date). 

“Net Senior Secured Leverage Ratio” means the ratio as of the last day of any Fiscal Quarter of (i) Consolidated
Senior Secured Net Debt as of such day to (ii) Consolidated Adjusted EBITDA for the four (4)-Fiscal Quarter period ending on such date. 
 “New Loans” means a New Revolving Loan or a New Term Loan, as applicable. 
 “New Revolving Loan” as defined in Section 2.24. 

“New Revolving Loan Commitments” as defined in Section 2.24. 

“New Revolving Loan Lender” as defined in Section 2.24. 

“New Term Loan” as defined in Section 2.24. 

“New Term Loan Commitments” as defined in Section 2.24. 

“New Term Loan Exposure” means, with respect to any Lender, as of any date of determination, the outstanding principal
amount of the New Term Loans of such Lender. 

  
 44 

 “New Term Loan Lender” as defined in Section 2.24. 

“New Term Loan Maturity Date” means the date on which New Term Loans of a Series shall become due and payable in full
hereunder, as specified in the applicable Joinder Agreement, including by acceleration or otherwise. 
 “Non-Consenting
Lender” as defined in Section 2.23. 
 “Non-Defaulting Lender” means, at any time, each Lender that is
not a Defaulting Lender at such time. 
 “Non-Extension Notice” as defined in Section 2.04(a). 

“Non-Extension Notice Date” means, with respect to a Letter of Credit, 30 days prior to the expiration date of such
Letter of Credit or as otherwise agreed by the Issuing Bank and Borrower in respect of such Letter of Credit. 

“Non-Institutional Incremental Term Facility” means an Incremental Facility other than an Institutional Incremental Term
Facility. 
 “Non-Public Information” means material non-public information (within the meaning of United
States federal, state or other applicable securities laws) with respect to the Borrower or its Affiliates or their respective Securities. 
 “Non-Public Lenders” means Lenders that wish to receive Non-Public Information with respect to the Borrower, its Affiliates or its or their respective Securities. 

“Non-U.S. Lender” as defined in Section 2.20(c). 

“Not Otherwise Applied” means, with reference to Consolidated Excess Cash Flow or the Available ECF Amount that is
proposed to be applied to a particular use or transaction, that such amount (a) was not required to prepay Loans pursuant to Section 2.14(e) (other than as a result of clause (y) thereof or Section 2.15(c)) and (b) has not
previously been (and is not simultaneously being) applied to anything other than such particular use or transaction (including, without limitation, Investments permitted under Section 6.06(h) or Restricted Junior Payments permitted under
Section 6.04(k)). 
 “Note” means (i) a Tranche A Term Loan Note, (ii) a Tranche B Term Loan
Note, (iii) a Revolving Loan Note or (iv) a Swing Line Note. 
 “Notice” means a Funding Notice, a
Letter of Credit Application, or a Conversion/Continuation Notice. 

  
 45 

 “Obligations” means (i) all obligations of every nature of each Credit
Party, including obligations from time to time owed to any Agent (including any former Agent), Lenders or any of them and Lender Counterparties, to the extent arising under any Credit Document or Hedge Agreement, whether for principal, interest
(including interest which, but for the filing of a petition in bankruptcy with respect to such Credit Party, would have accrued on any Obligation, whether or not a claim is allowed against such Credit Party for such interest in the related
bankruptcy proceeding), reimbursement of amounts drawn under Letters of Credit, payments for early termination of Hedge Agreements, fees, expenses, indemnification or otherwise and (ii) all Cash Management Obligations. 

“Obligee Guarantor” as defined in Section 7.07. 

“Obligors” means, collectively, the Borrower and the Guarantors, and “Obligor” means any of them.

 “Organizational Documents” means (i) with respect to any corporation or company, its certificate,
memorandum or articles of incorporation, organization or association, as amended, and its bylaws, as amended, (ii) with respect to any limited partnership, its certificate or declaration of limited partnership, as amended, and its partnership
agreement, as amended, (iii) with respect to any general partnership, its partnership agreement, as amended and (iv) with respect to any limited liability company, its articles of organization, as amended, and its operating agreement, as
amended. In the event any term or condition of this Agreement or any other Credit Document requires any Organizational Document to be certified by a secretary of state or similar governmental official, the reference to any such “Organizational
Document” shall only be to a document of a type customarily certified by such governmental official. 
 “Other
Connection Taxes” means with respect to any Recipient, Taxes imposed as a result of a present or former connection between such Recipient and the jurisdiction imposing such Tax (other than connections arising solely from such Recipient
having executed, delivered, become a party to, performed its obligations under, received payments under, received or perfected a security interest under, engaged in any other transaction pursuant to or enforced, any Credit Document, or having sold
or assigned an interest in any Loan or Credit Document). 
 “Other Taxes” means any and all present or future
stamp, documentary, excise, property or other similar taxes, charges or levies (and interest, fines, penalties and additions related thereto) arising from any payment made hereunder or under any other Credit Document or from the execution, delivery
or enforcement of, or otherwise with respect to, this Agreement or any other Credit Document; except any such Taxes that are Other Connection Taxes imposed on and with respect to an assignment (other than an assignment made pursuant to
Section 2.21 and Section 2.23). 

  
 46 

 “Participant Register” as defined in Section 10.06(g). 

“Participating Member State” means each state so described in any EMU Legislation. 

“PATRIOT Act” as defined in Section 3.01(s). 
 “PBGC” means the Pension Benefit Guaranty Corporation or any successor thereto. 
 “Pension Plan” means any Employee Benefit Plan, other than a Multiemployer Plan, which is subject to Sections 412 and 430 of the Internal Revenue Code or Sections 302 and 303 of ERISA.

 “Permitted Acquisition” means any acquisition, directly or indirectly, by the Borrower or any of its wholly
owned Subsidiaries, whether by purchase, merger or otherwise, of all or substantially all of the assets of, all of the Equity Interests of, or a business line or unit or a division of, any Person; provided, 

(a) immediately prior to, and after giving effect thereto, no Default or Event of Default shall have occurred and be continuing or would
result therefrom; 
 (b) all transactions in connection therewith shall be consummated, in all material respects, in accordance
with all applicable laws and in conformity with all applicable Governmental Authorizations; 
 (c) in the case of the
acquisition of Equity Interests, after giving effect to such Permitted Acquisition, all of the Equity Interests (except for any such Securities in the nature of directors’ qualifying shares required pursuant to applicable law) acquired or
otherwise issued, directly or indirectly, by such Person or any newly formed Subsidiary of the Borrower in connection with such acquisition shall be owned, directly or indirectly, 100% by the Borrower or a Guarantor, and the Borrower shall have
taken, or caused to be taken, as of the date such Person becomes a Subsidiary of the Borrower, each of the actions set forth in Sections 5.10 and/or 5.11, as applicable; provided that the aggregate Investment made after the Closing Date in
Persons that will not be a Credit Party (or assets that will not be owned by Credit Parties), in each case, after giving effect to such Permitted Acquisition, together with the aggregate amount of the Investments made after the Closing Date by
Credit Parties in Subsidiaries that are not Credit Parties pursuant to Section 6.06(l) shall not exceed $175,000,000 during the term of this Agreement; 

  
 47 

 (d) the Borrower and its Subsidiaries shall be in compliance with the financial covenants
set forth in Section 6.07 on a pro forma basis after giving effect to such acquisition as of the last day of the Fiscal Quarter most recently ended; 
 (e) the Borrower shall have delivered to the Administrative Agent (i) a Compliance Certificate evidencing compliance with Section 6.07 as required under clause (iv) above and (ii) in the
event the purchase price of such Permitted Acquisition is greater than $50,000,000, (A) all other relevant financial information with respect to such acquired assets, including the aggregate consideration for such acquisition and any other
information required to demonstrate compliance with Section 6.07 and (B) promptly upon request by the Administrative Agent, (i) a copy of the purchase agreement related to the proposed Permitted Acquisition (and any related documents
reasonably requested by the Administrative Agent) and (ii) quarterly and annual financial statements of the Person whose Equity Interests or assets are being acquired for the twelve (12)-month period immediately prior to such proposed Permitted
Acquisition, including any audited financial statements that are available; and 
 (f) any Person or assets or division as
acquired in accordance herewith shall be in same business or lines of business in which the Borrower and/or its Subsidiaries are engaged as of the Closing Date, including, without limitation, any medical pharmaceutical, diagnostic or other health
oriented business and any businesses similar, related, ancillary or incidental thereto, or that is an adjunct thereto (provided that the Administrative Agent consents to such adjunct if material), or a reasonable extension, development or
expansion thereof. 
 For the avoidance of doubt, the Acquisition constitutes a Permitted Acquisition for all purposes hereunder
and under the other Credit Documents. 
 “Permitted First Priority Refinancing Debt” means any secured
Indebtedness (including any Registered Equivalent Notes) incurred by the Borrower in the form of one or more series of senior secured notes; provided that (i) such Indebtedness is secured by the Collateral on a pari passu basis
(but without regard to the control of remedies) with the Obligations and under security documents substantially similar to the Collateral Documents and is not secured by any property or assets of the Borrower or any Subsidiary other than the
Collateral, (ii) such Indebtedness satisfies the requirements of clauses (a) through (c) of the definition of “Refinancing Indebtedness,” (iii) the maturity date of such Indebtedness shall be no earlier than the Latest
Maturity Date, (iv) such Indebtedness is not subject to mandatory redemption, repurchase, prepayment or sinking fund obligation (except customary asset sale or change-of-control provisions that provide for the prior repayment in full of the
Loans and all other Obligations), in each case prior to the Latest Maturity Date at the time such Indebtedness is incurred, (v) such Indebtedness is not at any time guaranteed by 

  
 48 

 
any Subsidiaries other than Subsidiaries that are Guarantors and the terms of such guarantee shall be no more favorable to the secured parties in respect of such Indebtedness than the terms of
the Guaranty provided hereunder, (vi) the holders of such Indebtedness (or their Senior Representative) and the Administrative Agent shall be party to an intercreditor agreement reasonably satisfactory to the Administrative Agent and
(vii) such Indebtedness shall have covenants, default and remedy provisions and other terms and conditions (other than interest, fees, premiums, funding discounts or optional prepayment provisions) that are substantially identical to, or less
favorable to the investors providing such Permitted First Priority Refinancing Debt than, those set forth in this Agreement. 

“Permitted Incremental Equivalent Debt” means any Indebtedness incurred by the Borrower in the form of one or more
series of secured or unsecured notes or loans; provided that (i) such Indebtedness shall either be (A) in the case of notes only, secured by the Collateral on a pari passu basis (but without regard to the control of remedies)
with the Obligations and shall not be secured by any property or assets of the Borrower or any Subsidiary other than Collateral or (B) secured by the Collateral on a junior basis (including with respect to the control of remedies) with the
Obligations and shall not be secured by any property or assets of the Borrower or any Subsidiary other than Collateral; provided that for the purpose of testing compliance with the Incremental Cap at any time, all Permitted Incremental
Equivalent Debt shall be deemed at all times to constitute Consolidated Senior Secured Debt, (ii) such Indebtedness shall not be at any time guaranteed by any Subsidiaries other than Subsidiaries that are Guarantors and the terms of such
guarantee shall be no more favorable to the secured parties in respect of such Indebtedness than the terms of the Guaranty, (iii) the holders of such Indebtedness (or their Senior Representative) and the Administrative Agent shall be party to
an intercreditor agreement reasonably satisfactory to the Administrative Agent, (iv) such Indebtedness shall have covenants, default and remedy provisions and other terms and conditions (other than interest, fees, premiums, funding discounts or
optional prepayment or redemption provisions) that are substantially identical to, or less favorable to the investors providing such Permitted Incremental Equivalent Debt than, those set forth in this Agreement, (v) there shall be no scheduled
amortization of such Indebtedness, and such Indebtedness shall not be subject to mandatory redemption, repurchase, prepayment or sinking fund obligation (except customary asset sale or change-of-control provisions that provide for the prior
repayment in full of the Loans and all other Obligations), in each case prior to the Latest Maturity Date at the time such Indebtedness is incurred, (vi) the maturity date of such Indebtedness shall be no earlier than the Latest Maturity Date
and (vii) with respect to any notes or loans secured on a junior basis or any unsecured notes or loans, such Indebtedness shall also satisfy clauses (i), (ii), (iv) and (v) of the Permitted Junior Debt Conditions. For the avoidance of
doubt, Loans and Commitment incurred pursuant to Section 2.24 shall not constitute Permitted Incremental Equivalent Debt. 

  
 49 

 “Permitted Junior Debt Conditions” means that such applicable debt
(i) is not scheduled to mature prior to the date that is 180 days after the Latest Maturity Date, (ii) does not have scheduled amortization payments of principal or payments of principal and is not subject to mandatory redemption,
repurchase, prepayment or sinking fund obligation (except customary asset sale or change-of-control provisions that provide for the prior repayment in full of the Loans and all other Obligations), in each case prior to the Latest Maturity Date at
the time such Indebtedness is incurred, (iii) is not at any time guaranteed by any Subsidiaries other than Subsidiaries that are Guarantors, and the terms of such guarantee shall be no more favorable to the secured parties in respect of such
Indebtedness than the terms of the Guaranty, (iv) has no financial maintenance covenants, other than in the case of any Indebtedness secured by a Lien on the Collateral that is junior to the Liens securing the Obligations (in which event the
financial maintenance covenants in the documentation governing such Indebtedness shall not be more restrictive than those set forth in this Agreement), (v) does not contain any provisions that cross-default to any Default or Event of Default
hereunder (it being understood and agreed that such debt may contain cross-acceleration provisions with respect to the Loans and Commitments hereunder) and (vi) has covenants, default and remedy provisions and other terms and conditions (other
than interest, fees, premiums and funding discounts or optional prepayment or redemption provisions) that are substantially identical to, or less favorable to the investors providing such debt than, those set forth in this Agreement. 

“Permitted Licenses” means (i) any non-exclusive licenses granted by the Borrower or a Subsidiary to third parties
or by a third party to the Borrower or any of its Subsidiaries in the ordinary course of business; (ii) any non-exclusive licenses granted by the Borrower or a Subsidiary to third parties in settlement of any dispute or litigation with third
parties; (iii) any licenses granted by the Borrower or a Subsidiary in settlement of any dispute or litigation with governmental regulatory authorities or otherwise necessary to comply with any legal or regulatory requirement; (iv) any
licenses entered into with a third party in connection with any strategic collaboration, including, without limitation, in connection with any Co-Development Agreement or any marketing, co-marketing, distribution, supply or joint venture agreement
or any similar arrangement; (v) the licensing of any non-core Intellectual Property; and (vi) the licensing of any Intellectual Property for an application other than an application for which the Borrower or any of its Subsidiaries uses
such Intellectual Property, which, in the case of each of clauses (i), (ii), (iv), (v) and (vi) above, does not materially interfere with the conduct of the Borrower’s or any of its Subsidiaries’ business as conducted on the
Closing Date (or as permitted by Section 6.11) or materially detract from the value thereof. 
 “Permitted
Liens” means each of the Liens permitted pursuant to Section 6.02. 

  
 50 

 “Permitted Refinancing” means, with respect to any Person, Indebtedness
issued, incurred or otherwise obtained in exchange for, or to extend, renew, replace or refinance, in whole or part, any Indebtedness of such Person (solely for purposes of this definition, “Refinanced Debt”); provided that
(a) such Indebtedness has a later maturity than and a weighted average life to maturity equal to or greater than the Refinanced Debt, (b) except as otherwise permitted hereunder (subject to dollar-for-dollar reduction of any applicable
basket) such Indebtedness shall not have a greater principal amount than the principal amount of the Refinanced Debt plus accrued interest, fees and premiums (if any) thereon and reasonable fees and expenses associated with the refinancing
(provided that the principal amount of such Indebtedness shall not include any principal constituting interest paid in kind), (c) such Refinanced Debt shall be repaid, defeased or satisfied and discharged on a dollar-for-dollar basis, and all
accrued interest, fees and premiums (if any) in connection therewith shall be paid, substantially concurrently with the incurrence of such Permitted Refinancing, (d) such Indebtedness shall not at any time be guaranteed by any Persons other
than Persons that are guarantors of the Refinanced Debt, and the terms of such guarantee shall be no more favorable to the secured parties in respect of such Indebtedness than the terms of the guarantee of the Refinanced Debt, (e) if the
Refinanced Debt is secured, the terms and conditions relating to collateral for such Indebtedness, taken as a whole, shall be no more favorable to the secured parties in respect of such Indebtedness than the terms and conditions with respect to the
collateral for the Refinanced Debt (and the Liens on any Collateral securing such Indebtedness shall have the same (or lesser) priority as the Refinanced Debt relative to the Liens on the Collateral securing the Obligations), (f) if the
Refinanced Debt is subordinated in right of payment to the Obligations, such Indebtedness shall be subordinated in right of payment to the Obligations on terms at least as favorable to the Lenders as the subordination terms applicable to the
Refinanced Debt, (g) such Indebtedness shall have covenants, default and remedy provisions and other terms and conditions (other than interest, fees, premiums, funding discounts, optional prepayment provisions, guarantees, collateral,
subordination and, with respect to the Convertible Notes, conversion rates, conversion prices and, solely to conform to market terms in effect at the time of such Permitted Refinancing, the conditions to conversion) that are substantially identical
to, or less favorable to the investors providing such Indebtedness than those applicable to the Refinanced Debt and (h) at the time thereof, no Default or Event of Default shall have occurred and be continuing. 

“Permitted Second Priority Refinancing Debt” means secured Indebtedness (including any Registered Equivalent Notes)
incurred by the Borrower in the form of one or more series of second lien (or other junior lien) secured notes or second lien (or other junior lien) secured loans; provided that (i) such Indebtedness shall be secured by the Collateral on
a second priority (or other junior priority) basis to the Liens securing the Obligations and under security 

  
 51 

 
documents substantially similar to (or less favorable to the investors providing such Permitted Second Priority Refinancing Debt than) the Collateral Documents and the obligations in respect of
any Permitted First Priority Refinancing Debt and not secured by any property or assets of the Borrower or any Subsidiary other than the Collateral, (ii) such Indebtedness shall satisfy the requirements of clauses (a) through (c) of
the definition of “Refinancing Indebtedness,” (iii) the holders of such Indebtedness (or their Senior Representative) and Administrative Agent shall be party to an intercreditor agreement reasonably satisfactory to the Administrative
Agent and (iv) such Indebtedness shall otherwise meet the Permitted Junior Debt Conditions. 
 “Permitted Unsecured
Refinancing Debt” means unsecured Indebtedness (including any Registered Equivalent Notes) incurred by the Borrower in the form of one or more series of senior or subordinated unsecured notes or loans; provided that such Indebtedness
(i) satisfies the requirements of clauses (a) through (c) of the definition of “Refinancing Indebtedness” and (ii) meets the Permitted Junior Debt Conditions. 

“Person” means and includes natural persons, corporations, limited partnerships, general partnerships, limited liability
companies, limited liability partnerships, joint stock companies, joint ventures, associations, companies, trusts, banks, trust companies, land trusts, business trusts or other organizations, whether or not legal entities, and Governmental
Authorities. 
 “Personal Property Collateral” means all Collateral other than Real Estate Assets. 

“Platform” as defined in Section 5.01(m). 
 “Pledge and Security Agreement” means the Pledge and Security Agreement to be executed by the Borrower and each Guarantor substantially in the form of Exhibit I, as it may be amended,
restated, supplemented or otherwise modified from time to time. 
 “Pledged Collateral” means any certificates
evidencing any Certificated Securities and Pledged Equity Interests, and any Instruments or Tangible Chattel Paper (each as defined in the Pledge and Security Agreement), described in Section 4.01 of the Pledge and Security Agreement.

 “Pounds Sterling” means the lawful currency of the United Kingdom. 

“Prepayment Date” as defined in Section 2.15(c). 

“Prime Rate” means the rate of interest quoted in the print edition of The Wall Street Journal, Money Rates
Section as the Prime Rate (currently defined as 

  
 52 

 
the base rate on corporate loans posted by at least 75% of the nation’s thirty (30) largest banks), as in effect from time to time. The Prime Rate is a reference rate and does not
necessarily represent the lowest or best rate actually charged to any customer. The Administrative Agent and any Lender may make commercial loans or other loans at rates of interest at, above or below the Prime Rate. 

“Principal Office” means, for each of the Administrative Agent, the Swing Line Lender and the Issuing Bank, such
Person’s “Principal Office” as set forth on Appendix B, or such other office or office of a third party or sub-agent, as appropriate, as such Person may from time to time designate in writing to the Borrower, the Administrative
Agent and each Lender. 
 “Prior Acquisition” means any acquisition, directly or indirectly, by the Borrower or
any of its wholly owned Subsidiaries, whether by purchase, merger or otherwise, of all or substantially all of the Equity Interests of, or a business unit, line of business or division of, any Person, which was consummated prior to the Closing Date.

 “Pro Forma Transaction” means any Investment that results in a Person becoming a Subsidiary, the
Acquisition, any other Permitted Acquisition, any Asset Sale that results in a Subsidiary ceasing to be a Subsidiary of the Borrower, any Investment constituting an acquisition of assets constituting a business unit, line of business or division of
another Person or a Disposition of a business unit, line of business or division of the Borrower or a Subsidiary, in each case whether by merger, consolidation, amalgamation or otherwise, and any other transaction that by the terms of this Agreement
requires a financial ratio test to be determined on a “pro forma basis” or to be given “pro forma effect.” 

“Pro Rata Share” means (i) with respect to all payments, computations and other matters relating to the Tranche A
Term Loan of any Lender, the percentage obtained by dividing (a) the Tranche A Term Loan Exposure of that Lender by (b) the aggregate Tranche A Term Loan Exposure of all Lenders; (ii) with respect to all payments, computations and
other matters relating to the Tranche B Term Loan of any Lender, the percentage obtained by dividing (a) the Tranche B Term Loan Exposure of that Lender by (b) the aggregate Tranche B Term Loan Exposure of all Lenders; (iii) with
respect to all payments, computations and other matters relating to the Revolving Commitment or Revolving Loans of any Lender or any Letters of Credit issued or participations purchased therein by any Lender or any participations in any Swing Line
Loans purchased by any Lender, the percentage obtained by dividing (a) the Revolving Exposure of that Lender by (b) the aggregate Revolving Exposure of all Lenders; and (iv) with respect to all payments, computations and other matters
relating to New Term Loan Commitments or New Term Loans of a particular Series, the percentage obtained by dividing (a) the New Term Loan Exposure of that Lender with respect to that Series by (b) the aggregate New Term Loan Exposure of
all 

  
 53 

 
Lenders with respect to that Series. For all other purposes with respect to each Lender, “Pro Rata Share” means the percentage obtained by dividing (A) an amount equal to
the sum of (i) the Tranche A Term Loan Exposure, (ii) the Tranche B Term Loan Exposure, (iii) the Revolving Exposure and (iv) the New Term Loan Exposure of that Lender by (B) an amount equal to the sum of the aggregate
Tranche A Term Loan Exposure, the aggregate Tranche B Term Loan Exposure, the aggregate Revolving Exposure and the aggregate New Term Loan Exposure of all Lenders. 
 “Projections” as defined in Section 4.08. 
 “Public
Lenders” means Lenders that do not wish to receive Non-Public Information with respect to the Borrower, its Affiliates or its or their respective Securities. 
 “Qualified Cash” means unrestricted Cash or Cash Equivalents (including Cash or Cash Equivalents representing a Convertible Note Repayment Reserve) of the Credit Parties which Cash and
Cash Equivalents are held in deposit and/or security accounts subject to a control agreement in favor of the Collateral Agent to the extent required by the Pledge and Security Agreement and not subject to any other Lien, claim or interest (other
than Liens permitted pursuant to Section 6.02(a), 6.02(n)(A) (to the extent such Indebtedness is permitted by Section 6.01(d)), 6.02(n)(C)) or 6.02(z)). 
 “Qualified Receivables Transaction” means any transaction or series of transactions that may be entered into by the Borrower or any of its Subsidiaries pursuant to which the Borrower or
any of its Subsidiaries may sell, convey or otherwise transfer to: (1) a Receivables Entity (in the case of a transfer by the Borrower or any of its Subsidiaries) or (2) any other Person (in the case of a transfer by a Receivables Entity),
or may grant a security interest in any accounts receivable (whether now existing or arising in the future) of the Borrower or any of its Subsidiaries, and any assets related thereto, including all collateral securing such accounts receivable, all
contracts and all guarantees or other obligations in respect of such accounts receivable, proceeds of such accounts receivable and other assets which are customarily transferred or in respect of which security interests are customarily granted in
connection with asset securitization transactions involving accounts receivable; provided that the financing terms, covenants, termination events and other provisions thereof shall be market terms (as determined in good faith by the chief
financial officer of the Borrower); provided further that the grant of a security interest in any accounts receivable of the Borrower or any of its Subsidiaries to secure Indebtedness permitted pursuant to Section 6.01(a), (o) or
(p) shall not be deemed a Qualified Receivables Transaction. 

  
 54 

 “Real Estate Asset” means, at any time of determination, any interest (fee,
leasehold or otherwise) then owned by any Credit Party in any real property. 
 “Receivables Entity” means
(a) a Subsidiary of the Borrower that is designated by the board of directors of the Borrower in a resolutions certified by the secretary of the Borrower as a Receivables Entity, with an officers’ certificate certifying that such
designation complies with the following conditions or (b) another Person engaging in a Qualified Receivables Transaction with the Borrower, which Person engages in the business of the financing of accounts receivable, and: (1) in either of
clause (a) or (b) above, no portion of the Indebtedness or any other obligations (contingent or otherwise) of such entity (A) is guaranteed by the Borrower or any Subsidiary (excluding guarantees of obligations (other than the
principal of, and interest on, Indebtedness) pursuant to Standard Securitization Undertakings), (B) is recourse to or obligates the Borrower or any Subsidiary in any way (other than pursuant to Standard Securitization Undertakings) or
(C) subjects any property or asset of the Borrower or any Subsidiary, directly or indirectly, contingently or otherwise, to the satisfaction thereof (other than pursuant to Standard Securitization Undertakings); and (2) in the case of
clause (b), (A) the entity is not an Affiliate of the Borrower or is an entity with which neither the Borrower nor any Subsidiary has any material contract, agreement, arrangement or understanding other than on terms that the Borrower
reasonably believes to be no less favorable to the Borrower or such Subsidiary than those that might be obtained at the time from Persons that are not Affiliates of the Borrower and (B) is an entity to which neither the Borrower nor any
Subsidiary has any obligation to maintain or preserve such entity’s financial condition or cause such entity to achieve certain levels of operating results. 
 “Recipient” means (a) the Administrative Agent, (b) any Lender and (c) the Issuing Bank, as applicable. 

“Refinancing” as defined in Section 3.01(e). 

“Refinancing Amendment” shall mean an amendment to this Agreement in form and substance reasonably satisfactory to the
Administrative Agent and the Borrower executed by each of (a) the Borrower and each other Credit Party, (b) the Administrative Agent and (c) each Additional Lender and Lender that agrees to provide any portion of the Credit Agreement
Refinancing Indebtedness being incurred pursuant thereto, in accordance with Section 2.26. 
 “Refinancing
Indebtedness” means (i) Permitted First Priority Refinancing Debt, (ii) Permitted Second Priority Refinancing Debt or (iii) Permitted Unsecured Refinancing Debt, in each case, issued, incurred or otherwise obtained (including
by means of the extension or renewal of existing Indebtedness) in exchange for, or to extend, renew, replace or refinance, in whole 

  
 55 

 
or in part, existing Term Loans, or any then-existing Refinancing Indebtedness (solely for purposes of this definition, “Refinanced Debt”); provided that (a) there
shall be no scheduled amortization of such Indebtedness, (b) such Indebtedness shall not have a greater principal amount than the principal amount of the Refinanced Debt plus accrued interest, fees and premiums (if any) thereon and reasonable
fees and expenses associated with the refinancing (provided that the principal amount of such Indebtedness shall not include any principal constituting interest paid in kind) and (c) such Refinanced Debt shall be repaid, defeased or
satisfied and discharged on a dollar-for-dollar basis, and all accrued interest, fees and premiums (if any) in connection therewith shall be paid, substantially concurrently with the incurrence of such Refinancing Indebtedness in accordance with the
provisions of Section 2.13. 
 “Refinancing Revolving Commitments” means Revolving Commitments established
pursuant to a Refinancing Amendment. 
 “Refinancing Revolving Lender” means a Lender with a Refinancing
Revolving Commitment or an outstanding Refinancing Revolving Loan. 
 “Refinancing Revolving Loans” means the
Revolving Loans made pursuant to the Refinancing Revolving Commitments. 
 “Refinancing Term Loan Commitment”
means the commitment of any Lender to make Refinancing Term Loans pursuant to Section 2.26 to the Borrower. 

“Refinancing Term Loan Lender” means a Lender with an outstanding Refinancing Term Loan. 

“Refinancing Term Loans” means Term Loans that result from a Refinancing Amendment. 

“Refunded Swing Line Loans” as defined in Section 2.03(b)(iv). 

“Register” as defined in Section 2.07(b). 
 “Registered Equivalent Notes” means, with respect to any notes originally issued in a Rule 144A or other private placement transaction under the Securities Act, substantially identical
notes (having the same Guarantees) issued in a dollar-for-dollar exchange therefor pursuant to an exchange offer registered with the U.S. Securities and Exchange Commission. 
 “Regulation D” means Regulation D of the Board of Governors, as in effect from time to time and all official rulings and interpretations thereunder or thereof. 

  
 56 

 “Regulation T” means Regulation T of the Board of Governors, as
in effect from time to time and all official rulings and interpretations thereunder or thereof. 

“Regulation U” means Regulation U of the Board of Governors, as in effect from time to time and all official
rulings and interpretations thereunder or thereof. 
 “Regulation X” means Regulation X of the Board
of Governors, as in effect from time to time and all official rulings and interpretations thereunder or thereof. 

“Reimbursement Date” as defined in Section 2.04(d). 

“Related Agreements” means the Acquisition Agreement and all other documents and agreements executed and delivered in
connection therewith or pursuant thereto. 
 “Related Fund” means, with respect to any Lender that is an
investment fund, any other investment fund that invests in commercial loans and that is managed or advised by the same investment advisor as such Lender or by an Affiliate of such investment advisor. 

“Release” means any release, spill, emission, leaking, pumping, pouring, injection, escaping, deposit, disposal,
discharge, dispersal, dumping, leaching or migration of any Hazardous Material into or through the indoor or outdoor environment (including the abandonment or disposal of any barrels, containers or other receptacles containing any Hazardous
Material). 
 “Replacement Lender” as defined in Section 2.23. 

“Repricing Transaction” as defined in Section 2.13(c). 

“Requisite Class Lenders” means, with respect to a Class of Loans, one or more Lenders having or holding Exposure with
respect to such Class representing more than 50% of the aggregate Exposure of all Lenders of such Class; provided that the Exposure of any Defaulting Lender shall be disregarded in determining the Requisite Class Lenders at any time.

 “Requisite Lenders” means one or more Lenders having or holding (i) Tranche A Term Loan Exposure,
(ii) Tranche B Term Loan Exposure, (iii) New Term Loan Exposure and/or (iv) Revolving Exposure, and representing more than 50% of the sum of (i) the aggregate Tranche A Term Loan Exposure of all Lenders, (ii) the aggregate
Tranche B Term Loan Exposure of all Lenders, (iii) the aggregate Revolving Exposure of all Lenders and (iv) the aggregate New Term Loan Exposure of all Lenders; provided that the Exposure of any Defaulting Lender shall be
disregarded in determining the Requisite Lenders at any time. 

  
 57 

 “Restricted Junior Payment” means (i) any dividend or other
distribution, direct or indirect, on account of any shares of any class of stock of the Borrower or any of its Subsidiaries (or any direct or indirect parent of the Borrower) now or hereafter outstanding, except a dividend payable solely in Equity
Interests (other than Disqualified Equity Interests) of the Borrower, (ii) any redemption, retirement, sinking fund or similar payment, purchase or other acquisition for value, direct or indirect, of any shares of any class of stock of the
Borrower or any of its Subsidiaries (or any direct or indirect parent thereof) now or hereafter outstanding, (iii) any payment made to retire, or to obtain the surrender of, any outstanding warrants, options or other rights to acquire shares of
any class of stock of Borrower or any of its Subsidiaries (or any direct or indirect parent of the Borrower) now or hereafter outstanding and (iv) any payment or prepayment of principal (other than regularly scheduled principal payments) or
redemption, purchase or repurchase, retirement, defeasance (including in substance or legal defeasance), sinking fund, cash settlement or similar payment with respect to Junior Financing prior to the scheduled maturity thereof. 

“Revaluation Date” means each of the following: (i) each date of issuance of any Letter of Credit, (ii) each
date of any amendment of any Letter of Credit that has the effect of increasing the Stated Amount thereof and (iii) each date of any payment by the Issuing Bank under any Letter of Credit. 

“Revolving Commitment” means the commitment of a Lender to make or otherwise fund any Revolving Loan and to acquire
participations in Letters of Credit and Swing Line Loans hereunder, and “Revolving Commitments” means such commitments of all Lenders in the aggregate. The amount of each Lender’s Revolving Commitment, if any, as of the Closing
Date is the amount set forth by such Lender’s name on Appendix A-3 attached to this Agreement or in the applicable Assignment Agreement or Joinder Agreement, as applicable, subject to any adjustment or reduction pursuant to the terms and
conditions hereof. The aggregate amount of the Revolving Commitments as of the Closing Date is $300,000,000. 

“Revolving Commitment Period” means the period from the Closing Date to, but excluding, the Revolving Commitment
Termination Date. 
 “Revolving Commitment Termination Date” means the earliest to occur of
(i) August 1, 2017, (ii) the date the Revolving Commitments are permanently reduced to zero pursuant to Section 2.13(b) or 2.14, and (iii) the date of the termination of the Revolving Commitments pursuant to Section 8.01.

  
 58 

 “Revolving Exposure” means, with respect to any Lender, as of any date of
determination, (i) prior to the termination of the Revolving Commitments, that Lender’s Revolving Commitment; and (ii) after the termination of the Revolving Commitments, the sum of (a) the aggregate outstanding principal amount
of the Revolving Loans of that Lender, (b) in the case of the Issuing Bank, the aggregate Letter of Credit Usage in respect of all Letters of Credit issued by that Lender (net of any participations by Lenders in such Letters of Credit),
(c) the aggregate amount of all participations by that Lender in any outstanding Letters of Credit or any unreimbursed drawing under any Letter of Credit, (d) in the case of the Swing Line Lender, the aggregate outstanding principal amount
of all Swing Line Loans (net of any participations therein by other Lenders) and (e) the aggregate amount of all participations by that Lender in any outstanding Swing Line Loans; provided that for purposes of
Section 2.22(a)(iii)(y), “Revolving Exposure” shall, at all times, have the meaning set forth in clause (ii) above. 
 “Revolving Lender” means a Lender with a Revolving Commitment or an outstanding Revolving Loan. 
 “Revolving Loan” means a Loan made by a Lender to the Borrower pursuant to Section 2.02(a), Section 2.24 or Section 2.26. 

“Revolving Loan Note” means a promissory note in the form of Exhibit B-3, as amended, restated, amended and restated,
supplemented or otherwise modified from time to time. 
 “S&P” means Standard & Poor’s, a
Division of The McGraw-Hill Companies, Inc. 
 “Sanctions” as defined in Section 4.27. 

“Secured Parties” has the meaning assigned to that term in the Pledge and Security Agreement. 

“Securities” means any stock, shares, partnership interests, voting trust certificates, certificates of interest or
participation in any profit-sharing agreement or arrangement, options, warrants, bonds, debentures, notes or other evidences of indebtedness, secured or unsecured, convertible, subordinated or otherwise, or in general any instruments commonly known
as “securities” or any certificates of interest, shares or participations in temporary or interim certificates for the purchase or acquisition of, or any right to subscribe to, purchase or acquire, any of the foregoing. 

“Securities Act” means the Securities Act of 1933, as amended from time to time, and any successor statute. 

  
 59 

 “Senior Notes” means the $1,000,000,000 6.25% Senior Notes due 2020 issued
under the indenture dated as of August 1, 2012 by and among the Borrower, the Subsidiaries party thereto and Wells Fargo Bank, National Association, as trustee. 
 “Senior Representative” means, with respect to any series of Permitted First Priority Refinancing Debt, Permitted Second Priority Refinancing Debt or secured Permitted Incremental
Equivalent Debt, the trustee, administrative agent, collateral agent, security agent or similar agent under the indenture or other agreement pursuant to which such Indebtedness is issued, incurred or otherwise obtained, as the case may be, and each
of their successors in such capacities. 
 “Series” as defined in Section 2.24. 

“Solvency Certificate” means a Solvency Certificate of the chief financial officer of the Borrower substantially in the
form of Exhibit G-2. 
 “Solvent” means, with respect to the Borrower and its Subsidiaries on a consolidated
basis, that as of the date of determination, both (i) (a) the sum of such Person’s debt (including contingent liabilities) does not exceed the present fair saleable value of such Parties’ present assets on a consolidated basis;
(b) such Person’s capital is not unreasonably small in relation to its business as contemplated on the Closing Date and reflected in the Projections or with respect to any transaction contemplated to be undertaken after the Closing Date on
a consolidated basis; and (c) such Persons have not incurred and do not intend to incur, or believe (nor should they reasonably believe) that they will incur, debts beyond their ability to pay such debts as they become due (whether at maturity
or otherwise) on a consolidated basis; and (ii) such Persons on a consolidated basis are not “insolvent” within the meaning given that term and similar terms under the Bankruptcy Code and other applicable laws relating to fraudulent
transfers and conveyances. For purposes of this definition, the amount of any contingent liability at any time shall be computed as the amount that, in light of all of the facts and circumstances existing at such time, represents the amount that
would reasonably be expected to become an actual or matured liability (irrespective of whether such contingent liabilities meet the criteria for accrual under Accounting Standards Codification 450 (previously referred to as Statement of Financial
Accounting Standards No. 5)). 
 “Specified Transaction” as defined in Section 3.01(t). 

“Spot Rate” means, with respect to any currency, the rate determined by the Issuing Bank to be the rate quoted by the
Issuing Bank as the spot rate for the purchase by the Issuing Bank of such currency with another currency through its principal foreign exchange trading office at approximately 11:00 a.m. on the date that is two (2) Business Days prior to the
date as of which the foreign exchange 

  
 60 

 
computation is made; provided that the Issuing Bank may obtain such spot rate from another financial institution designated by the Issuing Bank if it does not have as of the date of
determination a spot rate for any such currency. 
 “Spread Overlay Agreements” means one or more bond hedges,
warrants or other similar derivative transactions entered into by the Borrower in connection with its issuance of Convertible Notes. 
 “Standard Securitization Undertakings” means representations, warranties, covenants and indemnities entered into by the Borrower or any Subsidiary or another Receivables Entity that,
taken as a whole, are customary in an accounts receivable transaction. 
 “Stated Amount” means, with respect
to any Letter of Credit, the Dollar Equivalent of the stated amount from time to time available to be drawn thereunder, determined without regard to whether any conditions to drawing could then be met. 

“Subordinated Indebtedness” means any Indebtedness subordinated in right of payment to the Obligations on terms
reasonably satisfactory to the Administrative Agent. 
 “Subsidiary” means, with respect to any Person, any
corporation, partnership, limited liability company, association, joint venture or other business entity of which more than 50% of the total voting power of shares of stock or other ownership interests entitled (without regard to the occurrence of
any contingency) to vote in the election of the Person or Persons (whether directors, managers, trustees or other Persons performing similar functions) having the power to direct or cause the direction of the management and policies thereof is at
the time owned or controlled, directly or indirectly, by that Person or one or more of the other Subsidiaries of that Person or a combination thereof; provided, in determining the percentage of ownership interests of any Person controlled by
another Person, no ownership interest in the nature of a “qualifying share” of the former Person shall be deemed to be outstanding. Unless otherwise specified, “Subsidiary” shall mean a Subsidiary of the Borrower. 

“Swing Line Lender” means Goldman Sachs, in its capacity as lender of Swing Line Loans hereunder, together with its
permitted successors and assigns in such capacity. 
 “Swing Line Loan” means a Loan made by the Swing Line
Lender to the Borrower pursuant to Section 2.03. 

  
 61 

 “Swing Line Note” means a promissory note in the form of Exhibit B-4, as
amended, restated, amended and restated, supplemented or otherwise modified from time to time. 
 “Swing Line
Sublimit” means the lesser of (i) $20,000,000 and (ii) the aggregate unused amount of Revolving Commitments then in effect. 
 “TARGET Day” means any day on which the Trans-European Automated Realtime Gross Settlement Express Transfer (TARGET) payment system (or, if such payment system ceases to be operative,
such other payment system (if any) determined by the Administrative Agent to be a suitable replacement) is open for the settlement of payments in Euros. 
 “Tax” means any present or future tax, levy, impost, duty, assessment, fee, deduction or withholding (including backup withholding) or other charge imposed by any Governmental Authority,
as well as any interest, addition to tax, or penalty applicable thereto. 
 “Term Loan” means a Tranche A Term
Loan, a Tranche B Term Loan or a New Term Loan, as applicable. 
 “Term Loan Commitment” means the Tranche A
Term Loan Commitment, the Tranche B Term Loan Commitment or the New Term Loan Commitment, as the case may be, of a Lender, and “Term Loan Commitments” means such commitments of all Lenders. 

“Term Loan Maturity Date” means the Tranche A Term Loan Maturity Date, the Tranche B Term Loan Maturity Date or the New
Term Loan Maturity Date of any Series of New Term Loans, as applicable. 
 “Terminated Lender” as defined in
Section 2.23. 
 “Test Period” as defined in Section 1.05(b). 

“Title Policy” as defined in Section 3.01(h)(iii). 

“Total Assets” means the total amount of all assets of the Borrower and its Subsidiaries, determined on a consolidated
basis in accordance with GAAP as shown on the most recent balance sheet of the Borrower; provided that for purposes of determining the Immaterial Domestic Subsidiaries as of the Closing Date, Total Assets shall be calculated on a pro forma
basis giving effect to the Acquisition. 
 “Total Net Leverage Ratio” means the ratio as of the last day of any
Fiscal Quarter of (i) Consolidated Net Debt as of such day to (ii) Consolidated Adjusted EBITDA for the four (4)-Fiscal Quarter period ending on such date. 

  
 62 

 “Total Utilization of Revolving Commitments” means, as at any date of
determination, the sum of (i) the aggregate principal amount of all outstanding Revolving Loans (other than Revolving Loans made for the purpose of repaying any Refunded Swing Line Loans or reimbursing the Issuing Bank for any amount drawn
under any Letter of Credit, but not yet so applied), (ii) the aggregate principal amount of all outstanding Swing Line Loans and (iii) the Letter of Credit Usage. 
 “Tranche A Installment” as defined in Section 2.12(a). 

“Tranche A Term Loan” means a Tranche A Term Loan made by a Lender to the Borrower pursuant to Section 2.01(a)(i).

 “Tranche A Term Loan Commitment” means the commitment of a Lender to make or otherwise fund a Tranche A Term
Loan, and “Tranche A Term Loan Commitments” means such commitments of all Lenders in the aggregate. The amount of each Lender’s Tranche A Term Loan Commitment, if any, is set forth on Appendix A-1 or in the applicable
Assignment Agreement, subject to any adjustment or reduction pursuant to the terms and conditions hereof. The aggregate amount of the Tranche A Term Loan Commitments as of the Closing Date is $1,000,000,000. 

“Tranche A Term Loan Exposure” means, with respect to any Lender, as of any date of determination, the outstanding
principal amount of the Tranche A Term Loan of such Lender; provided, at any time prior to the making of the Tranche A Term Loans, the Tranche A Term Loan Exposure of any Lender shall be equal to such Lender’s Tranche A Term Loan
Commitment. 
 “Tranche A Term Loan Maturity Date” means the earlier of (i) August 1, 2017 and
(ii) the date on which all Tranche A Term Loans shall become due and payable in full hereunder, whether by acceleration or otherwise. 
 “Tranche A Term Loan Note” means a promissory note in the form of Exhibit B-1, as amended, restated, amended and restated, supplemented or otherwise modified from time to time.

 “Tranche B Installment” as defined in Section 2.12(b). 

“Tranche B Term Loan” means a Tranche B Term Loan made by a Lender to the Borrower pursuant to Section 2.01(a)(ii).

 “Tranche B Term Loan Commitment” means the commitment of a Lender to make or otherwise fund a Tranche B Term
Loan, and “Tranche B Term Loan Commitments” means such commitments of all Lenders in the aggregate. The amount of each Lender’s Tranche B Term Loan Commitment, if 

  
 63 

 
any, is set forth on Appendix A-2 or in the applicable Assignment Agreement, subject to any adjustment or reduction pursuant to the terms and conditions hereof. The aggregate amount of the
Tranche B Term Loan Commitments as of the Closing Date is $1,500,000,000. 
 “Tranche B Term Loan Exposure”
means, with respect to any Lender, as of any date of determination, the outstanding principal amount of the Tranche B Term Loan of such Lender; provided, at any time prior to the making of the Tranche B Term Loans, the Tranche B Term Loan
Exposure of any Lender shall be equal to such Lender’s Tranche B Term Loan Commitment. 
 “Tranche B Term Loan
Maturity Date” means the earlier of (i) August 1, 2019 and (ii) the date that all Tranche B Term Loans shall become due and payable in full hereunder, whether by acceleration or otherwise. 

“Tranche B Term Loan Note” means a promissory note in the form of Exhibit B-2, as amended, restated, amended and
restated, supplemented or otherwise modified from time to time. 
 “Transaction Costs” means the fees,
commissions, costs and expenses payable by the Borrower or any of the Borrower’s Subsidiaries on or before the Closing Date in connection with the transactions contemplated by the Credit Documents and the Related Agreements. 

“Type of Loan” means (i) with respect to either Term Loans or Revolving Loans, a Base Rate Loan or a Eurodollar
Rate Loan, and (ii) with respect to Swing Line Loans, a Base Rate Loan. 
 “U.S. Lender” as defined in
Section 2.20(c). 
 “U.S. Person” means any “United States Person” as defined in
Section 7701(a)(30) of the Internal Revenue Code. 
 “UCC” means the Uniform Commercial Code (or any
similar or equivalent legislation) as in effect from time to time in any applicable jurisdiction. 
 “Waivable Mandatory
Prepayment” as defined in Section 2.15(c). 
 “Weighted Average Yield” means with respect to any
Indebtedness, on any date of determination, the weighted average yield to maturity, in each case, based on the interest rate applicable to such Indebtedness on such date and giving effect to all upfront or similar fees or original issue discount
payable with respect to such Loan, as determined by the Administrative Agent. 
 Section 1.02. Accounting Terms.
Except as otherwise expressly provided herein, all accounting terms not otherwise defined herein shall have the meanings 

  
 64 

 
assigned to them in conformity with GAAP. Financial statements and other information required to be delivered by the Borrower to Lenders pursuant to Sections 5.01(a) and 5.01(b) shall be prepared
in accordance with GAAP as in effect at the time of such preparation (and delivered together with the reconciliation statements provided for in Section 5.01(d), if applicable) except that, for purposes of determining compliance with any provision of
this Agreement, (i) the determination of whether a lease is to be treated as an operating lease or capital lease shall be made without giving effect to any change in accounting for leases pursuant to GAAP, including, without limitation,
resulting from the implementation of proposed changes to Accounting Standards Codification Topic 840, Leases, by the Exposure Draft issued by the FASB and IASB on August 17, 2010 (and related updates and changes to the Exposure Draft), or any
successor proposal and (ii) no effect shall be given to any treatment of Indebtedness relating to convertible or equity-linked securities under Accounting Standards Codification 470-20 (or any other Accounting Standards Codification or
Financial Accounting Standard having a similar result or effect) requiring the valuation of any such Indebtedness in a reduced or bifurcated manner as described therein. Subject to the foregoing, calculations in connection with the definitions,
covenants and other provisions hereof shall utilize accounting principles and policies in conformity with those used to prepare the Historical Financial Statements. 
 Section 1.03. Interpretation, Etc. Any of the terms defined herein may, unless the context otherwise requires, be used in the singular or the plural, depending on the reference. References
herein to any Section, Appendix, Schedule or Exhibit shall be to a Section, an Appendix, a Schedule or an Exhibit, as the case may be, hereof unless otherwise specifically provided. The use herein of the word “include” or
“including,” when following any general statement, term or matter, shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to similar items or matters,
whether or not non-limiting language (such as “without limitation” or “but not limited to” or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other items or matters that fall
within the broadest possible scope of such general statement, term or matter. The terms lease and license shall include sub lease and sub-license, as applicable. 
 Section 1.04. Letter of Credit Amounts. Unless otherwise specified herein, the amount of a Letter of Credit at any time shall be deemed to be the Stated Amount of such Letter of Credit in
effect at such time; provided, however, that with respect to any Letter of Credit that, by its terms or the terms of any Issuer Document related thereto, provides for one or more automatic increases in the Stated Amount thereof, the amount of
such Letter of Credit shall be deemed to be the maximum Stated Amount of such Letter of Credit after giving effect to all such increases, whether or not such maximum Stated Amount is in effect at such time. 

  
 65 

 Section 1.05. Pro forma Calculations. (a) Notwithstanding anything to the
contrary herein, the Net Senior Secured Leverage Ratio, the Total Net Leverage Ratio and the Interest Coverage Ratio shall be calculated in the manner prescribed by this Section 1.05; provided that, notwithstanding anything to the
contrary herein, when calculating any such ratio for the purpose of the definition of Applicable Margin or Applicable Revolving Commitment Fee Percentage, any mandatory prepayment provision hereunder or compliance with Section 6.07, the events
set forth in clauses (a), (b), (c) and (d) below that occurred subsequent to the end of the applicable Test Period shall not be given pro forma effect. 
 (b) For purposes of calculating the Net Senior Secured Leverage Ratio, the Total Net Leverage Ratio and the Interest Coverage Ratio, Pro Forma Transactions (and the incurrence or repayment of any
Indebtedness in connection therewith) that have been consummated (i) during the applicable period of four (4) consecutive fiscal quarters for which such financial ratio is being determined (the “Test Period”) or
(ii) subsequent to such Test Period and prior to or simultaneously with the event for which the calculation of any such ratio is made, shall be calculated on a pro forma basis assuming that all such Pro Forma Transactions (and any increase or
decrease in Consolidated Adjusted EBITDA and the component financial definitions used therein attributable to any Pro Forma Transaction) had occurred on the first day of the applicable Test Period. 

(c) Whenever pro forma effect is to be given to a Pro Forma Transaction, the pro forma calculations shall be made in good faith by a
financial or accounting Authorized Officer of the Borrower and may include, for the avoidance of doubt, the amount of synergies and cost savings projected by the Borrower from actions taken or expected to be taken during the 12-month period
following the date of such Pro Forma Transaction, net of the amount of actual benefits theretofore realized during such period from such actions; provided that (A) such amounts are reasonably identifiable, quantifiable and factually
supportable in the good faith judgment of the Borrower and the Administrative Agent, (B) no amounts shall be added pursuant to this clause (c) to the extent duplicative of any amounts that are otherwise added back in computing Consolidated
Adjusted EBITDA, whether through a pro forma adjustment or otherwise, with respect to such period and (C) the aggregate amount of cost savings and synergies added pursuant to this clause (c) for any such period, together with any addback
to Consolidated Adjusted EBITDA pursuant to paragraph (f) thereof, during any such period, shall not exceed 10% of Consolidated Adjusted EBITDA for such period, calculated without giving effect to any adjustment pursuant to this clause
(c) or paragraphs (f) or (k) of the definition of Consolidated Adjusted EBITDA. Nothing in this clause (c) shall limit any adjustment to Consolidated Adjusted EBITDA permitted pursuant to

  
 66 

 
clause (y) of the proviso to paragraph (f) of the definition of Consolidated Adjusted EBITDA or paragraph (k) of the definition of Consolidated Adjusted EBITDA. 

(d) In the event that the Borrower or any Subsidiary incurs (including by assumption or guarantees) or repays (including by redemption,
repayment, retirement or extinguishment) any Indebtedness included in the calculations of the Net Senior Secured Leverage Ratio or the Total Net Leverage Ratio (other than Indebtedness incurred or repaid under any revolving credit facility in the
ordinary course of business for working capital purposes), subsequent to the end of the applicable Test Period and prior to or simultaneously with the event for which the calculation of any such ratio is made, then the Net Senior Secured Leverage
Ratio or the Total Net Leverage Ratio, as applicable, shall be calculated giving pro forma effect to such incurrence or repayment of Indebtedness, to the extent required, as if the same had occurred on the last day of the applicable Test Period.

 ARTICLE 2 
 LOANS AND LETTERS OF CREDIT 
 Section 2.01. Term Loans.  
 (a) Loan Commitments. Subject to
the terms and conditions hereof, 
 (i) each Lender severally agrees to make, on the Closing Date, a Tranche A
Term Loan to the Borrower in Dollars in an amount equal to such Lender’s Tranche A Term Loan Commitment; and 
 (ii) each Lender severally agrees to make, on the Closing Date, a Tranche B Term Loan to the Borrower in Dollars in an amount equal to such Lender’s Tranche B Term Loan Commitment. 

The Borrower may make only one borrowing under each of the Tranche A Term Loan Commitments and the Tranche B Term Loan Commitments which
shall be on the Closing Date. Any amounts borrowed under this Section 2.01(a) with respect to the Tranche A Term Loan and the Tranche B Term Loan and subsequently repaid or prepaid may not be reborrowed. Subject to Sections 2.13(a) and 2.14, all
amounts owed hereunder with respect to the Tranche A Term Loans and the Tranche B Term Loans shall be paid in full no later than the Tranche A Term Loan Maturity Date and the Tranche B Term Loan Maturity Date, respectively. Each Lender’s
Tranche A Term Loan Commitment and/or Tranche B Term Loan Commitment shall terminate immediately and without further action on the Closing Date, upon and after giving effect to the funding of such Lender’s Tranche A Term Loan and/or Tranche B
Term Loan on such date. 

  
 67 

 (b) Borrowing Mechanics for Term Loans. 

(i) The Borrower shall deliver to the Administrative Agent a fully executed Funding Notice no later than (x) 10:00
a.m. (New York City time) on a date that is one Business Day prior to the Closing Date with respect to Base Rate Loans and (y) 10:00 a.m. (New York City time) on a date that is three Business Days prior to the Closing Date with respect to
Eurodollar Rate Loans (or, in either case, such shorter period as may be acceptable to Administrative Agent). Promptly upon receipt by the Administrative Agent of such Funding Notice, the Administrative Agent shall notify each Lender of the proposed
borrowing. 
 (ii) Each Lender shall make its Tranche A Term Loan and/or Tranche B Term Loan, as the case may be,
available to the Administrative Agent not later than 12:00 noon (New York City time) on the Closing Date, by wire transfer of same day funds in Dollars, at the Principal Office designated by the Administrative Agent. Upon satisfaction or waiver of
the conditions precedent specified herein, the Administrative Agent shall make the proceeds of the applicable Term Loans available to the Borrower on the Closing Date, by causing an amount of same day funds in Dollars equal to the proceeds of all
such Loans received by the Administrative Agent from the Lenders to be credited to the account of the Borrower at the Principal Office designated by the Administrative Agent or to such other account as may be designated in writing to the
Administrative Agent by the Borrower. 
 Section 2.02. Revolving Loans.  

(a) Revolving Commitments. During the Revolving Commitment Period, subject to the terms and conditions hereof, each Lender
severally agrees to make Revolving Loans to the Borrower in Dollars in an aggregate amount up to but not exceeding such Lender’s Revolving Commitment; provided that (i) after giving effect to the making of any Revolving Loans in no event
shall the Total Utilization of Revolving Commitments exceed the Revolving Commitments then in effect and (ii) no Revolving Loans may be made on the Closing Date. Amounts borrowed pursuant to this Section 2.02(a) may be repaid and reborrowed during
the Revolving Commitment Period. Each Lender’s Revolving Commitment shall expire on the Revolving Commitment Termination Date and all Revolving Loans and all other amounts owed hereunder with respect to the Revolving Loans and the Revolving
Commitments shall be paid in full no later than such date. 
 (b) Borrowing Mechanics for Revolving Loans. 

(i) Except pursuant to Section 2.04(d), Revolving Loans that are Base Rate Loans shall be made in an aggregate minimum
amount of 

  
 68 

 
$5,000,000 and integral multiples of $1,000,000 in excess of that amount, and Revolving Loans that are Eurodollar Rate Loans shall be in an aggregate minimum amount of $5,000,000 and integral
multiples of $1,000,000 in excess of that amount. 
 (ii) Subject to Section 3.02(b), whenever the Borrower
desires that Lenders make Revolving Loans, the Borrower shall deliver to Administrative Agent a fully executed and delivered Funding Notice no later than 10:00 a.m. (New York City time) at least three (3) Business Days in advance of the
proposed Credit Date in the case of a Eurodollar Rate Loan, and at least one (1) Business Day in advance of the proposed Credit Date in the case of a Revolving Loan that is a Base Rate Loan. Except as otherwise provided herein, a Funding Notice
for a Revolving Loan that is a Eurodollar Rate Loan shall be irrevocable on and after the related Interest Rate Determination Date, and the Borrower shall be bound to make a borrowing in accordance therewith. 

(iii) Notice of receipt of each Funding Notice in respect of Revolving Loans, together with the amount of each
Lender’s Pro Rata Share thereof, if any, together with the applicable interest rate, shall be provided by the Administrative Agent to each applicable Lender by telefacsimile with reasonable promptness, but (provided the Administrative
Agent shall have received such notice by 10:00 a.m. (New York City time)) not later than 2:00 p.m. (New York City time) on the same day as the Administrative Agent’s receipt of such Funding Notice from the Borrower. 

(iv) Each Lender shall make the amount of its Revolving Loan available to the Administrative Agent not later than 12:00
noon (New York City time) on the applicable Credit Date by wire transfer of same day funds in Dollars, at the Principal Office designated by the Administrative Agent. Except as provided herein, upon satisfaction or waiver of the applicable
conditions precedent specified herein, the Administrative Agent shall make the proceeds of such Revolving Loans available to the Borrower on the applicable Credit Date by causing an amount of same day funds in Dollars equal to the proceeds of all
such Revolving Loans received by the Administrative Agent from Lenders to be credited to the account of the Borrower at the Principal Office designated by the Administrative Agent or such other account as may be designated in writing to the
Administrative Agent by the Borrower. 
 Section 2.03. Swing Line Loans. (a) Swing Line Loans
Commitments. During the Revolving Commitment Period, subject to the terms and conditions hereof, the Swing Line Lender may, from time to time in its discretion, agree to make Swing Line Loans to the Borrower in Dollars in the aggregate amount up
to 

  
 69 

 
but not exceeding the Swing Line Sublimit; provided that (i) after giving effect to the making of any Swing Line Loan, in no event shall the Total Utilization of Revolving Commitments
exceed the Revolving Commitments then in effect and (ii) no Swing Line Loans may be made on the Closing Date. Amounts borrowed pursuant to this Section 2.03 may be repaid and reborrowed during the Revolving Commitment Period. The Swing Line
Lender’s Revolving Commitment shall expire on the Revolving Commitment Termination Date and all Swing Line Loans and all other amounts owed hereunder with respect to the Swing Line Loans and the Revolving Commitments shall be paid in full no
later than such date. 
 (b) Borrowing Mechanics for Swing Line Loans. 

(i) Swing Line Loans shall be made in a minimum amount of $500,000 and integral multiples of $100,000 in excess of that
amount. 
 (ii) Subject to Section 3.02(b), whenever Borrower desires that the Swing Line Lender make a
Swing Line Loan, the Borrower shall deliver to the Administrative Agent a Funding Notice no later than 12:00 noon (New York City time) on the proposed Credit Date. 

(iii) The Swing Line Lender shall make the amount of its Swing Line Loan available to the Administrative Agent not later
than 2:00 p.m.(New York City time) on the applicable Credit Date by wire transfer of same day funds in Dollars, at the Administrative Agent’s Principal Office. Except as provided herein, upon satisfaction or waiver of the conditions precedent
specified herein, the Administrative Agent shall make the proceeds of such Swing Line Loan available to the Borrower on the applicable Credit Date by causing an amount of same day funds in Dollars equal to the proceeds of such Swing Line Loan
received by the Administrative Agent from the Swing Line Lender to be credited to the account of the Borrower at the Administrative Agent’s Principal Office or to such other account as may be designated in writing to the Administrative Agent by
the Borrower. 
 (iv) With respect to any Swing Line Loans which have not been voluntarily prepaid by the
Borrower pursuant to Section 2.13, the Swing Line Lender may at any time in its sole and absolute discretion deliver to the Administrative Agent (with a copy to the Borrower), no later than 1:00 p.m. (New York City time) at least one
(1) Business Day in advance of the proposed Credit Date, a notice (which shall be deemed to be a Funding Notice given by the Borrower) requesting that each Lender holding a Revolving Commitment make Revolving Loans that are Base Rate Loans to
the Borrower on such Credit Date in an amount equal to the amount of such Swing Line Loans (the “Refunded Swing Line Loans”) outstanding 

  
 70 

 
on the date such notice is given which the Swing Line Lender requests Lenders to prepay. Anything contained in this Agreement to the contrary notwithstanding, (1) the proceeds of such
Revolving Loans made by the Lenders other than the Swing Line Lender shall be immediately delivered by the Administrative Agent to the Swing Line Lender (and not to the Borrower) and applied to repay a corresponding portion of the Refunded Swing
Line Loans and (2) on the day such Revolving Loans are made, the Swing Line Lender’s Pro Rata Share of the Refunded Swing Line Loans shall be deemed to be paid with the proceeds of a Revolving Loan made by the Swing Line Lender to the
Borrower, and such portion of the Swing Line Loans deemed to be so paid shall no longer be outstanding as Swing Line Loans and shall no longer be due under the Swing Line Note of the Swing Line Lender but shall instead constitute part of the Swing
Line Lender’s outstanding Revolving Loans to the Borrower and shall be due under the Revolving Loan Note issued by the Borrower to the Swing Line Lender. The Borrower hereby authorizes the Administrative Agent and the Swing Line Lender to
charge the Borrower’s accounts with the Administrative Agent and the Swing Line Lender (up to the amount available in each such account) in order to immediately pay the Swing Line Lender the amount of the Refunded Swing Line Loans to the extent
the proceeds of such Revolving Loans made by Lenders, including the Revolving Loans deemed to be made by the Swing Line Lender, are not sufficient to repay in full the Refunded Swing Line Loans. If any portion of any such amount paid (or deemed to
be paid) to the Swing Line Lender should be recovered by or on behalf of the Borrower from the Swing Line Lender in bankruptcy, by assignment for the benefit of creditors or otherwise, the loss of the amount so recovered shall be ratably shared
among all Lenders in the manner contemplated by Section 2.17. 
 (v) If for any reason Revolving Loans are
not made pursuant to Section 2.03(b)(iv) in an amount sufficient to repay any amounts owed to the Swing Line Lender in respect of any outstanding Swing Line Loans on or before the third Business Day after demand for payment thereof by the Swing Line
Lender, each Lender holding a Revolving Commitment shall be deemed to, and hereby agrees to, have purchased a participation in such outstanding Swing Line Loans in an amount equal to its Pro Rata Share of the applicable unpaid amount together with
accrued interest thereon. Upon one (1) Business Day’s notice from the Swing Line Lender, each Lender holding a Revolving Commitment shall deliver to the Swing Line Lender an amount equal to its respective participation in the applicable
unpaid amount in same day funds at the Principal Office of the Swing Line Lender. In order to evidence such participation each Lender holding a Revolving Commitment agrees to enter into a customary participation agreement at the request of the Swing
Line Lender in form 

  
 71 

 
and substance reasonably satisfactory to the Swing Line Lender. In the event any Lender holding a Revolving Commitment fails to make available to the Swing Line Lender the amount of such
Lender’s participation as provided in this paragraph, the Swing Line Lender shall be entitled to recover such amount on demand from such Lender together with interest thereon for three (3) Business Days at the rate customarily used by the
Swing Line Lender for the correction of errors among banks and thereafter at the Base Rate, as applicable. 

(vi) Notwithstanding anything contained herein to the contrary, (A) each Lender’s obligation to make Revolving
Loans for the purpose of repaying any Refunded Swing Line Loans pursuant to the second preceding paragraph and each Lender’s obligation to purchase a participation in any unpaid Swing Line Loans pursuant to the immediately preceding paragraph
shall be absolute and unconditional and shall not be affected by any circumstance, including (1) any set off, counterclaim, recoupment, defense or other right which such Lender may have against the Swing Line Lender, any Credit Party or any
other Person for any reason whatsoever; (2) the occurrence or continuation of a Default or Event of Default; (3) any adverse change in the business, operations, properties, assets, condition (financial or otherwise) or prospects of any
Credit Party; (4) any breach of this Agreement or any other Credit Document by any party thereto; or (5) any other circumstance, happening or event whatsoever, whether or not similar to any of the foregoing; provided that such
obligations of each Lender are subject to the condition that the Swing Line Lender had not received prior notice from the Borrower or the Requisite Lenders that any of the conditions under Section 3.02 to the making of the applicable Refunded Swing
Line Loans or other unpaid Swing Line Loans were not satisfied at the time such Refunded Swing Line Loans or other unpaid Swing Line Loans were made; and (B) the Swing Line Lender shall not be obligated to make any Swing Line Loans (1) if
it has elected not to do so after the occurrence and during the continuation of a Default or Event of Default, (2) it does not in good faith believe that all conditions under Section 3.02 to the making of such Swing Line Loan have been
satisfied or waived by the Requisite Lenders or (3) at a time when any Lender is a Defaulting Lender unless the Swing Line Lender has entered into arrangements satisfactory to it and the Borrower to eliminate the Swing Line Lender’s risk
with respect to the Defaulting Lender’s participation in such Swing Line Loan, including by Cash Collateralizing such Defaulting Lender’s Pro Rata Share of the outstanding Swing Line Loans. 

Section 2.04. Issuance of Letters of Credit and Purchase of Participations Therein. (a) Letters of Credit. During
the Revolving Commitment Period, subject to the terms and conditions hereof, the Issuing Bank agrees to issue Letters of 

  
 72 

 
Credit for the account of the Borrower or its Subsidiaries (provided that the Borrower is an obligor on the Letter of Credit Application submitted to the Issuing Bank in connection with
any such Letter of Credit to be issued for the account of any of the Borrower’s Subsidiaries), or to amend or extend Letters of Credit previously issued by it, in the aggregate amount up to but not exceeding the Letter of Credit Sublimit;
provided, (i) each Letter of Credit shall be denominated in an Agreed Currency; (ii) the initial Stated Amount of each Letter of Credit shall not be less than $250,000 (or its equivalent in any other Agreed Currency) or such lesser
amount as is acceptable to the Issuing Bank; (iii) after giving effect to such issuance, in no event shall the Total Utilization of Revolving Commitments exceed the Revolving Commitments then in effect; (iv) after giving effect to such
issuance, in no event shall the Letter of Credit Usage exceed the Letter of Credit Sublimit then in effect; (v) in no event shall any Letter of Credit (x) have an expiration date later than the earlier of (1) five days prior to the
Revolving Commitment Termination Date and (2) the date that is one year from the date of issuance of such Letter of Credit; or (y) be issued if such Letter of Credit is otherwise unacceptable to the Issuing Bank in its reasonable
discretion; and (vi) in no event shall any commercial Letter of Credit (x) have an expiration date later than the earlier of (1) the Revolving Commitment Termination Date and (2) the date which is 180 days from the date of
issuance of such commercial Letter of Credit or (y) be issued if such commercial Letter of Credit is otherwise unacceptable to the Issuing Bank in its reasonable discretion. Subject to the foregoing, the Issuing Bank may agree that a standby
Letter of Credit will automatically be extended for one or more successive periods not to exceed one year each, unless the Issuing Bank elects not to extend for any such additional period by giving prior notice (“Non-Extension
Notice”) to the beneficiary thereof not later than the applicable Non-Extension Notice Date; provided, the Issuing Bank shall not extend any such Letter of Credit if it has received written notice that an Event of Default has
occurred and is continuing at least seven Business Days prior to such Non-Extension Notice Date; provided, further, the Issuing Bank shall not be under any obligation to issue any Letter of Credit if (x) any order, judgment or decree of any
Governmental Authority or arbitrator shall by its terms purport to enjoin or restrain the Issuing Bank from issuing such Letter of Credit, or any law applicable to the Issuing Bank or any request or directive (whether or not having the force of law)
from any Governmental Authority with jurisdiction over the Issuing Bank shall prohibit, or request that the Issuing Bank refrain from, the issuance of letters of credit generally or such Letter of Credit in particular or shall impose upon the
Issuing Bank with respect to such Letter of Credit any restriction, reserve or capital requirement (for which the Issuing Bank is not otherwise compensated hereunder) not in effect on the Closing Date, or shall impose upon the Issuing Bank any
unreimbursed loss, cost or expense which was not applicable on the Closing Date and which the Issuing Bank in good faith deems material to it or (y) the issuance of such Letter of Credit would violate one or more policies of the Issuing Bank
applicable to letters of credit generally. Each Existing Letter of Credit shall continue to be outstanding and shall be deemed to be a Letter of Credit hereunder, subject to the terms and conditions hereof. 

  
 73 

 (b) (i) Notice of Issuance. Each Letter of Credit shall be issued or amended, as the
case may be, upon the request of the Borrower delivered to the Issuing Bank (with a copy to the Administrative Agent) in the form of a Letter of Credit Application, appropriately completed and signed by an Authorized Officer of the Borrower. Such
Letter of Credit Application must be received by the Issuing Bank and the Administrative Agent not later than 11:00 a.m. (New York City time) at least three (3) Business Days (or such later date and time as the Administrative Agent and the
Issuing Bank may agree in a particular instance in their sole discretion) prior to the proposed issuance date or date of amendment, as the case may be. In the case of a request for an initial issuance of a Letter of Credit, such Letter of Credit
Application shall specify in form and detail satisfactory to the Issuing Bank: (A) the proposed issuance date of the requested Letter of Credit (which shall be a Business Day); (B) the amount and currency thereof; (C) the expiry date
thereof; (D) the name and address of the beneficiary thereof; (E) the documents to be presented by such beneficiary in case of any drawing thereunder; (F) the full text of any certificate to be presented by such beneficiary in case of
any drawing thereunder; (G) the purpose and nature (i.e., standby or commercial) of the requested Letter of Credit; and (H) such other matters as the Issuing Bank may require. In the case of a request for an amendment of any outstanding
Letter of Credit, such Letter of Credit Application shall specify in form and detail satisfactory to the Issuing Bank (1) the Letter of Credit to be amended; (2) the proposed date of amendment thereof (which shall be a Business Day);
(3) the nature of the proposed amendment; and (4) such other matters as the Issuing Bank may require. Additionally, the Borrower shall furnish to the Issuing Bank and the Administrative Agent such other documents and information pertaining
to such requested Letter of Credit issuance or amendment, including any Issuer Documents, as the Issuing Bank or the Administrative Agent may reasonably require. 

(ii) Promptly after receipt of any Letter of Credit Application, the Issuing Bank will confirm with the Administrative
Agent (by telephone or in writing) that the Administrative Agent has received a copy of such Letter of Credit Application from the Borrower and, if not, the Issuing Bank will provide the Administrative Agent with a copy thereof. Unless the Issuing
Bank has received from any Lender, the Administrative Agent or any Credit Party, at least one (1) Business Day prior to the requested date of issuance or amendment of the applicable Letter of Credit, written notice that one or more applicable
conditions contained in Section 3.02 shall not then be satisfied, then, subject to the terms and conditions hereof, the Issuing Bank shall, on the requested date, issue a Letter of Credit for the account of the Borrower or enter into the applicable
amendment, as the case may be, in each case in accordance with the 

  
 74 

 
Issuing Bank’s usual and customary business practices. Immediately upon the issuance of each Letter of Credit, each Lender shall be deemed to, and hereby irrevocably and unconditionally
agrees to, purchase from the Issuing Bank a risk participation in such Letter of Credit in an amount equal to such Lender’s Pro Rata Share of the Stated Amount of such Letter of Credit. 

(iii) Promptly after its delivery of any Letter of Credit or any amendment to a Letter of Credit to an advising bank with
respect thereto or to the beneficiary thereof, the Issuing Bank will also deliver to the Borrower and the Administrative Agent a true and complete copy of such Letter of Credit or amendment. 

(c) Responsibility of Issuing Bank With Respect to Requests for Drawings and Payments. In determining whether to honor any drawing
under any Letter of Credit by the beneficiary thereof, the Issuing Bank shall be responsible only to examine the documents delivered under such Letter of Credit with reasonable care so as to ascertain whether they appear on their face to be in
accordance with the terms and conditions of such Letter of Credit. As between the Borrower and the Issuing Bank, the Borrower assumes all risks of the acts and omissions of, or misuse of the Letters of Credit issued by the Issuing Bank by, the
respective beneficiaries of such Letters of Credit. In furtherance and not in limitation of the foregoing, the Issuing Bank shall not be responsible for: (i) the form, validity, sufficiency, accuracy, genuineness or legal effect of any document
submitted by any party in connection with the application for and issuance of any such Letter of Credit, even if it should in fact prove to be in any or all respects invalid, insufficient, inaccurate, fraudulent or forged; (ii) the validity or
sufficiency of any instrument transferring or assigning or purporting to transfer or assign any such Letter of Credit or the rights or benefits thereunder or proceeds thereof, in whole or in part, which may prove to be invalid or ineffective for any
reason; (iii) failure of the beneficiary of any such Letter of Credit to comply fully with any conditions required in order to draw upon such Letter of Credit; (iv) errors, omissions, interruptions or delays in transmission or delivery of
any messages, by mail, cable, telegraph, telex or otherwise, whether or not they be in cipher; (v) errors in interpretation of technical terms; (vi) any loss or delay in the transmission or otherwise of any document required in order to
make a drawing under any such Letter of Credit or of the proceeds thereof; (vii) the misapplication by the beneficiary of any such Letter of Credit of the proceeds of any drawing under such Letter of Credit; or (viii) any consequences
arising from causes beyond the control of the Issuing Bank, including any Governmental Acts; none of the above shall affect or impair, or prevent the vesting of, any of the Issuing Bank’s rights or powers hereunder. Without limiting the
foregoing and in furtherance thereof, any action taken or omitted by the Issuing Bank under or in connection with the Letters of Credit or any documents and certificates delivered thereunder, if taken or omitted in good faith, shall not give rise to
any liability on 

  
 75 

 
the part of the Issuing Bank to the Borrower. Notwithstanding anything to the contrary contained in this Section 2.04(c), the Borrower shall retain any and all rights it may have against the
Issuing Bank to the extent, but only to the extent, of any direct, as opposed to consequential or exemplary, damages suffered by the Borrower which the Borrower proves were caused solely out of the gross negligence or willful misconduct of the
Issuing Bank as determined by a final, non-appealable judgment of a court of competent jurisdiction. 
 (d) Reimbursement by
the Borrower of Amounts Drawn or Paid Under Letters of Credit. In the event the Issuing Bank has determined to honor a drawing under a Letter of Credit, it shall immediately notify the Borrower and the Administrative Agent of the amount and
currency of such drawing and the Dollar Equivalent thereof, and the Borrower shall reimburse the Issuing Bank through the Administrative Agent on or before the Applicable Time on the Business Day on which such drawing is honored (the
“Reimbursement Date”) in the same currency in which such drawing was made (or the Dollar Equivalent of such amount, at the option of and as notified by the Issuing Bank) and in same day funds equal to the amount of such honored
drawing; provided, anything contained herein to the contrary notwithstanding, (i) unless the Borrower shall have notified the Administrative Agent and the Issuing Bank prior to 10:00 a.m. (New York City time) on the date such drawing is
honored that the Borrower intends to reimburse the Issuing Bank for the amount of such honored drawing with funds other than the proceeds of Revolving Loans, the Borrower shall be deemed to have given a timely Funding Notice to the Administrative
Agent requesting Lenders with Revolving Commitments to make Revolving Loans that are Base Rate Loans on the Reimbursement Date in an amount in Dollars equal to the Dollar Equivalent of the amount of such honored drawing and (ii) subject to
satisfaction or waiver of the conditions specified in Section 3.02, Lenders with Revolving Commitments shall, on the Reimbursement Date, make Revolving Loans that are Base Rate Loans in the Dollar Equivalent of the amount of such honored drawing,
the proceeds of which shall be applied directly by the Administrative Agent to reimburse the Issuing Bank for the amount of such honored drawing; and provided further, if for any reason proceeds of Revolving Loans are not received by the
Issuing Bank on the Reimbursement Date in an amount equal to the Dollar Equivalent of the amount of such honored drawing, the Borrower shall reimburse the Issuing Bank, on demand, in an amount in same day funds equal to the excess of the Dollar
Equivalent of the amount of such honored drawing over the aggregate amount of such Revolving Loans, if any, which are so received. Nothing in this Section 2.04(d) shall be deemed to relieve any Lender with a Revolving Commitment from its obligation
to make Revolving Loans on the terms and conditions set forth herein, and the Borrower shall retain any and all rights it may have against any such Lender resulting from the failure of such Lender to make such Revolving Loans under this Section
2.04(d). 

  
 76 

 (e) Lenders’ Purchase of Participations in Letters of Credit. Immediately upon
the issuance of each Letter of Credit, each Lender having a Revolving Commitment shall be deemed to have purchased, and hereby agrees to irrevocably purchase, from the Issuing Bank a participation in such Letter of Credit and any drawings honored
thereunder in an amount equal to such Lender’s Pro Rata Share (with respect to the Revolving Commitments) of the maximum Stated Amount which is or at any time may become available to be drawn thereunder. In the event that the Borrower shall
fail for any reason to reimburse the Issuing Bank as provided in Section 2.04(d), the Administrative Agent shall promptly notify each Lender with a Revolving Commitment of the Dollar Equivalent of the unreimbursed amount of such honored drawing and
of such Lender’s respective participation therein based on such Lender’s Pro Rata Share of the Revolving Commitments. Each Lender with a Revolving Commitment shall make available to the Issuing Bank through the Administrative Agent an
amount equal to its respective participation, in Dollars and in same day funds, at the office of the Administrative Agent specified in such notice, not later than 12:00 noon (New York City time) on the first Business Day after the date notified by
the Administrative Agent. In the event that any Lender with a Revolving Commitment fails to make available to the Issuing Bank on such Business Day the amount of such Lender’s participation in such Letter of Credit as provided in this
Section 2.04(e), the Issuing Bank shall be entitled to recover such amount on demand from such Lender together with interest thereon for three (3) Business Days at the rate customarily used by the Issuing Bank for the correction of errors
among banks and thereafter at the Base Rate. Nothing in this Section 2.04(e) shall be deemed to prejudice the right of any Lender with a Revolving Commitment to recover from the Issuing Bank any amounts made available by such Lender to the Issuing
Bank pursuant to this Section in the event that the payment with respect to a Letter of Credit in respect of which payment was made by such Lender constituted gross negligence or willful misconduct on the part of the Issuing Bank. In the event the
Issuing Bank shall have been reimbursed by other Lenders pursuant to this Section 2.04(e) for all or any portion of any drawing honored by the Issuing Bank under a Letter of Credit, the Administrative Agent shall distribute to each Lender which has
paid all amounts payable by it under this Section 2.04(e) with respect to such honored drawing such Lender’s Pro Rata Share of all payments subsequently received by the Issuing Bank from the Borrower in reimbursement of such honored drawing
when such payments are received. Any such distribution shall be made to a Lender at its primary address set forth below its name on Appendix B or at such other address as such Lender may request. 

(f) Obligations Absolute. The obligation of the Borrower to reimburse the Issuing Bank for drawings honored under the Letters of
Credit issued by it and to repay any Revolving Loans made by Lenders pursuant to Section 2.04(d) and the obligations of Lenders under Section 2.04(e) shall be unconditional and 

  
 77 

 
irrevocable and shall be paid strictly in accordance with the terms hereof under all circumstances including any of the following circumstances: (i) any lack of validity or enforceability of
any Letter of Credit; (ii) the existence of any claim, set off, defense or other right which the Borrower or any Lender may have at any time against a beneficiary or any transferee of any Letter of Credit (or any Persons for whom any such
transferee may be acting), the Issuing Bank, any Lender or any other Person or, in the case of a Lender, against the Borrower, whether in connection herewith, the transactions contemplated herein or any unrelated transaction (including any
underlying transaction between the Borrower or one of its Subsidiaries and the beneficiary for which any Letter of Credit was procured); (iii) any draft or other document presented under any Letter of Credit proving to be forged, fraudulent,
invalid or insufficient in any respect or any statement therein being untrue or inaccurate in any respect; (iv) payment by the Issuing Bank under any Letter of Credit against presentation of a draft or other document which does not
substantially comply with the terms of such Letter of Credit; (v) any adverse change in the business, operations, properties, assets, condition (financial or otherwise) or prospects of the Borrower or any of its Subsidiaries; (vi) any
breach hereof or any other Credit Document by any party thereto; (vii) any adverse change in the relevant exchange rates or in the availability of the Agreed Currency to the Borrower or in the relevant currency markets generally;
(viii) any other circumstance or happening whatsoever, whether or not similar to any of the foregoing; or (ix) the fact that an Event of Default or a Default shall have occurred and be continuing; provided, in each case, that
payment by the Issuing Bank under the applicable Letter of Credit shall not have constituted gross negligence or willful misconduct of the Issuing Bank under the circumstances in question as determined by a final, non-appealable judgment of a court
of competent jurisdiction. 
 (g) Indemnification. Without duplication of any obligation of the Borrower under Section
10.02 or Section 10.03, in addition to amounts payable as provided herein, the Borrower hereby agrees to protect, indemnify, pay and save harmless the Issuing Bank from and against any and all claims, demands, liabilities, damages, losses, costs,
charges and expenses (including reasonable fees, expenses and disbursements of counsel and allocated costs of internal counsel) which the Issuing Bank may incur or be subject to as a consequence, direct or indirect, of (i) the issuance of any
Letter of Credit by the Issuing Bank, other than as a result of (A) the gross negligence or willful misconduct of the Issuing Bank, as determined by a final, non-appealable judgment of a court of competent jurisdiction or (B) the wrongful
dishonor by the Issuing Bank of a proper demand for payment made under any Letter of Credit issued by it or (ii) the failure of the Issuing Bank to honor a drawing under any such Letter of Credit as a result of any Governmental Act. 

(h) Additional Issuing Banks. The Borrower may, at any time and from time to time with the consent of the Administrative Agent
(which consent shall 

  
 78 

 
not be unreasonably withheld or delayed) and such Lender, designate one or more additional Lenders to act as an Issuing Bank under the terms of this Agreement, subject to reporting requirements
reasonably satisfactory to the Administrative Agent, including, without limitation, notices of issuances, amendments, extensions, cancellations and terminations of Letters of Credit by such additional Issuing Bank. Any Lender designated as an
issuing bank pursuant to this Section 2.04(h) shall be deemed to be an “Issuing Bank” (in addition to being a Lender) in respect of Letters of Credit issued or to be issued by such Lender, and, with respect to such Letters of Credit,
such term shall thereafter apply to the other Issuing Bank and such Lender. 
 (i) Letter of Credit Reports. To the
extent any Letters of Credit issued by an Issuing Bank are outstanding, such Issuing Bank shall furnish to the Administrative Agent (which shall promptly notify each Lender having a Revolving Commitment) and the Borrower not later than ten
(10) Business Days prior to the end of each calendar quarter and from time to time upon reasonable prior request of the Administrative Agent, a written Letter of Credit report in form and substance satisfactory to the Administrative Agent.

 Section 2.05. Pro Rata Shares; Availability of Funds. (a) Pro Rata Shares. All Loans shall be made,
and all participations purchased, by Lenders simultaneously and proportionately to their respective Pro Rata Shares, it being understood that no Lender shall be responsible for any default by any other Lender in such other Lender’s obligation
to make a Loan requested hereunder or purchase a participation required hereby nor shall any Term Loan Commitment or any Revolving Commitment of any Lender be increased or decreased as a result of a default by any other Lender in such other
Lender’s obligation to make a Loan requested hereunder or purchase a participation required hereby. 
 (b) Availability
of Funds. Unless the Administrative Agent shall have been notified by any Lender prior to the applicable Credit Date that such Lender does not intend to make available to the Administrative Agent the amount of such Lender’s Loan requested
on such Credit Date, the Administrative Agent may assume that such Lender has made such amount available to the Administrative Agent on such Credit Date and the Administrative Agent may, in its sole discretion, but shall not be obligated to, make
available to the Borrower a corresponding amount on such Credit Date. If such corresponding amount is not in fact made available to the Administrative Agent by such Lender, the Administrative Agent shall be entitled to recover such corresponding
amount on demand from such Lender, together with interest thereon for each day from such Credit Date until the date such amount is paid to the Administrative Agent, at the customary rate set by the Administrative Agent for the correction of errors
among banks for three (3) Business Days and thereafter at the Base Rate. In the event that (i) the Administrative Agent declines to make a requested amount available to the Borrower until such time as all applicable Lenders have made
payment to the 

  
 79 

 
Administrative Agent, (ii) a Lender fails to fund to the Administrative Agent all or any portion of the Loans required to be funded by such Lender hereunder prior to the time specified in
this Agreement and (iii) such Lender’s failure results in the Administrative Agent failing to make a corresponding amount available to the Borrower on the applicable Credit Date, at the Administrative Agent’s option, such Lender shall
not receive interest hereunder with respect to the requested amount of such Lender’s Loans for the period commencing with the time specified in this Agreement for receipt of payment by the Borrower through and including the time of the
Borrower’s receipt of the requested amount. If such Lender does not pay such corresponding amount forthwith upon the Administrative Agent’s demand therefor, the Administrative Agent shall promptly notify the Borrower, and the Borrower
shall immediately pay such corresponding amount to the Administrative Agent, together with interest thereon for each day from such Credit Date until the date such amount is paid to the Administrative Agent at the rate payable hereunder for Base Rate
Loans for such Class of Loans. Nothing in this Section 2.05(b) shall be deemed to relieve any Lender from its obligation to fulfill its Term Loan Commitments and Revolving Commitment hereunder or to prejudice any rights that the Borrower may have
against any Lender as a result of any default by such Lender hereunder. 
 Section 2.06. Use of Proceeds.
(a) The proceeds of the Term Loans shall be applied by the Borrower to fund the Acquisition (including the Refinancing and paying fees, commissions and expenses and other Transaction Costs in connection with the Acquisition and the issuance
of the Senior Notes) and may be used to pay Convertible Note Repayment Obligations or fund the Convertible Note Repayment Reserve as permitted hereunder. 
 (b) The proceeds of the Revolving Loans, Swing Line Loans and Letters of Credit made or issued on and after the Closing Date shall be applied by the Borrower to the working capital and general corporate
purposes of the Borrower and its Subsidiaries, including Permitted Acquisitions and permitted capital expenditures, and may be used to pay Convertible Note Repayment Obligations or fund the Convertible Note Repayment Reserve as permitted hereunder.

 (c) No portion of the proceeds of any Credit Extension shall be used in any manner that causes or might cause such Credit
Extension or the application of such proceeds to violate Regulation T, Regulation U or Regulation X of the Board of Governors or any other regulation thereof or to violate the Exchange Act. 

Section 2.07. Evidence of Debt; Register; Notes. (a) Lenders’ Evidence of Debt. Each Lender shall maintain
on its internal records an account or accounts evidencing the Obligations of the Borrower to such Lender, including the amounts of the Loans made by it and each repayment and prepayment in respect thereof. Any such recordation shall be conclusive
and binding on the Borrower, absent manifest error; provided that the failure to make any such recordation, or any 

  
 80 

 
error in such recordation, shall not affect any Lender’s Revolving Commitment or the Borrower’s Obligations in respect of any applicable Loans; and provided further, in the event
of any inconsistency between the Register and any Lender’s records, the recordations in the Register shall govern in the absence of demonstrable error therein. 
 (b) Register. The Administrative Agent (or its agent or sub-agent appointed by it) shall maintain at its Principal Office a register for the recordation of the names and addresses of Lenders and
the Revolving Commitment and Loans (and stated interest) of each Lender from time to time (the “Register”). The Register shall be available for inspection by the Borrower or any Lender (with respect to (i) any entry relating to such
Lender’s Loans and (ii) the identity of the other Lenders (but not any information with respect to such other Lender’s Loans) at any reasonable time and from time to time upon reasonable prior notice. The Administrative Agent shall record,
or shall cause to be recorded, in the Register the Revolving Commitments and the Loans (and stated interest) in accordance with the provisions of Section 10.06, and each repayment or prepayment in respect of the principal amount of the Loans, and
any such recordation shall be conclusive and binding on the Borrower and each Lender, absent manifest error; provided, failure to make any such recordation, or any error in such recordation, shall not affect any Lender’s Revolving
Commitment or the Borrower’s Obligations in respect of any Loan. The Borrower hereby designates the Administrative Agent to serve as the Borrower’s agent solely for purposes of maintaining the Register as provided in this Section 2.07, and
the Borrower hereby agrees that, to the extent the Administrative Agent serves in such capacity, the Administrative Agent and its officers, directors, employees, agents, sub-agents and affiliates shall constitute “Indemnitees.” 

(c) Notes. If so requested by any Lender by written notice to the Borrower (with a copy to the Administrative Agent) at least two
(2) Business Days prior to the Closing Date, or at any time thereafter, Borrower shall execute and deliver to such Lender (and/or, if applicable and if so specified in such notice, to any Person who is an assignee of such Lender pursuant to
Section 10.06) on the Closing Date (or, if such notice is delivered after the Closing Date, promptly after the Borrower’s receipt of such notice) a Note or Notes to evidence such Lender’s Term Loans, Revolving Loans or Swing Line Loans, as
the case may be. 

  
 81 

 Section 2.08. Interest on Loans. (a) Except as otherwise set forth herein,
each Class of Loans shall bear interest on the unpaid principal amount thereof from the date made through repayment (whether by acceleration or otherwise) thereof as follows: 

(i) in the case of Revolving Loans and Tranche A Term Loans, as applicable: 

(A) if a Base Rate Loan, at the Base Rate plus the Applicable Margin; or 

(B) if a Eurodollar Rate Loan, at the Adjusted Eurodollar Rate plus the Applicable Margin; and 

(ii) in the case of Swing Line Loans, at the Base Rate plus the Applicable Margin; and 

(iii) in the case of Tranche B Term Loans: 

(A) if a Base Rate Loan, at the Base Rate plus 2.50%; or 

(B) if a Eurodollar Rate Loan, at the Adjusted Eurodollar Rate plus 3.50%. 

(b) The basis for determining the rate of interest with respect to any Loan (except a Swing Line Loan which can be made and maintained
only as a Base Rate Loan), and the Interest Period with respect to any Eurodollar Rate Loan, shall be selected by the Borrower and notified to the Administrative Agent and Lenders pursuant to the applicable Funding Notice or Conversion/Continuation
Notice, as the case may be; provided, until the date on which the Administrative Agent notifies the Borrower that the primary syndication of the Loans and Revolving Commitments has been completed, as determined by the Administrative Agent,
the Term Loans shall be maintained as either (i) Eurodollar Rate Loans having an Interest Period of no longer than one month or (ii) Base Rate Loans. If on any day a Loan is outstanding with respect to which a Funding Notice or
Conversion/Continuation Notice has not been delivered to the Administrative Agent in accordance with the terms hereof specifying the applicable basis for determining the rate of interest, then for that day such Loan shall be a Base Rate Loan.

 (c) In connection with Eurodollar Rate Loans there shall be no more than ten (10) Interest Periods outstanding at any
time. In the event the Borrower fails to specify between a Base Rate Loan or a Eurodollar Rate Loan in the applicable Funding Notice or Conversion/Continuation Notice, such Loan will be made as a Base Rate Loan or (if outstanding as a Eurodollar
Rate Loan) will be automatically converted into a Base Rate Loan on the last day of the then current Interest Period for such Loan or (if outstanding as a Base Rate Loan) will remain as a Base Rate Loan. In the event the Borrower fails to specify an
Interest Period for any Eurodollar Rate Loan in the applicable Funding Notice or Conversion/Continuation Notice, the Borrower shall be deemed to have selected an Interest Period of one month. As soon as practicable after 10:00 a.m. (New York City
time) on each Interest Rate Determination Date, the Administrative 

  
 82 

 
Agent shall determine (which determination shall, absent manifest error, be final, conclusive and binding upon all parties) the interest rate that shall apply to the Eurodollar Rate Loans for
which an interest rate is then being determined for the applicable Interest Period and shall promptly give notice thereof (in writing or by telephone confirmed in writing) to the Borrower and each Lender. 

(d) Interest payable pursuant to Section 2.08(a) shall be computed (i) in the case of Base Rate Loans on the basis of a 365-day or
366-day year, as the case may be, and (ii) in the case of Eurodollar Rate Loans, on the basis of a 360 day year, in each case for the actual number of days elapsed in the period during which it accrues. In computing interest on any Loan, the
date of the making of such Loan or the first day of an Interest Period applicable to such Loan or, with respect to a Term Loan, the last Interest Payment Date with respect to such Term Loan or, with respect to a Base Rate Loan being converted from a
Eurodollar Rate Loan, the date of conversion of such Eurodollar Rate Loan to such Base Rate Loan, as the case may be, shall be included, and the date of payment of such Loan or the expiration date of an Interest Period applicable to such Loan or,
with respect to a Base Rate Loan being converted to a Eurodollar Rate Loan, the date of conversion of such Base Rate Loan to such Eurodollar Rate Loan, as the case may be, shall be excluded; provided, if a Loan is repaid on the same day on
which it is made, one (1) day’s interest shall be paid on that Loan. 
 (e) Except as otherwise set forth herein,
interest on each Loan (i) shall accrue on a daily basis and shall be payable in arrears on each Interest Payment Date with respect to interest accrued on and to each such payment date; (ii) shall accrue on a daily basis and shall be
payable in arrears upon any prepayment of that Loan, whether voluntary or mandatory, to the extent accrued on the amount being prepaid; and (iii) shall accrue on a daily basis and shall be payable in arrears at maturity of the Loans, including
final maturity of the Loans; provided, however, with respect to any voluntary prepayment of a Base Rate Loan, accrued interest shall instead be payable on the applicable Interest Payment Date. 

(f) the Borrower agrees to pay to the Issuing Bank, with respect to drawings honored under any Letter of Credit, interest on the amount
paid by the Issuing Bank in respect of each such honored drawing from the date such drawing is honored to but excluding the date such amount is reimbursed by or on behalf of the Borrower at a rate equal to (i) for the period from the date such
drawing is honored to but excluding the applicable Reimbursement Date, the rate of interest otherwise payable hereunder with respect to Revolving Loans that are Base Rate Loans and (ii) thereafter, a rate which is 2% per annum in excess of
the rate of interest otherwise payable hereunder with respect to Revolving Loans that are Base Rate Loans. 
 (g) Interest
payable pursuant to Section 2.08(f) shall be computed on the basis of a 365/366-day year for the actual number of days elapsed in the period 

  
 83 

 
during which it accrues, and shall be payable on demand or, if no demand is made, on the date on which the related drawing under a Letter of Credit is reimbursed in full. Promptly upon receipt by
the Issuing Bank of any payment of interest pursuant to Section 2.08(f), the Issuing Bank shall distribute to each Lender, out of the interest received by the Issuing Bank in respect of the period from the date such drawing is honored to but
excluding the date on which the Issuing Bank is reimbursed for the amount of such drawing (including any such reimbursement out of the proceeds of any Revolving Loans), the amount that such Lender would have been entitled to receive in respect of
the letter of credit fee that would have been payable in respect of such Letter of Credit for such period if no drawing had been honored under such Letter of Credit. In the event the Issuing Bank shall have been reimbursed by Lenders for all or any
portion of such honored drawing, the Issuing Bank shall distribute to each Lender which has paid all amounts payable by it under Section 2.04(e) with respect to such honored drawing such Lender’s Pro Rata Share of any interest received by the
Issuing Bank in respect of that portion of such honored drawing so reimbursed by such Lender for the period from the date on which the Issuing Bank was so reimbursed by such Lender to but excluding the date on which such portion of such honored
drawing is reimbursed by the Borrower. 
 Section 2.09. Conversion/Continuation. (a) Subject to
Section 2.18 and so long as no Default or Event of Default shall have occurred and then be continuing, the Borrower shall have the option: 
 (i) to convert at any time all or any part of any borrowing of Term Loans or Revolving Loans equal to $5,000,000 and integral multiples of $1,000,000 in excess of that amount from one Type of Loan to
another Type of Loan; provided, Eurodollar Rate Loans may only be converted on the expiration of the Interest Period applicable to such Eurodollar Rate Loans unless the Borrower shall pay all amounts due under Section 2.18 in connection with
any such conversion; or 
 (ii) upon the expiration of any Interest Period applicable to any borrowing of
Eurodollar Rate Loans, to continue all or any portion of such Loans equal to $5,000,000 and integral multiples of $1,000,000 in excess of that amount as Eurodollar Rate Loans. 
 (b) the Borrower shall deliver a Conversion/Continuation Notice to the Administrative Agent no later than 10:00 a.m. (New York City time) at least one (1) Business Day in advance of the proposed
conversion date (in the case of a conversion to Base Rate Loans) and at least three (3) Business Days in advance of the proposed conversion/continuation date (in the case of a conversion to, or a continuation of, Eurodollar Rate Loans). Except
as otherwise provided herein, a Conversion/Continuation Notice for conversion to, or continuation of, any Eurodollar Rate Loans (or telephonic notice in lieu thereof) shall be irrevocable on and after the related Interest Rate Determination Date,
and the Borrower shall be bound to effect a conversion or continuation in accordance therewith. 

  
 84 

 Section 2.10. Default Interest. Upon the occurrence and during the continuance
of an Event of Default under Section 8.01(a), (f) or (g), the amount of any payment of principal in respect of any outstanding Loan and, to the extent permitted by applicable law, any interest payments on the Loans or any fees or other
amounts owed hereunder and, in each case, not paid on or before the date due (or, in the case of interest on any Loan or any fee or any other amount due hereunder, not paid within five (5) days after the date due) shall thereafter bear interest
(including post-petition interest in any proceeding under Debtor Relief Laws) payable on demand at a rate that is 2% per annum in excess of the interest rate otherwise payable hereunder with respect to the applicable Loans (or, in the case of
any such fees and other amounts, at a rate which is 2% per annum in excess of the interest rate otherwise payable hereunder for Base Rate Loans that are Revolving Loans); provided, in the case of Eurodollar Rate Loans, upon the
expiration of the Interest Period in effect at the time any such increase in interest rate is effective such Eurodollar Rate Loans shall thereupon become Base Rate Loans and shall thereafter bear interest payable upon demand at a rate which is
2% per annum in excess of the interest rate otherwise payable hereunder for Base Rate Loans. Payment or acceptance of the increased rates of interest provided for in this Section 2.10 is not a permitted alternative to timely payment and shall
not constitute a waiver of any Event of Default or otherwise prejudice or limit any rights or remedies of the Administrative Agent or any Lender. 
 Section 2.11. Fees.  
 (a) The Borrower agrees to pay to Lenders
having Revolving Exposure: 
 (i) commitment fees equal to (A) the average of the daily difference during
the applicable quarterly period or portion thereof, as applicable, between (1) the Revolving Commitments and (2) the aggregate principal amount of (x) all outstanding Revolving Loans (for the avoidance of doubt, excluding Swing Line
Loans) plus (y) the Letter of Credit Usage, times (B) the Applicable Revolving Commitment Fee Percentage; and 
 (ii) letter of credit fees equal to (A) the Applicable Margin for Revolving Loans that are Eurodollar Rate Loans times (B) the average aggregate daily maximum amount available to be drawn
under all outstanding Letters of Credit (regardless of whether any conditions for drawing could then be met and determined as of the close of business on any date of determination) during the applicable quarterly period or portion thereof, as
applicable. 

  
 85 

 All fees referred to in this Section 2.11(a) shall be paid to the Administrative Agent at
its Principal Office and, upon receipt, the Administrative Agent shall promptly distribute to each applicable Lender its Pro Rata Share thereof. 
 (b) The Borrower agrees to pay directly to each Issuing Bank, for its own account, the following fees: 
 (i) a fronting fee equal to the rate or rates per annum separately agreed upon by the Borrower and such Issuing Bank, times the average daily amount of the Letter of Credit Usage with respect to
all Letters of Credit issued by such Issuing Bank (excluding any portion thereof attributable to unreimbursed amounts in respect of payments made by such Issuing Bank pursuant to any such Letter of Credit) during the period from and including the
Closing Date to but excluding the later of the Revolving Commitment Termination Date and the date on which there ceases to be any Letter of Credit Usage with respect to all Letters of Credit issued by such Issuing Bank; and 

(ii) such documentary and processing charges for any issuance, amendment, transfer or payment of a Letter of Credit as are
in accordance with such Issuing Bank’s standard schedule for such charges as in effect at the time of such issuance, amendment, transfer or payment, as the case may be. 
 (c) All fees referred to in Sections 2.11(a) and 2.11(b) shall be calculated on the basis of a 360-day year and the actual number of days elapsed and shall be payable quarterly in arrears on the last
Business Day of each Fiscal Quarter during the Revolving Commitment Period, commencing on the first such date to occur after the Closing Date, and ending on the Revolving Commitment Termination Date. 

(d) In addition to any of the foregoing fees, the Borrower agrees to pay to the Agents such other fees in the amounts and at the times
separately agreed upon. 
 Section 2.12. Scheduled Payments/Commitment Reductions. (a) The principal amounts of
the Tranche A Term Loans shall be repaid in consecutive quarterly installments (each, a “Tranche A Installment”) in the aggregate amounts and, on the corresponding “Amortization Dates,” set forth in the table below,
commencing October 31, 2012: 
  

			
	 Amortization Date
	  	 Tranche A Installments

	 October 31, 2012
	  	$12,500,000
	 January 31, 2013
	  	$12,500,000

  
 86 

			
	 Amortization Date
	  	 Tranche A Installments

	 April 30, 2013
	  	$12,500,000
	 July 31, 2013
	  	$12,500,000
	 October 31, 2013
	  	$12,500,000
	 January 31, 2014
	  	$12,500,000
	 April 30, 2014
	  	$12,500,000
	 July 31, 2014
	  	$12,500,000
	 October 31, 2014
	  	$25,000,000
	 January 31, 2015
	  	$25,000,000
	 April 30, 2015
	  	$25,000,000
	 July 31, 2015
	  	$25,000,000
	 October 31, 2015
	  	$50,000,000
	 January 31, 2016
	  	$50,000,000
	 April 30, 2016
	  	$50,000,000
	 July 31, 2016
	  	$50,000,000
	 October 31, 2016
	  	$50,000,000
	 January 31, 2017
	  	$50,000,000
	 April 30, 2017
	  	$50,000,000
	 July 31, 2017
	  	$50,000,000
	 Tranche A Term Loan Maturity Date
	  	$400,000,000 or such lesser aggregate principal amount of Tranche A Term Loans then outstanding

 (b) The principal amounts of the Tranche B Term Loans shall be repaid in consecutive quarterly
installments (each, a “Tranche B Installment”) in the aggregate amounts and, on the corresponding “Amortization Dates,” set forth in the table below, commencing October 31, 2012: 

 

			
	 Amortization Date
	  	 Tranche B Installments

	October 31, 2012	  	$3,750,000
	January 31, 2013	  	$3,750,000
	April 30, 2013	  	$3,750,000
	July 31, 2013	  	$3,750,000
	October 31, 2013	  	$3,750,000
	January 31, 2014	  	$3,750,000
	April 30, 2014	  	$3,750,000
	July 31, 2014	  	$3,750,000
	October 31, 2014	  	$3,750,000
	January 31, 2015	  	$3,750,000
	April 30, 2015	  	$3,750,000
	July 31, 2015	  	$3,750,000
	October 31, 2015	  	$3,750,000
	January 31, 2016	  	$3,750,000

  
 87 

			
	 Amortization Date
	  	 Tranche B Installments

	April 30, 2016	  	$3,750,000
	July 31, 2016	  	$3,750,000
	October 31, 2016	  	$3,750,000
	January 31, 2017	  	$3,750,000
	April 30, 2017	  	$3,750,000
	July 31, 2017	  	$3,750,000
	October 31, 2017	  	$3,750,000
	January 31, 2018	  	$3,750,000
	April 30, 2018	  	$3,750,000
	July 31, 2018	  	$3,750,000
	October 31, 2018	  	$3,750,000
	January 31, 2019	  	$3,750,000
	April 30, 2019	  	$3,750,000
	July 31, 2019	  	$3,750,000
	Tranche B Term Loan Maturity Date	  	$1,395,000,000 or such lesser aggregate principal amount of Tranche B Term Loans then outstanding

 ; provided that in the event any New Term Loans are made, such New Term Loans shall be repaid on each
“Amortization Date” occurring on or after the applicable Increased Amount Date in the manner specified in the applicable Joinder Agreement. 
 Notwithstanding the foregoing, (x) such Installments shall be reduced on a dollar-for-dollar basis in connection with any voluntary or mandatory prepayments of the Term Loans in accordance with
Sections 2.13, 2.14 and 2.15, as applicable; and (y) Term Loans, together with all other amounts owed hereunder with respect thereto, shall, in any event, be paid in full no later than the applicable Term Loan Maturity Date therefor.

 Section 2.13. Voluntary Prepayments/Commitment Reductions. (a) Voluntary Prepayments. 

(i) At any time and from time to time: 

(A) with respect to Base Rate Loans, the Borrower may prepay any such Loans on any Business Day in whole or in part in an
aggregate minimum amount of $5,000,000 and integral multiples of $1,000,000 in excess of that amount; 
 (B) with
respect to Eurodollar Rate Loans, the Borrower may prepay any such Loans on any Business Day in whole or in part in an aggregate minimum amount of $5,000,000 and integral multiples of $1,000,000 in excess of that amount; and 

  
 88 

 (C) with respect to Swing Line Loans, the Borrower may prepay any such Loans
on any Business Day in whole or in part in an aggregate minimum amount of $500,000, and in integral multiples of $100,000 in excess of that amount. 
 (ii) All such prepayments shall be made: 
 (A) upon not less than
one (1) Business Day’s prior written or telephonic notice in the case of Base Rate Loans; 
 (B) upon
not less than three (3) Business Days’ prior written or telephonic notice in the case of Eurodollar Rate Loans; and 
 (C) upon written or telephonic notice on the date of prepayment, in the case of Swing Line Loans; 

in each case given to the Administrative Agent or the Swing Line Lender, as the case may be, by 3:00 p.m. (New York City time) on the date required and,
if given by telephone, promptly confirmed in writing to the Administrative Agent (and the Administrative Agent will promptly transmit such telephonic or original notice for Term Loans or Revolving Loans, as the case may be, by telefacsimile or
telephone to each Lender) or the Swing Line Lender, as the case may be. Upon the giving of any such notice, the principal amount of the Loans specified in such notice shall become due and payable on the prepayment date specified therein. Any such
voluntary prepayment shall be applied as specified in Section 2.15(a). 
 (b) Voluntary Commitment Reductions.

 (i) The Borrower may, upon not less than three (3) Business Days’ prior written or telephonic notice
confirmed in writing to the Administrative Agent (which original written or telephonic notice the Administrative Agent will promptly transmit by telefacsimile or telephone to each applicable Lender), at any time and from time to time terminate in
whole or permanently reduce in part, without premium or penalty, the Revolving Commitments in an amount up to the amount by which the Revolving Commitments exceed the Total Utilization of Revolving Commitments at the time of such proposed
termination or reduction; provided, any such partial reduction of the Revolving Commitments shall be in an aggregate minimum amount of $5,000,000 and integral multiples of $1,000,000 in excess of that amount. 

  
 89 

 (ii) The Borrower’s notice to the Administrative Agent shall designate
the date (which shall be a Business Day) of such termination or reduction and the amount of any partial reduction, and such termination or reduction of the Revolving Commitments shall be effective on the date specified in the Borrower’s notice
and shall reduce the Revolving Commitment of each Lender proportionately to its Pro Rata Share thereof. 
 (c) Tranche B Term
Loan Call Protection. In the event that all or any portion of the Tranche B Term Loans is (i) repaid, prepaid, refinanced or replaced (including, without limitation, with Refinancing Indebtedness) or (ii) repriced or effectively refinanced
through any waiver, consent, amendment or amendment and restatement (including, without limitation, a Refinancing Amendment) (in each case, in connection with any waiver, consent, amendment or amendment and restatement to the Tranche B Term Loans
directed at, or the result of which would be, the lowering of the Weighted Average Yield of the Tranche B Term Loans or the incurrence of any Indebtedness having a Weighted Average Yield that is less than the Weighted Average Yield of the Tranche B
Term Loans (or portion thereof) so repaid, prepaid, refinanced, replaced or repriced (a “Repricing Transaction”)) occurring on or prior to the first anniversary of the Closing Date, such repayment, prepayment, refinancing,
replacement or repricing will be made at 101.0% of the principal amount of the Tranche B Term Loans so repaid, prepaid, refinanced, replaced or repriced. If all or any portion of the Tranche B Term Loans held by any Lender is repaid, prepaid,
refinanced or replaced (including through a mandatory assignment) pursuant to Section 2.23 as a result of, or in connection with, such Lender not agreeing or otherwise consenting to any waiver, consent or amendment referred to in clause
(ii) above (or otherwise in connection with a Repricing Transaction), such repayment, prepayment, refinancing or replacement will be made at 101.0% of the principal amount of the Tranche B Term Loans so repaid, prepaid, refinanced or replaced.
It is expressly agreed that, notwithstanding anything to the contrary herein, no premium, penalty or call protection under this Section 2.13(c) shall be due in connection with a mandatory prepayment of Loans required pursuant to
Section 2.14 hereof other than a mandatory prepayment under Section 2.14(d). 
 Section 2.14. Mandatory
Prepayments/Commitment Reductions. (a) Asset Sales. Subject to Section 2.15(e), no later than the fifth Business Day following the date of receipt by the Borrower or any of its Subsidiaries of any Net Asset Sale Proceeds arising
from an Asset Sale, the Borrower shall prepay the Loans as set forth in Section 2.15(b) in an aggregate amount equal to such Net Asset Sale Proceeds; provided so long as no Default or Event of Default shall have occurred and be
continuing, the Borrower shall have the option, directly or through one or more of its Subsidiaries, to invest or commit to invest such Net Asset Sale Proceeds within one year of receipt thereof in long-term productive assets of the general type
used in the business of the Borrower and its Subsidiaries, including through a Permitted Acquisition; provided that if any amount is so committed to 

  
 90 

 
be reinvested within such one-year period, but is not reinvested within the later to occur of (x) six months of the date of such commitment and (y) the end of such one year period, the
Borrower shall prepay the Loans in accordance with this Section 2.14(a) without giving further effect to such reinvestment right. 
 (b) Insurance/Condemnation Proceeds. Subject to Section 2.15(e), no later than the fifth Business Day following the date of receipt by the Borrower or any of its Subsidiaries, or the
Administrative Agent as loss payee, of any Net Insurance/Condemnation Proceeds, the Borrower shall prepay the Loans as set forth in Section 2.15(b) in an aggregate amount equal to such Net Insurance/Condemnation Proceeds (in excess of $1,000,000 for
any single event giving rise thereto or series of related events giving rise thereto); provided, so long as no Default or Event of Default shall have occurred and be continuing, the Borrower shall have the option, directly or through one or
more of its Subsidiaries, to invest or commit to invest such Net Insurance/Condemnation Proceeds within one year of receipt thereof in long-term productive assets of the general type used in the business of the Borrower and its Subsidiaries,
including through a Permitted Acquisition, which investment may include the repair, restoration or replacement of the applicable assets thereof; provided that if any amount is so committed to be reinvested within such one-year period, but is
not reinvested within the later to occur of (x) six months of the date of such commitment and (y) the end of such one year period, the Borrower shall prepay the Loans in accordance with this Section 2.14(b) without giving further
effect to such reinvestment right. 
 (c) Issuance of Equity Securities. Subject to Section 2.15(e), no later than
the fifth Business Day following the date of receipt by the Borrower of any Net Equity Proceeds, the Borrower shall prepay the Loans as set forth in Section 2.15(b) in an aggregate amount equal to 50% (the “Equity Percentage”) of
such Net Equity Proceeds; provided, during any period in which the Net Senior Secured Leverage Ratio (determined for any such period by reference to the Compliance Certificate delivered pursuant to Section 5.01(c) calculating the Net
Senior Secured Leverage Ratio as of the last day of the most recently ended Fiscal Quarter) shall be (i) 2.50:1.00 or less, the Equity Percentage shall be reduced to 25% or (ii) 2.00:1.00 or less, the Equity Percentage shall be reduced to
0%. 
 (d) Issuance of Debt. Subject to Section 2.15(e), no later than the fifth Business Day following the date of
receipt by the Borrower or any of its Subsidiaries of any net Cash proceeds from the incurrence of any Indebtedness of the Borrower or any of its Subsidiaries, the Borrower shall prepay the Loans as set forth in Section 2.15(b) in an aggregate
amount equal to 100% of such proceeds, net of underwriting discounts and commissions, and other reasonable costs and expenses associated therewith, including reasonable legal fees and expenses; provided, however, that the net Cash
proceeds of any Indebtedness permitted to be incurred pursuant to Section 6.01 shall be excluded from the application hereof. 

  
 91 

 (e) Consolidated Excess Cash Flow. In the event that there shall be Consolidated
Excess Cash Flow for any Fiscal Year (commencing with the Fiscal Year ending in September 2013), the Borrower shall, no later than ninety (90) days after the end of such Fiscal Year, prepay the Loans as set forth in Section 2.15(b) in an
aggregate amount equal to (x) 50% (the “ECF Percentage”) of such Consolidated Excess Cash Flow minus (y) voluntary repayments of the Loans (excluding repayments of Revolving Loans or Swing Line Loans except to the
extent the Revolving Commitments are permanently reduced in connection with such repayments) during such Fiscal Year; provided that if, as of the last day of such Fiscal Year, the Net Senior Secured Leverage Ratio (determined for any such
period by reference to the Compliance Certificate delivered pursuant to Section 5.01(c) calculating the Net Senior Secured Leverage Ratio as of the last day of such Fiscal Year) shall be (i) 2.50:1.00 or less, the ECF Percentage shall be
reduced to 25% or (ii) 2.00:1.00 or less, the ECF Percentage shall be reduced to 0%. 
 (f) Revolving Loans and Swing
Loans. The Borrower shall from time to time prepay first, the Swing Line Loans without reductions in Revolving Commitments and second, the Revolving Loans without reductions in Revolving Commitments to the extent necessary so that the Total
Utilization of Revolving Commitments shall not at any time exceed the Revolving Commitments then in effect. 
 (g) Letter of
Credit Sublimit. If at any time the Letter of Credit Usage shall exceed the Letter of Credit Sublimit, the Borrower shall immediately Cash Collateralize Letters of Credit in an amount equal to such excess. 

(h) Prepayment Certificate. Concurrently with any prepayment of the Loans pursuant to Sections 2.14(a) through 2.14(e), the
Borrower shall deliver to the Administrative Agent a certificate of an Authorized Officer demonstrating the calculation of the amount of the applicable net proceeds or Consolidated Excess Cash Flow, as the case may be. In the event that the Borrower
shall subsequently determine that the actual amount received exceeded the amount set forth in such certificate by more than $1,000,000, the Borrower shall promptly make an additional prepayment of the Loans in an amount equal to such excess, and the
Borrower shall concurrently therewith deliver to the Administrative Agent a certificate of an Authorized Officer demonstrating the derivation of such excess. 
 Section 2.15. Application of Prepayments/Reductions. (a) Application of Voluntary Prepayments by Type of Loans. Any voluntary prepayment of Term Loans pursuant to Section 2.13(a)
shall be applied to prepay the Term Loans and scheduled amortization payments as directed by the Borrower. In the absence of a 

  
 92 

 
designation by the Borrower, any voluntary prepayment of the Term Loans shall be applied to prepay the Term Loans on a pro rata basis (in accordance with the respective outstanding principal
amounts thereof); and further applied within each such Class of Loans to reduce the scheduled remaining Installments of such Class of Loans in direct order of maturity. 
 (b) Application of Mandatory Prepayments by Class of Loans. Subject to Section 2.15(c), any amount required to be paid pursuant to Sections 2.14(a) through 2.14(e) shall be applied as follows:

 first, to prepay the Term Loans on a pro rata basis (in accordance with the respective outstanding principal amounts
thereof), with such prepayments to be applied to reduce the Installments within each Class of Loans, first by application to the next eight Installments within such respective Class in direct order of maturity and then pro rata among the remaining
Installments of such Class of Loans; 
 second, to prepay the Swing Line Loans to the full extent thereof without
reduction of Revolving Commitments; 
 third, to prepay the Revolving Loans to the full extent thereof without reduction
of Revolving Commitments; 
 fourth, to prepay outstanding reimbursement obligations with respect to Letters of Credit;
and 
 fifth, to Cash Collateralize Letters of Credit. 

(c) Waivable Mandatory Prepayment. Anything contained herein to the contrary notwithstanding, so long as any Tranche B Term Loans
are outstanding, in the event the Borrower is required to make any mandatory prepayment (a “Waivable Mandatory Prepayment”) of the Term Loans, not less than three (3) Business Days prior to the date (the “Prepayment
Date”) on which the Borrower is required to make such Waivable Mandatory Prepayment, the Borrower shall notify the Administrative Agent of the amount of such prepayment, and the Administrative Agent will promptly thereafter notify each
Lender holding an outstanding Tranche B Term Loan of the amount of such Lender’s Pro Rata Share of such Waivable Mandatory Prepayment and such Lender’s option to elect to decline payment of such amount. Each such Lender may exercise such
option by giving written notice to the Borrower and the Administrative Agent of its election to do so on or before the first Business Day prior to the Prepayment Date (each, a “Declining Lender”) (it being understood that any Lender
that does not notify the Borrower and the Administrative Agent of its election to exercise such option on or before the first Business Day prior to the Prepayment Date shall be deemed to have elected, as of such date, not to exercise such option).
On the Prepayment 

  
 93 

 
Date, the Borrower shall pay to the Administrative Agent the amount of the Waivable Mandatory Prepayment, which amount shall be applied (i) in an amount equal to that portion of the Waivable
Mandatory Prepayment payable to the non-Declining Lenders, to prepay the Term Loans of such Lenders (which prepayment shall be applied to the Installments in accordance with Section 2.15(b)) and (ii) in an amount equal to that portion of the
Waivable Mandatory Prepayment otherwise payable to the Declining Lenders, to prepay the Term Loans of the non-Declining Lenders (which prepayment shall be further applied to the Installments in accordance with Section 2.15(b)); provided that
in the event any amount of the Waivable Mandatory Prepayment is outstanding after the non-Declining Lenders have been repaid in full, such outstanding amount shall be returned to the Borrower. 

(d) Application of Prepayments of Loans to Base Rate Loans and Eurodollar Rate Loans. Except as expressly directed by the Borrower
as provided in Section 2.15(a), considering each Class of Loans being prepaid separately, any prepayment thereof shall be applied first to Base Rate Loans to the full extent thereof before application to Eurodollar Rate Loans, in each case in a
manner which minimizes the amount of any payments required to be made by the Borrower pursuant to Section 2.18(c). 
 (e)
Eurodollar Prepayment Account. If the Borrower is required to make a mandatory prepayment of Eurodollar Rate Loans under Section 2.14, so long as no Event of Default exists, the Borrower shall have the right, in lieu of making such
prepayment in full, to deposit an amount equal to such mandatory prepayment with the Administrative Agent in a cash collateral account maintained (pursuant to documentation reasonably satisfactory to the Administrative Agent) by and in the sole
dominion and control of the Administrative Agent. Any amounts so deposited shall be held by the Administrative Agent as collateral for the prepayment of such Eurodollar Rate Loans and shall be applied to the prepayment of the applicable Eurodollar
Rate Loans at the end of the current Interest Periods applicable thereto or, sooner, at the election of the Administrative Agent, upon the occurrence of an Event of Default. At the request of the Borrower, amounts so deposited shall be invested by
the Administrative Agent in Cash Equivalents maturing on or prior to the date or dates on (and time or times by) which it is anticipated that such amounts will be applied to prepay such Eurodollar Rate Loans. Any interest earned on such Cash
Equivalents will be for the account of the Borrower and the Borrower will deposit with the Administrative Agent the amount of any loss on any such Cash Equivalents to the extent necessary in order that the deposited amounts equal or exceed the
amount of the applicable mandatory prepayment. 
 Section 2.16. General Provisions Regarding Payments.
(a) Except as otherwise set forth herein, all payments by the Borrower of principal, interest, fees and other Obligations shall be made in Dollars, in same day funds, without 

  
 94 

 
defense, recoupment, set-off or counterclaim, free of any restriction or condition, and delivered to the Administrative Agent not later than 2:00 p.m. (New York City time) (or, with respect to
Swing Line Loans, 4:00 p.m. (New York City time)) on the date due at the Principal Office designated by the Administrative Agent for the account of Lenders; for purposes of computing interest and fees, funds received by the Administrative Agent
after that time on such due date shall be deemed to have been paid by the Borrower on the next succeeding Business Day. All payments by the Borrower in an Agreed Currency other than Dollars shall be made to the Administrative Agent at the office of
the Administrative Agent in such Agreed Currency and in same day funds not later than the Applicable Time specified by the Administrative Agent to the Borrower on the dates specified herein. If, for any reason, the Borrower is prohibited by any law
from making any required payment hereunder in an Agreed Currency other than Dollars, the Borrower shall make such payment in Dollars in an amount equal to the Dollar Equivalent of such payment. 

(b) All payments in respect of the principal amount of any Loan (other than voluntary prepayments of Revolving Loans) shall be
accompanied by payment of accrued interest on the principal amount being repaid or prepaid, and all such payments (and, in any event, any payments in respect of any Loan on a date when interest is due and payable with respect to such Loan) shall be
applied to the payment of interest then due and payable before application to principal. 
 (c) The Administrative Agent (or its
agent or sub-agent appointed by it) shall promptly distribute to each Lender at such address as such Lender shall indicate in writing, such Lender’s applicable Pro Rata Share of all payments and prepayments of principal and interest due
hereunder, together with all other amounts due such Lender, including all fees payable with respect thereto, to the extent received by the Administrative Agent. 
 (d) Notwithstanding the foregoing provisions hereof, if any Conversion/ Continuation Notice is withdrawn as to any Affected Lender or if any Affected Lender makes Base Rate Loans in lieu of its Pro Rata
Share of any Eurodollar Rate Loans, the Administrative Agent shall give effect thereto in apportioning payments received thereafter. 
 (e) Subject to the provisos set forth in the definition of “Interest Period” as they may apply to Revolving Loans, whenever any payment to be made hereunder with respect to any Loan shall
be stated to be due on a day that is not a Business Day, such payment shall be made on the next succeeding Business Day and, with respect to Revolving Loans only, such extension of time shall be included in the computation of the payment of interest
hereunder or of the Revolving Commitment fees hereunder. 

  
 95 

 (f) The Borrower hereby authorizes the Administrative Agent to charge the Borrower’s
accounts with the Administrative Agent in order to cause timely payment to be made to the Administrative Agent of all principal, interest, fees and expenses due hereunder (subject to sufficient funds being available in its accounts for that
purpose). 
 (g) The Administrative Agent shall deem any payment by or on behalf of the Borrower hereunder that is not made in
same day funds prior to 2:00 p.m. (New York City time) (or, with respect to Swing Line Loans, 4:00 p.m. (New York City time)) to be a non-conforming payment. Any such payment shall be deemed not to have been received by the Administrative Agent
until the later of (i) the time such funds become available funds and (ii) the applicable next Business Day. The Administrative Agent shall give prompt telephonic notice to the Borrower and each applicable Lender (confirmed in writing) if
any payment is non-conforming. Any non-conforming payment may constitute or become a Default or Event of Default in accordance with the terms of Section 8.01(a). Interest shall continue to accrue on any principal as to which a non-conforming payment
is made until such funds become available funds (but in no event less than the period from the date of such payment to the next succeeding applicable Business Day) at the rate determined pursuant to Section 2.10 from the date such amount was due and
payable until the date such amount is paid in full. 
 (h) If an Event of Default shall have occurred and not otherwise been
waived, and the maturity of the Obligations shall have been accelerated pursuant to Section 8.01, all payments or proceeds received by the Agents hereunder in respect of any of the Obligations shall be applied in accordance with the application
arrangements described in Section 9.02 of the Pledge and Security Agreement. 
 Section 2.17. Ratable Sharing. The
Lenders hereby agree among themselves that if any of them shall, whether by voluntary payment (other than a voluntary prepayment of Loans made and applied in accordance with the terms hereof), through the exercise of any right of set-off or
banker’s lien, by counterclaim or cross-action or by the enforcement of any right under the Credit Documents or otherwise (except pursuant to an Assignment Agreement with an Eligible Assignee), or as adequate protection of a deposit treated as
cash collateral under the Bankruptcy Code, receive payment or reduction of a proportion of the aggregate amount of principal, interest, amounts payable in respect of Letters of Credit, fees and other amounts then due and owing to such Lender
hereunder or under the other Credit Documents (collectively, the “Aggregate Amounts Due” to such Lender) which is greater than the proportion received by any other Lender in respect of the Aggregate Amounts Due to such other Lender,
then the Lender receiving such proportionately greater payment shall (i) notify the Administrative Agent and each other Lender of the receipt of such payment and (ii) apply a portion of such payment to purchase participations (which it
shall be deemed to 

  
 96 

 
have purchased from each seller of a participation simultaneously upon the receipt by such seller of its portion of such payment) in the Aggregate Amounts Due to the other Lenders so that all
such recoveries of Aggregate Amounts Due shall be shared by all Lenders in proportion to the Aggregate Amounts Due to them; provided, if all or part of such proportionately greater payment received by such purchasing Lender is thereafter
recovered from such Lender upon the bankruptcy or reorganization of the Borrower or otherwise, those purchases shall be rescinded and the purchase prices paid for such participations shall be returned to such purchasing Lender ratably to the extent
of such recovery, but without interest. The Borrower expressly consents to the foregoing arrangement and agrees that any holder of a participation so purchased may exercise any and all rights of banker’s lien, consolidation, set-off or
counterclaim with respect to any and all monies owing by the Borrower to that holder with respect thereto as fully as if that holder were owed the amount of the participation held by that holder. The provisions of this Section 2.17 shall
(i) not be construed to apply to (a) any payment made by the Borrower pursuant to and in accordance with the express terms of this Agreement (including the application of funds arising from the existence of a Defaulting Lender) or
(b) any payment obtained by any Lender as consideration for the assignment or sale of a participation in any of its Loans or other Obligations owed to it and (ii) be subject to the provisions of Sections 2.24, 2.25 and 2.26. 

Section 2.18. Making or Maintaining Eurodollar Rate Loans. (a) Inability to Determine Applicable Interest Rate.
In the event that the Administrative Agent shall have determined (which determination shall be final and conclusive and binding upon all parties hereto), on any Interest Rate Determination Date with respect to any Eurodollar Rate Loans that, by
reason of circumstances affecting the London interbank market, adequate and fair means do not exist for ascertaining the interest rate applicable to such Loans on the basis provided for in the definition of Adjusted Eurodollar Rate, the
Administrative Agent shall on such date give notice (by telefacsimile or by telephone confirmed in writing) to the Borrower and each Lender of such determination, whereupon (i) no Loans may be made as, or converted to, Eurodollar Rate Loans
until such time as the Administrative Agent notifies the Borrower and Lenders that the circumstances giving rise to such notice no longer exist and (ii) any Funding Notice or Conversion/Continuation Notice given by the Borrower with respect to
the Loans in respect of which such determination was made shall be deemed to be rescinded by the Borrower. 
 (b) Illegality
or Impracticability of Eurodollar Rate Loans. In the event that on any date any Lender shall have determined (which determination shall be final and conclusive and binding upon all parties hereto but shall be made only after consultation with
the Borrower and the Administrative Agent) that the making, maintaining, converting to or continuation of its Eurodollar Rate Loans (i) has become unlawful as a result of compliance by such Lender in good faith

  
 97 

 
with any law, treaty, governmental rule, regulation, guideline or order (or would conflict with any such treaty, governmental rule, regulation, guideline or order not having the force of law even
though the failure to comply therewith would not be unlawful) or (ii) the Administrative Agent is advised by the Requisite Lenders (which determination shall be final and conclusive and binding upon all parties hereto) that the making,
maintaining, converting to or continuation of its Eurodollar Rate Loans has become impracticable as a result of contingencies occurring, in each case, after (A) the Closing Date or (B) the effective date of the Assignment Agreement
pursuant to which such Lender became a party to this Agreement (such date, as applicable, the “Applicable Date”) which materially and adversely affect the London interbank market or the position of such Lender in that market, then,
and in any such event, such Lenders (or in the case of the preceding clause (i), such Lender) shall be an “Affected Lender” and such Affected Lender shall on that day give notice (by email or by telephone confirmed in writing) to
the Borrower and the Administrative Agent of such determination (which notice the Administrative Agent shall promptly transmit to each other Lender). If the Administrative Agent receives a notice from (x) any Lender pursuant to clause
(i) of the preceding sentence or (y) a notice from Lenders constituting Requisite Lenders pursuant to clause (ii) of the preceding sentence, then (1) the obligation of the Lenders (or, in the case of any notice pursuant to clause
(i) of the preceding sentence, such Lender) to make Loans as, or to convert Loans to, Eurodollar Rate Loans shall be suspended until such notice shall be withdrawn by each Affected Lender, (2) to the extent such determination by the
Affected Lender relates to a Eurodollar Rate Loan then being requested by the Borrower pursuant to a Funding Notice or a Conversion/Continuation Notice, the Lenders (or in the case of any notice pursuant to clause (i) of the preceding sentence,
such Lender) shall make such Loan as (or continue such Loan as or convert such Loan to, as the case may be) a Base Rate Loan, (3) the Lenders’ (or in the case of any notice pursuant to clause (i) of the preceding sentence, such
Lender’s) obligations to maintain their respective outstanding Eurodollar Rate Loans (the “Affected Loans”) shall be terminated at the earlier to occur of the expiration of the Interest Period then in effect with respect to the
Affected Loans or when required by law and (4) the Affected Loans shall automatically convert into Base Rate Loans on the date of such termination. Notwithstanding the foregoing, to the extent a determination by an Affected Lender as described
above relates to a Eurodollar Rate Loan then being requested by the Borrower pursuant to a Funding Notice or a Conversion/Continuation Notice, the Borrower shall have the option, subject to the provisions of Section 2.18(c), to rescind such Funding
Notice or Conversion/Continuation Notice as to all Lenders by giving notice (by telefacsimile or by telephone promptly confirmed in writing) to the Administrative Agent of such rescission on the date on which the Affected Lender gives notice of its
determination as described above (which notice of rescission the Administrative Agent shall promptly transmit to each other Lender). Except as provided in the immediately preceding sentence, nothing in this Section 2.18(b)

  
 98 

 
shall affect the obligation of any Lender other than an Affected Lender to make or maintain Loans as, or to convert Loans to, Eurodollar Rate Loans in accordance with the terms hereof.

 (c) Compensation for Losses. The Borrower shall compensate (1) each Lender, upon written request by such Lender
(which request shall set forth the basis for requesting such amounts), for all reasonable losses, expenses and liabilities (including any interest paid or payable by such Lender to lenders of funds borrowed by it to make or carry its Eurodollar Rate
Loans and any loss, expense or liability sustained by such Lender in connection with the liquidation or re-employment of such funds but excluding loss of anticipated profits) which such Lender may sustain: (i) if for any reason (other than a
default by such Lender) a borrowing of any Eurodollar Rate Loan does not occur on a date specified therefor in a Funding Notice or a telephonic request for borrowing, or a conversion to or continuation of any Eurodollar Rate Loan does not occur on a
date specified therefor in a Conversion/Continuation Notice or a telephonic request for conversion or continuation; (ii) if any prepayment or other principal payment of, or any conversion of, any of its Eurodollar Rate Loans occurs on a date
prior to the last day of an Interest Period applicable to that Loan; or (iii) if any prepayment of any of its Eurodollar Rate Loans is not made on any date specified in a notice of prepayment given by the Borrower and (2) the Issuing Bank,
upon written request by the Issuing Bank, for all reasonable losses, expenses and liabilities which the Issuing Bank may sustain for any payment by the Borrower of any drawing under any Letter of Credit (or interest due thereon) in a different
currency from the Agreed Currency in which the applicable Letter of Credit is denominated (except to the extent the Issuing Bank required payment of such drawing in Dollars pursuant to Section 2.04(d)). 

(d) Booking of Eurodollar Rate Loans. Any Lender may make, carry or transfer Eurodollar Rate Loans at, to, or for the account of
any of its branch offices or the office of an Affiliate of such Lender. 
 (e) Assumptions Concerning Funding of Eurodollar
Rate Loans. Calculation of all amounts payable to a Lender under this Section 2.18 and under Section 2.19 shall be made as though such Lender had actually funded each of its relevant Eurodollar Rate Loans through the purchase of a Eurodollar
deposit bearing interest at the rate obtained pursuant to clause (i) of the definition of Adjusted Eurodollar Rate in an amount equal to the amount of such Eurodollar Rate Loan and having a maturity comparable to the relevant Interest Period
and through the transfer of such Eurodollar deposit from an offshore office of such Lender to a domestic office of such Lender in the United States of America; provided, however, each Lender may fund each of its Eurodollar Rate Loans
in any manner it sees fit and the foregoing assumptions shall be utilized only for the purposes of calculating amounts payable under this Section 2.18 and under Section 2.19. 

  
 99 

 Section 2.19. Increased Costs; Capital Adequacy. (a) Compensation For
Increased Costs and Taxes. If any Change in Law shall: 
 (i) subject a Lender (which term shall include the
Issuing Bank for purposes of this Section 2.19(a)) (or its applicable lending office) to any additional Tax (other than (A) Indemnified Taxes, (B) Taxes described in clause (b) through (d) of the definition of Excluded Taxes
and (C) Connection Income Taxes) on its Loans, loan principal, Letters of Credit, Commitments or other Obligations, or its deposits, reserves, other liabilities or capital attributable thereto; 

(ii) impose, modify or hold applicable any reserve (including any marginal, emergency, supplemental, special or other
reserve), special deposit, liquidity, compulsory loan, FDIC insurance or similar requirement against assets held by, or deposits or other liabilities in or for the account of, or advances or loans by, or other credit extended by, or any other
acquisition of funds by, any office of such Lender (other than any such reserve or other requirements with respect to Eurodollar Rate Loans that are reflected in the definition of “Adjusted Eurodollar Rate”); or 

(iii) impose any other condition (other than with respect to a Tax matter) on or affecting such Lender (or its applicable
lending office) or such Lender’s obligations hereunder or the London interbank market; and the result of any of the foregoing is to increase the cost to such Lender of agreeing to make, making or maintaining Loans or participations in Swing
Line Loans or Letters of Credit or issuing Letters of Credit hereunder or to reduce any amount received or receivable by such Lender (or its applicable lending office) with respect thereto; 
 then, in any such case, the Borrower shall promptly pay to such Lender, upon receipt of the statement referred to in the next sentence, such additional amount or amounts (in the form of an increased rate
of, or a different method of calculating, interest or in a lump sum or otherwise as such Lender in its sole discretion shall determine) as may be necessary to compensate such Lender for any such increased cost or reduction in amounts received or
receivable hereunder. Such Lender shall deliver to the Borrower (with a copy to the Administrative Agent) a written statement, setting forth in reasonable detail the basis for calculating the additional amounts owed to such Lender under this Section
2.19(a), which statement shall be conclusive and binding upon all parties hereto absent manifest error. 
 (b) Capital
Adequacy Adjustment. In the event that any Lender (which term shall include the Issuing Bank for purposes of this Section 2.19(b)) determines that any Change in Law affecting such Lender or any lending office of such Lender or such Lender’s
holding company, if any, regarding capital or 

  
 100

 
liquidity requirements, has or would have the effect of reducing the rate of return on such Lender’s capital or on the capital of such Lender’s holding company, if any, as a consequence
of this Agreement, the Commitments of such Lender or the Loans made by, or participations in Letters of Credit or Swing Line Loans held by, such Lender, or the Letters of Credit issued by any Issuing Bank, to a level below that which such Lender or
such Lender’s holding company could have achieved but for such Change in Law (taking into consideration such Lender’s policies and the policies of such Lender’s holding company with respect to capital adequacy or liquidity), then from
time to time within five (5) Business Days after receipt by the Borrower from such Lender of the statement referred to in the next sentence, the Borrower will pay to such Lender such additional amount or amounts as will compensate such Lender
or such Lender’s holding company for any such reduction suffered. Such Lender shall deliver to the Borrower (with a copy to the Administrative Agent) a written statement, setting forth in reasonable detail the basis for calculating the
additional amounts owed to Lender under this Section 2.19(b), which statement shall be conclusive and binding upon all parties hereto absent manifest error. 
 (c) Refunds. If the Administrative Agent or any Lender determines, in its sole discretion, that it has received a refund of any Taxes as to which the Borrower has paid additional amounts pursuant
to this Section 2.19 or Section 2.20, it shall pay over such refund to the Borrower (but only to the extent of additional amounts paid by the Borrower under this Section 2.19 or Section 2.20 with respect to the Taxes giving rise to such refund), net
of all out-of-pocket expenses of the Administrative Agent or such Lender and without interest (other than any interest paid by the relevant Governmental Authority with respect to such refund); provided that the Borrower, upon the request of
the Administrative Agent or such Lender, agrees to repay the amount paid over to the Borrower (plus any penalties, interest or other charges imposed by the relevant Governmental Authority) to the Administrative Agent or such Lender in the event the
Administrative Agent or such Lender is required to repay such refund to such Governmental Authority. This paragraph shall not be construed to require the Administrative agent or any Lender to make available its tax returns (or any other information
relating to its taxes which it deems confidential) to the Borrower or any other Person. 
 Section 2.20. Taxes;
Withholding, Etc. (a) Payments to Be Free and Clear. All sums payable by or on behalf of any Credit Party hereunder and under the other Credit Documents shall (except to the extent required by law) be paid free and clear of, and
without any deduction or withholding on account of, any Taxes, except as required by applicable law. 
 (b) Withholding of
Taxes. If any Credit Party or any other Person (acting as a withholding agent) is (in such withholding agent’s reasonable good faith discretion) required by law to make any deduction or withholding on account

  
 101

 
of any Tax from any sum paid or payable by any Credit Party to the Administrative Agent or any Lender (which term shall include the Issuing Bank for purposes of this Section 2.20) under any of
the Credit Documents: (i) such Credit Party shall notify the Administrative Agent of any such requirement or any change in any such requirement as soon as the Borrower becomes aware of it; (ii) such Credit Party shall pay, or cause to be
paid, any such Tax before the date on which penalties attach thereto, such payment to be made (if the liability to pay is imposed on any Credit Party) for its own account or (if that liability is imposed on the Administrative Agent or such Lender,
as the case may be) on behalf of and in the name of the Administrative Agent or such Lender; (iii) if such Tax is an Indemnified Tax, the sum payable by such Credit Party in respect of which the relevant deduction, withholding or payment is
required shall be increased to the extent necessary to ensure that, after the making of that deduction, withholding or payment, the Administrative Agent or such Lender, as the case may be, receives on the due date a net sum equal to what it would
have received had no such deduction, withholding or payment been required or made; and (iv) within thirty (30) days after paying any sum from which it is required by law to make any deduction or withholding, and within thirty
(30) days after the due date of payment of any Tax which it is required by clause (ii) above to pay, the Borrower shall deliver to the Administrative Agent evidence reasonably satisfactory to the other affected parties of such deduction,
withholding or payment and of the remittance thereof to the relevant taxing or other authority. 
 (c) Evidence of Exemption
from U.S. Withholding Tax. (i) Any Lender that is entitled to an exemption from or reduction of withholding Tax with respect to payments made under any Credit Document shall deliver to the Borrower and the Administrative Agent, at the time
or times reasonably requested by the Borrower or the Administrative Agent, such properly completed and executed documentation reasonably requested by the Borrower or the Administrative Agent as will permit such payments to be made without
withholding or at a reduced rate of withholding. In addition, any Lender, if reasonably requested by the Borrower or the Administrative Agent, shall deliver such other documentation prescribed by applicable law or reasonably requested by the
Borrower or the Administrative Agent as will enable the Borrower or the Administrative Agent to determine whether or not such Lender is subject to backup withholding or information reporting requirements. Notwithstanding anything to the contrary in
the preceding two sentences, the completion, execution and submission of such documentation (other than such documentation set forth in Section 2.20(c)(ii)(A), Section 2.20(c)(ii)(B) and Section 2.20(d) below) shall not be required if
in the Lender’s reasonable judgment such completion, execution or submission would subject such Lender to any material unreimbursed cost or expense or would materially prejudice the legal or commercial position of such Lender. 

  
 102

 (ii) Without limiting the generality of the foregoing: 

(A) Each Lender that is not a U.S. Person (a “Non-U.S. Lender”), to the extent it is legally able to do
so, shall deliver to the Administrative Agent for itself and for transmission to the Borrower (in such number of copies as shall be requested by the recipient), on or prior to the Applicable Date, and at such other times as may be necessary in the
determination of the Borrower or the Administrative Agent (each in the reasonable exercise of its discretion), whichever of the following that is applicable: 
 (1) in the case of a Non-U.S. Lender claiming the benefits of an income tax treaty to which the United States is a party (x) with respect to payments of interest under any Credit Document, executed
originals of Internal Revenue Service Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “interest” article of such tax treaty and (y) with respect to any other applicable
payments under any Credit Document, Internal Revenue Service Form W-8BEN establishing an exemption from, or reduction of, U.S. federal withholding Tax pursuant to the “business profits” or “other income” article of such tax
treaty; 
 (2) executed original copies of Internal Revenue Service Form W-8ECI; 

(3) to the extent a Non-U.S. Lender is not the beneficial owner, executed originals of Internal Revenue Service Form
W-8IMY accompanied by the documentation and other Internal Revenue Service forms contemplated by that Form W-8IMY (or, in each case, any successor forms), properly completed and duly executed by such Lender, and such other documentation required
under the Internal Revenue Code and reasonably requested by the Borrower or Administrative Agent to establish that such Lender is not subject to, or is subject to a reduced rate of, deduction or withholding of U.S. federal income tax with respect to
any payments to such Lender of principal, interest, fees or other amounts payable under any of the Credit Documents; or 
 (4) in the case of a Non-U.S. Lender claiming the benefits of the exemption for portfolio interest under Section 881(c) of the Internal Revenue Code, (x) a certificate (in the form of Exhibit F
) to the 

  
 103

 
effect that such Non-U.S. Lender is not a “bank” within the meaning of Section 881(c)(3)(A) of the Internal Revenue Code, a “10 percent shareholder” of the Borrower
within the meaning of Section 881(c)(3)(B) of the Code, or a “controlled foreign corporation” described in Section 881(c)(3)(C) of the Internal Revenue Code and (y) executed originals of Internal Revenue Service Form W-8BEN.

 (B) Each Lender that is a U.S. Person (a “U.S. Lender”) shall deliver to the Administrative
Agent and the Borrower on or prior to the Applicable Date two (2) original copies of Internal Revenue Service Form W-9 (or any successor form), properly completed and duly executed by such Lender, certifying that such U.S. Lender is entitled to
an exemption from United States backup withholding. 
 (C) Each Lender required to deliver any forms,
certificates or other evidence with respect to U.S. federal income tax withholding matters pursuant to this Section 2.20(c) hereby agrees, from time to time after the initial delivery by such Lender of such forms, certificates or other evidence,
whenever a lapse in time or change in circumstances renders such forms, certificates or other evidence obsolete or inaccurate in any material respect, that such Lender shall promptly deliver to the Administrative Agent for itself and for
transmission to the Borrower two (2) new original copies of Internal Revenue Service Form W-8BEN, W-8ECI and/or W-8IMY (or, in each case, any successor form), or a Certificate re Non-Bank Status and two (2) original copies of Internal
Revenue Service Form W-8BEN (or any successor form), as the case may be, properly completed and duly executed by such Lender, and such other documentation required under the Internal Revenue Code and reasonably requested by the Borrower or the
Administrative Agent to confirm or establish that such Lender is not subject to, or is subject to a reduced rate of, deduction or withholding of U.S. federal income tax with respect to payments to such Lender under the Credit Documents, or notify
the Administrative Agent and the Borrower of its inability to deliver any such forms, certificates or other evidence. 
 (D) The Borrower shall not be required to pay any additional amount to any Non-U.S. Lender under Section 2.20(b)(iii) if such Lender shall have failed (1) to deliver the forms, certificates or other
evidence referred to in of this Section 2.20(c) or (2) to notify the Administrative Agent and the Borrower 

  
 104

 
of its inability to deliver any such forms, certificates or other evidence, as the case may be; provided, if such Lender shall have satisfied the requirements of this Section 2.20(c) on
the Applicable Date, nothing in this subsection of Section 2.20(c) shall relieve the Borrower of its obligation to pay any additional amounts pursuant to this Section 2.20 in the event that, as a result of any change in any applicable law, treaty or
governmental rule, regulation or order, or any change in the interpretation, administration or application thereof, such Lender is no longer properly entitled to deliver forms, certificates or other evidence at a subsequent date establishing the
fact that such Lender is not subject to withholding as described herein. 
 (d) If a payment made to a Lender under any Credit
Document would be subject to U.S. federal withholding tax imposed by FATCA if such Lender were to fail to comply with the applicable reporting requirements of FATCA (including those contained in Section 1471(b) or 1472(b) of the Internal
Revenue Code, as applicable), such Lender shall deliver to the Borrower and the Administrative Agent at the time or times prescribed by law and at such time or times reasonably requested by the Borrower or the Administrative Agent such documentation
prescribed by applicable law (including as prescribed by Section 1471(b)(3)(C)(i) of the Internal Revenue Code) and such additional documentation reasonably requested by the Borrower or the Administrative Agent as may be necessary for the
Borrower and the Administrative Agent to comply with their obligations under FATCA and to determine that such Lender has complied with such Lender’s obligations under FATCA or to determine the amount to deduct and withhold from such payment.
Solely for purposes of the preceding sentence, “FATCA” shall include any amendments made to FATCA after the date of this Agreement. Notwithstanding anything to the contrary, the Borrower shall not be required to pay any additional amount
pursuant to Section 2.20(b) with respect to any United States federal withholding tax imposed on any “withholdable payments” payable to a recipient as a result of the failure of such recipient to satisfy the applicable requirements as
set forth in FATCA. 
 (e) Without limiting the provisions of Section 2.20(b), the Borrower shall timely pay all Other
Taxes to the relevant Governmental Authorities in accordance with applicable law. Borrower shall deliver to the Administrative Agent official receipts or other evidence of such payment reasonably satisfactory to the Administrative Agent in respect
of any Other Taxes payable hereunder promptly after payment of such Other Taxes. 
 (f) Borrower Indemnification for Failure
to Pay Required Taxes, Etc. The Borrower shall indemnify the Administrative Agent and the Lenders and any of their respective Affiliates for any Taxes imposed on any amounts paid under any Credit Document for which additional amounts are
required to be paid 

  
 105

 
pursuant to this Section 2.20 (including any Taxes imposed or asserted or attributable to amounts payable under this Section) and reasonable expenses arising therefrom or with respect
thereto, regardless of whether such Taxes were correctly or legally imposed or asserted by the relevant Governmental Authority. A certificate as to the amount of such payment or liability delivered to such Credit Party shall be conclusive absent
manifest error. Payment under this indemnification must be made within 10 days from the date the Administrative Agent or any Lender or any of their respective Affiliates makes written demand therefor. 

Section 2.21. Obligation to Mitigate. Each Lender (which term shall include the Issuing Bank for purposes of this
Section 2.21) agrees that, as promptly as practicable after the officer of such Lender responsible for administering its Loans or Letters of Credit, as the case may be, becomes aware of the occurrence of an event or the existence of a condition
that would cause such Lender to become an Affected Lender or that would entitle such Lender to receive payments under Section 2.18, 2.19 or 2.20, it will, to the extent not inconsistent with the internal policies of such Lender and any applicable
legal or regulatory restrictions, use reasonable efforts to (a) make, issue, fund or maintain its Credit Extensions, including any Affected Loans, through another office of such Lender or (b) take such other measures as such Lender may
deem reasonable, if as a result thereof the circumstances which would cause such Lender to be an Affected Lender would cease to exist or the additional amounts which would otherwise be required to be paid to such Lender pursuant to Section 2.18,
2.19 or 2.20 would be materially reduced and if, as determined by such Lender in its sole discretion, the making, issuing, funding or maintaining of its Revolving Commitment, Loans or Letters of Credit through such other office or in accordance with
such other measures, as the case may be, would not otherwise adversely affect such Revolving Commitment, Loans or Letters of Credit or the interests of such Lender; provided, such Lender will not be obligated to utilize such other office
pursuant to this Section 2.21 unless the Borrower agrees to pay all incremental expenses incurred by such Lender as a result of utilizing such other office as described above. A certificate as to the amount of any such expenses payable by the
Borrower pursuant to this Section 2.21 (setting forth in reasonable detail the basis for requesting such amount) submitted by such Lender to the Borrower (with a copy to the Administrative Agent) shall be conclusive absent manifest error.

  
 106

 Section 2.22. Defaulting Lenders.  

(a) Defaulting Lender Adjustments. Notwithstanding anything to the contrary contained in this Agreement, if any Lender becomes a
Defaulting Lender, then, until such time as such Lender is no longer a Defaulting Lender, to the extent permitted by applicable law: 
 (i) Defaulting Lender Waterfall. Any payment of principal, interest, fees or other amounts received by the Administrative Agent for the account of such Defaulting Lender (whether voluntary or
mandatory, at maturity, pursuant to Article 8 or otherwise) or received by the Administrative Agent from a Defaulting Lender pursuant to Section 10.04 shall be applied at such time or times as may be determined by the Administrative Agent as
follows: first, to the payment of any amounts owing by such Defaulting Lender to the Administrative Agent hereunder; second, to the payment on a pro rata basis of any amounts owing by such Defaulting Lender to the Issuing Bank or the
Swing Line Lender hereunder; third, to Cash Collateralize the Issuing Bank’s Fronting Exposure with respect to such Defaulting Lender in accordance with Section 2.22(d); fourth, as the Borrower may request (so long as no
Default exists), to the funding of any Loan in respect of which such Defaulting Lender has failed to fund its portion thereof as required by this Agreement, as determined by the Administrative Agent; fifth, if so determined by the
Administrative Agent and the Borrower, to be held in a Deposit Account and released pro rata in order to (x) satisfy such Defaulting Lender’s potential future funding obligations with respect to Loans under this Agreement and (y) Cash
Collateralize the Issuing Bank’s future Fronting Exposure with respect to such Defaulting Lender with respect to future Letters of Credit issued under this Agreement, in accordance with Section 2.22(d); sixth, to the payment of any
amounts owing to the Lenders, the Issuing Bank or the Swing Line Lender as a result of any judgment of a court of competent jurisdiction obtained by any Lender, the Issuing Bank or the Swing Line Lender against such Defaulting Lender as a result of
such Defaulting Lender’s breach of its obligations under this Agreement; seventh, so long as no Default or Event of Default exists, to the payment of any amounts owing to the Borrower as a result of any judgment of a court of competent
jurisdiction obtained by the Borrower against such Defaulting Lender as a result of such Defaulting Lender’s breach of its obligations under this Agreement; and eighth, to such Defaulting Lender or as otherwise directed by a court of
competent jurisdiction; provided that if (x) such payment is a payment of the principal amount of any Loans or reimbursement obligations with respect to Letters of Credit in respect of which such Defaulting Lender has not fully funded
its appropriate share and (y) such Loans were made or the related Letters of Credit were issued at a time when the conditions set forth in Section 3.02 were satisfied and waived, such payment shall be applied solely to pay the Loans of,
and reimbursement obligations with respect to Letters of Credit owed to, all Non-Defaulting Lenders on a pro rata basis prior to being applied to the payment of any Loans of, or reimbursement obligations with respect to Letters of Credit owed to,
such Defaulting Lender until such time as all Loans and funded and unfunded 

  
 107

 
participations in Letters of Credit and Swing Line Loans are held by the Lenders pro rata in accordance with the applicable Commitments without giving effect to Section 2.22(a)(iii). Any
payments, prepayments or other amounts paid or payable to a Defaulting Lender that are applied (or held) to pay amounts owed by a Defaulting Lender or to post Cash Collateral pursuant to this Section 2.22(a)(i) shall be deemed paid to and
redirected by such Defaulting Lender, and each Lender irrevocably consents hereto. 
 (ii) Certain Fees.

 (A) No Defaulting Lender shall be entitled to receive any fee pursuant to Section 2.11(a) for any period
during which that Lender is a Defaulting Lender (and the Borrower shall not be required to pay any such fee that otherwise would have been required to have been paid to that Defaulting Lender); provided such Defaulting Lender shall be
entitled to receive fees pursuant to Section 2.11(a)(ii) for any period during which that Lender is a Defaulting Lender only to extent allocable to its Pro Rata Share of the Stated Amount of Letters of Credit for which it has provided Cash
Collateral pursuant to Section 2.22(d). 
 (B) With respect to any fees not required to be paid to any
Defaulting Lender pursuant to clause (A) above, the Borrower shall (x) pay to each Non-Defaulting Lender that portion of any such fee otherwise payable to such Defaulting Lender with respect to such Defaulting Lender’s participation
in Letters of Credit or Swing Line Loans that has been reallocated to such Non-Defaulting Lender pursuant to clause (iii) below, (y) pay to the Issuing Bank the amount of any such fee otherwise payable to such Defaulting Lender to the
extent allocable to the Issuing Bank’s Fronting Exposure to such Defaulting Lender and (z) not be required to pay the remaining amount of any such fee. 

(iii) Reallocation of Participations to Reduce Fronting Exposure. All or any part of such Defaulting Lender’s
participation in Letters of Credit and Swing Line Loans shall be reallocated among the Non-Defaulting Lenders in accordance with their respective Pro Rata Shares (calculated without regard to such Defaulting Lender’s Commitment) but only to the
extent that (x) the conditions set forth in Section 3.02 are satisfied at the time of such reallocation (and, unless the Borrower shall have otherwise notified the Administrative Agent at such time, the Borrower shall be deemed to have
represented and warranted that such conditions are satisfied at such time) and (y) such reallocation does not cause the aggregate Revolving Exposure of any Non-Defaulting Lender to exceed such Non-Defaulting Lender’s Revolving Commitment.

  
 108

 
No reallocation hereunder shall constitute a waiver or release of any claim of any party hereunder against a Defaulting Lender arising from that Lender having become a Defaulting Lender,
including any claim of a Non-Defaulting Lender as a result of such Non-Defaulting Lender’s increased exposure following such reallocation. 
 (iv) Cash Collateral, Repayment of Swing Line Loans. If the reallocation described in clause (iii) above cannot, or can only partially, be effected, the Borrower shall, without prejudice to
any right or remedy available to it hereunder or under law, (x) first, prepay Swing Line Loans in an amount equal to the Swing Line Lenders’ Fronting Exposure with respect to the Defaulting Lender and (y) second, Cash Collateralize
the Issuing Bank’s Fronting Exposure with respect to the Defaulting Lender in accordance with the procedures set forth in Section 2.22(d). 
 (b) Defaulting Lender Cure. If the Borrower, the Administrative Agent, the Swing Line Lender and the Issuing Bank agree in writing that a Lender is no longer a Defaulting Lender, the Administrative
Agent will so notify the parties hereto, whereupon as of the effective date specified in such notice and subject to any conditions set forth therein (which may include arrangements with respect to any Cash Collateral), that Lender will, to the
extent applicable, purchase at par that portion of outstanding Loans of the other Lenders or take such other actions as Administrative Agent may determine to be necessary to cause the Loans and funded and unfunded participations in Letters of Credit
and Swing Line Loans to be held pro rata by the Lenders in accordance with the applicable Revolving Commitments (without giving effect to Section 2.22(a)(iii)), whereupon such Lender will cease to be a Defaulting Lender; provided that no
adjustments will be made retroactively with respect to fees accrued or payments made by or on behalf of the Borrower while that Lender was a Defaulting Lender; provided further, that except to the extent otherwise expressly agreed by the
affected parties, no change hereunder from Defaulting Lender to Lender will constitute a waiver or release of any claim of any party hereunder arising from that Lender having been a Defaulting Lender. 

(c) New Swing Line Loans/Letters of Credit. So long as any Revolving Lender is a Defaulting Lender, (i) the Swing Line Lender
shall not be required to fund any Swing Line Loans unless it is satisfied that it will have no Fronting Exposure after giving effect to such Swing Line Loan and (ii) the Issuing Bank shall not be required to issue, extend, renew or increase any
Letter of Credit unless it is satisfied that it will have no Fronting Exposure after giving effect thereto. 
 (d) Cash
Collateral. At any time that there shall exist a Defaulting Lender that is a Revolving Lender, within one (1) Business Day following the written request of the Administrative Agent or the Issuing Bank (with a copy to

  
 109

 
the Administrative Agent) the Borrower shall Cash Collateralize the Issuing Bank’s Fronting Exposure with respect to such Defaulting Lender (determined after giving effect to
Section 2.22(a)(iii) and any Cash Collateral provided by such Defaulting Lender) in an amount not less than the Minimum Collateral Amount. 
 (i) Grant of Security Interest. The Borrower, and to the extent provided by any Defaulting Lender, such Defaulting Lender, hereby grants to the Administrative Agent, for the benefit of the Issuing
Bank, and agrees to maintain, a first priority security interest in all such Cash Collateral as security for the Defaulting Lenders’ obligation to fund participations in respect of Letters of Credit, to be applied pursuant to clause
(ii) below. If at any time the Administrative Agent determines that Cash Collateral is subject to any right or claim of any Person other than the Administrative Agent and the Issuing Bank as herein provided, or that the total amount of such
Cash Collateral is less than the Minimum Collateral Amount, the Borrower will, promptly upon demand by the Administrative Agent, pay or provide to the Administrative Agent additional Cash Collateral in an amount sufficient to eliminate such
deficiency (after giving effect to any Cash Collateral provided by the Defaulting Lender). 
 (ii)
Application. Notwithstanding anything to the contrary contained in this Agreement, Cash Collateral provided under this Section 2.22 in respect of Letters of Credit shall be applied to the satisfaction of the Defaulting Lender’s
obligation to fund participations in respect of Letters of Credit (including, as to Cash Collateral provided by a Defaulting Lender, any interest accrued on such obligation) for which the Cash Collateral was so provided, prior to any other
application of such property as may otherwise be provided for herein. 
 (iii) Termination of Requirement.
Cash Collateral (or the appropriate portion thereof) provided to reduce the Issuing Bank’s Fronting Exposure shall no longer be required to be held as Cash Collateral pursuant to this Section 2.22 following (i) the elimination of the
applicable Fronting Exposure (including by the termination of Defaulting Lender status of the applicable Lender) or (ii) the determination by the Administrative Agent and the Issuing Bank that there exists excess Cash Collateral;
provided that, subject to the other provisions of this Section 2.22, the Person providing Cash Collateral and the Issuing Bank may agree that Cash Collateral shall be held to support future anticipated Fronting Exposure or other
obligations; provided further that to the extent that such Cash Collateral was provided by the Borrower, such Cash Collateral shall remain subject to the security interest granted pursuant to the Credit Documents. 

  
 110

 Section 2.23. Removal or Replacement of a Lender. Anything contained herein to
the contrary notwithstanding, in the event that: (a) (i) any Lender (an “Increased Cost Lender”) shall give notice to the Borrower that such Lender is an Affected Lender or that such Lender is entitled to receive payments
under Section 2.18, 2.19 or 2.20, (ii) the circumstances which have caused such Lender to be an Affected Lender or which entitle such Lender to receive such payments shall remain in effect and (iii) such Lender shall fail to withdraw such
notice within five (5) Business Days after the Borrower’s request for such withdrawal; or (b) any Lender shall become and continues to be a Defaulting Lender; or (c) in connection with any proposed amendment, modification,
termination, waiver or consent with respect to any of the provisions hereof as contemplated by Section 10.05(b), the consent of the Requisite Lenders shall have been obtained but the consent of one or more of such other Lenders (each a
“Non-Consenting Lender”) whose consent is required shall not have been obtained; then, with respect to each such Increased Cost Lender, Defaulting Lender or Non Consenting Lender (the “Terminated Lender”), the
Borrower may, by giving written notice to the Administrative Agent and any Terminated Lender of its election to do so, elect to cause such Terminated Lender (and such Terminated Lender hereby irrevocably agrees) to assign its outstanding Loans,
participations in Letters of Credit and Swing Line Loans and its Revolving Commitment, if any, in full to one or more Eligible Assignees (each a “Replacement Lender”) in accordance with the provisions of Section 10.06 and the
Borrower shall pay the fees, if any, payable thereunder in connection with any such assignment from a Terminated Lender (it being understood and agreed that any Terminated Lender that is a Defaulting Lender shall reimburse the Borrower for such
fees); provided, (1) on the date of such assignment, the Replacement Lender shall pay to Terminated Lender an amount equal to the sum of (A) an amount equal to the principal of, and all accrued interest on all outstanding Loans of
the Terminated Lender, (B) an amount equal to all unreimbursed drawings under Letters of Credit that have been funded by such Terminated Lender, together with all then unpaid interest with respect thereto at such time and (C) an amount
equal to all accrued, but theretofore unpaid fees owing to such Terminated Lender pursuant to Section 2.11; (2) on the date of such assignment, the Borrower shall pay any amounts payable to such Terminated Lender pursuant to Section
2.18(c), 2.19 or 2.20 or if such replacement is of a Non-Consenting Lender and is in connection with a Repricing Transaction, any prepayment premium payable pursuant to Section 2.13(c), in each case as if such assignment were a prepayment; and
(3) in the event such Terminated Lender is a Non Consenting Lender, each Replacement Lender shall consent, at the time of such assignment, to each matter in respect of which such Terminated Lender was a Non Consenting Lender; provided,
the Borrower may not make such election with respect to any Terminated Lender that is also an Issuing Bank unless, prior to the effectiveness of such election, the Borrower shall either (x) have caused each outstanding Letter of Credit issued
by such Terminated Lender to be cancelled or (y) have delivered Cash Collateral or 

  
 111

 
back-up letters of credit reasonably acceptable to the Issuing Bank in an amount equal to at least 101% of the sum of (x) then undrawn Stated Amount of such Letter of Credit and (y) any
unreimbursed drawings thereunder. Upon the prepayment of all amounts owing to any Terminated Lender and the termination of such Terminated Lender’s Revolving Commitment, if any, such Terminated Lender shall no longer constitute a
“Lender” for purposes hereof; provided, any rights of such Terminated Lender to indemnification hereunder shall survive as to such Terminated Lender. Each Lender agrees that if the Borrower exercises its option hereunder to cause an
assignment by such Lender as a Non-Consenting Lender or Terminated Lender, such Lender shall, promptly after receipt of written notice of such election, execute and deliver all documentation necessary to effectuate such assignment in accordance with
Section 10.06. In the event that a Terminated Lender does not comply with the requirements of the immediately preceding sentence within one (1) Business Day after receipt of such notice, each Lender hereby authorizes and directs the
Administrative Agent to execute and deliver such documentation as may be required to give effect to an assignment in accordance with Section 10.06 on behalf of a Terminated Lender and any such documentation so executed by the Administrative Agent
shall be effective for purposes of documenting an assignment pursuant to Section 10.06. Any removal of Goldman Sachs or its successor as a Defaulting Lender pursuant to this Section 2.23 shall also constitute the removal of Goldman Sachs or its
successor as Administrative Agent pursuant to Section 9.07. 
 Section 2.24. Incremental Facilities. (a) The
Borrower may by written notice to the Administrative Agent elect to request the establishment of one or more new term loan commitments (the “New Term Loan Commitments”) and/or (prior to the Revolving Commitment Termination Date) an
increase to the existing Revolving Commitments (any such increase, the “New Revolving Loan Commitments”) the aggregate amount of all such increased commitments and new loans, together with any Permitted Incremental Equivalent Debt
incurred at or prior to such time, not to exceed the greater of (1) $500,000,000 and (2) the maximum amount that would not cause the Net Senior Secured Leverage Ratio to exceed 3.50:1.00 (calculated on a pro forma basis as of the last day
of the most recently ended Fiscal Quarter as if all such incremental or increased Commitments had been fully drawn on such date but without netting the proceeds thereof) (the “Incremental Cap”). Any such increased commitment or new
loan shall be in an amount not less than $25,000,000 individually and integral multiples of $10,000,000 in excess of that amount. Each such notice shall specify (a) the date (each, an “Increased Amount Date”) on which the
Borrower proposes that the New Revolving Loan Commitments or New Term Loan Commitments, as applicable, shall be effective, which shall be a date not less than five (5) Business Days after the date on which such notice is delivered to the
Administrative Agent and (b) the identity of each Lender or other Person that is an Eligible Assignee (each, a “New Revolving Loan Lender” or “New Term 

  
 112

 
Loan Lender,” as applicable) to whom the Borrower proposes any portion of such New Revolving Loan Commitments or New Term Loan Commitments, as applicable, be allocated and the amounts
of such allocations; provided that the Administrative Agent may elect or decline to arrange such New Revolving Loan Commitments or New Term Loan Commitments in its sole discretion and any Lender approached to provide all or a portion of the
New Revolving Loan Commitments or New Term Loan Commitments may elect or decline, in its sole discretion, to provide a New Revolving Loan Commitment or a New Term Loan Commitment. Such New Revolving Loan Commitments or New Term Loan Commitments
shall become effective as of such Increased Amount Date; provided that (i) no Default or Event of Default shall exist on such Increased Amount Date before or after giving effect to such New Revolving Loan Commitments or New Term Loan
Commitments, as applicable; (ii) both before and after giving effect to the making of any Series of New Term Loans, each of the conditions set forth in Section 3.02 shall be satisfied; (iii) the Borrower and its Subsidiaries shall be
in pro forma compliance with each of the covenants set forth in Section 6.07 (calculated on a pro forma basis as of the last day of the most recently ended Fiscal Quarter as if all such incremental or increased Commitments had been fully drawn
on such date but without netting the proceeds thereof); (iv) the New Revolving Loan Commitments or New Term Loan Commitments, as applicable, shall be effected pursuant to one or more Joinder Agreements executed and delivered by the Borrower,
each New Revolving Loan Lender or New Term Loan Lender, as applicable, and the Administrative Agent, each of which shall be recorded in the Register, and each New Revolving Loan Lender or New Term Loan Lender shall be subject to the requirements set
forth in Section 2.20(c); (v) the Borrower shall make any payments required pursuant to Section 2.18(c) in connection with the New Revolving Loan Commitments or New Term Loan Commitments, as applicable; and (vi) the Borrower shall deliver
or cause to be delivered any legal opinions or other documents reasonably requested by the Administrative Agent in connection with any such transaction. Any New Term Loans made on an Increased Amount Date shall be designated a separate series (a
“Series”) of New Term Loans for all purposes of this Agreement. 
 (b) (i) On any Increased Amount Date on
which New Revolving Loan Commitments are effected, subject to the satisfaction of the foregoing terms and conditions, (A) each of the Revolving Lenders shall assign to each of the New Revolving Loan Lenders, and each of the New Revolving Loan
Lenders shall purchase from each of the Revolving Lenders, at the principal amount thereof (together with accrued interest), such interests in the Revolving Loans outstanding on such Increased Amount Date as shall be necessary in order that, after
giving effect to all such assignments and purchases, such Revolving Loans will be held by existing Revolving Lenders and New Revolving Loan Lenders ratably in accordance with their Revolving Commitments after giving effect to the addition of such
New Revolving Loan Commitments to the Revolving Commitments, (B)

  
 113

 
each of the Revolving Lenders shall automatically and without further act be deemed to have assigned to each of the New Revolving Loan Lenders, and each such New Revolving Loan Lender will
automatically and without further act be deemed to have assumed, a portion of such Revolving Lender’s participations hereunder in outstanding Letters of Credit as shall be necessary in order that, after giving effect to all such assignments,
such participations in Letters of Credit will be held by existing Revolving Lenders and New Revolving Loan Lenders ratably in accordance with their Revolving Commitments after giving effect to the addition of such New Revolving Loan Commitments to
the Revolving Commitments, (C) each New Revolving Loan Commitment shall be deemed for all purposes a Revolving Commitment and each Loan made thereunder (a “New Revolving Loan”) shall be deemed, for all purposes, a Revolving Loan and
(D) each New Revolving Loan Lender shall become a Lender with respect to the New Revolving Loan Commitment and all matters relating thereto. 
 (ii) On any Increased Amount Date on which any New Term Loan Commitments of any Series are effective, subject to the satisfaction of the foregoing terms and conditions, (A) each New Term Loan Lender
of any Series shall make a Loan to the Borrower (a “New Term Loan”) in an amount equal to its New Term Loan Commitment of such Series and (B) each New Term Loan Lender of any Series shall become a Lender hereunder with respect
to the New Term Loan Commitment of such Series and the New Term Loans of such Series made pursuant thereto. 
 (c) The
Administrative Agent shall notify Lenders promptly upon receipt of the Borrower’s notice of each Increased Amount Date and in respect thereof (x) the New Revolving Loan Commitments and the New Revolving Loan Lenders or the Series of New
Term Loan Commitments and the New Term Loan Lenders of such Series, as applicable, and (y) in the case of each notice to any Revolving Lender, the respective interests in such Revolving Lender’s Revolving Loans subject to the assignments
contemplated by this Section. 
 (d) The terms and provisions of the New Term Loans and New Term Loan Commitments of any Series
shall be, except as otherwise set forth herein or in the Joinder Agreement and reasonably acceptable to the Administrative Agent, substantially the same as the Tranche A Term Loans (in the case of a Non-Institutional Incremental Facility) or the
Tranche B Term Loans (in the case of an Institutional Incremental Facility). The terms and provisions of the New Revolving Loans shall be identical to the Revolving Loans. In any event (i) (A) the weighted average life to maturity of all
New Term Loans of any Series shall be no shorter than the weighted average life to maturity of the Tranche B Term Loans and (B) the New Term Loan Maturity Date of each Series shall be no earlier than the Latest Maturity Date; provided
that the Borrower may incur New Term Loans that do not satisfy clauses (A) and (B) above so long as such New Term Loans (x) are in an aggregate principal amount, together with all other New

  
 114

 
Term Loans incurred pursuant to this proviso, not greater than $250,000,000, (y) have a New Term Loan Maturity Date on or after the Tranche A Term Loan Maturity Date and (z) have a
weighted average life to maturity that is equal to or longer than the weighted average life to maturity of the Tranche A Term Loans, (ii) the Weighted Average Yield applicable to the New Term Loans of each Series shall be determined by the
Borrower and the applicable New Term Lenders and shall be set forth in each applicable Joinder Agreement; provided that in the event that (x) the Weighted Average Yield applicable to a Non-Institutional Incremental Term Facility is more
than 0.50% higher than the Weighted Average Yield applicable to the Tranche A Term Facility, then the Applicable Margin that shall apply to the calculation of the interest rate on the Tranche A Term Loans shall, in the case of each Tier set forth in
the table contained in the definition of “Applicable Margin,” be increased by an amount equal to the difference between the Weighted Average Yield with respect to such Non-Institutional Incremental Term Facility and the Weighted Average
Yield on the Tranche A Term Facility, minus 0.50% or (y) the Weighted Average Yield applicable to an Institutional Incremental Term Facility is more than 0.50% higher than the Weighted Average Yield applicable to the Tranche B Term
Facility, then the Applicable Margin that shall apply to the calculation of the interest rate on the Tranche B Term Loans shall be increased by an amount equal to the difference between the Weighted Average Yield with respect to such Institutional
Incremental Term Facility and the Weighted Average Yield on the Tranche B Term Facility, minus 0.50%, (iii) such New Term Loans and New Revolving Loans will rank pari passu in right of payment and of security with the other
Obligations hereunder, and (iv) such New Term Loans and New Revolving Loans shall be guaranteed by the Guaranty. Notwithstanding anything to the contrary in this Section 2.24, New Term Loan Commitments may also take the form of an increase
to an existing Class of Term Loans. Each Joinder Agreement may, without the consent of any other Lenders, effect such amendments to this Agreement and the other Credit Documents as may be necessary or appropriate, in the opinion of Administrative
Agent, to effect the provisions of this Section 2.24. 
 Section 2.25. Extensions of Loans. (a) The Borrower
may from time to time, pursuant to the provisions of this Section 2.25, agree with one or more Lenders holding Loans and Commitments of any Class (an “Existing Class”) to extend the maturity date and to provide for other terms
consistent with this Section 2.25 (each such modification, an “Extension”) pursuant to one or more written offers (each an “Extension Offer”) made from time to time by the Borrower to all Lenders under any
Class that is proposed to be extended under this Section 2.25, in each case on a pro rata basis (based on the relative principal amounts of the outstanding Loans and Commitments of each Lender in such Class) and on the same terms to each such
Lender. In connection with each Extension, the Borrower will provide notification to the Administrative Agent (for distribution to the Lenders of the applicable Class) no later than 30 days prior to

  
 115

 
the maturity date of the applicable Class to be extended of the requested new maturity date for the extended Loans or Commitments of such Class (each an “Extended Maturity Date”)
and the due date for Lender responses. In connection with any Extension, each Lender of the applicable Class wishing to participate in such Extension shall, prior to such due date, provide the Administrative Agent with a written notice thereof in a
form reasonably satisfactory to the Administrative Agent. Any Lender that does not respond to an Extension Offer by the applicable due date shall be deemed to have rejected such Extension. In connection with any Extension, the Borrower shall agree
to such procedures, if any, as may be reasonably established by, or acceptable to, the Administrative Agent to accomplish the purposes of this Section 2.25. 
 (b) After giving effect to any Extension, the Term Loans or Revolving Commitments so extended shall cease to be a part of the Class that they were a part of immediately prior to the Extension and shall be
a new Class hereunder; provided that at no time shall there be more than four different Classes of Term Loans and three different classes of Revolving Commitments; provided further, that, in the case of any Extension Amendment
relating to Revolving Commitments or Revolving Loans, (i) all borrowings and all prepayments of Revolving Loans shall continue to be made on a ratable basis among all Revolving Lenders, based on the relative amounts of their Revolving
Commitments, until the repayment of the Revolving Loans (and termination of the Revolving Commitments) attributable to the non-extended Revolving Commitments on the relevant maturity date, (ii) the allocation of the participation exposure with
respect to any then-existing or subsequently issued or made Letter of Credit or Swing Line Loan as between the Revolving Commitments of such new “Class” and the remaining Revolving Commitments shall be made on a ratable basis in accordance
with the relative amounts thereof until the maturity date relating to such non-extended Revolving Commitments has occurred, (iii) no termination of Extended Revolving Commitments and no repayment of Loans under Extended Revolving Commitments
accompanied by a corresponding permanent reduction in Extended Revolving Commitments shall be permitted unless such termination or repayment (and corresponding reduction) is accompanied by at least a pro rata termination or permanent repayment (and
corresponding pro rata permanent reduction), as applicable, of the Existing Revolving Commitments and Loans under Existing Revolving Commitments (or all Existing Revolving Commitments of such Class and related Loans under Existing Revolving
Commitments shall have otherwise been terminated and repaid in full) and (iv) with respect to Letters of Credit and Swing Line Loans, the maturity date with respect to the Revolving Commitments may not be extended without the prior written
consent of the Issuing Bank and the Swing Line Lender. If the Total Utilization of Revolving Commitments exceeds the Revolving Commitment as a result of the occurrence of the maturity date with respect to any Class of Revolving Commitments while an
extended Class of Revolving Commitments remains outstanding, the Borrower shall make such payments as are necessary in order to eliminate such excess on such maturity date. 

  
 116

 (c) The consummation and effectiveness of each Extension shall be subject to the following:

 (i) no Default or Event of Default shall have occurred and be continuing at the time any Extension Offer is
delivered to the Lenders or at the time of such Extension; 
 (ii) the Term Loans or Revolving Commitments, as
applicable, of any Lender extended pursuant to any Extension (as applicable, “Extended Term Loans” or “Extended Revolving Commitments”) shall have the same terms as the Class of Term Loans or Revolving Commitments,
as applicable, subject to the related Extension Amendment (as applicable, “Existing Term Loans” or “Existing Revolving Commitments”); except (A) (1) the final maturity date of any Extended Term Loans or
Extended Revolving Commitments of a Class to be extended pursuant to an Extension shall be later than the Maturity Date of the Class of Existing Term Loans or Existing Revolving Commitments, as applicable, subject to the related Extension Amendment,
(2) the weighted average life to maturity of any Extended Term Loans of a Class to be extended pursuant to an Extension shall be no shorter than the weighted average life to maturity of the Class of Existing Term Loans subject to the related
Extension Amendment and (3) there shall be no scheduled amortization of the Extended Revolving Commitments and the scheduled termination date of the Extended Revolving Commitments shall not be earlier than the scheduled termination date of the
Existing Revolving Commitments; (B) the Weighted Average Yield with respect to the Extended Term Loans or Extended Revolving Commitments, as applicable, may be higher or lower than the Weighted Average Yield for the Existing Term Loans or
Existing Revolving Commitments, as applicable; (C) the revolving credit commitment fee rate with respect to the Extended Revolving Commitments may be higher or lower than the revolving credit commitment fee rate for Existing Revolving
Commitments, in each case, to the extent provided in the applicable Extension Amendment; (D) no repayment of any Extended Term Loans shall be permitted unless such repayment is accompanied by an at least pro rata repayment of all earlier
maturing Term Loans (including previously extended Term Loans) (or all earlier maturing Term Loans (including previously extended Term Loans) shall otherwise be or have been terminated and repaid in full); (E) the Extended Term Loans and/or
Extended Revolving Commitments may contain a “most favored nation” provision for the benefit of Lenders holding previously Extended Term Loans or previously Extended Revolving Commitments, as applicable;
(F)

  
 117

 
such Extended Term Loans and/or Extended Revolving Commitments will rank pari passu in right of payment and of security with the other Obligations hereunder; (G) such Extended Term
Loans and/or Extended Revolving Commitments shall be guaranteed by the Guaranty; and (H) the other terms and conditions applicable to Extended Term Loans and/or Extended Revolving Commitments may be different than those with respect to the
Existing Term Loans or Existing Revolving Commitments, as applicable, so long as such terms and conditions only apply after the Latest Maturity Date; 
 (iii) all documentation in respect of such Extension shall be consistent with the foregoing, and all written communications by the Borrower generally directed to the applicable Lenders under the
applicable Class in connection therewith shall be in form and substance consistent with the foregoing and otherwise reasonably satisfactory to the Administrative Agent; 

(iv) a minimum amount in respect of such Extension (to be determined in the Borrower’s discretion and specified in
the relevant Extension Offer, but in no event less than $25,000,000, unless a lesser amount is agreed to by the Administrative Agent) shall be satisfied; and 
 (v) no Extension shall become effective unless, on the proposed effective date of such Extension, the conditions set forth in Section 3.02 shall be satisfied (with all references in such Section to a
Credit Date being deemed to be references to the Extension on the applicable date of such Extension) or waived by the Lenders whose Loans are being extended pursuant to such Extension, and the Administrative Agent shall have received a certificate
to that effect dated the applicable date of such Extension and executed by an Authorized Officer of the Borrower. 
 (d) For the
avoidance of doubt, it is understood and agreed that the provisions of Section 2.17 and Section 10.05 will not apply to Extensions of Term Loans or Revolving Commitments, as applicable, pursuant to Extension Offers made pursuant to and in
accordance with the provisions of this Section 2.25, including to any payment of interest or fees in respect of any Extended Term Loans or Extended Revolving Commitments, as applicable, that have been extended pursuant to an Extension at a rate
or rates different from those paid or payable in respect of Loans or Commitments of any other Class, in each case as is set forth in the relevant Extension Offer. 
 (e) No Lender who rejects any request for an Extension shall be deemed a Non-Consenting Lender for purposes of Section 2.23; provided, however, that if so requested by the Borrower in
an Extension Offer, the Requisite Lenders may approve an amendment to have such Lenders be deemed Non-Consenting Lenders and subject to the terms and conditions of Section 2.23. 

  
 118

 (f) The Lenders hereby irrevocably authorize the Administrative Agent to enter into
amendments (collectively, “Extension Amendments”) to this Agreement and the other Credit Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower, in order to give effect
to the provisions of this Section 2.25, including any amendments necessary to establish new Classes of Term Loans or Revolving Commitments, as applicable, created pursuant to an Extension, in each case on terms consistent with this
Section 2.25; provided that no such Extension Amendment shall effect any amendments that would require the consent of each affected Lender pursuant to Section 10.05(b) without compliance with the requirements thereof. All such
Extension Amendments entered into with the Borrower by the Administrative Agent hereunder shall be binding on the Lenders. Without limiting the foregoing, in connection with any Extension, (i) the appropriate Credit Parties shall (at their
expense) amend (and the Administrative Agent is hereby directed to amend) any Mortgage (or any other Credit Document that the Administrative Agent or the Collateral Agent reasonably requests to be amended to reflect an Extension) that has a maturity
date prior to the latest Extended Maturity Date so that such maturity date is extended to the then latest Extended Maturity Date (or such later date as may be advised by local counsel to the Administrative Agent) and (ii) the Borrower shall
deliver board resolutions, secretary’s certificates, officer’s certificates and other documents as shall reasonably be requested by the Administrative Agent in connection therewith and a legal opinion of counsel reasonably acceptable to
the Administrative Agent. 
 (g) Promptly following the consummation and effectiveness of any Extension, the Borrower will
furnish to the Administrative Agent (who shall promptly furnish to each Lender) written notice setting forth the Extended Maturity Date and material economic terms of the Extension and the aggregate principal amount of each class of Loans and
Commitments after giving effect to the Extension and attaching a copy of the fully executed Extension Amendment. 

Section 2.26. Refinancing Amendments. (a) The Borrower may, by written notice to the Administrative Agent from time to
time, request Indebtedness in exchange for, or to extend, renew, replace or refinance, in whole or part, existing Term Loans or existing Revolving Loans (or unused Revolving Commitments), or any then existing Credit Agreement Refinancing
Indebtedness (solely for purposes of this Section 2.26, “Refinanced Debt”) in the form of (i) Refinancing Term Loans in respect of all or any portion of any Class of Term Loans then outstanding under this Agreement or
(ii) Refinancing Revolving Commitments in respect of all or any portion of any Revolving Loans (and the unused Revolving Commitments with respect to such Revolving Loans) then outstanding under this Agreement, in each case pursuant to a
Refinancing Amendment (such 

  
 119

 
Indebtedness, “Credit Agreement Refinancing Indebtedness”). Each written notice to the Administrative Agent requesting a Refinancing Amendment shall set forth (i) the amount
of the Refinancing Term Loans or Refinancing Revolving Commitments being requested (which shall be in minimum increments of $25,000,000 and a minimum amount of $50,000,000) and (ii) the date on which such Refinancing Term Loans or Refinancing
Revolving Commitments are requested to become effective (which shall not be less than 10 Business Days (or such shorter period as the Administrative Agent may agree in its sole discretion) after the date of such notice). The Borrower may seek Credit
Agreement Refinancing Indebtedness from existing Lenders (each of which shall be entitled to agree or decline to participate in its sole discretion) or any Person that is an Eligible Assignee (each such Person that is not an existing Lender and that
agrees to provide any portion of the Credit Agreement Refinancing Indebtedness pursuant to a Refinancing Amendment in accordance with this Section 2.26, an “Additional Lender”). 

(b) Notwithstanding the foregoing, the effectiveness of any Refinancing Amendment shall be subject to (i) on the date of
effectiveness thereof, no Default or Event of Default shall have occurred and be continuing or shall be caused thereby, (ii) the terms of the applicable Credit Agreement Refinancing Indebtedness shall comply with Section 2.26(c),
(iii) before and after giving effect to the incurrence of any Credit Agreement Refinancing Indebtedness, each of the conditions set forth in Section 3.02 shall be satisfied and (iv) except as otherwise specified in the applicable
Refinancing Amendment, the Administrative Agent shall have received (with sufficient copies for each of the Refinancing Term Loan Lenders and Refinancing Revolving Lenders, as applicable) legal opinions, board resolutions and other closing
certificates reasonably requested by the Administrative Agent and consistent with those delivered on the Closing Date under Section 3.01. 
 (c) The terms and provisions of any Credit Agreement Refinancing Indebtedness incurred pursuant to any Refinancing Amendment shall be, except as otherwise set forth herein or in the Refinancing Amendment
and reasonably acceptable to the Administrative Agent, substantially the same as the Refinanced Debt; provided that (i) such Credit Agreement Refinancing Indebtedness consisting of Refinancing Term Loans shall have a later maturity than
and a weighted average life to maturity equal to or greater than the Refinanced Debt, (ii) there shall be no scheduled amortization of such Credit Agreement Refinancing Indebtedness consisting of Refinancing Revolving Commitments and the
scheduled termination date of such Refinancing Revolving Commitments shall not be earlier than the scheduled termination date of the Refinanced Debt, (iii) such Credit Agreement Refinancing Indebtedness will rank pari passu in right of
payment and of security with the other Obligations hereunder, (iv) such Credit Agreement Refinancing Indebtedness shall be guaranteed by the Guaranty, (v) the interest rate margin, rate floors, fees, original issue discount and premiums

  
 120

 
applicable to such Credit Agreement Refinancing Indebtedness shall be determined by the Borrower and the Lenders providing such Credit Agreement Refinancing Indebtedness, (vi) such Credit
Agreement Refinancing Indebtedness (including, if such Indebtedness includes any Refinancing Revolving Commitments, the unused portion of such Refinancing Revolving Commitments) shall not have a greater principal amount than the principal amount of
the Refinanced Debt plus accrued interest, fees and premiums (if any) thereon and reasonable fees and expenses associated with the refinancing (provided that the principal amount of such Credit Agreement Refinancing Indebtedness shall
not include any principal constituting interest paid in kind), and the aggregate unused Refinancing Revolving Commitments shall not exceed the unused Revolving Commitments being replaced and (vii) such Refinanced Debt shall be repaid, defeased
or satisfied and discharged on a dollar-for-dollar basis, and all accrued interest, fees and premiums (if any) in connection therewith shall be paid, substantially concurrently with the incurrence of such Credit Agreement Refinancing Indebtedness in
accordance with the provisions of Section 2.13; provided further that to the extent that such Credit Agreement Refinancing Indebtedness consists of Refinancing Revolving Commitments, the Revolving Commitments being refinanced by such
Credit Agreement Refinancing Indebtedness shall be terminated, and all accrued fees in connection therewith shall be paid, on the date such Credit Agreement Refinancing Indebtedness is issued, incurred or obtained. Any Refinancing Amendment may
provide for the issuance of Letters of Credit for the account of the Borrower, pursuant to any Refinancing Revolving Commitments established thereby, in each case on terms substantially equivalent to the terms applicable to Letters of Credit under
the Revolving Commitments to be refinanced thereby; provided that terms relating to pricing, fees or premiums may vary to extent otherwise permitted by this Section 2.26 and set forth in such Refinancing Amendment. 

(d) In connection with any Credit Agreement Refinancing Indebtedness pursuant to this Section 2.26, the Borrower, the Administrative
Agent and each applicable Lender or Additional Lender shall execute and deliver to the Administrative Agent a Refinancing Amendment and such other documentation as the Administrative Agent shall reasonably specify to evidence such Credit Agreement
Refinancing Indebtedness. The Administrative Agent shall promptly notify each Lender as to the effectiveness of each Refinancing Amendment. Each of the parties hereto hereby agrees that, upon the effectiveness of any Refinancing Amendment, this
Agreement shall be deemed amended to the extent necessary to reflect the existence and terms of the Credit Agreement Refinancing Indebtedness incurred pursuant thereto. Any Refinancing Amendment may, without the consent of any other Lenders, effect
such amendments to this Agreement and the other Credit Documents as may be necessary or appropriate, in the reasonable opinion of the Administrative Agent and the Borrower, to effect the provisions of this Section 2.26, including any amendments
necessary to establish the Refinancing 

  
 121

 
Term Loans and Refinancing Revolving Commitments as new Classes, tranches or sub-tranches of Term Loans or Revolving Commitments and such other technical amendments as may be necessary or
appropriate in the reasonable opinion of the Administrative Agent and the Borrower in connection therewith, in each case on terms not inconsistent with this Section 2.26; provided that no such Refinancing Amendment shall effect any
amendments that would require the consent of each affected Lender pursuant to Section 10.05(b) without compliance with the requirements thereof. 
 ARTICLE 3 
 CONDITIONS PRECEDENT 

Section 3.01. Closing Date. The obligation of each Lender or the Issuing Bank, as applicable, to make a Credit Extension on
the Closing Date is subject to the satisfaction, or waiver in accordance with Section 10.05 on or before the Closing Date of the following conditions. 
 (a) Credit Documents. The Administrative Agent and Lead Arrangers shall have received sufficient copies of each Credit Document as the Administrative Agent shall request, originally executed and
delivered by each applicable Credit Party. 
 (b) Organizational Documents; Incumbency. The Administrative Agent shall
have received (i) sufficient copies of each Organizational Document executed and delivered by each Credit Party, as applicable, and, to the extent applicable, certified as of the Closing Date or a recent date prior thereto by the appropriate
Governmental Authority; (ii) signature and incumbency certificates of the officers of such Persons executing the Credit Documents on behalf of each Credit Party; (iii) resolutions of the Board of Directors or similar governing body of each
Credit Party approving and authorizing the execution, delivery and performance of this Agreement, the other Credit Documents and such Related Agreements as are executed and/or delivered in connection with the Acquisition or otherwise on or about the
Closing Date to which it is a party or by which it or its assets may be bound as of the Closing Date, certified as of the Closing Date by its secretary or an assistant secretary as being in full force and effect without modification or amendment;
(iv) a good standing certificate from the applicable Governmental Authority (A) of each Credit Party’s jurisdiction of incorporation, organization or formation and (B) in each jurisdiction in which such Credit Party is qualified
as a foreign corporation or other entity to do business the absence of which would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect, each dated the Closing Date or a recent date prior thereto;
(v) signature and incumbency certificates of one or more officers of the Borrower who are authorized to execute Funding Notices delivered under this Agreement, 

  
 122

 
in substantially the form of Exhibit L (with such amendments or modifications as may be approved by the Administrative Agent); and (vi) such other documents as the Administrative Agent may
reasonably request. 
 (c) (i) Consummation of Transactions Contemplated by Related Agreements. The Acquisition shall
have been consummated (or shall, substantially concurrently with such Credit Extension be consummated) in accordance with the terms of the Acquisition Agreement, without giving effect to any modifications, consents, amendments or waivers thereto
that are materially adverse to the Lenders and the Lead Arrangers, unless consented to by each of the Lead Arrangers. 
 (ii) The Administrative Agent shall have received a fully executed or conformed copy of each Related Agreement and any documents executed in connection therewith. 

(d) No Acquired Business Material Adverse Change. Since December 31, 2011, no change, effect, event or circumstance has
occurred that, in the reasonable judgment of the Administrative Agent, has had, or would reasonably be expected to have, individually or in the aggregate, an Acquired Business Material Adverse Effect. 

(e) Existing Indebtedness. On the Closing Date, the Borrower and its Subsidiaries shall have outstanding no Indebtedness or
preferred stock other than (i) the Loans and other Credit Extensions hereunder, (ii) the Senior Notes, (iii) the Convertible Notes, (iv) Capital Leases, (v) Indebtedness described in Schedule 6.01 and other Indebtedness
permitted under Section 6.01 in an aggregate principal amount not to exceed $25,000,000 and (vi) Indebtedness permitted by the Acquisition Agreement (the “Refinancing”). 

(f) Transaction Costs. On or prior to the Closing Date, the Borrower shall have delivered to the Administrative Agent the
Borrower’s reasonable best estimate of the Transaction Costs (other than fees payable to any Agent and any costs and expenses incurred by Agents and for which Agents are entitled to reimbursement hereunder). 

(g) Governmental Authorizations and Consents. Each Credit Party shall have obtained all Governmental Authorizations and all
consents of other Persons, in each case that are necessary in connection with the transactions contemplated by the Credit Documents and the Related Agreements and each of the foregoing shall be in full force and effect and in form and substance
reasonably satisfactory to the Administrative Agent and the Lead Arrangers. All applicable waiting periods shall have expired without any action being taken or threatened by any competent authority which would restrain, prevent or otherwise impose
adverse conditions on the transactions contemplated by the Credit Documents or the 

  
 123

 
Related Agreements or the financing thereof and no action, request for stay, petition for review or rehearing, reconsideration or appeal with respect to any of the foregoing shall be pending, and
the time for any applicable agency to take action to set aside its consent on its own motion shall have expired. 
 (h) Real
Estate Assets. In order to create in favor of the Collateral Agent, for the benefit of the Secured Parties, a valid and, subject to any filing and/or recording referred to herein, perfected First Priority security interest in any Material Real
Estate Asset, the Collateral Agent shall have received from the Borrower and each applicable Guarantor: 
 (i)
fully executed and notarized Mortgages, in proper form for recording in all appropriate places in all applicable jurisdictions, encumbering each Material Real Estate Asset listed in Schedule 1.1B (each, a “Closing Date Mortgaged
Property”); 
 (ii) an opinion of counsel (which counsel shall be reasonably satisfactory to the
Collateral Agent) in each state in which a Closing Date Mortgaged Property is located with respect to the enforceability of the form(s) of Mortgages to be recorded in such state and such other matters as the Collateral Agent may reasonably request,
in each case in form and substance reasonably satisfactory to the Collateral Agent; 
 (iii) (A) ALTA mortgagee
title insurance policies or unconditional commitments therefor issued by Fidelity National Title Insurance Company or one or more other title companies reasonably satisfactory to the Collateral Agent with respect to each Closing Date Mortgaged
Property (each, a “Title Policy”), in amounts not less than the fair market value of each Closing Date Mortgaged Property, together with copies of all recorded documents listed as exceptions to title or otherwise referred to
therein, each in form and substance reasonably satisfactory to Collateral Agent and (B) evidence satisfactory to the Collateral Agent that such Credit Party has paid to the title company or to the appropriate Governmental Authorities all
expenses and premiums of the title company and all other sums required in connection with the issuance of each Title Policy and all recording and stamp taxes (including mortgage recording taxes) payable in connection with recording the Mortgages for
each Closing Date Mortgaged Property in the appropriate real estate records; 
 (iv) (A) a completed Flood
Certificate with respect to each Closing Date Mortgaged Property, which Flood Certificate shall (x) be addressed to the Collateral Agent and (y) otherwise comply with the Flood Program; (B) if the Flood Certificate states that such
Closing Date Mortgaged Property is located in a Flood Zone, the Borrower’s written acknowledgment of receipt of written notification from the Collateral 

  
 124

 
Agent (x) as to the existence of such Closing Date Mortgaged Property and (y) as to whether the community in which each Closing Date Mortgaged Property is located is participating in
the Flood Program; and (C) if such Closing Date Mortgaged Property is located in a Flood Zone and is located in a community that participates in the Flood Program, evidence that the Borrower has obtained a policy of flood insurance that is in
compliance with all applicable requirements of the Flood Program; and 
 (v) if required to remove a so called
“standard survey exception” from any Title Policy or issue any customary survey-related endorsements thereto, in each case, as reasonably requested by the Collateral Agent, an ALTA survey of the applicable Closing Date Mortgaged Property,
certified to Collateral Agent and dated not more than thirty days prior to the Closing Date; provided, however, that if, despite the Borrower’s commercially reasonable efforts, such survey can not be delivered on or prior to the
Closing Date, this clause (v) shall be deemed to be satisfied if (a) the Borrower delivers such survey within 120 days after the Closing Date and (b) in connection with the delivery of such survey, the Borrower causes the applicable
title company to issue such endorsements or modifications to the corresponding Title Policy as reasonably requested by the Collateral Agent. 
 (i) Personal Property Collateral. In order to create in favor of Collateral Agent, for the benefit of Secured Parties, a valid, perfected First Priority security interest in the Personal Property
Collateral, each Credit Party shall have delivered to the Collateral Agent: 
 (i) evidence that such Credit
Party shall have taken or caused to be taken any action, executed and delivered or caused to be executed and delivered any agreement, document or instrument (including any Intellectual Property Security Agreements, intercompany notes evidencing
Indebtedness permitted to be incurred pursuant to Section 6.01(b) or (x), UCC financing statements, originals of securities, instruments and chattel paper, any agreements governing deposit and/or securities accounts, in each case, as provided
under and subject to the provisions of the Pledge and Security Agreement and any other Collateral Documents) and made or caused to be made searches of UCC filings in the jurisdiction of the chief executive office and state of incorporation of each
Credit Party and each jurisdiction where a filing would need to be made in order to perfect the Collateral Agent’s security interest in the Collateral, or any filing or recording in furtherance thereof or in connection therewith, in each case,
to the extent reasonably required by the Collateral Agent and in each case, subject to the provisions of the Pledge and Security Agreement and the other provisions hereof; 

  
 125

 (ii) completed Collateral Questionnaire dated as of the Closing Date and
executed by an Authorized Officer of each Credit Party, together with all attachments contemplated thereby; 

(iii) fully executed and notarized Intellectual Property Security Agreements, in proper form for filing or recording in
all appropriate places in all applicable jurisdictions within the United States, memorializing and recording the encumbrance of the Intellectual Property Assets listed in Schedule 5.07 to the Pledge and Security Agreement; 

(iv) opinions of counsel (which counsel shall be reasonably satisfactory to the Collateral Agent) with respect to the
creation and perfection, of the security interests in favor of the Collateral Agent in such Collateral and such other matters governed by the laws of each jurisdiction within the United States in which such Credit Party or any Personal Property
Collateral is located as the Collateral Agent may reasonably request, in each case in form and substance reasonably satisfactory to the Collateral Agent (and each Credit Party hereby instructs such counsel to deliver such opinions to the Agents and
the Lenders as of the Closing Date); and 
 (v) evidence that each Credit Party shall have taken or caused to be
taken any other action, executed and delivered or caused to be executed and delivered any other agreement, document and instrument and made or caused to be made any other filing and recording (other than as set forth herein) reasonably required by
Collateral Agent. 
 Notwithstanding anything to the contrary in Section 3.01(h) or 3.01(i) it is understood and agreed
that the perfection of a security interest in or a Lien on the Collateral (other than any Collateral the security interest in or Lien on which may be perfected by the filing of a UCC financing statement, domestic Intellectual Property filings or the
delivery of stock certificates with respect to the Borrower and each of its Domestic Subsidiaries (including, without limitation, the Acquired Business)) shall not constitute a condition precedent to the Closing Date or the obligation of the Issuing
Bank and each Lender to make the initial Credit Extensions to the extent that, after using its commercially reasonable efforts to do so, the Borrower is unable to perfect such security interest or provide such deliverable related to the perfection
of security interests or liens in the Collateral on or prior to the Closing Date. 
 (j) Financial Statements;
Projections. The Borrower shall, or shall cause the Acquired Business to, deliver to the Lenders (i) the Historical Financial Statements and (ii) pro forma consolidated balance sheets of the Borrower and its Subsidiaries (including,
for the avoidance of doubt, the Acquired Business and its Subsidiaries) as at the Closing Date, and reflecting the consummation of the 

  
 126

 
Acquisition, the related financings and the other transactions contemplated by the Credit Documents to occur on or prior to the Closing Date, which pro forma financial statements shall meet the
requirements of Regulation S-X for a Form S-1 Registration Statement except that no footnote pursuant to Regulation S-X 3-10 shall be required with respect to Guarantors. 
 (k) Evidence of Insurance. The Collateral Agent shall have received a certificate from the applicable Credit Party’s insurance broker or other evidence satisfactory to it that all insurance
required to be maintained pursuant to Section 5.05 is in full force and effect, together with endorsements naming Collateral Agent, for the benefit of Secured Parties, as additional insured and loss payee thereunder to the extent required under
Section 5.05. 
 (l) Opinions of Counsel to Credit Parties. The Agents and the Lenders and their respective counsel
shall have received originally executed copies of the favorable written opinions of (i) Brown Rudnick LLP, counsel for the Credit Parties in the form of Exhibit D-1 and (ii) Richards, Layton & Finger, P.A., Delaware counsel for the
Credit Parties, Newmeyer & Dillion, LLP, California counsel for the Credit Parties, Brownstein Hyatt Farber Schreck, LLP, Nevada counsel for the Credit Parties and Whyte Hirschboeck Dudek S.C., Wisconsin counsel for the Credit Parties, in
the form of Exhibit D-2, D-3, D-4 and D-5, respectively and as to such other matters as the Administrative Agent may reasonably request, dated as of the Closing Date and otherwise in form and substance reasonably satisfactory to the Administrative
Agent (and each Credit Party hereby instructs such counsel to deliver such opinions to the Agents and the Lenders). 
 (m)
Fees, Costs and Expenses. The Borrower shall have paid (i) to the Agents the fees payable on or before the Closing Date referred to in Section 2.11(d) and (ii) payable pursuant to Section 10.02 which have accrued to the
Closing Date. 
 (n) Existing Acquired Business Credit Agreement. On or prior to the Closing Date, (i) the Existing
Acquired Business Credit Agreement shall have been repaid in full and all commitments to lend or make other extensions of credit thereunder shall have been terminated, (ii) the Borrower shall have delivered to the Administrative Agent all
documents or instruments necessary to release or evidence the release of all Liens securing the Existing Acquired Business Credit Agreement or other obligations thereunder being repaid on the Closing Date and (iii) the Borrower shall have made
arrangements satisfactory to the Administrative Agent and Lead Arrangers with respect to the cancellation or Cash Collateralization of any letters of credit outstanding thereunder or the issuance of Letters of Credit to support the obligations with
respect thereto. 

  
 127

 (o) Solvency Certificate. On the Closing Date, the Administrative Agent shall have
received a Solvency Certificate from the Borrower in form, scope and substance satisfactory to the Administrative Agent, and demonstrating that after giving effect to the consummation of the Acquisition and any rights of contribution, the Borrower
and its Subsidiaries, on a consolidated basis, are Solvent. 
 (p) Closing Date Certificate. The Borrower shall have
delivered to the Administrative Agent an originally executed Closing Date Certificate, together with all attachments thereto. 

(q) Closing Date. Lenders shall have made the Term Loans to the Borrower on or before October 29, 2012. 

(r) Letter of Direction. The Administrative Agent shall have received a duly executed letter of direction from the Borrower
addressed to the Administrative Agent, on behalf of itself and Lenders, directing the disbursement on the Closing Date of the proceeds of the Loans made on such date. 
 (s) PATRIOT Act. At least three (3) days prior to the Closing Date, each Lender shall have received all documentation and other information required by bank regulatory authorities under
applicable “know-your-customer” and anti-money laundering rules and regulations, including the U.S.A. PATRIOT Act (Title III of Pub. L. 107-56 (signed into law October 26, 2001), the “PATRIOT Act”) to the extent
requested in writing by such Lender in writing at least 10 days prior to the Closing Date. 
 (t) Specified Transactions.
From and including April 29, 2012 through the Closing Date, neither the Borrower nor any of its Subsidiaries (prior to giving effect to the Acquisition) shall have consummated any merger (other than any merger of a Domestic Subsidiary into
another Domestic Subsidiary or a Subsidiary into the Borrower), acquisition or disposition (other than any disposition effected to satisfy one or more of the conditions precedent set forth in the Acquisition Agreement) or paid any dividend (other
than any dividends made from a Subsidiary to another Subsidiary or made by a Subsidiary to Borrower) or effected any share buybacks (or entered into an agreement to consummate any of the foregoing) (each a “Specified Transaction”)
other than the Acquisition, except any such Specified Transactions (x) in the ordinary course of business, (y) that are not in the ordinary course of business and involve, in the aggregate across all such Specified Transactions, no more
than $100,000,000 of consideration or payments, as applicable, or (z) consented to by each of the Lead Arrangers (such consent not to be unreasonably withheld or delayed). 

Section 3.02. Conditions to Each Credit Extension. (a) Conditions Precedent. The obligation of each Lender to
make any Loan, or the Issuing Bank 

  
 128

 
to issue any Letter of Credit, on any Credit Date, including the Closing Date, are subject to the satisfaction, or waiver in accordance with Section 10.05, of the following conditions precedent:

 (i) the Administrative Agent shall have received a fully executed and delivered Funding Notice or Letter of
Credit Application, as the case may be; 
 (ii) with respect to the Revolving Commitments, after making the
Credit Extensions requested on such Credit Date, the Total Utilization of Revolving Commitments shall not exceed the Revolving Commitments then in effect; 
 (iii) with respect to the Revolving Commitments, the Term Loan Commitments and the New Term Loans, as of such Credit Date, the representations and warranties contained herein and in the other Credit
Documents shall be true and correct in all material respects on and as of that Credit Date to the same extent as though made on and as of that date, except to the extent such representations and warranties specifically relate to an earlier date, in
which case such representations and warranties shall have been true and correct in all material respects on and as of such earlier date; provided that, (A) in each case, such materiality qualifier shall not be applicable to any
representations and warranties that already are qualified or modified by materiality in the text thereof and (B) with respect to any Loans made on the Closing Date, the representations and warranties the accuracy of which shall be a condition
to the funding of such Loans shall be limited to (1) those set forth in Section 4.01(a) (other than with respect to the applicable Person being in good standing in each applicable jurisdiction), 4.01(b)(ii), 4.03, 4.04(a)(i), 4.04(a)(ii),
4.06, 4.17(a)(i), 4.17(b), 4.18, 4.22, 4.27, 4.28 and (subject to the limitations on perfection of security interests set forth in the last paragraph of Section 3.01(i)) 4.29, and, with respect to the Borrower only, Section 4.07 and
(2) the Acquisition Agreement Representations, and shall be made subject to the applicable materiality qualifiers referenced above; 
 (iv) other than with respect to the Credit Extensions made on the Closing Date, as of such Credit Date, no event shall have occurred and be continuing or would result from the consummation of the
applicable Credit Extension that would constitute an Event of Default or a Default; and 
 (v) on or before the
date of issuance of any Letter of Credit, the Administrative Agent shall have received all other information required by the applicable Letter of Credit Application, and such other documents or information as the Issuing Bank may reasonably require
in connection with the issuance of such Letter of Credit. 

  
 129

 Any Agent or the Requisite Lenders shall be entitled, but not obligated to, request and
receive, prior to the making of any Credit Extension, additional information reasonably satisfactory to the requesting party confirming the satisfaction of any of the foregoing if, in the good faith judgment of such Agent or the Requisite Lenders,
such request is warranted under the circumstances. 
 (b) Notices. Any Notice shall be executed by an Authorized Officer
in a writing delivered to the Administrative Agent. In lieu of delivering a Notice, the Borrower may give the Administrative Agent telephonic notice by the required time of any proposed borrowing, conversion/continuation or issuance of a Letter of
Credit, as the case may be; provided each such notice shall be promptly confirmed in writing by delivery of the applicable Notice to the Administrative Agent on or before the close of business on the date that the telephonic notice is given.
In the event of a discrepancy between the telephone notice and the written Notice, the written Notice shall govern. In the case of any Notice that is irrevocable once given, if Borrower provides telephonic notice in lieu thereof, such telephone
notice shall also be irrevocable once given. Neither the Administrative Agent nor any Lender shall incur any liability to the Borrower in acting upon any telephonic notice referred to above that the Administrative Agent believes in good faith to
have been given by a duly authorized officer or other person authorized on behalf of the Borrower or for otherwise acting in good faith. 
 ARTICLE 4 
 REPRESENTATIONS AND
WARRANTIES 
 In order to induce the Lenders and the Issuing Bank to enter into this Agreement and to make each
Credit Extension to be made thereby, each Credit Party makes the following representations and warranties to each Lender and the Issuing Bank, on the Closing Date and on each Credit Date (it being understood and agreed that the representations and
warranties made on the Closing Date are deemed to be made concurrently with the consummation of the Acquisition): 

Section 4.01. Organization; Requisite Power and Authority; Qualification. Each of the Borrower and its Subsidiaries (other
than any Immaterial Domestic Subsidiary) (a) is duly organized, validly existing and (to the extent the concept is applicable in such jurisdiction) in good standing under the laws of its jurisdiction of organization as identified in Schedule
4.01, (b) has all requisite power and authority (i) to own and operate its properties and carry on its business as now conducted and as proposed to be conducted except to the extent the combined effect of all such failures and exceptions
would not have a Material Adverse Effect, (ii) to enter into the Credit Documents to which it is a party and to carry 

  
 130

 
out the transactions contemplated thereby and (iii) to the extent such concepts are applicable in such jurisdictions, is qualified to do business and in good standing in every jurisdiction
where its assets are located and wherever necessary to carry out its business and operations, except in jurisdictions where the failure to be so qualified or in good standing has not had, and would not be reasonably expected to have, a Material
Adverse Effect. 
 Section 4.02. Equity Interests and Ownership. The Equity Interests of each Subsidiary of the
Borrower (other than any Immaterial Domestic Subsidiary) and the other Credit Parties have been duly authorized and validly issued and is fully paid and non-assessable. As of the Closing Date, there is no existing option, warrant, call, right,
commitment or other agreement to which the Borrower or any of its Subsidiaries (other than any Immaterial Domestic Subsidiary) is a party requiring, and there is no membership interest or other Equity Interests of the Borrower or any of its
Subsidiaries (other than any Immaterial Domestic Subsidiary) outstanding which upon conversion or exchange would require, the issuance by the Borrower or such Subsidiary of any additional membership interests or other Equity Interests of the
Borrower or such Subsidiary or other Securities convertible into, exchangeable for or evidencing the right to subscribe for or purchase, a membership interest or other Equity Interests of the Borrower or such Subsidiary. Schedule 4.02 correctly sets
forth the organizational structure, including the ownership interest of the Borrower and each of its Subsidiaries in their respective Subsidiaries, and capital structure of the Borrower and its Subsidiaries as of the Closing Date both before and
after giving effect to the Acquisition. 
 Section 4.03. Due Authorization. The execution, delivery and performance
of the Credit Documents have been duly authorized by all necessary action on the part of each Credit Party that is a party thereto. 
 Section 4.04. No Conflict. The execution, delivery and performance by the Credit Parties of the Credit Documents to which they are parties and the consummation of the transactions contemplated
by the Credit Documents do not and will not (a) violate (i) any provision of any law or any governmental rule or regulation applicable to the Borrower or any of its Subsidiaries (ii) any of the Organizational Documents of the Borrower
or any of its Subsidiaries, or (iii) in any material respect, any order, judgment or decree of any court or other agency of government binding on the Borrower or any of its Subsidiaries; (b) conflict with, result in a breach of or
constitute (with due notice or lapse of time or both) a default under any Contractual Obligation of the Borrower or any of its Subsidiaries, except to the extent the combined effect of all such conflicts, breaches and defaults would not have a
Material Adverse Effect; (c) result in or require the creation or imposition of any Lien upon any of the properties or assets of the Borrower or any of its Subsidiaries (other than any Liens permitted under any of the Credit Documents or
created under any of the Credit Documents in 

  
 131

 
favor of the Collateral Agent, on behalf of the Secured Parties); or (d) require any approval of stockholders, members or partners or any approval or consent of any Person under any
Contractual Obligation of the Borrower or any of its Subsidiaries, except (x) for such approvals or consents which will be obtained on or before the Closing Date and disclosed in writing to Lenders or (y) to the extent the combined effect
of the failure to obtain all such approvals and consents would not have a Material Adverse Effect. 
 Section 4.05.
Governmental Consents. The execution, delivery and performance by the Credit Parties of the Credit Documents to which they are parties and the consummation of the transactions contemplated by the Credit Documents do not and will not require any
material registration with, consent or approval of, or notice to, or other action to, with or by, any Governmental Authority except as otherwise set forth in the Acquisition Agreement, unless such action is taken, notice given or consents obtained
on or prior to the Closing Date and except for filings and recordings with respect to the Collateral to be made, or otherwise delivered to the Collateral Agent for filing and/or recordation, on or before the Closing Date. 

Section 4.06. Binding Obligation. Each Credit Document has been duly executed and delivered by each Credit Party that is a
party thereto and is the legally valid and binding obligation of such Credit Party, enforceable against such Credit Party in accordance with its respective terms, except as may be limited by bankruptcy, insolvency, reorganization, moratorium or
similar laws relating to or limiting creditors’ rights generally or by equitable principles relating to enforceability. 

Section 4.07. Historical Financial Statements. The Historical Financial Statements were prepared in conformity with GAAP and
fairly present, in all material respects, the financial position, on a consolidated basis, of the Persons described in such financial statements as at the respective dates thereof and the results of operations and cash flows, on a consolidated
basis, of the entities described therein for each of the periods then ended, subject, in the case of any such unaudited financial statements, to changes resulting from audit and normal year-end adjustments, and the absence of footnotes. As of the
Closing Date, neither the Borrower nor any of its Subsidiaries has any contingent liability or liability for Taxes, long-term lease or unusual forward or long-term commitment that is required by GAAP to be reflected in the Historical Financial
Statements and is not reflected in the Historical Financial Statements or the notes thereto and which in any such case is material in relation to the business, operations, properties, assets or condition (financial or otherwise) of the Borrower and
any of its Subsidiaries taken as a whole. 
 Section 4.08. Projections. On and as of the Closing Date, the
projections of the Borrower and its Subsidiaries for the period of Fiscal Year 2012 through 

  
 132

 
and including Fiscal Year 2019 (the “Projections”) are based on good faith estimates and assumptions made by the management of the Borrower; provided, the Projections are
not to be viewed as facts and that actual results during the period or periods covered by the Projections may differ from such Projections and that the differences may be material; provided further, as of the Closing Date, management of the
Borrower believed that the Projections were reasonable and attainable. 
 Section 4.09. No Material Adverse Change.
Since September 30, 2011, no event, circumstance or change has occurred that has caused or evidences, either in any case or in the aggregate, a Material Adverse Effect. 

Section 4.10. No Restricted Junior Payments. Since September 30, 2011, neither the Borrower nor any of its Subsidiaries
has directly or indirectly declared, ordered, paid or made, or set apart any sum or property for, any Restricted Junior Payment or agreed to do so except as permitted pursuant to Section 6.04. 

Section 4.11. Adverse Proceedings, Etc. Except as set forth on Schedule 4.11, there are no Adverse Proceedings, individually
or in the aggregate, that would reasonably be expected to have a Material Adverse Effect. Neither the Borrower nor any of its Subsidiaries (a) is in violation of any applicable laws (including Environmental Laws) that, individually or in the
aggregate, would reasonably be expected to have a Material Adverse Effect or (b) is subject to or in default with respect to any final judgments, writs, injunctions, decrees, rules or regulations of any court or any federal, state, municipal or
other governmental department, commission, board, bureau, agency or instrumentality, domestic or foreign, that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. 

Section 4.12. Payment of Taxes. Except as otherwise permitted under Section 5.03, all federal, state and other material
tax returns and tax reports of the Borrower and its Subsidiaries required to be filed by any of them have been timely filed (taking into account any extension of time granted to them), and all federal, state and other taxes shown on such tax returns
to be due and payable and all federal, state, and other material taxes, assessments, fees and other governmental charges upon the Borrower and its Subsidiaries and upon their respective properties, assets, income, businesses and franchises which are
due and payable have been paid when due and payable, except those which are being contested in good faith by appropriate proceedings and for which adequate reserves have been made or provided in accordance with GAAP. The Borrower has not received
notice of any proposed federal, state or other material tax assessment against the Borrower or any of its Subsidiaries which is not being actively contested by the Borrower or such Subsidiary in good faith and by appropriate proceedings;
provided, such reserves or other appropriate provisions, if any, as shall be required in conformity with GAAP shall have been made or provided therefor. 

  
 133

 Section 4.13. Properties. (a) Title. Each of the Borrower and its
Subsidiaries has (i) good, sufficient and legal title to (in the case of fee interests in real property), (ii) valid leasehold interests in (in the case of leasehold interests in real or personal property), (iii) valid licensed rights
in (in the case of licensed interests in Intellectual Property) and (iv) good title to (in the case of all other personal property) all of their respective properties and assets reflected in their respective Historical Financial Statements
referred to in Section 4.07 and in the most recent financial statements delivered pursuant to Section 5.01, in each case except for assets disposed of since the date of such financial statements in the ordinary course of business or as
otherwise permitted under Section 6.08, except for such defects in title, leasehold interest or licensed interest as would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Except as permitted by this
Agreement or any Collateral Document, all such properties and assets are free and clear of Liens in all material respects. 

(b) Real Estate. As of the Closing Date, Schedule 4.13(b) contains a true, accurate and complete list of (i) all Real Estate
Assets and (ii) all leases, tenancies, franchise agreements, licenses or other occupancy arrangements (together with all amendments, modifications, supplements, renewals or extensions of any thereof) to which any Credit Party is party as owner,
lessor, licensor, franchisor or grantor with respect to any Material Real Estate Asset. Each lease or assignments of lease affecting any Real Estate Asset of any Credit Party, regardless of whether such Credit Party is the landlord or tenant
(whether directly or as an assignee or successor in interest) under such lease or assignment is in full force and effect with respect to the Credit Party and the Borrower does not have knowledge of any default that has occurred and is continuing
thereunder, except where such defaults individually or in the aggregate would not reasonably be expected to have a Material Adverse Effect, and each such agreement constitutes the legally valid and binding obligation of each applicable Credit Party,
enforceable against such Credit Party in accordance with its terms, except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or limiting creditors’ rights generally or by equitable
principles. 
 (c) Intellectual Property. Each of the Borrower and its Subsidiaries owns or is validly licensed to use
all Intellectual Property that is necessary for the present conduct of its business, free and clear of Liens (other than Permitted Liens), without conflict with the rights of any other Person unless the failure to own or benefit from such valid
license would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Neither the Borrower nor any of its Subsidiaries is infringing, misappropriating, diluting or otherwise

  
 134

 
violating the Intellectual Property rights of any other Person unless such infringement, misappropriation, dilution or violation would not, individually or in the aggregate, reasonably be
expected to have a Material Adverse Effect. Other than as set forth on Schedule 4.13(c), there is no pending or, to the best knowledge of the Borrower and its Subsidiaries, threatened claim, investigation, litigation or other proceeding against the
Borrower or any of its Subsidiaries alleging any such infringement, misappropriation, dilution or other violation that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. To the best knowledge of the
Borrower and its Subsidiaries, during the past two (2) years (or earlier if presently not resolved), no Person has infringed, misappropriated, diluted or otherwise violated any Intellectual Property Assets unless such infringement,
misappropriation, dilution or violation would not, individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. Each of the Borrower and each of its Subsidiaries has taken and are taking commercially reasonable steps,
consistent with industry standards, to maintain and protect all Intellectual Property Assets that are material to the conduct of its respective business. 
 Section 4.14. Environmental Matters. Neither the Borrower nor any of its Subsidiaries nor any of their respective Facilities or operations are subject to any outstanding written order, consent
decree or settlement agreement with any Person relating to any Environmental Law, any Environmental Claim or any Hazardous Materials Activity that, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect.
Neither the Borrower nor any of its Subsidiaries or, to any Credit Party’s knowledge, any predecessor of the Borrower or any of its Subsidiaries, has received any letter or request for information under Section 104 of the Comprehensive
Environmental Response, Compensation, and Liability Act (42 U.S.C. § 9604) or any comparable state law. There are and, to each of the Borrower’s and its Subsidiaries’ knowledge, have been, no conditions, occurrences or Hazardous
Materials Activities which would reasonably be expected to form the basis of an Environmental Claim against the Borrower or any of its Subsidiaries or any predecessor of the Borrower or any of its Subsidiaries that, individually or in the aggregate,
would reasonably be expected to have a Material Adverse Effect. None of the Borrower’s and its Subsidiaries’ operations that involve the generation, transportation, treatment, storage or disposal of hazardous waste, including as defined
under 40 C.F.R. Parts 260 et seq. or any state equivalent, individually or in the aggregate, would reasonably be expected to have a Material Adverse Effect. Compliance with all requirements pursuant to or under Environmental Laws would not be
reasonably expected to have, individually or in the aggregate, a Material Adverse Effect. No event or condition has occurred or is occurring with respect to the Borrower or any of its Subsidiaries or, to any Credit Party’s knowledge, any
predecessor of the Borrower or any of its Subsidiaries, relating to any Environmental Law or any Hazardous Materials Activity which individually or in the aggregate has had, or would reasonably be expected to have, a Material Adverse Effect.

  
 135

 Section 4.15. No Defaults. Neither the Borrower nor any of its Subsidiaries is
in material default in the performance, observance or fulfillment of any of the obligations, covenants or conditions contained in any of its Contractual Obligations, and no condition exists which, with the giving of notice or the lapse of time or
both, could constitute such a default, except where the consequences, direct or indirect, of such default or defaults, if any, would not reasonably be expected to have a Material Adverse Effect. 

Section 4.16. Material Contracts. Schedule 4.16 contains a true, correct and complete list of all agreement evidencing
Contractual Obligations of the Borrower and its Subsidiaries in effect on the Closing Date which are required by U.S. securities laws to be filed by the Borrower as exhibits to the periodic reports it files with the U.S. Securities and Exchange
Commission except for employment agreements. Except as set forth on Schedule 4.16, all Material Contracts are in full force and effect and, to the Borrower’s knowledge, no defaults currently exist thereunder. 

Section 4.17. Governmental Regulation. (a) Neither the Borrower nor any of its Subsidiaries is subject to regulation
under (i) the Investment Company Act of 1940 or (ii) any other federal or state statute or regulation which, in each case, may limit its ability to incur Indebtedness or which may otherwise render all or any portion of the Obligations
unenforceable. 
 (b) Neither the Borrower nor any of its Subsidiaries is a “registered investment company” or a
company “controlled” by a “registered investment company” or a “principal underwriter” of a “registered investment company” as such terms are defined in the Investment Company Act of 1940. 

Section 4.18. Margin Stock. After applying the proceeds of the Term Loans, not more than 25% of the assets of the Borrower
and its Subsidiaries consist of Margin Stock. Neither the Borrower nor any of its Subsidiaries is engaged principally, or as one of its important activities, in the business of extending credit for the purpose of buying or carrying Margin Stock.

 Section 4.19. Employee Matters. Neither the Borrower nor any of its Subsidiaries is engaged in any unfair labor
practice that would reasonably be expected to have a Material Adverse Effect. There is (a) no unfair labor practice complaint pending against the Borrower or any of its Subsidiaries, or to the knowledge of the Borrower, threatened against any
of them before the National Labor Relations Board and no grievance or arbitration proceeding arising out of or under any collective bargaining agreement that is so pending against the Borrower or any of its Subsidiaries or to the knowledge of the
Borrower, 

  
 136

 
threatened against any of them, (b) no strike or work stoppage in existence or threatened involving the Borrower or any of its Subsidiaries and (c) to the knowledge of the Borrower, no
union representation question existing with respect to the employees of the Borrower or any of its Subsidiaries and, to the knowledge of the Borrower, no union organization activity that is taking place, except (with respect to any matter specified
in clause (a), (b) or (c) above, either individually or in the aggregate) such as would not reasonably be expected to have a Material Adverse Effect. 
 Section 4.20. Employee Benefit Plans. The Borrower, each of its Subsidiaries and each of their respective ERISA Affiliates are in compliance in all material respects with all applicable
provisions and requirements of ERISA and the Internal Revenue Code and the regulations and published interpretations thereunder with respect to each Employee Benefit Plan, and have performed in all material respects all their obligations under each
Employee Benefit Plan. Each Employee Benefit Plan which is intended to qualify under Section 401(a) of the Internal Revenue Code has received or requested a favorable determination letter from the Internal Revenue Service indicating that such
Employee Benefit Plan is so qualified and nothing has occurred subsequent to the issuance of such determination letter which would cause such Employee Benefit Plan to lose its qualified status. No material liability to the PBGC (other than required
premium payments), the Internal Revenue Service, any Employee Benefit Plan or any trust established under Title IV of ERISA has been or is expected to be incurred by the Borrower, any of its Subsidiaries or any of their ERISA Affiliates. No ERISA
Event has occurred or is reasonably expected to occur. Except to the extent required under Section 4980B of the Internal Revenue Code or similar state laws, no Employee Benefit Plan provides health or welfare benefits (through the purchase of
insurance or otherwise) for any retired or former employee of the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates. The present value of the aggregate benefit liabilities under each Pension Plan sponsored, maintained or
contributed to by the Borrower, any of its Subsidiaries or any of their ERISA Affiliates (determined as of the end of the most recent plan year on the basis of the actuarial assumptions specified for funding purposes in the most recent actuarial
valuation for such Pension Plan) did not materially exceed the aggregate current value of the assets of such Pension Plan. As of the most recent valuation date for each Multiemployer Plan for which the actuarial report is available, the potential
liability of the Borrower, its Subsidiaries and their respective ERISA Affiliates for a complete withdrawal from such Multiemployer Plan (within the meaning of Section 4203 of ERISA), when aggregated with such potential liability for a complete
withdrawal from all Multiemployer Plans, based on information available pursuant to Section 4221(e) of ERISA is not materially more than zero. The Borrower, each of its Subsidiaries and each of their ERISA Affiliates have complied with the
requirements of Section 515 of ERISA with respect to each Multiemployer Plan and are not in material “default” (as defined 

  
 137

 
in Section 4219(c)(5) of ERISA) with respect to payments to a Multiemployer Plan. Neither the Borrower nor any Subsidiary has received any notice or is otherwise aware that its Foreign
Pension Plans are not in compliance with their terms or with the requirements of any applicable laws, statutes, rules, regulations and orders, and the aggregate unfunded liabilities with respect to such Foreign Pension Plans would not reasonably be
expected to result in a Material Adverse Effect. 
 Section 4.21. Certain Fees. No broker’s or finder’s
fee or commission will be payable with respect to the transactions contemplated by the Related Agreements, except as payable to the Agents and the Lenders and those fees and commissions payable to the financial advisors of the Borrower and/or the
Acquired Business (and their respective Subsidiaries) in connection with the Acquisition and the financing obtained in connection therewith. 
 Section 4.22. Solvency. The Credit Parties are, in the aggregate, and, upon the incurrence of any Obligation by any Credit Party on any date on which this representation and warranty is made,
will be, in the aggregate, Solvent. 
 Section 4.23. Related Agreements. The Borrower shall have delivered to the
Administrative Agent complete and correct copies of (i) each Related Agreement and of all exhibits and schedules thereto as of the Closing Date and (ii) copies of any material amendment, restatement, supplement or other modification to or
waiver of each Related Agreement entered into after the Closing Date. 
 Section 4.24. Compliance with Statutes, Etc.
Except as set forth on Schedule 4.24, each of the Borrower and its Subsidiaries is in compliance with all applicable statutes, regulations and orders of, and all applicable restrictions imposed by, all Governmental Authorities, in respect of the
conduct of its business and the ownership of its property (including compliance with all applicable Environmental Laws and the requirements of any permits issued under such Environmental Laws with respect to any Real Estate Asset or the operations
of the Borrower or any of its Subsidiaries), except such non-compliance that, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect. 

Section 4.25. Disclosure. No representation or warranty of any Credit Party contained in any Credit Document or in any other
documents, certificates or written statements furnished to any Agent or Lender by or on behalf of the Borrower or any of its Subsidiaries for use in connection with the transactions contemplated hereby contains any untrue statement of a material
fact or omits to state a material fact (known to the Borrower, in the case of any document not furnished by either of them) necessary in order to make the statements contained herein or therein not misleading in light of the circumstances in which
the same 

  
 138

 
were made. Any projections and pro forma financial information contained in such materials are based upon good faith estimates and assumptions believed by the Borrower to be reasonable at the
time made, it being recognized by Lenders that such projections as to future events are not to be viewed as facts and that actual results during the period or periods covered by any such projections may differ materially from the projected results.
There are no facts known (or which should upon the reasonable exercise of diligence be known) to the Borrower (other than matters of a general economic nature) that, individually or in the aggregate, would reasonably be expected to result in a
Material Adverse Effect and that have not been disclosed herein or in such other documents, certificates and statements furnished to Lenders for use in connection with the transactions contemplated hereby. 

Section 4.26. Senior Indebtedness. The Obligations constitute “Senior Indebtedness,” “Designated Senior
Indebtedness” or any similar designation under and as defined in any agreement governing any Subordinated Indebtedness and the subordination provisions set forth in each such agreement are legally valid and enforceable against the Credit
Parties party thereto except as may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or limiting creditors’ rights generally or by equitable principles relating to enforceability. 

Section 4.27. PATRIOT Act; Sanctioned Persons. (a) To the extent applicable, each Credit Party is in compliance, in all
material respects, with (i) the United States Trading with the Enemy Act, as amended, and each of the foreign assets control regulations of the United States Treasury Department (31 C.F.R., Subtitle B, Chapter V, as amended) and any other
enabling legislation or executive order relating thereto and (ii) the PATRIOT Act. No part of the proceeds of the Loans will be used, directly or indirectly, for any payments to any governmental official or employee, political party, official
of a political party, candidate for political office, or anyone else acting in an official capacity, in order to obtain, retain or direct business or obtain any improper advantage, in violation of the United States Foreign Corrupt Practices Act of
1977, as amended. 
 (b) Neither the Borrower, nor any of its Subsidiaries nor, to the knowledge of the Borrower, any director,
officer, employee, agent or affiliate of the Borrower is an individual or entity (for purposes of this Section 4.27(b), a “Person”) that is, or is owned or controlled by Persons that are: (i) the subject of any sanctions
(A) administered or enforced by the U.S. Department of the Treasury’s Office of Foreign Assets Control, the United Nations Security Council, the European Union, Her Majesty’s Treasury or other relevant sanctions authority or
(B) pursuant to the U.S. Iran Sanctions Act, as amended, or Executive Order 13590 (collectively, “Sanctions”) or (ii) located, organized or resident in a country or territory that is, or whose government is, the subject of
Sanctions (including, without limitation, Burma/Myanmar, Cuba, Iran, North Korea, Sudan 

  
 139

 
and Syria). The Borrower will not, directly or indirectly, use the proceeds of the Loans, or lend, contribute or otherwise make available such proceeds to any Subsidiary, joint venture partner or
other Person, (i) to fund any activities or business of or with any Person, or in any country or territory, that, at the time of such funding, is, or whose government is, the subject of Sanctions, or (ii) in any other manner that would
result in a violation of Sanctions by any Person (including any Person participating in the Loan, whether as lender, underwriter, advisor, investor or otherwise). 
 Section 4.28. Use of Proceeds. The Borrower will use the proceeds of the Loans and will request the issuance of Letters of Credit only for the purposes specified in Section 2.06.

 Section 4.29. Security Documents. (a) The Pledge and Security Agreement, upon execution and delivery thereof
by the parties thereto, will create in favor of the Collateral Agent, for the ratable benefit of the Secured Parties, a legal, valid and enforceable security interest in the Personal Property Collateral and the proceeds described herein and
(i) when the Pledged Collateral is delivered to the Collateral Agent in accordance with the terms of the Pledge and Security Agreement, the Lien created under Pledge and Security Agreement shall constitute a fully perfected first priority Lien
on, and security interest in, all right, title and interest of the Credit Parties in such Pledged Collateral, in each case prior and superior in right to any other Person and (ii) when financing statements in appropriate form are filed in the
offices specified in the Collateral Questionnaire delivered on the Closing Date, the Lien created under the Pledge and Security Agreement will constitute a fully perfected Lien on, and security interest in, all right, title and interest of the
Credit Parties in the Personal Property Collateral described in such statements (other than Intellectual Property (as defined in the Pledge and Security Agreement) and any Personal Property Collateral which may not be perfected by filing of a
financing statement) in each case prior and superior in right to any other Person, other than with respect to Liens expressly permitted by Section 6.02. 
 (b) Upon the recordation of the Pledge and Security Agreement (or a short-form security agreement in form and substance reasonably satisfactory to the Borrower and the Collateral Agent) with the United
States Patent and Trademark Office and the United States Copyright Office, together with the financing statements in appropriate form filed in the offices specified in the Collateral Questionnaire delivered on the Closing Date, the Lien created
under the Pledge and Security Agreement shall constitute a fully perfected Lien on, and security interest in, all right, title and interest of the Credit Parties in the Intellectual Property (as defined in the Pledge and Security Agreement) in which
a security interest may be perfected by filing in the United States and its territories and possessions, in each case prior and superior in right to any other Person other than Liens permitted by Section 6.02 (it being understood that
subsequent 

  
 140

 
recordings in the United States Patent and Trademark Office and the United States Copyright Office may be necessary to perfect a Lien on registered trademarks and patents, trademark and patent
applications and registered copyrights acquired by the Credit Parties after the Closing Date). 
 (c) Each Mortgage is effective
to create in favor of the Collateral Agent, a legal, valid and enforceable First Priority Lien on all of the applicable Credit Party’s right, title and interest in and to the Closing Date Mortgaged Property thereunder and the proceeds thereof,
except as enforcement may be limited by bankruptcy, insolvency, reorganization, moratorium or similar laws relating to or limiting creditors’ rights generally or by equitable principles, and when such Mortgage is filed in the offices specified
in the Collateral Questionnaire delivered on the Closing Date, such Mortgage shall constitute a fully perfected First Priority Lien on, and security interest in, all right, title and interest of such Credit Party in such Closing Date Mortgaged
Property and the proceeds thereof, in each case prior and superior in right to any other Person, other than with respect to Liens expressly permitted by Section 6.02. 
 ARTICLE 5 
 AFFIRMATIVE COVENANTS 

Each Credit Party covenants and agrees that, so long as any Commitment is in effect and until payment in full of all Obligations and
cancellation or expiration of all Letters of Credit, each Credit Party shall perform, and shall cause each of its Subsidiaries to perform, all covenants in this Article 5. 
 Section 5.01. Financial Statements and Other Reports. The Borrower will deliver to the Administrative Agent and Lenders: 

(a) Quarterly Financial Statements. Promptly when available, and in any event within 45 days after the end of each of the first
three Fiscal Quarters of each Fiscal Year, commencing with the Fiscal Quarter in which the Closing Date occurs, the consolidated balance sheets of the Borrower and its Subsidiaries as at the end of such Fiscal Quarter and the related consolidated
statements of income, stockholders’ equity and cash flows of the Borrower and its Subsidiaries for such Fiscal Quarter and for the period from the beginning of the then current Fiscal Year to the end of such Fiscal Quarter, setting forth in
each case in comparative form the corresponding figures for the corresponding periods of the previous Fiscal Year, all in reasonable detail, together with a Financial Officer Certification with respect thereto (it being agreed that the furnishing of
the Borrower’s quarterly report on Form 10-Q for such Fiscal Quarter, as filed with the U.S. Securities and Exchange Commission, will satisfy the Borrower’s obligations under this Section 5.01(a) with respect to such Fiscal Quarter).

  
 141

 (b) Annual Financial Statements. As soon as available, and in any event within 90
days after the end of each Fiscal Year, commencing with the Fiscal Year in which the Closing Date occurs, (i) the consolidated balance sheets of the Borrower and its Subsidiaries as at the end of such Fiscal Year and the related consolidated
statements of income, stockholders’ equity and cash flows of the Borrower and its Subsidiaries for such Fiscal Year, setting forth in each case in comparative form the corresponding figures for the previous Fiscal Year, in reasonable detail,
together with a Financial Officer Certification with respect thereto; and (ii) with respect to such consolidated financial statements a report thereon of Ernst & Young LLP or other independent certified public accountants of recognized
national standing selected by the Borrower, and reasonably satisfactory to the Administrative Agent (which report and/or the accompanying financial statements shall be unqualified as to going concern and scope of audit), and shall be prepared in
accordance with audit standards of the Public Accounting Oversight Board and applicable Laws (it being agreed that the furnishing of the Borrower’s annual report on Form 10-K for such year, as filed with the U.S. Securities and Exchange
Commission, will satisfy the Borrower’s obligation under this Section 5.01(b) with respect to such year). 
 (c)
Compliance Certificate. Together with each delivery of financial statements of the Borrower and its Subsidiaries pursuant to Sections 5.01(a) and 5.01(b), a duly executed and completed Compliance Certificate. 

(d) Statements of Reconciliation after Change in Accounting Principles. If, as a result of any change in accounting principles and
policies from those used in the preparation of the Historical Financial Statements, the consolidated financial statements of the Borrower and its Subsidiaries required to be delivered pursuant to Section 5.01(a) and 5.01(b) will differ in any
material respect from the consolidated financial statements that would have been delivered pursuant to such subdivisions had no such change in accounting principles and policies been made, then, together with the first delivery of such financial
statements after such change, one or more statements of reconciliation for all such prior financial statements in form and substance satisfactory to the Administrative Agent. 
 (e) Notice of Default. Promptly upon any Authorized Officer of the Borrower obtaining knowledge (i) of any condition or event that constitutes a Default or an Event of Default or that notice
has been given to the Borrower with respect thereto; (ii) that any Person has given any notice to the Borrower or any of its Subsidiaries or taken any other action with respect to any event or condition set forth in Section 8.01(b); or
(iii) of the occurrence of any event or change that has caused or evidences, either in any case or in the aggregate, a Material Adverse Effect, a certificate of an Authorized Officer specifying the nature and period of existence of such
condition, event or change, or specifying the notice given and action taken by any such Person and the nature of such claimed Event of Default, Default, default, event or condition, and what action the Borrower has taken, is taking and proposes to
take with respect thereto. 

  
 142

 (f) Notice of Litigation. Promptly upon any Authorized Officer of the Borrower
obtaining knowledge of (i) any Adverse Proceeding not previously disclosed in writing by the Borrower to Lenders or (ii) any development in any Adverse Proceeding that, in the case of either clause (i) or (ii), would be reasonably expected
to have a Material Adverse Effect, or seeks to enjoin or otherwise prevent the consummation of, or to recover any damages or obtain relief as a result of, the transactions contemplated hereby, written notice thereof together with such other
information as may be reasonably available to the Borrower to enable Lenders and their counsel to evaluate such matters; provided that the Borrower shall not be required to compromise in any way its attorney-client privilege. 

(g) ERISA. Provided that the Borrower shall not be required to compromise in any way its attorney-client privilege,
(i) promptly upon becoming aware of the occurrence of or forthcoming occurrence of any ERISA Event, a written notice specifying the nature thereof, what action the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates
has taken, is taking or proposes to take with respect thereto and, when known, any action taken or threatened by the Internal Revenue Service, the Department of Labor or the PBGC with respect thereto; and (ii) with reasonable promptness upon
request, copies of (1) each Schedule B (Actuarial Information) to the annual report (Form 5500 Series) filed by the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates with the Internal Revenue Service with respect to
each Pension Plan; (2) all notices received by the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates from a Multiemployer Plan sponsor concerning an ERISA Event; and (3) copies of such other documents or
governmental reports or filings relating to any Employee Benefit Plan as the Administrative Agent shall reasonably request. 

(h) Business Plan. Promptly and in any event no later than ninety (90) days after the beginning of each Fiscal Year, a
consolidated business plan and projected operating budget for such Fiscal Year, including (i) a forecasted consolidated balance sheet and forecasted consolidated statements of income and cash flows of the Borrower and its Subsidiaries for such
Fiscal Year and an explanation of the assumptions on which such forecasts are based and (ii) forecasted consolidated statements of income and cash flows of the Borrower and its Subsidiaries for each Fiscal Quarter of such Fiscal Year.

 (i) Insurance Report. As soon as practicable and in any event by the last day of each Fiscal Year, a certificate from
the Borrower’s insurance broker(s) outlining all material insurance coverage maintained as of the date of such certificate by the Borrower and its Subsidiaries. 

  
 143

 (j) Information Regarding Collateral. The Borrower agrees promptly (and in any event
no later than the earlier of (x) 30 days after such change and (y) 10 days prior to the date on which the perfection of the Liens under the Collateral Documents would (absent additional filings or other actions) lapse, in whole or in part,
by reason of such change) to (i) furnish to the Collateral Agent written notice of any change (A) in any Credit Party’s corporate name, (B) in any Credit Party’s identity or corporate structure, (C) in any Credit
Party’s jurisdiction of organization or (D) in any Credit Party’s Federal Taxpayer Identification Number or state organizational identification number and (ii) make all filings under the UCC or otherwise that are required in
order for the Collateral Agent to continue at all times following such change to have a valid, legal and perfected security interest in all material respects in all the Collateral as contemplated in the Collateral Documents. The Borrower also agrees
promptly to notify the Collateral Agent if any material portion of the Collateral is damaged or destroyed. 
 (k) Annual
Collateral Verification. Each year, at the time of delivery of annual financial statements with respect to the preceding Fiscal Year pursuant to Section 5.01(b), the Borrower shall deliver to the Collateral Agent a certificate of its Authorized
Officer certifying that all UCC financing statements (including fixtures filings, as applicable) and all supplemental Intellectual Property security agreements (including the Intellectual Property Security Agreements) or other appropriate filings,
recordings or registrations, have been filed of record in each governmental, municipal or other appropriate office in each applicable jurisdiction to the extent necessary to effect, protect and perfect the security interests in the Collateral owned
by the Credit Parties as of such date, in accordance with the Collateral Documents, subject to the compliance periods set forth therein, for a period of not less than 18 months after the Closing Date or the date of such certificate (except as noted
therein with respect to any continuation statements to be filed within such period). 
 (l) Other Information.
(i) Promptly upon their becoming available, copies of (A) all financial statements, reports, notices and proxy statements sent or made available generally by the Borrower to its security holders acting in such capacity or by any Subsidiary
of the Borrower to its security holders other than the Borrower or another Subsidiary of the Borrower, (B) all regular and periodic reports and all registration statements and prospectuses, if any, filed by the Borrower or any of its
Subsidiaries with any securities exchange or with the U.S. Securities and Exchange Commission or any other Governmental Authority, provided that the Borrower shall not be required to compromise in any way its attorney-client privilege and
(C) all press releases and other statements made available generally by the Borrower or any of its Subsidiaries to the public concerning material developments in the business of the Borrower or any of its Subsidiaries and (ii) such other
information and data with respect to the Borrower or any of its Subsidiaries as from time to time may be reasonably requested by the Administrative Agent or any Lender, provided that the Borrower shall not be required to compromise in any way
its attorney-client privilege. 

  
 144

 (m) Certification of Public Information. The Borrower and each Lender acknowledge
that certain of the Lenders may be Public Lenders and, if documents or notices required to be delivered pursuant to this Section 5.01 or otherwise are being distributed through IntraLinks/IntraAgency, SyndTrak or another relevant website or
other information platform (the “Platform”), any document or notice that the Borrower has indicated contains Non-Public Information shall not be posted on that portion of the Platform designated for such Public Lenders. The Borrower
agrees to clearly designate all information provided to the Administrative Agent by or on behalf of the Borrower which is suitable to make available to Public Lenders. If the Borrower has not indicated whether a document or notice delivered pursuant
to this Section 5.01 contains Non-Public Information, the Administrative Agent reserves the right to post such document or notice solely on that portion of the Platform designated for Lenders who wish to receive material Non-Public Information
with respect to the Borrower, its Subsidiaries and their securities. 
 (n) Immaterial Domestic Subsidiaries. Together
with each delivery of financial statements of the Borrower and its Subsidiaries pursuant to Section 5.01(a) or 5.01(b), a certificate of an Authorized Officer of the Borrower designating any Domestic Subsidiary that qualifies as an Immaterial
Domestic Subsidiary, and certifying that such Immaterial Domestic Subsidiary, together with all other Immaterial Domestic Subsidiaries, (x) has assets comprising less than 2% of Total Assets on the last day of the Fiscal Quarter or Fiscal Year
to which such financial statements relate and (y) contributes less than 2% of Consolidated Adjusted EBITDA for the period of four consecutive Fiscal Quarters ending on the last day of the Fiscal Quarter or Fiscal Year to which such financial
statements relate, which certificate shall be deemed to supplement Schedule 1.1C for all purposes hereof; provided that any Subsidiary that shall have become a Guarantor hereunder and a Grantor under the Pledge and Security Agreement and
otherwise complied with the provisions of Section 5.10 shall be deemed not to be an Immaterial Domestic Subsidiary and excluded from the calculations set forth above. 
 (o) Electronic Delivery. Documents required to be delivered pursuant to Section 5.01(a), 5.01(b), 5.01(d) or 5.01(l) (to the extent any such documents are included in materials otherwise filed
with the U.S. Securities and Exchange Commission) may be delivered electronically and if so delivered, shall be deemed to have been delivered on the date (i) on which the Borrower posts such documents, or provides a link thereto on the
Borrower’s website on the internet and, other than information required to be delivered pursuant to Section 5.01(l), informs the Administrative Agent in writing on the same date of such posting; or (ii) on which such documents are posted
on the Borrower’s behalf on an internet 

  
 145

 
or intranet website, if any, to which each Lender and the Administrative Agent have access (whether a commercial or governmental, third-party website or whether sponsored by the Administrative
Agent) and, other than information required to be delivered pursuant to Section 5.01(l) informs the Administrative Agent in writing on the same date of such posting. Notwithstanding anything contained herein, in every instance the Borrower shall be
required to provide electronic or paper copies of the Compliance Certificates required by Section 5.01(c) to the Administrative Agent. Except for such Compliance Certificates, the Administrative Agent shall have no obligation to request the
delivery or to maintain copies of the documents referred to above, and in any event shall have no responsibility to monitor compliance by the Borrower with any such request for delivery, and each Lender shall be solely responsible for requesting
delivery to it from the Administrative Agent or maintaining its copies of such documents. 
 Section 5.02. Existence.
Except (x) as otherwise permitted under Section 6.08 (other than Section 6.08(s)) and (y) that no Credit Party (other than the Borrower with respect to existence) or any of its Subsidiaries shall be required to preserve any
such existence, right or franchise, licenses and permits if such Person’s board of directors (or similar governing body) shall determine that the preservation thereof is no longer desirable in the conduct of the business of such Person, and
that the loss thereof is not disadvantageous in any material respect to such Person or to Lenders, each Credit Party will, and will cause each of its Subsidiaries to, at all times preserve and keep in full force and effect its existence and all
rights and franchises, licenses and permits material to its business. 
 Section 5.03. Payment of Taxes and Claims.
Each Credit Party will, and will cause each of its Subsidiaries to, pay all material taxes imposed upon it or any of its properties or assets or in respect of any of its income, businesses or franchises before any material penalty or fine
accrues thereon, and all material claims (including claims for labor, services, materials and supplies) for sums that have become due and payable and that by law have or may become a Lien upon any of its properties or assets, prior to the time when
any material penalty or fine shall be incurred with respect thereto; provided, no such tax or claim need be paid if it is being contested in good faith by appropriate proceedings promptly instituted and diligently conducted, so long as
(a) adequate reserve or other appropriate provision, as shall be required in conformity with GAAP, shall have been made therefor and (b) in the case of a tax or claim which has or may become a Lien against any of the Collateral, and which
is not permitted pursuant to Section 6.02, such contest proceedings conclusively operate to stay the sale of any portion of the Collateral to satisfy such Tax or claim. No Credit Party will, nor will it permit any of its Subsidiaries to, file
or consent to the filing of any consolidated income tax return with any Person (other than the Borrower or any of its Subsidiaries). 

  
 146

 Section 5.04. Maintenance of Properties. Each Credit Party will, and will cause
each of its Subsidiaries to, maintain or cause to be maintained in good repair, working order and condition, ordinary wear and tear excepted, all material properties reasonably necessary in the operation of or used or useful in the business of the
Borrower and its Subsidiaries and from time to time will make or cause to be made all appropriate repairs, renewals and replacements thereof. Nothing in this Section 5.04 shall prevent (a) Dispositions, consolidations or mergers in
accordance with Section 6.08 or (b) the abandonment of rights, franchises, licenses trade names, copyrights, patents, trademarks or other Intellectual Property in accordance with Section 6.08(g). 

Section 5.05. Insurance. The Borrower will maintain or cause to be maintained, with financially sound and reputable insurers,
such public liability insurance, third-party property damage insurance, business interruption insurance and casualty insurance with respect to liabilities, losses or damage, in respect of the assets, properties and businesses of the Borrower and its
Subsidiaries as may customarily be carried or maintained under similar circumstances by Persons of established reputation engaged in similar businesses, in each case in such amounts (giving effect to self-insurance), with such deductibles, covering
such risks and otherwise on such terms and conditions as shall be customary for such Persons. Without limiting the generality of the foregoing, the Borrower will maintain or cause to be maintained (a) to the extent required by law flood
insurance with respect to each Flood Hazard Property that is located in a community that participates in the Flood Program, in each case in compliance with any applicable regulations of the Board of Governors and (b) replacement value casualty
insurance on the Collateral under such policies of insurance, with such insurance companies, in such amounts, with such deductibles, and covering such risks as are at all times carried or maintained under similar circumstances by Persons of
established reputation engaged in similar businesses. Each such policy of insurance shall name the Collateral Agent, on behalf of the Secured Parties, as an additional insured thereunder as its interests may appear or contain a loss payable clause
or endorsement, reasonably satisfactory in form and substance to the Collateral Agent, that names the Collateral Agent, on behalf of the Secured Parties, as the loss payee thereunder, as applicable, and provide for at least thirty
(30) days’ (or such shorter period as may be consented to by the Administrative Agent in its reasonable discretion) prior written notice to the Collateral Agent of any modification or cancellation of such policy; provided that,
unless an Event of Default shall have occurred and be continuing, the Collateral Agent shall turn over to the Borrower any amounts received by it as loss payee under any casualty insurance maintained by the Borrower or its Subsidiaries, the
disposition of such amounts to be subject to the provisions of Section 2.14(b), and, unless an Event of Default shall have occurred and be continuing, the Collateral Agent agrees that the Borrower and/or the applicable Subsidiary shall have the sole
right to adjust or settle any claims under such insurance. 

  
 147

 Section 5.06. Books and Records; Inspections. Each Credit Party will, and will
cause each of its Subsidiaries to, keep proper books of record and accounts in which full, true and correct entries in conformity in all material respects with GAAP shall be made of all dealings and transactions in relation to its business and
activities. Each Credit Party will, and will cause each of its Subsidiaries to, permit any authorized representatives designated by any Lender at the expense of such Lender (or, after the occurrence and during the continuation of an Event of
Default, the expense of the Borrower) to visit and inspect any of the properties of any Credit Party and any of its respective Subsidiaries, to inspect, copy and take extracts from its and their financial and accounting records, and to discuss its
and their affairs, finances and accounts with its and their officers and independent public accountants, all upon reasonable notice and at such reasonable times during normal business hours and as often as may reasonably be requested. 

Section 5.07. Lenders Meetings. The Borrower will, upon the request of the Administrative Agent or the Requisite Lenders,
participate in a meeting of the Administrative Agent and Lenders once during each Fiscal Year to be held at the Borrower’s corporate offices (or at such other location as may be agreed to by the Borrower and the Administrative Agent) at such
time as may be agreed to by the Borrower and the Administrative Agent (the expense of conducting such meeting to be borne by the Borrower; provided that (i) each Person shall pay her or its travel expenses and the fees and expenses of
her or its advisors and (ii) the Borrower may satisfy its obligations under this Section 5.07 by participating in a Lenders-only conference call in lieu of such meeting. 

Section 5.08. Compliance with Laws. Each Credit Party will comply, and shall cause each of its Subsidiaries and all other
Persons, if any, on or occupying any Facilities to comply, with the requirements of all applicable laws, rules, regulations and orders of any Governmental Authority (including all Environmental Laws), except in such instances in which the failure to
comply therewith would not reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 

Section 5.09. Environmental Matters. (a) Environmental Disclosure. Provided that the Borrower shall not be
required to compromise in any way its attorney-client privilege (except that such attorney-client privilege shall not be asserted in connection with any environmental audits, investigations, analyses and reports of any kind or character prepared by
a third party that is not legal counsel for the Borrower or any of its Subsidiaries), the Borrower will deliver to the Administrative Agent and the Lenders: 
 (i) as soon as practicable following receipt thereof, copies of all environmental audits, investigations, analyses and reports of any kind or character, whether prepared by personnel of the Borrower or
any of its Subsidiaries or by independent consultants, Governmental Authorities or 

  
 148

 
any other Persons, with respect to significant environmental matters relating to the Borrower or any of its Subsidiaries or any Facility or with respect to any Environmental Claims that would
reasonably be expected to have a Material Adverse Effect; 
 (ii) promptly upon an Authorized Officer, the
Corporate Director (Facilities/Environmental, Health and Safety/Real Estate) or Senior Manager (Corporate Environmental, Health and Safety) obtaining knowledge thereof, written notice describing in reasonable detail (A) any Release required to
be reported to any Governmental Authority under any applicable Environmental Laws unless the Borrower reasonably determines that such Release would not reasonably be expected to have a Material Adverse Effect, (B) any remedial action taken by
the Borrower or any other Person in response to (1) any Hazardous Materials Activities the existence of which would reasonably be expected to result in one or more Environmental Claims having, individually or in the aggregate, a Material
Adverse Effect or (2) any Environmental Claims that, individually or in the aggregate, would reasonably be expected to result in a Material Adverse Effect and (C) the Borrower’s discovery of any occurrence or condition on any real
property adjoining or in the vicinity of any Facility that could cause such Facility or any part thereof to be subject to any restrictions on the ownership, occupancy, transferability or use thereof under any Environmental Laws, except to the extent
that such restrictions, individually or in the aggregate, would not reasonably be expected to result in a Material Adverse Effect; 
 (iii) as soon as practicable following the sending or receipt thereof by the Borrower or any of its Subsidiaries, a copy of any and all written communications with respect to (A) any Environmental
Claims that, individually or in the aggregate, would reasonably be expected to result in a Material Adverse Effect, (B) any Release required to be reported to any Governmental Authority that would reasonably be expected to have a Material
Adverse Effect and (C) any request for information from any Governmental Authority that suggests such Governmental Authority is investigating whether the Borrower or any of its Subsidiaries may be potentially responsible for any Hazardous
Materials Activity that would reasonably be expected to have a Material Adverse Effect; 
 (iv) prompt written
notice describing in reasonable detail (A) any proposed acquisition of stock, assets or property by the Borrower or any of its Subsidiaries that would reasonably be expected to (1) expose the Borrower or any of its Subsidiaries to, or
result in, Environmental Claims that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect or (2) affect the ability of the 

  
 149

 
Borrower or any of its Subsidiaries to maintain in full force and effect all material Governmental Authorizations required under any Environmental Laws for their respective operations and
(B) any proposed action to be taken by the Borrower or any of its Subsidiaries to modify current operations in a manner that would reasonably be expected to subject the Borrower or any of its Subsidiaries to any additional obligations or
requirements under any Environmental Laws that would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect; and 
 (v) with reasonable promptness, such other documents and information as from time to time may be reasonably requested by the Administrative Agent in relation to any matters disclosed pursuant to this
Section 5.09(a). 
 (b) Hazardous Materials Activities, Etc. Each Credit Party shall promptly take, and shall cause
each of its Subsidiaries promptly to take, any and all actions necessary to (i) cure any violation of applicable Environmental Laws by such Credit Party or its Subsidiaries that would reasonably be expected to have, individually or in the
aggregate, a Material Adverse Effect and (ii) make an appropriate response to any Environmental Claim against such Credit Party or any of its Subsidiaries and discharge any obligations it may have to any Person thereunder where failure to do so
would reasonably be expected to have, individually or in the aggregate, a Material Adverse Effect. 
 Section 5.10.
Subsidiaries. (a) Unless such Person qualifies as an Excluded Subsidiary, in the event that any Person becomes a Domestic Subsidiary of the Borrower: 
 (i) the Borrower shall promptly (and in any event within ten (10) Business Days) cause such Subsidiary to become a Guarantor hereunder and a Grantor under the Pledge and Security Agreement by
executing and delivering to the Administrative Agent and the Collateral Agent a Counterpart Agreement; and 

(ii) the Borrower and such Subsidiary shall take all such actions and execute and deliver, or cause to be executed and
delivered, all such documents, instruments, agreements and certificates reasonably requested by Collateral Agent, including those which are similar to those described in (x) Sections 3.01(b), 3.01(h) (to the extent such Person owns any Material
Real Estate Asset at such time) and 3.01(i) promptly following the occurrence thereof and (y) Section 5.12(d) (to the extent such Person owns any Material Real Estate Asset at such time) within 90 days following the occurrence thereof.

  
 150

 (b) In the event that any Person becomes a First-Tier Foreign Subsidiary, and the Equity
Interests of such Foreign Subsidiary are owned by the Borrower or by any Domestic Subsidiary thereof, the Borrower shall, or shall cause such Domestic Subsidiary to, deliver all such documents, instruments, agreements and certificates as are similar
to those described in Section 3.01(b), and the Borrower shall take, or shall cause such Domestic Subsidiary to take, all of the actions referred to in Section 3.01(i) necessary to grant and to perfect a First Priority Lien in favor of the
Collateral Agent, for the benefit of the Secured Parties, under the Pledge and Security Agreement in 65% of the Equity Interests of such First-Tier Foreign Subsidiary (it being understood and agreed that (x) no actions to grant or perfect any
lien or security interest in a Foreign Jurisdiction or under the laws of a Foreign Jurisdiction shall be required to be undertaken with respect to such Equity Interests and (y) neither the Borrower nor any of its Subsidiaries shall be required
to enter into any security agreements or pledge agreements governed by laws of any non-U.S. jurisdictions). 
 (c) With respect
to any Person that becomes a Subsidiary of the Borrower, the Borrower shall promptly send to the Administrative Agent written notice setting forth with respect to such Person (x) the date on which such Person became a Subsidiary of the Borrower
and (y) all of the data required to be set forth in Schedule 4.01 with respect to Subsidiaries of the Borrower, and such written notice shall be deemed to supplement Schedule 4.01 for all purposes hereof. 

Section 5.11. Additional Material Real Estate Assets. In the event that any Credit Party acquires a Material Real Estate
Asset or any Real Estate Asset owned on the Closing Date or acquired thereafter becomes a Material Real Estate Asset due to the construction of improvements thereon following the Closing Date or the acquisition thereof, as applicable, and such
interest has not otherwise been made subject to the Lien of the Collateral Documents in favor of the Collateral Agent, for the benefit of the Secured Parties, then such Credit Party shall promptly take all such actions and execute and deliver, or
cause to be executed and delivered, all such Mortgages, documents (including environmental reports), instruments, agreements, opinions and certificates, including those which are similar to those described in Section 3.01(h) and
Section 5.12(d) with respect to each such Material Real Estate Asset that the Collateral Agent shall reasonably request to create in favor of the Collateral Agent, for the benefit of the Secured Parties, a valid and, subject to any filing
and/or recording referred to herein, perfected First Priority Lien in such Material Real Estate Assets; provided that no such Lien shall be required to be granted as contemplated by this Section 5.11 on any owned Real Estate Asset or fixtures
the acquisition of which is financed, or is to be financed in whole or in part through the incurrence of Indebtedness permitted by Section 6.01(n) or Section 6.09 until such Indebtedness is repaid in full (without giving effect to any
refinancing thereof) or, as the case may be, the Borrower determines not to proceed with such financing or refinancing. In 

  
 151

 
addition to the foregoing, the Borrower shall, at the request of the Collateral Agent, deliver, from time to time, to the Collateral Agent such appraisals as are required by law or regulation of
Material Real Estate Assets with respect to which the Collateral Agent has been granted a Lien to the extent that Borrower or any other party has a copy of the appraisal and is permitted by the applicable third party appraisers and/or lenders to
deliver a copy to Collateral Agent. 
 Section 5.12. Further Assurances. (a) At any time or from time to time
upon the request of the Administrative Agent, each Credit Party will, at its expense, promptly execute, acknowledge and deliver such further documents and do such other acts and things as the Administrative Agent or the Collateral Agent may
reasonably request in order to effect fully the purposes of the Credit Documents. In furtherance and not in limitation of the foregoing, each Credit Party shall take such actions as the Administrative Agent or the Collateral Agent may reasonably
request from time to time to ensure that the Obligations are guaranteed by each Domestic Subsidiary that is not an Excluded Subsidiary and are secured by substantially all of the assets of the Borrower and the Guarantors and all of the outstanding
Equity Interests of the Domestic Subsidiaries and 65% of the Equity Interests of First-Tier Foreign Subsidiaries subject, in each case, to the provisions set forth herein, in the Pledge and Security Agreement and the other Credit Documents.

 (b) If, at any time and from time to time after the Closing Date, any Domestic Subsidiary that is not a Credit Party,
together with all other Immaterial Domestic Subsidiaries, (i) has assets comprising more than 2% of Total Assets on the last day of the most recent Fiscal Quarter or Fiscal Year for which financial statements are required to be delivered
pursuant to this Agreement or (ii) contributes more than 2% of the Consolidated Adjusted EBITDA for the period of four Fiscal Quarters ending on the last day of the Fiscal Quarter or Fiscal Year most recently ended for which financial
statements are required to be delivered pursuant to this Agreement, then the Borrower shall, not later than 30 days after the date by which financial statements for such Fiscal Quarter or Fiscal Year are required to be delivered pursuant to this
Agreement, cause one or more Domestic Subsidiaries to become Credit Parties such that the conditions contained in clauses (i) and (ii) of this Section 5.12(b) cease to be true. 

(c) The Borrower shall, or cause the applicable Credit Party to, complete the actions listed on Schedule 5.12(c) by the times stated
therein (or such later date as may be consented to by the Administrative Agent in its reasonable discretion). 
 (d) The
Borrower shall prepare and deliver Phase I Environmental Site Assessments and reliance letters for each Closing Date Mortgaged Property, each in form and substance reasonably acceptable to the Collateral Agent, prepared (i) within 180 days
prior to delivery thereof to the Collateral Agent and (ii) in 

  
 152

 
accordance with ASTM E1527-05 by a nationally recognized environmental consultant reasonably acceptable to the Collateral Agent, and delivered to the Collateral Agent within sixty (60) days
after the Closing Date (or such longer period as may be consented to by the Administrative Agent in its reasonable discretion). 

Section 5.13. Miscellaneous Covenants. Unless otherwise consented to by the Administrative Agent: 

(a) Maintenance of Ratings. At all times, the Borrower shall use commercially reasonable efforts to maintain (i) a public
corporate family rating issued by Moody’s and a public corporate credit rating issued by S&P and (ii) a public credit rating from each of Moody’s and S&P with respect to each of the facilities provided hereunder and the Senior
Notes. 
 (b) Cash Management Systems. The cash management systems of the Borrower and its Subsidiaries are acceptable in
form to the Administrative Agent. The Borrower and its Subsidiaries shall not materially change these systems unless such change is reasonably acceptable to the Administrative Agent. 

ARTICLE 6 

NEGATIVE COVENANTS 
 Each Credit Party covenants and agrees that, so long as any Commitment is in effect and until payment in full of all Obligations and cancellation or expiration of all Letters of Credit, such Credit Party
shall perform, and shall cause each of its Subsidiaries to perform, all covenants in this Article 6. 
 Section 6.01.
Indebtedness. No Credit Party shall, nor shall it permit any of its Subsidiaries to, directly or indirectly, create, incur, assume or guaranty, or otherwise become or remain directly or indirectly liable with respect to any Indebtedness, except:

 (a) the Obligations; 
 (b) Indebtedness of any Credit Party to the Borrower or any Subsidiary; provided (i) all such Indebtedness shall be evidenced by an Intercompany Note, which, to the extent evidencing
Indebtedness owing to a Credit Party, shall be subject to a First Priority Lien pursuant to the Pledge and Security Agreement and (ii) all such Indebtedness that is owed to a Subsidiary that is not a Credit Party shall be unsecured and
subordinated in right of payment to the payment in full of the Obligations pursuant to the terms of the applicable Intercompany Note; 

  
 153

 (c) obligations in respect of workers’ compensation claims, self-insurance obligations,
bankers’ acceptances, performance, bid, stay, customs, appeal, replevin, statutory and surety bonds and performance and completion guaranties provided by the Borrower or any Subsidiary in the ordinary course of business; 

(d) Indebtedness (i) in respect of netting services, overdraft protections and otherwise in connection with deposit accounts or
(ii) arising from the honoring by a bank or other financial institution of a check, draft, credit card, purchase card or similar instrument drawn against insufficient funds in the ordinary course of business or other cash management services
(including automated clearinghouse (ACH) transfers) in the ordinary course of business; provided that such Indebtedness in respect of credit or purchase cards is extinguished within 60 days from its incurrence; 

(e) Indebtedness arising from agreements providing for indemnification, adjustment of purchase price, earn-out or similar obligations
(including Indebtedness consisting of the deferred or contingent purchase price of property or services acquired in a Permitted Acquisition), or from guaranties or letters of credit, surety bonds or performance bonds securing the performance of the
Borrower or any such Subsidiary pursuant to such agreements, in connection with Permitted Acquisitions or permitted dispositions of any business, assets or Subsidiary of the Borrower or any of its Subsidiaries; 

(f) (i) Indebtedness of a Person or Indebtedness attaching to assets of a Person that, in either case, becomes a Subsidiary or
Indebtedness attaching to assets that are acquired by the Borrower or any of its Subsidiaries, in each case after the Closing Date as the result of a Permitted Acquisition, in an aggregate amount not to exceed $150,000,000 at any one time
outstanding, provided that (x) such Indebtedness existed at the time such Person became a Subsidiary or at the time such assets were acquired and, in each case, was not created in anticipation thereof and (y) such Indebtedness is
not guarantied in any respect by the Borrower or any Subsidiary (other than by any such person that so becomes a Subsidiary), and (ii) any Permitted Refinancing of any Indebtedness specified in subclause (i) above, provided that such
Permitted Refinancing shall not be secured by any assets other than the assets securing the Indebtedness being renewed, extended or refinanced and the proceeds of such asset or supporting obligations in connection therewith; 

(g) guaranties by the Borrower and its Subsidiaries with respect to Indebtedness otherwise permitted to be incurred pursuant to this
Section 6.01 (except that a Subsidiary that is not a Credit Party may not by virtue of this clause (g) guaranty any Indebtedness that such Subsidiary could not otherwise incur under this Section 6.01); provided that (A) if
the Indebtedness that is being guarantied is unsecured and/or subordinated to the Obligations, the guaranty shall 

  
 154

 
also be unsecured and/or subordinated to the Obligations, (B) no guaranty by any Subsidiary of any Junior Financing shall be permitted unless such Subsidiary shall have also guarantied the
Obligations on substantially the same terms as the Guaranty and (C) any guaranty by a Credit Party of Indebtedness of a Subsidiary that is not a Credit Party would have been permitted as an Investment pursuant to Section 6.06(l);

 (h) Indebtedness described in Schedule 6.01 and any Permitted Refinancing thereof; 

(i) Indebtedness (contingent or otherwise) of the Borrower or any Subsidiary existing or arising under any Hedge Agreements entered into
in the ordinary course of business and not for speculative purposes; 
 (j) (i) the Senior Notes in an aggregate principal
amount not to exceed $1,000,000,000 and any Permitted Refinancing thereof and (ii) the Convertible Notes and any Permitted Refinancing thereof; 
 (k) unsecured Indebtedness (including Subordinated Indebtedness and Indebtedness convertible into equity of the Borrower) that (i) is issued on terms (including, in the case of Subordinated
Indebtedness, subordination terms) customary at the time for unsecured debt securities issued in a public offering or a Rule 144A offering, (ii) matures after, and does not require any scheduled amortization or other scheduled or mandatory
payments of principal or first scheduled put right prior to, the date which is at least 180 days after the latest maturity date of the Term Loans (it being understood that such Indebtedness may have mandatory prepayment, repurchase or redemption
provisions satisfying the requirement of clause (iii) hereof), (iii) has terms and conditions (other than interest rate, redemption premiums and subordination terms), taken as a whole, that are not materially less favorable to the Borrower than
the terms and conditions customary at the time for unsecured debt securities, as applicable, issued in a public offering or a Rule 144A offering, (iv) shall not be at any time guaranteed by any Subsidiaries other than Subsidiaries that are
Guarantors and the terms of such guarantee shall be no more favorable to the secured parties in respect of such Indebtedness than the terms of the Guaranty and (v) is incurred by the Borrower; provided that both immediately prior and
after giving effect to the incurrence thereof, (x) no Default or Event of Default shall exist or result therefrom and (y) the Borrower will be in pro forma compliance with the covenants set forth in Section 6.07 (assuming, in the case of
the Total Net Leverage Ratio, that the maximum Total Net Leverage Ratio was the level otherwise required by Section 6.07(b) minus 0.50); provided further that a certificate of an Authorized Officer delivered to the Administrative
Agent at least 10 days prior to the incurrence of such Indebtedness, together with a reasonably detailed description of the material terms and conditions of such Indebtedness or drafts of the documentation relating thereto, stating that the Borrower
has 

  
 155

 
determined in good faith that such terms and conditions satisfy the requirements of this clause (k) shall be conclusive evidence that such terms and conditions satisfy the foregoing requirement
unless the Administrative Agent notifies the Borrower in writing within five (5) days of receipt of such certificate that it disagrees with such determination; 
 (l) Indebtedness of any Subsidiary that is not a Credit Party to the Borrower or any Subsidiary; provided that such Indebtedness shall be evidenced by an Intercompany Note, which, to the extent
owed to a Credit Party, shall be subject to a First Priority Lien pursuant to the Pledge and Security Agreement; 
 (m) (i)
deposits or guaranties incurred in the ordinary course of business and required by any Governmental Authority in a foreign jurisdiction to conduct business in such jurisdiction and (ii) Indebtedness of (including, for the avoidance of doubt,
guaranties by) any Subsidiary that is not a Credit Party; provided that the aggregate amount of all such Indebtedness permitted by this clause (ii) shall not exceed $100,000,000 at any time; 

(n) Indebtedness of the Borrower and any of its Subsidiaries incurred to finance or refinance the acquisition, leasing, construction or
improvement of fixed or capital assets (whether pursuant to a loan, a Capital Lease or otherwise) otherwise permitted pursuant to this Agreement, and any other Capital Leases and purchase money Indebtedness and Indebtedness incurred pursuant to a
Sale and Leaseback Transaction permitted under Section 6.09, and in each case a Permitted Refinancing thereof, in an aggregate principal amount not exceeding in the aggregate as to the Borrower and its Subsidiaries $150,000,000 at any one time
outstanding; 
 (o) Refinancing Indebtedness, applied as required pursuant to the definition thereof; provided that
(i) if any Term Loans remain outstanding after giving effect to the prepayment required under this clause (o), the aggregate principal amount of such outstanding Term Loans shall not be less than $25,000,000 and (ii) before and after
giving effect to the incurrence of any Refinancing Indebtedness, each of the conditions set forth in Section 3.02 shall be satisfied; 
 (p) Permitted Incremental Equivalent Debt; provided that after giving effect to the incurrence thereof (i) the sum of the aggregate principal amount of (x) all New Term Loans and New
Revolving Loan Commitments established (and, without duplication, New Revolving Loans incurred) at or prior to such time pursuant to Section 2.24 and (y) any other Permitted Incremental Equivalent Debt shall not exceed the Incremental Cap,
(ii) the Borrower and its Subsidiaries shall be in pro forma compliance with each of the covenants set forth in Section 6.07 as of the last day of the most recently ended Fiscal Quarter after giving effect to the incurrence of such
Indebtedness, (iii) before and after giving effect to the 

  
 156

 
incurrence of any Permitted Incremental Equivalent Debt, each of the conditions set forth in Section 3.02 shall be satisfied and (iv) the Borrower shall deliver to the Administrative
Agent at least ten (10) Business Days prior to the incurrence of such Permitted Incremental Equivalent Debt (x) a certificate of an Authorized Officer, together with all relevant financial information reasonably requested by the
Administrative Agent, demonstrating compliance with clauses (i), (ii) and (iii) of this clause (provided that such certificate shall be conclusive evidence that such terms and conditions satisfy such requirements unless the
Administrative Agent provides notice to the Borrower of its objection during such ten Business Day period) and (y) any customary legal opinions, board resolutions, officers’ certificates and/or reaffirmation agreements reasonably requested
by the Administrative Agent; 
 (q) Indebtedness incurred by a Receivables Entity that is a Subsidiary in a Qualified
Receivables Transaction in an aggregate amount not to exceed $100,000,000 outstanding at any time; 
 (r) Indebtedness in the
form of guaranties of loans and advances to officers, directors, consultants and employees of the Borrower and/or its Subsidiaries, in an aggregate amount not to exceed $10,000,000 outstanding at any time; 

(s) Indebtedness consisting of guaranties of Indebtedness of joint ventures to the extent such guaranty would have been permitted as an
Investment pursuant to Section 6.06(o); 
 (t) Indebtedness incurred in connection with the settlement of the Adverse
Proceedings set forth on Schedule 4.11; 
 (u) Indebtedness of the Borrower or any of its Subsidiaries consisting of take-or-pay
obligations contained in supply agreements, in each case, in the ordinary course of business; 
 (v) Indebtedness consisting of
obligations to make payments to current or former officers, directors, former or current consultants and employees of the Credit Parties or any of their Subsidiaries and their respective estates, spouses or former spouses with respect to the
cancellation, purchase or redemption of, Equity Interests of the Borrower to the extent permitted under Section 6.04(d); 

(w) letters of credit or bank guaranties (other than Letters of Credit issued pursuant to this Agreement) not supporting Indebtedness and
having an aggregate face amount not to exceed $25,000,000 outstanding at any time; and 
 (x) other unsecured Indebtedness of
the Borrower and its Subsidiaries in an aggregate amount not to exceed $200,000,000 outstanding at any time. 

  
 157

 Section 6.02. Liens. No Credit Party shall, nor shall it permit any of its
Subsidiaries to, directly or indirectly, create, incur, assume or permit to exist any Lien on or with respect to any property or asset of any kind (including any document or instrument in respect of goods or accounts receivable) of the Borrower or
any of its Subsidiaries, whether now owned or hereafter acquired, created or licensed, or any income, profits or royalties therefrom, or file or permit the filing of, or permit to remain in effect, any financing statement or other similar notice of
any Lien with respect to any such property, asset, income, profits or royalties under the UCC of any State or under any similar recording or notice statute or under any applicable Intellectual Property laws, rules or procedures, except: 

(a) Liens in favor of the Collateral Agent for the benefit of the Secured Parties granted pursuant to any Credit Document; 

(b) Liens for Taxes that are (i) not yet due and payable or (ii) being contested in good faith by appropriate proceedings being
diligently conducted and for which adequate reserves have been made in accordance with GAAP; 
 (c) statutory Liens of
landlords, banks (and rights of set off), of carriers, warehousemen, mechanics, repairmen, workmen and materialmen or customers in connection with purchase orders and other agreements entered into in ordinary course of business, and other Liens
imposed by law (other than any such Lien imposed pursuant to Section 430(k) of the Internal Revenue Code or ERISA or a violation of Section 436 of the Internal Revenue Code), in each case incurred in the ordinary course of business
(i) for amounts not yet more than 30 days overdue or (ii) for amounts that are more than 30 days overdue and that (in the case of any such amounts overdue for a period in excess of 30 days) are being contested in good faith by appropriate
proceedings, so long as such reserves or other appropriate provisions, if any, as shall be required by GAAP shall have been made for any such contested amounts; 
 (d) Liens incurred in the ordinary course of business in connection with workers’ compensation, unemployment insurance laws or similar legislation and other types of social security, or to secure the
performance of tenders, public or statutory obligations, surety and appeal bonds, bids, leases, government contracts, trade contracts, performance and return of money bonds, import duties or for the payment of rent and other similar obligations
(exclusive of obligations for the payment of borrowed money or other Indebtedness) or deposits to secure public or statutory obligations of such Persons, so long as no foreclosure, sale or similar proceedings have been commenced with respect to any
portion of the Collateral on account thereof; 
 (e) easements, rights of way, restrictions, encroachments, reservations of
rights of others for licenses, sewers, electric lines, telegraph and telephone lines 

  
 158

 
and other similar purposes, and other minor survey exceptions, defects, encumbrances or irregularities in title, in each case which do not and will not interfere in any material respect with the
ordinary conduct of the business of the Borrower or any of its Subsidiaries; 
 (f) any interest or title of a lessor under any
lease of real estate permitted hereunder; 
 (g) Liens solely on any cash earnest money deposits made by the Borrower or any of
its Subsidiaries in connection with any letter of intent or purchase agreement permitted hereunder; 
 (h) (i) Liens evidenced
by the filing of precautionary UCC financing statements and (ii) Liens arising from UCC financing statements regarding operating leases or consignments entered into by the Credit Parties in the ordinary course of business; 

(i) Liens in favor of customs and revenue authorities arising as a matter of law to secure payment of customs duties in connection with
the importation of goods; 
 (j) any zoning or similar law or right reserved to or vested in any governmental office or agency
to control or regulate the use of any real property; 
 (k) (i) Liens consisting of Permitted Licenses and (ii) leases of
Real Estate or equipment entered into in the ordinary course of business or consistent with past practice which do not (x) interfere in any material respect with the business of the Borrower and its Subsidiaries or (y) secure any
Indebtedness; 
 (l) Liens described in Schedule 6.02; 
 (m) (A) Liens securing Indebtedness permitted pursuant to Section 6.01(n); provided that any such Lien shall encumber only the asset acquired with the proceeds of such Indebtedness and the proceeds
of such asset or supporting obligations in connection therewith and (B) Liens securing Indebtedness permitted by Section 6.01(f); provided that such Lien was not incurred in contemplation of the Permitted Acquisition referred to in
Section 6.01(f) and only encumbers the assets acquired in such Permitted Acquisition; 
 (n) (A) Liens on cash or deposits
securing Indebtedness permitted pursuant to Section 6.01(c) or (d), (B) Liens on property in favor of any Credit Party securing Indebtedness permitted by Section 6.01(l) and (C) Liens securing Indebtedness permitted pursuant to
Section 6.01(o) and (p); 
 (o) Liens securing judgments for the payment of money not constituting an Event of Default;

  
 159

 (p) Liens on property of a Subsidiary that is not a Credit Party that secure Indebtedness of
such Subsidiary permitted under Section 6.01(m)(ii); 
 (q) Liens on accounts receivable and related assets of the types
specified in the definition of “Qualified Receivables Transaction” incurred in connection with a Qualified Receivables Transaction; 
 (r) (i) any other Liens (not securing Indebtedness) arising under, pursuant to or in connection with Co-Development Agreements and (ii) Liens on Discontinued Real Property (or any lease relating
thereto); 
 (s) Liens on specific items of inventory or other goods and proceeds of any Person arising in the ordinary course
of business securing such Person’s obligations in respect of bankers’ acceptances issued or created for the account of such Person to facilitate the purchase, shipment or storage of such inventory or other goods; 

(t) Liens arising out of conditional sale, title retention, consignment or similar arrangements for the sale of goods, or otherwise
arising on goods in favor of suppliers of such goods, in each case in the ordinary course of business; 
 (u) Liens (i) of
a collection bank arising under Section 4-210 of the UCC on items in the course of collection and (ii) attaching to commodity trading accounts or other commodities brokerage accounts incurred in the ordinary course of business, including
Liens encumbering reasonable customary initial deposits and margin deposits; 
 (v) Liens on insurance policies and the proceeds
thereof securing financing of the premiums with respect thereto; 
 (w) Liens consisting of an agreement to dispose of any
property permitted to be sold pursuant to Section 6.08; 
 (x) any customary encumbrance or restriction on the Equity
Interests in a joint venture, including customary rights of first refusal, “tag-along” and “drag along” rights, transfer restrictions and put and call arrangements with respect to the Equity Interests of any joint venture
pursuant to any joint venture or similar agreement; 
 (y) Liens arising on property in connection with a Sale and Leaseback
transaction with respect to such property as permitted under Section 6.09; provided that such Lien applies solely to the property subject to such Sale and Leaseback Transaction; 

(z) Liens that are contractual rights of set-off (i) relating to the establishment of depositary relations with banks or other
financial institutions and 

  
 160

 
not given in connection with the issuance of Indebtedness, (ii) related to pooled deposit or sweep accounts of the Borrower or any of its Subsidiaries to permit satisfaction of overdraft or
similar obligations incurred in the ordinary course of business or (iii) relating to purchase orders and other agreement entered into with customers of the Borrower or any of the Subsidiaries in the ordinary course of business; 

(aa) the modification, replacement, renewal or extension of any Lien permitted by Sections 6.02(l) and (m); provided that
(i) such Lien does not extend to any additional property other than (A) after acquired property that is affixed or incorporated into the property covered by such Lien and (B) the proceeds and products thereof and (ii) the
renewal, extension or refinancing of the obligations secured by such Lien is permitted by Section 6.01; 
 (bb) three-way
technology escrow agreements entered into using reputable escrow agents in connection with the license, development and distribution agreements of the Borrower and its Subsidiaries, pursuant to which Intellectual Property of the Borrower and its
Subsidiaries, as applicable, is placed in escrow for the benefit of the agreement party that do not materially interfere with the conduct of the Borrower’s or any of its Subsidiaries’ business as conducted on the Closing Date (or as
permitted by Section 6.11) or materially detract from the value thereof; provided that (1) the escrowed Intellectual Property is only released to the agreement party upon the bankruptcy, cessation of business, repudiation of
material obligations or similar industry standard trigger events of the Borrower and its Subsidiaries and (2) upon such release, the agreement party’s use is limited to its internal use only, consistent with the manner in which the
Intellectual Property was used by the Borrower and/or its Subsidiaries on behalf on the agreement party prior to the technology’s release from escrow; and 
 (cc) other Liens securing Indebtedness in an aggregate amount not to exceed $100,000,000. 
 Section 6.03. No Further Negative Pledges. No Credit Party nor any of its Subsidiaries shall enter into any agreement prohibiting the creation or assumption of any Lien upon any of its
properties or assets, whether now owned or hereafter acquired, to secure the Obligations except (a) with respect to specific property subject to a Lien permitted hereunder to secure payment of Indebtedness permitted hereunder or to be sold
pursuant to an executed agreement with respect to a Asset Sale permitted hereunder; provided that such restrictions are limited to the property so encumbered or subject to such Asset Sale, (b) customary restrictions contained in any
Permitted License, lease or similar agreement permitted hereunder (provided that such restrictions are limited to the property or assets subject to such Permitted License, lease or similar agreement), (c) customary provision in joint
venture agreements applicable to joint ventures 

  
 161

 
permitted hereunder; provided that such restrictions are applicable solely to such joint venture entered into in the ordinary course of business, (d) customary provisions set forth in
Co-Development Agreements; provided that such restrictions are applicable solely to the property subject to such Co-Development Agreement, (e) with respect to Discontinued Real Property, (f) restrictions identified on Schedule 6.03,
(g) restrictions set forth in Indebtedness permitted under Section 6.01(f) that impose restrictions on the property so acquired in connection with the Permitted Acquisition referred to in Section 6.01(f), (h) restrictions under
any Refinancing Indebtedness or Permitted Incremental Equivalent Debt and (i) restrictions contained in the indentures relating to the Convertible Notes and the Senior Notes. 

Section 6.04. Restricted Junior Payments. No Credit Party shall, nor shall it permit any of its Subsidiaries or Affiliates
through any manner or means or through any other Person to, directly or indirectly, declare, order, pay, make or set apart, or agree to declare, order, pay, make or set apart, any sum for any Restricted Junior Payment, except (a) each
Subsidiary may make Restricted Junior Payments consisting of a dividend or distribution with respect to its Equity Interests to the Borrower and its other Subsidiaries (and, in the case of non-wholly owned Subsidiaries to the Borrower and any of its
other Subsidiaries and to each other owner of Equity Interest of such Subsidiary based on their relative ownership interest of the relevant class), (b) the Borrower and each Subsidiary may make Restricted Junior Payments of the type referred to
in clause (iv) of the definition thereof to the Borrower or one or more other Subsidiaries, subject only to the subordination provisions, if any, applicable thereto, (c) the Borrower may pay Convertible Note Repayment Obligations then due
and payable so long as (i) no Default or Event of Default shall have occurred and be continuing or shall be caused thereby and (ii) the Borrower shall have delivered to the Administrative Agent a compliance certificate signed by an
Authorized Officer demonstrating pro forma compliance with the financial covenants in Section 6.07 after giving effect to the subject Restricted Junior Payment, (d) so long as no Default or Event of Default shall have occurred and be
continuing or shall be caused thereby, the Borrower may repurchase, redeem or otherwise acquire or retire for value any Equity Interests of the Borrower or any of its Subsidiaries held by any current or former officer, director, consultant or
employee of the Borrower or any of its Subsidiaries, or his or her estate, spouse, former spouse or family member (or pay principal or interest on any Indebtedness issued in connection with such repurchase, redemption or other acquisition) pursuant
to any equity subscription agreement, stock option agreement, shareholders’ agreement, similar agreement or any other agreement pursuant to which such Equity Interests were acquired or benefit plan of any kind and pay the amount of withholding
taxes owed by the recipient of such payment on account thereof, (e) the Borrower may make cash payments in the form of cash settlements with respect to the Spread Overlay Agreements in accordance with the terms thereof, and only to the extent
required 

  
 162

 
thereby, so long as the Borrower receives contemporaneously with or within ninety (90) days preceding such distribution aggregate cash payments in connection with such Spread Overlay
Agreements of not less than the amount of such distribution, (f) as set forth on Schedule 6.04 hereof, (g) the Borrower may refinance any Junior Financing with the proceeds of the Permitted Refinancing thereof, (h) the Borrower may
make payments or distributions to dissenting stockholders pursuant to applicable law, pursuant to or in connection with a consolidation, merger or disposition of assets that complies, if applicable, with the provisions of this Agreement, (i) so
long as no Default or Event of Default shall have occurred and be continuing, to the extent that such payment is not required to be used to make a mandatory prepayment pursuant to Section 2.14(c), the Borrower or any Subsidiary may purchase,
redeem or acquire its outstanding Equity Interests or any Indebtedness with the Net Equity Proceeds received from a substantially concurrent issuance of new Equity Interests, (j) any Credit Party may make any Restricted Junior Payment on
account of the repurchase of Equity Interests deemed to occur upon exercise of stock options, warrants or similar rights or grant, vesting or lapse of restrictions on the grant of any other performance shares, restricted stock, restricted stock
units or other equity awards to the extent that shares of such Equity Interests represent all or a portion of (i) the exercise or purchase price of such options, warrants or similar rights or other equity awards and (ii) the amount of
withholding taxes owed by the recipient of such award in respect of such grant, exercise, vesting or lapse of restrictions covered by clause (i) and (k) so long as no Default or Event of Default shall have occurred and be continuing or
shall be caused thereby, the Borrower may make other Restricted Junior Payments in an aggregate amount during the term of this Agreement not to exceed the sum of (i) $25,000,000 plus (ii) if, both immediately before and after giving
effect such payment, the Total Net Leverage Ratio is less than 3.50:1.00, the Available ECF Amount. 
 Section 6.05.
Restrictions on Subsidiary Distributions. No Credit Party shall, nor shall it permit any of its Subsidiaries to, create or otherwise cause or suffer to exist or become effective any consensual encumbrance or restriction of any kind on the
ability of any Subsidiary of the Borrower to (a) pay dividends or make any other distributions on any of such Subsidiary’s Equity Interests owned by the Borrower or any other Subsidiary of the Borrower, (b) repay or prepay any
Indebtedness owed by such Subsidiary to the Borrower or any other Subsidiary of the Borrower, (c) make loans or advances to the Borrower or any other Subsidiary of the Borrower or (d) transfer, lease or license any of its property or
assets to the Borrower or any other Subsidiary of the Borrower other than (i) with respect to specific property subject to a Lien permitted hereunder to secure payment of Indebtedness permitted hereunder or to be sold pursuant to an executed
agreement with respect to a Asset Sale permitted hereunder; provided that such restrictions are limited to the property so encumbered or subject to such Asset Sale, (ii) customary restrictions contained in any Permitted License, leases
or similar 

  
 163

 
agreements permitted hereunder; provided that such restrictions are limited to the property or assets subject to such Permitted License, lease or similar agreement, (iii) customary
provision in joint venture agreements applicable to joint ventures permitted hereunder; provided that such restrictions are applicable solely to such joint venture entered into in the ordinary course of business, (iv) customary provision
set forth in Co-Development Agreements; provided that such restrictions are applicable solely to the property subject to such Co-Development Agreements, (v) with respect to Discontinued Real Property, (vi) restrictions identified on
Schedule 6.05, (vii) restrictions set forth in Indebtedness permitted under Section 6.01(f) that imposes restrictions on the property so acquired in connection with the Permitted Acquisition referred to in Section 6.01(f),
Section 6.01(g) (to the extent not more restrictive that the restrictions contained in this Agreement), 6.01(k) (to the extent not more restrictive that the restrictions contained in this Agreement), Section 6.01(m)(ii) (solely with
respect to the entity incurring such Indebtedness), Section 6.01(n) (solely with respect to the assets financed thereby), Section 6.01(q) and Section 6.01(x) (to the extent not more restrictive that the restrictions contained in this
Agreement), (viii) restrictions under any Refinancing Indebtedness or Permitted Incremental Equivalent Debt, (ix) restrictions contained in this Agreement and the indentures relating to the Convertible Notes and the Senior Notes,
(x) restrictions on cash or other deposits or customary net worth provisions imposed by customers under contracts entered into in the ordinary course of business, (xi) pursuant to any amendment, modification, restatement, renewal,
increase, supplement, refunding, replacement or refinancing of an agreement referred to in clauses (i) through (x) above; provided, however, that such amendment, modification, restatement, renewal, increase, supplement, refunding,
replacement or refinancing is no more materially restrictive with respect to such encumbrances and other restrictions taken as a whole than those prior to such amendment, modification, restatement, renewal, increase, supplement, refunding,
replacement or refinancing. 
 Section 6.06. Investments. No Credit Party shall, nor shall it permit any of its
Subsidiaries to, directly or indirectly, make or own any Investment in any Person, including any joint venture, except: 
 (a)
Investments in Cash, Cash Equivalents, Investment Grade Securities and Acquired Non-Investment-Grade Securities; 
 (b)
Investments owned as of or made prior to the Closing Date in any Subsidiary and Investments made after the Closing Date in any Credit Party; 
 (c) Investments (i) in any Securities received in satisfaction or partial satisfaction thereof from financially troubled account debtors and (ii) deposits, prepayments and other credits to
suppliers made in the ordinary course of business of the Borrower and its Subsidiaries; 

  
 164

 (d) Investments made by any Subsidiary that is not a Credit Party in another Subsidiary that
is not a Credit Party; 
 (e) Investments in the nature of pledges or deposits with respect to leases, utilities, worker’s
compensation, performance and other similar deposits provided to third parties in the ordinary course of business; 
 (f)
Investments consisting of extensions of credit in the nature of accounts receivable or notes receivable arising from the grant of trade credit in the ordinary course of business; 

(g) Investments representing non-cash consideration received by the Borrower or any of its Subsidiaries in connection with (A) any
Asset Sale effected in accordance with Section 6.08(c) or (B) a Disposition of assets not constituting an Asset Sale; provided that any such non-cash consideration received by the Borrower or any other Credit Party is pledged to the
Collateral Agent for the benefit of the Secured Parties pursuant to the Collateral Documents; 
 (h) Investments by the Borrower
or any of its Subsidiaries in a Person in an aggregate amount not to exceed at any time an amount equal to (i) $150,000,000 plus (ii) the Available ECF Amount during the term of this Agreement; provided that before and
immediately after giving effect to such Investment, no Default or Event of Default shall have occurred and be continuing or would result therefrom; 
 (i) loans and advances to employees, directors, officers and consultants of the Borrower and its Subsidiaries made in the ordinary course of business in an aggregate principal amount not to exceed
$10,000,000 at any time outstanding in the aggregate; 
 (j) Permitted Acquisitions; 

(k) Investments existing on the Closing Date or made pursuant to legally binding written contracts in existence on the Closing Date, in
each case as described in Schedule 6.06(k) and any modification, replacement, renewal or extension thereof so long as the amount of such Investment is not increased thereby other than as otherwise permitted by this Section 6.06; 

(l) Investments made by any Credit Party in any Subsidiary that is not a Credit Party in an aggregate amount not to exceed at any time,
together with the aggregate amount of any Investment pursuant to the proviso to clause (c) of the definition of Permitted Acquisition, $175,000,000 during the term of this Agreement; provided that any such Investments in the form of
loans shall comply with Section 6.01(l); 

  
 165

 (m) the Spread Overlay Agreements to the extent constituting an Investment; 

(n) all Investments existing or arising under any Hedge Agreement entered into in the ordinary course of business and not for speculative
purposes; 
 (o) Investments in any joint ventures in an amount outstanding at any one time not to exceed the greater of
(i) $100,000,000 or (ii) 1.0% of Total Assets; 
 (p) any Investments received in good faith in settlement or
compromise of obligations of trade creditors or customers that were incurred in the ordinary course of business, including pursuant to any plan of reorganization or similar arrangement upon the bankruptcy or insolvency of any trade creditor or
customer; 
 (q) any Permitted License to the extent constituting an Investment; 

(r) Investments in the ordinary course of business consisting of endorsements for collection or deposit; 

(s) Investments made solely in exchange for the issuance of Equity Interests (other than Disqualified Equity Interests) of the Borrower;

 (t) Investments related to the development or marketing of Makena Products and Interests in connection with (x) the
exercise of the Borrower’s or a Subsidiary’s rights and remedies with respect to, and/or the sale, assignment, license or other disposition (including following the exercise of such rights and remedies) of, any Makena Products and
Interests and (y) the settlement or unwinding of any contractual arrangements with KV relating to the Makena Products and Interests; 
 (u) Investments in a Receivables Entity, or any Investment by a Receivables Entity in any other Person in connection with a Qualified Receivables Transaction, including Investments of funds held in
accounts permitted or required by the arrangements governing such Qualified Receivables Transaction or any related Indebtedness; provided, however, that any Investment in a Receivables Entity is in the form of a purchase money note,
contribution of additional receivables or an equity interest; 
 (v) Investments held by a Subsidiary acquired after the Closing
Date, including by way of a merger, amalgamation or consolidation with or into the Borrower or any of its Subsidiaries in a transaction that is not prohibited by Section 6.08 to the extent that such Investments were not made in contemplation of
such acquisition, merger, amalgamation or consolidation and were in existence on the date of such acquisition, merger, amalgamation or consolidation (it being understood that Investments in Subsidiaries of such acquired Subsidiary must be otherwise
permitted by Section 6.06(j)); 

  
 166

 (w) Investments in guaranteed investment contracts, annuities, mutual funds, insurance
policies and similar products and investments purchased in the ordinary course of business in accordance with the Borrower’s qualified and/or non-qualified deferred compensation plan; and 

(x) Investments held by a Massachusetts securities corporation in an aggregate amount not to exceed $1,000,000. 

Notwithstanding the foregoing, in no event shall any Credit Party make any Investment that results in or facilitates in any manner any
Restricted Junior Payment not otherwise permitted under the terms of Section 6.04. 
 Section 6.07. Financial Covenants.
(a) Interest Coverage Ratio. The Borrower shall not permit the Interest Coverage Ratio as of the last day of any Fiscal Quarter ending on or about each date set forth below, beginning with the second Fiscal Quarter ending after the
Closing Date, to be less than the correlative ratio indicated opposite such date: 
  

			
	 Fiscal Quarter
	 	 Interest Coverage Ratio

	December 31, 2012	 	3.25:1
	March 31, 2013	 	3.25:1
	June 30, 2013	 	3.25:1
	September 30, 2013	 	3.25:1
	December 31, 2013	 	3.25:1
	March 31, 2014	 	3.25:1
	June 30, 2014	 	3.25:1
	September 30, 2014	 	3.25:1
	December 31, 2014	 	3.25:1
	March 31, 2015	 	3.25:1
	June 30, 2015	 	3.50:1
	September 30, 2015	 	3.50:1
	December 31, 2015	 	3.50:1
	March 31, 2016	 	3.50:1
	June 30, 2016	 	3.50:1
	September 30, 2016	 	3.50:1
	December 31, 2016	 	3.50:1
	March 31, 2017	 	3.50:1
	June 30, 2017	 	3.50:1
	September 30, 2017	 	3.75:1
	December 31, 2017	 	3.75:1
	March 31, 2018	 	3.75:1
	June 30, 2018	 	3.75:1
	September 30, 2018	 	3.75:1
	December 31, 2018	 	3.75:1
	March 31, 2019	 	3.75:1
	June 30, 2019 and thereafter	 	3.75:1

  
 167

 (b) Total Net Leverage Ratio. The Borrower shall not permit the Total Net Leverage
Ratio as of the last day of any Fiscal Quarter ending on or about each date set forth below, beginning with the second Fiscal Quarter ending after the Closing Date, to exceed the correlative ratio indicated opposite such date: 

 

			
	 Fiscal Quarter
	 	 Total Net Leverage Ratio

	December 31, 2012	 	7.00:1
	March 31, 2013	 	7.00:1
	June 30, 2013	 	7.00:1
	September 30, 2013	 	7.00:1
	December 31, 2013	 	7.00:1
	March 31, 2014	 	6.00:1
	June 30, 2014	 	6.00:1
	September 30, 2014	 	6.00:1
	December 31, 2014	 	6.00:1
	March 31, 2015	 	5.50:1
	June 30, 2015	 	5.50:1
	September 30, 2015	 	5.50:1
	December 31, 2015	 	5.25:1
	March 31, 2016	 	5.25:1
	June 30, 2016	 	5.25:1
	September 30, 2016	 	5.00:1
	December 31, 2016	 	5.00:1
	March 31, 2017	 	4.75:1
	June 30, 2017	 	4.75:1
	September 30, 2017	 	4.00:1
	December 31, 2017	 	4.00:1
	March 31, 2018	 	4.00:1
	June 30, 2018	 	4.00:1
	September 30, 2018	 	4.00:1
	December 31, 2018	 	4.00:1
	March 31, 2019	 	4.00:1
	June 30, 2019 and thereafter	 	4.00:1

 Section 6.08. Fundamental Changes; Disposition of Assets; Acquisitions. No Credit Party
shall, nor shall it permit any of its Subsidiaries to, enter into any 

  
 168

 
transaction of merger or consolidation, or liquidate, wind up or dissolve itself (or suffer any liquidation or dissolution), or convey, sell, lease or license, exchange, transfer or otherwise
dispose of, in one transaction or a series of transactions all or any part of its business, assets or property of any kind whatsoever, whether real, personal or mixed and whether tangible or intangible, whether now owned or hereafter acquired,
created, leased or licensed, or acquire by purchase or otherwise (other than purchases or other acquisitions of inventory, materials and equipment and capital expenditures in the ordinary course of business) the business, substantially all property
or fixed assets of, or stock or other evidence of beneficial ownership of, any Person or any division or line of business or other business unit of any Person, except: 
 (a) (i) any Subsidiary of the Borrower may be merged with or into the Borrower or any Guarantor, or be liquidated, wound up or dissolved, or all or any part of its business, property or assets may be
conveyed, sold, leased, transferred or otherwise Disposed of, in one transaction or a series of transactions, to the Borrower or any Guarantor; provided, in the case of such a merger, the Borrower or such Guarantor, as applicable shall be the
continuing or surviving Person; (ii) any Massachusetts securities corporation may be merged with or into any other Massachusetts securities corporation, or be liquidated, wound up or dissolved, or all or any part of its business, property or
assets may be conveyed, sold, leased, transferred or otherwise Disposed of, in one transaction or a series of transactions, to any other Massachusetts securities corporation; and (iii) any Subsidiary that is not a Credit Party may be merged
with or into any other Subsidiary, or be liquidated, wound up or dissolved, or all or any part of its business, property or assets may be conveyed, sold, leased, transferred or otherwise Disposed of, in one transaction or a series of transactions to
any other Subsidiary (other than an Excluded Subsidiary); 
 (b) sales, licenses, leases or other Dispositions of assets that do
not constitute Asset Sales; 
 (c) Asset Sales, the proceeds of which (valued at the principal amount thereof in the case of
non-Cash proceeds consisting of notes or other debt Securities and valued at fair market value in the case of other non-Cash proceeds) (i) are less than $50,000,000 with respect to any single Asset Sale or series of related Asset Sales and
(ii) when aggregated with the proceeds of all other Asset Sales made within the same Fiscal Year, are less than the sum of (x) $100,000,000 and (y) an amount equal to the lesser of (A) any unused portion of the basket provided
for in this clause (ii) from the immediately prior Fiscal Year and (B) $100,000,000; provided (A) the consideration received for such assets shall be in an amount at least equal to the fair market value thereof (determined in
good faith by the board of directors of the Borrower (or similar governing body)), (B) no less than 70% thereof shall be paid in Cash; provided that for the purpose of this clause (B), the following shall be deemed to be Cash:
(1) any securities 

  
 169

 
received by the Borrower or such Subsidiary that are converted by the Borrower or such Subsidiary into Cash or Cash Equivalents (to the extent of the Cash or Cash Equivalents received in such
conversion) within 180 days following the closing of the applicable Asset Sale and (2) any Designated Non-Cash Consideration in respect of such Asset Sale having an aggregate fair market value, taken together with the Designated Non-Cash
Consideration in respect of all such Asset Sales, not to exceed at any time the greater of $100,000,000 and 1% of Total Assets, (C) the Net Asset Sale Proceeds thereof shall be applied as required by Section 2.14(a) and (D) at the time of
such Asset Sale, no Default or Event of Default shall have occurred and be continuing or would result therefrom; 
 (d)
Disposals of obsolete, worn out or surplus property or damaged property no longer useful in the business of the Borrower and its Subsidiaries; 
 (e) Permitted Acquisitions; 
 (f) Investments made in accordance with
Section 6.06 and Sale and Leaseback Transactions made in accordance with Section 6.09; 
 (g) (i) the abandonment of
rights, franchises, licenses, trade names, copyrights, patents, trademarks or other Intellectual Property that are, in the reasonable judgment of the Borrower, either no longer economically practicable to maintain or no longer useful in the conduct
of the business of the Borrower and its Subsidiaries taken as a whole, (ii) the transfer of Intellectual Property rights (including Permitted Licenses) in settlement of any dispute or litigation with governmental regulatory authorities or
otherwise necessary to comply with any legal or regulatory requirement, (iii) the transfer of Intellectual Property rights (including Permitted Licenses) to third parties in settlement of any dispute or litigation with third parties and
(iv) the transfer, sale or other disposition of non-core Intellectual Property, which, in the case of clauses (i), (iii) and (iv), does not materially interfere with the conduct of the Borrower’s or any of its Subsidiaries’
business as conducted on the Closing Date (or as permitted by Section 6.11) or materially detract from the value thereof; 

(h) sales to a Receivables Entity or transfers by a Receivable Entity of accounts receivable and related assets of the type specified in
the definition of “Qualified Receivables Transaction”; 
 (i) to the extent allowable under Section 1031 of the
Internal Revenue Code, any exchange of like-kind property (excluding any boot thereon) for use in any business or lines of business in which the Borrower and/or its Subsidiaries are engaged as of the Closing Date (or as permitted by
Section 6.11); provided that to the extent the property exchanged is Collateral, such replacement property shall constitute Collateral; 

  
 170

 (j) sales, licenses, leases or other Dispositions of property to the Borrower or a
Subsidiary; provided that if the transferor of such property is a Credit Party either (i) the transferee thereof must be a Credit Party, (ii) such sale, license, lease or other Disposition must be for fair market value or
(iii) such transaction shall constitute an Investment and must be permitted by Section 6.06; 
 (k) the unwinding of
any Hedge Agreement; 
 (l) sales, transfers and other Dispositions of Investments in joint ventures to the extent required by,
or made pursuant to, customary buy/sell arrangements between the joint venture parties set forth in joint venture arrangements, which do not materially interfere with the conduct of the business of the Borrower and its Subsidiaries; 

(m) the creation of a Lien permitted under Section 6.02 (other than 6.02(w)); 

(n) dispositions of Investments or accounts receivable in connection with the compromise, settlement or collection thereof in the
ordinary course of business or in bankruptcy or similar proceedings and exclusive of factoring or similar arrangements; 
 (o)
the sale, discount or other Disposition of accounts receivable or notes receivable in the ordinary course of business or the conversion of accounts receivable to notes receivable; 

(p) the taking of any Real Estate Asset by any Person pursuant to the power of eminent domain, condemnation or otherwise; provided
that any Net Insurance/Condemnation Proceeds realized by the Borrower or any of its Subsidiaries in connection with such taking are applied in accordance with Section 2.14(b), if applicable; 

(q) the sale or other Disposition of (i) any assets of the Acquired Business or any of its Subsidiaries, to the extent such assets
were owned by the Acquired Business or any such Subsidiary at the time of the Acquisition and were not acquired in contemplation thereof, in an aggregate amount not to exceed $50,000,000 and (ii) any Acquired Business Non-Core Assets;

 (r) the sale or other Disposition of Acquired Non-Investment-Grade Securities; and 

(s) the abandonment, termination or lapse of rights, franchises, licenses and permits to the extent permitted by Section 5.02.

 Section 6.09. Sales and Leasebacks. Except as set forth on Schedule 6.09, no Credit Party shall, nor shall it
permit any of its Subsidiaries to, directly or 

  
 171

 
indirectly, become or remain liable as lessee or as a guarantor or other surety with respect to any lease of any property (whether real, personal or mixed), whether now owned or hereafter
acquired, which such Credit Party (a) has sold or transferred or is to sell or to transfer to any other Person (other than the Borrower or any of its Subsidiaries) or (b) intends to use for substantially the same purpose as any other
property which has been or is to be sold or transferred by such Credit Party to any Person (other than the Borrower or any of its Subsidiaries) in connection with such lease, unless (i) the Borrower shall be in compliance, on a pro forma basis
after giving effect to the consummation of the Sale and Leaseback Transaction and the application of the proceeds thereof, with the Total Net Leverage Ratio set forth in subsection 6.07, recomputed as at the last day of the most recently ended
Fiscal Quarter of the Borrower for which the relevant information is available as if such Sale and Leaseback Transaction had been consummated on the first day of the relevant period for testing such compliance (such calculation to be made in a
manner reasonably satisfactory to the Administrative Agent and to be evidenced by a certificate in form and substance reasonably satisfactory to the Administrative Agent signed by an Authorized Officer of the Borrower and delivered to the
Administrative Agent (which shall promptly deliver copies to each Lender) at least three (3) Business Days prior to the consummation of such Sale and Leaseback Transaction), (ii) the lease entered into by the Borrower or any of its
Subsidiaries in connection with such Sale and Leaseback Transaction is either (A) a Capital Lease or (B) a lease the payments under which will be treated as an operating expense for purposes of determining Consolidated Adjusted EBITDA and
(iii) an amount equal to 100% of the Net Cash Proceeds of such Sale and Leaseback Transaction is applied in accordance with Section 2.14(a). 
 Section 6.10. Transactions with Shareholders and Affiliates. No Credit Party shall, nor shall it permit any of its Subsidiaries to, directly or indirectly, enter into or permit to exist any
transaction involving aggregate consideration in excess of $5,000,000 (including the purchase, sale, lease or exchange of any property or the rendering of any service) with any Affiliate of the Borrower on terms that are less favorable to the
Borrower or that Subsidiary, as the case may be, than those that might be obtained at the time from a Person who is not such a holder or Affiliate; provided, the foregoing restriction shall not apply to (a) any transaction between the
Borrower and any of its Subsidiaries or among Subsidiaries of the Borrower; (b) customary fees paid to members of the board of directors (or similar governing body) of the Borrower and its Subsidiaries; (c) compensation or fees to, or the
provision of benefits for officers, consultants and former consultants, directors and employees of the Borrower and its Subsidiaries entered into in the ordinary course of business (including, without limitation, loans and advances permitted under
Section 6.06(i)); (d) transactions or arrangements described in Schedule 6.10 or any renewals or extensions of any such agreements (so long as such renewals or extensions are not less favorable in

  
 172

 
any material respect to the Borrower or its Subsidiaries); (e) any transactions between a Credit Party and any Person that is an Affiliate solely because a director of such Person is also a
director of a Credit Party, so long as such director abstains from voting as a director of such Credit Party in any matter involving such Person; (f) Restricted Junior Payments permitted to be made under Section 6.04; (g) transactions
with consultants, customers, clients, suppliers, lessees or purchasers or sellers of goods or services, in each case in the ordinary course of business and otherwise in compliance with the terms of this Agreement; (h) transactions effected as a
part of a Qualified Receivables Transaction and any Permitted Refinancing thereof; (i) Investments permitted under Sections 6.06(c), (o), (p) and (t); (j) the issuances of Equity Interests or other securities or other payments, awards
or grants in cash, securities or otherwise pursuant to, or the funding of, employment arrangements, stock option and stock ownership plans or similar employee benefit plans approved by a majority of the Board of Directors of the Borrower or majority
of disinterested members of the Board of Directors or any direct or indirect parent company of a Subsidiary of the Borrower, as appropriate, in good faith; (k) any employment or consulting agreement, incentive agreement, employee benefit plan,
severance agreement, stock option or stock ownership plan, or any similar arrangement entered into by the Borrower or any of its Subsidiaries in the ordinary course of business approved by the Board of Directors of the Borrower, and payments,
awards, grants or issuances of Capital Stock or other securities pursuant thereto; (l) any transaction with a Person in its capacity as a holder of Indebtedness or Equity Interests of the Borrower or any of its Subsidiaries where such Person is
treated no more favorably than the other holders of Indebtedness or Equity Interests of the Borrower or any of its Subsidiaries; and (m) entering into, making payments pursuant to and otherwise performing an indemnification and contribution
agreement in favor of any Person and each Person who is or becomes a director, officer, agent or employee of the Borrower or any of its Subsidiaries, in respect of liabilities (i) arising under the Securities Act, the Exchange Act and any other
applicable securities laws or otherwise, in connection with any offering of securities by the Borrower, (ii) incurred to third parties for any action or failure to act of the Borrower or any of its Subsidiaries, predecessors or successors,
(iii) arising out of the fact that any indemnitee was or is a director, officer, agent or employee of the Borrower or any of its Subsidiaries, or is or was serving at the request of any such corporation as a director, officer, employee or agent
of another corporation, partnership, joint venture, trust or enterprise or (iv) to the fullest extent permitted by Delaware or other applicable state law, arising out of any breach or alleged breach by such indemnitee of his or her fiduciary
duty as a director or officer of the Borrower or any of its Subsidiaries. 
 For purposes of this Section 6.10, any
transaction with any Affiliate shall be deemed to have satisfied the standard set forth in the first sentence hereof if such transaction shall be approved (in form and substance reasonably satisfactory

  
 173

 
to the Administrative Agent) by a nationally recognized expert with expertise in appraising the terms and conditions of the type of transaction for which approval is required. 

Section 6.11. Conduct of Business. From and after the Closing Date, no Credit Party shall, nor shall it permit any of its
Subsidiaries to, engage in any business other than (i) the businesses engaged in by such Credit Party on the Closing Date including, without limitation, any medical, pharmaceutical, diagnostic or other health oriented business and any
businesses similar, related, ancillary or incidental thereto or a reasonable extension, development or expansion thereof; (ii) any other business acquired in connection with a Permitted Acquisition and any businesses similar, related, ancillary
or incidental thereto, or that is an adjunct thereto (provided that the Administrative Agent consents to such adjunct if material), or a reasonable extension, development or expansion thereof, and (iii) such other lines of business as
may be consented to by the Requisite Lenders. 
 Section 6.12. Amendments or Waivers of Organizational Documents and
Certain Related Agreements. Except as contemplated by Section 3.01(c), no Credit Party shall nor shall it permit any of its Subsidiaries to, agree to any material amendment, restatement, supplement or other modification to, or waiver of,
any of its Organizational Documents or any of its material rights under any Related Agreement if such amendment, restatement, supplement, modification or waiver would have a Material Adverse Effect on the rights or remedies of the Lenders under the
Credit Documents or with respect to the Credit Parties, without in each case obtaining the prior written consent of the Requisite Lenders to such amendment, restatement, supplement or other modification or waiver. 

Section 6.13. Amendments or Waivers with Respect to Junior Financing. Except in connection with a Permitted Refinancing
thereof, no Credit Party shall, nor shall it permit any of its Subsidiaries to, amend or otherwise change the terms of any Junior Financing, or make any payment consistent with an amendment thereof or change thereto, if the effect of such amendment
or change is to change (to earlier dates) any dates upon which payments of principal or interest are due thereon, change any event of default or condition to an event of default with respect thereto (other than to eliminate any such event of default
or increase any grace period related thereto or otherwise make such event of default more favorable to the Credit Party), change the redemption, prepayment or defeasance provisions thereof, change the subordination provisions of such Junior
Financing (or of any guaranty thereof), if applicable, or if the effect of such amendment or change, together with all other amendments or changes made, is to increase materially the obligations of the obligor thereunder or to confer any additional
rights on the holders of such Junior Financing (or a trustee or other representative on their behalf) which would be adverse to any Credit Party or Lenders. 

  
 174

 Section 6.14. Fiscal Year. The Borrower shall not change its Fiscal Year end for
SEC reporting purposes from the last Saturday in September. 
 Section 6.15. Massachusetts Securities Corporation.
Notwithstanding any other provision of this Article 6, (a) no Credit Party shall permit any Subsidiary that is a Massachusetts securities corporation to create, incur, assume or suffer to exist any Liens or any Indebtedness, Dispose of any
assets (other than (i) in compliance with Section 6.08(a)(ii) or (ii) Dispositions to the Borrower or a Subsidiary Guarantor or in connection with the sale and purchase of Investments), make any Investments or engage in any other
business operations, other than Investments permitted by Section 6.06(a), in each case in accordance with Massachusetts General Laws Chapter 63, § 38B and, in addition, (b) no Credit Party shall permit any Subsidiary that is a
Massachusetts securities corporation to engage in any business other than (i) investing in assets and securities of all kinds, including but not limited to debt securities and securities sold in transactions originated by it or its manager and
(ii) other activities required by law to maintain tax advantaged status under Massachusetts General Laws Chapter 63, § 38B. 
 ARTICLE 7 
 GUARANTY 

Section 7.01. Guaranty of the Obligations. Subject to the provisions of Section 7.02, Guarantors jointly and severally
hereby irrevocably and unconditionally guaranty to the Administrative Agent for the ratable benefit of the Beneficiaries the due and punctual payment in full of all Obligations when the same shall become due, whether at stated maturity, by required
prepayment, declaration, acceleration, demand or otherwise (including amounts that would become due but for the operation of the automatic stay under Section 362(a) of the Bankruptcy Code, 11 U.S.C. § 362(a)) (collectively, the
“Guaranteed Obligations”). 
 Section 7.02. Contribution by Guarantors. All Guarantors desire to
allocate among themselves (collectively, the “Contributing Guarantors”), in a fair and equitable manner, their obligations arising under this Guaranty. Accordingly, in the event any payment or distribution is made on any date by a
Guarantor (a “Funding Guarantor”) under this Guaranty such that its Aggregate Payments exceeds its Fair Share as of such date, such Funding Guarantor shall be entitled to a contribution from each of the other Contributing Guarantors
in an amount sufficient to cause each Contributing Guarantor’s Aggregate Payments to equal its Fair Share as of such date. “Fair Share” means, with respect to a Contributing Guarantor as of any date of determination, an amount
equal to (a) the ratio of (i) the Fair Share Contribution Amount with respect to such Contributing Guarantor to (ii) the aggregate of the Fair Share Contribution 

  
 175

 
Amounts with respect to all Contributing Guarantors multiplied by (b) the aggregate amount paid or distributed on or before such date by all Funding Guarantors under this Guaranty in respect
of the obligations Guaranteed. “Fair Share Contribution Amount” means, with respect to a Contributing Guarantor as of any date of determination, the maximum aggregate amount of the obligations of such Contributing Guarantor under
this Guaranty that would not render its obligations hereunder or thereunder subject to avoidance as a fraudulent transfer or conveyance under Section 548 of Title 11 of the United States Code or any comparable applicable provisions of state
law; provided, solely for purposes of calculating the “Fair Share Contribution Amount” with respect to any Contributing Guarantor for purposes of this Section 7.02, any assets or liabilities of such Contributing Guarantor
arising by virtue of any rights to subrogation, reimbursement or indemnification or any rights to or obligations of contribution hereunder shall not be considered as assets or liabilities of such Contributing Guarantor. “Aggregate
Payments” means, with respect to a Contributing Guarantor as of any date of determination, an amount equal to (1) the aggregate amount of all payments and distributions made on or before such date by such Contributing Guarantor in
respect of this Guaranty (including in respect of this Section 7.02), minus (2) the aggregate amount of all payments received on or before such date by such Contributing Guarantor from the other Contributing Guarantors as contributions
under this Section 7.02. The amounts payable as contributions hereunder shall be determined as of the date on which the related payment or distribution is made by the applicable Funding Guarantor. The allocation among Contributing Guarantors of
their obligations as set forth in this Section 7.02 shall not be construed in any way to limit the liability of any Contributing Guarantor hereunder. Each Guarantor is a third party beneficiary to the contribution agreement set forth in this Section
7.02. 
 Section 7.03. Payment by Guarantors. Subject to Section 7.02, Guarantors hereby jointly and severally
agree, in furtherance of the foregoing and not in limitation of any other right which any Beneficiary may have at law or in equity against any Guarantor by virtue hereof, that upon the failure of the Borrower to pay any of the Guaranteed Obligations
when and as the same shall become due, whether at stated maturity, by required prepayment, declaration, acceleration, demand or otherwise (including amounts that would become due but for the operation of the automatic stay under Section 362(a)
of the Bankruptcy Code, 11 U.S.C. § 362(a)), Guarantors will upon demand pay, or cause to be paid, in Cash, to the Administrative Agent for the ratable benefit of Beneficiaries, an amount equal to the sum of the unpaid principal amount of all
Guaranteed Obligations then due as aforesaid, accrued and unpaid interest on such Guaranteed Obligations (including interest which, but for the Borrower’s becoming the subject of a case under the Bankruptcy Code, would have accrued on such
Guaranteed Obligations, whether or not a claim is allowed against the Borrower for such interest in the related bankruptcy case) and all other Guaranteed Obligations then owed to Beneficiaries as aforesaid. 

  
 176

 Section 7.04. Liability of Guarantors Absolute. Each Guarantor agrees that its
obligations hereunder are irrevocable, absolute, independent and unconditional and shall not be affected by any circumstance which constitutes a legal or equitable discharge of a guarantor or surety other than payment in full of the Guaranteed
Obligations. In furtherance of the foregoing and without limiting the generality thereof, each Guarantor agrees as follows: 

(a) this Guaranty is a guaranty of payment when due and not of collectability. This Guaranty is a primary obligation of each Guarantor
and not merely a contract of surety; 
 (b) the Administrative Agent may enforce this Guaranty upon the occurrence of an Event
of Default notwithstanding the existence of any dispute between the Borrower and any Beneficiary with respect to the existence of such Event of Default; 
 (c) the obligations of each Guarantor hereunder are independent of the obligations of the Borrower and the obligations of any other guarantor (including any other Guarantor) of the obligations of the
Borrower, and a separate action or actions may be brought and prosecuted against such Guarantor whether or not any action is brought against the Borrower or any of such other guarantors and whether or not the Borrower is joined in any such action or
actions; 
 (d) payment by any Guarantor of a portion, but not all, of the Guaranteed Obligations shall in no way limit, affect,
modify or abridge any Guarantor’s liability for any portion of the Guaranteed Obligations which has not been paid. Without limiting the generality of the foregoing, if the Administrative Agent is awarded a judgment in any suit brought to
enforce any Guarantor’s covenant to pay a portion of the Guaranteed Obligations, such judgment shall not be deemed to release such Guarantor from its covenant to pay the portion of the Guaranteed Obligations that is not the subject of such
suit, and such judgment shall not, except to the extent satisfied by such Guarantor, limit, affect, modify or abridge any other Guarantor’s liability hereunder in respect of the Guaranteed Obligations; 

(e) any Beneficiary, upon such terms as it deems appropriate, without notice or demand and without affecting the validity or
enforceability hereof or giving rise to any reduction, limitation, impairment, discharge or termination of any Guarantor’s liability hereunder, from time to time may (i) renew, extend, accelerate, increase the rate of interest on, or
otherwise change the time, place, manner or terms of payment of the Guaranteed Obligations; (ii) settle, compromise, release or discharge, or accept or refuse any offer of performance 

  
 177

 
with respect to, or substitutions for, the Guaranteed Obligations or any agreement relating thereto and/or subordinate the payment of the same to the payment of any other obligations;
(iii) request and accept other guaranties of the Guaranteed Obligations and take and hold security for the payment hereof or the Guaranteed Obligations; (iv) release, surrender, exchange, substitute, compromise, settle, rescind, waive,
alter, subordinate or modify, with or without consideration, any security for payment of the Guaranteed Obligations, any other guaranties of the Guaranteed Obligations, or any other obligation of any Person (including any other Guarantor) with
respect to the Guaranteed Obligations; (v) enforce and apply any security now or hereafter held by or for the benefit of such Beneficiary in respect hereof or the Guaranteed Obligations and direct the order or manner of sale thereof, or
exercise any other right or remedy that such Beneficiary may have against any such security, in each case as such Beneficiary in its discretion may determine consistent herewith or the applicable Hedge Agreement and any applicable security
agreement, including foreclosure on any such security pursuant to one or more judicial or nonjudicial sales, whether or not every aspect of any such sale is commercially reasonable, and even though such action operates to impair or extinguish any
right of reimbursement or subrogation or other right or remedy of any Guarantor against any other Credit Party or any security for the Guaranteed Obligations; and (vi) exercise any other rights available to it under the Credit Documents or any
Hedge Agreements; and 
 (f) this Guaranty and the obligations of the Guarantors hereunder shall be valid and enforceable and
shall not be subject to any reduction, limitation, impairment, discharge or termination for any reason (other than payment in full of the Guaranteed Obligations), including the occurrence of any of the following, whether or not any Guarantor shall
have had notice or knowledge of any of them: (i) any failure or omission to assert or enforce or agreement or election not to assert or enforce, or the stay or enjoining, by order of court, by operation of law or otherwise, of the exercise or
enforcement of, any claim or demand or any right, power or remedy (whether arising under the Credit Documents or any Hedge Agreements, at law, in equity or otherwise) with respect to the Guaranteed Obligations or any agreement relating thereto, or
with respect to any other guaranty of or security for the payment of the Guaranteed Obligations; (ii) any rescission, waiver, amendment or modification of, or any consent to departure from, any of the terms or provisions (including provisions
relating to events of default) hereof, any of the other Credit Documents, any of the Hedge Agreements or any agreement or instrument executed pursuant thereto, or of any other guaranty or security for the Guaranteed Obligations, in each case whether
or not in accordance with the terms hereof or such Credit Document, such Hedge Agreement or any agreement relating to such other guaranty or security; (iii) the Guaranteed Obligations, or any agreement relating thereto, at any time being found
to be illegal, invalid or unenforceable in any respect; (iv) the application of payments received from any source (other than payments received pursuant to the 

  
 178

 
other Credit Documents or any of the Hedge Agreements or from the proceeds of any security for the Guaranteed Obligations, except to the extent such security also serves as collateral for
indebtedness other than the Guaranteed Obligations) to the payment of indebtedness other than the Guaranteed Obligations, even though any Beneficiary might have elected to apply such payment to any part or all of the Guaranteed Obligations;
(v) any Beneficiary’s consent to the change, reorganization or termination of the corporate structure or existence of the Borrower or any of its Subsidiaries and to any corresponding restructuring of the Guaranteed Obligations;
(vi) any failure to perfect or continue perfection of a security interest in any collateral which secures any of the Guaranteed Obligations; (vii) any defenses, set offs or counterclaims which the Borrower may allege or assert against any
Beneficiary in respect of the Guaranteed Obligations, including failure of consideration, breach of warranty, payment, statute of frauds, statute of limitations, accord and satisfaction and usury; and (viii) any other act or thing or omission,
or delay to do any other act or thing, which may or might in any manner or to any extent vary the risk of any Guarantor as an obligor in respect of the Guaranteed Obligations. 
 Section 7.05. Waivers by Guarantors. Each Guarantor hereby waives, for the benefit of Beneficiaries: (a) any right to require any Beneficiary, as a condition of payment or performance by
such Guarantor, to (i) proceed against the Borrower, any other guarantor (including any other Guarantor) of the Guaranteed Obligations or any other Person, (ii) proceed against or exhaust any security held from the Borrower, any such other
guarantor or any other Person, (iii) proceed against or have resort to any balance of any Deposit Account or credit on the books of any Beneficiary in favor of any Credit Party or any other Person or (iv) pursue any other remedy in the
power of any Beneficiary whatsoever; (b) any defense arising by reason of the incapacity, lack of authority or any disability or other defense of the Borrower or any other Guarantor including any defense based on or arising out of the lack of
validity or the unenforceability of the Guaranteed Obligations or any agreement or instrument relating thereto or by reason of the cessation of the liability of the Borrower or any other Guarantor from any cause other than payment in full of the
Guaranteed Obligations; (c) any defense based upon any statute or rule of law which provides that the obligation of a surety must be neither larger in amount nor in other respects more burdensome than that of the principal; (d) any defense
based upon any Beneficiary’s errors or omissions in the administration of the Guaranteed Obligations, except behavior which amounts to bad faith; (e) (i) any principles or provisions of law, statutory or otherwise, which are or might
be in conflict with the terms hereof and any legal or equitable discharge of such Guarantor’s obligations hereunder, (ii) the benefit of any statute of limitations affecting such Guarantor’s liability hereunder or the enforcement
hereof, (iii) any rights to set-offs, recoupments and counterclaims and (iv) promptness, diligence and any requirement that any Beneficiary protect, secure, perfect or insure any security

  
 179

 
interest or lien or any property subject thereto; (f) notices, demands, presentments, protests, notices of protest, notices of dishonor and notices of any action or inaction, including
acceptance hereof, notices of default hereunder, the Hedge Agreements or any agreement or instrument related thereto, notices of any renewal, extension or modification of the Guaranteed Obligations or any agreement related thereto, notices of any
extension of credit to the Borrower and notices of any of the matters referred to in Section 7.04 and any right to consent to any thereof; and (g) any defenses or benefits that may be derived from or afforded by law which limit the
liability of or exonerate guarantors or sureties, or which may conflict with the terms hereof. 
 Section 7.06.
Guarantors’ Rights of Subrogation, Contribution, Etc. Until the Guaranteed Obligations shall have been indefeasibly paid in full and the Revolving Commitments shall have terminated and all Letters of Credit shall have expired or been
cancelled, each Guarantor hereby waives any claim, right or remedy, direct or indirect, that such Guarantor now has or may hereafter have against the Borrower or any other Guarantor or any of its assets in connection with this Guaranty or the
performance by such Guarantor of its obligations hereunder, in each case whether such claim, right or remedy arises in equity, under contract, by statute, under common law or otherwise and including (i) any right of subrogation, reimbursement
or indemnification that such Guarantor now has or may hereafter have against the Borrower with respect to the Guaranteed Obligations, (ii) any right to enforce, or to participate in, any claim, right or remedy that any Beneficiary now has or
may hereafter have against the Borrower and (iii) any benefit of, and any right to participate in, any collateral or security now or hereafter held by any Beneficiary. In addition, until the Guaranteed Obligations shall have been indefeasibly
paid in full and the Revolving Commitments shall have terminated and all Letters of Credit shall have expired or been cancelled, each Guarantor shall withhold exercise of any right of contribution such Guarantor may have against any other guarantor
(including any other Guarantor) of the Guaranteed Obligations, including any such right of contribution as contemplated by Section 7.02. Each Guarantor further agrees that, to the extent the waiver or agreement to withhold the exercise of its rights
of subrogation, reimbursement, indemnification and contribution as set forth herein is found by a court of competent jurisdiction to be void or voidable for any reason, any rights of subrogation, reimbursement or indemnification such Guarantor may
have against the Borrower or against any collateral or security, and any rights of contribution such Guarantor may have against any such other guarantor, shall be junior and subordinate to any rights any Beneficiary may have against the Borrower, to
all right, title and interest any Beneficiary may have in any such collateral or security, and to any right any Beneficiary may have against such other guarantor. If any amount shall be paid to any Guarantor on account of any such subrogation,
reimbursement, indemnification or contribution rights at any time when all Guaranteed Obligations shall not have been finally and indefeasibly 

  
 180

 
paid in full, such amount shall be held in trust for the Administrative Agent on behalf of the Beneficiaries and shall forthwith be paid over to the Administrative Agent for the benefit of the
Beneficiaries to be credited and applied against the Guaranteed Obligations, whether matured or unmatured, in accordance with the terms hereof. 
 Section 7.07. Subordination of Other Obligations. Any Indebtedness of the Borrower or any Guarantor now or hereafter held by any Guarantor (the “Obligee Guarantor”) is hereby
subordinated in right of payment to the Guaranteed Obligations, and any such Indebtedness collected or received by the Obligee Guarantor after an Event of Default has occurred and is continuing shall be held in trust for the Administrative Agent on
behalf of the Beneficiaries and shall forthwith be paid over to the Administrative Agent for the benefit of the Beneficiaries to be credited and applied against the Guaranteed Obligations but without affecting, impairing or limiting in any manner
the liability of the Obligee Guarantor under any other provision hereof. 
 Section 7.08. Continuing Guaranty. This
Guaranty is a continuing guaranty and shall remain in effect until all of the Guaranteed Obligations shall have been paid in full and the Revolving Commitments shall have terminated and all Letters of Credit shall have expired or been cancelled.
Each Guarantor hereby irrevocably waives any right to revoke this Guaranty as to future transactions giving rise to any Guaranteed Obligations. 
 Section 7.09. Authority of Guarantors or Borrower. It is not necessary for the enforcement of this Article 7 for any Beneficiary to inquire into the capacity or powers of any Guarantor or the
Borrower or the officers, directors or any agents acting or purporting to act on behalf of any of them. 
 Section 7.10.
Financial Condition of Borrower. Any Credit Extension may be made to the Borrower or continued from time to time, and any Hedge Agreements may be entered into from time to time, in each case without notice to or authorization from any Guarantor
regardless of the financial or other condition of the Borrower at the time of any such grant or continuation or at the time such Hedge Agreement is entered into, as the case may be. No Beneficiary shall have any obligation to disclose or discuss
with any Guarantor its assessment, or any Guarantor’s assessment, of the financial condition of the Borrower. Each Guarantor has adequate means to obtain information from the Borrower on a continuing basis concerning the financial condition of
the Borrower and its ability to perform its obligations under the Credit Documents and the Hedge Agreements, and each Guarantor assumes the responsibility for being and keeping informed of the financial condition of the Borrower and of all
circumstances bearing upon the risk of nonpayment of the Guaranteed Obligations. Each Guarantor hereby waives and relinquishes any duty on the part of any Beneficiary to disclose any matter, fact or thing relating to the business, operations or
conditions of the Borrower now known or hereafter known by any Beneficiary. 

  
 181

 Section 7.11. Bankruptcy, Etc. (a) So long as any Guaranteed Obligations
remain outstanding, no Guarantor shall, without the prior written consent of the Administrative Agent acting pursuant to the instructions of the Requisite Lenders, commence or join with any other Person in commencing any bankruptcy, reorganization
or insolvency case or proceeding of or against the Borrower or any other Guarantor. The obligations of the Guarantors hereunder shall not be reduced, limited, impaired, discharged, deferred, suspended or terminated by any case or proceeding,
voluntary or involuntary, involving the bankruptcy, insolvency, receivership, reorganization, liquidation or arrangement of the Borrower or any other Guarantor or by any defense which the Borrower or any other Guarantor may have by reason of the
order, decree or decision of any court or administrative body resulting from any such proceeding. 
 (b) Each Guarantor
acknowledges and agrees that any interest on any portion of the Guaranteed Obligations which accrues after the commencement of any case or proceeding referred to in clause (a) above (or, if interest on any portion of the Guaranteed Obligations
ceases to accrue by operation of law by reason of the commencement of such case or proceeding, such interest as would have accrued on such portion of the Guaranteed Obligations if such case or proceeding had not been commenced) shall be included in
the Guaranteed Obligations because it is the intention of Guarantors and Beneficiaries that the Guaranteed Obligations which are guaranteed by Guarantors pursuant hereto should be determined without regard to any rule of law or order which may
relieve the Borrower of any portion of such Guaranteed Obligations. Guarantors will permit any trustee in bankruptcy, receiver, debtor in possession, assignee for the benefit of creditors or similar Person to pay the Administrative Agent, or allow
the claim of the Administrative Agent in respect of, any such interest accruing after the date on which such case or proceeding is commenced. 
 (c) In the event that all or any portion of the Guaranteed Obligations are paid by the Borrower, the obligations of Guarantors hereunder shall continue and remain in full force and effect or be
reinstated, as the case may be, in the event that all or any part of such payment(s) are rescinded or recovered directly or indirectly from any Beneficiary as a preference, fraudulent transfer or otherwise, and any such payments which are so
rescinded or recovered shall constitute Guaranteed Obligations for all purposes hereunder. 
 Section 7.12. Discharge of
Guaranty Upon Sale of Guarantor. If all of the Equity Interests of any Guarantor or any of its successors in interest hereunder shall be sold or otherwise disposed of (including by merger or consolidation) in accordance with the terms and
conditions hereof, the Guaranty of such Guarantor or such successor in interest, as the case may be, hereunder shall automatically be discharged and released without any further action by any Beneficiary or any other Person effective as of the time
of such sale. 

  
 182

 ARTICLE 8 
 EVENTS OF DEFAULT 

Section 8.01. Events of Default. If any one or more of the following conditions or events shall occur: 

(a) Failure to Make Payments When Due. Failure by the Borrower to pay (i) when due any Installment or payment of principal of
any Loan, whether at stated maturity, by acceleration, by notice of voluntary prepayment, by mandatory prepayment or otherwise; (ii) when due any amount payable to the Issuing Bank in reimbursement of any drawing under a Letter of Credit or any
Cash Collateralization required pursuant to Section 2.22(d); or (iii) any interest on any Loan or any fee or any other amount due hereunder within five (5) Business Days after the date due; or 

(b) Default in Other Agreements. (i) Except for the failure to fund the disputed portion of a payment in connection with an
earn-out that is the subject of a good faith dispute and for which adequate reserve or other appropriate provision shall have been made in accordance with GAAP, failure of any of the Credit Parties or any of their respective Subsidiaries to pay when
due any principal of or interest on or any other amount, including any payment in settlement, payable in respect of one or more items of Indebtedness (other than Indebtedness referred to in Section 8.01(a)) individually or in the aggregate in a
principal amount (or Net Mark-to-Market Exposure) of $50,000,000 or more, in each case beyond the grace period, if any, provided therefor; or (ii) breach or default by any Credit Party with respect to any other material term of (A) one or
more items of Indebtedness in the individual or aggregate principal amounts (or Net Mark-to-Market Exposure) referred to in clause (i) above or (B) any loan agreement, mortgage, indenture or other agreement relating to such item(s) of
Indebtedness, in each case beyond the grace period, if any, provided therefor, if the effect of such breach or default is to cause, or to permit the holder or holders of that Indebtedness (or a trustee on behalf of such holder or holders), to cause,
that Indebtedness to become or be declared due and payable (or subject to a compulsory repurchase or redeemable) prior to its stated maturity or the stated maturity of any underlying obligation, as the case may be; or 

(c) Breach of Certain Covenants. Failure of any Credit Party to perform or comply with any term or condition contained in
Section 2.06, 5.01(e) or 5.02 or Article 6; or 

  
 183

 (d) Breach of Representations, Etc. Any representation, warranty, certification or
other statement made or deemed made by any Credit Party in any Credit Document or in any statement or certificate at any time given by any Credit Party or any of its Subsidiaries in writing pursuant hereto or thereto or in connection herewith or
therewith shall be false in any material respect as of the date made or deemed made; or 
 (e) Other Defaults Under Credit
Documents. Any Credit Party shall default in the performance of or compliance with any term contained herein or in any of the other Credit Documents, other than any such term referred to in any other paragraph of this Section 8.01, and such
default shall not have been remedied or waived within thirty (30) days after the earlier of (i) an Authorized Officer of such Credit Party becoming aware of such default or (ii) receipt by the Borrower of notice from the
Administrative Agent or any Lender of such default; or 
 (f) Involuntary Bankruptcy; Appointment of Receiver, Etc.
(i) A court of competent jurisdiction shall enter a decree or order for relief in respect of the Borrower or any of its Subsidiaries (other than any Immaterial Domestic Subsidiary) in an involuntary case under any Debtor Relief Laws now or
hereafter in effect, which decree or order is not stayed; or any other similar relief shall be granted under any applicable federal or state law; or (ii) an involuntary case shall be commenced against the Borrower or any of its Subsidiaries
(other than any Immaterial Domestic Subsidiary) under any Debtor Relief Laws now or hereafter in effect; or a decree or order of a court having jurisdiction in the premises for the appointment of a receiver, liquidator, sequestrator, trustee,
custodian or other officer having similar powers over the Borrower or any of its Subsidiaries (other than any Immaterial Domestic Subsidiary), or over all or a substantial part of its property, shall have been entered; or there shall have occurred
the involuntary appointment of an interim receiver, trustee or other custodian of the Borrower or any of its Subsidiaries (other than any Immaterial Domestic Subsidiary) for all or a substantial part of its property; or a warrant of attachment,
execution or similar process shall have been issued against any substantial part of the property of the Borrower or any of its Subsidiaries (other than any Immaterial Domestic Subsidiary), and any such event described in this clause (ii) shall
continue for sixty days without having been dismissed, bonded or discharged; or 
 (g) Voluntary Bankruptcy; Appointment of
Receiver, Etc. (i) The Borrower or any of its Subsidiaries (other than any Immaterial Domestic Subsidiary) shall have an order for relief entered with respect to it or shall commence a voluntary case under any Debtor Relief Laws now or
hereafter in effect, or shall consent to the entry of an order for relief in an involuntary case, or to the conversion of an involuntary case to a voluntary case, under any such law, or shall consent to the appointment of or taking possession by a
receiver, trustee or other custodian for all or a substantial part of its property; or the Borrower or 

  
 184

 
any such Subsidiaries shall make any assignment for the benefit of creditors; or (ii) the Borrower or any of its Subsidiaries (other than any Immaterial Domestic Subsidiary) shall be unable,
or shall fail generally, or shall admit in writing its general inability, to pay its debts as such debts become due; or the board of directors (or similar governing body) of the Borrower or any such Subsidiaries (or any committee thereof) shall
adopt any resolution or otherwise authorize any action to approve any of the actions referred to herein or in Section 8.01(f); or 
 (h) Judgments and Attachments. Any money judgment, writ or warrant of attachment or similar process involving in any individual case or in the aggregate in an amount in excess of $50,000,000 (in
either case to the extent not adequately covered by insurance as to which a solvent and unaffiliated insurance company has acknowledged coverage) shall be entered or filed against the Borrower or any of its Subsidiaries or any of their respective
assets and shall remain undischarged, unvacated, unbonded or unstayed for a period of sixty (60) days (or in any event later than five (5) days prior to the date of any proposed sale thereunder); or 

(i) Dissolution. Any order, judgment or decree shall be entered against any Credit Party decreeing the dissolution or split up of
such Credit Party and such order shall remain undischarged or unstayed for a period in excess of thirty (30) days; or 

(j) Employee Benefit Plans. (i) There shall occur one or more ERISA Events which individually or in the aggregate results in
or would reasonably be expected to result in liability of the Borrower, any of its Subsidiaries or any of their respective ERISA Affiliates in excess of $50,000,000 during the term hereof; or (ii) there exists any fact or circumstance that
reasonably could be expected to result in the imposition of a Lien or security interest pursuant to Section 430(k) of the Internal Revenue Code or ERISA or a violation of Section 436 of the Internal Revenue Code; or 

(k) Change of Control. There occurs any Change of Control; or 

(l) Guaranties, Collateral Documents and other Credit Documents. At any time after the execution and delivery thereof,
(i) the Guaranty for any reason, other than the satisfaction in full of all Obligations, shall cease to be in full force and effect (other than in accordance with its terms) or shall be declared to be null and void or any Guarantor shall
repudiate its obligations thereunder, (ii) this Agreement or any Collateral Document ceases to be in full force and effect (other than by reason of a release of Collateral in accordance with the terms hereof or thereof or the satisfaction in
full of the Obligations in accordance with the terms hereof) or shall be declared null and void, or the Collateral Agent shall not have or shall cease to have a valid and perfected Lien in any Collateral purported to be covered by the Collateral
Documents with the priority required by the relevant 

  
 185

 
Collateral Document, except as otherwise provided in any Collateral Document, in each case for any reason other than the failure of the Collateral Agent or any Secured Party to take any action
within its control or (iii) any Credit Party shall contest the validity or enforceability of any Credit Document in writing or deny in writing that it has any further liability, including with respect to future advances by Lenders, under any
Credit Document to which it is a party or shall contest the validity or perfection of any Lien in any Collateral purported to be granted by the Collateral Documents; or 
 (m) Subordination Provisions. The Borrower or any Credit Party shall make any payment in violation of any subordination terms or conditions, if any, with respect to any Junior Financing;

 THEN, (1) upon the occurrence of any Event of Default described in Sections 8.01(f) or 8.01(g), automatically, and
(2) upon the occurrence and during the continuance of any other Event of Default, at the request of (or with the consent of) the Requisite Lenders, upon notice to the Borrower by the Administrative Agent, (A) the Revolving Commitments,
Tranche A Term Loan Commitments and Tranche B Term Loan Commitments, if any, of each Lender having such Revolving Commitments, Tranche A Term Loan Commitments and Tranche B Term Loan Commitments, respectively, and the obligation of the Issuing Bank
to issue any Letter of Credit shall immediately terminate; (B) each of the following shall immediately become due and payable, in each case without presentment, demand, protest or other requirements of any kind, all of which are hereby
expressly waived by each Credit Party: (1) the unpaid principal amount of and accrued interest and premium on the Loans, (2) an amount equal to the maximum amount that may at any time be drawn under all Letters of Credit then outstanding
(regardless of whether any beneficiary under any such Letter of Credit shall have presented, or shall be entitled at such time to present, the drafts or other documents or certificates required to draw under such Letters of Credit) and (3) all
other Obligations; provided, the foregoing shall not affect in any way the obligations of Lenders under Section 2.03(b)(v) or Section 2.04(e); (C) the Administrative Agent may cause the Collateral Agent to enforce any and all
Liens and security interests created pursuant to Collateral Documents; and (D) the Administrative Agent shall direct the Borrower to pay (and the Borrower hereby agrees upon receipt of such notice, or upon the occurrence of any Event of Default
specified in Sections 8.01(f) or 8.01(g) to pay) to the Administrative Agent such additional amounts of cash as reasonably requested by the Issuing Bank, to Cash Collateralize Letters of Credit then outstanding. 

  
 186

 ARTICLE 9 
 AGENTS 
 Section 9.01. Appointment of Agents. Each of
JPMS and Citi is hereby appointed a Co-Syndication Agent hereunder, and each Lender hereby authorizes each of JPMS and Citi to act as a Co-Syndication Agent in accordance with the terms hereof and the other Credit Documents. Each of Goldman Sachs,
JPMS and Citi is hereby appointed a joint bookrunner hereunder (in such capacity, the “Bookrunners”) and each Lender hereby authorizes each of Goldman Sachs, JPMS and Citi to act as a Bookrunner in accordance with the terms hereof
and the other Credit Documents. Goldman Sachs is hereby appointed the Administrative Agent and the Collateral Agent hereunder and under the other Credit Documents and each Lender hereby authorizes Goldman Sachs to act as the Administrative Agent and
the Collateral Agent in accordance with the terms hereof and the other Credit Documents. Each of DNB Bank ASA, The Bank of Tokyo-Mitsubishi UFJ Ltd. and Fifth Third Bank is hereby appointed the Co-Documentation Agent hereunder, and each Lender
hereby authorizes DNB Bank ASA, The Bank of Tokyo-Mitsubishi UFJ Ltd. and Fifth Third Bank to act as the Co-Documentation Agents in accordance with the terms hereof and the other Credit Documents. Each Agent hereby agrees to act in its capacity as
such upon the express conditions contained herein and the other Credit Documents, as applicable. The provisions of this Article 9 are solely for the benefit of the Agents and the Lenders and no Credit Party shall have any rights as a third party
beneficiary of any of the provisions thereof. In performing its functions and duties hereunder, each Agent shall act solely as an agent of the Lenders and does not assume and shall not be deemed to have assumed any obligation towards or relationship
of agency or trust with or for the Borrower or any of its Subsidiaries. Each of the Co-Syndication Agents, Bookrunners and Co-Documentation Agents, without consent of or notice to any party hereto, may assign any and all of its rights or obligations
hereunder to any of its Affiliates. None of Goldman Sachs, JPMS or Citi in their capacities as Co-Syndication Agents or Bookrunners, nor DNB Bank ASA, The Bank of Tokyo-Mitsubishi UFJ Ltd. or Fifth Third Bank in their capacities as the
Co-Documentation Agents, shall have any obligations but shall be entitled to all benefits of this Article 9. Each of the Co-Syndication Agents, Co-Documentation Agents, Bookrunner and any Agent described in the definition thereof may resign from
such role at any time, with immediate effect, by giving prior written notice thereof to Administrative Agent and Borrower. 

Section 9.02. Powers and Duties. Each Lender irrevocably authorizes each Agent to take such action on such Lender’s
behalf and to exercise such powers, rights and remedies hereunder and under the other Credit Documents as are specifically delegated or granted to such Agent by the terms hereof and thereof, together with such powers, rights and remedies as are
reasonably incidental thereto. Each Agent shall have only those duties and responsibilities that are expressly specified herein and the other Credit Documents. Each Agent may 

  
 187

 
exercise such powers, rights and remedies and perform such duties by or through its agents or employees. No Agent shall have, by reason hereof or any of the other Credit Documents, a fiduciary
relationship in respect of any Lender or any other Person; and nothing herein or any of the other Credit Documents, expressed or implied, is intended to or shall be so construed as to impose upon any Agent any obligations in respect hereof or any of
the other Credit Documents except as expressly set forth herein or therein. 
 Section 9.03. General Immunity.
(a) No Responsibility for Certain Matters. No Agent shall be responsible to any Lender for the execution, effectiveness, genuineness, validity, enforceability, collectability or sufficiency hereof or any other Credit Document or for
any representations, warranties, recitals or statements made herein or therein or made in any written or oral statements or in any financial or other statements, instruments, reports or certificates or any other documents furnished or made available
by any Agent to Lenders or by or on behalf of any Credit Party to any Agent or any Lender in connection with the Credit Documents and the transactions contemplated thereby or for the financial condition or business affairs of any Credit Party or any
other Person liable for the payment of any Obligations, nor shall any Agent be required to ascertain or inquire as to the performance or observance of any of the terms, conditions, provisions, covenants or agreements contained in any of the Credit
Documents or as to the use of the proceeds of the Loans or as to the existence or possible existence of any Event of Default or Default or to make any disclosures with respect to the foregoing. Anything contained herein to the contrary
notwithstanding, the Administrative Agent shall not have any liability arising from confirmations of the amount of outstanding Loans or the Letter of Credit Usage or the component amounts thereof. 

(b) Exculpatory Provisions. No Agent nor any of its officers, partners, directors, employees or agents shall be liable to Lenders
for any action taken or omitted by any Agent under or in connection with any of the Credit Documents except to the extent caused by such Agent’s gross negligence or willful misconduct, as determined by a final, non-appealable judgment of a
court of competent jurisdiction. Each Agent shall be entitled to refrain from any act or the taking of any action (including the failure to take an action) in connection herewith or any of the other Credit Documents or from the exercise of any
power, discretion or authority vested in it hereunder or thereunder unless and until such Agent shall have received instructions in respect thereof from the Requisite Lenders (or such other Lenders as may be required to give such instructions under
Section 10.05) and, upon receipt of such instructions from the Requisite Lenders (or such other Lenders, as the case may be), such Agent shall be entitled to act or (where so instructed) refrain from acting, or to exercise such power, discretion or
authority, in accordance with such instructions, including for the avoidance of doubt, refraining from any action that, in its opinion or the opinion of its counsel, may be in violation of the automatic stay under any Debtor Relief

  
 188

 
Law or that may effect a forfeiture, modification or termination of property of a Defaulting Lender in violation of any Debtor Relief Law. Without prejudice to the generality of the foregoing,
(i) each Agent shall be entitled to rely, and shall be fully protected in relying, upon any communication, instrument or document believed by it to be genuine and correct and to have been signed or sent by the proper Person or Persons, and
shall be entitled to rely and shall be protected in relying on opinions and judgments of attorneys (who may be attorneys for the Borrower and its Subsidiaries), accountants, experts and other professional advisors selected by it; and (ii) no
Lender shall have any right of action whatsoever against any Agent as a result of such Agent acting or (where so instructed) refraining from acting hereunder or any of the other Credit Documents in accordance with the instructions of the Requisite
Lenders (or such other Lenders as may be required to give such instructions under Section 10.05). 
 (c) Delegation of
Duties. The Administrative Agent may perform any and all of its duties and exercise its rights and powers under this Agreement or under any other Credit Document by or through any one or more sub-agents appointed by the Administrative Agent. The
Administrative Agent and any such sub-agent may perform any and all of its duties and exercise its rights and powers by or through their respective Affiliates. The exculpatory, indemnification and other provisions of this Section 9.03 and of
Section 9.06 shall apply to any the Affiliates of the Administrative Agent and shall apply to their respective activities in connection with the syndication of the credit facilities provided for herein as well as activities as the
Administrative Agent. All of the rights, benefits and privileges (including the exculpatory and indemnification provisions) of this Section 9.03 and of Section 9.06 shall apply to any such sub-agent and to the Affiliates of any such sub-agent,
and shall apply to their respective activities as sub-agent as if such sub-agent and Affiliates were named herein. Notwithstanding anything herein to the contrary, with respect to each sub-agent appointed by the Administrative Agent, (i) such
sub-agent shall be a third-party beneficiary under this Agreement with respect to all such rights, benefits and privileges (including exculpatory rights and rights to indemnification) and shall have all of the rights and benefits of a third-party
beneficiary, including an independent right of action to enforce such rights, benefits and privileges (including exculpatory rights and rights to indemnification) directly, without the consent or joinder of any other Person, against any or all of
the Credit Parties and the Lenders, (ii) such rights, benefits and privileges (including exculpatory rights and rights to indemnification) shall not be modified or amended without the consent of such sub-agent and (iii) such sub-agent
shall only have obligations to the Administrative Agent and not to any Credit Party, Lender or any other Person and no Credit Party, Lender or any other Person shall have any rights, directly or indirectly, as a third-party beneficiary or otherwise,
against such sub-agent. 
 Section 9.04. Agents Entitled to Act as Lender. The agency hereby created shall in no way
impair or affect any of the rights and powers of, or impose any 

  
 189

 
duties or obligations upon, any Agent in its individual capacity as a Lender hereunder. With respect to its participation in the Loans and the Letters of Credit, each Agent shall have the same
rights and powers hereunder as any other Lender and may exercise the same as if it were not performing the duties and functions delegated to it hereunder, and the term “Lender” shall, unless the context clearly otherwise indicates, include
each Agent in its individual capacity. Any Agent and its Affiliates may accept deposits from, lend money to, own securities of, and generally engage in any kind of banking, trust, financial advisory or other business with the Borrower or any of its
Affiliates as if it were not performing the duties specified herein, and may accept fees and other consideration from the Borrower for services in connection herewith and otherwise without having to account for the same to Lenders. 

Section 9.05. Lenders’ Representations, Warranties and Acknowledgment. (a) Each Lender represents and warrants that
it has made its own independent investigation of the financial condition and affairs of the Borrower and its Subsidiaries in connection with Credit Extensions hereunder and that it has made and shall continue to make its own appraisal of the
creditworthiness of the Borrower and its Subsidiaries. No Agent shall have any duty or responsibility, either initially or on a continuing basis, to make any such investigation or any such appraisal on behalf of Lenders or to provide any Lender with
any credit or other information with respect thereto, whether coming into its possession before the making of the Loans or at any time or times thereafter, and no Agent shall have any responsibility with respect to the accuracy of or the
completeness of any information provided to Lenders. 
 (b) Each Lender, by delivering (or if delivered in escrow, upon
releasing from such escrow) its signature page to this Agreement, an Assignment Agreement or a Joinder Agreement and funding its Tranche A Term Loan, Tranche B Term Loan and/or Revolving Loans on the Closing Date or by the funding of any New Term
Loans or New Revolving Loans, as the case may be, shall be deemed to have acknowledged receipt of, and consented to and approved, each Credit Document and each other document required to be approved by any Agent, the Requisite Lenders or the
Lenders, as applicable on the Closing Date, or as of the date of funding of such New Loans. 
 (c) Each Lender acknowledges that
the Borrower may purchase Tranche B Term Loans hereunder from Lenders from time to time, subject to the restrictions set forth in Section 10.06. 
 Section 9.06. Right to Indemnity. Each Lender, in proportion to its Pro Rata Share, severally agrees to indemnify each Agent, to the extent that such Agent shall not have been reimbursed by
any Credit Party, for and against any and all liabilities, obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses (including reasonable counsel fees and disbursements) or

  
 190

 
disbursements of any kind or nature whatsoever which may be imposed on, incurred by or asserted against such Agent in exercising its powers, rights and remedies or performing its duties hereunder
or under the other Credit Documents or otherwise in its capacity as such Agent in any way relating to or arising out of this Agreement or the other Credit Documents; provided, no Lender shall be liable for any portion of such liabilities,
obligations, losses, damages, penalties, actions, judgments, suits, costs, expenses or disbursements resulting from such Agent’s gross negligence or willful misconduct, as determined by a final, non-appealable judgment of a court of competent
jurisdiction. If any indemnity furnished to any Agent for any purpose shall, in the opinion of such Agent, be insufficient or become impaired, such Agent may call for additional indemnity and cease, or not commence, to do the acts indemnified
against until such additional indemnity is furnished; provided, in no event shall this sentence require any Lender to indemnify any Agent against any liability, obligation, loss, damage, penalty, action, judgment, suit, cost, expense or
disbursement in excess of such Lender’s Pro Rata Share thereof; and provided further, this sentence shall not be deemed to require any Lender to indemnify any Agent against any liability, obligation, loss, damage, penalty, action,
judgment, suit, cost, expense or disbursement described in the proviso in the immediately preceding sentence. 

Section 9.07. Successor Administrative Agent, Collateral Agent and Swing Line Lender. (a) The Administrative Agent shall
have the right to resign at any time by giving prior written notice thereof to the Lenders and the Borrower and the Administrative Agent may be removed at any time with or without cause by an instrument or concurrent instruments in writing delivered
to the Borrower and the Administrative Agent and signed by the Requisite Lenders. The Administrative Agent shall have the right to appoint a financial institution to act as the Administrative Agent and/or Collateral Agent hereunder, subject to the
reasonable satisfaction of the Borrower and the Requisite Lenders, and the Administrative Agent’s resignation shall become effective on the earliest of (i) 30 days after delivery of the notice of resignation (regardless of whether a
successor has been appointed or not), (ii) the acceptance of such successor Administrative Agent by the Borrower and the Requisite Lenders or (iii) such other date, if any, agreed to by the Requisite Lenders. Upon any such notice of
resignation or any such removal, if a successor Administrative Agent has not already been appointed by the retiring Administrative Agent, the Requisite Lenders shall have the right, upon five (5) Business Days’ notice to the Borrower, to
appoint a successor Administrative Agent. If neither the Requisite Lenders nor the Administrative Agent shall have appointed a successor Administrative Agent, the Requisite Lenders shall be deemed to have succeeded to and become vested with all the
rights, powers, privileges and duties of the retiring Administrative Agent; provided that, until a successor Administrative Agent is so appointed by the Requisite Lenders or the Administrative Agent, any collateral security held by the
Administrative Agent in its role as Collateral Agent on behalf of the Lenders or 

  
 191

 
the Issuing Bank under any of the Credit Documents shall continue to be held by the retiring Collateral Agent as nominee until such time as a successor Collateral Agent is appointed. Upon the
acceptance of any appointment as the Administrative Agent hereunder by a successor Administrative Agent, that successor Administrative Agent shall thereupon succeed to and become vested with all the rights, powers, privileges and duties of the
retiring or removed Administrative Agent and the retiring or removed Administrative Agent shall promptly (i) transfer to such successor Administrative Agent all sums, Securities and other items of Collateral held under the Collateral Documents,
together with all records and other documents necessary or appropriate in connection with the performance of the duties of such successor Administrative Agent under the Credit Documents and (ii) execute and deliver to such successor
Administrative Agent such amendments to financing statements, and take such other actions as may be necessary or appropriate in connection with the assignment to such successor Administrative Agent of the security interests created under the
Collateral Documents, whereupon such retiring or removed Administrative Agent shall be discharged from its duties and obligations hereunder. Except as provided above, any resignation or removal of Goldman Sachs or its successor as the Administrative
Agent pursuant to this Section shall also constitute the resignation or removal of Goldman Sachs or its successor as the Collateral Agent. After any retiring or removed Administrative Agent’s resignation or removal hereunder as the
Administrative Agent, the provisions of this Section shall inure to its benefit as to any actions taken or omitted to be taken by it while it was the Administrative Agent hereunder. Any successor Administrative Agent appointed pursuant to this
Section 9.07(a) shall, upon its acceptance of such appointment, become the successor Collateral Agent for all purposes hereunder. 
 (b) In addition to the foregoing, the Collateral Agent may resign at any time by giving prior written notice thereof to the Lenders and the Grantors, and the Collateral Agent may be removed at any time
with or without cause by an instrument or concurrent instruments in writing delivered to the Grantors and the Collateral Agent signed by the Requisite Lenders. The Administrative Agent shall have the right to appoint a financial institution as the
Collateral Agent hereunder, subject to the reasonable satisfaction of the Borrower and the Requisite Lenders and the Collateral Agent’s resignation shall become effective on the earliest of (i) 30 days after delivery of the notice of
resignation, (ii) the acceptance of such successor Collateral Agent by the Borrower and the Requisite Lenders or (iii) such other date, if any, agreed to by the Requisite Lenders. Upon any such notice of resignation or any such removal,
the Requisite Lenders shall have the right, upon five (5) Business Days’ notice to the Administrative Agent, to appoint a successor Collateral Agent. Until a successor Collateral Agent is so appointed by the Requisite Lenders or the
Administrative Agent, any collateral security held by Collateral Agent on behalf of the Lenders or the Issuing Bank under any of the Credit Documents shall continue to be held by the retiring Collateral Agent as

  
 192

 
nominee until such time as a successor Collateral Agent is appointed. Upon the acceptance of any appointment as the Collateral Agent hereunder by a successor Collateral Agent, that successor
Collateral Agent shall thereupon succeed to and become vested with all the rights, powers, privileges and duties of the retiring or removed Collateral Agent under this Agreement and the Collateral Documents, and the retiring or removed Collateral
Agent under this Agreement shall promptly (i) transfer to such successor Collateral Agent all sums, Securities and other items of Collateral held hereunder or under the Collateral Documents, together with all records and other documents
necessary or appropriate in connection with the performance of the duties of the successor Collateral Agent under this Agreement and the Collateral Documents and (ii) execute and deliver to such successor Collateral Agent or otherwise authorize
the filing of such amendments to financing statements, and take such other actions, as may be necessary or appropriate in connection with the assignment to such successor Collateral Agent of the security interests created under the Collateral
Documents, whereupon such retiring or removed Collateral Agent shall be discharged from its duties and obligations under this Agreement and the Collateral Documents. After any retiring or removed Collateral Agent’s resignation or removal
hereunder as the Collateral Agent, the provisions of this Agreement and the Collateral Documents shall inure to its benefit as to any actions taken or omitted to be taken by it under this Agreement or the Collateral Documents while it was the
Collateral Agent hereunder. 
 Section 9.08. Collateral Documents and Guaranty. (a) Agents under Collateral
Documents and Guaranty. Each Secured Party hereby further authorizes the Administrative Agent or the Collateral Agent, as applicable, on behalf of and for the benefit of the Secured Parties, to be the agent for and representative of the Secured
Parties with respect to the Guaranty, the Collateral and the Collateral Documents; provided that neither the Administrative Agent nor the Collateral Agent shall owe any fiduciary duty, duty of loyalty, duty of care, duty of disclosure or any
other obligation whatsoever to any holder of Obligations with respect to any Hedge Agreement. Subject to Section 10.05, without further written consent or authorization from any Secured Party, the Administrative Agent or the Collateral Agent, as
applicable may execute any documents or instruments necessary to (i) in connection with a sale or disposition of assets permitted by this Agreement, release any Lien encumbering any item of Collateral that is the subject of such sale or other
disposition of assets or to which the Requisite Lenders (or such other Lenders as may be required to give such consent under Section 10.05) have otherwise consented or (ii) release any Guarantor from the Guaranty pursuant to Section 7.12 or
with respect to which the Requisite Lenders (or such other Lenders as may be required to give such consent under Section 10.05) have otherwise consented. 
 (b) Right to Realize on Collateral and Enforce Guaranty. Anything contained in any of the Credit Documents to the contrary notwithstanding, the

  
 193

 
Borrower, the Administrative Agent, the Collateral Agent and each Secured Party hereby agree that (i) no Secured Party shall have any right individually to realize upon any of the Collateral
or to enforce the Guaranty, it being understood and agreed that all powers, rights and remedies hereunder and under any of the Credit Documents may be exercised solely by the Administrative Agent or the Collateral Agent, as applicable, for the
benefit of the Secured Parties in accordance with the terms hereof and thereof and all powers, rights and remedies under the Collateral Documents may be exercised solely by the Collateral Agent for the benefit of the Secured Parties in accordance
with the terms thereof and (ii) in the event of a foreclosure or similar enforcement action by the Collateral Agent on any of the Collateral pursuant to a public or private sale or other disposition (including, without limitation, pursuant to
Section 363(k), Section 1129(b)(2)(a)(ii) or otherwise of the Bankruptcy Code), the Collateral Agent (or any Lender, except with respect to a “credit bid” pursuant to Section 363(k), Section 1129(b)(2)(a)(ii) or
otherwise of the Bankruptcy Code), may be the purchaser or licensor of any or all of such Collateral at any such sale or other disposition and the Collateral Agent, as agent for and representative of the Secured Parties (but not any Lender or
Lenders in its or their respective individual capacities) shall be entitled, upon instructions from the Requisite Lenders, for the purpose of bidding and making settlement or payment of the purchase price for all or any portion of the Collateral
sold at any such sale or disposition, to use and apply any of the Obligations as a credit on account of the purchase price for any Collateral payable by Collateral Agent at such sale or other disposition. 

(c) Rights under Hedge Agreements and Cash Management Agreements. No Hedge Agreement will create (or be deemed to create) in favor
of any Lender Counterparty that is party thereto and no Cash Management Agreement will create (or be deemed to create) in favor of any Cash Management Provider that is a party thereto, any rights in connection with the management or release of any
Collateral or of the obligations of any Guarantor under the Credit Documents, except as expressly provided in Section 9.02 of the Pledge and Security Agreement. By accepting the benefits of the Collateral, such Lender Counterparty and Cash
Management Provider shall be deemed to have appointed the Collateral Agent as its agent and agreed to be bound by the Credit Documents as a Secured Party, subject to the limitations set forth in this clause (c). 

(d) Release of Collateral and Guarantees; Termination of Credit Documents. Notwithstanding anything to the contrary contained
herein or any other Credit Document, when all Obligations (other than obligations in respect of any Hedge Agreement) have been paid in full, all Commitments have terminated or expired and no Letter of Credit shall be outstanding, upon request of the
Borrower, the Administrative Agent shall (without notice to, or vote or consent of, any Lender, or any affiliate of any Lender that is a party to any Hedge Agreement) take such actions as shall be required to release its security interest in all
Collateral, and to release all guarantee obligations provided for in any Credit 

  
 194

 
Document, whether or not on the date of such release there may be outstanding Obligations in respect of Hedge Agreements. Any such release of guarantee obligations shall be deemed subject to the
provision that such guarantee obligations shall be reinstated if after such release any portion of any payment in respect of the Obligations guaranteed thereby shall be rescinded or must otherwise be restored or returned upon the insolvency,
bankruptcy, dissolution, liquidation or reorganization of the Borrower or any Guarantor, or upon or as a result of the appointment of a receiver, intervenor or conservator of, or trustee or similar officer for, the Borrower or any Guarantor or any
substantial part of its property, or otherwise, all as though such payment had not been made. 
 (e) The Collateral Agent shall
not be responsible for or have a duty to ascertain or inquire into any representation or warranty regarding the existence, value or collectability of the Collateral, the existence, priority or perfection of the Collateral Agent’s Lien thereon,
or any certificate prepared by any Credit Party in connection therewith, nor shall the Collateral Agent be responsible or liable to the Lenders for any failure to monitor or maintain any portion of the Collateral. 

Section 9.09. Withholding Taxes. To the extent required by any applicable law, the Administrative Agent may withhold from any
payment to any Lender an amount equivalent to any applicable withholding Tax. If the Internal Revenue Service or any other Governmental Authority asserts a claim that the Administrative Agent did not properly withhold Tax from amounts paid to or for
the account of any Lender because the appropriate form was not delivered or was not properly executed or because such Lender failed to notify the Administrative Agent of a change in circumstance which rendered the exemption from, or reduction of,
withholding Tax ineffective or for any other reason, or if Administrative Agent reasonably determines that a payment was made to a Lender pursuant to this Agreement without deduction of applicable withholding tax from such payment, such Lender shall
indemnify the Administrative Agent fully for all amounts paid, directly or indirectly, by the Administrative Agent as tax or otherwise, including any penalties or interest and together with all expenses (including reasonable legal expenses,
allocated internal costs and out-of-pocket expenses) incurred. 
 Section 9.10. Administrative Agent May File Bankruptcy
Disclosure and Proofs of Claim. In case of the pendency of any proceeding under any Debtor Relief Laws relative to any Credit Party, the Administrative Agent (irrespective of whether the principal of any Loan or Obligation under a Letter of
Credit shall then be due and payable as herein expressed or by declaration or otherwise and irrespective of whether the Administrative Agent shall have made any demand on the Borrower) shall be entitled and empowered (but not obligated) by
intervention in such proceeding or otherwise: 
 (a) to file a verified statement pursuant to rule 2019 of the Federal Rules of
Bankruptcy Procedure that, in its sole opinion, complies with such rule’s disclosure requirements for entities representing more than one creditor; 

  
 195

 (b) to file and prove a claim for the whole amount of the principal and interest owing and
unpaid in respect of the Loans and all other Obligations that are owing and unpaid and to file such other documents as may be necessary or advisable in order to have the claims of the Lenders, the Issuing Bank and the Administrative Agent (including
any claim for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its respective agents and counsel and all other amounts due to the Administrative Agent under Sections 2.11, 10.02 and 10.03) allowed in
such judicial proceeding; and 
 (c) to collect and receive any monies or other property payable or deliverable on any such
claims and to distribute the same; 
 and any custodian, receiver, assignee, trustee, liquidator, sequestrator or other similar official in any
such judicial proceeding is hereby authorized by each Lender and the Issuing Bank to make such payments to the Administrative Agent and, in the event that the Administrative Agent shall consent to the making of such payments directly to the Lenders
and the Issuing Bank, to pay to the Administrative Agent any amount due for the reasonable compensation, expenses, disbursements and advances of the Administrative Agent and its agents and counsel, and any other amounts due the Administrative Agent
under Sections 2.11, 10.02 and 10.03. To the extent that the payment of any such compensation, expenses, disbursements and advances of the Administrative Agent, its agents and counsel, and any other amounts due the Administrative Agent under
Sections 2.11, 10.02 and 10.03 out of the estate in any such proceeding, shall be denied for any reason, payment of the same shall be secured by a Lien on, and shall be paid out of, any and all distributions, dividends, money, securities and other
properties that the Lenders or the Issuing Bank may be entitled to receive in such proceeding whether in liquidation or under any plan of reorganization or arrangement or otherwise. 

Nothing contained herein shall be deemed to authorize the Administrative Agent to authorize or consent to or accept or adopt on behalf of
any Lender any plan of reorganization, arrangement, adjustment or composition affecting the Obligations or the rights of any Lender or to authorize the Administrative Agent to vote in respect of the claim of any Lender in any such proceeding.

  
 196

 ARTICLE 10 
 MISCELLANEOUS 
 Section 10.01. Notices.
(a) Notices Generally. Any notice or other communication herein required or permitted to be given to a Credit Party, the Co-Syndication Agents, the Collateral Agent, the Administrative Agent, the Swing Line Lender, the Issuing Bank
or the Co-Documentation Agents shall be sent to such Person’s address as set forth on Appendix B or in the other relevant Credit Document, and in the case of any Lender, the address as indicated on Appendix B or otherwise indicated to the
Administrative Agent in writing. Except as otherwise set forth in Section 3.02(b) or paragraph (ii) below, each notice hereunder shall be in writing and may be personally served, telexed or sent by telefacsimile (except for any notices sent to
the Administrative Agent) or United States mail or courier service and shall be deemed to have been given when delivered in person or by courier service and signed for against receipt thereof, upon receipt of telefacsimile or telex, or three
(3) Business Days after depositing it in the United States mail with postage prepaid and properly addressed; provided no notice to any Agent shall be effective until received by such Agent; provided, further, any such notice or
other communication shall, at the request of the Administrative Agent, be provided to any sub-agent appointed pursuant to Section 9.03(c) hereto as designated by the Administrative Agent from time to time. 

(b) Electronic Communications. 
 (i) Notices and other communications to any Agent, any Lender, the Swing Line Lender and the Issuing Bank hereunder may be delivered or furnished by electronic communication (including e-mail and Internet
or intranet websites, including the Platform) pursuant to procedures approved by the Administrative Agent; provided that the foregoing shall not apply to service of process or to notices to any Agent, any Lender, the Swing Line Lender or the
Issuing Bank pursuant to Article 2 if such Lender or the Issuing Bank, as applicable, has notified the Administrative Agent that it is incapable of receiving notices under such Section by electronic communication. The Administrative Agent or the
Borrower may, in its discretion, agree to accept notices and other communications to it hereunder by electronic communication pursuant to procedures approved by it; provided that approval of such procedures may be limited to particular
notices or communications. Unless the Administrative Agent otherwise prescribes, (1) notices and other communications sent to an e-mail address shall be deemed received upon the sender’s receipt of an acknowledgement from the intended
recipient (such as by the “return receipt requested” function, as available, return e-mail or other written acknowledgement); provided that if such notice or other communication is not sent during the normal business hours of
the recipient, such notice or communication shall be deemed to have been sent 

  
 197

 
at the opening of business on the next Business Day for the recipient, and (2) notices or communications posted to an Internet or intranet website shall be deemed received upon the deemed
receipt by the intended recipient at its e-mail address as described in the foregoing clause (1) of notification that such notice or communication is available and identifying the website address therefor. 

(ii) Each Credit Party understands that the distribution of material through an electronic medium is not necessarily
secure and that there are confidentiality and other risks associated with such distribution and agrees and assumes the risks associated with such electronic distribution, except to the extent caused by the willful misconduct or gross negligence of
the Administrative Agent, as determined by a final, non-appealable judgment of a court of competent jurisdiction. 
 (iii) The Platform and any Approved Electronic Communications are provided “as is” and “as available.” None of the Agents nor any of their respective officers, directors, employees,
agents, advisors or representatives (the “Agent Affiliates”) warrant the accuracy, adequacy or completeness of the Approved Electronic Communications or the Platform, and each expressly disclaims liability for errors or omissions in
the Platform and the Approved Electronic Communications. No warranty of any kind, express, implied or statutory, including any warranty of merchantability, fitness for a particular purpose, non-infringement of third-party rights or freedom from
viruses or other code defects is made by the Agent Affiliates in connection with the Platform or the Approved Electronic Communications. 
 (iv) Each Credit Party, each Lender, the Issuing Bank and each Agent agrees that the Administrative Agent may, but shall not be obligated to, store any Approved Electronic Communications on the Platform
in accordance with the Administrative Agent’s customary document retention procedures and policies. 
 (v)
Any notice of Default or Event of Default may be provided by telephone if confirmed promptly thereafter by delivery of written notice thereof. 
 (c) Private Side Information Contacts. Each Public Lender agrees to cause at least one individual at or on behalf of such Public Lender to at all times have selected the “Private Side
Information” or similar designation on the content declaration screen of the Platform in order to enable such Public Lender or its delegate, in accordance with such Public Lender’s compliance procedures and applicable law, including United
States federal and state securities laws, to make reference to information that is not made available through the “Public Side 

  
 198

 
Information” portion of the Platform and that may contain Non-Public Information with respect to the Borrower, its Subsidiaries, its or their securities for purposes of United States federal
or state securities laws. In the event that any Public Lender has determined for itself to not access any information disclosed through the Platform or otherwise, such Public Lender acknowledges that (i) other Lenders may have availed
themselves of such information and (ii) neither the Borrower nor the Administrative Agent has any responsibility for such Public Lender’s decision to limit the scope of the information it has obtained in connection with this Agreement and
the other Credit Documents. 
 Section 10.02. Expenses. Whether or not the transactions contemplated hereby shall be
consummated, the Borrower agrees to pay promptly (a) all the actual and reasonable costs and expenses of the Agents incurred in connection with the negotiation, preparation and execution of the Credit Documents and any consents, amendments,
waivers or other modifications thereto; (b) all the costs of the Agents for the furnishing of all opinions by counsel for the Borrower and the other Credit Parties; (c) the reasonable fees, expenses and disbursements of counsel to the
Agents in connection with the negotiation, preparation, execution and administration of the Credit Documents and any consents, amendments, waivers or other modifications thereto and any other documents or matters requested by the Borrower;
provided that prior to the occurrence, and during the continuance, of a Default or Event of Default, reasonable attorney’s fees shall be limited to one primary counsel and, if reasonably required by the Administrative Agent, local or
specialist counsel; provided, further, that no such limitation shall apply if counsel for the Administrative Agent determines in good faith that there is an actual or potential conflict of interest that requires separate representation for
any Agent; (d) all the actual costs and reasonable expenses of creating, perfecting, recording, maintaining and preserving Liens in favor of the Collateral Agent, for the benefit of the Secured Parties, including filing and recording fees,
expenses and taxes, stamp or documentary taxes, search fees, title insurance premiums and reasonable fees, expenses and disbursements of counsel to each Agent and of counsel providing any opinions that any Agent or the Requisite Lenders may request
in respect of the Collateral or the Liens created pursuant to the Collateral Documents; (e) all the actual costs and reasonable fees, expenses and disbursements of any auditors, accountants, consultants or appraisers retained by the Agents;
(f) all the actual costs and reasonable expenses (including the reasonable fees, expenses and disbursements of any appraisers, consultants, advisors and agents employed or retained by the Collateral Agent and its counsel) in connection with the
custody or preservation of any of the Collateral; (g) all other actual and reasonable costs and expenses incurred by each Agent in connection with the syndication of the Loans and Commitments and the transactions contemplated by the Credit
Documents and any consents, amendments, waivers or other modifications thereto; and (h) after the occurrence of a Default or an Event of Default, all costs and expenses (including reasonable

  
 199

 
attorneys fees) and costs of settlement, incurred by any Agent and the Lenders in enforcing any Obligations of or in collecting any payments due from any Credit Party hereunder or under the other
Credit Documents by reason of such Default or Event of Default (including in connection with the sale, lease or license of, collection from or other realization upon any of the Collateral or the enforcement of the Guaranty) or in connection with any
refinancing or restructuring of the credit arrangements provided hereunder in the nature of a “work out” or pursuant to any insolvency or bankruptcy cases or proceedings. 

Section 10.03. Indemnity. (a) In addition to the payment of expenses pursuant to Section 10.02, whether or not the
transactions contemplated hereby shall be consummated, each Credit Party agrees to defend (subject to Indemnitees’ selection of counsel), indemnify, pay and hold harmless each Agent, each Lender and each of their respective Affiliates and
officers, partners, members, directors, trustees, advisors, employees, agents, sub-agents and controlling persons (if any) of such Agent, Lender or Affiliates (each, an “Indemnitee”) from and against any and all Indemnified
Liabilities; provided no Credit Party shall have any obligation to any Indemnitee hereunder with respect to any Indemnified Liabilities to the extent such Indemnified Liabilities result from the gross negligence or willful misconduct of such
Indemnitee, in each case, as determined by a final, non-appealable judgment of a court of competent jurisdiction. To the extent that the undertakings to defend, indemnify, pay and hold harmless set forth in this Section 10.03 may be unenforceable in
whole or in part because they are violative of any law or public policy, the applicable Credit Party shall contribute the maximum portion that it is permitted to pay and satisfy under applicable law to the payment and satisfaction of all Indemnified
Liabilities incurred by Indemnitees or any of them. 
 (b) To the extent permitted by applicable law, no Credit Party shall
assert, and each Credit Party hereby waives, any claim against each Lender, each Agent and their respective Affiliates, directors, employees, attorneys, agents or sub-agents, on any theory of liability, for special, indirect, consequential or
punitive damages (as opposed to direct or actual damages) (whether or not the claim therefor is based on contract, tort or duty imposed by any applicable legal requirement) arising out of, in connection with, as a result of, or in any way related to
this Agreement or any Credit Document or any agreement or instrument contemplated hereby or thereby or referred to herein or therein, the transactions contemplated hereby or thereby, any Loan or the use of the proceeds thereof or any act or omission
or event occurring in connection herewith or therewith, and the Borrower hereby waives, releases and agrees not to sue upon any such claim or any such damages, whether or not accrued and whether or not known or suspected to exist in its favor.

 (c) Each Credit Party also agrees that no Lender, Agent nor their respective Affiliates, directors, employees, attorneys,
agents or sub-agents will 

  
 200

 
have any liability to any Credit Party or any person asserting claims on behalf of or in right of any Credit Party or any other person in connection with or as a result of this Agreement or any
Credit Document or any agreement or instrument contemplated hereby or thereby or referred to herein or therein, the transactions contemplated hereby or thereby, any Loan or the use of the proceeds thereof or any act or omission or event occurring in
connection therewith, in each case, except in the case of any Credit Party to the extent that any losses, claims, damages, liabilities or expenses incurred by such Credit Party or its affiliates, shareholders, partners or other equity holders have
been found by a final, non-appealable judgment of a court of competent jurisdiction to have resulted from the gross negligence or willful misconduct of such Lender, Agent or their respective Affiliates, directors, employees, attorneys, agents or
sub-agents in performing its obligations under this Agreement or any Credit Document or any agreement or instrument contemplated hereby or thereby or referred to herein or therein; provided, however, that in no event will such Lender,
Agent or their respective Affiliates, directors, employees, attorneys, agents or sub-agents have any liability for any indirect, consequential, special or punitive damages in connection with or as a result of such Lender’s, Agent’s or
their respective Affiliates’, directors’, employees’, attorneys’, agents’ or sub-agents’ activities related to this Agreement or any Credit Document or any agreement or instrument contemplated hereby or thereby or
referred to herein or therein. 
 Section 10.04. Set-off. In addition to any rights now or hereafter granted under
applicable law and not by way of limitation of any such rights, upon the occurrence of any Event of Default, each Lender and the Issuing Bank (and their respective Affiliates) are hereby authorized by each Credit Party at any time or from time to
time, without notice to any Credit Party or to any other Person (other than the Administrative Agent), any such notice being hereby expressly waived, to set off and to appropriate and to apply any and all deposits (general or special, including
Indebtedness evidenced by certificates of deposit, whether matured or unmatured, but not including trust accounts) and any other Indebtedness at any time held or owing by such Lender or the Issuing Bank or their respective Affiliates to or for the
credit or the account of any Credit Party against and on account of the obligations and liabilities of any Credit Party to such Lender or the Issuing Bank or their respective Affiliates hereunder, the Letters of Credit and participations therein and
under the other Credit Documents, including all claims of any nature or description arising out of or connected hereto, the Letters of Credit and participations therein or with any other Credit Document, irrespective of whether or not (a) such
Lender or Issuing Bank (or any of their respective Affiliates) shall have made any demand hereunder or (b) the principal of or the interest on the Loans or any amounts in respect of the Letters of Credit or any other amounts due hereunder shall
have become due and payable pursuant to Article 2 and although such obligations and liabilities, or any of them, may be contingent or unmatured; provided that in the event that any Defaulting Lender

  
 201

 
shall exercise any such right of set-off, (x) all amounts so set off shall be paid over immediately to the Administrative Agent for further application in accordance with the provisions of
Sections 2.17 and 2.22 and, pending such payment, shall be segregated by such Defaulting Lender from its other funds and deemed held in trust for the benefit of the Administrative Agent, the Issuing Bank and the Lenders and (y) the Defaulting
Lender shall provide promptly to the Administrative Agent a statement describing in reasonable detail the Obligations owing to such Defaulting Lender as to which it exercised such right of set-off. The rights of each Lender, the Issuing Bank and
their respective Affiliates under this Section 10.04 are in addition to other rights and remedies (including other rights of set-off) that such Lender, the Issuing Bank or their respective Affiliates may have. 

Section 10.05. Amendments and Waivers. (a) Requisite Lenders’ Consent. Except as provided in Sections 2.24,
2.25 and 2.26, subject to the additional requirements of Sections 10.05(b) and 10.05(c), no amendment, modification, termination or waiver of any provision of the Credit Documents, or consent to any departure by any Credit Party therefrom, shall in
any event be effective without the written concurrence of the Requisite Lenders; provided that the Administrative Agent may, with the consent of the Borrower only, amend, modify or supplement this Agreement or any other Credit Document to
cure any ambiguity, omission, defect or inconsistency (as reasonably determined by the Administrative Agent), so long as such amendment, modification or supplement does not adversely affect the rights of any Lender (or the Issuing Bank, if
applicable). 
 (b) Affected Lenders’ Consent. Without the written consent of each Lender (other than a Defaulting
Lender) that would be directly affected thereby, no amendment, modification, termination or consent shall be effective if the effect thereof would: 
 (i) extend the scheduled final maturity of any Loan or Note; 
 (ii)
waive, reduce or postpone any scheduled repayment (but not prepayment); 
 (iii) extend the stated expiration
date of any Letter of Credit beyond the Revolving Commitment Termination Date; 
 (iv) reduce the rate of
interest on any Loan (other than any waiver of any increase in the interest rate applicable to any Loan pursuant to Section 2.10) or any fee or any premium payable hereunder; 

(v) extend the time for payment of any such interest or fees or premium; 

  
 202

 (vi) reduce the principal amount of any Loan or any reimbursement obligation
in respect of any Letter of Credit; 
 (vii) amend, modify, terminate or waive any provision of this
Section 10.05(b), Section 10.05(c) or any other provision of this Agreement that expressly provides that the consent of all Lenders is required; 
 (viii) amend (x) the definition of “Requisite Lenders”, “Requisite Class Lenders” or “Pro Rata Share” or (y) Section 2.11(a), 2.16(c) or
2.17 in a manner which would alter the requirement that payments be made to the Lenders in accordance with their Pro Rata Share; provided, with the consent of the Requisite Lenders, additional extensions of credit pursuant hereto may be
included in the determination of “Requisite Lenders”, “Requisite Class Lenders” or “Pro Rata Share” on substantially the same terms and conditions as the Term Loan Commitments, the Term Loans, the
Revolving Commitments and the Revolving Loans are included on the Closing Date; 
 (ix) release all or
substantially all of the Collateral or any material Guarantor from the Guaranty except as expressly provided in the Credit Documents and except in connection with a “credit bid” undertaken by the Collateral Agent at the direction of the
Requisite Lenders pursuant to Section 363(k), Section 1129(b)(2)(a)(ii) or otherwise of the Bankruptcy Code or other sale or disposition of assets in connection with an enforcement action with respect to the Collateral permitted pursuant
to the Credit Documents (in which case only the consent of the Requisite Lenders will be needed for such release); or 
 (x) consent to the assignment or transfer by any Credit Party of any of its rights and obligations under any Credit Document; 
 provided that (i) for the avoidance of doubt, all Lenders shall be deemed directly affected thereby with respect to any amendment described in clauses (vii), (viii), (ix) and
(x) (other than as set forth in the proviso to clause (viii) or in clause (ix)), (ii) (1) the Commitment of any Defaulting Lender may not be increased or extended and (2) the principal amount of any Loans of any Defaulting
Lender may not be reduced and the scheduled final maturity date thereof may not be extended, in any such case, without the consent of such Defaulting Lender and (iii) any amendment, modification, termination or consent requiring the consent of
all Lenders or each affected Lender, that by its terms affects any Defaulting Lender more adversely than other affected Lenders shall require the consent of such Defaulting Lender. 

  
 203

 (c) Other Consents. No amendment, modification, termination or waiver of any
provision of the Credit Documents, or consent to any departure by any Credit Party therefrom, shall: 
 (i)
increase any Revolving Commitment of any Lender over the amount thereof then in effect without the consent of such Lender; provided no amendment, modification or waiver of any condition precedent, covenant, Default or Event of Default shall
constitute an increase in any Revolving Commitment of any Lender; 
 (ii) amend, modify, terminate or waive any
provision hereof relating to the Swing Line Sublimit or the Swing Line Loans without the consent of the Swing Line Lender; 
 (iii) alter the required application of any repayments or prepayments as among Classes pursuant to Section 2.15 or Section 9.02 of the Pledge and Security Agreement without the consent of the
Requisite Class Lenders with respect to each Class which is being allocated a lesser repayment or prepayment as a result thereof; provided that the Requisite Lenders may waive, in whole or in part, any prepayment under Section 2.15 so
long as the application, as among Classes, of any portion of such prepayment which is still required to be made is not altered; 
 (iv) amend, modify, terminate or waive any obligation of Lenders relating to the purchase of participations in Letters of Credit as provided in Section 2.04(e) without the written consent of the
Administrative Agent and of the Issuing Bank; 
 (v) amend, modify, terminate or waive any provision of the
Credit Documents as the same applies to any Agent, or any other provision hereof as the same applies to the rights or obligation of any Agent, in each case without the consent of such Agent; 

(vi) amend, modify, terminate or waive any provision of the Credit Documents in a manner that by its terms directly and
materially adversely affects the rights of Lenders holding Loans of one Class in respect of payments required to be made to such Lenders hereunder differently from the rights of Lenders holding Loans of any other Class in respect of their rights to
receive payments on account of such Loans without the prior written consent of the Requisite Class Lenders with respect to each adversely affected Class; or 
 (vii) amend, modify, terminate or waive any provision of Section 3.02 (other than in connection with the making of the Term Loans) without the prior written consent of the Requisite Class Lenders
with respect to Revolving Loans. 

  
 204

 (d) Execution of Amendments, Etc. The Administrative Agent may, but shall have no
obligation to, with the concurrence of any Lender, execute amendments, modifications, waivers or consents on behalf of such Lender. Any waiver or consent shall be effective only in the specific instance and for the specific purpose for which it was
given. No notice to or demand on any Credit Party in any case shall entitle any Credit Party to any other or further notice or demand in similar or other circumstances. Any amendment, modification, termination, waiver or consent effected in
accordance with this Section 10.05 shall be binding upon each Lender at the time outstanding, each future Lender and each Credit Party signatory thereto. 
 Section 10.06. Successors and Assigns; Participations. (a) Generally. This Agreement shall be binding upon the parties hereto and their respective successors and assigns and shall
inure to the benefit of the parties hereto and the successors and assigns of Lenders. No Credit Party’s rights or obligations hereunder nor any interest therein may be assigned or delegated by any Credit Party without the prior written consent
of all Lenders. Nothing in this Agreement, expressed or implied, shall be construed to confer upon any Person (other than the parties hereto, their respective successors and assigns permitted hereby and, to the extent expressly contemplated hereby,
Affiliates of each of the Agents and Lenders and other Indemnitees) any legal or equitable right, remedy or claim under or by reason of this Agreement. 
 (b) Register. The Borrower, the Administrative Agent and the Lenders shall deem and treat the Persons listed as Lenders in the Register as the holders and owners of the corresponding Commitments
and Loans listed therein for all purposes hereof, and, subject to Section 10.06(h) hereof, no assignment or transfer of any such Commitment or Loan shall be effective, in each case, unless and until recorded in the Register following receipt of a
fully executed Assignment Agreement effecting the assignment or transfer thereof, together with the required forms and certificates regarding tax matters and any fees payable in connection with such assignment, in each case, as provided in
Section 10.06(d). Each assignment shall be recorded in the Register promptly following receipt by the Administrative Agent of the fully executed Assignment Agreement and all other necessary documents and approvals, and prompt notice thereof
shall be provided to the Borrower and a copy of such Assignment Agreement shall be maintained, as applicable. The date of such recordation of a transfer shall be referred to herein as the “Assignment Effective Date.” Any request,
authority or consent of any Person who, at the time of making such request or giving such authority or consent, is listed in the Register as a Lender shall be conclusive and binding on any subsequent holder, assignee or transferee of the
corresponding Commitments or Loans. 

  
 205

 (c) Right to Assign. Each Lender shall have the right at any time to sell, assign or
transfer all or a portion of its rights and obligations under this Agreement, including all or a portion of its Commitment or Loans or other Obligations owing to it (provided, however, that pro rata assignments shall not be required, and each
assignment shall be of a uniform, and not varying, percentage of all rights and obligations under and in respect of any applicable Loan and any related Commitments): 

(i) to any Eligible Assignee meeting the criteria of clause (i) of the definition thereof upon the giving of notice
to the Borrower and the Administrative Agent; or 
 (ii) to any Eligible Assignee meeting the criteria of clause
(ii) of the definition thereof (except in the case of assignments made to Goldman Sachs or in connection with the primary syndication of the credit facilities provided hereunder), consented to by each of the Borrower and the Administrative
Agent (such consents not to be (x) unreasonably withheld or delayed or (y) in the case of the Borrower, required at any time an Event of Default shall have occurred and then be continuing); provided, further, that (A) the
Borrower shall be deemed to have consented to any such assignment of Loans or Commitments unless it shall object thereto by written notice to the Administrative Agent within five (5) Business Days after receiving notice thereof and
(B) each such assignment pursuant to this Section 10.06(c)(ii) shall be in an aggregate amount of not less than (1) $2,500,000 with respect to the assignment of the Revolving Commitments, the Revolving Loans, the Tranche A Term Loans
and New Term Loans constituting Non-Institutional Incremental Facilities and (2) $1,000,000 with respect to the assignment of the Tranche B Term Loans and New Term Loans constituting Institutional Incremental Facilities (or, if less,
(x) the amount agreed to by the Borrower and the Administrative Agent or (y) the aggregate amount of the Loans of the assigning Lender with respect to the Class being assigned). 

(d) Mechanics. Assignments and assumptions of Loans and Commitments by Lenders shall be effected by manual execution and delivery
to the Administrative Agent of an Assignment Agreement. Assignments made pursuant to the foregoing provision shall be effective as of the Assignment Effective Date. In connection with all assignments there shall be delivered to the Administrative
Agent such forms, certificates or other evidence, if any, with respect to United States federal income tax withholding matters as the assignee under such Assignment Agreement may be required to deliver pursuant to Section 2.20(c), together with
payment to the Administrative Agent of a registration and processing fee of $3,500 (except that (i) no such registration and processing fee shall be payable (y) in connection with an assignment by or to Goldman Sachs or any Affiliate
thereof or (z) in the case of an assignee which is already a Lender or 

  
 206

 
is an Affiliate or Related Fund of a Lender or a Person under common management with a Lender and (ii) no more than one such fee shall be payable in connection with simultaneous assignments
to or by two (2) or more Related Funds). 
 (i) In connection with any assignment of rights and obligations
of any Defaulting Lender hereunder, no such assignment shall be effective unless and until, in addition to the other conditions thereto set forth herein, the parties to the assignment shall make such additional payments to the Administrative Agent
in an aggregate amount sufficient, upon distribution thereof as appropriate (which may be outright payment, purchases by the assignee of participations or subparticipations, or other compensating actions, including funding, with the consent of the
Borrower and the Administrative Agent, the applicable Pro Rata Share of Loans previously requested but not funded by the Defaulting Lender, to each of which the applicable assignee and assignor hereby irrevocably consent), to (x) pay and
satisfy in full all payment liabilities then owed by such Defaulting Lender to the Administrative Agent, the Issuing Bank, the Swing Line Lender and each other Lender hereunder (and interest accrued thereon) and (y) acquire (and fund as
appropriate) its Pro Rata Share of all Loans and participations in Letters of Credit and Swing Line Loans. Notwithstanding the foregoing, in the event that any assignment of rights and obligations of any Defaulting Lender hereunder shall become
effective under applicable law without compliance with the provisions of this paragraph, then the assignee of such interest shall be deemed to be a Defaulting Lender for all purposes of this Agreement until such compliance occurs. 

(e) Representations and Warranties of Assignee. Each Lender, upon execution and delivery hereof or upon succeeding to an interest
in the Commitments and Loans, as the case may be represents and warrants as of the Closing Date or as of the Assignment Effective Date that (i) it is an Eligible Assignee; (ii) it has experience and expertise in the making of or investing
in commitments or loans such as the applicable Commitments or Loans, as the case may be; and (iii) it will make or invest in, as the case may be, its Commitments or Loans for its own account in the ordinary course and without a view to
distribution of such Commitments or Loans within the meaning of the Securities Act or the Exchange Act or other federal securities laws (it being understood that, subject to the provisions of this Section 10.06 the disposition of such Commitments or
Loans or any interests therein shall at all times remain within its exclusive control). 
 (f) Effect of Assignment.
Subject to the terms and conditions of this Section 10.06, as of the applicable “Assignment Effective Date” with respect to any assignee and assignor (i) such assignee shall have the rights and obligations

  
 207

 
of a “Lender” hereunder to the extent of its interest in the Loans and Commitments as reflected in the Register and shall be a party hereto and a “Lender” for all purposes
hereof with respect to the interest assigned, in addition to any interests hereunder it may theretofore hold as a Lender; (ii) the assigning Lender thereunder shall, to the extent that rights and obligations hereunder have been assigned to the
assignee, relinquish its rights (other than any rights which survive the termination hereof under Section 10.08) and be released from its obligations hereunder (and, in the case of an assignment covering all or the remaining portion of an
assigning Lender’s rights and obligations hereunder, such Lender shall cease to be a party hereto on the Assignment Effective Date; provided, anything contained in any of the Credit Documents to the contrary notwithstanding, (y) the
Issuing Bank shall continue to have all rights and obligations with respect to such Letters of Credit until the cancellation or expiration of such Letters of Credit and the reimbursement of any amounts drawn thereunder and (z) such assigning
Lender shall continue to be entitled to the benefit of all indemnities of a Lender hereunder as specified herein with respect to matters arising out of the prior involvement of such assigning Lender as a Lender hereunder); (iii) the Commitments
shall be modified to reflect any Commitment of such assignee and of such assigning Lender, if any; and (iv) if any such assignment occurs after the issuance of any Note to the assigning Lender, the assigning Lender shall, upon the effectiveness
of such assignment or as promptly thereafter as practicable, surrender its applicable Notes to the Administrative Agent for cancellation, and thereupon the Borrower shall issue and deliver new Notes, if so requested by the assignee and/or assigning
Lender, to such assignee and/or to such assigning Lender, with appropriate insertions, to reflect the new Revolving Commitments and/or outstanding Loans of the assignee and/or the assigning Lender. 

(g) Participations. 
 (i) Each Lender shall have the right at any time to sell one or more participations to any Person (other than the Borrower, any of its Subsidiaries or any of its Affiliates) in all or any part of its
Commitments, Loans or in any other Obligation. Each Lender that sells a participation pursuant to this Section 10.06(g) shall, acting solely for U.S. federal income tax purposes as an agent of the Borrower, maintain a register on which it
records the name and address of each participant and the principal amounts (and stated interest) of each participant’s participation interest with respect to the Term Loan (each, a “Participant Register”); provided that
no Lender shall have any obligation to disclose all or any portion of the Participant Register to any Person (including the identity of any participant or any information relating to a participant’s interest in any Commitments, Loans or its
other obligations under this Agreement) except to the extent that the relevant parties, acting reasonably and in good faith, determine that such disclosure is necessary to establish that such 

  
 208

 
Commitment, Loan or other obligation is in registered form under Section 5f.103-1(c) of the United States Treasury Regulations. Unless otherwise required by the Internal Revenue Service, any
disclosure required by the foregoing sentence shall be made by the relevant Lender directly and solely to the Internal Revenue Service. The entries in the Participant Register shall be conclusive absent manifest error, and such Lender shall treat
each Person whose name is recorded in the Participant Register as the owner of a participation with respect to the Term Loan for all purposes under this Agreement, notwithstanding any notice to the contrary. 

(ii) The holder of any such participation, other than an Affiliate of the Lender granting such participation, shall not be
entitled to require such Lender to take or omit to take any action hereunder except with respect to any amendment, modification or waiver that would (A) extend the final scheduled maturity of any Loan, Note or Letter of Credit (unless such
Letter of Credit is not extended beyond the Revolving Commitment Termination Date) in which such participant is participating, or reduce the rate or extend the time of payment of interest or fees thereon (except in connection with a waiver of
applicability of any post default increase in interest rates) or reduce the principal amount thereof, or increase the amount of the participant’s participation over the amount thereof then in effect (it being understood that a waiver of any
Default or Event of Default or of a mandatory reduction in the Commitment shall not constitute a change in the terms of such participation, and that an increase in any Commitment or Loan shall be permitted without the consent of any participant if
the participant’s participation is not increased as a result thereof), (B) consent to the assignment or transfer by any Credit Party of any of its rights and obligations under this Agreement or (C) release all or substantially all of
the Collateral under the Collateral Documents or all of substantially all of the Guarantors from the Guaranty (in each case, except as expressly provided in the Credit Documents) supporting the Loans hereunder in which such participant is
participating. 
 (iii) The Borrower agrees that each participant shall be entitled to the benefits of Sections
2.18, 2.19 and 2.20 to the same extent as if it were a Lender and had acquired its interest by assignment pursuant to paragraph (iii) of this Section; provided, (x) a participant shall not be entitled to receive any greater payment under
Section 2.19 or 2.20 than the applicable Lender would have been entitled to receive with respect to the participation sold to such participant, unless the sale of the participation to such participant is made with the Borrower’s prior written
consent (not to be unreasonably withheld or delayed) and (y) a participant that would be a Non US Lender if it were a Lender shall not be entitled to the benefits of Section 2.20 unless the Borrower is notified of the participation sold to such
participant and such participant agrees, for the benefit of the 

  
 209

 
Borrower, to comply with Section 2.20 as though it were a Lender; provided further that, except as specifically set forth in clauses (x) and (y) of this sentence, nothing herein
shall require any notice to the Borrower or any other Person in connection with the sale of any participation. To the extent permitted by law, each participant also shall be entitled to the benefits of Section 10.04 as though it were a Lender,
provided such Participant agrees to be subject to Section 2.17 as though it were a Lender. 
 (h) Certain Other
Assignments and Participations. In addition to any other assignment or participation permitted pursuant to this Section 10.06, any Lender may assign, pledge and/or grant a security interest in all or any portion of its Loans, the other
Obligations owed to such Lender, and its Notes, if any, to secure obligations of such Lender including obligations to any Federal Reserve Bank as collateral security pursuant to Regulation A of the Board of Governors and any operating circular
issued by such Federal Reserve Bank; provided that no Lender, as between the Borrower and such Lender, shall be relieved of any of its obligations hereunder as a result of any such assignment and pledge; and provided further, that in
no event shall the applicable Federal Reserve Bank, pledgee or trustee, be considered to be a “Lender” or be entitled to require the assigning Lender to take or omit to take any action hereunder. 

(i) Assignments to the Borrower. Notwithstanding anything to the contrary contained in this Section 10.06 or any other
provision of this Agreement, so long as no Default or Event of Default has occurred and is continuing or would result therefrom, each Lender shall have the right at any time to sell, assign or transfer all or a portion of the Tranche B Term Loans
owing to it to the Borrower on a non-pro rata basis, subject to the following limitations: 
 (i) Such sale,
assignment or transfer shall be pursuant to one or more modified Dutch auctions conducted by the Borrower (each, an “Auction”) to repurchase all or any portion of the Tranche B Term Loans, provided that, (A) notice of
and the option to participate in the Auction shall be provided to all Tranche B Term Loan Lenders and (B) the Auction shall be conducted pursuant to such procedures as the Auction Manager may establish which are consistent with this
Section 10.06(i) and the Auction Procedures and are otherwise reasonably acceptable to the Borrower, the Auction Manager and the Administrative Agent; 
 (ii) With respect to all repurchases made by the Borrower pursuant to this Section 10.06(i), (A) the Borrower shall deliver to the Auction Manager a certificate of an Authorized Officer stating
that (1) no Default or Event of Default has occurred and is continuing or would result from such repurchase and (2) as of the launch date of the related Auction and the effective date of any Affiliate Assignment Agreement, it is not in
possession of any information regarding the Borrower, its Subsidiaries or 

  
 210

 
its Affiliates, or their assets, the Borrower’s ability to perform its Obligations or any other matter that may be material to a decision by any Lender to participate in any Auction or enter
into any Affiliate Assignment Agreement or any of the transactions contemplated thereby that has not previously been disclosed to the Auction Manager, the Administrative Agent and the Non-Public Lenders, (B) the Borrower shall not use the
proceeds of any Revolving Loans to repurchase such Tranche B Term Loans and (C) the assigning Lender and the Borrower shall execute and deliver to the Auction Manager an Affiliate Assignment Agreement; 

(iii) Following a repurchase by the Borrower pursuant to this Section 10.06(i), the Tranche B Term Loans so
repurchased shall, without further action by any Person, be deemed cancelled and no longer outstanding (and may not be resold by the Borrower) for all purposes of this Agreement and all other Credit Documents, including, but not limited to
(A) the making of, or the application of, any payments to the Lenders under this Agreement or any other Credit Document, (B) the making of any request, demand, authorization, direction, notice, consent or waiver under this Agreement or any
other Credit Document or (C) the determination of the Requisite Lenders, or for any similar or related purpose, under this Agreement or any other Credit Document. In connection with any Tranche B Term Loans repurchased and cancelled pursuant to
this Section 10.06(i), the Administrative Agent is authorized to make appropriate entries in the Register to reflect any such cancellation; and 
 (iv) It is understood and agreed that any such repurchase of Tranche B Term Loans by the Borrower shall not be deemed a repayment of Term Loans (and shall, therefore, not be deducted) for purposes of the
mandatory prepayment under Section 2.14(e). 
 Section 10.07. Independence of Covenants. All covenants
hereunder shall be given independent effect so that if a particular action or condition is not permitted by any of such covenants, the fact that it would be permitted by an exception to, or would otherwise be within the limitations of, another
covenant shall not avoid the occurrence of a Default or an Event of Default if such action is taken or condition exists. 

Section 10.08. Survival of Representations, Warranties and Agreements. All representations, warranties and agreements made
herein shall survive the execution and delivery hereof and the making of any Credit Extension. Notwithstanding anything herein or implied by law to the contrary, the agreements of each Credit Party set forth in Sections 2.18(c), 2.19, 2.20, 10.02,
10.03 and 10.04 and the agreements of the Agents and the 

  
 211

 
Lenders set forth in Sections 2.17, 9.03(b), 9.06 and 10.17 shall survive the payment of the Loans, the cancellation or expiration of the Letters of Credit and the reimbursement of any amounts
drawn thereunder, and the termination hereof. 
 Section 10.09. No Waiver; Remedies Cumulative. No failure or delay
on the part of any Agent or any Lender in the exercise of any power, right or privilege hereunder or under any other Credit Document shall impair such power, right or privilege or be construed to be a waiver of any default or acquiescence therein,
nor shall any single or partial exercise of any such power, right or privilege preclude other or further exercise thereof or of any other power, right or privilege. The rights, powers and remedies given to each Agent and each Lender hereby are
cumulative and shall be in addition to and independent of all rights, powers and remedies existing by virtue of any statute or rule of law or in any of the other Credit Documents or any of the Hedge Agreements. Any forbearance or failure to
exercise, and any delay in exercising, any right, power or remedy hereunder shall not impair any such right, power or remedy or be construed to be a waiver thereof, nor shall it preclude the further exercise of any such right, power or remedy.

 Section 10.10. Marshalling; Payments Set Aside. Neither any Agent nor any Lender shall be under any obligation to
marshal any assets in favor of any Credit Party or any other Person or against or in payment of any or all of the Obligations. To the extent that any Credit Party makes a payment or payments to the Administrative Agent, the Issuing Bank or the
Lenders (or to the Administrative Agent, on behalf of the Lenders or the Issuing Bank), or any Agent, the Issuing Bank or Lender enforces any security interests or exercises any right of set-off, and such payment or payments or the proceeds of such
enforcement or set-off or any part thereof are subsequently invalidated, declared to be fraudulent or preferential, set aside and/or required to be repaid to a trustee, receiver or any other party under any bankruptcy law, any other state or federal
law, common law or any equitable cause, then, to the extent of such recovery, the obligation or part thereof originally intended to be satisfied, and all Liens, rights and remedies therefor or related thereto, shall be revived and continued in full
force and effect as if such payment or payments had not been made or such enforcement or set-off had not occurred. 

Section 10.11. Severability. In case any provision in or obligation hereunder or under any other Credit Document shall be
invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired
thereby. 
 Section 10.12. Obligations Several; Independent Nature of Lenders’ Rights. The obligations of
Lenders hereunder are several and no Lender shall be responsible for the obligations or Commitment of any other Lender hereunder. 

  
 212

 
Nothing contained herein or in any other Credit Document, and no action taken by Lenders pursuant hereto or thereto, shall be deemed to constitute Lenders as a partnership, an association, a
joint venture or any other kind of entity. The amounts payable at any time hereunder to each Lender shall be a separate and independent debt, and each Lender shall be entitled to protect and enforce its rights arising out of this Agreement and the
other Credit Documents and it shall not be necessary for any Agent or any other Lender to be joined as an additional party in any proceeding for such purpose. 
 Section 10.13. Headings. Section headings herein are included herein for convenience of reference only and shall not constitute a part hereof for any other purpose or be given any substantive
effect. 
 Section 10.14. APPLICABLE LAW. THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER
(INCLUDING, WITHOUT LIMITATION, ANY CLAIMS SOUNDING IN CONTRACT LAW OR TORT LAW ARISING OUT OF THE SUBJECT MATTER HEREOF AND ANY DETERMINATIONS WITH RESPECT TO POST JUDGMENT INTEREST) SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. 

Section 10.15. CONSENT TO JURISDICTION. SUBJECT TO CLAUSE (E) OF THE FOLLOWING SENTENCE, ALL JUDICIAL PROCEEDINGS
BROUGHT AGAINST ANY PARTY ARISING OUT OF OR RELATING HERETO OR ANY OTHER CREDIT DOCUMENTS, OR ANY OF THE OBLIGATIONS, SHALL BE BROUGHT IN ANY FEDERAL COURT OF THE UNITED STATES OF AMERICA SITTING IN THE BOROUGH OF MANHATTAN OR, IF THAT COURT DOES
NOT HAVE SUBJECT MATTER JURISDICTION, IN ANY STATE COURT LOCATED IN THE CITY AND COUNTY OF NEW YORK. BY EXECUTING AND DELIVERING THIS AGREEMENT, EACH CREDIT PARTY, FOR ITSELF AND IN CONNECTION WITH ITS PROPERTIES, IRREVOCABLY (A) SUBJECT TO
CLAUSE (E), ACCEPTS GENERALLY AND UNCONDITIONALLY THE EXCLUSIVE JURISDICTION AND VENUE OF SUCH COURTS; (B) WAIVES ANY DEFENSE OF FORUM NON CONVENIENS; (C) AGREES THAT SERVICE OF ALL PROCESS IN ANY SUCH PROCEEDING IN ANY SUCH COURT MAY BE
MADE BY REGISTERED OR CERTIFIED MAIL, RETURN RECEIPT REQUESTED, TO THE APPLICABLE CREDIT PARTY AT ITS ADDRESS PROVIDED IN ACCORDANCE WITH SECTION 10.01; (D) AGREES THAT SERVICE AS PROVIDED IN CLAUSE (C) ABOVE IS SUFFICIENT TO CONFER
PERSONAL JURISDICTION OVER THE 

  
 213

 
APPLICABLE CREDIT PARTY IN ANY SUCH PROCEEDING IN ANY SUCH COURT, AND OTHERWISE CONSTITUTES EFFECTIVE AND BINDING SERVICE IN EVERY RESPECT; AND (E) (I) AGREES THAT AGENTS AND LENDERS
RETAIN THE RIGHT TO SERVE PROCESS IN ANY OTHER MANNER PERMITTED BY LAW OR TO BRING ANY ACTION OR PROCEEDING RELATING TO THIS AGREEMENT OR ANY OTHER CREDIT DOCUMENT AGAINST ANY CREDIT PARTY OR ITS PROPERTIES IN THE COURTS OF ANY OTHER JURISDICTION
AND (II) ACCEPTS GENERALLY AND UNCONDITIONALLY THE JURISDICTION AND VENUE OF THE COURTS OF ANY SUCH JURISDICTION. 

Section 10.16. WAIVER OF JURY TRIAL. EACH OF THE PARTIES HERETO HEREBY AGREES TO WAIVE ITS RESPECTIVE RIGHTS TO A JURY TRIAL
OF ANY CLAIM OR CAUSE OF ACTION BASED UPON OR ARISING HEREUNDER OR UNDER ANY OF THE OTHER CREDIT DOCUMENTS OR ANY DEALINGS BETWEEN THEM RELATING TO THE SUBJECT MATTER OF THIS LOAN TRANSACTION OR THE LENDER/BORROWER RELATIONSHIP THAT IS BEING
ESTABLISHED. THE SCOPE OF THIS WAIVER IS INTENDED TO BE ALL ENCOMPASSING OF ANY AND ALL DISPUTES THAT MAY BE FILED IN ANY COURT AND THAT RELATE TO THE SUBJECT MATTER OF THIS TRANSACTION, INCLUDING CONTRACT CLAIMS, TORT CLAIMS, BREACH OF DUTY CLAIMS
AND ALL OTHER COMMON LAW AND STATUTORY CLAIMS. EACH PARTY HERETO ACKNOWLEDGES THAT THIS WAIVER IS A MATERIAL INDUCEMENT TO ENTER INTO A BUSINESS RELATIONSHIP, THAT EACH HAS ALREADY RELIED ON THIS WAIVER IN ENTERING INTO THIS AGREEMENT, AND THAT EACH
WILL CONTINUE TO RELY ON THIS WAIVER IN ITS RELATED FUTURE DEALINGS. EACH PARTY HERETO FURTHER WARRANTS AND REPRESENTS THAT IT HAS REVIEWED THIS WAIVER WITH ITS LEGAL COUNSEL AND THAT IT KNOWINGLY AND VOLUNTARILY WAIVES ITS JURY TRIAL RIGHTS
FOLLOWING CONSULTATION WITH LEGAL COUNSEL. THIS WAIVER IS IRREVOCABLE, MEANING THAT IT MAY NOT BE MODIFIED EITHER ORALLY OR IN WRITING (OTHER THAN BY A MUTUAL WRITTEN WAIVER SPECIFICALLY REFERRING TO THIS SECTION 10.16 AND EXECUTED BY EACH OF THE
PARTIES HERETO), AND THIS WAIVER SHALL APPLY TO ANY SUBSEQUENT AMENDMENTS, RENEWALS, SUPPLEMENTS OR MODIFICATIONS HERETO OR ANY OF THE OTHER CREDIT DOCUMENTS OR TO ANY OTHER DOCUMENTS OR AGREEMENTS RELATING TO THE LOANS MADE HEREUNDER. IN THE EVENT
OF LITIGATION, THIS AGREEMENT MAY BE FILED AS A WRITTEN CONSENT TO A TRIAL BY THE COURT. 

  
 214

 Section 10.17. Confidentiality. Each Agent and each Lender (which term shall for
the purposes of this Section 10.17 include the Issuing Bank) shall hold all non public information regarding the Borrower and its Subsidiaries and Affiliates and their businesses identified as such by the Borrower and obtained by such Agent or
such Lender pursuant to the requirements hereof in accordance with such Agent’s and such Lender’s customary procedures for handling confidential information of such nature, it being understood and agreed by the Borrower that, in any event,
the Administrative Agent may disclose such information to the Lenders and each Agent and each Lender and each Agent may make (i) disclosures of such information to Affiliates of such Lender or Agent and to its or their respective officers,
directors, partners, members, employees, legal counsel, independent auditors and other advisors, experts or agents who need to know such information and on a confidential basis (and to other Persons authorized by a Lender or Agent to organize,
present or disseminate such information in connection with disclosures otherwise made in accordance with this Section 10.17), (ii) disclosures of such information reasonably required by any potential or prospective assignee, transferee or
participant in connection with the contemplated assignment, transfer or participation of any Loans or any participations therein or by any direct or indirect contractual counterparties (or the professional advisors thereto) to any swap or derivative
transaction relating to the Borrower and its obligations (provided, such assignees, transferees, participants, counterparties and advisors are advised of and agree to be bound by either the provisions of this Section 10.17 or other
provisions at least as restrictive as this Section 10.17), (iii) disclosure to any rating agency when required by it, provided that, prior to any disclosure, such rating agency shall undertake in writing to preserve the confidentiality of
any confidential information relating to Credit Parties received by it from any Agent or any Lender, (iv) disclosure on a confidential basis to the CUSIP Service Bureau or any similar agency in connection with the issuance and monitoring of
CUSIP numbers with respect to the Loans, (v) disclosures in connection with the exercise of any remedies hereunder or under any other Credit Document, (vi) disclosures made pursuant to the order of any court or administrative agency or in
any pending legal or administrative proceeding, or otherwise as required by applicable law or compulsory legal process (in which case such Person agrees to inform the Borrower promptly thereof to the extent not prohibited by law) and
(vii) disclosures made upon the request or demand of any regulatory or quasi-regulatory authority purporting to have jurisdiction over such Person or any of its Affiliates. In addition, each Agent and each Lender may disclose the existence of
this Agreement and the information about this Agreement to market data collectors, similar services providers to the lending industry, and service providers to the Agents and the Lenders in connection with the administration and management of this
Agreement and the other Credit Documents. 

  
 215

 Section 10.18. Usury Savings Clause. Notwithstanding any other provision herein,
the aggregate interest rate charged with respect to any of the Obligations, including all charges or fees in connection therewith deemed in the nature of interest under applicable law shall not exceed the Highest Lawful Rate. If the rate of interest
(determined without regard to the preceding sentence) under this Agreement at any time exceeds the Highest Lawful Rate, the outstanding amount of the Loans made hereunder shall bear interest at the Highest Lawful Rate until the total amount of
interest due hereunder equals the amount of interest which would have been due hereunder if the stated rates of interest set forth in this Agreement had at all times been in effect. In addition, if when the Loans made hereunder are repaid in full
the total interest due hereunder (taking into account the increase provided for above) is less than the total amount of interest which would have been due hereunder if the stated rates of interest set forth in this Agreement had at all times been in
effect, then to the extent permitted by law, the Borrower shall pay to the Administrative Agent an amount equal to the difference between the amount of interest paid and the amount of interest which would have been paid if the Highest Lawful Rate
had at all times been in effect. Notwithstanding the foregoing, it is the intention of Lenders and the Borrower to conform strictly to any applicable usury laws. Accordingly, if any Lender contracts for, charges, or receives any consideration which
constitutes interest in excess of the Highest Lawful Rate, then any such excess shall be cancelled automatically and, if previously paid, shall at such Lender’s option be applied to the outstanding amount of the Loans made hereunder or be
refunded to the Borrower. 
 Section 10.19. Counterparts. This Agreement may be executed in any number of
counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument. 
 Section 10.20. Effectiveness; Entire Agreement. This Agreement shall become effective upon the execution of a counterpart hereof by each of the parties hereto and receipt by the Borrower and
the Administrative Agent of written or telephonic notification of such execution and authorization of delivery thereof. Delivery of an executed counterpart of a signature page of this Agreement by facsimile or in electronic format (i.e.,
“pdf” or “tif”) shall be effective as delivery of a manually executed counterpart of this Agreement. Upon the termination of that certain Amended and Restated Commitment Letter, dated May 11, 2012, among Goldman Sachs, JPMS,
Citi and the Borrower (the “Commitment Letter”) in accordance with the terms thereof (other than those terms that expressly survive termination thereof), Goldman Sachs, JPMS, Citi and their respective Affiliates and the Borrower and
its Subsidiaries shall be released from all liability in connection therewith, including any claim for injury or damages, whether consequential, special, direct, indirect, punitive or otherwise. 

  
 216

 Section 10.21. PATRIOT Act. Each Lender and the Administrative Agent (for itself
and not on behalf of any Lender) hereby notifies each Credit Party that pursuant to the requirements of the PATRIOT Act, it is required to obtain, verify and record information that identifies each Credit Party, which information includes the name
and address of each Credit Party and other information that will allow such Lender or the Administrative Agent, as applicable, to identify such Credit Party in accordance with the PATRIOT Act. 

Section 10.22. Electronic Execution of Assignments. The words “execution,” “signed,”
“signature,” and words of like import in any Assignment Agreement shall be deemed to include electronic signatures or the keeping of records in electronic form, each of which shall be of the same legal effect, validity or
enforceability as a manually executed signature or the use of a paper-based recordkeeping system, as the case may be, to the extent and as provided for in any applicable law, including the Federal Electronic Signatures in Global and National
Commerce Act, the New York State Electronic Signatures and Records Act, or any other similar state laws based on the Uniform Electronic Transactions Act. 
 Section 10.23. No Fiduciary Duty. Each Agent, each Lender and their Affiliates (collectively, solely for purposes of this paragraph, the “Lenders”), may have economic
interests that conflict with those of the Credit Parties, their stockholders and/or their Affiliates. Each Credit Party agrees that nothing in the Credit Documents or otherwise will be deemed to create an advisory, fiduciary or agency relationship
or fiduciary or other implied duty between any Lender, on the one hand, and such Credit Party, its stockholders or its Affiliates, on the other. The Credit Parties acknowledge and agree that (a) the transactions contemplated by the Credit
Documents (including the exercise of rights and remedies thereunder) are arm’s-length commercial transactions between the Lenders, on the one hand, and the Credit Parties, on the other, (b) in connection therewith and with the process
leading to such transaction each Lender is acting solely as a principal and not the agent or fiduciary of the Borrower, its management, stockholders, creditors or any other person and (c) other than as set forth below, no Lender has assumed an
advisory or fiduciary responsibility in favor of any Credit Party, its stockholders or its Affiliates with respect to the transactions contemplated hereby (or the exercise of rights or remedies with respect thereto) or the process leading thereto
(irrespective of whether any Lender has advised, is currently advising or will advise any Credit Party, its stockholders or its Affiliates on other matters) or any other obligation to any Credit Party except the obligations expressly set forth in
the Credit Documents. Each Credit Party acknowledges and agrees that it has consulted its own legal and financial advisors to the extent it deemed appropriate and that it is responsible for making its own independent judgment with respect to such
transactions and the process leading thereto. Each Credit Party agrees that it will not claim that any Lender has rendered advisory services of any nature or respect, or owes a fiduciary or similar duty to such Credit Party, in connection with such
transaction or the process leading thereto. 

  
 217

 [Remainder of page intentionally left blank] 

  
 218

 IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be duly executed and
delivered by their respective officers or representatives thereunto duly authorized as of the date first written above. 
  

					
	HOLOGIC, INC., as Borrower
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Finance and Administration,
		 		 	Chief Financial Officer and
		 		 	Assistant Treasurer and
		 		 	Assistant Secretary
	
	BIOLUCENT, LLC, as Guarantor
	
	By: Hologic, Inc.,
	Its Sole Member and Manager
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Finance and Administration,
		 		 	Chief Financial Officer and
		 		 	Assistant Treasurer and
		 		 	Assistant Secretary
	
	CRUISER, INC., as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary

 [Signature Page to Credit Agreement] 

 
					
	CYTYC CORPORATION, as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	CYTYC DEVELOPMENT COMPANY
	LLC, as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	CYTYC INTERIM, INC., as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	CYTYC INTERNATIONAL, INC., as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary

 [Signature Page to Credit Agreement] 

 
					
	CYTYC LIMITED LIABILITY
	COMPANY, as Guarantor
	
	By: Cytyc Corporation,
	Its Sole Member
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	CYTYC PRENATAL PRODUCTS
	CORP., as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	CYTYC SURGICAL PRODUCTS II,
	LIMITED PARTNERSHIP, as
	Guarantor
	
	By: Cytyc Corporation,
	Its General Partner
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary

 [Signature Page to Credit Agreement] 

 
					
	CYTYC SURGICAL PRODUCTS III,
	INC., as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	CYTYC SURGICAL PRODUCTS,
	LIMITED PARTNERSHIP, as
	Guarantor
	
	By: Cytyc Corporation,
	Its General Partner
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	DIRECT RADIOGRAPHY CORP., as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary

 [Signature Page to Credit Agreement] 

 
					
	HOLOGIC LIMITED PARTNERSHIP,
	as Guarantor
		
	By:	 	Cytyc Corporation,
	Its General Partner
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	INTERLACE MEDICAL, INC., as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	SENTINELLE MEDICAL USA INC., as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	SUROS SURGICAL SYSTEMS, INC., as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary

 [Signature Page to Credit Agreement] 

 
					
	SST MERGER CORP., as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	THIRD WAVE AGBIO, INC., as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	THIRD WAVE TECHNOLOGIES, INC.,
	as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	GEN-PROBE INCORPORATED, as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary

 [Signature Page to Credit Agreement] 

 
					
	GEN-PROBE SALES & SERVICE, INC.,
	as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	GEN-PROBE INTERNATIONAL, INC.,
	as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	GEN-PROBE HOLDINGS, INC., as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	GEN-PROBE TRANSPLANT
	DIAGNOSTICS, INC., as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary

 [Signature Page to Credit Agreement] 

 
					
	GEN-PROBE GTI DIAGNOSTICS
	HOLDING COMPANY, as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	GEN-PROBE GTI DIAGNOSTICS,
	INC., as Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary
	
	GEN-PROBE PRODESSE, INC., as
	Guarantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President,
		 		 	Treasurer and Assistant
		 		 	Secretary

 [Signature Page to Credit Agreement] 

 
			
	 GOLDMAN SACHS BANK USA
 as Joint Lead Arranger and Joint Lead Bookrunner, Administrative Agent, Collateral Agent, Swing Line Lender and Lender

		
	By:	 	 /s/ Meredith Mackey

		 	Authorized Signatory

 
			
	 J.P. MORGAN SECURITIES LLC
 as Joint Lead Arranger and Joint Lead Bookrunner and Co-Syndication Agent

		
	By:	 	 /s/ Edward S. Pyne

		 	Name: Edward S. Pyne
		 	Title Vice President

 
			
	 CITIGROUP GLOBAL MARKETS INC.,
 as Joint Lead Arranger and Joint Lead Bookrunner and Co-Syndication Agent

		
	By:	 	 /s/ Stuart G. Dickson

		 	Name: Stuart G. Dickson
		 	Title Managing Director

 
					
	Bank of America, N.A., as Lender
		
	By:	 	 /s/ Linda Alto

		 	Name:	 	Linda Alto
		 	Title:	 	Senior Vice President
	
	CIT Finance LLC, as Lender
		
	By:	 	 /s/ Terence Sullivan

		 	Name:	 	Terence Sullivan
		 	Title:	 	Managing Director
	
	CITIBANK, N.A., as Lender
		
	By:	 	 /s/ Stuart G. Dickson

		 	Name:	 	Stuart G. Dickson
		 	Title:	 	Vice President
	
	 DNB BANK ASA, Grand Cayman Branch, as Lender

		
	By:	 	 /s/ Kristie Li

		 	Name:	 	Kristie Li
		 	Title:	 	First Vice President
		
	By:	 	 /s/ Thomas Tangen

		 	Name:	 	Thomas Tangen
		 	Title:	 	Senior Vice President
	
	FIFTH THIRD BANK, as Lender
		
	By:	 	 /s/ Joshua N. Livingston

		 	Name:	 	Joshua N. Livingston
		 	Title:	 	Duly Authorized Signatory

					
	 GOLDMAN SACHS LENDING PARTNERS LLC, as Lender

		
	By:	 	 /s/ Meredith Mackey

		 	Authorized Signatory
	
	HSBC Bank USA, National Association, as Lender
		
	By:	 	 /s/ Kenneth V. McGraime

		 	Name:	 	Kenneth V. McGraime
		 	Title:	 	Senior Vice President
	
	JPMorgan Chase Bank, N.A., as Lender
		
	By:	 	 /s/ Peter M. Killea

		 	Name:	 	Peter M. Killea
		 	Title:	 	Senior Vice President
	
	Bank Leumi USA, as Lender
		
	By:	 	 /s/ Joung Hee Hong

		 	Name:	 	Joung Hee Hong
		 	Title:	 	First Vice President
	
	RBS Citizens, N.A., as Lender
		
	By:	 	 /s/ Cheryl Carangelo

		 	Name:	 	Cheryl Carangelo
		 	Title:	 	Senior Vice President
	
	RAYMOND JAMES BANK, N.A., as Lender
		
	By:	 	 /s/ Alexander L. Rody

		 	Name:	 	Alexander L. Rody
		 	Title:	 	Senior Vice President

					
	 Sumitomo Mitsui Banking Corporation, as Lender

		
	By:	 	 /s/ David W. Kee

		 	Name:	 	David W. Kee
		 	Title:	 	Managing Director
	
	The Bank of Nova Scotia, as Lender
		
	By:	 	 /s/ Michelle C. Phillips

		 	Name:	 	Michelle C. Phillips
		 	Title:	 	Director
	
	 THE BANK OF TOKYO-MITSUBISHI UFJ, LTD., as Lender

		
	By:	 	 /s/ Brian McNany

		 	Name:	 	Brian McNany
		 	Title:	 	Vice President

 EXHIBIT A-1 TO 
 CREDIT AND GUARANTY AGREEMENT 
 FUNDING NOTICE 

Reference is made to the Credit and Guaranty Agreement dated as of
[            ], 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the
terms defined therein and not otherwise defined herein being used herein as therein defined) by and among HOLOGIC, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower, as Guarantors, the Lenders party
thereto from time to time, GOLDMAN SACHS BANK USA, J.P. MORGAN SECURITIES LLC and CITIGROUP GLOBAL MARKETS INC., as Joint Lead Arrangers and Joint Lead Bookrunners, GOLDMAN SACHS BANK USA, as Administrative Agent and Collateral Agent, and J.P.
MORGAN SECURITIES LLC and CITIGROUP GLOBAL MARKETS INC., as Co-Syndication Agents. 
 Pursuant to Section [2.01][2.02][2.03] of
the Credit Agreement, the Borrower desires that Lenders make the following Loans to the Borrower in accordance with the applicable terms and conditions of the Credit Agreement on
[                 ], 201[    ] (the “Credit Date”): 

 

							
	[Tranche A Term Loans	  			
	 ̈	  	Base Rate Loans:	  	$	[    ,    ,    	] 
	 ̈	  	Eurodollar Rate Loans, with an initial Interest Period of              month(s):	  	$	[    ,    ,    	]] 
		
	[Tranche B Term Loans	  			
	 ̈	  	Base Rate Loans:	  	$	[    ,    ,    	] 
	 ̈	  	Eurodollar Rate Loans, with an initial Interest Period of              month(s):	  	$	[    ,    ,    	]] 
		
	[Revolving Loans	  			
	 ̈	  	Base Rate Loans:	  	$	[    ,    ,    	] 
	 ̈	  	Eurodollar Rate Loans, with an initial Interest Period of              month(s):	  	$	[    ,    ,    	]] 
	[Swing Line Loans:	  	$	[    ,    ,    	]] 

  
 EXHIBIT A-1-1

 The Borrower hereby certifies that: 

(i) after making the Revolving Loans requested on the Credit Date, the Total Utilization of Revolving Commitments shall not exceed the
Revolving Commitments then in effect; 
 (iii) as of the Credit Date, [the representations and warranties
contained in each of the Credit Documents]1 [(1) the
representations and warranties set forth in Sections 4.01(a) (other than with respect to the applicable Person being in good standing in each applicable jurisdiction), 4.01(b)(ii), 4.03, 4.04(a)(i), 4.04(a)(ii), 4.06, 4.17(a)(i), 4.17(b), 4.18,
4.22, 4.27, 4.28 and (subject to the limitations on perfection of security interests set forth in the last paragraph of Section 3.01(i)) 4.29, and, with respect to the Borrower only, Section 4.07 of the Credit Agreement, and (2) the
Acquisition Agreement Representations]2 are true and
correct in all material respects on and as of such Credit Date to the same extent as though made on and as of such Credit Date, except to the extent such representations and warranties specifically relate to an earlier date, in which case such
representations and warranties shall have been true and correct in all material respects on and as of such earlier date; provided that, in each case, such materiality qualifier shall not be applicable to any representations and warranties
that already are qualified or modified by materiality in the text thereof; and 
 (iv) other than with respect to the Credit
Extensions made on the Closing Date, as of the Credit Date, no event has occurred and is continuing or would result from the consummation of the borrowing contemplated hereby that would constitute an Event of Default or a Default. 

The account of Borrower to which the proceeds of the Loans requested on the Credit Date are to be made available by the Administrative
Agent to the Borrower are as follows: 
  

			
	Bank Name:	    	  

	Bank Address:	    	  

	ABA Number:	    	  

	Account Number:	    	  

	Attention:	    	  

	Reference:	    	  

  

	1 	 Select this language for any borrowing request in respect of Loans other than Loans to be made on the Closing Date. 

	2 	 Select this language for any borrowing request to be made on the Closing Date. 

  
 EXHIBIT A-1-2

									
	Date: [                 ], 201[    ]	 		 	HOLOGIC, INC.
					
		 	  
	 		 	By:	 	  

		 		 		 		 	Name:
		 		 		 		 	Title:

  
 EXHIBIT A-1-3

 EXHIBIT A-2 TO 
 CREDIT AND GUARANTY AGREEMENT 
 CONVERSION/CONTINUATION NOTICE 

Reference is made to the Credit and Guaranty Agreement dated as of
[            ], 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the
terms defined therein and not otherwise defined herein being used herein as therein defined) by and among HOLOGIC, INC., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower, as Guarantors, the Lenders party
thereto from time to time, GOLDMAN SACHS BANK USA, J.P. MORGAN SECURITIES LLC and CITIGROUP GLOBAL MARKETS INC., as Joint Lead Arrangers and Joint Lead Bookrunners, GOLDMAN SACHS BANK USA, as Administrative Agent and Collateral Agent, and J.P.
MORGAN SECURITIES LLC and CITIGROUP GLOBAL MARKETS INC., as Co-Syndication Agents. 
 Pursuant to Section 2.09 of the
Credit Agreement, the Borrower desires to convert or to continue the following Loans, each such conversion and/or continuation to be effective as of [                 ],
201[    ]: 
  

			
	1. [Tranche A Term Loans:	  	
		
	 $[    ,    ,    ]
	  	Eurodollar Rate Loans to be continued with Interest Period of [        ] month(s)
	 $[    ,    ,    ]
	  	Base Rate Loans to be converted to Eurodollar Rate Loans with Interest Period of [        ] month(s)
	 $[    ,    ,    ]
	  	Eurodollar Rate Loans to be converted to Base Rate Loans]
	2. [Tranche B Term Loans:	  	
		
	 $[    ,    ,    ]
	  	Eurodollar Rate Loans to be continued with Interest Period of [        ] month(s)
	 $[    ,    ,    ]
	  	Base Rate Loans to be converted to Eurodollar Rate Loans with Interest Period of [        ] month(s)
	 $[    ,    ,    ]
	  	Eurodollar Rate Loans to be converted to Base Rate Loans]

  
 EXHIBIT A-2-1

			
	 3. [Revolving Loans:
	  	
		
	 $[    ,    ,    ]
	  	Eurodollar Rate Loans to be continued with Interest Period of [        ] month(s)
	 $[    ,    ,    ]
	  	Base Rate Loans to be converted to Eurodollar Rate Loans with Interest Period of [        ] month(s)
	 $[    ,    ,    ]
	  	Eurodollar Rate Loans to be converted to Base Rate Loans]

 The Borrower hereby certifies that as of the date hereof, no event has occurred and is continuing or
would result from the consummation of the conversion and/or continuation contemplated hereby that would constitute an Event of Default or a Default. 
  

							
	Date: [                 ], 201[    ]	 		 	HOLOGIC, INC.
				
		 		 	By:	 	  

		 		 		 	Name:
		 		 		 	Title:

  
 EXHIBIT A-2-2

 EXHIBIT B-1 TO 
 CREDIT AND GUARANTY AGREEMENT 
 TRANCHE A TERM LOAN NOTE 

$[    ,    ,    ] 

			
	[                 ], 20[    ]	 	New York, New York

 FOR VALUE RECEIVED, HOLOGIC, INC., a Delaware corporation (the “Borrower”),
promises to pay [NAME OF LENDER] (the “Payee”) or its registered assigns the principal amount of [        ] DOLLARS
($[    ,    ,    ]) in the Installments referred to below. 
 The
Borrower also promises to pay interest on the unpaid principal amount hereof, from the date hereof until paid in full, at the rates and at the times which shall be determined in accordance with the provisions of the Credit and Guaranty Agreement
dated as of [            ], 2012 as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit
Agreement”; the terms defined therein and not otherwise defined herein being used herein as therein defined) by and among the Borrower, certain Subsidiaries of the Borrower, as Guarantors, the Lenders party thereto from time to time,
Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and
Citigroup Global Markets Inc., as Co-Syndication Agents. 
 The Borrower shall make scheduled principal payments (the
“Installments”) on this Tranche A Term Loan Note (this “Note”) as set forth in Section 2.12(a) of the Credit Agreement. 
 This Note is one of the “Tranche A Term Loan Notes” in the aggregate principal amount of $1,000,000,000 issued pursuant to and is entitled to the benefits of the Credit Agreement, to which
reference is hereby made for a more complete statement of the terms and conditions under which the Tranche A Term Loan evidenced hereby was made and is to be repaid. 
 All payments of principal and interest in respect of this Note shall be made in lawful money of the United States of America in same day funds at the Principal Office of the Administrative Agent or at
such other place as shall be designated in writing for such purpose in accordance with the terms of the Credit Agreement. Unless and until an Assignment Agreement or settlement confirmation effecting the assignment or transfer of the obligations
evidenced hereby shall have been accepted by the Administrative Agent and recorded in the Register, the Borrower, each Agent and Lenders shall be entitled to deem and 

  
 EXHIBIT B-1-1

 
treat the Payee as the owner and holder of this Note and the obligations evidenced hereby. The Payee hereby agrees, by its acceptance hereof, that before disposing of this Note or any part hereof
it will make a notation hereon of all principal payments previously made hereunder and of the date to which interest hereon has been paid; provided, the failure to make a notation of any payment made on this Note shall not limit or otherwise
affect the obligations of the Borrower hereunder with respect to payments of principal of or interest on this Note. 
 This Note
is subject to mandatory prepayment and to prepayment at the option of the Borrower, each as provided in the Credit Agreement. 

THIS NOTE AND THE RIGHTS AND OBLIGATIONS OF THE BORROWER AND THE PAYEE HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND
ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. 

Upon the occurrence of an Event of Default, the unpaid balance of the principal amount of this Note, together with all accrued and unpaid
interest thereon, may become, or may be declared to be, due and payable in the manner, upon the conditions and with the effect provided in the Credit Agreement. 
 The terms of this Note are subject to amendment only in the manner provided in the Credit Agreement. 
 No reference herein to the Credit Agreement and no provision of this Note or the Credit Agreement shall alter or impair the obligations of the Borrower, which are absolute and unconditional, to pay the
principal of and interest on this Note at the place, at the respective times, and in the currency herein prescribed. 
 The
Borrower promises to pay all costs and expenses, including reasonable attorneys’ fees, all as and to the extent provided in the Credit Agreement, incurred in the collection and enforcement of this Note. The Borrower and any endorsers of this
Note hereby consent to renewals and extensions of time at or after the maturity hereof, without notice, and hereby waive diligence, presentment, protest, demand notice of every kind and, to the full extent permitted by law, the right to plead any
statute of limitations as a defense to any demand hereunder. 
 [Remainder of page intentionally left blank] 

  
 EXHIBIT B-1-2

 IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered by
its officer thereunto duly authorized as of the date and at the place first written above. 
  

			
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  
 EXHIBIT B-1-3

 TRANSACTIONS ON 
 TRANCHE A TERM LOAN NOTE 
  

									
	 Date
	  	Amount of Loan
Made This Date	  	Amount of Principal
Paid This Date	  	Outstanding Principal
Balance This Date	  	Notation
Made By
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 EXHIBIT B-1-4

 EXHIBIT B-2 TO 
 CREDIT AND GUARANTY AGREEMENT 
 TRANCHE B TERM LOAN NOTE 

$[    ,    ,    ] 

			
	[                 ], 20[    ]	 	New York, New York

 FOR VALUE RECEIVED, HOLOGIC, INC., a Delaware corporation (the “Borrower”),
promises to pay [NAME OF LENDER] (the “Payee”) or its registered assigns the principal amount of [        ] DOLLARS
($[    ,    ,    ]) in the Installments referred to below. 
 The
Borrower also promises to pay interest on the unpaid principal amount hereof, from the date hereof until paid in full, at the rates and at the times which shall be determined in accordance with the provisions of the Credit and Guaranty Agreement
dated as of [            ], 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit
Agreement”; the terms defined therein and not otherwise defined herein being used herein as therein defined) by and among the Borrower, certain Subsidiaries of the Borrower, as Guarantors, the Lenders party thereto from time to time,
Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and
Citigroup Global Markets Inc., as Co-Syndication Agents. 
 The Borrower shall make principal payments (the
“Installments”) on this Tranche B Term Loan Note (this “Note”) as set forth in Section 2.12(b) of the Credit Agreement. 
 This Note is one of the “Tranche B Term Loan Notes” in the aggregate principal amount of $1,500,000,000 issued pursuant to and is entitled to the benefits of the Credit Agreement, to which
reference is hereby made for a more complete statement of the terms and conditions under which the Term Loan evidenced hereby was made and is to be repaid. 
 All payments of principal and interest in respect of this Note shall be made in lawful money of the United States of America in same day funds at the Principal Office of the Administrative Agent or at
such other place as shall be designated in writing for such purpose in accordance with the terms of the Credit Agreement. Unless and until an Assignment Agreement or settlement confirmation effecting the assignment or transfer of the obligations
evidenced hereby shall have been accepted by the Administrative Agent and recorded in the Register, the Borrower, each Agent and Lenders shall be entitled to deem and 

  
 EXHIBIT B-2-1

 
treat the Payee as the owner and holder of this Note and the obligations evidenced hereby. The Payee hereby agrees, by its acceptance hereof, that before disposing of this Note or any part hereof
it will make a notation hereon of all principal payments previously made hereunder and of the date to which interest hereon has been paid; provided, the failure to make a notation of any payment made on this Note shall not limit or otherwise
affect the obligations of the Borrower hereunder with respect to payments of principal of or interest on this Note. 
 This Note
is subject to mandatory prepayment and to prepayment at the option of the Borrower, each as provided in the Credit Agreement. 

THIS NOTE AND THE RIGHTS AND OBLIGATIONS OF THE BORROWER AND THE PAYEE HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND
ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. 

Upon the occurrence of an Event of Default, the unpaid balance of the principal amount of this Note, together with all accrued and unpaid
interest thereon, may become, or may be declared to be, due and payable in the manner, upon the conditions and with the effect provided in the Credit Agreement. 
 The terms of this Note are subject to amendment only in the manner provided in the Credit Agreement. 
 No reference herein to the Credit Agreement and no provision of this Note or the Credit Agreement shall alter or impair the obligations of the Borrower, which are absolute and unconditional, to pay the
principal of and interest on this Note at the place, at the respective times, and in the currency herein prescribed. 
 The
Borrower promises to pay all costs and expenses, including reasonable attorneys’ fees, all as and to the extent provided in the Credit Agreement, incurred in the collection and enforcement of this Note. The Borrower and any endorsers of this
Note hereby consent to renewals and extensions of time at or after the maturity hereof, without notice, and hereby waive diligence, presentment, protest, demand notice of every kind and, to the full extent permitted by law, the right to plead any
statute of limitations as a defense to any demand hereunder. 
 [Remainder of page intentionally left blank] 

  
 EXHIBIT B-2-2

 IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered by
its officer thereunto duly authorized as of the date and at the place first written above. 
  

			
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  
 EXHIBIT B-2-3

 TRANSACTIONS ON 
 TRANCHE B TERM LOAN NOTE 
  

									
	 Date
	  	Amount of Loan
Made This Date	  	Amount of Principal
Paid This Date	  	Outstanding Principal
Balance This Date	  	Notation
Made By
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 EXHIBIT B-2-4

 EXHIBIT B-3 TO 
 CREDIT AND GUARANTY AGREEMENT 
 REVOLVING LOAN NOTE 

$[    ,    ,    ] 

			
	[                 ], 20[    ]	 	New York, New York

 FOR VALUE RECEIVED, HOLOGIC, INC., a Delaware corporation (the “Borrower”),
promises to pay [NAME OF LENDER] (the “Payee”) or its registered assigns, on or before [            ], 2017, the lesser of
(a) [        ] DOLLARS ($[    ,    ,    ]) and (b) the unpaid principal amount of all advances made by Payee to the Borrower as Revolving
Loans under the Credit Agreement referred to below. 
 The Borrower also promises to pay interest on the unpaid principal amount
hereof, from the date hereof until paid in full, at the rates and at the times which shall be determined in accordance with the provisions of that certain Credit and Guaranty Agreement dated as of
[            ], 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the
terms defined therein and not otherwise defined herein being used herein as therein defined) by and among the Borrower, certain Subsidiaries of the Borrower, as Guarantors, the Lenders party thereto from time to time, Goldman Sachs Bank USA, J.P.
Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as
Co-Syndication Agents. 
 This Note is one of the “Revolving Loan Notes” in the aggregate principal amount of
$300,000,000 issued pursuant to and is entitled to the benefits of the Credit Agreement, to which reference is hereby made for a more complete statement of the terms and conditions under which the Loans evidenced hereby were made and are to be
repaid. 
 All payments of principal and interest in respect of this Note shall be made in lawful money of the United States of
America in same day funds at the Principal Office of the Administrative Agent or at such other place as shall be designated in writing for such purpose in accordance with the terms of the Credit Agreement. Unless and until an Assignment Agreement
effecting the assignment or transfer of the obligations evidenced hereby shall have been accepted by the Administrative Agent and recorded in the Register, the Borrower, each Agent and Lenders shall be entitled to deem and treat the Payee as the
owner and holder of this Note and the obligations evidenced hereby. The Payee hereby agrees, by its acceptance hereof, that before disposing of this Note or any part hereof it will 

  
 EXHIBIT B-3-1

 
make a notation hereon of all principal payments previously made hereunder and of the date to which interest hereon has been paid; provided, the failure to make a notation of any payment
made on this Note shall not limit or otherwise affect the obligations of the Borrower hereunder with respect to payments of principal of or interest on this Note. 
 This Note is subject to mandatory prepayment and to prepayment at the option of the Borrower, each as provided in the Credit Agreement. 

THIS NOTE AND THE RIGHTS AND OBLIGATIONS OF THE BORROWER AND PAYEE HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN
ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. 

Upon the occurrence of an Event of Default, the unpaid balance of the principal amount of this Note, together with all accrued and unpaid
interest thereon, may become, or may be declared to be, due and payable in the manner, upon the conditions and with the effect provided in the Credit Agreement. 
 The terms of this Note are subject to amendment only in the manner provided in the Credit Agreement. 
 No reference herein to the Credit Agreement and no provision of this Note or the Credit Agreement shall alter or impair the obligations of the Borrower, which are absolute and unconditional, to pay the
principal of and interest on this Note at the place, at the respective times, and in the currency herein prescribed. 
 The
Borrower promises to pay all costs and expenses, including reasonable attorneys’ fees, all as and to the extent provided in the Credit Agreement, incurred in the collection and enforcement of this Note. The Borrower and any endorsers of this
Note hereby consent to renewals and extensions of time at or after the maturity hereof, without notice, and hereby waive diligence, presentment, protest, demand notice of every kind and, to the full extent permitted by law, the right to plead any
statute of limitations as a defense to any demand hereunder. 
 [Remainder of page intentionally left blank] 

  
 EXHIBIT B-3-2

 IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered by
its officer thereunto duly authorized as of the date and at the place first written above. 
  

			
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  
 EXHIBIT B-3-3

 TRANSACTIONS ON 
 REVOLVING LOAN NOTE 
  

									
	 Date
	  	Amount of Loan
Made This Date	  	Amount of Principal
Paid This Date	  	Outstanding Principal
Balance This Date	  	Notation
Made By
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 EXHIBIT B-3-4

 EXHIBIT B-4 TO 
 CREDIT AND GUARANTY AGREEMENT 
 SWING LINE NOTE 

 

			
	$[    ,    ,    ]	 	
	[            ], 20[    ]	 	New York, New York

 FOR VALUE RECEIVED, HOLOGIC, INC., a Delaware corporation (the “Borrower”),
promises to pay to [            ], as Swing Line Lender (the “Payee”), on or before [            ], 2017, the
lesser of (a) [            ] ($[        ]) and (b) the unpaid principal amount of all advances made by Payee to the Borrower as Swing Line
Loans under the Credit Agreement referred to below. 
 The Borrower also promises to pay interest on the unpaid principal amount
hereof, from the date hereof until paid in full, at the rates and at the times which shall be determined in accordance with the provisions of the Credit and Guaranty Agreement dated as of
[            ], 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the
terms defined therein and not otherwise defined herein being used herein as therein defined) by and among the Borrower, certain Subsidiaries of the Borrower, as Guarantors, the Lenders party thereto from time to time, Goldman Sachs Bank USA, J.P.
Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as
Co-Syndication Agents. 
 This Swing Line Note (this “Note”) is the “Swing Line Note” issued pursuant
to and is entitled to the benefits of the Credit Agreement, to which reference is hereby made for a more complete statement of the terms and conditions under which the Swing Line Loans evidenced hereby were made and are to be repaid. 

All payments of principal and interest in respect of this Note shall be made in lawful money of the United States of America in same day
funds at the Principal Office of the Swing Line Lender or at such other place as shall be designated in writing for such purpose in accordance with the terms of the Credit Agreement. 

This Note is subject to mandatory prepayment and to prepayment at the option of the Borrower, each as provided in the Credit Agreement.

  
 EXHIBIT B-4-1

 THIS NOTE AND THE RIGHTS AND OBLIGATIONS OF THE BORROWER AND PAYEE HEREUNDER SHALL BE
GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK, WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES OTHER THAN THE LAW OF THE STATE OF NEW YORK THAT WOULD RESULT IN THE APPLICATION OF ANY LAW.

 Upon the occurrence of an Event of Default, the unpaid balance of the principal amount of this Note, together with all
accrued and unpaid interest thereon, may become, or may be declared to be, due and payable in the manner, upon the conditions and with the effect provided in the Credit Agreement. 

The terms of this Note are subject to amendment only in the manner provided in the Credit Agreement. 

No reference herein to the Credit Agreement and no provision of this Note or the Credit Agreement shall alter or impair the obligations
of the Borrower, which are absolute and unconditional, to pay the principal of and interest on this Note at the place, at the respective times, and in the currency herein prescribed. 

The Borrower promises to pay all costs and expenses, including reasonable attorneys’ fees, all as and to the extent provided in the
Credit Agreement, incurred in the collection and enforcement of this Note. The Borrower and any endorsers of this Note hereby consent to renewals and extensions of time at or after the maturity hereof, without notice, and hereby waive diligence,
presentment, protest, demand notice of every kind and, to the full extent permitted by law, the right to plead any statute of limitations as a defense to any demand hereunder. 
 [Remainder of page intentionally left blank] 

  
 EXHIBIT B-4-2

 IN WITNESS WHEREOF, the Borrower has caused this Note to be duly executed and delivered by
its officer thereunto duly authorized as of the date and at the place first written above. 
  

			
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  
 EXHIBIT B-4-3

 TRANSACTIONS ON 
 SWING LINE NOTE 
  

									
	 Date
	  	Amount of Loan
Made This Date	  	Amount of Principal
Paid This Date	  	Outstanding Principal
Balance This Date	  	Notation
Made By
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	
		  		  		  		  	

  
 EXHIBIT B-4-4

 EXHIBIT C TO 
 CREDIT AND GUARANTY AGREEMENT 
 COMPLIANCE CERTIFICATE 

THE UNDERSIGNED HEREBY CERTIFIES AS FOLLOWS: 
 1. I am the Chief Financial Officer of HOLOGIC, INC., a Delaware corporation (the “Borrower”). 
 2. I have reviewed the terms of the Credit and Guaranty Agreement dated as of [            ], 2012 (as it may be refinanced, amended, restated,
amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the terms defined therein and not otherwise defined herein being used herein as therein defined) by and among the Borrower, certain
Subsidiaries of the Borrower, as Guarantors, the Lenders party thereto from time to time, Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank
USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Co-Syndication Agents, and I have made, or have caused to be made under my supervision, a review in reasonable detail of the
transactions and condition of the Borrower and its Subsidiaries during the accounting period covered by the attached financial statements. 
 3. To the best of my knowledge after due inquiry, the examination described in paragraph 2 above did not disclose, and I have no knowledge of, the existence of any condition or event which constitutes an
Event of Default or Default during or at the end of the accounting period covered by the attached financial statements or as of the date of this Compliance Certificate (this “Certificate”), except as set forth in a separate
attachment, if any, to this Certificate, describing in detail the nature of the condition or event, the period during which it has existed and the action which the Borrower has taken, is taking, or proposes to take with respect to each such
condition or event. 
 4. Set forth on Schedule 1.1C hereto are all Immaterial Domestic Subsidiaries (other than those
Immaterial Domestic Subsidiary listed on Schedule 1.1C of the Credit Agreement or any other schedule (including, without limitation, each Schedule 1.1C attached to any and all Compliance Certificates delivered to the Administrative Agent prior to
the date hereof) that supplements such Schedule 1.1C). Each Immaterial Domestic Subsidiary listed on Schedule 1.1C hereto, together with all other Immaterial Domestic Subsidiaries, (x) has assets comprising less than 2% of Total Assets on the
last day of the accounting period covered by the attached financial statements and (y) contributes less than 2% of Consolidated Adjusted EBITDA for the period of four consecutive Fiscal Quarters ending on the last day of the accounting period
covered by the attached financial statements. 

  
 EXHIBIT C-1

 The foregoing certifications, together with the computations set forth in the Annex A [and
Exhibit A] hereto and the financial statements delivered with this Certificate in support hereof and thereof, are made and delivered [            ], 20[    ]
pursuant to Section 5.01(c) of the Credit Agreement. 
  

			
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:
		 	Title:  Chief Financial Officer

  
 EXHIBIT C-2

 ANNEX A TO 
 COMPLIANCE CERTIFICATE 
 FOR THE FISCAL [QUARTER] [YEAR] ENDED
[            ], 20[    ] 
  

					
	1. [Consolidated Total Debt:	  			
		
	 the aggregate stated balance sheet amount of all Indebtedness of the Borrower and its Subsidiaries determined on a consolidated basis in accordance
with GAAP:]
	  	$	[    ,    ,    	] 
		
	2. [Consolidated Net Debt:	  			
		
	 (i)      Consolidated Total Debt:
	  	$	[    ,    ,    	] 
		
	 (ii)     the aggregate amount (not to exceed $250,000,000) of Qualified Cash:
	  	$	[    ,    ,    	] 
		
	 Consolidated Net Debt: (i) – (ii) = ]
	  	$	[    ,    ,    	] 
		
	 3. [Consolidated Senior Secured Debt:
  

Consolidated Total Debt that is secured by a Lien on the assets of the Credit Parties:]
	  	$	[    ,    ,    	] 
		
	4. Adjusted Consolidated Interest Expense:	  			
		
	 total interest expense in accordance with GAAP (including that portion attributable to Capital Leases in accordance with GAAP, capitalized interest,
amortization of deferred financing fees and amortization in relation to terminated Hedge Agreements) of the Borrower and its Subsidiaries on a consolidated basis with respect to all outstanding Indebtedness of the Borrower and its Subsidiaries,
including all commissions, discounts and other fees and charges owed with respect to letters of credit, net costs under Interest Rate Agreements, capitalized interest and the interest component of all Attributable Receivables
Indebtedness:
	  	$	[    ,    ,    	] 

  
 EXHIBIT C-3

					
	5. Consolidated Net Income:	  	$	[    ,    ,    	] 
		
	 (i)      the consolidated net income (or loss) of the Borrower and its Subsidiaries for such
period, determined on a consolidated basis in accordance with GAAP:
	  	$	[    ,    ,    	] 
		
	 (ii)     the sum, without duplication, of (a) through (h):
	  	$	[    ,    ,    	] 
		
	 (a)     the income (or deficit) of any Person accrued prior to the date it becomes a Subsidiary of the
Borrower or is merged into or consolidated with the Borrower or any of its Subsidiaries (except as contemplated by Section 1.05 of the Credit Agreement):
	  	$	[    ,    ,    	] 
		
	 (b)     the income (or deficit) of any Person in which the Borrower or any of its Subsidiaries has an
ownership interest that is either (x) not a Subsidiary or (y) accounted for by the equity method of accounting, except to the extent that any such income is actually received by the Borrower or such Subsidiary in the form of dividends or
similar distributions;
	  	$	[    ,    ,    	] 
		
	 (c)     the undistributed earnings of any Subsidiary of the Borrower to the extent that the declaration
or payment of dividends or similar distributions by such Subsidiary is not at the time permitted by the terms of any agreement, instrument, contract or other undertaking to which such Subsidiary is a party or by which any of its property is bound or
any law, treaty, rule, regulation or determination of an arbitrator or a court of competent jurisdiction or other Governmental Authority, in each case, applicable or binding upon such Subsidiary or any of its property or to which such Subsidiary or
any of its property is subject:
	  	$	[    ,    ,    	] 
		
	 (d)     any fees and expenses recognized during such period, or any amortization thereof for such
period, in connection with the consummation of the Acquisition, any Prior Acquisition, Permitted Acquisition, Investment, asset disposition, issuance or repayment of Indebtedness, issuance of Equity Interests, refinancing transaction or amendment or
other modification of any Indebtedness (in each case, including any such transaction consummated prior to the Closing
	  			

  
 EXHIBIT C-4

					
	 Date and any such transaction undertaken but not completed) and any charges or non-recurring costs recognized during such period as a result of any
such transaction:
	  	$	[    ,    ,    	] 
		
	 (e)     any amortization of deferred charges resulting from the application of Accounting Standards
Codification 470-20, Debt (but only to the extent of the information therein that was codified from Financial Accounting Standards Board Staff Position No. APB 14-1—Accounting for Convertible Debt Instruments That May Be Settled in Cash upon
Conversion (Including Partial Cash Settlement) or related interpretations or guidance) (including, for the avoidance of doubt, as a result of its application to Convertible Notes issued in exchange for other Convertible Notes):
	  	$	[    ,    ,    	] 
		
	 (f)      any extraordinary gain or loss (including, without limitation, any gains or losses arising
out of the settlement of any Adverse Proceeding listed on Schedule 4.11 to the Credit Agreement):
	  	$	[    ,    ,    	] 
		
	 (g)     any income (loss) for such period attributable to the exchange or early extinguishment of
Indebtedness, together with any related provision for taxes on any such income:
	  	$	[    ,    ,    	] 
		
	 (h)     any net after-tax gains or losses attributable to asset dispositions other than in the ordinary
course of business, as determined in good faith by the Borrower:
	  	$	[    ,    ,    	] 
		
	 Consolidated Net Income: (i) – (ii) =
	  	$	[    ,    ,    	] 
		
	 6. Consolidated Adjusted EBITDA:
	  	$	[    ,    ,    	] 
		
	 (i)      Consolidated Net Income of the Borrower and its Subsidiaries:
	  	$	[    ,    ,    	] 
		
	 (ii)     without duplication and (except with respect to clause (k) below), to the extent reducing
net income (and not excluded in determining Consolidated Net Income) for such period, the sum of clauses (a) through (k):
	  	$	[    ,    ,    	] 

  
 EXHIBIT C-5

					
	 (a)     any expense and provision for taxes, paid or accrued:
	  	$	[    ,    ,    	] 
		
	 (b)     Adjusted Consolidated Interest Expense milestone payments in connection with any investment or
series of related investments and costs of surety bonds in connection with financing activities:
	  	$	[    ,    ,    	] 
		
	 (c)     Consolidated Depreciation and Amortization Expense:
	  	$	[    ,    ,    	] 
		
	 (d)     any non-cash charges and non-cash revenue loss recorded in respect of purchase accounting
(including, but not limited, to revenue not recognized as a result of the write-up of accounts receivable), and non-cash exchange, translation or performance losses relating to any foreign currency hedging transactions or currency
fluctuations:
	  	$	[    ,    ,    	] 
		
	 (e)     any other non-cash charges (including, without limitation, incurred pursuant to any equity
incentive plan or award or arising from any impairment of intangible assets or goodwill, but excluding any such non-cash charge to the extent that it represents an accrual or reserve for cash expenses in any future period, an amortization of a
prepaid cash expense that was paid in a prior period or a write-off, writedown or reserve with respect to current assets) for such period:
	  	$	[    ,    ,    	] 
		
	 (f)      any unusual expenses or charges, including without limitation, any restructuring,
integration, transition and similar charges accrued during such period, including any charges to establish accruals and reserves or to make payments associated with the reassessment or realignment of the business and operations of the Borrower and
its Subsidiaries, including, without limitation, the sale or closing of facilities, severance and curtailments or modifications to pension and post-retirement employee benefit
	  			

  
 EXHIBIT C-6

					
	 plans, retention payments in connection therewith, asset write-downs or asset disposals, write-downs for purchase and lease commitments, write-downs
of excess, obsolete or unbalanced inventories, relocation costs which are not otherwise capitalized and any related costs of existing products or product lines; provided that (x) subject to clause (y), the aggregate amount added back pursuant to
this paragraph (f), together with the amount of projected synergies and cost savings added back pursuant to Section 1.05(c) of the Credit Agreement, shall not exceed 10% of Consolidated Adjusted EBITDA for such period, calculated without giving
effect to any adjustment pursuant to this paragraph (f), paragraph (k) or Section 1.05(c) of the Credit Agreement as it relates to projected synergies and cost savings and (y) in addition to the amount set forth in clause (x) above, there may also
be added back pursuant to this paragraph (f) such expenses and charges incurred in connection with the Acquisition during the period commencing on the Closing Date and ending on September 26, 2015, in an aggregate amount not to exceed
$50,000,000:
	  	$	[    ,    ,    	] 
		
	 (g)     charges with respect to casualty events:
	  	$	[    ,    ,    	] 
		
	 (h)     to the extent actually reimbursed, expenses incurred to the extent covered by indemnification
provisions in any agreement in connection with any acquisition permitted hereunder:
	  	$	[    ,    ,    	] 
		
	 (i)      any contingent or deferred payments (including, but not limited to, severance, retention,
earn-out payments, non-compete payments and consulting payments but excluding ongoing royalty payments) made in connection with the Acquisition, any Prior Acquisition or any Permitted Acquisition:
	  	$	[    ,    ,    	] 
		
	 (j)      non-cash charges pursuant to Statement of Financial Accounting Standards No. 158
(codified within Accounting Standards
	  	$	[    ,    ,    	] 

  
 EXHIBIT C-7

					
	 Codifications 715-20, Defined Benefit Plans—General and 715-30, Defined Benefit Plans—Pension):
	  			
		
	 (k)     in addition to synergies and cost savings permitted to be added back in connection with a Pro
Forma Transaction pursuant to Section 1.05(c) of the Credit Agreement, the amount of synergies and cost savings projected by the Borrower in good faith to result from actions taken or expected to be taken in connection with the Acquisition, in the
period commencing on the Closing Date and ending on September 26, 2015, net of the amount of actual benefits during such period realized from such actions or otherwise added back pursuant to this definition; provided that (A) such amounts are
reasonably identifiable, quantifiable and factually supportable in the good faith judgment of the Borrower and (B) the aggregate amount added back pursuant to this paragraph (k) shall not exceed $75,000,000:
	  	$	[    ,    ,    	] 
		
	 (iii)   to the extent increasing net income (and not excluded in determining Consolidated Net Income) for such
period, the sum of (a) through (c):
	  	$	[    ,    ,    	] 
		
	 (a)     any cash payments made during such period on account of non-cash charges added to Consolidated
Net Income pursuant to clause (e) above in such period or any prior period:
	  	$	[    ,    ,    	] 
		
	 (b)     all non-cash income or gains (but excluding any such amount (x) in respect of which cash or
other assets were received in a prior period or will be received or (y) which represents the reversal of an accrual or cash reserve for, anticipated cash charges in any prior period) and non-cash exchange, translation or performance gains
relating to any foreign currency hedging transactions or currency fluctuations:
	  	$	[    ,    ,    	] 
		
	 (c)     any unusual income or gains, all calculated for the Borrower and its Subsidiaries in accordance
with GAAP on a consolidated basis:
	  	$	[    ,    ,    	] 

  
 EXHIBIT C-8

					
	 Consolidated Adjusted EBITDA3: (i) + (ii) – (iii) =
	  	$	[    ,    ,    	] 
		
	 7.      [Total Net Leverage Ratio] [Net Senior Secured Leverage Ratio]:4
	  	$	[    ,    ,    	] 
		
	 (i)      [Consolidated Total Debt] [Consolidated Net Debt] [Consolidated Senior Secured
Debt]:
	  	$	[    ,    ,    	] 
		
	 (ii)     Consolidated Adjusted EBITDA5:
	  	$	[    ,    ,    	] 
		
	 [Total Net Leverage Ratio] [Net Senior Secured Leverage Ratio]: (i) / (ii) =
	  			

					
		
		  	 
  
	Actual:   .    :1.00
 Required:   .    :1.00
	  
   

		
	 8.      Interest Coverage Ratio6:
	  			
	
	 [The ratio as of the last day of the most recently ended Fiscal Quarter of (i) Consolidated7 Adjusted EBITDA for the four (4)-Fiscal Quarter period ending on such
date to (ii) Adjusted Consolidated Cash Interest Expense for such four (4)-Fiscal Quarter period.]8
	
  
 

  

	3 	Without duplication and to the extent included in Consolidated Net Income, any adjustments resulting from the application of Accounting Standards Codification 815 shall
be excluded in determining Consolidated Adjusted EBITDA. For purposes of calculating the Total Net Leverage Ratio and Net Senior Secured Leverage Ratio, Consolidated Adjusted EBITDA will be deemed to be equal to (1) for the fiscal quarter ended
September 24, 2011, $239,780,000, (2) for the fiscal quarter ended December 24, 2011, $248,894,000 and (3) for the fiscal quarter ended March 24, 2012, $234,588,000 (it being understood and agreed that the foregoing
Consolidated Adjusted EBITDA amounts set forth in clauses (1), (2) and (3) each reflect the inclusion of synergies of $18,750,000 (which accordingly utilizes a portion of the basket set forth in clause (k) above) and each other
adjustment contemplated by this definition for the applicable period but is without limitation of the pro forma adjustment contemplated by Section 1.05 of the Credit Agreement). 

	4 	Please see footnote 3. 

	5 	Please see footnote 3. 

	6 	Please see footnote 3. 

	7 	To be determined on a pro forma basis for the Acquisition and related transactions, assuming such transactions occurred on the first day of such period.

	8 	Select this language in respect of any Compliance Certificate delivered prior to the last day of the first full Fiscal Quarter ending after the Closing Date.

  
 EXHIBIT C-9

					
	The ratio as of the last day of the first full Fiscal Quarter ending after the Closing Date of (i) Consolidated Adjusted EBITDA for the prior four (4)-Fiscal
Quarter period ending on such date, to (ii) Adjusted Consolidated Cash Interest Expense for such Fiscal Quarter period multiplied by four (4).]9	    
	
	[The ratio as of the last day of the second full Fiscal Quarter ending after the Closing Date of (i) Consolidated Adjusted EBITDA for the prior four (4)-Fiscal
Quarter period ending on such date, to (ii) Adjusted Consolidated Cash Interest Expense for such two (2)-Fiscal Quarter period multiplied by two (2).]10	    
	
	[The ratio as of the last day of the third full Fiscal Quarter ending after the Closing Date of (i) Consolidated Adjusted EBITDA for the prior four (4)-Fiscal
Quarter period ending on such date to (ii) Adjusted Consolidated Cash Interest Expense for such three (3)-Fiscal Quarter period multiplied by four thirds (4/3).]11	    
	
	 [The ratio as of the last day of any other Fiscal Quarter of (i) Consolidated Adjusted EBITDA for the prior four
(4)-Fiscal Quarter period then ending to (ii) Adjusted Consolidated Cash Interest Expense for such four (4)-Fiscal Quarter period.]12
	
   

		
	 (i)     Consolidated Adjusted EBITDA13
	  	$	[    ,    ,    	] 
		
	 (ii)    Adjusted Consolidated Interest Expense
	  	$	[    ,    ,    	] 
		
	 Interest Coverage Ratio: (i) / (ii) =
	  			

					
		
		  	 	Actual:   .    :1.00	  

   

 

	9 	Select this language in respect of the Compliance Certificate delivered in connection with the first full Fiscal Quarter ending after the Closing Date.

	10 	Select this language in respect of the Compliance Certificate delivered in connection with the second full Fiscal Quarter ending after the Closing Date.

	11 	Select this language in respect of the Compliance Certificate delivered in connection with the third full Fiscal Quarter ending after the Closing Date.

	12 	Select this language in respect of any Compliance Certificate delivered in connection with any Fiscal Quarter other than those Fiscal Quarters set forth in footnotes 9,
10 and 11. 

	13 	Please see footnote 3. 

  
 EXHIBIT C-10

			
		 	Required:   .    :1.00
	
	[9. Attached hereto as Exhibit A hereto are statements of reconciliation in respect of the financial statements delivered in respect of the Fiscal [Quarter[s]]
ended [                 ], 20[    ][,[                 ],
20[    ] and [                 ], 20[    ]] [and the Fiscal [Year[s] ended
[                 ], 20[    ][,[                 ],
20[    ] and [                 ], 20[    ]]14.

  

	14 	Insert this certification if, as a result of any change in accounting principles and policies from those used in the preparation of the Historical Financial Statements,
the consolidated financial statements of the Borrower and its Subsidiaries delivered pursuant to Section 5.01(a) or 5.01(b) of the Credit Agreement prior to the date of this Compliance Certificate will differ in any material respect from the
consolidated financial statements that would have been delivered pursuant to such subdivisions had no such change in accounting principles and policies been made and such reconciliation of financial statements is required by GAAP.

  
 EXHIBIT C-11

 SCHEDULE 1.1C TO 
 COMPLIANCE CERTIFICATE 
 Additional Immaterial Domestic Subsidiaries 

  
 EXHIBIT C-12

 [EXHIBIT A TO 
 COMPLIANCE CERTIFICATE 
 FOR THE FISCAL [QUARTER] [YEAR] ENDED
[                 ], 20[    ] 
 Statements of Reconciliation] 

  
 EXHIBIT C-13

 EXHIBIT D-1 TO 
 CREDIT AND GUARANTY AGREEMENT 
 OPINION OF BROWN RUDNICK LLP 

[PROVIDED SEPARATELY] 

  
 EXHIBIT D-1

 EXHIBIT D-2 TO 
 CREDIT AND GUARANTY AGREEMENT 
 OPINION OF RICHARDS, LAYTON & FINGER,
P.A. 
 [PROVIDED SEPARATELY] 

  
 EXHIBIT D-2

 EXHIBIT D-3 TO 
 CREDIT AND GUARANTY AGREEMENT 
 OPINION OF NEWMEYER & DILLION, LLP

 [PROVIDED SEPARATELY] 

  
 EXHIBIT D-3

 EXHIBIT D-4 TO 
 CREDIT AND GUARANTY AGREEMENT 
 OPINION OF BROWNSTEIN HYATT FARBER SCHRECK, LLP

 [PROVIDED SEPARATELY] 

  
 EXHIBIT D-4

 EXHIBIT D-5 TO 
 CREDIT AND GUARANTY AGREEMENT 
 OPINION OF WHYTE HIRSCHBOECK DUDEK S.C.

 [PROVIDED SEPARATELY] 

  
 EXHIBIT D-5

 EXHIBIT E TO 
 CREDIT AND GUARANTY AGREEMENT 
 ASSIGNMENT AND ASSUMPTION AGREEMENT

 This Assignment and Assumption Agreement (the “Assignment”) is dated as of the Effective Date set forth
below and is entered into by and between the assignor named below (the “Assignor”) and the assignee named below (the “Assignee”). Capitalized terms used but not defined herein shall have the meanings given to them
in the Credit Agreement identified below, receipt of a copy of which is hereby acknowledged by the Assignee. The Standard Terms and Conditions set forth in Annex 1 attached hereto are hereby agreed to and incorporated herein by reference and made a
part of this Assignment as if set forth herein in full. 
 For an agreed consideration, the Assignor hereby irrevocably sells
and assigns to the Assignee, and the Assignee hereby irrevocably purchases and assumes from the Assignor, subject to and in accordance with the Standard Terms and Conditions and the Credit Agreement, as of the Effective Date inserted by the
Administrative Agent as contemplated below, (i) all of the Assignor’s rights and obligations in its capacity as a Lender under the Credit Agreement and any other documents or instruments delivered pursuant thereto to the extent related to
the amount and percentage interest identified below of all of the Assignor’s outstanding rights and obligations under the respective facilities identified below (including without limitation any letters of credit, guarantees and swingline loans
included in such facilities ), and (ii) to the extent permitted to be assigned under applicable law, all claims, suits, causes of action and any other right of the Assignor (in its capacity as a Lender) against any Person, whether known or
unknown, arising under or in connection with the Credit Agreement, any other documents or instruments delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the foregoing, including, but not
limited to, contract claims, tort claims, malpractice claims, statutory claims and all other claims at law or in equity related to the rights and obligations sold and assigned pursuant to clause (i) above (the rights and obligations sold and
assigned by the Assignor to the Assignee pursuant to clauses (i) and (ii) above being referred to herein collectively as the “Assigned Interest”). Such sale and assignment is without recourse to the Assignor and, except as
expressly provided in this Assignment and the Credit Agreement, without representation or warranty by the Assignor. 
  

					
	 1.      Assignor:
	  	  
	  	
			
		  	[Assignor is not a Defaulting Lender]	  	

  
 EXHIBIT E-1

			
	 2.      Assignee:
	  	
                         
                [and is an Affiliate/Related Fund of [identify Lender]]
  

Markit Entity Identifier (if any):

		
		  	
_______________________                      
                  

		
	 3.      Borrower:
	  	Hologic, Inc., a Delaware corporation
		
	 4.      Administrative Agent:
	  	Goldman Sachs Bank USA, as the administrative agent under the Credit Agreement
		
	 5.      Credit Agreement:
	  	The Credit and Guaranty Agreement dated as of [            ], 2012 (as it may be refinanced, amended, restated,
amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) by and among the Borrower, certain subsidiaries of the Borrower, as guarantors, the Lenders party thereto from time to time and
Goldman Sachs Bank USA, as administrative agent and collateral agent.
		
	 6.      Assigned Interest:
	  	

  

													
	 Facility Assigned
	  	Aggregate Amount 
of
Commitment/Loans
for all Lenders	 	  	Amount of
Commitment/Loans
Assigned	 	  	Percentage Assigned
of
Commitment/Loans15	 
	
                       16
	  	$	            	  	  	$	            	  	  	 	        	% 
		  	$	            	  	  	$	            	  	  	 	        	% 
		  	$	            	  	  	$	            	  	  	 	        	% 

 Effective Date:             , 201     [TO
BE INSERTED BY THE ADMINISTRATIVE AGENT AND WHICH SHALL BE THE EFFECTIVE DATE OF RECORDATION OF TRANSFER IN THE REGISTER THEREFOR.] 

 

	15 	Set forth, to at least 9 decimals, as a percentage of the Commitment/Loans of all Lenders thereunder. 

	16 	Fill in the appropriate terminology for the types of facilities under the Credit Agreement that are being assigned under this Assignment (e.g. “Revolving
Commitment,” “Tranche A Term Loans” or “Tranche B Term Loans”). 

  
 EXHIBIT E-2

	7.	Notice and Wire Instructions: 

  

									
	[NAME OF ASSIGNOR]	 		 	[NAME OF ASSIGNEE]
					
	Notices:	 		 		 	Notices:	 	
					
		 	  
	 		 		 	  

		 	  
	 		 		 	  

		 	  
	 		 		 	  

		 	 Attention:

Telecopier:
	 		 		 	 Attention:

Telecopier:

			
	with a copy to:	 		 	with a copy to:
					
		 	  
	 		 		 	  

		 	  
	 		 		 	  

		 	  
	 		 		 	  

		 	 Attention:

Telecopier:
	 		 		 	 Attention:

Telecopier:

			
	Wire Instructions:	 		 	Wire Instructions:

  
 EXHIBIT E-3

 The terms set forth in this Assignment are hereby agreed to: 

 

			
	 ASSIGNOR
 [NAME OF
ASSIGNOR]

		
	By:	 	  

		 	Title:
	
	 ASSIGNEE
 [NAME OF
ASSIGNEE]

		
	By:	 	  

		 	Title:

 [Consented to and]17 Accepted: 
  

			
	GOLDMAN SACHS BANK USA,
	as Administrative Agent
		
	By:	 	  

	Authorized Signatory

 [Consented to:]18 
  

			
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  

	17 	To be added only if the consent of the Administrative Agent is required by the terms of the Credit Agreement. 

	18 	To be added only if the consent of the Borrower is required by the terms of the Credit Agreement. 

  
 EXHIBIT E-4

 ANNEX 1 
 STANDARD TERMS AND CONDITIONS FOR ASSIGNMENT 
 AND ASSUMPTION AGREEMENT 

 

	1.	Representations and Warranties. 

  

	 	1.1	Assignor. The Assignor (a) represents and warrants that (i) it is the legal and beneficial owner of the Assigned Interest, (ii) the Assigned
Interest is free and clear of any lien, encumbrance or other adverse claim, (iii) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and to consummate the transactions contemplated hereby
and (iv) it is not a Defaulting Lender; and (b) assumes no responsibility with respect to (i) any statements, warranties or representations made in or in connection with any Credit Document, (ii) the execution, legality,
validity, enforceability, genuineness, sufficiency or value of the Credit Agreement or any other instrument or document delivered pursuant thereto, other than this Assignment (herein collectively the “Credit Documents”), or any
collateral thereunder, (iii) the financial condition of the Borrower, any of its Subsidiaries or Affiliates or any other Person obligated in respect of any Credit Document or (iv) the performance or observance by the Borrower, any of its
Subsidiaries or Affiliates or any other Person of any of their respective obligations under any Credit Document. 

  

	 	1.2	 Assignee. The Assignee (a) represents and warrants that (i) it has full power and authority, and has taken all action necessary, to
execute and deliver this Assignment and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement, (ii) it meets all requirements of an Eligible Assignee under the Credit Agreement, (iii) from and
after the Effective Date, it shall be bound by the provisions of the Credit Agreement and, to the extent of the Assigned Interest, shall have (in addition to any such rights and obligations then otherwise held by it) the rights and obligations of a
Lender thereunder, (iv) it is sophisticated with respect to decisions to acquire assets of the type represented by the Assigned Interest and either it, or the Person exercising discretion in making its decision to acquire the Assigned Interest,
is experienced in acquiring assets of such type, (v) it has received a copy of the Credit Agreement, and has received or has been accorded the opportunity to receive copies of the most recent financial statements delivered pursuant to
Section 5.01(a) and (b) thereof, as applicable, and such other documents 

  
 EXHIBIT E-5

	 	
and information as it has deemed appropriate to make its own credit analysis and decision to enter into this Assignment and to purchase the Assigned Interest, (vi) it has, independently and
without reliance upon the Administrative Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its own credit analysis and decision to enter into this Assignment and to purchase the Assigned
Interest, and (vii) if it is a Non-US Lender, attached to this Assignment is any documentation required to be delivered by it pursuant to the terms of the Credit Agreement, duly completed and executed by the Assignee; and (b) agrees that
(i) it will, independently and without reliance on the Administrative Agent, the Assignor or any other Lender, and based on such documents and information as it shall deem appropriate at that time, continue to make its own credit decisions in
taking or not taking action under the Credit Documents, and (ii) it will perform in accordance with their terms all of the obligations which by the terms of the Credit Documents are required to be performed by it as a Lender.

  

	2.	Payments. All payments with respect to the Assigned Interests shall be made on the Effective Date as follows: 

 

	 	2.1	From and after the Effective Date, the Administrative Agent shall make all payments in respect of the Assigned Interest (including payments of principal, interest, fees
and other amounts) to the Assignor for amounts which have accrued to but excluding the Effective Date and to the Assignee for amounts which have accrued from and after the Effective Date. Notwithstanding the foregoing, the Administrative Agent shall
make all payments of interest, fees or other amounts paid or payable in kind from and after the Effective Date to the Assignee. 

  

	3.	General Provisions. This Assignment shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors and assigns. This Assignment
may be executed in any number of counterparts, which together shall constitute one instrument. Delivery of an executed counterpart of a signature page of this Assignment by telecopy shall be effective as delivery of a manually executed counterpart
of this Assignment. This Assignment shall be governed by, and construed in accordance with, the law of the State of New York without regard to conflict of laws principles thereof (other than New York General Obligations Law, Section 5-1401).

 [Remainder of page intentionally left blank] 

  
 EXHIBIT E-6

 EXHIBIT F TO 
 CREDIT AND GUARANTY AGREEMENT 
 CERTIFICATE RE NON-BANK STATUS 

Reference is made to the Credit and Guaranty Agreement dated as of
[            ], 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the
terms defined therein and not otherwise defined herein being used herein as therein defined) by and among Hologic, Inc., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower, as Guarantors, the Lenders party
thereto from time to time, Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P.
Morgan Securities LLC and Citigroup Global Markets Inc., as Co-Syndication Agents. 
 Pursuant to Section 2.20(c) of the
Credit Agreement, the undersigned hereby certifies that (i) it is the sole record and beneficial owner of the Loan(s) (as well as any Note(s) evidencing such Loan(s)) in respect of which it is providing this certificate, (ii) it is not a
bank within the meaning of Section 881(c)(3)(A) of the Internal Revenue Code, (iii) it is not a ten percent shareholder of the Borrower within the meaning of Section 881(c)(3)(B) of the Internal Revenue Code and (iv) it is not a
controlled foreign corporation related to the Borrower as described in Section 881(c)(3)(C) of the Internal Revenue Code. 

The undersigned has furnished the Administrative Agent and the Borrower with a certificate of its non-U.S. Person status on Internal
Revenue Service Form W-8BEN. By executing this certificate, the undersigned agrees that (1) if the information provided on this certificate changes, the undersigned shall promptly so inform the Borrower and the Administrative Agent, and
(2) the undersigned shall have at all times furnished the Borrower and the Administrative Agent with a properly completed and currently effective certificate in either the calendar year in which each payment is to be made to the undersigned, or
in either of the two calendar years preceding such payments. 
  

					
	[NAME OF LENDER]
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	

  
 EXHIBIT F-1

 EXHIBIT G-1 TO 
 CREDIT AND GUARANTY AGREEMENT 
 CLOSING DATE CERTIFICATE 

THE UNDERSIGNED HEREBY CERTIFIES AS FOLLOWS: 
 1. I am the chief financial officer of Hologic, Inc., a Delaware corporation (the “Borrower”). 
 2. I have reviewed the terms of Section 3 of the Credit and Guaranty Agreement dated as of [            ], 2012 (as it may be refinanced,
amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the terms defined therein and not otherwise defined herein being used herein as therein defined) by and among the
Borrower, certain Subsidiaries of the Borrower, as Guarantors, the Lenders party thereto from time to time, Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners,
Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Co-Syndication Agents, and the definitions and provisions contained in such Credit Agreement relating thereto,
and in my opinion I have made, or, to the best of my knowledge after due inquiry, have caused to be made under my supervision, such examination or investigation as is necessary to enable me to express an informed opinion as to the matters referred
to herein. 
 3. Based upon my review and examination described in paragraph 2 above, I certify, on behalf of the Borrower, that
as of the date hereof to the best of my knowledge after due inquiry: 
 (i) (a) the representations and
warranties set forth in Section 4.01(a) (other than with respect to the applicable Person being in good standing in each applicable jurisdiction), 4.01(b)(ii), 4.03, 4.04(a)(i), 4.04(a)(ii), 4.06, 4.17(a)(i), 4.17(b), 4.18, 4.22, 4.27, 4.28 and
(subject to the limitations on perfection of security interests set forth in the last paragraph of Section 3.01(i)) 4.29, and, with respect to the Borrower only, Section 4.07 of the Credit Agreement and (b) the Acquisition Agreement
Representations are true and correct in all material respects on and as of the Closing Date; provided that, in each case, such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or
modified by materiality in the text thereof; 
 (ii) since December 31, 2011, no change, effect, event or
circumstance has occurred that has had, or would reasonably be expected to have, individually or in the aggregate, an Acquired Business Material Adverse Effect; 

  
 EXHIBIT G-1-1

 (iii) On the Closing Date, the Borrower and its Subsidiaries have
outstanding no Indebtedness or preferred stock other than (i) the Loans and other Credit Extensions under the Credit Agreement, (ii) the [Senior Notes] [and Bridge Loans], (iii) the Convertible Notes, (iv) Capital Leases,
(v) Indebtedness described in Schedule 6.01 of the Credit Agreement and other Indebtedness permitted under Section 6.01 of the Credit Agreement in an aggregate principal amount not to exceed $25,000,000 and (vi) Indebtedness permitted
by the Acquisition Agreement; and 
 (iv) Each Credit Party has obtained all Governmental Authorizations and all
consents of other Persons, in each case that are necessary in connection with the transactions contemplated by the Credit Documents and the Related Agreements and each of the foregoing are in full force and effect and in form and substance
reasonably satisfactory to the Administrative Agent and the Lead Arrangers. All applicable waiting periods have expired without any action being taken or threatened by any competent authority which would restrain, prevent or otherwise impose adverse
conditions on the transactions contemplated by the Credit Documents or the Related Agreements or the financing thereof and no action, request for stay, petition for review or rehearing, reconsideration or appeal with respect to any of the foregoing
shall be pending, and the time for any applicable agency to take action to set aside its consent on its own motion has expired. 

4. Attached as Annex A hereto are true and complete (and, where applicable, executed and conformed) copies of each of the Related
Agreements. 
 5. Each Credit Party has requested (i) Brown Rudnick LLP to deliver to the Agents and Lenders on the Closing
Date favorable written opinions setting forth substantially the matters in the opinions designated in Exhibit D-1, annexed to the Credit Agreement and (ii) Richards, Layton & Finger, P.A., Newmeyer & Dillion, LLP, Brownstein
Hyatt Farber Schreck, LLP and Whyte Hirschboeck Dudek S.C. to deliver to the Agents and Lenders on the Closing Date favorable written opinions setting forth substantially the matters in the opinions designated in Exhibits D-2, D-3, D-4 and D-5 to
the Credit Agreement, respectively, and in the case of each of clauses (i) and (ii) of this paragraph, as to such other matters as the Administrative Agent may reasonably request. 

6. Attached hereto as Annex B are true, complete and correct copies of (a) the Historical Financial Statements and (b) pro
forma consolidated balance sheets of the Borrower and its Subsidiaries (including, for the avoidance of doubt, 

  
 EXHIBIT G-1-2

 
the Acquired Business and its Subsidiaries) as at the Closing Date reflecting the consummation of the Acquisition, the related financings and the other transactions contemplated by the Credit
Documents to occur on or prior to the Closing Date, which pro forma financial statements shall meet the requirements of Regulation S-X for a Form S-1 Registration Statement except that no footnote pursuant to Regulation S-X 3-10 shall be required
with respect to the Guarantors. 
 The foregoing certifications are made and delivered as of
[            ], 2012. 
  

					
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	Chief Financial Officer

  
 EXHIBIT G-1-3

 Annex A to Closing Date Certificate 

Related Agreements 
 [Attached] 

  
 EXHIBIT G-1-4

 Annex B to Closing Date Certificate 

Historical Financial Statements and Pro Forma Consolidated Balance Sheets 

[Attached] 

  
 EXHIBIT G-1-5

 EXHIBIT G-2 TO 
 CREDIT AND GUARANTY AGREEMENT 
 SOLVENCY CERTIFICATE 

THE UNDERSIGNED HEREBY CERTIFIES AS FOLLOWS: 
 1. I am the chief financial officer of Hologic, Inc., a Delaware corporation (the “Borrower”). 
 2. Reference is made to the Credit and Guaranty Agreement dated as of [            ], 2012 (as it may be refinanced, amended, restated, amended
and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the terms defined therein and not otherwise defined herein being used herein as therein defined) by and among the Borrower, certain
Subsidiaries of the Borrower, as Guarantors, the Lenders party thereto from time to time, Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank
USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Co-Syndication Agents. 
 3. I have reviewed the terms of Sections 3 and 4 of the Credit Agreement and the definitions and provisions contained in the Credit Agreement relating thereto, together with each of the Related
Agreements, and, have made, or have caused to be made under my supervision, such examination or investigation as is in my opinion, necessary to enable me to express an informed opinion as to the matters referred to herein. 

4. Based upon my review and examination described in paragraph 3 above, I certify that as of the date hereof, after giving effect to the
consummation of the Acquisition and other transactions contemplated to occur on or before the Closing Date by the Related Agreements, the related financings and the other transactions contemplated to occur on or before the Closing Date by the Credit
Documents, the Credit Parties are, on a consolidated basis, Solvent. 
 The foregoing certifications are made and delivered as
of [            ], 2012. 
  

					
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	Chief Financial Officer

  
 EXHIBIT G-2-1

 EXHIBIT H TO 
 CREDIT AND GUARANTY AGREEMENT 
 COUNTERPART AGREEMENT 

This COUNTERPART AGREEMENT, dated [            
    ], 20[    ] (this “Counterpart Agreement”) is delivered pursuant to the Credit and Guaranty Agreement dated as of
[            ], 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the
terms defined therein and not otherwise defined herein being used herein as therein defined) by and among Hologic, Inc., a Delaware corporation (the “Borrower”), certain Subsidiaries of the Borrower, as Guarantors, the Lenders party
thereto from time to time, Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P.
Morgan Securities LLC and Citigroup Global Markets Inc., as Co-Syndication Agents. 
 Section 1. Pursuant to
Section 5.10 of the Credit Agreement, the undersigned hereby: 
 (a) agrees that this Counterpart Agreement
may be attached to the Credit Agreement and that by the execution and delivery hereof, the undersigned becomes a Guarantor under the Credit Agreement and agrees to be bound by all of the applicable terms thereof; 

(b) represents and warrants that each of the representations and warranties contained in Sections 4.01, 4.02, 4.03, 4.04,
4.06, 4.13, 4.17, 4.22, 4.27 and 4.29 the Credit Agreement and each other Credit Documents applicable to the undersigned is true and correct in all material respects on and as of the date hereof both before and after giving effect to this
Counterpart Agreement, except to the extent any such representation or warranty specifically relates to an earlier date, in which case each such representation and warranty is true and correct in all material respects on and as of such earlier date;
provided that, in each case, such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof; 

(d) irrevocably and unconditionally guaranties the due and punctual payment in full of all Obligations when the same shall
become due, whether at stated maturity, by required prepayment, declaration, acceleration, demand or otherwise (including amounts that would become due but for the operation of the automatic stay under Section 362(a) of the Bankruptcy Code, 11
U.S.C. § 362(a)) in accordance with Section 7 of the Credit Agreement; and 

  
 EXHIBIT H-1

 (e) the undersigned hereby (i) agrees that this Counterpart Agreement
may be attached to the Pledge and Security Agreement, (ii) agrees that the undersigned will comply with all the terms and conditions of the Pledge and Security Agreement as if it were an original signatory thereto, (iii) pursuant to the
terms of, and subject to the exceptions contained in, the Pledge and Security Agreement, grants to the Collateral Agent a security interest in all of the undersigned’s right, title and interest in and to all “Collateral” (as such term
is defined in the Pledge and Security Agreement) of the undersigned, in each case whether now or hereafter existing or in which the undersigned now has or hereafter acquires an interest and wherever the same may be located, and (iv) delivers to
Collateral Agent supplements to all schedules attached to the Pledge and Security Agreement. All such Collateral shall be deemed to be part of the “Collateral” and hereafter subject to each of the terms and conditions of the Pledge and
Security Agreement. 
 Section 2. The undersigned agrees from time to time, upon request of the Administrative Agent, to
take such additional actions and to execute and deliver such additional documents and instruments as the Administrative Agent may request to effect the transactions contemplated by, and to carry out the intent of, this Counterpart Agreement. Neither
this Counterpart Agreement nor any term hereof may be changed, waived, discharged or terminated, except by an instrument in writing signed by the party (including, if applicable, any party required to evidence its consent to or acceptance of this
Counterpart Agreement) against whom enforcement of such change, waiver, discharge or termination is sought (provided that this Counterpart Agreement may be modified by the requisite number of Lenders that are required to modify corresponding
terms of the Credit Agreement or the Pledge and Security Agreement, as the case may be). Any notice or other communication herein required or permitted to be given shall be given pursuant to Section 10.01 of the Credit Agreement, and all for
purposes thereof the notice address of the undersigned shall be the address set forth on the signature page hereof. In case any provision of or obligation under this Counterpart Agreement shall be invalid, illegal or unenforceable in any
jurisdiction, the validity, legality and enforceability of the remaining provisions or obligations, or of such provision of or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. 

THIS COUNTERPART AGREEMENT SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW
YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. 
 [Remainder of page intentionally left blank] 

  
 EXHIBIT H-2

 IN WITNESS WHEREOF, the undersigned has caused this Counterpart Agreement to be duly
executed and delivered by its duly authorized officer as of the date above first written. 
  

			
	[NAME OF SUBSIDIARY]
		
	By:	 	  

		 	Name:
		 	Title:

 Address for Notices: 
 Hologic, Inc. 
 35 Crosby Drive 

Bedford, MA 01730 

Attention: Glenn P. Muir, Executive Vice President, Finance and Administration 

Facsimile: +1 781 282-0669 
 with a copy to: 
 Brown Rudnick LLP 

One Financial Center, Boston MA 02111 
 Attention: Philip J. Flink, Esq. 
 Facsimile: +1 617 856-8201 

 

			
	ACKNOWLEDGED AND ACCEPTED,
	as of the date above first written:
	
	GOLDMAN SACHS BANK USA,
	as Administrative Agent and Collateral Agent
		
	By:	 	  

		 	Authorized Signatory

  
 EXHIBIT H-3

 EXHIBIT I TO 
 CREDIT AND GUARANTY AGREEMENT 
 PLEDGE AND SECURITY AGREEMENT 

[Separately Attached] 

  
 EXHIBIT I-1

 EXHIBIT J TO 
 CREDIT AND GUARANTY AGREEMENT 
 JOINDER AGREEMENT 

THIS JOINDER AGREEMENT dated as of [            
    ], 20[    ] (this “Agreement”) by and among [NEW LENDERS] (each a “Lender” and collectively the “Lenders”), HOLOGIC, INC., a Delaware corporation (the
“Borrower”), and GOLDMAN SACHS BANK USA, as Administrative Agent (together with its permitted successors in such capacity, the “Administrative Agent”). 

RECITALS: 

WHEREAS, reference is hereby made to the Credit and Guaranty Agreement dated as of
[            ], 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”; the
terms defined therein and not otherwise defined herein being used herein as therein defined) by and among the Borrower, certain Subsidiaries of the Borrower, as Guarantors, the Lenders party thereto from time to time, Goldman Sachs Bank USA, J.P.
Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets
Inc., as Co-Syndication Agents. 
 WHEREAS, subject to the terms and conditions of the Credit Agreement, the
Borrower may request the increase of the existing Revolving Loan Commitments and/or the establishment of New Term Loan Commitments by entering into one or more Joinder Agreements with New Term Loan Lenders and/or New Revolving Loan Lenders, as
applicable. 
 NOW, THEREFORE, in consideration of the premises and agreements, provisions and covenants herein
contained, the parties hereto agree as follows: 
 Each Lender party hereto hereby agrees to commit to provide its respective
Commitment as set forth on Schedule A annexed hereto, on the terms and subject to the conditions set forth below: 
 Each Lender
(i) confirms that it has received a copy of the Credit Agreement and the other Credit Documents, together with copies of the financial statements referred to therein and such other documents and information as it has deemed appropriate to make
its own credit analysis and decision to enter into this Agreement and it is sophisticated with respect to decisions to make loans similar to those contemplated to be made hereunder and it is experienced in making loans

  
 EXHIBIT J-1

 
of such type; (ii) agrees that it will, independently and without reliance upon the Administrative Agent or any other Lender or Agent and based on such documents and information as it shall
deem appropriate at the time, continue to make its own credit decisions in taking or not taking action under the Credit Agreement; (iii) appoints and authorizes the Administrative Agent to take such action as agent on its behalf and to exercise
such powers under the Credit Agreement and the other Credit Documents as are delegated to the Administrative Agent by the terms thereof, together with such powers as are reasonably incidental thereto; and (iv) agrees that it will perform in
accordance with their terms all of the obligations which by the terms of the Credit Documents are required to be performed by it as a Lender. 
 Each Lender hereby agrees to make its Commitment on the following terms and conditions: 
 1. Applicable Margin. The Applicable Margin for each Series [    ] New Term Loan shall mean, as of any date of determination, [    ]% per annum. 

2. Principal Payments. The Borrower shall make principal payments on the Series [    ] New Term Loans in
Installments on the dates and in the amounts set forth below: 
  

			
	(A) Payment Date	  	(B) Scheduled Repayment of Series [    ] New Term Loans
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
		  	$            
	 TOTAL
	  	$            

 3. Voluntary and Mandatory Prepayments. Installments of the [Series [    ]]
New Term Loans set forth above shall be reduced in connection with any voluntary or mandatory prepayments of the [Series [    ]] New Term Loans in accordance with Sections 2.12, 2.13 and 2.14 of the Credit Agreement;
provided, 

  
 EXHIBIT J-2

 
that the final Installment payable by the Borrower in respect of the [Series [    ]] New Term Loans on such date shall be in an amount, if such amount is different from the
amount specified above, sufficient to repay all amounts owing by the Borrower under the Credit Agreement with respect to the [Series [    ]] New Term Loans. 

4. Prepayment Fees. The Borrower agrees to pay to each Lender the following prepayment fees, if any:
[                    ].] 

[5. Other Fees. The Borrower agrees to pay each Lender its Pro Rata Share of an aggregate fee equal to
[  ,    ,    .    ] on [                 ], 20[    ].] 

6. Proposed Borrowing. This Agreement represents the Borrower’s request to borrow [Series [    ] New Term
Loans] from the New Term Loan Lenders as follows (the “Proposed Borrowing”): 
  

			
	                 a.        Business Day of
Proposed Borrowing: [                 ], 20[    ]
	
	                 b.        Amount of
Proposed Borrowing: $[    ,    ,    .    ]
		
	                 c.        Interest rate
option:	 	 ̈ Base Rate Loan(s)
		 	 ̈ Eurodollar Rate Loans with an initial Interest Period of [        ]
month(s)

 7. [New Lenders. Each Lender acknowledges and agrees that upon its execution of this Agreement
[and the making of [Series     ] New Term Loans]] that such Lender shall become a “Lender” under, and for all purposes of, the Credit Agreement and the other Credit Documents and shall be subject to and bound by
the terms thereof and shall perform all the obligations of and have all rights of a Lender
thereunder.]19 

8. Credit Agreement Governs. Except as set forth in this Agreement, [New Revolving Loans] [Series [    ] New
Term Loans] shall otherwise be subject to the provisions of the Credit Agreement and the other Credit Documents. 
  

	19 	Insert bracketed language if the lending institution is not already a Lender. 

  
 EXHIBIT J-3

 9. Borrower’s Certifications. By its execution of this Agreement, the
undersigned officer, to the best of his or her knowledge, and the Borrower hereby certify that: 
  

	 	i.	The representations and warranties contained in the Credit Agreement and the other Credit Documents are true and correct in all material respects on and as of the date
hereof to the same extent as though made on and as of the date hereof, except to the extent such representations and warranties specifically relate to an earlier date, in which case such representations and warranties are true and correct in all
material respects on and as of such earlier date; provided that, in each case, such materiality qualifier shall not be applicable to any representations and warranties that already are qualified or modified by materiality in the text thereof;

  

	 	ii.	No event has occurred and is continuing or would result from the [consummation of the Proposed Borrowing] [giving effect to the New Revolving Loan Commitments]
contemplated hereby that would constitute a Default or an Event of Default; and 

  

	 	iii.	Both before and after giving effect to the making of any Series of New Term Loans all conditions set forth in Section 3.02 of the Credit Agreement shall be
satisfied on the date hereof. 

 10. Borrower Covenants. By its execution of this Agreement, the Borrower
hereby covenants that: 
  

	 	i.	[The Borrower shall make any payments required pursuant to Section 2.18(c) of the Credit Agreement in connection with the New Revolving Loan Commitments;]20 

 

	 	ii.	The Borrower shall deliver or cause to be delivered the following legal opinions and documents: 

[                    ], together with
all other legal opinions and other documents reasonably requested by the Administrative Agent in connection with this Agreement; and 
  

	 	iii.	Set forth on the attached Officers’ Certificate are the calculations (in reasonable detail) demonstrating pro forma compliance with each of the covenants set forth

  

	20 	 Insert where the Lender is a New Revolving Lender. 

  
 EXHIBIT J-4

	 	
described in Section 6.07 of the Credit Agreement as of the last day of the most recently ended Fiscal Quarter after giving effect to the [New Revolving Loan Commitments] [New Term Loan
Commitments] (calculated on a pro forma basis as of the last day of such Fiscal Quarter as if all such Commitments had been fully drawn on such date but without netting the proceeds thereof). 

11. Eligible Assignee. By its execution of this Agreement, each Lender represents and warrants that it is an Eligible Assignee.

 12. Notice. For purposes of the Credit Agreement, the initial notice address of each Lender shall be as set forth
below its signature below. 
 13. Non-US Lenders. For each Lender that is a Non-US Lender, delivered herewith to the
Administrative Agent are such forms, certificates or other evidence with respect to United States federal income tax withholding matters as such Lender may be required to deliver to the Administrative Agent pursuant to subsection 2.20(c) of the
Credit Agreement. 
 14. Recordation of the New Loans. Upon execution and delivery hereof, the Administrative Agent will
record the [Series [    ] New Term Loans] [New Revolving Loan Commitments] made by Lenders in the Register. 

15. Amendment, Modification and Waiver. This Agreement may not be amended, modified or waived except by an instrument or
instruments in writing signed and delivered on behalf of each of the parties hereto. 
 16. Entire Agreement. This
Agreement, the Credit Agreement and the other Credit Documents constitute the entire agreement among the parties with respect to the subject matter hereof and thereof and supersede all other prior agreements and understandings, both written and
verbal, among the parties or any of them with respect to the subject matter hereof. 
 17. GOVERNING LAW. THIS AGREEMENT
AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE
APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. 
 18. Severability. Any term or provision of this
Agreement which is invalid or unenforceable in any jurisdiction shall, as to that jurisdiction, be 

  
 EXHIBIT J-5

 
ineffective to the extent of such invalidity or unenforceability without rendering invalid or unenforceable the remaining terms and provisions of this Agreement or affecting the validity or
enforceability of any of the terms or provisions of this Agreement in any other jurisdiction. If any provision of this Agreement is so broad as to be unenforceable, the provision shall be interpreted to be only so broad as would be enforceable.

 19. Counterparts. This Agreement may be executed in counterparts, each of which shall be deemed to be an original, but
all of which shall constitute one and the same agreement. Delivery of an executed signature page to this Agreement by facsimile or other electronic transmission shall be as effective as delivery of a manually signed counterpart of this Agreement.

 [Remainder of page intentionally left blank] 

  
 EXHIBIT J-6

 IN WITNESS WHEREOF, each of the undersigned has caused its duly authorized officer to
execute and deliver this Joinder Agreement as of the date first written above. 
  

			
	[NAME OF NEW LENDER]
		
	By:	 	  

		 	Name:
		 	Title:

 
			
	
	Notice Address:
		
	Attention:	 	
	Telephone:	 	
	Facsimile:	 	
	
	HOLOGIC, INC.

 
			
		
	By:	 	  

		 	Name:
		 	Title:
	
	 GOLDMAN SACHS BANK USA,
     as Administrative Agent

		
	By:	 	  

		 	Authorized Signatory

  
 EXHIBIT J-7

 SCHEDULE A 
 TO JOINDER AGREEMENT 
  

							
	Name of Lender	  	Type of Commitment	  	Amount	 
	
[                        
                ]
	  	[New Term Loan Commitment] [New Revolving Loan Commitment]	  	$	            	  
			
		  	Total:	  	$	            	  

  
 EXHIBIT J-8

 EXHIBIT K TO 
 CREDIT AND GUARANTY AGREEMENT 
 MODIFIED DUTCH AUCTION PROCEDURES

 This Outline is intended to summarize certain basic terms of the modified Dutch auction procedures pursuant to and in
accordance with the terms and conditions of Sections 10.06(i) of the Credit Agreement, of which this Exhibit K is a part (the “Auction Procedures”). It is not intended to be a definitive statement of all of the terms
and conditions of a modified Dutch auction, the definitive terms and conditions for which shall be set forth in the applicable auction procedures set for each Auction (the “Offer Documents”). None of the Administrative
Agent, the Auction Manager and any other Agent, or any of their respective Affiliates, makes any recommendation pursuant to the Offer Documents as to whether or not any Lender should sell its Tranche B Term Loans to Borrower (the
“Purchaser”) pursuant to the Offer Documents, nor shall the decision by the Administrative Agent, the Auction Manager or any other Agent (or any of their Affiliates) in its capacity as a Lender be deemed to constitute
such a recommendation. Each Lender should make its own decision on whether to sell any of its Tranche B Term Loans and, if it decides to do so, the principal amount of and price to be sought for such Tranche B Term Loans. In addition, each Lender
should consult its own attorney, business advisor or tax advisor as to legal, business, tax and related matters concerning this Auction and the Offer Documents. Capitalized terms not otherwise defined in this Exhibit have the meanings assigned to
them in the Credit Agreement. 
 Summary. The Purchaser may conduct one or more modified Dutch auctions in
order to purchase Tranche B Term Loans (each, an “Auction”) pursuant to the procedures described herein. 

Notice Procedures. In connection with each Auction, the Purchaser will provide notification to the Auction Manager (for
distribution to the Lenders) of the Tranche B Term Loans substantially in the form of Annex A to this Exhibit K that will be the subject of the Auction (an “Auction Notice”). Each Auction Notice shall contain (i) the maximum
principal amount of Tranche B Term Loans that the Purchaser is willing to purchase in the Auction (the “Auction Amount”), which shall be no less than $5,000,000 or an integral multiple of $1,000,000 in excess thereof;
(ii) the range of discounts to par (the “Discount Range”), expressed as a range of prices per $1,000 (in increments of $5), at which the Purchaser would be willing to purchase Tranche B Term Loans in the Auction; and
(iii) the date on which the Auction will conclude, on which date Return Bids (as defined below) will be due by 1:00 p.m. New York time, as such date and time may be extended (such time, the “Expiration Time”) for a period
not exceeding three Business Days upon notice by the Purchaser to the Auction Manager received not less than 24 hours before the original Expiration Time; provided, 

  
 EXHIBIT K-1

 
however, that only one extension per offer shall be permitted (unless approved by the Auction Manager). An Auction shall be regarded as a “Failed Auction” in the event
that either (x) Purchaser withdraws such Auction in accordance with the terms hereof or (y) the Expiration Time occurs with no Qualifying Bids having been received. In the event of a Failed Auction, Purchaser shall not be permitted to
deliver a new Auction Notice prior to the date occurring five (5) Business Days after such withdrawal or Expiration Time, as the case may be. 
 Reply Procedures. In connection with any Auction, each Lender holding Tranche B Term Loans wishing to participate in such Auction shall, prior to the Expiration Time, provide the Auction
Manager with a notice of participation substantially in the form of Annex B to this Exhibit K (the “Return Bid”) which shall specify (i) a discount to par expressed as a price per $1,000 (in increments of $5) of Tranche B Term
Loans (the “Reply Price”) within the Discount Range and (ii) the principal amount of Tranche B Term Loans, in an amount not less than $1,000,000 or an integral multiple in excess thereof, that such Lender is willing to offer
for sale at its Reply Price (the “Reply Amount”); provided, that each Lender may submit a Reply Amount that is less than the minimum amount and/or incremental amount requirements described above only if the Reply Amount
comprises the entire amount of Tranche B Term Loans held by such Lender. Lenders may only submit one Return Bid per Auction but each Return Bid may contain up to three component bids, each of which may result in a separate Qualifying Bid (as defined
below) and each of which will not be contingent on any other component bid submitted by such Lender resulting in a Qualifying Bid. In addition to the Return Bid, the participating Lender must execute and deliver, to be held by the Auction
Manager, an Affiliate Assignment Agreement. The Purchaser will not purchase any Tranche B Term Loans at a price that is outside of the applicable Discount Range, nor will any Return Bids (including any component bids specified therein) submitted at
a price that is outside such applicable Discount Range be considered in any calculation of the Applicable Threshold Price (as defined below). 
 Acceptance Procedures. Based on the Reply Prices and Reply Amounts received by the Auction Manager, the Auction Manager, in consultation with the Purchaser, will calculate the lowest
purchase price (the “Applicable Threshold Price”) for the Auction within the Discount Range for the Auction that will allow the Purchaser to complete the Auction by purchasing the full Auction Amount (or such lesser amount of
Tranche B Term Loans for which the Purchaser has received Qualifying Bids (as defined below)). The Purchaser shall purchase Tranche B Term Loans from each Lender whose Return Bid is within the Discount Range and contains a Reply Price that is equal
to or less than the Applicable Threshold Price (each, a “Qualifying Bid”). All Tranche B Term Loans included in Qualifying Bids (including multiple component Qualifying Bids contained in a single Return Bid) received at a Reply
Price lower than the Applicable Threshold Price will be purchased at the applicable Reply Price and shall not be subject to proration. 

  
 EXHIBIT K-2

 Proration Procedures. All Tranche B Term Loans offered in Return Bids (or, if
applicable, any component bid thereof) constituting Qualifying Bids at the Applicable Threshold Price will be purchased at the Applicable Threshold Price; provided that if the aggregate principal amount of all Tranche B Term Loans for which
Qualifying Bids have been submitted in any given Auction at the Applicable Threshold Price would exceed the remaining portion of the Auction Amount (after deducting all Tranche B Term Loans to be purchased below the Applicable Threshold Price), the
Purchaser shall purchase the Tranche B Term Loans for which the Qualifying Bids submitted were at the Applicable Threshold Price ratably based on the respective principal amounts offered and in an aggregate amount equal to the amount necessary to
complete the purchase of the Auction Amount. No Return Bids (or any component thereof) will be accepted above the Applicable Threshold Price. 
 Notification Procedures. The Auction Manager will notify the Purchaser of the Return Bids received and calculate the Applicable Threshold Price and post the Applicable Threshold Price and
proration factor onto an internet site (including an IntraLinks, SyndTrak or other electronic workspace) in accordance with the Auction Manager’s standard dissemination practices by 4:00 p.m. New York time on the same Business Day as the
date the Return Bids were due. The Auction Manager will insert the principal amount of Tranche B Term Loans to be assigned and the applicable settlement date determined by the Auction Manager in consultation with the Purchaser into each applicable
Affiliate Assignment Agreement received in connection with a Qualifying Bid. Upon request of the submitting Lender, the Auction Manager will promptly return any Affiliate Assignment Agreement received in connection with a Return Bid that is not a
Qualifying Bid. 
 Additional Procedures. Once initiated by an Auction Notice, the Purchaser may withdraw an
Auction only in the event that, as of such time, no Qualifying Bid has been received by the Auction Manager. Furthermore, in connection with any Auction, upon submission by a Lender of a Return Bid, such Lender will not have any withdrawal rights.
Any Return Bid (including any component bid thereof) delivered to the Auction Manager may not be modified, revoked, terminated or cancelled by a Lender. However, an Auction may become void if the conditions to the purchase of Tranche B Term Loans by
the Purchaser required by the terms and conditions of Section 10.06(i)(ii) of the Credit Agreement are not met. The purchase price for each purchase of Tranche B Term Loans shall be paid by the Purchaser directly to the respective assigning
Lender on a settlement date as determined by the Auction Manager in consultation with the Purchaser (which shall be no later than ten (10) Business Days after the date Return Bids are due). The Purchaser shall execute each applicable Affiliate
Assignment Agreement received in connection with a Qualifying Bid. 

  
 EXHIBIT K-3

 All questions as to the form of documents and validity and eligibility of Tranche B Term
Loans that are the subject of an Auction will be determined by the Auction Manager, in consultation with the Purchaser, which determination will be final and binding absent manifest error, so long as the determination is not inconsistent with the
applicable terms of the Credit Agreement and this Exhibit K. The Auction Manager’s interpretation of the terms and conditions of the Offer Document, in consultation with the Purchaser, will be final and binding absent manifest error, so long as
the determination is not inconsistent with the applicable terms of the Credit Agreement and this Exhibit K. 
 None of the
Administrative Agent, the Auction Manager, any other Agent or any of their respective Affiliates assumes any responsibility for the accuracy or completeness of the information concerning the Purchaser, the Credit Parties, or any of their Affiliates
(whether contained in the Offer Documents or otherwise) or for any failure to disclose events that may have occurred and may affect the significance or accuracy of such information. 

This Exhibit K shall not require the Purchaser to initiate any Auction. 

  
 EXHIBIT K-4

 Annex A to Exhibit K to 

Credit and Guaranty Agreement 
 AUCTION NOTICE 
 [Hologic, Inc. Letterhead] 

Goldman Sachs Bank USA, as Auction Manager 
 200
West Street 
 New York, NY 10282-2198 

Attention: [                    ] 

Fax No.: [                    ] 

Email: [                    ]@gs.com 

 

	Re:	Tranche B Term Loan Auction 

 Ladies and
Gentlemen: 
 Reference is made to the Credit and Guaranty Agreement, dated as of
[            ], 2012 (as amended from time to time, the “Credit Agreement”), by and among Hologic, Inc., a Delaware corporation (“Borrower”), certain
subsidiaries of Borrower, as guarantors, the lenders party thereto from time to time (the “Lenders”), Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead
Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Co-Syndication Agents. Capitalized terms used but not defined herein have the meanings given to
such terms in the Credit Agreement. 
 Hologic, Inc. (the “Purchaser”) hereby gives notice to the Lenders that
it desires to conduct the following Auction: 
  

	 	•	 	 Auction Amount: $[            ] in principal amount of Tranche B Term Loans

  

	 	•	 	 Discount Range: Not less than $[            ] nor greater than
$[            ] per $1,000 principal amount of Tranche B Term Loans. 

 The Purchaser acknowledges that this Auction Notice may not be withdrawn other than in accordance with the Auction Procedures. The Auction shall be consummated in accordance with the Auction Procedures
with all Return Bids due no later than 1:00 p.m. (New York time) on [            ], 201[    ]. 

The Purchaser hereby represents and warrants that (i) it is not in possession of any information regarding Borrower, its
Subsidiaries or its 

  
 EXHIBIT K-5

 
Affiliates, or their assets, Borrower’s ability to perform its Obligations or any other matter that may be material to a decision by any Lender to participate in any Auction or enter into
any Affiliate Assignment Agreement or any of the transactions contemplated thereby that has not previously been disclosed to the Auction Manager, Administrative Agent and the Non-Public Lenders and (ii) no Default or Event of Default has
occurred and is continuing or would result from such repurchase. 
  

			
	Very truly yours,
	
	HOLOGIC, INC.
		
	By:	 	  

		 	Name:
		 	Title:

  
 EXHIBIT K-6

 Annex B to Exhibit K to 

Credit and Guaranty Agreement 
 RETURN BID 
 Goldman Sachs Bank USA, as Auction Manager 

200 West Street 
 New York, NY 10282-2198

 Attention:
[                    ] 
 Fax
No.: [                    ] 

Email: [                    ]@gs.com

 Ladies and Gentlemen: 
 Reference is made to the Credit and Guaranty Agreement, dated as of [            ], 2012 (as amended from time to time, the “Credit
Agreement”), by and among Hologic, Inc., a Delaware corporation (“Borrower”), certain subsidiaries of Borrower, as guarantors, the lenders party thereto from time to time (the “Lenders”), Goldman Sachs Bank
USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets
Inc., as Co-Syndication Agents. Capitalized terms used but not defined herein have the meanings given to such terms in the Credit Agreement. 
 The undersigned Lender hereby gives notice of its participation in the Auction by submitting the following Return Bid21: 
  

							
	Reply Price 
(price per $1,000)	 	 	Reply
Amount
(principal amount of Tranche B Term
Loans)	 
	US$	 	  	 	US$	 	  
	US$	 	  	 	US$	 	  
	US$	 	  	 	US$	 	  

  

	21 	Lender may submit up to three component bids but need not submit more than one. The sum of Lender’s bid(s) may not exceed the aggregate principal face amount of
Tranche B Term Loans held by it as lender of record on the date of submission of its Return Bid. 

  
 EXHIBIT K-7

 The undersigned Lender acknowledges that the submission of this Return Bid along with an
executed Affiliate Assignment Agreement, to be held in escrow by the Auction Manager, obligates the Lender to sell the entirety or its pro rata portion of the Reply Amount in accordance with the Auction Procedures, as applicable. 

 

			
	Very truly yours,
	
	[NAME OF LENDER]
		
	By:	 	  

		 	Name:
		 	Title:

  
 EXHIBIT K-8

 Annex C to Exhibit K to 

Credit and Guaranty Agreement 
 AFFILIATE ASSIGNMENT AND ASSUMPTION AGREEMENT 
 This Affiliate Assignment
and Assumption Agreement (this “Assignment”) is dated as of the Affiliate Assignment Effective Date set forth below and is entered into by and between [Insert name of Assignor] (the “Assignor”) and Hologic,
Inc., a Delaware Corporation (the “Assignee”). Capitalized terms used but not defined herein shall have the meanings given to them in the Credit Agreement identified below, receipt of a copy of which is hereby acknowledged by the
Assignee. The Standard Terms and Conditions set forth in Annex 1 attached hereto are hereby agreed to and incorporated herein by reference and made a part of this Assignment as if set forth herein in full. 

For an agreed consideration, the Assignor hereby irrevocably sells and assigns to the Assignee, and the Assignee hereby irrevocably
purchases and assumes from the Assignor, subject to and in accordance with the Standard Terms and Conditions and the Credit Agreement, as of the Affiliate Assignment Effective Date inserted by the Auction Manager as contemplated in the Auction
Procedures, (i) all of the Assignor’s rights and obligations in its capacity as a Lender under the Credit Agreement and any other documents or instruments delivered pursuant thereto to the extent related to the amount and percentage
interest identified below of all of the Assignor’s outstanding rights and obligations under the Tranche B Term Loans facility (including without limitation any guarantees thereof), and (ii) to the extent permitted to be assigned under
applicable law, all claims, suits, causes of action and any other right of the Assignor (in its capacity as a Lender) against any Person, whether known or unknown, arising under or in connection with the Credit Agreement, any other documents or
instruments delivered pursuant thereto or the loan transactions governed thereby or in any way based on or related to any of the foregoing, including, but not limited to, contract claims, tort claims, malpractice claims, statutory claims and all
other claims at law or in equity related to the rights and obligations sold and assigned pursuant to clause (i) above (the rights and obligations sold and assigned by the Assignor to the Assignee pursuant to clauses (i) and (ii) above
being referred to herein collectively as the “Assigned Interest”). Such sale and assignment is without recourse to the Assignor and, except as expressly provided in this Assignment and the Credit Agreement, without representation or
warranty by the Assignor. 
  

							
	1.	  	Assignor:	  		  	  

				
	2.	  	Assignee:	  		  	Hologic, Inc., a Delaware corporation Markit Entity Identifier (if any):
				
		  		  		  	  

  
 EXHIBIT K-9

							
	3.	  	Borrower:	  		  	Hologic, Inc., a Delaware corporation
				
	4.	  	Administrative Agent:	  		  	Goldman Sachs Bank USA, as the administrative agent under the Credit Agreement
				
	5.	  	Credit Agreement:	  		  	The Credit and Guaranty Agreement, dated as of [            ], 2012, by and among Hologic, Inc., a Delaware corporation
(“Borrower”), certain subsidiaries of Borrower, as guarantors, the lenders party thereto from time to time, Goldman Sachs Bank USA, as administrative agent and collateral agent.
		
	6.	  	Assignor’s Interest under the Credit Agreement:

  

							
	Aggregate Principal Face Amount
of Tranche B Term Loans of
Assignor	 	 	Percentage of Tranche B Term
Loans
of Assignor22	 
	$	            	  	 	 	        	% 

  

	7.	Assigned Interest: 

 List below
the Tranche B Term Loans to be assigned by Assignor to Assignee, which shall be subject to the terms and conditions of the Auction, including, without limitation, the pro rata reduction procedures set forth in the Auction Procedures. 

 

	22 	 To be completed by Assignor, to at least 9 decimals, as a percentage of the Tranche B Loans of all Lenders thereunder. 

  
 EXHIBIT K-10

															
	Reply Price with respect
to
Tranche B Term
Loans being offered for
assignment to Assignee
(price per $1,000
principal amount)23	 	  	Reply Amount
(principal face
amount
of Tranche B Term
Loans to be
Assigned
to Assignee at relevant
Reply Price) (subject
to pro rata reduction)24	 	  	Pro Rated Principal
Face Amount
of
Tranche B Term
Loans Assigned25	 	  	Percentage Assigned
of Tranche B
Term
Loans26	 
	$	            	  	  	$	            	  	  	$	            	  	  	 	        	% 
	$	            	  	  	$	            	  	  	$	            	  	  	 	        	% 
	$	            	  	  	$	            	  	  	$	            	  	  	 	        	% 

  

	8.	Affiliate Assignment Effective Date:             , 201     [TO BE INSERTED BY
AUCTION MANAGER IN CONSULTATION WITH ASSIGNEE AND WHICH SHALL BE THE AFFILIATE ASSIGNMENT EFFECTIVE DATE OF RECORDATION OF TRANSFER IN THE REGISTER THEREFOR.] 

 

	23 	 To be completed by Assignor. 

	24 	 To be completed by Assignor. The sum of Lender’s Reply Amount(s) may not exceed the aggregate principal face amount of Tranche B Term Loans held
by it as lender of record on the date of submission of its Return Bid. 

	25 	 To be completed by the Auction Manager, if necessary, based on the proration procedures set forth in the Auction Procedures.

	26 	 To be completed by the Auction Manager to at least 9 decimals as a percentage of the Tranche B Term Loans of all Lenders thereunder.

  
 EXHIBIT K-11

	9.	Notice and Wire Instructions: 

  

					
	ASSIGNOR:	 		  	ASSIGNEE:
			
	[NAME OF ASSIGNOR]	 		  	HOLOGIC, INC.
			
	Notices:	 		  	Notices:
			
	  
	 		  	  

	  
	 		  	  

	  
	 		  	  

	Attention:	 		  	Attention:
	Telecopier:	 		  	Telecopier:
			
	with a copy to:	 		  	with a copy to:
			
	  
	 		  	
	  
	 		  	  

	  
	 		  	  

	Attention:	 		  	  

	Telecopier:	 		  	Attention:
		 		  	Telecopier:

 Wire Instructions: 
 The Assignor acknowledges and agrees that (i) submission of a Return Bid in respect of the Tranche B Term Loans will constitute a binding offer by the Assignor to the Assignee in accordance with the
terms and conditions of the Auction Procedures and the Credit Agreement; (ii) Tranche B Term Loans will be deemed to have been accepted by the Assignee to the extent such Tranche B Term Loans are validly offered by the Assignor to the Assignee
in accordance with the terms and conditions of the Auction Procedures and the Credit Agreement upon notification by the Auction Manager to the Assignor that such Tranche B Term Loans are part of a Qualifying Bid (subject to applicable proration in
accordance with the terms and conditions of the Auction); and (iii) it does not have any withdrawal rights with respect to any offer to assign of its Tranche B Term Loans. 

Subject to and effective upon the acceptance by the Assignee for purchase of the principal amount of the Tranche B Term Loans to be
assigned by the Assignor to the Assignee, the Assignor hereby irrevocably constitutes and appoints the Auction Manager as the true and lawful agent and attorney-in-fact of the Assignor with respect to such Tranche B Term Loans, with full powers of
substitution and revocation (such power of attorney being deemed to be an irrevocable power coupled with an interest) to complete or fill-in the blanks in this Assignment and deliver the completed Assignment to the Assignee and the Assignor.

 [Signature page follows] 

  
 EXHIBIT K-12

 The Assignor acknowledges and agrees that its offer to assign Tranche B Term Loans pursuant
to the Auction Procedures constitute the Assignor’s acceptance of the terms and conditions (including the proration procedures) contained in the Auction Procedures, the Credit Agreement and this Assignment. 

The terms set forth in this Assignment are hereby agreed to: 

 

					
	 ASSIGNOR
 [NAME
OF ASSIGNOR]

		
	By:	 	  

		 	Name:	 	
		 	Title:	 	
	
	HOLOGIC, INC., as Assignee and Borrower
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	

  
 EXHIBIT K-13

 Accepted: 
  

					
	GOLDMAN SACHS BANK USA, as Administrative Agent and Auction Manager
		
	By:	 	  

		 	Name:	 	
		 	Title:	 	
		
	 By:
	 	  

		 	Authorized Signatory
		 	Title:	 	

  
 EXHIBIT K-14

 Annex 1 to 
 Affiliate Assignment and Assumption Agreement 
 STANDARD TERMS AND
CONDITIONS FOR AFFILIATE 
 ASSIGNMENT AND ACCEPTANCE 

1. Representations and Warranties. 
 (a) Assignor. The Assignor (i) represents and warrants that (A) it is the legal and beneficial owner of the Assigned Interest, (B) the Assigned Interest is, and on the applicable
Affiliate Assignment Effective Date will be, free and clear of any lien, encumbrance or other adverse claim; (C) it has full power and authority, and has taken all action necessary, to execute and deliver this Assignment and to consummate the
transactions contemplated hereby; (D) it has received a copy of all documents and other information as it has deemed appropriate to make its own decision to enter into this Assignment and to sell and assign the Assigned Interest on the basis of
which it has made such decision and (E) it is not a Defaulting Lender, (ii) assumes no responsibility with respect to (A) any statements, warranties or representations made in or in connection with any Credit Document, (B) the
execution, legality, validity, enforceability, genuineness, sufficiency or value of the Credit Agreement or any other instrument or document delivered pursuant thereto, other than this Assignment (herein collectively the “Credit
Documents”), or any collateral thereunder, (C) the financial condition of Borrower, any of its Subsidiaries or Affiliates or any other Person obligated in respect of any Credit Document or (D) the performance or observance by
Borrower, any of its Subsidiaries or Affiliates or any other Person of any of their respective obligations under any Credit Document, and (iii) has read and agrees to all of the terms and conditions (including the pro ration procedures) of the
Auction Procedures set forth in the Offer Documents. The Assignor will, upon request, execute and deliver any additional documents deemed by Administrative Agent or the Assignee to be necessary or desirable to complete the sale, assignment and
transfer of the Assigned Interest. In the event that the Assignor has determined for itself to not access any information disclosed by Assignee in connection with the Auction or this Assignment, the Assignor acknowledges that (A) other Lenders
may have availed themselves of such information and (B) none of Borrower, the Auction Manager and Administrative Agent has any responsibility for the Assignor’s decision to limit the scope of the information it has obtained in connection
with its evaluation of the Auction or its decision to enter into this Assignment. 
 (b) Assignee. The
Assignee (i) represents and warrants that (A) it has full power and authority, and has taken all action necessary, to 

  
 EXHIBIT K-15

 
execute and deliver this Assignment and to consummate the transactions contemplated hereby and to become a Lender under the Credit Agreement until such time as the Loans are automatically
cancelled without further action by any Person on the Affiliate Assignment Effective Date, (B) it has transmitted same day funds to the Assignor on the Affiliate Assignment Effective Date, (C) it is sophisticated with respect to decisions
to acquire assets of the type represented by the Assigned Interest, (D) it has, independently and without reliance upon Administrative Agent or any other Lender and based on such documents and information as it has deemed appropriate, made its
own credit analysis and decision to enter into this Assignment and to purchase the Assigned Interest, and (E) it is not in possession of any information regarding Borrower, its Subsidiaries or its Affiliates, or their assets, Borrower’s
ability to perform its Obligations or any other matter that may be material to a decision by any Lender (including the Assignor) to participate in any Auction, if applicable, or enter into this Assignment or any of the transactions contemplated
hereby that has not previously been disclosed to the Auction Manager, Administrative Agent and the Lenders (other than any Public Lenders that have elected not to access information disclosed through the Platform or otherwise); and (ii) agrees
that (A) it will, independently and without reliance on the Administrative Agent, the Auction Manager, the Assignor or any other Lender, and based on such documents and information as it shall deem appropriate at that time, continue to make its
own credit decisions in taking or not taking action under the Credit Documents, and (B) it acknowledges that the Assigned Interest shall, from and after the Affiliate Assignment Effective Date, and without further action by any Person, be
deemed cancelled for all purposes and no longer outstanding and that the Assignee shall have no ability to vote or receive payments in respect of the Assigned Interest. 

(c) No Violation of Laws. Each of the Assignor and Assignee acknowledges that it has not violated any applicable
laws relating to this Assignment or the transactions contemplated herein. 
 2. Payments. Payment to the Assignor by the
Assignee in respect of the settlement of the assignment of the Assigned Interest shall be paid by Assignee directly to the Assignor and shall include all unpaid interest that has accrued in respect of the Assigned Interest through the Affiliate
Assignment Effective Date. No interest shall accrue with respect to the Assigned Interest from and after the Affiliate Assignment Effective Date and such Assigned Interest shall, from and after the Affiliate Assignment Effective Date, and without
further action by any Person, be deemed cancelled for all purposes and no longer outstanding. 

  
 EXHIBIT K-16

 3. No Default. On the Affiliate Assignment Effective Date, no Default or Event of
Default has occurred and is continuing or would result from this Assignment. 
 4. General Provisions. This Assignment
shall be binding upon, and inure to the benefit of, the parties hereto and their respective successors and assigns. This Assignment may be executed in any number of counterparts, which together shall constitute one instrument. Delivery of an
executed counterpart of a signature page of this Assignment by telecopy shall be effective as delivery of a manually executed counterpart of this Assignment. This Assignment shall be governed by, and construed in accordance with, the internal laws
of the State of New York without regard to conflict of laws principles thereof that would require the application of laws other than those of the State of New York. 

  
 EXHIBIT K-17

 EXHIBIT L TO 
 CREDIT AND GUARANTY AGREEMENT 
 INCUMBENCY CERTIFICATE 

Reference is made to the Credit and Guaranty Agreement, dated as of
[            ], 2012; the terms defined therein and not otherwise defined herein being used herein as therein defined), by and among Hologic, Inc., a Delaware Corporation (the
“Borrower”), certain Subsidiaries of Borrower, as Guarantors, the Lenders party thereto from time to time, Goldman Sachs Bank USA, J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Joint Lead Arrangers and Joint Lead
Bookrunners, Goldman Sachs Bank USA, as Administrative Agent and Collateral Agent, and J.P. Morgan Securities LLC and Citigroup Global Markets Inc., as Co-Syndication Agents. 
 The following persons are now duly elected and qualified officers of Borrower, each holding the respective office or offices indicated next to his or her name below, and the signature set forth opposite
his or her name below is the true and genuine signature of such officer, and such officer is duly authorized to execute and deliver, on behalf of Borrower, the Credit Documents to which Borrower is a party and any certificate or other document to be
delivered by Borrower pursuant to the Credit Documents: 
  

					
	 Name
	 	 Office
	 	 Signature

			
		 		 	  

			
		 		 	  

			
		 		 	  

			
		 		 	  

			
		 		 	  

 [Remainder of page intentionally left blank] 

  
 EXHIBIT L-1

 IN WITNESS WHEREOF, I have caused this Certificate to be duly executed and delivered as of
the date and at the place first written above. 
  

					
	By:	 	  

		 	Name:	 	
		 	Title:	 	Secretary

  
 EXHIBIT L-2

 CONFIDENTIAL TREATMENT REQUESTED: Certain portions of this document have been omitted
pursuant to a request for confidential treatment and, where applicable, have been marked with an asterisk (“[***]”) to denote where omissions have been made. The confidential material has been filed separately with the Securities and
Exchange Commission. 
 CREDIT AGREEMENT SCHEDULES 

The following Schedules (the “Schedules” or “Disclosure Schedules”) relate to the Credit and Guaranty
Agreement dated August 1, 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Credit Agreement”) by and among Hologic, Inc.
(“Hologic” or the “Borrower”), a Delaware corporation, certain Subsidiaries of Hologic, the Agents party thereto and the Lenders party thereto from time to time, whether by execution of the Credit Agreement or an
Assignment Agreement. 
 Capitalized terms used but not defined herein shall have the same meanings ascribed to them in the
Credit Agreement. 
 The Disclosure Schedules are qualified in their entirety by reference to specific provisions of the Credit
Agreement, and are not intended to constitute, and shall not be construed as constituting, representations or warranties of any Credit Party except and to the extent expressly provided in the Credit Agreement. 

The headings contained in the Disclosure Schedules are included for convenience only and are not intended to limit the effect of the
disclosures contained in the Disclosure Schedules or to expand the scope of the information required to be disclosed in the Disclosure Schedules. 
 The fact that any item or information is disclosed in the Disclosure Schedules shall not be construed to mean that such information is required to be disclosed by the Credit Agreement. The inclusion of an
item in the Disclosure Schedules as an exception to a representation or warranty will not be deemed an admission that such item represents a material exception or material fact, event or circumstance or that such item has had or would reasonably be
expected to have a Material Adverse Effect. 

 SCHEDULE 1.1A 
 ASSET SALES 
 NONE 

 SCHEDULE 1.1B 
 CLOSING DATE MORTGAGED PROPERTIES 
  

							
	 ENTITY OF RECORD
	  	 LOCATION ADDRESS
	  	 OWNED OR

LEASED

	 Gen-Probe Incorporated
	  	 10808 Willow Court
 San Diego, CA 92127
	  	Owned
				
	 Gen-Probe Incorporated
	  	 6333 Sequence Drive
 San
Diego, CA 92121
	  	These
 three

properties
 are

contiguous
	  	Owned
	  	  
 10210 Genetic Center Drive

San Diego, CA 92121
	  	  
	  	  
 Genetic Center Drive / Sequence Drive

San Diego, CA 92121 (undeveloped)
	  	  
			
	 Hologic, Inc.
	  	 600 Technology Drive
 (including Building 600 & Building
 400)

Newark, DE 19702
	  	Owned

 SCHEDULE 1.1C 
 IMMATERIAL DOMESTIC SUBSIDIARIES 
 NONE 

 SCHEDULE 1.1D 
 EXISTING LETTERS OF CREDIT 
  

											
	GEN-PROBE EXISTING LETTERS OF CREDIT
	 Grantor/
 Beneficiary
	  	 Date
	  	Obligor	  	Issued By	  	USD or LC Amt.	  	Denomination
	 J.P. Morgan

Chase Bank,
 NA (UK
 Office)
	  	June 28, 2012	  	Gen-Probe Incorporated

10210 Genetic Center
Drive

San Diego, CA 92121-4362

USA
	  	JP Morgan
Chase Bank	  	1,200,000.00	  	GBP

  

											
	HOLOGIC EXISTING LETTERS OF CREDIT
	 Grantor/
 Beneficiary
	  	 JPM Reference #
	  	 Obligor
	  	 Issued By
	  	 USD or LC Amt.
	  	 Denomination

	 SFERS REAL

ESTATE
 CORP. U
	  	TPTS-248407	  	Hologic, Inc.	  	 JP Morgan
 Chase
Bank
	  	109,908.28	  	USD
	 THE

TRAVELERS
 INDEMNITY
 COMPANY
	  	TPTS-247178	  	Hologic, Inc.	  	 JP Morgan
 Chase
Bank
	  	110,000.00	  	USD
	 THE

TRAVELERS
 INDEMNITY
 COMPANY
	  	TPTS-320846	  	Hologic, Inc.	  	 JP Morgan
 Chase
Bank
	  	1,550,000.00	  	USD
	 Marlborough

Campus Ltd.
	  	T-244779	  	Cytyc Corporation	  	 JP Morgan
 Chase
Bank
	  	500,000.00	  	USD
	 Bayerische

Hypo- und
 VereinsBank
	  	S-647761	  	Cytyc Corporation	  	 JP Morgan
 Chase
Bank
	  	500,000.00	  	Euro

 SCHEDULE 1.1E 
 ACQUIRED BUSINESS NON-CORE ASSETS 
  

	 	•	 	 [***] (and/or any or all of the assets used in connection with the business) or any or all of the stock of [***] or any of their respective
subsidiaries. 

  

	 	•	 	 [***] and other related [***] products and/or intellectual property rights. 

 

	 	•	 	 [***] 

  

	 	•	 	 [***] business (and/or any or all of the assets used in connection with the business) or any or all of the stock of [***] and/or another entity in
which the only material assets are the [***] business. 

  

	 	•	 	 [***] 

  

	 	•	 	 [***] or any or all of the stock of [***] and/or [***]. 

 

	 	•	 	 [***] 

  

	[***]	This redacted material has been omitted pursuant to a request for confidential treatment, and the material has been filed separately with the SEC.

 SCHEDULE 4.01 
 JURISDICTIONS OF ORGANIZATION AND QUALIFICATION, CAPITAL STRUCTURE 
  

			
	 Entity
	 	 Jurisdiction of Organization

	 BioLucent, LLC
	 	Delaware
	 Cruiser, Inc.
	 	Delaware
	 Cytyc Corporation
	 	Delaware
	 Cytyc Development Company LLC
	 	Delaware
	 Cytyc Interim, Inc.
	 	Delaware
	 Cytyc International, Inc.
	 	Delaware
	 Cytyc Limited Liability Company
	 	Delaware
	 Cytyc Prenatal Products Corp.
	 	Delaware
	 Cytyc Securities Corporation
	 	Massachusetts
	 Cytyc Surgical Products, Limited Partnership
	 	Massachusetts
	 Cytyc Surgical Products II, Limited Partnership
	 	Massachusetts
	 Cytyc Surgical Products III, Inc.
	 	Delaware
	 Direct Radiography Corp.
	 	Delaware
	 Hologic, Inc.
	 	Delaware
	 Hologic Investment Corp.
	 	Massachusetts
	 Hologic Limited Partnership
	 	Massachusetts
	 Interlace Medical Inc.
	 	Delaware
	 Sentinelle Medical USA Inc.
	 	Nevada
	 SST Merger Corp.
	 	Delaware
	 Suros Surgical Systems, Inc.
	 	Delaware
	 Third Wave Agbio Inc.
	 	Delaware
	 Third Wave Technologies, Inc.
	 	Delaware
	 Gen-Probe Incorporated
	 	Delaware
	 Gen-Probe GTI Diagnostics Holding Company
	 	Delaware
	 Gen-Probe Holdings, Inc.
	 	Delaware
	 Gen-Probe International, Inc.
	 	Delaware
	 Gen-Probe Sales & Service, Inc.
	 	Delaware
	 Gen-Probe Transplant Diagnostics, Inc.
	 	Delaware
	 Gen-Probe GTI Diagnostics, Inc.
	 	Wisconsin
	 Gen-Probe Prodesse, Inc.
	 	Wisconsin
	 Hologic Hitec-Imaging GmbH (formerly known as AEG Elektrofotografie GmbH)
	 	Germany
	 Cytyc Cayman Limited
	 	Cayman Islands
	 Hologic Asia Pacific Limited
	 	Hong Kong

			
	 Entity
	 	 Jurisdiction of Organization

	 Hologic Asia Limited
	 	Hong Kong
	 Third Wave Japan, Inc.
	 	Japan
	 Hologic (Australia) PTY Ltd.
	 	Australia
	 Hologic Benelux B.V.
	 	Netherlands
	 Hologic Canada Limited
	 	Canada
	 Hologic Deutschland GmbH
	 	Germany
	 Hologic Europe Middle East and Africa S.A.
	 	Switzerland
	 Hologic France SARL
	 	Switzerland
	 Hologic Iberia S.L.
	 	Spain
	 Hologic International Holdings B.V.
	 	Netherlands
	 Hologic Italia S.r.l.
	 	Italy
	 Hologic Surgical Products Costa Rica S.A.
	 	Costa Rica
	 Hologic (UK) Limited
	 	England and Wales
	 R2 Technology Canada, Inc.
	 	Canada
	 Sentinelle Medical Inc. (fka 2247491 Ontario Inc.)
	 	Canada
	 Beijing Healthcome Technology Co., Ltd.
	 	China
	 Navagation Three Limited
	 	Hong Kong
	 TCT International Co. Ltd.
	 	British Virgin Islands
	 Hologic (China) Enterprise Management Consulting Co., Ltd
	 	China
	 Gen-Probe Netherlands B.V.
	 	Netherlands
	 Gen-Probe France SAS
	 	France
	 Gen-Probe Denmark ApS
	 	Denmark
	 Gen-Probe Czech Republic s.r.o.
	 	Czech Republic
	 Gen-Probe Life Sciences Ltd.
	 	UK
	 Gen-Probe Deutschland GmbH
	 	Germany

			
	 Entity
	 	 Jurisdiction of Organization

	 Gen-Probe France Holdings SAS
	 	France
	 Gen-Probe Belgium BVBA
	 	Belgium
	 Tepnel Scientific Services Limited
	 	UK
	 Tepnel Biosystems Limited
	 	UK
	 Tepnel Medical Limited
	 	UK
	 Tepnel Diagnostics Limited
	 	UK
	 Food DNA Services Limited
	 	UK
	 Wildlife DNA Services Limited
	 	UK
	 GTI Diagnostics GmbH
	 	Germany
	 Gen-Probe GTI Diagnostics K.K.
	 	Japan
	 Gen-Probe Diaclone SAS
	 	France
	 Gen-Probe Australia Pty Ltd
	 	Australia
	 Gen-Probe UK Limited
	 	UK
	 Gen-Probe Sweden AB
	 	Sweden

 SCHEDULE 4.02 
 EQUITY INTERESTS AND OWNERSHIP 
  

							
	 Issuer
	  	 Record Owner
	  	 Type of
Organization
	  	 % Owned

	BioLucent, LLC	  	Hologic, Inc.	  	Limited
Liability
Company	  	100%
	Cruiser, Inc.	  	Cytyc
Corporation	  	Corporation	  	100%
	 Cytyc Corporation
 (formerly known as Nor’Easter Corp.)
	  	Hologic, Inc.	  	Corporation	  	100%
	Cytyc Development Company LLC	  	Cytyc
Corporation	  	Corporation	  	100%
	Cytyc Interim, Inc.	  	Cytyc
International,
Inc.	  	Corporation	  	100%
	Cytyc International, Inc.	  	Cytyc
Corporation	  	Corporation	  	100%
	Cytyc Limited Liability Company	  	Cytyc
Corporation	  	Limited
Liability
Company	  	100%
	Cytyc Prenatal Products Corp.	  	Cytyc
Corporation	  	Corporation	  	100%
	Cytyc Securities Corporation	  	Cytyc
Corporation	  	Corporation	  	100%
	Cytyc Surgical Products, Limited Partnership	  	Cytyc
Corporation  

Cruiser, Inc.
  

Cytyc LLC
	  	Limited
Partnership	  	1% General Partner  

1% Limited Partner
  

98% Limited Partner

	Cytyc Surgical Products II, Limited Partnership	  	Cytyc
Corporation  

Cruiser, Inc.
  

Cytyc LLC
	  	Limited
Partnership	  	1% General Partner  

1% Limited Partner
  

98% Limited Partner

	Cytyc Surgical Products III, Inc.	  	Cytyc
Corporation	  	Corporation	  	100%
	Direct Radiography Corp.	  	Hologic, Inc.	  	Corporation	  	100%
	Hologic Investment Corp.	  	Hologic, Inc.	  	Corporation	  	100%

							
	 Issuer
	  	 Record Owner
	  	 Type of
Organization
	  	 % Owned

	Hologic Limited Partnership	  	Cytyc
Corporation  

Cruiser, Inc.
  

Cytyc LLC
	  	Limited
Partnership	  	1% General Partner  

1% Limited Partner
  

98% Limited Partner

	Interlace Medical, Inc.	  	Hologic, Inc.	  	Corporation	  	100%
	Sentinelle Medical USA Inc.	  	Sentinelle
Medical Inc.	  	Corporation	  	100%
	SST Merger Corp.	  	Cytyc
Corporation	  	Corporation	  	100%
	Suros Surgical Systems, Inc.	  	Hologic, Inc.	  	Corporation	  	100%
	Third Wave Agbio, Inc.	  	Third Wave
Technologies,
Inc.	  	Corporation	  	100%
	Third Wave Technologies, Inc.	  	Hologic, Inc.	  	Corporation	  	100%
	Third Wave Japan, Inc.	  	Third Wave
Technologies,
Inc.	  	Japanese
Corporation	  	99%
	 Hologic Hitec-Imaging GmbH
 (formerly known as AEG Elektrofotografie GmbH)
	  	Hologic, Inc.	  	German
Corporation	  	100%
	Cytyc Cayman Limited	  	Cytyc
Corporation	  	Cayman
Corporation	  	100%
	Hologic Asia Pacific Limited	  	Cytyc Interim,
Inc.  

Cytyc
Corporation
  

Cytyc
Corporation
	  	Hong Kong
Limited
Company	  	.1%  
 65%
  
 34.9%

	Hologic Asia Limited	  	Hologic, Inc.  
 Hologic
Europer N.V.
	  	Hong Kong
Limited
Company	  	99%  
 1%

							
	 Issuer
	  	 Record Owner
	  	 Type of
Organization
	  	 % Owned

	Hologic (Australia) PTY Ltd.	  	Cytyc
Corporation	  	Australian
Corporation	  	100%
	Hologic Benelux B.V.	  	Cytyc
Corporation	  	Netherlands
Limited
Company	  	100%
	Hologic Canada Limited	  	Cytyc
Corporation	  	Canadian
Corporation	  	100%
	Hologic Deutschland GmbH	  	Cytyc
Corporation	  	German
Corporation	  	100%
	Hologic Europe Middle East and Africa S.A.	  	Cytyc
Corporation	  	Switzerland
Corporation	  	100%
	Hologic France SARL	  	Cytyc
Corporation	  	Switzerland
Limited
Liability
Corporation	  	100%
	Hologic Iberia S.L.	  	Cytyc
Corporation	  	Corporation	  	100%
	Hologic International Holdings B.V.	  	Hologic, Inc.	  	Dutch
Corporation	  	100%
	Hologic Italia S.r.l.	  	Cytyc
Corporation	  	Italian
Corporation	  	100%

							
	 Issuer
	  	 Record Owner
	  	 Type of
Organization
	  	 % Owned

	Hologic Surgical Products Costa Rica S.A.	  	Hologic
Surgical
Products,
Limited
Partnership (fka
Cytyc Surgical
Products,
Limited
Partnership	  	Costa Rican
Corporation	  	100%
	Hologic (UK) Limited	  	Cytyc
Corporation	  	UK
Corporation	  	100%
	R2 Technology Canada, Inc.	  	Hologic, Inc.	  	Canadian
Corporation	  	100%
	 Sentinelle Medical Inc.
 (formerly known as 2247491 Ontario Inc.)
	  	Hologic, Inc.	  	Canadian
Corporation	  	100%
	Beijing Healthcome Technology Co., Ltd.	  	Hologic, Inc.	  	Chinese
Limited
Company	  	100%
	Navigation Three Limited	  	Hologic, Inc.	  	Hong Kong
Limited
Company	  	100%
	TCT International Co. Ltd.	  	Hologic, Inc.
 Navigation
Three
Limited
	  	British Virgin
Islands
Limited
Company	  	100%

							
	 Issuer
	  	 Record Owner
	 	 Type of
Organization
	  	 % Owned

	Hologic (China) Enterprise Management Consulting Co., Ltd	  	Hologic, Inc.	 	Chinese
Limited
Company	  	100%
	Gen-Probe Incorporated	  	Hologic, Inc.1	 	Corporation	  	100%
	Gen-Probe Sales & Service, Inc.	  	Gen-Probe
Incorporated	 	Corporation	  	100%
	Gen-Probe International, Inc.	  	Gen-Probe
Incorporated	 	Corporation	  	100%
	Gen-Probe Holdings, Inc.	  	Gen-Probe
Incorporated	 	Corporation	  	100%
	Gen-Probe Transplant Diagnostics, Inc.	  	Gen-Probe
Holdings, Inc.	 	Corporation	  	100%
	Gen-Probe Prodesse, Inc.	  	Gen-Probe
Incorporated	 	Corporation	  	100%
	Gen-Probe GTI Diagnostics Holding Company	  	Gen-Probe
Incorporated	 	Corporation	  	100%
	Gen-Probe GTI Diagnostics, Inc.	  	Gen-Probe GTI
Diagnostics
Holding
Company	 	Corporation	  	100%
	Gen-Probe UK Limited	  	Gen-Probe
Incorporated	 	Private
Limited UK
Company	  	100%
	Molecular Light Technology Limited	  	Gen-Probe UK
Limited	 	Private
Limited UK
Company	  	100%

 

	1 	Prior to the Gen-Probe Acquisition, Gen-Probe was a publicly-listed corporation that traded on NASDAQ. 

							
	 Issuer
	  	 Record Owner
	  	 Type of
Organization
	  	 % Owned

	Bioanalysis Limited	  	Molecular
Light
Technology
Limited	  	Private
Limited UK
Company	  	100%
	Gen-Probe Cardiff Ltd.	  	Molecular
Light
Technology
Limited	  	Private
Limited UK
Company	  	100%
	Gen-Probe Australia Pty Ltd	  	Gen-Probe
Incorporated	  	Proprietary
Australian
Company
Limited by
Shares	  	100%
	Gen-Probe Sweden AB	  	Gen-Probe
Incorporated	  	LLC	  	100%
	Gen-Probe Italia S.r.l.	  	Gen-Probe
Incorporated	  	LLC	  	100%
	Gen-Probe Netherlands B.V.	  	Gen-Probe
Incorporated	  	LLC	  	100%
	Gen-Probe France SAS	  	Gen-Probe
Incorporated	  	LLC	  	100%
	Gen-Probe Denmark ApS	  	Gen-Probe
Incorporated	  	LLC	  	100%
	Gen-Probe Czech Republic s.r.o.	  	Gen-Probe
Incorporated	  	LLC	  	100%
	Gen-Probe Life Sciences Ltd.	  	Gen-Probe
Incorporated	  	Private
Limited UK
Company	  	100%
	Gen-Probe Deutschland GmbH	  	Gen-Probe
Incorporated	  	LLC	  	100%

							
	 Issuer
	  	 Record Owner
	  	 Type of
Organization
	  	 % Owned

	Gen-Probe France Holdings SAS	  	Gen-Probe Life
Sciences Ltd.	  	LLC	  	100%
	Gen-Probe Belgium BVBA	  	Gen-Probe
Transplant
Diagnostics,
Inc.	  	LLC	  	100%
	Tepnel Scientific Services Limited	  	Gen-Probe Life
Sciences Ltd.	  	Private
Limited UK
Company	  	100%
	Tepnel Biosystems Limited	  	Gen-Probe Life
Sciences Ltd.	  	Private
Limited UK
Company	  	100%
	Tepnel Medical Limited	  	Gen-Probe Life
Sciences Ltd.	  	Private
Limited UK
Company	  	100%
	Tepnel Diagnostics Limited	  	Gen-Probe Life
Sciences Ltd.	  	Private
Limited UK
Company	  	100%
	Food DNA Services Limited	  	Gen-Probe Life
Sciences Ltd.	  	Private
Limited UK
Company	  	100%
	Wildlife DNA Services Limited	  	Gen-Probe Life
Sciences Ltd.	  	Private
Limited UK
Company	  	100%
	GTI Diagnostics GmbH	  	Gen-Probe GTI
Diagnostics,
Inc.	  	LLC	  	100%
	Gen-Probe GTI Diagnostics K.K.	  	Gen-Probe GTI
Diagnostics,
Inc.	  	Japanese
Stock
Company	  	100%
	Gen-Probe Diaclone SAS	  	Gen-Probe
France
Holdings SAS	  	LLC	  	100%

 SCHEDULE 4.11 
 ADVERSE PROCEEDINGS 
  

	 	•	 	 Enzo Life Sciences, Inc. v. Hologic, Inc., Case No. 1:12-cv-00276-LPS (D. Del.). 

 

	 	¡
 	 	 On March 6, 2012, Enzo Life Sciences, Inc. (“Enzo”) filed a suit against Hologic in the United States District Court of Delaware. In the
complaint, it is alleged that certain of our molecular diagnostics products, including without limitation products based on our proprietary Invader chemistry such as Cervista HPV high risk and Cervista HPV 16/18, infringe Enzo’s U.S. patent
6,992,180. The complaint seeks permanent injunctive relief and unspecified damages. Hologic was formally served with the complaint on July 3, 2012, but no hearing has been scheduled. 

 

	 	•	 	 Enzo Life Sciences Inc. v. Gen-Probe Incorporated, Case No. 1:12-cv-00104-LPS (D. Del.). 

 

	 	¡
 	 	 In January 2012, Gen-Probe was sued by Enzo Life Sciences, Inc. (“Enzo”), in the United States District Court for the District of Delaware.
Enzo alleges that Gen-Probe has infringed United States patent number 6,992,180 through the manufacture and sale of molecular diagnostic assays that incorporate its patented HPA technology. The products alleged to infringe include Gen-Probe’s
APTIMA Combo 2 assay and APTIMA HPV assay. 

  

	 	•	 	 Shareholder Litigation 

  

	 	•	 	 A number of lawsuits have been filed against Hologic, Gen-Probe Incorporated, and Gen-Probe’s board of directors. These include:
(1) Teamsters Local Union No. 727 Pension Fund v. Gen-Probe Incorporated, et al., Case No. 37-2012-00096793-CU-BT-CTL (Superior Court of the State of California for the County of San Diego); (2) Timothy Coyne v. Gen-Probe
Incorporated, et al. (Delaware Chancery Court); (3) Douglas R. Klein v. John W. Brown, et al. (Delaware Chancery Court). 

  

	 	¡
 	 	 The two Delaware actions have been consolidated into a single action titled: In re: Gen-Probe Inc. Shareholders Litigation, Consolidated Civil Action
No. 7495-VCL (Delaware Chancery Court). The suits were filed after the announcement of the Gen-Probe acquisition on April 30, 2012 as putative stockholder class actions. Each of the actions assert similar claims alleging that
Gen-Probe’s board of directors failed to discharge adequately its fiduciary duties to shareholders by failing to adequately value Gen-Probe’s shares and ensure that Gen-Probe’s shareholders received adequate consideration in
Hologic’s proposed acquisition of Gen-Probe, that the Gen-Probe acquisition is the product of a flawed sales process, and that Hologic aided and abetted the alleged breach of fiduciary duty. The plaintiffs demand, among other things, a
preliminary and permanent injunction enjoining the Gen-Probe acquisition and rescinding the transaction or any part thereof that has been implemented. On May 24, 2012, the plaintiffs in the

	 	 
Delaware action filed an amended complaint, adding allegations that the disclosures in Gen-Probe’s preliminary proxy statement were inadequate. The defendants in the Delaware action answered
the complaint on June 4, 2012. On July 18, 2012, the parties in the Delaware action entered into a memorandum of understanding regarding settlement. The proposed settlement is conditioned upon, among other things, the execution of an
appropriate stipulation of settlement, consummation of the merger, and final approval of the proposed settlement by the Delaware Court of Chancery. Also, on May 21, 2012 and May 22, 2012, respectively, the defendants in the California
action filed a motion to stay such action. On July 9, 2012, the Plaintiffs in the California action filed for voluntary dismissal without prejudice. On July 12, 2012 the California Superior Court entered an order dismissing the California
complaint without prejudice. 

  

	 	•	 	 Smith & Nephew, Inc. v. Interlace Medical, Inc., Case No. 1:10-cv-10951-RWZ (D. Mass.) and Smith & Nephew, Inc. v. Hologic,
Inc., Case No. 1:11-cv-12064-RWZ (D. Mass.). 

  

	 	¡
 	 	 On July 16, 2010, Smith & Nephew, Inc. (“Smith & Nephew”) filed suit against Interlace, which Hologic acquired on
January 6, 2011, in the United States District Court for the District of Massachusetts. In the complaint, it is alleged that the Interlace MyoSure hysteroscopic tissue removal device infringes U.S. patent 7,226,459. The complaint seeks
permanent injunctive relief and unspecified damages. A Markman hearing was held November 9, 2010, and a ruling was issued on April 21, 2011. On November 22, 2011, Smith & Nephew, Inc. filed suit against Hologic in the United
States District Court for the District of Massachusetts. In the complaint, it is alleged that use of the MyoSure hysteroscopic tissue removal system infringes U.S. patent 8,061,359. The complaint seeks preliminary and permanent injunctive relief and
unspecified damages. On January 17, 2012, at a hearing on Smith & Nephew’s motion for preliminary injunction with respect to the suit filed November 22, 2011, the judge did not issue an injunction, consolidated the two
matters for a single trial and scheduled a trial on the merits for both claims for June 25, 2012. A case management conference held on February 14, 2012 resulted in the trial being rescheduled to begin on August 20, 2012. On
March 15, 2012, the Court heard summary judgment arguments related to the ‘459 patent and claim construction arguments related to the ‘359 patent. On June 5, 2012, the Court denied Smith & nephew’s request for
summary judgment of infringement, denied Smith & Nephew’s request for preliminary injunction, and denied Hologic’s requests for summary judgment of non-infringement and invalidity. The trial remains scheduled for August 20,
2012. The purchase and sale agreement associated with the acquisition of Interlace includes an indemnification provision that provides for the reimbursement of a portion of legal expenses in defense of the Interlace

	 	 
intellectual property. Hologic has the right to collect certain amounts set aside in escrow and, as applicable, offset contingent consideration payments of qualifying legal costs. Hologic has
recorded legal fees incurred for this suit under the indemnification provision net within accrued expenses. 

  

	 	•	 	 SenoRx, Inc. v. Hologic, Inc., Case No. 1:12-cv-00173-LPS-CJB (D. Del.). 

 

	 	¡
 	 	 On February 10, 2012, SenoRx, Inc. (“SenoRx”) filed a suit against Hologic in the United States District Court of the District of
Delaware. In the complaint, it is alleged that Hologic’s MammoSite product infringes SenoRx’s U.S. patents 8,079,946 and 8,075,469. The complaint seeks permanent injunctive relief and unspecified damages. 

 

	 	•	 	 Alere Mediation 

  

	 	¡
 	 	 During July 2011, Alere, Inc. (“Alere”) contacted Hologic and requested an audit of royalty payments due under a patent license agreement
that had originally been entered into by and between Adeza and Inverness Medical, Inc. (Inverness having been recently acquired by Alere). The patent license licensed certain Inverness patents to Hologic for the fetal fibronectin (fFn) product. On
August 12, 2011, Alere sent a letter to Hologic stating they believed that Hologic underpaid royalties by approximately $400K on its fFn product, and requested payment of $750,000.00 for Hologic’s sale of the Quikcheck fFn product. After
review of the patents under agreement, Hologic believes they do not cover the Quikcheck or fFn products. Hologic sent a letter to Alere on September 9, 2011, informing Alere that it did not intend to make further payments under the license and
requested a meeting to seek a resolution. Counsel for Hologic and Alere met on September 24, 2011 and exchanged names of business contacts. On November 29, 2011, Hologic met with Alere to discuss bases for Hologic’s position regarding
the license agreement; no consensus was reached. On December 12, 2011, Hologic contacted Alere with a proposed settlement involving royalty payments only on the QuikCheck product. On December 16, 2011, Alere’s counsel called to
indicate that they would not consider the settlement and intended to deliver a letter to Hologic in early January, officially notifying Hologic that they believed us in breach of our licensing agreement. On January 16, 2012, Alere forwarded a
letter to Hologic, stating their belief that Hologic is in breach of the license agreement, stating their belief that the fFn products are covered by an additional Alere patent, and providing an alternative settlement proposal, which includes
royalties to the additional patent. On April 30, 2012, Hologic and Alere agreed to mediate the dispute. Mediation is currently scheduled for August 9, 2012. 

 SCHEDULE 4.13(b) 

REAL ESTATE ASSETS 
  

									
	 Entity of
 Record
	  	 Location

Address
	  	 Owned

or
Leased
	  	 Landlord/Owner if Leased
	  	 Description of Lease Documents

					
	Hologic, Inc.	  	 6929 Tylersville Road,
 West
Chester Corporate Center, West Chester, OH
	  	Leased	  	 The Mills Judy Company
 3360
Red Bank Road
 Cincinnati, Ohio 45227
	  	 Lease Term 7/28/2009 to 8/31/2013
  

Original Lease Dated 7/28/09
  
 1 Year Extension 5/10/10
  
 1
Year Extension 5/3/11
  
 1 Year Extension 3/30/12

					
	Cytyc Corporation	  	250 Campus Drive, The Campus at Marlborough, Marlborough, MA 01752	  	Leased	  	 Hines Interest Limited Partnership
 100 Campus Drive
 Marlborough, MA 01752
	  	 Lease Term 1/1/2004 to 12/31/2018
  

Original Lease Dated 12/31/03

					
	Cytyc Corporation	  	445 Simarano Drive, Marlborough, MA 01752	  	Leased	  	 RAM Management, LLC
 445
Simarano Drive
 Marlborough MA 01752
	  	 Lease Term 11/14/2006 to 2/28/2019
  

Original Lease 7/11/06

					
	Cytyc Corporation	  	4 Navigator Road, Londonderry, NH	  	Owned	  	N/A	  	N/A
					
	Cytyc Corporation	  	 14 Aegean Drive,
 Methuen, MA
01844
	  	Leased	  	 AEW LT Acquisition Co. LLC
 c/o
AEW Capital Management
 World Trade Center East, 2 Seaport Lane
 Boston, Ma 02110
	  	 Lease Term 4/1/2003 to 2/28/2018
  

Original Lease 11/21/02
  
 First Amendment 5/23/12

					
	Cytyc Corporation	  	 1240 Elko Drive,
 Sunnyvale, CA
94089
	  	Leased	  	 Tasman Drive, LLC
 c/o
Portfolio Realty Management, Inc.
 4125 Blackford Av.
 Suite 250 San Jose, CA
	  	 Lease Term 7/1/2007 to 3/31/2020
  

Original Lease 5/28/07
  
 First Amendment 2/7/08- Storage Shed
  
 Second Amendment 6/5/08
  
 Third
Amendment 5/12/09
  
 New Lease
4/1/2010

									
	 Entity of
 Record
	  	 Location

Address
	  	 Owned

or
Leased
	  	 Landlord/Owner if Leased
	  	 Description of Lease Documents

					
	Cytyc Surgical Products, Limited Partnership	  	301 East Evelyn Avenue, Mountain View, CA 94039	  	Leased	  	RREEF Asset Manager	  	 Lease Term 9/1/2005 to 8/31/2012
  

Original Lease 5/24/05
  
 Concentric Sublease Document 4/24/07
  
 Expires 8/2012

					
	Hologic, Inc.	  	 600 Technology Drive

(including Building 600 & Building 400)

Newark, DE 19702
	  	Owned	  	N/A	  	N/A
					
	Hologic, Inc.	  	35 Crosby Drive, Bedford, MA 01730	  	Leased	  	 BONE (DE) QRS 15-12, Inc.
 c/o
W.P. Carey & Co. , LLC
	  	 Lease Term 8/22/2002 to 8/31/2022
  

Original Lease 8/22/02

					
	Hologic, Inc.	  	36 Apple Ridge Road, Danbury, CT 06810	  	Leased	  	 BONE (DE) QRS 15-12, Inc.
 c/o
W.P. Carey & Co. , LLC
	  	 Lease Term 8/22/2002 to 8/31/2022
  

Original Lease 8/22/02

					
	Hologic, Inc.	  	37 Apple Ridge Road, Danbury, CT 06810	  	Leased	  	 M&M Realty
 c/o Mel
Powers
	  	 Lease Term 12/26/2095 to 12/31/2017
  

Original Lease 12/20/95
  
 First Addendum 3/96
  
 Second
Addendum 4/96
  
 Third Addendum 5/96

 
 Fourth Addendum 9/05

 
 Fifth Addendum
3/12

									
	 Entity of
 Record
	  	 Location

Address
	  	 Owned

or
Leased
	  	 Landlord/Owner if Leased
	  	 Description of Lease Documents

					
	Suros Surgical Systems, Inc.	  	 6120 Technology
 Center
Drive
 Buildings J, K, & L

Indianapolis, IN 46278
	  	Leased	  	 TCD Associates, LLC
 c/o
Browning Investments
	  	 Lease Term 8/1/2007 to 7/31/2014
  

Original Lease 5/30/07
  
 Addendum 10/24/07

					
	Third Wave Technologies, Inc.	  	502 South Rosa Road, University Research Park, Madison, WI 53719	  	Leased	  	University Research Park, Inc.	  	 Lease Term 7/1/2007 to 9/30/2014
  

Original Lease 7/13/07
  
 Roche Nimblegen Sublease 5/1/08
  

Amendment One 6/5/08

					
	Hologic, Inc.	  	 2585 Augustine Drive,
 Santa
Clara, CA 95054
	  	Leased	  	Arden Realty, Inc.	  	 Lease Term 11/1/2006 to 10/31/2015
  

R2 Original Lease 5/25/06
  
 eASIC Sublease 8/7/07
  
 First
Amendment 1/10/10

					
	Gen-Probe Incorporated	  	10210 Genetic Center Drive, San Diego, CA 92121-4362	  	Owned	  	N/A	  	N/A
					
	Gen-Probe Incorporated	  	 6333 Sequence Drive
 San Diego,
CA 92121-4362
	  	Owned	  	N/A	  	N/A

									
	 Entity of
 Record
	  	 Location

Address
	  	 Owned

or
Leased
	  	 Landlord/Owner if Leased
	  	 Description of Lease Documents

					
	Gen-Probe Incorporated	  	 10808 Willow Court
 San Diego,
CA 92127
	  	Owned	  	N/A	  	N/A
					
	Gen-Probe Incorporated	  	20925 Crossroads Circle, Waukesha, WI 53186	  	Leased	  	20925 Crossroads Circle, LLC	  	 Lease Agreement dated June 21, 2002.
  

Letter Agreement dated November 21, 2002.
  

Letter Agreement dated February 16, 2004.
  

First Amendment to Lease dated April 1, 2007.
  

Assignment of Lease dated June 28, 2011.
  

Second Amendment to Lease dated June 28, 2011.

					
	Gen-Probe Transplant Diagnostics, Inc.	  	 550 West Avenue
 Stamford, CT
06902
	  	Leased	  	West Avenue Realty Associates, L.L.C.	  	 Lease Agreement dated December 15, 1991.
  

First Amendment to Lease dated April 24, 1992.
  

Second Amendment to Lease dated October 30, 1997.
  

Third Amendment to Lease dated August 13, 1998.
  

Fourth Amendment to Lease dated July 30, 1999.
  

Fifth Amendment to Lease dated January 25, 2008.
  

Generator Agreement dated June 23, 2010.

 SCHEDULE 4.13(c) 

INTELLECTUAL PROPERTY LITIGATION 
  

	 	•	 	 Enzo Life Sciences, Inc. v. Hologic, Inc., Case No. 1:12-cv-00276-LPS (D. Del.). 

 

	 	¡
 	 	 On March 6, 2012, Enzo Life Sciences, Inc. (“Enzo”) filed a suit against Hologic in the United States District Court of Delaware. In the
complaint, it is alleged that certain of our molecular diagnostics products, including without limitation products based on our proprietary Invader chemistry such as Cervista HPV high risk and Cervista HPV 16/18, infringe Enzo’s U.S. patent
6,992,180. The complaint seeks permanent injunctive relief and unspecified damages. Hologic was formally served with the complaint on July 3, 2012, but no hearing has been scheduled. 

 

	 	•	 	 Enzo Life Sciences Inc. v. Gen-Probe Incorporated, Case No. 1:12-cv-00104-LPS (D. Del.). 

 

	 	¡
 	 	 In January 2012, Gen-Probe was sued by Enzo Life Sciences, Inc. (“Enzo”), in the United States District Court for the District of Delaware.
Enzo alleges that Gen-Probe has infringed United States patent number 6,992,180 through the manufacture and sale of molecular diagnostic assays that incorporate its patented HPA technology. The products alleged to infringe include Gen-Probe’s
APTIMA Combo 2 assay and APTIMA HPV assay. 

  

	 	•	 	 Smith & Nephew, Inc. v. Interlace Medical, Inc., Case No. 1:10-cv-10951-RWZ (D. Mass.) and Smith & Nephew, Inc. v. Hologic,
Inc., Case No. 1:11-cv-12064-RWZ (D. Mass.). 

  

	 	¡
 	 	 On July 16, 2010, Smith & Nephew, Inc. (“Smith & Nephew”) filed suit against Interlace, which Hologic acquired on
January 6, 2011, in the United States District Court for the District of Massachusetts. In the complaint, it is alleged that the Interlace MyoSure hysteroscopic tissue removal device infringes U.S. patent 7,226,459. The complaint seeks
permanent injunctive relief and unspecified damages. A Markman hearing was held November 9, 2010, and a ruling was issued on April 21, 2011. On November 22, 2011, Smith & Nephew, Inc. filed suit against Hologic in the United
States District Court for the District of Massachusetts. In the complaint, it is alleged that use of the MyoSure hysteroscopic tissue removal system infringes U.S. patent 8,061,359. The complaint seeks preliminary and permanent injunctive relief and
unspecified damages. On January 17, 2012, at a hearing on Smith & Nephew’s motion for preliminary injunction with respect to the suit filed November 22, 2011, the judge did not issue an injunction, consolidated the two
matters for a single trial and scheduled a trial on the merits for both claims for June 25, 2012. A case management conference held on February 14, 2012 resulted in the trial being rescheduled to begin on August 20, 2012. On
March 15, 2012, the Court heard 

	 	 
summary judgment arguments related to the ‘459 patent and claim construction arguments related to the ‘359 patent. On June 5, 2012, the Court denied Smith & nephew’s
request for summary judgment of infringement, denied Smith & Nephew’s request for preliminary injunction, and denied Hologic’s requests for summary judgment of non-infringement and invalidity. The trial remains scheduled for
August 20, 2012. The purchase and sale agreement associated with the acquisition of Interlace includes an indemnification provision that provides for the reimbursement of a portion of legal expenses in defense of the Interlace intellectual
property. Hologic has the right to collect certain amounts set aside in escrow and, as applicable, offset contingent consideration payments of qualifying legal costs. Hologic has recorded legal fees incurred for this suit under the indemnification
provision net within accrued expenses. 

  

	 	•	 	 SenoRx, Inc. v. Hologic, Inc., Case No. 1:12-cv-00173-LPS-CJB (D. Del.). 

 

	 	¡
 	 	 On February 10, 2012, SenoRx, Inc. (“SenoRx”) filed a suit against Hologic in the United States District Court of the District of
Delaware. In the complaint, it is alleged that Hologic’s MammoSite product infringes SenoRx’s U.S. patents 8,079,946 and 8,075,469. The complaint seeks permanent injunctive relief and unspecified damages. 

 

	 	•	 	 Alere Mediation 

  

	 	¡
 	 	 During July 2011, Alere, Inc. (“Alere”) contacted Hologic and requested an audit of royalty payments due under a patent license agreement
that had originally been entered into by and between Adeza and Inverness Medical, Inc. (Inverness having been recently acquired by Alere). The patent license licensed certain Inverness patents to Hologic for the fetal fibronectin (fFn) product. On
August 12, 2011, Alere sent a letter to Hologic stating they believed that Hologic underpaid royalties by approximately $400K on its fFn product, and requested payment of $750,000.00 for Hologic’s sale of the Quikcheck fFn product. After
review of the patents under agreement, Hologic believes they do not cover the Quikcheck or fFn products. Hologic sent a letter to Alere on September 9, 2011, informing Alere that it did not intend to make further payments under the license and
requested a meeting to seek a resolution. Counsel for Hologic and Alere met on September 24, 2011 and exchanged names of business contacts. On November 29, 2011, Hologic met with Alere to discuss bases for Hologic’s position regarding
the license agreement; no consensus was reached. On December 12, 2011, Hologic contacted Alere with a proposed settlement involving royalty payments only on the QuikCheck product. On December 16, 2011, Alere’s counsel called to
indicate that they would not consider the settlement and intended to deliver a letter to Hologic in early January, officially notifying Hologic that they believed us in breach of our licensing agreement. On January 16, 2012, Alere forwarded a
letter to Hologic, stating their belief that Hologic is in breach 

	 	 
of the license agreement, stating their belief that the fFn products are covered by an additional Alere patent, and providing an alternative settlement proposal, which includes royalties to the
additional patent. On April 30, 2012, Hologic and Alere agreed to mediate the dispute. Mediation is currently scheduled for August 9, 2012. 

 SCHEDULE 4.16 
 CONTRACTUAL OBLIGATIONS REQUIRED TO BE FILED BY U.S. SECURITIES LAWS 
 AS EXHIBITS
TO THE PERIODIC REPORTS REQUIRED TO BE FILED WITH THE U.S. 
 SECURITIES AND EXCHANGE COMMISSION EXCEPT FOR EMPLOYMENT AGREEMENTS

 Agreement and Plan of Merger dated April 29, 2012 by and among Hologic, Inc., Gold Acquisition Corp., and Gen-Probe Incorporated.

 Amended and Restated Rights Agreement dated April 2, 2008. 
 Indenture, dated as of December 10, 2007, by and between Wilmington Trust Company, as Trustee, and Hologic. 
 First Supplemental Indenture, dated December 10, 2007, by and between Wilmington Trust Company, as Trustee, and Hologic. 
 Second Supplemental Indenture, dated November 23, 2010, by and between Wilmington Trust Company, as Trustee, and Hologic. 
 Third Supplemental Indenture, dated March 5, 2012, by and between Wilmington Trust Company, as Trustee, and Hologic. 
 Second Amended and Restated 1999 Equity Incentive Plan. 
 Amendment No. 1 to Second Amended
and Restated 1999 Equity Incentive Plan. 
 Amendment No. 2 to Second Amended and Restated 1999 Equity Incentive Plan. 

Amendment No. 3 to Second Amended and Restated 1999 Equity Incentive Plan. 
 2000 Acquisition Equity Incentive Plan. 
 2008 Equity Incentive Plan. 

Form of Employee Stock Option Award Agreement Under 2008 Equity Incentive Plan. 

 Form of Employee Restricted Stock Unit Award Agreement Under 2008 Equity Incentive Plan. 

Form of Special Retention Employee Restricted Stock Unit Award Agreement Under 2008 Equity Incentive Plan. 

Form of Independent Director Stock Option Award Agreement Under 2008 Equity Incentive Plan. 
 Form of Independent Director Restricted Stock Unit Award Agreement Under 2008 Equity Incentive Plan. 
 Amended and Restated 2008 Employee Stock Purchase Plan. 
 Hologic 2011 Short-Term Incentive Plan.

 Cytyc Corporation 1995 Stock Plan. 

Cytyc Corporation 1995 Non-Employee Director Stock Option Plan. 
 Cytyc Corporation 1998 Stock Plan of Pro Duct Health, Inc. 
 Cytyc Corporation 2001 Non-Employee
Director Stock Plan. 
 Cytyc Corporation 2004 Omnibus Stock Plan. 
 Form of Indemnification Agreement (as executed with each director of Hologic). 
 Nonqualified
Deferred Compensation Plan (formerly known as Amended and Restated Supplemental Executive Retirement Plan). 
 Rabbi Trust Agreement.

 Executive Financial Services Program. 
 Facility Lease (Danbury) dated as of December 30, 1995 by and among Melvin J. Powers and Mary P. Powers D/B/A M&N Realty and Lorad. 
 Lease Agreement (Danbury and Bedford) by and between BONE (DE) QRS 15-12, INC., and Hologic dated as of August 28, 2002. 
 First Amendment to Lease Agreement (Danbury and Bedford) by and between BONE (DE) QRS 15-12, INC., and Hologic dated as of October 29, 2007. 

 Office Lease dated December 31, 2003 between Cytyc and Marlborough Campus Limited Partnership.

 Lease Agreement by and between Zona Franca Coyol S.A. and Cytyc Surgical Products Costa Rica S.A. dated April 23, 2007. 

Lease Agreement by and between 445 Simarano Drive, Marlborough LLC and Cytyc dated July 11, 2006. 

Lease Guaranty dated October 22, 2007 between Bel Marlborough I LLC and Hologic, as guarantor thereunder. 

Supply Agreement between Cytyc, Whatman, Inc. and Whatman SA dated as of December 31, 2000, as amended, October 16, 2001 and May 2, 2002.

 Form of Exchange Agreement. 
 Form
of 2012 Exchange Agreement. 
 Hologic, Inc. 2012 Short-Term Incentive Plan 
 Hologic, Inc. 2012 Employee Stock Purchase Plan 
 Commitment Letter, dated April 29, 2012, by
and among Hologic, Inc., Goldman Sachs Bank USA, and Goldman Sachs Lending Partners LLC. 
 Amended and Restated Commitment Letter dated
May 11, 2012 by and among Hologic, Inc., Goldman Sachs Bank USA, Goldman Sachs Lending Partners LLC, JPMorgan Chase Bank, N.A., J.P. Morgan Securities LLC, and Citigroup Global Markets Inc. 

Agreement and Plan of Merger, dated as of April 29, 2012, by and among Gen-Probe Incorporated, Hologic, Inc. and Gold Acquisition Corp. 

Separation and Distribution Agreement, dated May 24, 2002, and amended and restated as of August 6, 2002, between Gen-Probe Incorporated and
Chugai Pharmaceutical Co., Ltd. (now Fujirebio, Inc.). 
 The 2002 New Hire Stock Option Plan of Gen-Probe Incorporated (as last amended on
November 16, 2006). 
 The 2002 New Hire Stock Option Plan Form of Agreement and Grant Notice (as last amended on November 16, 2006).

 The 2003 Incentive Award Plan of Gen-Probe Incorporated (as last amended effective as of May 19, 2011).

 Sixth Amendment to the 2003 Incentive Award Plan of Gen-Probe Incorporated (adopted as of February 8, 2012). 

The 2003 Incentive Award Plan Form of Agreements and Grant Notices (as last amended on February 8, 2007). 

The 2003 Incentive Award Plan Form of Restricted Stock Award Agreement and Grant Notice, as amended. 

The 2003 Incentive Award Plan Form of Performance Stock Award Grant Notice and Performance Stock Award Agreement. 

Employee Stock Purchase Plan of Gen-Probe Incorporated, as amended. 
 Gen-Probe Incorporated 2007 Executive Bonus Plan. 
 Gen-Probe Incorporated 2012 Executive Bonus
Plan. 
 Gen-Probe 2011 Employee Bonus Plan. 
 Gen-Probe 2012 Employee Bonus Plan. 
 Amended and Restated Gen-Probe Incorporated Deferred
Compensation Plan, effective January 1, 2008. 
 Gen-Probe Incorporated Change-In-Control Severance Compensation Plan for Employees.

 Amendment to Gen-Probe Incorporated Change-in-Control Severance Compensation Plan, dated October 2, 2008. 

Restated Agreement dated as of July 24, 2009 by and between Gen-Probe Incorporated and Novartis Vaccines and Diagnostics, Inc. as modified by the
Product Development Addendum for the Panther Instrument and Ultrio Elite Assay signed as of March 11, 2011 by and between Gen-Probe Incorporated and Novartis Vaccines and Diagnostics, Inc. 

Co-Exclusive License Agreement effective as of April 23, 1997 by and between Gen-Probe Incorporated and The Board of Trustees of the Leland Stanford
Junior University, as amended. 

 Non-Assertion Agreement dated February 7, 1997 between Gen-Probe Incorporated and Organon Teknika B.V.

 Development, License and Supply Agreement effective October 16, 2000 between Gen-Probe Incorporated and KMC Systems, Inc. 

First Amendment made as of September, 2001 to Agreement entered into as of October 16, 2000 between Gen-Probe Incorporated and KMC Systems, Inc.

 Supply Agreement effective March 5, 1998 between Gen-Probe Incorporated and Boehringer Mannheim GmbH. 

First Amendment effective February 21, 2001 between Gen-Probe Incorporated and Roche Diagnostics GmbH (the successor-in-interest to Boehringer
Mannheim GmbH) to the Supply Agreement effective as of March 5, 1998 between Gen-Probe Incorporated and Boehringer Mannheim GmbH. 
 Second
Amendment dated August 31, 2004 between Gen-Probe Incorporated and Roche Diagnostics (the successor-in-interest to Boehringer Mannheim GmbH) to the Supply Agreement effective as of March 5, 1998 between Gen-Probe Incorporated and
Boehringer Mannheim GmbH. 
 Third Amendment effective January 1, 2007 between Gen-Probe Incorporated and Roche Diagnostics (the
successor-in-interest to Boehringer Mannheim GmbH) to the Supply Agreement effective as of March 5, 1998 between Gen-Probe Incorporated and Boehringer Mannheim GmbH. 
 License, Development and Cooperation Agreement dated November 19, 2003 between Gen-Probe Incorporated and DiagnoCure Inc. 
 Amendment No. 1 to License, Development and Cooperation Agreement effective May 24, 2006 between Gen-Probe Incorporated and DiagnoCure, Inc. 

Amendment No. 2 to License, Development and Cooperation Agreement, effective as of April 28, 2009, between Gen-Probe Incorporated and
DiagnoCure, Inc. 
 Supply and Purchase Agreement effective February 15, 2005 between Gen-Probe Incorporated, F. Hoffman-La Roche Ltd. and
Roche Molecular Systems, Inc. 
 Supply Agreement for Panther Instrument System effective November 22, 2006 between Gen-Probe Incorporated
and STRATEC Biomedical Systems AG. 

 Collaboration Agreement dated as of June 15, 2010 by and between Gen-Probe Incorporated and Pacific
Biosciences of California, Inc. 
 Credit Agreement dated as of February 27, 2009 by and between Gen-Probe Incorporated, as Borrower, and
Bank of America, N.A., as Lender. 
 Security Agreement (Securities) dated as of February 27, 2009 by Gen-Probe Incorporated in favor of
Bank of America, N.A. 
 Amendment to Credit Agreement dated as of March 23, 2009 by and between Gen-Probe Incorporated, as Borrower, and
Bank of America, N.A., as Lender. 
 Amendment No. 2 to Credit Agreement dated as of February 11, 2010 by and between Gen-Probe
Incorporated, as Borrower, and Bank of America, N.A., as Lender. 
 Amendment No. 3 to Credit Agreement dated as of February 10, 2011
by and between Gen-Probe Incorporated, as Borrower, and Bank of America, N.A., as Lender. 
 Amendment No. 4 to Credit Agreement dated as
of June 24, 2011 by and between Gen-Probe Incorporated, as Borrower, and Bank of America, N.A., as Lender. 
 Amendment No. 5 to
Credit Agreement, Amendment No. 1 to Security Agreement and Amendment No. 1 to Pledged Collateral Account Agreement dated as of September 30, 2011 by and between Gen-Probe Incorporated, as Borrower, and Bank of America, N.A., as
Lender. 
 Amendment No. 6 to Credit Agreement dated as of February 10, 2012 by and between Gen-Probe Incorporated, as Borrower, and
Bank of America, N.A., as Lender. 
 Form of Indemnification Agreement between Gen-Probe Incorporated and its Executive Officers and Directors.

 Form of Employee Stock Option Agreement and Grant Notice for use Under the 2003 Incentive Award Plan of Gen-Probe Incorporated (adopted as of
February 8, 2012). 

 SCHEDULE 4.24 
 COMPLIANCE WITH STATUTES 
 NONE 

 SCHEDULE 5.12(c) 

POST-CLOSING REQUIREMENTS 
  

	1.	On or prior to the date that is three (3) Business Days after the Closing Date (or such later date as may be consented to by the Administrative Agent in its
reasonable discretion), delivery to the Collateral Agent of a fully executed and notarized Deed of Trust, in proper form for recording in all appropriate places in all applicable jurisdictions, encumbering the following properties (and all legal
opinions required to be delivered in connection therewith pursuant to the Credit Agreement): 

  

	 	•	 	 10808 Willow Court, San Diego, CA 92127 

	 	•	 	 6333 Sequence Drive, San Diego, CA 92121 

	 	•	 	 10210 Genetic Center Drive, San Diego, CA 92121 

	 	•	 	 That certain undeveloped parcel of land owned by Gen-Probe Incorporated, which parcel is located on the corner of Genetic Center Drive and Sequence
Drive in San Diego, CA 92121 

  

	2.	On or prior to the date that is seven (7) days after the Closing Date (or such later date as may be consented to by the Administrative Agent in its reasonable
discretion), with respect to the Borrower’s product liability insurance policy number ADT20974442304, an endorsement providing for at least thirty (30) days’ (or shorter period as may be consented to by the Administrative Agent in its
reasonable discretion) prior written notice to the Collateral Agent of any modification or cancellation of such policy. 

  

	3.	On or prior to the date that is forty-five (45) days after the Closing Date (or such later date as may be consented to by the Administrative Agent in its
reasonable discretion), with respect to all First-Tier Foreign Subsidiaries whose stock or other equity interests are not certificated, Borrower shall (x) deliver to the Collateral Agent Uncertificated Securities Control Agreements or
(y) register the Collateral Agent as the registered owner of such stock or other equity interests on the books and records of such Subsidiaries. 

  

	4.	On or prior to the date that is forty-five (45) days after the Closing Date (or such later date as may be consented to by the Administrative Agent in its
reasonable discretion), delivery to the Collateral Agent of signature pages of all Foreign Subsidiaries (who are required to sign the Intercompany Note pursuant to the Credit Agreement) to the Intercompany Note. 

 

	5.	On or prior to the date that is forty-five (45) days after the Closing Date (or such later date as may be consented to by the Administrative Agent in its
reasonable discretion), delivery to the Collateral Agent of executed Deposit Account Control Agreements with respect to the following Deposit Accounts: 

					
	 Owner
	  	 Type of Account
	  	 Bank or
Intermediary

	 Cytyc Corporation
	  	Deposit Account	  	Fifth Third Bank  
 38 Fountain
Square Plaza
  

Cincinnati, OH
45263
  

	 Gen-Probe GTI

Diagnostics, Inc.
	  	Deposit	  	Bank of America
Southern
California 355  

	 Gen-Probe

Incorporated
	  	Deposit	  	Bank of America
Southern
California 355  

	 Gen-Probe

Prodesse, Inc.
	  	Deposit	  	Bank of America
Southern
California 355  

	 Gen-Probe Sales

& Service, Inc.
	  	Deposit	  	Bank of America
Southern
California 355  

	 Gen-Probe

Transplant
 Diagnostics, Inc.
	  	Deposit	  	Bank of America
Southern
California 355  

 SCHEDULE 6.01 
 CERTAIN INDEBTEDNESS 
 Indebtedness and Disqualified Equity Interest 

To the extent any former shareholder of any company or other entity has not tendered shares in such company or entity held by such shareholder
immediately prior to the acquisition by Hologic or any of its Subsidiaries of all of the Equity Interests of such company or entity, payment of consideration in respect of such shares. 
 European Line of Credit, European Office Lease and Guarantees and Performance Bonds 

Foreign Line of Credit for the equivalent of $3 million issued by BNP Paribas to Hologic Europe N.V. (“Hologic European Line of
Credit”). As of May 24, 2008, no amounts were outstanding under such line of credit. 
 Guarantee by Hologic, Inc. in favor of BNP
Paribas, guaranteeing the Hologic European Line of Credit. 
 Guarantee by Hologic Europe N.V. in the amount of €171,611 and €23,000
for Office and Storage Lease of Hologic Europe N.V. in favor of Woluwe Corner Property and MULTIMAS N.V., respectively (which amount is the equivalent of 6 months of rental payments for such lease). 

Obligations related to Leases 

Guarantee by Gen-Probe for the Lease Agreement between Deanery Estates Verwaltungs GmbH & Co. Borsigstrasse KG and Gen-Probe Deutschland GmbH.

 Additional indebtedness up to $18.8 million of to be incurred under the following capital leases: 

 

	 	•	 	 Lease Agreement, dated July 11, 2006 between Cytyc and 445 Simarano Dr., Massachusetts, LLC for facility located at 445 Simarano Drive,
Marlborough, MA. 

	 	•	 	 Lease between Zona Frana Coyol S.A. and Cytyc Surgical Products Costa Rica S.A., dated April 23, 2007. 

Guarantees by Hologic for the lease agreements referenced on Schedule 4.13(b) for 445 Simarano Drive, Marlborough, MA. 

Guarantee by Cytyc for lease agreements referenced on Schedule 4.13(b) for (i) the lease agreement dated November 21, 2002 of Cytyc Limited
Partnership with Boston Industrial-Aegean LLC for 14 Aegean Drive, Methuen, MA, as amended and (ii) the lease agreement of Cytyc Surgical Products Limited Partnership with Sfers Real Estate Corp. U dated May 24, 2005 for 301 East Evelyn
Avenue, Mountain View, CA. 

 Guarantee by Cytyc Surgical Products Limited Partnership, dated April 23, 2007 for the lease between
Zona France Coyol S.A. and Cytyc Surgical Products Costa Rica S.A., dated April 23, 2007. 
 Cash collateralization of Cytyc Surgical
Products Costa Rica S.A.’s letter of credit issued by SunTrust Bank. 
 Guarantee by Hologic Europe N.V. in the amount of €171,611 and
€23,000 for Office and Storage Lease of Hologic Europe N.V. in favor of Woluwe Corner Property and MULTIMAS N.V., respectively (which amount is the equivalent of 6 months of rental payments for such lease). 

Other obligations to the extent such obligations constitute Indebtedness under the Credit Agreement 

Pursuant to that certain Non-Exclusive License Agreement by and between Innogenetics N.V. and Third Wave dated January 1, 2006, if Third Wave does
not terminate the Non-Exclusive License Agreement, Third Wave shall pay an additional license fee in the amount of EUR 3.9 million. 
 Letter of
Credit issued by Wells Fargo Bank, N.A. in the face amount of $50,000 to secure certain workers compensation policies. 

 SCHEDULE 6.02 
 CERTAIN LIENS 
 Cash collateralization of Cytyc Surgical Products Costa Rica S.A.’s letter of
credit issued by SunTrust Bank 
 Cytyc Cayman Limited 
 Lien of sellers of the Helica Thermal Coagulator Product Line thereon, pursuant to the terms of that certain Asset Purchase Agreement dated October 25, 2006 between Cytyc Cayman Limited and Helica
Instruments Limited. 

 SCHEDULE 6.03 
 NEGATIVE PLEDGES 
 Specified Minority Interests (as defined in the Pledge and Security Agreement)

 Restrictions contained in the lease agreements set forth on Schedule 4.13(b). 
 Restriction contained in the European Line of Credit referenced in Schedule 6.01. 
 Restrictions
pursuant to the cash collateralization of Cytyc Surgical Products Costa Rica S.A.’s letter of credit issued by SunTrust Bank 

Restrictions contained in any instruments or agreements evidencing or related to the investment by Hologic, Inc. in Sunocine, Inc., including without
limitation, the Investment and Right of First Refusal Agreement in the original principal amount of $3,000,000 convertible into 1,875,000 Series B Preferred shares of Sunocine, Inc. contingent upon Sunocine, Inc. raising an additional $2,000,000
from other investors on or before December 31, 2012. 
 Restrictions contained in any instruments or agreements evidencing or related to
the investment by Hologic, Inc. in Collaborative Health Innovations, Inc., including without limitation, the Convertible Note in the original principal amount of $500,000 in favor of Hologic, Inc. and convertible into shares of Collaborative Health
Innovations, Inc. 

 SCHEDULE 6.04 
 CERTAIN RESTRICTED PAYMENTS 
 NONE 

 SCHEDULE 6.05 
 RESTRICTIONS ON SUBSIDIARY DISTRIBUTIONS 
 Restrictions on making distributions contained in the
European Line of Credit (as referenced in Schedule 6.01) which such restrictions are triggered upon the occurrence of an event of default. 

 SCHEDULE 6.06(k) 

INVESTMENTS 
 Investment by
Hologic, Inc. in Collaborative Health Innovations, Inc. evidenced by a Convertible Note in the original principal amount of $500,000 in favor of Hologic, Inc. and convertible into shares of Collaborative Health Innovations, Inc. 

Investment by Hologic, Inc. in Sunocine, Inc. evidenced by a Investment and Right of First Refusal Agreement in the original principal amount of
$3,000,000 convertible into 1,875,000 Series B Preferred shares of Sunocine, Inc. contingent upon Sunocine, Inc. raising an additional $2,000,000 from other investors on or before December 31, 2012. 

Specified Minority Interests (as defined in the Pledge and Security Agreement). 
 To the extent such conversion constitutes a new or separate Investment, conversion of any or all Indebtedness owed by Sentinelle Medical Inc. to Hologic, Inc. into Equity Interests of Sentinelle Medical
Inc. issued to Hologic, Inc. 

 SCHEDULE 6.09 
 SALE AND LEASEBACKS 
  

	 	•	 	 Lease Agreement between BONE (DE) QRS 15-12, INC. and Hologic, dated August 28, 2002, as amended by that certain First Amendment to Lease
Agreement dated October, 29, 2007 and as such may be further amended. 

  

	 	•	 	 Lease between Zona Frana Coyol S.A. and Cytyc Surgical Products Costa Rica S.A., dated April 23, 2007 

 

	 	•	 	 Lease between 445 Simarano Drive, Marlborough LLC and Cytyc, dated July 11, 2006 

 SCHEDULE 6.10 
 CERTAIN AFFILIATE TRANSACTIONS 
 NONE<![CDATA[Pledge & Security Agreement ]]>

 Exhibit 10.2 
 Execution Version 
 PLEDGE AND SECURITY AGREEMENT 

dated as of August 1, 2012 between 
 EACH OF THE GRANTORS PARTY HERETO 
 and 

GOLDMAN SACHS BANK USA, 
 as Collateral Agent 

 TABLE OF CONTENTS 

 

							
	 	 	 	  	PAGE	 
			
		 	ARTICLE 1	  			
		 	DEFINITIONS; GRANT OF SECURITY	  			
			
	 Section 1.01.
	 	 General Definitions
	  	 	2	  
	 Section 1.02.
	 	 Definitions; Interpretation
	  	 	9	  
			
		 	ARTICLE 2	  			
		 	GRANT OF SECURITY	  			
			
	 Section 2.01.
	 	 Grant of Security
	  	 	10	  
	 Section 2.02.
	 	 Certain Limited Exclusions
	  	 	11	  
			
		 	ARTICLE 3	  			
		 	SECURITY FOR OBLIGATIONS; GRANTORS REMAIN LIABLE	  			
			
	 Section 3.01.
	 	 Security for Obligations
	  	 	13	  
	 Section 3.02.
	 	 Continuing Liability Under Collateral
	  	 	13	  
			
		 	ARTICLE 4	  			
		 	CERTAIN PERFECTION REQUIREMENTS	  			
			
	 Section 4.01.
	 	 Delivery Requirements
	  	 	14	  
	 Section 4.02.
	 	 Control Requirements
	  	 	15	  
	 Section 4.03.
	 	 Intellectual Property Recording Requirements
	  	 	16	  
	 Section 4.04.
	 	 Other Actions
	  	 	17	  
	 Section 4.05.
	 	 Timing and Notice
	  	 	18	  
			
		 	ARTICLE 5	  			
		 	REPRESENTATIONS AND WARRANTIES	  			
			
	 Section 5.01.
	 	 Grantor Information & Status
	  	 	18	  
	 Section 5.02.
	 	 Collateral Identification, Special Collateral
	  	 	19	  
	 Section 5.03.
	 	 Ownership Of Collateral And Absence Of Other Liens
	  	 	20	  
	 Section 5.04.
	 	 Status of Security Interest
	  	 	21	  
	 Section 5.05.
	 	 Goods and Receivables
	  	 	22	  
	 Section 5.06.
	 	 Pledged Equity Interests, Investment Related Property
	  	 	23	  
	 Section 5.07.
	 	 Intellectual Property
	  	 	23	  
	 Section 5.08.
	 	 Miscellaneous
	  	 	25	  

  
 i 

							
	 	 	ARTICLE 6	  	 	 
		 	COVENANTS AND AGREEMENTS	  			
			
	 Section 6.01.
	 	 Grantor Information and Status
	  	 	25	  
	 Section 6.02.
	 	 Collateral Identification; Special Collateral
	  	 	25	  
	 Section 6.03.
	 	 Ownership of Collateral and Absence of Other Liens
	  	 	26	  
	 Section 6.04.
	 	 Status of Security Interest
	  	 	26	  
	 Section 6.05.
	 	 Goods & Receivables
	  	 	27	  
	 Section 6.06.
	 	 Pledged Equity Interests, Investment Related Property
	  	 	29	  
	 Section 6.07.
	 	 Intellectual Property
	  	 	32	  
	 Section 6.08.
	 	 Miscellaneous
	  	 	33	  
			
		 	ARTICLE 7	  			
		 	ACCESS; RIGHT OF INSPECTION AND FURTHER ASSURANCES;
ADDITIONAL GRANTORS	  			
			
	 Section 7.01.
	 	 Access; Right of Inspection
	  	 	34	  
	 Section 7.02.
	 	 Further Assurances
	  	 	34	  
	 Section 7.03.
	 	 Additional Grantors
	  	 	35	  
			
		 	ARTICLE 8	  			
		 	COLLATERAL AGENT APPOINTED ATTORNEY-IN-FACT	  			
			
	 Section 8.01.
	 	 Power of Attorney
	  	 	36	  
	 Section 8.02.
	 	 No Duty On The Part Of Collateral Agent Or Secured Parties
	  	 	37	  
	 Section 8.03.
	 	 Appointment Pursuant to Credit Agreement
	  	 	37	  
			
		 	ARTICLE 9	  			
		 	REMEDIES	  			
			
	 Section 9.01.
	 	 Generally
	  	 	37	  
	 Section 9.02.
	 	 Application of Proceeds
	  	 	39	  
	 Section 9.03.
	 	 Sales on Credit
	  	 	40	  
	 Section 9.04.
	 	 Investment Related Property
	  	 	40	  
	 Section 9.05.
	 	 Grant of Intellectual Property License
	  	 	41	  
	 Section 9.06.
	 	 Intellectual Property
	  	 	41	  
	 Section 9.07.
	 	 Cash Proceeds; Deposit Accounts
	  	 	43	  

  
 ii 

	
	ARTICLE 10
	COLLATERAL AGENT
	
	ARTICLE 11
	CONTINUING SECURITY INTEREST; TRANSFER OF LOANS
	
	ARTICLE 12
	STANDARD OF CARE; COLLATERAL AGENT MAY
PERFORM
	
	ARTICLE 13
	MISCELLANEOUS

  

	
	
	 SCHEDULE 1.01A — CLOSING DATE MINORITY INVESTMENTS

	
	 SCHEDULE 5.01 — GENERAL INFORMATION

	
	 SCHEDULE 5.02 — COLLATERAL IDENTIFICATION

	
	 SCHEDULE 5.04 — FINANCING STATEMENTS

	
	 SCHEDULE 5.05 — LOCATION OF EQUIPMENT AND INVENTORY

	
	 SCHEDULE 5.06 — PLEDGED EQUITY INTERESTS

	
	 SCHEDULE 5.07 — INTELLECTUAL PROPERTY

	
	 SCHEDULE 5.08 — CONSENTS

	
	 EXHIBIT A — PLEDGE SUPPLEMENT

	
	 EXHIBIT B — UNCERTIFICATED SECURITIES CONTROL AGREEMENT

	
	 EXHIBIT C — SECURITIES ACCOUNT CONTROL AGREEMENT

	
	 EXHIBIT D — DEPOSIT ACCOUNT CONTROL AGREEMENT

	
	 EXHIBIT E — TRADEMARK SECURITY AGREEMENT

	
	 EXHIBIT F — COPYRIGHT SECURITY AGREEMENT

	
	 EXHIBIT G — PATENT SECURITY AGREEMENT

  
 iii

 This PLEDGE AND SECURITY AGREEMENT dated as of August 1, 2012 between Hologic,
Inc. (the “Borrower”) and certain domestic subsidiaries of the Borrower party hereto from time to time, whether as an original signatory hereto or as an Additional Grantor (as herein defined) (other than the Collateral Agent, each,
a “Grantor”), and Goldman Sachs Bank USA, as collateral agent for the Secured Parties (as herein defined) (in such capacity as collateral agent, together with its successors and permitted assigns, the “Collateral
Agent”). 
 RECITALS: 
 WHEREAS, reference is made to that certain Credit and Guaranty Agreement, dated as of the date hereof (as it may be amended, restated, supplemented or otherwise modified from time to time, the
“Credit Agreement”) by and among the Borrower, the other Grantors party thereto, as Guarantors, the Collateral Agent, the other Agents party thereto and the Lenders party thereto from time to time; 

WHEREAS, subject to the terms and conditions of the Credit Agreement, certain Grantors may enter into (i) one or more Hedge
Agreements with one or more Lender Counterparties and (ii) one or more Cash Management Agreements with one or more Cash Management Providers; 
 WHEREAS, in consideration of the extensions of credit and other accommodations of the Lenders, the Lender Counterparties and Cash Management Providers as set forth in the Credit Agreement, the
Hedge Agreements and the Cash Management Agreements, respectively, each Grantor has agreed to secure such Grantor’s obligations under the Credit Documents, the Hedge Agreements and the Cash Management Agreements, as set forth herein; and

 WHEREAS, pursuant to Sections 3.01(a) and 3.01(i)(i) of the Credit Agreement, the Grantors are required to execute and
deliver certain agreements and documents in order to perfect the Collateral Agent’s security interest in the Collateral on the terms set forth herein; 

 NOW, THEREFORE, in consideration of the premises and the agreements, provisions and
covenants herein contained, and for other good and valuable consideration the receipt and sufficiency of which is hereby acknowledged, each Grantor and the Collateral Agent agree as follows: 

ARTICLE 1 

DEFINITIONS; GRANT OF SECURITY 

Section 1.01. General Definitions. In this Agreement, the following terms shall have the following meanings:

 “Additional Grantors” shall have the meaning assigned in Section 7.03. 

“Agreement” shall mean this Pledge and Security Agreement dated as of August 1, 2012, as it may be amended,
restated, amended and restated, supplemented or otherwise modified from time to time, in accordance with the terms of the Credit Agreement. 
 “Borrower” shall have the meaning set forth in the preamble. 

“Cash Proceeds” shall have the meaning assigned in Section 9.07. 

“Collateral” shall have the meaning assigned in Section 2.01. 

“Collateral Account” shall mean any account established by the Collateral Agent. 

“Collateral Agent” shall have the meaning set forth in the preamble. 

“Collateral Records” shall mean books, records, ledger cards, files, correspondence, customer lists, supplier lists,
blueprints, technical specifications, manuals, computer software and related documentation, computer printouts, tapes, disks and other electronic storage media and related data processing software and similar items that at any time evidence or
contain information relating to any of the Collateral or are otherwise necessary or helpful in the collection thereof or realization thereupon. 
 “Collateral Support” shall mean all property (real or personal) assigned, hypothecated or otherwise securing any Collateral and shall include any security agreement or other agreement
granting a lien or security interest in such real or personal property. 
 “Control” shall mean: (1) with
respect to any Deposit Accounts, control within the meaning of Section 9-104 of the UCC, (2) with respect to any Securities Accounts, Security Entitlements, Commodity Contract or Commodity Account, control within the meaning of
Section 9-106 of the UCC, (3) with respect to any Uncertificated Securities, control within the meaning of Section 8-106(c) of the UCC, (4) with respect to any Certificated Security, control within the meaning of
Section 8-106(a) or (b) of the UCC, (5) with respect to any Electronic Chattel Paper, control within the meaning of Section 9-105 of the UCC, (6) with respect to Letter- of-Credit Rights, control within the meaning of
Section 9-107 of the UCC and (7) with respect to any “transferable record” (as that term is defined in Section 201 of the Federal Electronic Signatures in Global and 

  
 2 

 
National Commerce Act or in Section 16 of the Uniform Electronic Transactions Act as in effect in any relevant jurisdiction), control within the meaning of Section 201 of the Federal
Electronic Signatures in Global and National Commerce Act or in Section 16 of the Uniform Electronic Transactions Act as in effect in the jurisdiction relevant to such transferable record. 

“Copyright Licenses” shall mean any and all agreements, licenses and covenants (whether or not in writing) providing for
the granting of any right in or to any Copyright or otherwise providing for a covenant not to sue (whether such Grantor is licensee or licensor thereunder) including, without limitation, each agreement required to be listed in Schedule 5.02(II)
under the heading “Copyright Licenses” (as such schedule may be amended or supplemented from time to time). 

“Copyright Security Agreement” shall mean a Copyright Security Agreement substantially in the form of Exhibit F.

 “Copyrights” shall mean all United States and foreign copyrights (including Community designs), including
but not limited to copyrights in software and all rights in and to databases, and all Mask Works (as defined under 17 U.S.C. 901 of the U.S. Copyright Act), whether registered or unregistered and whether or not the underlying works of authorship
have been published, moral rights, reversionary interests, termination rights, and, with respect to any and all of the foregoing: (i) all registrations and applications therefor including, without limitation, the registrations and applications
required to be listed in Schedule 5.02(II) under the heading “Copyrights” (as such schedule may be amended or supplemented from time to time), (ii) all extensions and renewals thereof, (iii) the right to sue or otherwise recover
for past, present and future infringements or other violations thereof thereof, and (iv) all Proceeds of the foregoing, including, without limitation, licenses, fees, royalties, income, payments, claims, damages and proceeds of suit now or
hereafter due and/or payable with respect thereto, and (v) all other rights of any kind accruing thereunder or pertaining thereto throughout the world. 
 “Credit Agreement” shall have the meaning set forth in the recitals. 
 “Equity Interest” shall have the meaning set forth for such term in the Credit Agreement. 
 “Excluded Asset” shall mean any asset of any Grantor excluded from the security interest hereunder by virtue of Section 2.02 hereof but only to the extent, and for so long as, so
excluded thereunder. 
 “Excluded Foreign Equity Interests” shall mean the capital stock of and/or any other
Equity Interests in any Foreign Subsidiary that is not a First-Tier Foreign Subsidiary. 

  
 3 

 “Foreign Intellectual Property” shall mean any Collateral (whether now
owned or existing or hereafter acquired, created, developed or arising) consisting of foreign, international, or multi-national issued/registered Patents, registered Trademarks, registered Copyrights, or any applications for the foregoing.

 “Grantors” shall have the meaning set forth in the preamble. 

“Indemnitee” shall mean the Collateral Agent, and its and its Affiliates’ officers, partners, directors, trustees,
employees, agents. 
 “Insurance” shall mean (i) all insurance policies covering any or all of the
Collateral (regardless of whether the Collateral Agent is the loss payee thereof or an additional insured thereon) and (ii) any key man life insurance policies. 
 “Intellectual Property” shall mean, the collective reference to all rights, priorities and privileges relating to intellectual property, whether arising under the laws of the United
States (or of any state or political subdivision thereof) or of any Foreign Jurisdiction or otherwise, including without limitation, the Copyrights, the Copyright Licenses, the Patents, the Patent Licenses, the Trademarks, the Trademark Licenses,
the Trade Secrets, and the Trade Secret Licenses, and the right to sue or otherwise recover for past, present and future infringement, dilution, misappropriation or other violation or impairment thereof, including the right to receive all Proceeds
therefrom, including without limitation license fees, royalties, income, payments, claims, damages and proceeds of suit, now or hereafter due and/or payable with respect thereto. 

“Intellectual Property Licenses” shall mean, collectively, the Copyright Licenses, Patent Licenses, Trademark Licenses
and Trade Secret Licenses. 
 “Investment Accounts” shall mean the Collateral Account, Securities Accounts,
Commodity Accounts and Deposit Accounts. 
 “Investment Related Property” shall mean: (i) all
“investment property” (as such term is defined in Article 9 of the UCC) and (ii) all of the following (regardless of whether classified as investment property under the UCC): all Pledged Equity Interests, Pledged Debt, the Investment
Accounts and certificates of deposit. 
 “Material Intellectual Property” shall mean any item of Intellectual
Property included in the Collateral which is material to the business of the Grantors, taken as a whole, or is otherwise of material value to the Grantors, taken as a whole. 
 “Non-Assignable Contract” shall mean any agreement, contract or license to which any Grantor is a party that by its terms purports to restrict or prevent the assignment or granting of a
security interest therein (either by its terms or by any federal or state statutory prohibition or otherwise irrespective of whether such prohibition or restriction is enforceable under Section 9-406 through 409 of the UCC). 

  
 4 

 “Patent Licenses” shall mean all agreements, licenses and covenants
(whether or not in writing) providing for the granting of any right in or to any Patent or otherwise providing for a covenant not to sue (whether such Grantor is licensee or licensor thereunder), including, without limitation, each agreement
required to be listed in Schedule 5.02(II) under the heading “Patent Licenses” (as such schedule may be amended or supplemented from time to time). 
 “Patent Security Agreement” shall mean a Patent Security Agreement substantially in the form of Exhibit G. 
 “Patents” shall mean all United States and foreign patents and certificates of invention, inventions or similar industrial property rights, and applications for any of the foregoing,
including, but not limited to: (i) each patent and patent application required to be listed in Schedule 5.02(II) under the heading “Patents” (as such schedule may be amended or supplemented from time to time), (ii) all reissues,
divisions, continuations, continuations-in-part, extensions, renewals, and reexaminations thereof, (iii) all improvements thereto, (iv) the right to sue or otherwise recover for past, present and future infringements or other violations
thereof, (v) all Proceeds of the foregoing, including, without limitation, license fees, royalties, income, payments, claims, damages, and proceeds of suit now or hereafter due and/or payable with respect thereto, and (vi) all other rights
of any kind accruing thereunder or pertaining thereto throughout the world. 
 “Pledged Debt” shall mean all
indebtedness for borrowed money owed to such Grantor, whether or not evidenced by any Instrument, including, without limitation, all indebtedness described on Schedule 5.02(I) under the heading “Pledged Debt” (as such schedule may be
amended or supplemented from time to time), issued by the obligors named therein, the instruments, if any, evidencing such any of the foregoing, and all interest, cash, instruments and other property or proceeds from time to time received,
receivable or otherwise distributed in respect of or in exchange for any or all of the foregoing. 
 “Pledged Equity
Interests” shall mean all Pledged Stock, Pledged LLC Interests, Pledged Partnership Interests and any other participation or interests in any equity or profits of any business entity including, without limitation, any trust and all
management rights relating to any entity whose Equity Interests are included as Pledged Equity Interests provided that, for the avoidance of doubt, the Pledged Equity Interests shall not include any Excluded Asset. 

“Pledged LLC Interests” shall mean, other than any Excluded Asset, all interests in any limited liability company and
each series thereof owned by any Grantor, including, without limitation, all limited liability company interests listed on Schedule 5.02(I) under the heading “Pledged LLC Interests” (as such schedule may be amended or supplemented from
time to time) and the certificates, if any, 

  
 5 

 
representing such limited liability company interests and any interest of such Grantor on the books and records of such limited liability company or on the books and records of any securities
intermediary pertaining to such interest and all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time received, receivable or otherwise distributed in respect of or in
exchange for any or all of such limited liability company interests and all rights as a member of the related limited liability company that constitutes “Collateral” hereunder. 

“Pledged Partnership Interests” shall mean, other than any Excluded Asset, all interests in any general partnership,
limited partnership, limited liability partnership or other partnership owned by any Grantor, including, without limitation, all partnership interests listed on Schedule 5.02(I) under the heading “Pledged Partnership Interests” (as such
schedule may be amended or supplemented from time to time) and the certificates, if any, representing such partnership interests and any interest of such Grantor on the books and records of such partnership or on the books and records of any
securities intermediary pertaining to such interest and all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time received, receivable or otherwise distributed in respect
of or in exchange for any or all of such partnership interests and all rights as a partner of the related partnership that constitutes “Collateral” hereunder. 
 “Pledged Stock” shall mean, other than any Excluded Asset, all shares of capital stock owned by any Grantor, including, without limitation, all shares of capital stock described on
Schedule 5.02(I) under the heading “Pledged Stock” (as such schedule may be amended or supplemented from time to time), and the certificates, if any, representing such shares and any interest of such Grantor in the entries on the books of
the issuer of such shares or on the books of any securities intermediary pertaining to such shares, and all dividends, distributions, cash, warrants, rights, options, instruments, securities and other property or proceeds from time to time received,
receivable or otherwise distributed in respect of or in exchange for any or all of such shares that constitutes “Collateral” hereunder. 
 “Pledge Supplement” shall mean an agreement substantially in the form of Exhibit A hereto. 
 “Receivables” shall mean all rights to payment, whether or not earned by performance, for goods or other property sold, leased, licensed, assigned or otherwise disposed of, or services
rendered or to be rendered, including, without limitation all such rights constituting or evidenced by any Account, Chattel Paper, Instrument, General Intangible or Investment Related Property, together with all of Grantor’s rights, if any, in
any goods or other property giving rise to such right to payment and all Collateral Support and Supporting Obligations related thereto and all Receivables Records. 

  
 6 

 “Receivables Records” shall mean (i) all original copies of all
documents, instruments or other writings or electronic records or other Records evidencing the Receivables, (ii) all books, correspondence, credit or other files, Records, ledger sheets or cards, invoices, and other papers relating to
Receivables, including, without limitation, all tapes, cards, computer tapes, computer discs, computer runs, record keeping systems and other papers and documents relating to the Receivables, whether in the possession or under the control of Grantor
or any computer bureau or agent from time to time acting for Grantor or otherwise, (iii) all evidences of the filing of financing statements and the registration of other instruments in connection therewith, and amendments, supplements or other
modifications thereto, notices to other creditors, secured parties or agents thereof, and certificates, acknowledgments, or other writings, including, without limitation, lien search reports, from filing or other registration officers, (iv) all
credit information, reports and memoranda relating thereto and (v) all other written or non-written forms of information related in any way to the foregoing or any Receivable. 

“Secured Obligations” shall have the meaning assigned in Section 3.01. 

“Secured Parties” shall mean the Agents, Lenders, the Issuing Bank, the Lender Counterparties and the Cash Management
Providers and shall include, without limitation, all former Agents, Lenders, Lender Counterparties and Cash Management Providers to the extent that any Obligations owing to such Persons were incurred while such Persons were Agents, Lenders, Lender
Counterparties or Cash Management Providers and such Obligations have not been paid or satisfied in full. 

“Securities” shall mean any stock, shares, partnership interests, voting trust certificates, certificates of interest or
participation in any profit-sharing agreement or arrangement, options, warrants, bonds, debentures, notes, or other evidences of indebtedness, secured or unsecured, convertible, subordinated or otherwise, or in general any instruments commonly known
as “securities” or any certificates of interest, shares or participations in temporary or interim certificates for the purchase or acquisition of, or any right to subscribe to, purchase or acquire, any of the foregoing. 

“Specified Closing Date Minority Investments” shall mean the Grantors’ Equity Interests set forth in Schedule 1.01A
or Equity Interests received in exchange therefor or on account thereof. 
 “Specified Equipment and Inventory”
shall mean, at any time, any (A) Equipment and/or Inventory which is installed or otherwise located at a physician’s office, hospital, medical clinic, laboratory or other third party location pursuant to a Customer Usage Agreement, System
Loan and Product Purchase Agreement, use agreements, conditional sales agreements, leases and other similar contracts entered into by a Grantor with end users or other third parties that directly or indirectly contract with end users and which the
Grantors, in their 

  
 7 

 
discretion, determine are a necessary or desirable means of generating revenue from such Equipment or Inventory, including through the diagnostic processes related thereto, including, but not
limited to, (i) diagnostic Equipment or Inventory, such as Thin Prep PAP Processors, Tigres, Panther, ETS (Direct Tube Sampling Instruments) and mammography and osteoporosis Equipment and Inventory, (ii) surgical Equipment or Inventory,
such as NovaSure and MyoSure controller and (iii) molecular Equipment or Inventory; (B) any Equipment and/or Inventory which is stored with FedEx Supply Chain Systems, Inc. or any of its Affiliates or located at a warehouse, distribution
center, or other location owned by FedEx Supply Chain Systems, Inc., North American, Crane, Certified Van Service of CT or their Affiliates or in which Fedex Supply Chain Systems, Inc., North American, Crane, Certified Van Service of CT or their
Affiliates stores such Equipment and/or Inventory; and (C) any Equipment and/or Inventory consisting of molds, plastics and assembly manufacturing equipment in the possession of any third party manufacturer. 

“Specified Post Closing Minority Investments” means any Equity Interest acquired by any Grantor in any Person (other
than a Subsidiary) after the Closing Date that, together with all other Specified Post Closing Minority Investments, has an aggregate book value of less than $30,000,000 or Equity Interests received in exchange therefor or on account thereof.

 “Specified Minority Investments” means, collectively, the Specified Closing Date Minority Investments and
Specified Post Closing Minority Investments. 
 “Trademark Licenses” shall mean any and all agreements,
licenses and covenants (whether or not in writing) providing for the granting of any right in or to any Trademark or otherwise providing for a covenant not to sue or permitting co-existence (whether such Grantor is licensee or licensor thereunder),
including, without limitation, each agreement required to be listed in Schedule 5.02(II) under the heading “Trademark Licenses” (as such schedule may be amended or supplemented from time to time). 

“Trademark Security Agreement” shall mean a Trademark Security Agreement substantially in the form of Exhibit E.

 “Trademarks” shall mean all United States and foreign trademarks, trade names, trade dress, corporate names,
company names, business names, fictitious business names, Internet domain names, service marks, certification marks, collective marks, logos, other source or business identifiers, designs and general intangibles of a like nature, whether or not
registered, and with respect to any and all of the foregoing: (i) all registrations and applications therefor including, without limitation, the registrations and applications required to be listed in Schedule 5.02(II) under the heading
“Trademarks” (as such schedule may be amended or supplemented from time to time), (ii) all extensions or renewals of any of the foregoing, (iii) all of the goodwill of the business connected with the

  
 8 

 
use of and symbolized by any of the foregoing, (iv) the right to sue or otherwise recover for past, present and future infringement, dilution or other violation of any of the foregoing or
for any injury to the related goodwill, (v) all Proceeds of the foregoing, including, without limitation, license fees, royalties, income, payments, claims, damages, and proceeds of suit now or hereafter due and/or payable with respect thereto,
and (vi) all other rights of any kind accruing thereunder or pertaining thereto throughout the world. 
 “Trade
Secret Licenses” shall mean any and all agreements (whether or not in writing) providing for the granting of any right in or to Trade Secrets (whether such Grantor is licensee or licensor thereunder) including, without limitation, each
agreement required to be listed in Schedule 5.02(II) under the heading “Trade Secret Licenses” (as such schedule may be amended or supplemented from time to time). 
 “Trade Secrets” shall mean all trade secrets and all other confidential or proprietary information and know-how whether or not such Trade Secret has been reduced to a writing or other
tangible form, including all documents and things embodying, incorporating, or referring in any way to such Trade Secret, including but not limited to: (i) the right to sue or otherwise recover for past, present and future misappropriation or
other violation thereof, (ii) all Proceeds of the foregoing, including, without limitation, license fees, royalties, income, payments, claims, damages, and proceeds of suit now or hereafter due and/or payable with respect thereto; and
(iii) all other rights of any kind accruing thereunder or pertaining thereto throughout the world. 

“UCC” shall mean the Uniform Commercial Code as in effect from time to time in the State of New York;
provided, however, that in the event that, by reason of mandatory provisions of law, any or all of the perfection or priority of, or remedies with respect to, any Collateral is governed by the Uniform Commercial Code as enacted and in
effect in a jurisdiction other than the State of New York, the term “UCC” shall mean the Uniform Commercial Code as enacted and in effect in such other jurisdiction solely for purposes of the provisions hereof relating to such perfection,
priority or remedies. 
 “United States” shall mean the United States of America. 

Section 1.02. Definitions; Interpretation. (a) In this Agreement, the following capitalized terms shall
have the meaning given to them in the UCC (and, if defined in more than one Article of the UCC, shall have the meaning given in Article 9 thereof): Account, Account Debtor, As-Extracted Collateral, Bank, Certificated Security, Chattel Paper,
Commercial Tort Claims, Commodity Account, Commodity Contract, Commodity Intermediary, Consignee, Consignment, Consignor, Deposit Account, Document, Entitlement Order, Electronic Chattel Paper, Equipment, Farm Products, Fixtures, General
Intangibles, Goods, Health-Care-Insurance Receivable, 

  
 9 

 
Instrument, Inventory, Letter-of-Credit Right, Manufactured Home, Money, Payment Intangible, Proceeds, Record, Securities Account, Securities Intermediary, Security Certificate, Security
Entitlement, Supporting Obligations, Tangible Chattel Paper and Uncertificated Security. 
 (b) All other capitalized terms used
herein (including the preamble and recitals hereto) and not otherwise defined herein shall have the meanings ascribed thereto in the Credit Agreement. The incorporation by reference of terms defined in the Credit Agreement shall survive any
termination of the Credit Agreement until this Agreement is terminated as provided in Article 11 hereof. Any of the terms defined herein may, unless the context otherwise requires, be used in the singular or the plural, depending on the reference.
References herein to any Section, Appendix, Schedule or Exhibit shall be to a Section, an Appendix, a Schedule or an Exhibit, as the case may be, hereof unless otherwise specifically provided. The use herein of the word “include” or
“including,” when following any general statement, term or matter, shall not be construed to limit such statement, term or matter to the specific items or matters set forth immediately following such word or to similar items or matters,
whether or not non-limiting language (such as “without limitation” or “but not limited to” or words of similar import) is used with reference thereto, but rather shall be deemed to refer to all other items or matters that fall
within the broadest possible scope of such general statement, term or matter. The terms lease and license shall include sub-lease and sub-license, as applicable. If any conflict or inconsistency exists between this Agreement and the Credit
Agreement, the Credit Agreement shall govern. All references herein to provisions of the UCC shall include all successor provisions under any subsequent version or amendment to any Article of the UCC. 

ARTICLE 2 

GRANT OF SECURITY 

Section 2.01. Grant of Security. Each Grantor hereby grants to the Collateral Agent, for the benefit of the
Secured Parties, a security interest in and continuing lien on all of such Grantor’s right, title and interest in, to and under all personal property of such Grantor including, but not limited to the following, in each case whether now owned or
hereafter existing, in which any Grantor now has or hereafter acquires an interest, creates or develops or otherwise arising and wherever the same may be located (all of which, other than to the extent constituting Excluded Assets, being hereinafter
collectively referred to as the “Collateral”): 
 (a) Accounts; 

(b) Chattel Paper; 

  
 10 

 (c) Documents; 
 (d) General Intangibles; 
 (e) Goods (including, without limitation, Inventory and
Equipment); 
 (f) Instruments; 
 (g) Insurance; 
 (h) Intellectual Property; 

(i) Investment Related Property (including, without limitation, Deposit Accounts); 

(j) Letter-of-Credit Rights; 
 (k) Money; 
 (l) Receivables and Receivable Records; 

(m) Commercial Tort Claims now or hereafter described on Schedule 5.02; 

(n) to the extent not otherwise included above, all other personal property of any kind and all Collateral Records, Collateral Support
and Supporting Obligations relating to any of the foregoing; and 
 (o) to the extent not otherwise included above, all
Proceeds, products, accessions, rents and profits of or in respect of any of the foregoing. 

Section 2.02. Certain Limited Exclusions. Notwithstanding anything herein to the contrary, in no event shall
the Collateral include or the security interest granted under Section 2.01 hereof attach to (a) any lease, license, contract or agreement to which any Grantor is a party, or any of its rights or interests thereunder, if and to the extent
that a security interest (x) is prohibited by or would be in violation of (i) any law, rule or regulation applicable to such Grantor, or (ii) a term, provision or condition of any such lease, license, contract or agreement (unless
such law, rule, regulation, term, provision or condition would be rendered ineffective with respect to the creation of the security interest hereunder pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the UCC (or any successor provision or
provisions) of any relevant jurisdiction or any other applicable law (including the Bankruptcy Code) or principles of equity) or (y) would result in a breach, default or other violation of any term, provision or condition of any such lease,
license, contract or agreement after giving effect to Sections 9-406, 9-407, 9-408 or 9-409 of the UCC (or any successor provision or 

  
 11 

 
provisions) of any relevant jurisdiction or any other applicable law (including the Bankruptcy Code) or principles of equity; provided, however, that the Collateral shall include
(and such security interest shall attach) immediately at such time as the contractual or legal prohibition shall no longer be applicable and to the extent severable, shall attach immediately to any portion of such lease, license, contract or
agreement not subject to the prohibitions specified in subclause (i) or (ii) of clause (a) of this Section 2.02; provided further that the exclusions referred to in clause (a) of this Section 2.02 shall not
include any Proceeds of any such lease, license, contract or agreement; (b) any of the outstanding capital stock of or other Equity Interest in a (I) First-Tier Foreign Subsidiary in excess of 65% of the voting power of all classes of
capital stock of such First-Tier Foreign Subsidiary entitled to vote; provided that immediately upon the amendment of the Internal Revenue Code to allow the pledge of a greater percentage of the voting power of capital stock in a First-Tier
Foreign Subsidiary without adverse tax consequences, the Collateral shall include, and the security interest granted by each Grantor shall attach to, such greater percentage of capital stock of each First-Tier Foreign Subsidiary and (II)
“security corporation” under Massachusetts General Laws (“M.G.L.”) chapter 63, § 38B, but only to the extent that the pledge of such capital stock or other Equity Interest would result in such entity ceasing to
qualify as a “security corporation” under M.G.L. chapter 63, § 38B; (c) any Excluded Foreign Equity Interests; (d) any “intent-to-use” application for trademark or service mark registration filed pursuant to
Section 1(b) of the Lanham Act, 15 U.S.C. §1051, prior to the filing under Section 1(c) or Section 1(d) of the Lanham Act of a “Statement of Use” or an “Amendment to Allege Use” with respect thereto, solely to
the extent, if any, that, and solely during the period, if any, in which, the grant of a security interest therein prior to such filing would impair the validity or enforceability of any registration that issues from such intent-to-use trademark or
service mark application under applicable federal law; (e) motor vehicles and other Goods covered by a certificate of title the perfection of a security interest in which is excluded from the Uniform Commercial Code in the relevant
jurisdiction; (f) Foreign Intellectual Property; (g) Margin Stock or Equity Interests in any Person (other than wholly owned Subsidiaries of the Borrower) if and to the extent that a security interest (x) is prohibited by or would be
in violation of any term, provision or condition of such Person’s organizational or joint venture documents (unless such term, provision or condition would be rendered ineffective with respect to the creation of the security interest hereunder
pursuant to Sections 9-406, 9-407, 9-408 or 9-409 of the UCC (or any successor provision or provisions) of any relevant jurisdiction or any other applicable law (including the Bankruptcy Code) or principles of equity) or (y) would result in a
breach, default 

  
 12 

 
or other violation of any term, provision or condition of such documents after giving effect to Sections 9-406, 9-407, 9-408 or 9-409 of the UCC (or any successor provision or provisions) of any
relevant jurisdiction or any other applicable law (including the Bankruptcy Code) or principles of equity; provided, however, that the Collateral shall include (and such security interest shall attach) immediately at such time as the
contractual prohibition shall no longer be applicable and to the extent severable, shall attach immediately to any portion of such Equity Interests not subject to the prohibitions specified in this clause 2.02(g) or (h) any property and/or
assets of Grantors (other than (i) Intellectual Property, (ii) Pledged Equity Interests, (iii) intercompany loans and (iv) the Proceeds of any Collateral) located outside of the United States, provided that the aggregate value of
such property and assets does not exceed $75,000,000 at any time. 
 ARTICLE 3 

SECURITY FOR OBLIGATIONS; GRANTORS REMAIN LIABLE

 Section 3.01. Security for Obligations. This Agreement secures, and the Collateral is collateral
security for, the prompt and complete payment or performance in full when due, whether at stated maturity, by required prepayment, declaration, acceleration, demand or otherwise (including the payment of amounts that would become due but for the
operation of the automatic stay under Section 362(a) of the Bankruptcy Code, 11 U.S.C. §362(a) (and any successor provision thereof)), of all the Obligations (the “Secured Obligations”). 

Section 3.02. Continuing Liability Under Collateral. Notwithstanding anything herein to the contrary,
(a) each Grantor shall remain liable for all obligations under the Collateral and nothing contained herein is intended or shall be a delegation of duties to the Collateral Agent or any other Secured Party, (b) each Grantor shall remain
liable under each of the agreements included in the Collateral, including, without limitation, any agreements relating to Pledged Partnership Interests or Pledged LLC Interests, to perform all of the obligations undertaken by it thereunder all in
accordance with and pursuant to the terms and provisions thereof and neither the Collateral Agent nor any Secured Party shall have any obligation or liability under any of such agreements by reason of or arising out of this Agreement or any other
document related thereto nor shall the Collateral Agent nor any Secured Party have any obligation to make any inquiry as to the nature or sufficiency of any payment received by it or have any obligation to take any action to collect or enforce any
rights under any agreement included in the Collateral, including, without limitation, any agreements relating to Pledged Partnership 

  
 13 

 
Interests or Pledged LLC Interests and (c) the exercise by the Collateral Agent of any of its rights hereunder shall not release any Grantor from any of its duties or obligations under the
contracts and agreements included in the Collateral. 
 ARTICLE 4 

CERTAIN PERFECTION REQUIREMENTS 

Section 4.01. Delivery Requirements. (a) With respect to any Certificated Securities included in
the Collateral, each Grantor shall deliver to the Collateral Agent the Security Certificates evidencing such Certificated Securities duly indorsed by an effective indorsement (within the meaning of Section 8-107 of the UCC), or accompanied by
share transfer powers or other instruments of transfer duly endorsed by such an effective endorsement, in each case, to the Collateral Agent or in blank. In addition, each Grantor shall cause any certificates evidencing any Pledged Equity Interests
included in the Collateral, including, without limitation, any Pledged Partnership Interests included in the Collateral or Pledged LLC Interests included in the Collateral, to be similarly delivered to the Collateral Agent regardless of whether such
Pledged Equity Interests constitute Certificated Securities. Notwithstanding the foregoing, the delivery requirements set forth in this Section 4.01(a) shall be subject to the delivery periods set forth in Section 4.05 and shall not apply
to any certificates evidencing Equity Interests or equity investments valued at less than $500,000 individually, except to the extent the aggregate value of such Equity Interests and equity investments exceeds $2,500,000 (in which case the delivery
requirements under this Section 4.01(a) shall apply to the certificates evidencing all such Equity Interests and equity investments in excess of such aggregate threshold); provided that (x) such exception shall not apply to any
certificates evidencing the Equity Interests or equity investments in the Borrower’s Subsidiaries and (y) the requirements of this Section 4.01(a) shall not apply to Specified Minority Investments. 

(b) With respect to any Instruments or Tangible Chattel Paper included in the Collateral, each Grantor shall deliver, within the delivery
periods set forth in Section 4.05, to the Collateral Agent all such Instruments or Tangible Chattel Paper to the Collateral Agent duly indorsed in blank; provided, however, that such delivery requirement shall not apply to
(i) any Instruments or Tangible Chattel Paper having a face amount of less than $5,000,000 individually, except to the extent the aggregate outstanding face amount of such Instruments and Tangible Chattel Paper exceeds $15,000,000 (in which
case the delivery requirements under this Section 4.01(b) shall apply to all such Instruments and Tangible Chattel Paper in excess of such aggregate threshold) or (ii) any Tangible Chattel Paper relating to or in respect of any Specified
Equipment and Inventory. 

  
 14 

 Section 4.02. Control Requirements. (a) With respect to any
Deposit Accounts, Securities Accounts, Security Entitlements, Commodity Accounts and Commodity Contracts included in the Collateral, each Grantor shall ensure that the Collateral Agent has Control thereof within the compliance period set forth in
Section 4.05; provided, however, that such Control requirement shall not apply to any (i) Deposit Accounts with a value of less than, or having funds or other assets credited thereto with a value of less than, $1,000,000
individually, Deposit Accounts specifically and exclusively used for payroll, payroll taxes and other employee wage and benefit payments to or for the benefit of a Grantor’s employees, and Deposit Accounts specifically and exclusively used for
cash collateral to secure letters of credit permitted under the Credit Agreement (other than Letters of Credit thereunder) and (ii) Securities Accounts, Security Entitlements, Commodity Accounts and Commodity Contracts with a value of less
than, or having funds or other assets credited thereto with a value of less than, $1,000,000 individually. With respect to any Securities Accounts or Securities Entitlements that the applicable Grantor is required to ensure that the Collateral Agent
has Control thereof pursuant to the first sentence of this Section 4.02(a), such Control shall be accomplished by such Grantor causing the Securities Intermediary maintaining such Securities Account or Security Entitlement to enter into an
agreement substantially in the form of Exhibit C hereto (or such other agreement in form and substance reasonably satisfactory to the Collateral Agent) pursuant to which the Securities Intermediary shall agree to comply with the Collateral
Agent’s Entitlement Orders without further consent by such Grantor. With respect to any Deposit Account that the applicable Grantor is required to ensure that the Collateral Agent has Control thereof pursuant to the first sentence of this
Section 4.02(a), such Grantor shall cause the depositary institution maintaining such account to enter into an agreement substantially in the form of Exhibit D hereto (or such other agreement in form and substance reasonably satisfactory to the
Collateral Agent), pursuant to which such depository institution shall agree to comply with the Collateral Agent’s instructions with respect to disposition of funds in the Deposit Account without further consent by such Grantor. With respect to
any Commodity Accounts or Commodity Contracts that the applicable Grantor is required to ensure that the Collateral Agent has Control thereof pursuant to the first sentence of this Section 4.02(a), such Grantor shall cause Control in favor of
the Collateral Agent in a manner reasonably acceptable to the Collateral Agent. 

  
 15 

 (b) With respect to any Uncertificated Security included in the Collateral (other than any
Uncertificated Securities constituting (x) Collateral credited to a Securities Account and (y) Specified Minority Investments), each Grantor shall cause, within the compliance period set forth in Section 4.05, the issuer of such
Uncertificated Security to either (i) register the Collateral Agent as the registered owner thereof on the books and records of the issuer or (ii) execute an agreement substantially in the form of Exhibit B hereto (or such other agreement
in form and substance reasonably satisfactory to the Collateral Agent), pursuant to which such issuer agrees to comply with the Collateral Agent’s instructions with respect to such Uncertificated Security without further consent by such
Grantor. 
 (c) With respect to any Letter-of-Credit Rights included in the Collateral (other than any Letter-of-Credit Rights
constituting a Supporting Obligation for a Receivable in which the Collateral Agent has a valid and perfected security interest) with a value in excess of $7,500,000 individually, each Grantor shall ensure, within the compliance period set forth in
Section 4.05, that Collateral Agent has Control thereof by obtaining the written consent of each issuer of each related letter of credit to the assignment of the proceeds of such letter of credit to the Collateral Agent. 

(d) With respect to any Electronic Chattel Paper or “transferable record” (as that term is defined in Section 201 of the
Federal Electronic Signatures in Global and National Commerce Act or in Section 16 of the Uniform Electronic Transactions Act as in effect in any relevant jurisdiction) included in the Collateral, each Grantor shall ensure, within the
compliance period set forth in Section 4.05, that the Collateral Agent has Control thereof; provided, however, that such Control requirement shall not apply to (i) any Electronic Chattel Paper or transferable record having a
face amount of less than $5,000,000 individually, except to the extent that the aggregate outstanding face amount of such Electronic Chattel Paper exceeds $15,000,000 (in which case, such Control requirement under this Section 4.02(d) shall
apply to all Electronic Chattel Paper in excess of such aggregate amount) or (ii) any Electronic Chattel Paper or transferable record relating to or in respect of any Specified Equipment and Inventory; provided that each Grantor
covenants and agrees not to permit any other Person to have Control of any such Electronic Chattel Paper or transferable record. 
 Section 4.03. Intellectual Property Recording Requirements. (a) In the case of any Collateral (whether now owned or existing or hereafter acquired, created, developed or arising)
consisting of Patents issued in the United States or pending Patent applications filed in the United States, each Grantor shall execute and deliver, within the compliance period set forth in Section 4.05, to the Collateral Agent a Patent
Security Agreement in substantially the form of Exhibit G hereto (or a supplement thereto) covering all such Patents in appropriate form for recordation with the United States Patent and Trademark Office with respect to the security interest of the
Collateral Agent. 

  
 16 

 (b) In the case of any Collateral (whether now owned or existing or hereafter acquired,
created, developed or arising) consisting of Trademarks registered in the United States or pending Trademark applications filed in the United States, each Grantor shall execute and deliver, within the compliance period set forth in
Section 4.05, to the Collateral Agent a Trademark Security Agreement in substantially the form of Exhibit E hereto (or a supplement thereto) covering all such Trademarks, in appropriate form for recordation with the United States Patent and
Trademark Office with respect to the security interest of the Collateral Agent. 
 (c) In the case of any Collateral (whether
now owned or existing or hereafter acquired, created, developed or arising) consisting of Copyrights registered in the United States or pending Copyright applications filed in the United States, or consisting of exclusive Copyright Licenses that
constitute Material Intellectual Property in respect of Copyrights registered in the United States for which any Grantor is the licensee, the Grantor shall execute and deliver, within the compliance period set forth in Section 4.05, to the
Collateral Agent a Copyright Security Agreement in substantially the form of Exhibit F hereto (or a supplement thereto) covering all such Copyright and exclusive Copyright Licenses, in appropriate form for recordation with the United States
Copyright Office with respect to the security interest of the Collateral Agent. 
 Section 4.04. Other
Actions. With respect to any Pledged Partnership Interests and Pledged LLC Interests included in the Collateral (other than any Specified Minority Investment), if the Grantors own less than 100% of the Equity Interests in any issuer of such
Pledged Partnership Interests or Pledged LLC Interests constituting Collateral, the Grantors shall, within the compliance period set forth in Section 4.05, use their commercially reasonable efforts to obtain the consent of each other holder of
partnership interest or limited liability company interests in such issuer to the security interest of the Collateral Agent hereunder and following an Event of Default, the transfer of such Pledged Partnership Interests and Pledged LLC Interests
constituting Collateral to the Collateral Agent or its designee, and to the substitution of the Collateral Agent or its designee as a partner or member with all the rights and powers related thereto. Each Grantor consents to the grant by each other
Grantor of a Lien in all Investment Related Property constituting Collateral to the Collateral Agent and without limiting the generality of the foregoing consents to the transfer of any Pledged Partnership Interest and any Pledged LLC Interest
constituting Collateral to the Collateral Agent or its designee following an Event of Default for the purposes of enabling the Collateral Agent to exercise rights and remedies under the Credit Agreement and Article 9 hereof and to the substitution
of the 

  
 17 

 
Collateral Agent or its designee as a partner in any partnership or as a member in any limited liability company with all the rights and powers related thereto. 

Section 4.05. Timing and Notice. Notwithstanding any provisions set forth herein, with respect to any
Collateral in existence on the Closing Date, each Grantor shall comply with the requirements of Article 4 on the Closing Date, subject to the last paragraph of Section 3.01(i) of the Credit Agreement and Section 5.12(c) of the Credit
Agreement, and with respect to any Collateral hereafter owned or acquired, created, developed or arising such Grantor shall (i) for the avoidance of doubt, comply with the requirements of Sections 5.10 and 5.11 of the Credit Agreement as
applicable, and (ii) comply with the requirements of Article 4 and/or Sections 6.02(a), 6.02(b) and 6.05(b) hereof, as applicable, (x) with respect to (1) Material Intellectual Property and (2) Collateral (other than Intellectual
Property) valued, in the aggregate with all other Collateral (other than Intellectual Property) acquired, created, developed or arising in the same Fiscal Quarter, in excess of the greater of (1) $50,000,000 and (2) 0.5% of Total Assets,
within 45 days after such Collateral is acquired, created, developed or otherwise arises and (y) with respect to all other Collateral, within the later of (I) 45 days after such Collateral is acquired, created, developed or otherwise
arises and (II) 15 days after the end of such Fiscal Quarter in which such Collateral is acquired, created, developed or otherwise arises; provided that the Collateral Agent may grant an extension therefor if the applicable Grantor in respect
thereof is using commercially reasonable efforts to comply with such requirements. 
 ARTICLE 5 

REPRESENTATIONS AND WARRANTIES 

Each Grantor hereby represents and warrants, on the Closing Date and on each Credit Date, that the following statements are true and
correct in all material respects as of such date other than to the extent such representation or warranty specifically relate to an earlier date (in which case such representation or warranty shall be true and correct in all material respects as of
such earlier date), in each case, subject to Sections 4.05: 
 Section 5.01. Grantor
Information & Status. (a) As of the Closing Date, Schedule 5.01(A) and (B) sets forth under the appropriate headings: (1) the full legal name of such Grantor, (2) all trade names or other names under which such
Grantor (currently) commonly conducts business, (3) the type of organization of such Grantor, (4) the jurisdiction of organization of such Grantor, (5) its 

  
 18 

 
organizational identification number, if any, and (6) the jurisdiction where the chief executive office or its sole place of business (or the principal residence if such Grantor is a natural
person) is located. 
 (b) Except as provided on Schedule 5.01(C), as of the Closing Date, it has not changed its name,
jurisdiction of organization, chief executive office or sole place of business (or principal residence if such Grantor is a natural person) or its corporate structure in any way (e.g., by merger, consolidation, change in corporate form or otherwise)
and has not commonly done business under any other name, in each case, within the past five (5) years. 
 (c) It has not
within the last five (5) years become bound (whether as a result of merger or otherwise) as debtor under a security agreement entered into by another Person, which has not heretofore been terminated other than the agreements identified on
Schedule 5.01(D) hereof (as such schedule may be amended or supplemented from time to time). 
 (d) As of the Closing Date, such
Grantor has been duly organized and is validly existing as an entity of the type as set forth opposite such Grantor’s name on Schedule 5.01(A) solely under the laws of the jurisdiction as set forth opposite such Grantor’s name on Schedule
5.01(A) and, except as permitted by the Credit Agreement, remains duly existing as such. Except as permitted by the Credit Agreement, such Grantor has not filed any certificates of dissolution or liquidation, any certificates of domestication,
transfer or continuance in any other jurisdiction. 
 (e) No Grantor is a “transmitting utility” (as defined in
Section 9-102(a)(80) of the UCC). 
 Section 5.02. Collateral Identification, Special
Collateral.  
 (a) On the Closing Date, Schedule 5.02 sets forth under the appropriate headings all of such Grantor’s:
(1) Pledged Equity Interests constituting Collateral, other than any Pledged Equity Interests valued at less than $100,000 individually, except to the extent that the aggregate value of such Pledged Equity Interests exceeds $500,000,
provided that such exception shall not apply to any Pledged Equity Interests evidencing the Equity Interests in the Borrower’s Subsidiaries, (2) Pledged Debt other than any Pledged Debt having a face amount of less than $5,000,000
individually, except to the extent that the aggregate face amount of such Pledged Debt exceeds $15,000,000, (3) Securities Accounts, Security Entitlements, Commodity Accounts and Commodity Contracts other than any Securities Accounts, Security
Entitlements, Commodity Accounts and Commodity Contracts having a value of less than, or having funds or other assets credited thereto with a value of less than, $1,000,000 individually, (4) Deposit Accounts other than any Deposit Accounts
holding less than $1,000,000 individually, (5) United States registrations and issuances of and applications for Patents, Trademarks, and Copyrights owned by such Grantor constituting 

  
 19 

 
Material Intellectual Property, (6) Patent Licenses, Trademark Licenses, Trade Secret Licenses and Copyright Licenses constituting Material Intellectual Property other than employment
related agreements or consulting agreements with individuals to the extent that such agreements can be characterized as Patent Licenses, Trademark Licenses, Trade Secret Licenses and/or Copyright Licenses, (7) Commercial Tort Claims other than
any Commercial Tort Claims having a value of less than $5,000,000 individually, except to the extent that the aggregate value of such Commercial Tort Claims exceeds $15,000,000, (8) Letter-of-Credit Rights for letters of credit other than any
individual Letters of Credit Rights worth less than $2,000,000, (9) the name and address of any warehouseman, bailee or other third party in possession of any Inventory, Equipment and other tangible personal property other than
(A) Specified Equipment and Inventory, (B) other Equipment, Inventory and other tangible personal property with salesmen, servicemen, customers or such items in transit, under repair or with assemblers, (C) any other Inventory,
Equipment and other tangible personal property at one location having a value less than $5,000,000 individually, except to the extent the aggregate value of such Inventory, Equipment or other tangible person property exceeds $15,000,000 or
(D) listed on Schedule 5.05 and (10) Material Contracts. 
 (b) None of the Collateral in excess of $2,500,000
individually or $7,500,000 in the aggregate constitutes, or is the Proceeds of, (1) Farm Products, (2) As-Extracted Collateral, (3) Manufactured Homes, (4) Health-Care-Insurance Receivables; (5) timber to be cut, or
(6) aircraft, aircraft engines, satellites, ships or railroad rolling stock. 
 (c) All information supplied by any Grantor
with respect to any of the Collateral (in each case taken as a whole with respect to any particular Collateral) is accurate and complete in all material respects, subject to the thresholds, exclusions and limitations set forth in this Agreement or
the Collateral Questionnaire, as applicable. 
 Section 5.03. Ownership Of Collateral And Absence Of
Other Liens. (a) Other than as provided herein and in the Credit Agreement, it owns the Collateral purported to be owned by it or otherwise has the rights it purports to have in each item of Collateral and, as to all Collateral whether now
existing or hereafter acquired, developed or created (including by way of lease or license), will continue to own or have such rights in each item of the Collateral, in each case free and clear of any and all Liens, rights or claims of all other
Persons, including, without limitation, liens arising as a result of such Grantor becoming bound (as a result of merger or otherwise) as debtor under a security agreement entered into by another Person other than any Permitted Liens, in each case,
except if the failure to own or have 

  
 20 

 
rights in such Collateral or if the rights or claims of other Persons in the Collateral would not reasonably be expected to have a Material Adverse Effect. 

(b) Other than any financing statements filed in favor of the Collateral Agent, no effective financing statement, fixture filing or other
instrument similar in effect under any applicable law covering all or any part of the Collateral is on file in any filing or recording office except for (x) financing statements for which duly authorized proper termination statements have been
delivered to the Collateral Agent for filing and (y) financing statements, fixture filings or instruments similar in effect filed in connection with Permitted Liens. Other than the Collateral Agent and any automatic control in favor of a Bank,
Securities Intermediary or Commodity Intermediary maintaining a Deposit Account, Securities Account or Commodity Contract, no Person is in Control of any Collateral other than in connection with Permitted Liens. 

Section 5.04. Status of Security Interest. (a) Upon the filing of any financing statement naming such
Grantor as “debtor” and the Collateral Agent as “secured party” and describing the Collateral in the filing offices set forth opposite such Grantor’s name on Schedule 5.04 hereof (as such schedule may be amended or
supplemented from time to time), the security interest of the Collateral Agent in all Collateral that can be perfected by the filing of a financing statement under the Uniform Commercial Code as in effect in the applicable jurisdiction will
constitute valid, perfected, First Priority Liens with respect to such Collateral under the law of such jurisdiction (to the extent applicable thereto). Each agreement purporting to give the Collateral Agent Control over any Collateral is effective
to establish the Collateral Agent’s Control of the Collateral subject thereto. 
 (b) To the extent perfection or priority
of the security interest therein is not subject to Article 9 of the UCC, upon recordation in the applicable intellectual property registries in the United States (including but not limited to the United States Patent and Trademark Office and the
United States Copyright Office) of the security interests granted hereunder in all Collateral consisting of Patents registered or issued in the United States (and all applications therefor), Trademarks registered or issued in the United States (and
all applications therefor), Copyrights registered in the United States (and all applications therefor) and exclusive Copyright Licenses (with respect to Copyrights registered in the United States), the security interests granted to the Collateral
Agent hereunder in such Collateral listed therein shall constitute valid, perfected, First Priority Liens in Grantor’s interest therein. 
 (c) Except (x) as set forth in the Credit Agreement and (y) with respect to the Specified Minority Investments, no authorization, consent, approval or other action by, and no notice to or filing
with, any Governmental Authority or regulatory body or any other Person is required for either the pledge or grant by 

  
 21 

 
any Grantor of the Liens in the Collateral purported to be created in favor of the Collateral Agent hereunder, except (A) for the filings contemplated by clauses (a) and (b) of
Section 5.04 above, (B) as may be required, in connection with the disposition of any Investment Related Property, by laws generally affecting the offering and sale of Securities and (C) for such consents previously obtained.

 (d) Such Grantor is in compliance with its obligations under Article 4 hereof. 

Section 5.05. Goods and Receivables. (a) Each Receivable (i) is and will be the legal, valid and
binding obligation of the Account Debtor in respect thereof, representing an unsatisfied obligation of such Account Debtor, (ii) is and will be enforceable in accordance with its terms, (iii) is not and will not be subject to any credits,
rights of recoupment, setoffs, defenses, taxes, counterclaims (except with respect to refunds, returns and allowances in the ordinary course of business with respect to damaged merchandise or ordinary course intercompany note payment mechanics) and
(iv) is and will be in compliance with all applicable laws, whether federal, state, local or foreign, unless failure to comply with clauses (i), (ii), (iii) and/or (iv) of this Section 5.05(a) would not have a Material Adverse
Effect. 
 (b) Except as otherwise identified on Schedule 5.05 hereto, as of the Closing Date, (i) the aggregate amount of
all Receivables constituting Collateral owed by or due from the federal government of the United States, or any agency or instrumentality thereof, collectively, does not exceed $150,000,000; and (ii) the aggregate amount of all Receivables
constituting Collateral owed by or due from the governments of states or municipalities of the United States, collectively, does not exceed $75,000,000. 
 (c) Any Goods now or hereafter produced by any Grantor included in the Collateral have been and will be produced in compliance with the requirements of the Fair Labor Standards Act, as amended, and the
rules and regulations promulgated thereunder, except where the failure to do so would not reasonably be expected to have a Material Adverse Effect. 
 (d) Other than any (i) Inventory or Equipment in transit, being repaired or in the possession or control of any warehouseman, bailee, repairman, serviceman, salesman, customer, assembler or other
third party, (ii) Specified Equipment and Inventory and (iii) any other Inventory, Equipment and other tangible personal property at one location having a value less than $5,000,000 individually, except to the extent the aggregate value of
such Inventory, Equipment or other tangible person property exceeds $15,000,000, all of the Equipment and Inventory included in the Collateral is located only at the locations specified in Schedule 5.05 (as such schedule may be amended or
supplemented from time to time). 

  
 22 

 Section 5.06. Pledged Equity Interests, Investment Related Property.
(a) Except as otherwise permitted in the Credit Agreement or herein, it is the record and beneficial owner of the Pledged Equity Interests free of all Liens (other than Permitted Liens), rights or claims of other Persons (other than
Permitted Liens) and, other than as set forth in Schedule 5.06 hereof (as such schedule may be amended or supplemented from time to time), there are no outstanding warrants, options or other rights to purchase, or shareholder, voting trust or
similar agreements outstanding with respect to, or property that is convertible into, or that requires the issuance or sale of, any Pledged Equity Interests. 
 (b) Except (x) as set forth in Schedule 5.06 (as such schedule may be amended or supplemented from time to time) and (y) with respect to the Specified Minority Investments, no consent of any
Person including any other general or limited partner, any other member of a limited liability company, any other shareholder or any other trust beneficiary is necessary or reasonably desirable in connection with the creation, perfection or First
Priority status of the security interest of the Collateral Agent in any Pledged Equity Interests constituting Collateral other than those consents previously obtained. 
 (c) Except as set forth in Schedule 5.06(c) (as such schedule may be amended or supplemented from time to time), all of the Pledged LLC Interests and Pledged Partnership Interests constituting Collateral
(other than Specified Minority Investments) are or represent interests that by their terms provide that they are securities governed by the uniform commercial code of an applicable jurisdiction. 

Section 5.07. Intellectual Property. (a) Except as set forth in Schedule 5.07 or otherwise permitted
under the Credit Agreement (including without limitation, with respect to any licenses permitted thereunder), it is the sole and exclusive owner of the entire right, title and interest in and to all Patents, Trademarks, and Copyrights listed on
Schedule 5.02 (as such schedule may be amended or supplemented from time to time); and it owns or has the valid right to use and, where Grantor does so, sublicense others to use, all Intellectual Property used in or necessary to conduct its
business, free and clear of all Liens, claims, and licenses, except, in each case, (x) for Permitted Liens and the licenses set forth on Schedule 5.02 (as such schedule may be amended or supplemented from time to time) or (y) as would not,
individually or in the aggregate, reasonably be expected to have a Material Adverse Effect. 
 (b) Except as set forth in
Schedule 5.07 and other than any Intellectual Property the disposition or license of which is otherwise permitted under Section 6.08 of the Credit Agreement, each Patent, Trademark and Copyright listed on Schedule 5.02 that constitutes Material
Intellectual Property is subsisting and has 

  
 23 

 
not been adjudged invalid or unenforceable, in whole or in part, nor, in the case of Patents constituting Material Intellectual Property, is the subject of a reexamination proceeding, and such
Grantor has performed in all material respects all acts and has paid all renewal, maintenance and other fees and taxes required to maintain in full force and effect each and every registration and application of Copyrights, Patents and Trademarks
that constitute Material Intellectual Property. 
 (c) No action or proceeding is pending, or to such Grantors’ knowledge,
threatened, challenging the validity, enforceability, registration, ownership or use of any of such Grantor’s Patents, Trademarks, or Copyrights listed on Schedule 5.02 that constitute Material Intellectual Property that is reasonably likely to
have a Material Adverse Effect. 
 (d) None of the Trademarks, Patents, Copyrights or Trade Secrets that constitute Material
Intellectual Property has been licensed by any Grantor to any Affiliate or third party, except as disclosed in Schedule 5.07 (as such schedule may be amended or supplemented from time to time) or otherwise permitted under the Credit Agreement , and
all exclusive Copyright Licenses (with respect to Copyrights registered in the United States) that constitute Material Intellectual Property have been properly recorded in the United States Copyright Office. 

(e) Such Grantor has been using appropriate statutory notice of registration in connection with its use of registered Trademarks, proper
marking practices in connection with the use of issued Patents and pending Patent applications, and appropriate notice of copyright in connection with the publication of Copyrights, except where failure to use such statutory notice of registration,
proper marking practices and appropriate notice of copyright would not have a Material Adverse Effect. 
 (f) Such Grantor has
taken commercially reasonable steps to protect the confidentiality of its Trade Secrets that constitute Material Intellectual Property in accordance with industry standards; 
 (g) Such Grantor has maintained its standards of quality in the manufacture, distribution, and sale of all products sold and in the provision of all services rendered under or in connection with all
Trademarks of such Grantor and has taken commercially reasonable actions to insure that all licensees of the Trademarks owned by such Grantor meet such standards of quality, in each case, except where failure to maintain or meet such standards is
not reasonably likely have a Material Adverse Effect. 
 (h) Such Grantor is not infringing, misappropriating, diluting, or
otherwise violating the Intellectual Property rights of any other Person, and there is no pending or, to the best knowledge of such Grantor, threatened claim or litigation against such Grantor alleging any such infringement, misappropriation,
dilution or other violation of the Intellectual Property rights of any other Person, 

  
 24 

 
in each case except as set forth on Schedule 5.07 hereof (as such schedule may be amended or supplemented from time to time) or as would not reasonably be likely to have a Material Adverse
Effect. 
 (i) [Intentionally Omitted] 
 (j) no settlement or consents, covenants not to sue, co-existence agreements, non-assertion assurances, or releases have been entered into by such Grantor or binds such Grantor in a manner that is
reasonably likely to materially adversely affect such Grantor’s rights to own, license or use any Material Intellectual Property, except, in each case, as disclosed in Schedule 5.07 hereof (as such schedule may be amended or supplemented from
time to time). 
 Section 5.08. Miscellaneous. No Material Contract prohibits assignment or requires
consent of or notice to any Person in connection with the assignment to the Collateral Agent hereunder, except such as has been given or made or is currently sought pursuant to Section 6.08 hereof or was sought in accordance with
Section 6.08 hereof and not given or made, as set forth in Schedule 5.08 (as such schedule may be amended or supplemented from time to time). 
 ARTICLE 6 
 COVENANTS AND AGREEMENTS

 Each Grantor hereby covenants and agrees that, subject to the compliance periods set forth in Section 4.05: 

Section 6.01. Grantor Information and Status. Without limiting any prohibitions or restrictions on mergers or
other transactions set forth in the Credit Agreement, and except as it may be permitted to do so under the Credit Agreement, each Grantor covenants and agrees to comply with the requirements of Section 5.01(j) of the Credit Agreement within the
time periods set forth therein and take all actions necessary or advisable to maintain the continuous validity, perfection and the same or better priority of the Collateral Agent’s security interest in that portion of the Collateral granted or
intended to be granted and agreed to hereby, which in the case of any merger or other change in corporate structure shall include, without limitation, executing and delivering to the Collateral Agent a completed Pledge Supplement, substantially in
the form of Exhibit A attached hereto, upon completion of such merger or other change in corporate structure confirming the grant of the security interest hereunder. 

Section 6.02. Collateral Identification; Special Collateral. (a) In the event that it hereafter
acquires any Collateral of a type described 

  
 25 

 
in Section 5.02(b) hereof with a fair market value in excess of $2,500,000 individually or $7,500,000 in the aggregate, it shall promptly notify the Collateral Agent thereof in writing and
take such actions and execute such documents and make such filings all at such Grantor’s expense as the Collateral Agent may reasonably request to the extent that such actions, execution of documents and/or filings are otherwise required under
Article 4 hereof in order to ensure that the Collateral Agent has a valid, perfected, First Priority Lien in such Collateral. 

(b) In the event that it hereafter acquires or has any Commercial Tort Claim that an Authorized Officer of such Grantor reasonably
believes has a value in excess of $5,000,000 individually or $15,000,000 in the aggregate it shall deliver to the Collateral Agent a completed Pledge Supplement, substantially in the form of Exhibit A attached hereto, together with all Supplements
to Schedules thereto, identifying such new Commercial Tort Claims; provided that the Borrower shall not be required to compromise in any way its attorney-client privilege. 

Section 6.03. Ownership of Collateral and Absence of Other Liens. (a) Except for the security interest
created by this Agreement and Permitted Liens, and without duplication of Section 6.07(e), it shall not create or suffer to exist any Lien upon or with respect to any of the Collateral, and such Grantor shall use commercially reasonable efforts
to defend the Collateral against all Persons (other than the holders of Permitted Liens) at any time claiming any interest therein. 
 (b) Upon any Authorized Officer of such Grantor obtaining knowledge thereof, it shall promptly notify the Collateral Agent in writing of any event that may have a Material Adverse Effect on the value of
the Collateral (taken as a whole), the ability of such Grantor or the Collateral Agent to dispose of all or any material portion of the Collateral, or the rights and remedies of the Collateral Agent in relation thereto, including, without
limitation, the levy of any legal process against all or any material portion of the Collateral, in each case, other than Dispositions permitted under Section 6.08 of the Credit Agreement. 

(c) It shall not sell, transfer or assign (by operation of law or otherwise) or exclusively license to another Person any Collateral
except as otherwise permitted by the Credit Agreement. 
 Section 6.04. Status of Security Interest.
(a) Subject to the limitations set forth in Article 4 hereof and subsection (b) of this Section 6.04, such Grantor shall maintain the security interest of the Collateral Agent hereunder in all Collateral as valid, perfected, First
Priority Liens to the extent required hereunder. 

  
 26 

 (b) Notwithstanding anything to the contrary herein, no Grantor shall be required to take
any action to (i) perfect any Collateral that can only be perfected by Control, in each case except as and to the extent specified in Article 4 hereof and (ii) grant or perfect any lien or security interest in Collateral in a Foreign
Jurisdiction or under or pursuant to the laws of a Foreign Jurisdiction. 
 Section 6.05.
Goods & Receivables.  
 (a) [Intentionally Omitted] 

(b) (1) If any Equipment or Inventory is in possession or control of any warehouseman, bailee or other third party (other than a
Consignee under a Consignment for which such Grantor is the Consignor), such Grantor shall join with the Collateral Agent in notifying the third party of the Collateral Agent’s security interest and upon the reasonable request of the Collateral
Agent, obtaining an acknowledgment from the third party that it is holding the Equipment and Inventory for the benefit of the Collateral Agent and will permit the Collateral Agent to have access to Equipment or Inventory for purposes of inspecting
such Collateral or, following an Event of Default, to remove same from such premises if the Collateral Agent so elects; provided that this requirement shall not apply to (A) Specified Equipment and Inventory, (B) Equipment,
Inventory and other tangible personal property which is with salesmen, servicemen, customers or such items in transit, under repair or with assemblers and (C) Equipment or Inventory valued at less than $5,000,000 individually, except to the
extent that the aggregate value of such Equipment and Inventory exceeds $15,000,000 (in which case, the requirement shall apply to all such Equipment and Inventory in excess of such aggregate threshold); and (2) with respect to any Goods
subject to a Consignment for which such Grantor is the Consignor, such Grantor shall file appropriate financing statements against the Consignee and take such other action as may be necessary to ensure that such Grantor has a first priority
perfected security interest in such Goods subject to any nonmaterial Liens; provided that this requirement shall not apply to Goods valued at less than $2,500,000 individually, except to the extent that the aggregate value of such Goods
exceeds $7,500,000 (in which case, the requirement shall apply to all such Goods in excess of such aggregate threshold). 
 (c)
It shall keep the Equipment, Inventory and any Documents evidencing any material Equipment and Inventory in the locations specified on Schedule 5.05 (as such schedule may be amended or supplemented from time to time) or as otherwise provided by
Section 5.05 unless it shall have notified the Collateral Agent in writing prior to thirty (30) days after any change in locations, identifying such new locations and providing such other information in connection therewith as the
Collateral Agent may reasonably request. 
 (d) It shall keep and maintain at its own cost and expense satisfactory and complete
records of the Receivables, including, but not limited to, to the extent it is commercially reasonable to do so, the originals of all documentation 

  
 27 

 
with respect to all Receivables and records of all payments received and all credits granted on the Receivables, all merchandise returned and all other material dealings therewith. 

(e) Anything to the contrary contained in the foregoing notwithstanding, following the occurrence of any Event of Default and at the
direction of the Collateral Agent, all Grantors in respect of Receivables constituting Collateral owed by or due from the government of the United States, or any agency or instrumentality thereof, or any government of a state or municipality of the
United States or any foreign sovereign shall take all steps necessary, upon the Collateral Agent’s notice to the Borrower directing the Borrower or the applicable Grantor to take all such steps, such that (A) all monies due or to become
due on account of any such Receivables shall be subject to a valid, perfected, First Priority Lien in favor of the Collateral Agent for the benefit of the Secured Parties and (B) each applicable Governmental Authority is directed to deposit all
monies due or to become due on account of any such Receivables into a deposit and/or security account subject to a control agreement in favor of the Collateral Agent, on terms reasonably satisfactory to the Collateral Agent, irrespective of the
individual or aggregate value of such Receivable. 
 (f) Other than in the ordinary course of business (i) it shall not
amend, modify, terminate or waive any provision of any Receivable other than such amendments, modifications, terminations or waivers that would not have a Material Adverse Effect; provided that this Section 6.04(f)(i) shall not be
applicable with respect to any contracts, agreements, licenses, documents or instruments entered into between any Grantor and K-V Pharmaceutical Company; and (ii) following and during the continuation of an Event of Default, such Grantor shall
not, upon receipt of notice from the Collateral Agent directing it not to do so, (w) grant any extension or renewal of the time of payment of any Receivable, (x) compromise or settle any dispute, claim or legal proceeding with respect to
any Receivable for less than the total unpaid balance thereof, (y) release, wholly or partially, any Person liable for the payment thereof, or (z) allow any credit or discount thereon. 

(g) At any time following the occurrence and during the continuation of an Event of Default, the Collateral Agent shall have the right at
any time to notify, or require such Grantor to notify, any Account Debtor of the Collateral Agent’s security interest in the Receivables and any Supporting Obligation and, in addition, the Collateral Agent may: (1) direct the Account
Debtors under any Receivables to make payment of all amounts due or to become due to such Grantor thereunder directly to the Collateral Agent; (2) notify, or require such Grantor to notify, each Person maintaining a lockbox or similar
arrangement to which Account Debtors under any Receivables have been directed to make payment to remit all amounts representing collections on checks and other payment items from time to time sent to or deposited in such lockbox or other arrangement
directly to the Collateral Agent; and (3) enforce, at the expense of such Grantor, collection of any such Receivables and to adjust, settle or 

  
 28 

 
compromise the amount or payment thereof, in the same manner and to the same extent as such Grantor might have done. If the Collateral Agent notifies such Grantor that it has elected to collect
the Receivables in accordance with the preceding sentence, any payments of Receivables received by such Grantor shall be forthwith (and in any event within two (2) Business Days) deposited by such Grantor in the exact form received, duly
indorsed by such Grantor to the Collateral Agent if required, in the Collateral Account maintained under the sole dominion and control of the Collateral Agent, and until so turned over, all amounts and proceeds (including checks and other
instruments) received by such Grantor in respect of the Receivables, any Supporting Obligation or Collateral Support shall be received in trust for the benefit of the Collateral Agent hereunder and shall be segregated from other funds of such
Grantor and such Grantor shall not, except as may be permitted by the Collateral Agent, adjust, settle or compromise the amount or payment of any Receivable, or release wholly or partly any Account Debtor or obligor thereof, or allow any credit or
discount thereon. 
 Section 6.06. Pledged Equity Interests, Investment Related Property.
(a) Except as provided in the next sentence, in the event such Grantor receives any dividends, interest, distributions, securities or other property on account of any Pledged Equity Interest or other Investment Related Property constituting
Collateral, upon the merger, consolidation, liquidation or dissolution of any issuer of such Pledged Equity Interest or Investment Related Property, then (i) such dividends, interest, distributions, securities or other property shall be
included in the definition of Collateral without further action (unless otherwise constituting an Excluded Asset) and (ii) such Grantor shall promptly take all steps, if any, necessary or reasonably advisable to ensure the validity, perfection,
priority and, if applicable, control of the Collateral Agent over such dividends, interest, distributions, securities or other property (including, without limitation, delivery thereof to the Collateral Agent) and pending any such action such
Grantor shall be deemed to hold such dividends, interest, distributions, securities or other property in trust for the benefit of the Collateral Agent and shall segregate such dividends, interest, distributions, securities or other property from all
other property of such Grantor; provided that, for the avoidance of doubt, such Grantor shall not be required to (x) comply with the delivery and control requirements set forth in Article 4 with respect to any such Investment Related
Property that constitutes Specified Minority Investments and (y) take any action to perfect Collateral Agent’s liens on any such dividends, interest, distributions, securities or other property, in each case, constituting Specified
Minority Investments other than as required pursuant to Article 4 hereof. Notwithstanding the foregoing, so long as no Event of Default shall have occurred and be continuing, the Collateral Agent authorizes such Grantor to retain all cash dividends,
securities, distributions and other property paid consistent with the past practice of the issuer and all scheduled payments of interest. 

  
 29 

 (b) Voting. 

(i) So long as no Event of Default shall have occurred and be continuing, except as otherwise provided under the covenants
and agreements relating to Investment Related Property in this Agreement or elsewhere herein or in the Credit Agreement, such Grantor shall be entitled to exercise or refrain from exercising any and all voting and other consensual rights pertaining
to the Investment Related Property included in the Collateral or any part thereof for any purpose not inconsistent with the terms of this Agreement or the Credit Agreement; provided, such Grantor shall not exercise or refrain from exercising
any such right if the Collateral Agent shall have notified such Grantor that, in the Collateral Agent’s reasonable judgment, such action would have a Material Adverse Effect; and provided further, such Grantor shall give the Collateral
Agent at least five (5) Business Days prior written notice of the manner in which it intends to exercise, or the reasons for refraining from exercising, any such right in a manner that could have a Material Adverse Effect; it being understood,
however, that neither the voting by such Grantor of any Pledged Stock for, or such Grantor’s consent to, the election of directors (or similar governing body) at a regularly scheduled annual or other meeting of stockholders or with respect to
incidental matters at any such meeting, nor such Grantor’s consent to or approval of any action otherwise permitted under this Agreement and the Credit Agreement, shall be deemed inconsistent with the terms of this Agreement or the Credit
Agreement within the meaning of this Section 6.06(b)(i) and no notice of any such voting or consent need be given to the Collateral Agent. 
 (ii) Upon the occurrence and during the continuation of an Event of Default: 
 (A) upon receipt of written notice from Collateral Agent terminating such Grantor’s voting rights, all rights of such Grantor to exercise or refrain from exercising the voting and other consensual
rights which it would otherwise be entitled to exercise pursuant hereto shall cease and all such rights shall thereupon become vested in the Collateral Agent (to the extent permitted by applicable law and the applicable agreements and organization
documents) who shall thereupon have the sole right to exercise such voting and other consensual rights; provided that (x) to the extent the applicable agreements or organizational documents prohibit the vesting of such voting rights in
the Collateral Agent (including, without limitation, through the use of a proxy or power-of-attorney), such Grantor shall exercise such voting and other consensual rights solely in accordance with the instructions

  
 30 

 
of the Collateral Agent and (y) such rights shall automatically revert back to such Grantor upon the waiver or cure of all Events of Default then existing; and 

(B) in order to permit the Collateral Agent to exercise the voting and other consensual rights which it may be entitled
to exercise pursuant hereto and to receive all dividends and other distributions which it may be entitled to receive hereunder: (1) such Grantor shall promptly execute and deliver (or cause to be executed and delivered) to the Collateral Agent
all proxies, dividend payment orders and other instruments as the Collateral Agent may from time to time reasonably request and (2) such Grantor acknowledges that the Collateral Agent may utilize the power of attorney set forth in
Section 8.01. 
 (c) Except (x) to the extent not prohibited by the Credit Agreement and (y) with respect to the
Specified Minority Investments, without the prior written consent of the Collateral Agent, it shall not vote to enable or take any other action to: (i) cause to be amended or terminated any partnership agreement, limited liability company
agreement, certificate of incorporation, by-laws or other organizational documents in any way that materially changes, in an adverse manner, the rights of such Grantor with respect to any Investment Related Property constituting Collateral or
adversely affects the validity, perfection or priority of the Collateral Agent’s security interest, (ii) cause any issuer of any Pledged Equity Interest to issue any additional stock, partnership interests, limited liability company
interest or other Equity Interests of any nature or to issue securities convertible into or granting the right of purchaser or exchange for any such additional stock, partnership interests, limited liability company interest or other Equity
Interests of any nature of such issuer unless such additional stock, partnership interests, limited liability company interest or any other Equity Interests owned by such Grantor (or, in each case, any portion thereof) has been pledged to the
Collateral Agent to the extent required by the terms and conditions of Sections 2.01 and 2.02, (iii) cause any issuer of any Pledged Equity Interest to dispose of all or a material portion of their assets, (iv) waive any material default
under or material breach of any terms of organizational document relating to the issuer of any Pledged Equity Interest or the terms of any Pledged Debt, (v) cause any issuer of any Pledged Partnership Interests or Pledged LLC Interests that are
not securities (for purposes of the UCC) on the Closing Date to elect or otherwise take any action to cause such Pledged Partnership Interests or Pledged LLC Interests to be treated as securities for purposes of the UCC or (vi) cause any
Pledged Partnership Interests or Pledged LLC Interests to be certificated without delivering each such certificate to the Collateral Agent in accordance with Section 4.01(a), subject to the delivery periods set forth in Section 4.05, and
such Grantor shall fulfill all other requirements under Article 4 applicable in respect thereof; provided, however, notwithstanding the foregoing, if any issuer of any Pledged Partnership Interests or Pledged LLC Interests takes any
such action in violation 

  
 31 

 
of the foregoing in this clause (v), such Grantor shall promptly notify the Collateral Agent in writing of any such election or action and, in such event, shall take all steps necessary or
advisable to establish the Collateral Agent’s “control” thereof. 
 (d) Except as expressly permitted by the
Credit Agreement, without the prior written consent of the Collateral Agent, it shall not permit any issuer (that is a Subsidiary) of any Pledged Equity Interest constituting Collateral to merge or consolidate unless (i) such issuer creates a
security interest that is perfected by a filed financing statement (that is not effective solely under section 9-508 of the UCC) in collateral in which such new debtor has or acquires rights, (ii) all the outstanding capital stock or other
Equity Interests of the surviving or resulting corporation, limited liability company, partnership or other entity is, upon such merger or consolidation, pledged hereunder (subject to Section 2.02 hereof) and no cash, securities or other
property is distributed in respect of the outstanding Equity Interests of any other constituent Grantor; provided that if the surviving or resulting Grantors upon any such merger or consolidation involving an issuer which is a First-Tier
Foreign Subsidiary, then such Grantor shall only be required to pledge Equity Interests in accordance with Sections 2.01 and 2.02 and (iii) such Grantor promptly complies with the delivery and control requirements of Article 4 hereof.

 Section 6.07. Intellectual Property. (a) Other than to the extent permitted by the Credit
Agreement, it shall not do any act or omit to do any act whereby any of the Material Intellectual Property may lapse, or become abandoned, canceled, dedicated to the public, forfeited or unenforceable, or which would adversely affect in any material
respect the validity, grant, or enforceability of the security interest granted therein. 
 (b) Other than to the extent
permitted in the Credit Agreement, it shall not, with respect to any Trademarks constituting Material Intellectual Property, cease the use of any of such Trademarks or fail to maintain the level of the quality of products sold and services rendered
under any of such Trademark at a level at least substantially consistent with the quality of such products and services as of the Closing Date, and such Grantor shall take all reasonable steps to insure that licensees of such Trademarks use such
consistent standards of quality except where the failure to use such Trademarks, to maintain such level of quality or take such steps would not have a Material Adverse Effect. 
 (c) It shall promptly notify the Collateral Agent if it knows or has reason to know that any item of Material Intellectual Property may become (i) abandoned or dedicated to the public or placed in
the public domain, (ii) invalid or unenforceable, (iii) subject to any adverse determination or development regarding such Grantor’s ownership, registration or use or the validity or enforceability of such item of Material
Intellectual Property (including the institution of, or any such determination or development in, any action or 

  
 32 

 
proceeding in the United States Patent and Trademark Office, the United States Copyright Office, any state registry within the United States or any court) or (iv) the subject of any
reversion or termination rights. 
 (d) Other than to the extent permitted by the Credit Agreement, it shall take all
commercially reasonable steps, including in any proceeding before the United States Patent and Trademark Office, the United States Copyright Office, any state registry within the United States or any court, to pursue any application and maintain any
registration or issuance of each Trademark, Patent, and Copyright, that, in each case, constitutes Material Intellectual Property owned by or exclusively licensed to such Grantor, subject to Section 6.08 hereof, including, but not limited to,
those items on Schedule 5.02 (II). 
 (e) In the event that any Material Intellectual Property owned by or exclusively licensed
to such Grantor is infringed, misappropriated, or diluted by a third party, such Grantor shall promptly take action in response to such infringement, misappropriation, or dilution to protect its rights in such Material Intellectual Property to the
extent that such Grantor deems it commercially reasonable to do so and such infringement, misappropriation or dilution would reasonably be expected to significantly detract from the value of such Material Intellectual Property. 

(f) It shall take commercially reasonable steps, consistent with industry standards, to protect the secrecy of all Trade Secrets that
constitute Material Intellectual Property, including, without limitation, entering into confidentiality agreements with employees and consultants and labeling and restricting access to secret information and documents. 

(g) It shall use commercially reasonable efforts to use proper statutory notice, consistent with industry standards, in connection with
its use of any of the Material Intellectual Property. 
 Section 6.08. Miscellaneous. Such Grantor
shall, within thirty (30) days after the Closing Date, with respect to any Material Contract that is a Non-Assignable Contract (other than any Material Contract that constitutes (i) an Account, Chattel Paper or Payment Intangible of such
Grantor or (ii) a Specified Minority Investment) in effect on the Closing Date and within thirty (30) days after entering into any Material Contract (entered into after the Closing Date) that is a Non-Assignable Contract (other than any
Specified Minority Investment), request in writing the consent of the counterparty or counterparties to such Non-Assignable Contract pursuant to the terms of such Non-Assignable Contract or applicable law to the assignment or granting of a security
interest in such Non- Assignable Contract to the Secured Parties and use commercially reasonable efforts to obtain such consent as soon as practicable thereafter. 

  
 33 

 ARTICLE 7 
 ACCESS; RIGHT OF INSPECTION AND FURTHER ASSURANCES; ADDITIONAL
GRANTORS 
 Section 7.01. Access; Right of Inspection. The Collateral Agent shall at
all times have free reasonable access during normal business hours to all the books, correspondence and records of each Grantor, and the Collateral Agent and its representatives may examine the same, take extracts therefrom and make photocopies
thereof, and each Grantor agrees to render to the Collateral Agent, at such Grantor’s cost and expense, such clerical and other assistance as may be reasonably requested with regard thereto. The Collateral Agent and its representatives shall
upon reasonable notice and at such reasonable times during normal business hours also have the right to enter any premises of each Grantor and inspect any property of each Grantor where any of the Collateral of such Grantor granted pursuant to this
Agreement is located for the purpose of inspecting the same, observing its use or otherwise protecting its interests therein. 
 Section 7.02. Further Assurances. (a) Each Grantor agrees that from time to time, at the expense of such Grantor, that it shall, subject to the other provisions hereof, promptly execute
and deliver all further instruments and documents, and take all further action, that may be necessary or desirable, or that the Collateral Agent may reasonably request, in order to create and/or maintain the validity, perfection or priority of and
protect any security interest granted or purported to be granted hereby or to enable the Collateral Agent to exercise and enforce its rights and remedies hereunder with respect to any Collateral. Without limiting the generality of the foregoing and
subject to Article 4 and Article 6 hereof, in each case, each Grantor shall: 
 (i) file such financing or
continuation statements, or amendments thereto, record security interests in Intellectual Property and execute and deliver such other agreements, instruments, endorsements, powers of attorney or notices, as may be necessary or desirable, or as the
Collateral Agent may reasonably request, in order to effect, reflect, perfect and preserve the security interests granted or purported to be granted hereby; 
 (ii) take all actions necessary to ensure the recordation of appropriate evidence of the liens and security interest granted hereunder in the Intellectual Property with any intellectual property registry
in the United States in which said Intellectual Property is registered or issued or in which an application for registration or issuance is pending including, without limitation, the United States Patent and Trademark Office, the United States
Copyright Office and the various Secretaries of State; 

  
 34 

 (iii) at any reasonable time, upon reasonable request by the Collateral
Agent, assemble the Collateral and allow inspection of the Collateral by the Collateral Agent, or persons designated by the Collateral Agent; 
 (iv) at the Collateral Agent’s request, appear in and defend any action or proceeding that may affect such Grantor’s title to or the Collateral Agent’s security interest in all or any
material part of the Collateral; and 
 (v) furnish the Collateral Agent with such information regarding the
Collateral, including, without limitation, the location thereof, as the Collateral Agent may reasonably request from time to time. 
 (b) Each Grantor hereby authorizes the Collateral Agent to file a Record or Records, including, without limitation, financing or continuation statements, intellectual property security agreements and
amendments to any of the foregoing, in any jurisdictions and with any filing offices, in each case, in the United States as the Collateral Agent may determine, in its sole discretion, are necessary or advisable to perfect or otherwise protect the
security interest granted to the Collateral Agent herein (subject to Article 2, Article 4 and Article 6 hereof). Such financing statements may describe the Collateral in the same manner as described herein or may contain an indication or description
of collateral that describes such property in any other manner as the Collateral Agent may determine, in its sole discretion, is necessary, advisable or prudent to ensure the perfection of the security interest in the Collateral granted to the
Collateral Agent herein, including, without limitation, describing such property as “all assets, whether now owned or hereafter acquired, developed or created” or words of similar effect. Each Grantor shall furnish to the Collateral Agent
from time to time statements and schedules further identifying and describing the Collateral and such other reports in connection with the Collateral as the Collateral Agent may reasonably request, all in reasonable detail. 

Section 7.03. Additional Grantors. From time to time subsequent to the Closing Date, additional domestic
Persons may become parties hereto as additional Grantors (each, an “Additional Grantor”), by executing a Pledge Supplement. Upon delivery of any such Pledge Supplement to the Collateral Agent, notice of which is hereby waived by Grantors,
each Additional Grantor shall be a Grantor and shall be as fully a party hereto as if Additional Grantor were an original signatory hereto. Each Grantor expressly agrees that its obligations arising hereunder shall not be affected or diminished by
the addition or release of any other Grantor hereunder, nor by any election of the Collateral Agent not to cause any Subsidiary of Borrower to become an Additional Grantor hereunder. This Agreement shall be fully effective as to any Grantor that is
or becomes a party hereto regardless of whether any other Person becomes or fails to become or ceases to be a Grantor hereunder. 

  
 35 

 ARTICLE 8 
 COLLATERAL AGENT APPOINTED ATTORNEY-IN-FACT 

Section 8.01. Power of Attorney. Each Grantor hereby irrevocably appoints the Collateral Agent (such
appointment being coupled with an interest) as such Grantor’s attorney-in-fact, with full authority in the place and stead of such Grantor and in the name of such Grantor, the Collateral Agent or otherwise, from time to time in the Collateral
Agent’s discretion to take any action and to execute any instrument that the Collateral Agent may deem reasonably necessary or advisable to accomplish the purposes of this Agreement, including, without limitation, the following: 

(a) upon the occurrence and during the continuance of any Event of Default, to obtain and adjust insurance required to be maintained by
such Grantor or paid to the Collateral Agent pursuant to and to the extent provided in the Credit Agreement; 
 (b) upon the
occurrence and during the continuance of any Event of Default, to ask for, demand, collect, sue for, recover, compound, receive and give acquittance and receipts for moneys due and to become due under or in respect of any of the Collateral;

 (c) upon the occurrence and during the continuance of any Event of Default, to receive, endorse and collect any drafts or
other instruments, documents and chattel paper in connection with clause (b) above; 
 (d) upon the occurrence and during
the continuance of any Event of Default, to file any claims or take any action or institute any proceedings that the Collateral Agent may deem necessary or desirable for the collection of any of the Collateral or otherwise to enforce the rights of
the Collateral Agent with respect to any of the Collateral; 
 (e) to prepare and file any UCC financing statements against such
Grantor as debtor; 
 (f) subject to any exceptions contained in Article 2 and Article 4 hereof, to prepare, sign, and file for
recordation in any intellectual property registry within the United States, appropriate evidence of the lien and security interest granted herein in the Intellectual Property in the name of such Grantor as debtor; 

(g) upon the occurrence and during the continuance of any Event of Default, to take or cause to be taken all actions necessary to perform
or comply or 

  
 36 

 
cause performance or compliance with the terms of this Agreement, including, without limitation, access to pay or discharge taxes or Liens (other than Permitted Liens) levied or placed upon or
threatened against the Collateral, the legality or validity thereof and the amounts necessary to discharge the same to be determined by the Collateral Agent in its sole discretion, any such payments made by the Collateral Agent to become obligations
of such Grantor to the Collateral Agent, due and payable immediately without demand; and 
 (h) upon the occurrence and during
the continuance of any Event of Default, generally to sell, transfer, lease, license, pledge, make any agreement with respect to or otherwise deal with any of the Collateral as fully and completely as though the Collateral Agent were the absolute
owner thereof for all purposes, and to do, at the Collateral Agent’s option and such Grantor’s expense, at any time or from time to time, all acts and things that the Collateral Agent deems reasonably necessary to protect, preserve or
realize upon the Collateral and the Collateral Agent’s security interest therein in order to effect the intent of this Agreement, all as fully and effectively as such Grantor might do. 

Section 8.02. No Duty On The Part Of Collateral Agent Or Secured Parties. The powers conferred on the
Collateral Agent hereunder are solely to protect the interests of the Secured Parties in the Collateral and shall not impose any duty upon the Collateral Agent or any Secured Party to exercise any such powers. The Collateral Agent and the Secured
Parties shall be accountable only for amounts that they actually receive as a result of the exercise of such powers, and neither they nor any of their officers, directors, employees or agents shall be responsible to any Grantor for any act or
failure to act hereunder, except for their own gross negligence or willful misconduct. 
 Section 8.03.
Appointment Pursuant to Credit Agreement. The Collateral Agent has been appointed as collateral agent pursuant to the Credit Agreement. The rights, duties, privileges, immunities and indemnities of the Collateral Agent hereunder are subject
to the provisions of the Credit Agreement. 
 ARTICLE 9 
 REMEDIES 
 Section 9.01. Generally.
(a) If any Event of Default shall have occurred and be continuing, the Collateral Agent may exercise in respect of the Collateral, in addition to all other rights and remedies provided for herein or otherwise available to it at law
or in equity, all the rights and remedies of the Collateral Agent on default under the UCC (whether or not the UCC applies to the affected Collateral) to collect, enforce or satisfy any Secured Obligations then owing, whether by acceleration or
otherwise, and also may pursue any of the following separately, successively or simultaneously: 
 (i) require
any Grantor to, and each Grantor hereby agrees that it shall at its expense and promptly upon request of the Collateral Agent forthwith, assemble all or part of the Collateral as directed by the Collateral Agent and make it available to the
Collateral Agent at a place to be designated by the Collateral Agent that is reasonably convenient to both parties; 

  
 37 

 (ii) enter onto the property where any Collateral is located and take
possession thereof with or without judicial process; 
 (iii) prior to the disposition of the Collateral, store,
process, repair or recondition the Collateral or otherwise prepare the Collateral for disposition in any manner to the extent the Collateral Agent deems appropriate; and 

(iv) without notice except as specified below or under the UCC, sell, assign, lease, license (on an exclusive or
nonexclusive basis) or otherwise dispose of the Collateral or any part thereof in one or more parcels at public or private sale, at any of the Collateral Agent’s offices or elsewhere, for cash, on credit or for future delivery, at such time or
times and at such price or prices and upon such other terms as the Collateral Agent may deem commercially reasonable. 
 (b) The
Collateral Agent or any Secured Party may be the purchaser of any or all of the Collateral at any public or private (to the extent to the portion of the Collateral being privately sold is of a kind that is customarily sold on a recognized market or
the subject of widely distributed standard price quotations) sale in accordance with the UCC and the Collateral Agent, as collateral agent for and representative of the Secured Parties, shall be entitled, for the purpose of bidding and making
settlement or payment of the purchase price for all or any portion of the Collateral sold at any such sale made in accordance with the UCC, to use and apply any of the Secured Obligations as a credit on account of the purchase price for any
Collateral payable by the Collateral Agent at such sale. Each purchaser at any such sale shall hold the property sold absolutely free from any claim or right on the part of any Grantor, and each Grantor hereby waives (to the extent permitted by
applicable law) all rights of redemption, stay and/or appraisal which it now has or may at any time in the future have under any rule of law or statute now existing or hereafter enacted. Each Grantor agrees that, to the extent notice of sale shall
be required by law, at least ten (10) days notice to such Grantor of the time and place of any public sale or the time after which any private sale is to be made shall constitute reasonable notification. The Collateral Agent shall not be
obligated to make any sale of Collateral regardless of notice of sale having been given. The Collateral Agent may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and

  
 38 

 
such sale may, without further notice, be made at the time and place to which it was so adjourned. Each Grantor agrees that it would not be commercially unreasonable for the Collateral Agent to
dispose of the Collateral or any portion thereof by using Internet sites that provide for the auction of assets of the types included in the Collateral or that have the reasonable capability of doing so, or that match buyers and sellers of assets.
Each Grantor hereby waives any claims against the Collateral Agent arising by reason of the fact that the price at which any Collateral may have been sold at such a private sale was less than the price which might have been obtained at a public
sale, even if the Collateral Agent accepts the first offer received and does not offer such Collateral to more than one offeree. If the proceeds of any sale or other disposition of the Collateral are insufficient to pay all the Secured Obligations,
the Grantors shall be liable for the deficiency and the fees of any attorneys employed by the Collateral Agent to collect such deficiency. Each Grantor further agrees that a breach of any of the covenants contained in this Section will cause
irreparable injury to the Collateral Agent, that the Collateral Agent has no adequate remedy at law in respect of such breach and, as a consequence, that each and every covenant contained in this Section shall be specifically enforceable against
such Grantor, and such Grantor hereby waives and agrees not to assert any defenses against an action for specific performance of such covenants except for a defense that no default has occurred giving rise to the Secured Obligations becoming due and
payable prior to their stated maturities. Nothing in this Section shall in any way limit the rights of the Collateral Agent hereunder. 
 (c) The Collateral Agent may sell the Collateral without giving any warranties as to the Collateral. The Collateral Agent may specifically disclaim or modify any warranties of title or the like. This
procedure will not be considered to adversely affect the commercial reasonableness of any sale of the Collateral. 
 (d) The
Collateral Agent shall have no obligation to marshal any of the Collateral. 
 Section 9.02. Application
of Proceeds. Except as expressly provided elsewhere in this Agreement, all proceeds received by the Collateral Agent in the event that an Event of Default shall have occurred and not otherwise been waived, and the maturity of the Obligations
shall have been accelerated pursuant to Section 8.01 of the Credit Agreement and in respect of any sale of, any collection from, or other realization upon all or any part of the Collateral shall be applied in full or in part by the Collateral
Agent against, the Secured Obligations in the following order of priority: first, to the payment of all costs and expenses of such sale, collection or other realization, including reasonable compensation to the Collateral Agent and its agents
and counsel, and all other expenses, liabilities and advances made or incurred by the Collateral Agent in connection therewith, and all amounts for which the Collateral Agent is entitled to indemnification hereunder (in its capacity as the
Collateral Agent and 

  
 39 

 
not as a Lender) and all advances made by the Collateral Agent hereunder for the account of the applicable Grantor, and to the payment of all costs and expenses paid or incurred by the Collateral
Agent in connection with the exercise of any right or remedy hereunder or under the Credit Agreement, all in accordance with the terms hereof or thereof; second, to the extent of any excess of such proceeds, to the payment of all other
Secured Obligations for the ratable benefit of the Secured Parties; and third, to the extent of any excess of such proceeds, to the payment to or upon the order of such Grantor or to whosoever may be lawfully entitled to receive the same or
as a court of competent jurisdiction may direct. 
 Section 9.03. Sales on Credit. If Collateral
Agent sells any of the Collateral upon credit, the Grantor will be credited only with payments actually made by purchaser and received by the Collateral Agent and applied to indebtedness of the purchaser. In the event the purchaser fails to pay for
the Collateral, Collateral Agent may resell the Collateral and Grantor shall be credited with proceeds of the sale. 
 Section 9.04. Investment Related Property. Each Grantor recognizes that, by reason of certain prohibitions contained in the Securities Act and applicable state securities laws, the Collateral
Agent may be compelled, with respect to any sale of all or any part of the Investment Related Property included in the Collateral conducted without prior registration or qualification of such Investment Related Property included in the Collateral
under the Securities Act and/or such state securities laws, to limit purchasers to those who will agree, among other things, to acquire the Investment Related Property included in the Collateral for their own account, for investment and not with a
view to the distribution or resale thereof. Each Grantor acknowledges that any such private sale may be at prices and on terms less favorable than those obtainable through a public sale without such restrictions (including a public offering made
pursuant to a registration statement under the Securities Act) and, notwithstanding such circumstances, each Grantor agrees that any such private sale shall be deemed to have been made in a commercially reasonable manner and that the Collateral
Agent shall have no obligation to engage in public sales and no obligation to delay the sale of any Investment Related Property included in the Collateral for the period of time necessary to permit the issuer thereof to register it for a form of
public sale requiring registration under the Securities Act or under applicable state securities laws, even if such issuer would, or should, agree to so register it. If the Collateral Agent determines to exercise its right to sell any or all of the
Investment Related Property included in the Collateral, upon written request, each Grantor shall and shall cause each issuer of any Pledged Stock to be sold hereunder, each 

  
 40 

 
partnership and each limited liability company from time to time to furnish to the Collateral Agent all such information as the Collateral Agent may request in order to determine the number and
nature of interest, shares or other instruments included in the Investment Related Property included in the Collateral which may be sold by the Collateral Agent in exempt transactions under the Securities Act and the rules and regulations of the
Securities and Exchange Commission thereunder, as the same are from time to time in effect. 

Section 9.05. Grant of Intellectual Property License. For the purpose of enabling the Collateral Agent, during
the continuance of an Event of Default, to exercise rights and remedies under Article 9 hereof at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies, and for no other purpose, each Grantor hereby grants
to the Collateral Agent, to the extent assignable, an irrevocable, non-exclusive license (exercisable without payment of royalty or other compensation to such Grantor), subject, in the case of Trademarks, to sufficient rights to quality control and
inspection in favor of such Grantor to avoid the risk of invalidation of said Trademarks, to use, assign, license or sublicense any of the Intellectual Property now owned or hereafter acquired, developed or created by such Grantor, wherever the same
may be located. Such license shall include access to all media in which any of the licensed items may be recorded or stored and to all computer programs used for the compilation or printout hereof. 

Section 9.06. Intellectual Property. (a) Anything contained herein to the contrary notwithstanding, in
addition to the other rights and remedies provided herein, upon the occurrence and during the continuation of an Event of Default: 
 (i) the Collateral Agent shall have the right (but not the obligation) to bring suit or otherwise commence any action or proceeding in the name of any Grantor, the Collateral Agent or otherwise, in the
Collateral Agent’s sole discretion, to enforce any Intellectual Property rights, in which event such Grantor shall, at the request of the Collateral Agent, do any and all lawful acts and execute any and all documents required by the Collateral
Agent in aid of such enforcement and such Grantor shall promptly, upon demand, reimburse and indemnify the Collateral Agent as provided in Article 12 hereof in connection with the exercise of its rights under this Section, and, to the extent that
the Collateral Agent shall elect not to bring suit to enforce any Intellectual Property rights as provided in this Section, each Grantor agrees to use all reasonable measures, whether by action, suit, proceeding or otherwise, to prevent the
infringement, misappropriation, dilution or other violation of any of such Grantor’s rights in the Intellectual Property by others and for that purpose agrees to diligently maintain any action, suit or proceeding

  
 41 

 
against any Person so infringing, misappropriating, diluting or otherwise violating as shall be necessary to prevent such infringement, misappropriation, dilution or other violation; 

(ii) upon written demand from the Collateral Agent, for the purpose of enabling the Collateral Agent, to exercise rights
and remedies under Article 9 hereof at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies, and for no other purpose, each Grantor shall grant, assign, convey or otherwise transfer to the Collateral
Agent or such Collateral Agent’s designee all of such Grantor’s right, title and interest in and to the Intellectual Property and shall execute and deliver to the Collateral Agent such documents as are necessary or appropriate to carry out
the intent and purposes of this Agreement; 
 (iii) each Grantor agrees that such an assignment and/or recording
shall be applied to reduce the Secured Obligations outstanding only to the extent that the Collateral Agent (or any Secured Party) receives cash proceeds in respect of the sale of, or other realization upon, the Intellectual Property; 

(iv) within five (5) Business Days after written notice from the Collateral Agent, each Grantor shall make available
to the Collateral Agent, to the extent within such Grantor’s power and authority, such personnel in such Grantor’s employ on the date of such Event of Default as the Collateral Agent may reasonably designate, by name, title or job
responsibility, to permit such Grantor to continue, directly or indirectly, to produce, advertise and sell the products and services sold or delivered by such Grantor under or in connection with the Trademarks or the Trademark Licenses, such persons
to be available to perform their prior functions on the Collateral Agent’s behalf and to be compensated by the Collateral Agent at such Grantor’s expense on a per diem, pro-rata basis consistent with the salary and benefit structure
applicable to each as of the date of such Event of Default; and 
 (v) the Collateral Agent shall have the right
to notify, or require each Grantor to notify, any obligors with respect to amounts due or to become due to such Grantor in respect of the Intellectual Property, of the existence of the security interest created herein, to direct such obligors to
make payment of all such amounts directly to the Collateral Agent, and, upon such notification and at the expense of such Grantor, to enforce collection of any such amounts and to adjust, settle or compromise the amount or payment thereof, in the
same manner and to the same extent as such Grantor might have done: 
 (A) all amounts and proceeds (including
checks and other instruments) received by Grantor in respect of amounts due 

  
 42 

 
to such Grantor in respect of the Collateral or any portion thereof shall be received in trust for the benefit of the Collateral Agent hereunder, shall be segregated from other funds of such
Grantor and shall be forthwith paid over or delivered to the Collateral Agent in the same form as so received (with any necessary endorsement) to be held as cash Collateral and applied as provided by Section 9.07 hereof; and 

(B) the Grantor shall not adjust, settle or compromise the amount or payment of any such amount or release wholly or
partly any obligor with respect thereto or allow any credit or discount thereon. 
 (b) If (i) an Event of Default shall
have occurred and, by reason of cure, waiver, modification, amendment or otherwise, no longer be continuing, (ii) no other Event of Default shall have occurred and be continuing, (iii) an assignment or other transfer to the Collateral
Agent of any rights, title and interests in and to the Intellectual Property shall have been previously made and shall have become absolute and effective, and (iv) the Secured Obligations shall not have become immediately due and payable, upon
the written request of any Grantor, the Collateral Agent shall promptly execute and deliver to such Grantor, at such Grantor’s sole cost and expense, such assignments or other transfer as may be necessary to reassign to such Grantor any such
rights, title and interests as may have been assigned to the Collateral Agent as aforesaid, subject to any disposition thereof that may have been made by the Collateral Agent; provided, after giving effect to such reassignment, the Collateral
Agent’s security interest granted pursuant hereto, as well as all other rights and remedies of the Collateral Agent granted hereunder, shall continue to be in full force and effect; and provided further, the rights, title and interests
so reassigned shall be free and clear of any other Liens granted by or on behalf of the Collateral Agent and the Secured Parties. 
 Section 9.07. Cash Proceeds; Deposit Accounts. (a) If any Event of Default shall have occurred and be continuing, in addition to the rights of the Collateral Agent specified in
Section 6.05 with respect to payments of Receivables, all proceeds of any Collateral received by any Grantor consisting of cash, checks and other near-cash items (collectively, “Cash Proceeds”), shall be deemed to be held by such
Grantor in trust for the Collateral Agent and, upon the written direction of the Collateral Agent, segregated from other funds of such Grantor, and shall, forthwith upon receipt by such Grantor, be turned over to the Collateral Agent in the exact
form received by such Grantor (duly indorsed by such Grantor to the Collateral Agent, if required) and held by the Collateral Agent in the Collateral Account. Any Cash Proceeds received by the Collateral Agent (whether from a Grantor or otherwise)
during the continuation of any Event(s) of Default may, in the sole discretion of the Collateral Agent, (i) be held by the Collateral Agent 

  
 43 

 
for the ratable benefit of the Secured Parties, as collateral security for the Secured Obligations (whether matured or unmatured) only for so long as it reasonably appears there may be additional
Secured Obligations that arise and/or (ii) then or at any time thereafter may be applied by the Collateral Agent against the Secured Obligations then due and owing. 
 (b) If any Event of Default shall have occurred and be continuing, the Collateral Agent may apply the balance from any Deposit Account or instruct the bank at which any Deposit Account is maintained to
pay the balance of any Deposit Account to or for the benefit of the Collateral Agent which shall be applied by the Collateral Agent in accordance with Section 9.07(a) hereof. For the avoidance of doubt, the Collateral Agent shall not be
entitled or permitted to provide any instruction to the bank or securities or commodities intermediary (as applicable) at which any Deposit Account, Security Account or Commodity Account is maintained with respect to the assets or balance therein
unless an Event of Default shall have occurred and be continuing. 
 ARTICLE 10 

COLLATERAL AGENT 
 The Collateral Agent has been appointed to act as Collateral Agent hereunder by Lenders and, by their acceptance of the benefits hereof, the other Secured Parties. The Collateral Agent shall be obligated,
and shall have the right hereunder, to make demands, to give notices, to exercise or refrain from exercising any rights, and to take or refrain from taking any action (including, without limitation, the release or substitution of Collateral), solely
in accordance with this Agreement and the Credit Agreement. In furtherance of the foregoing provisions of this Section, each Secured Party, by its acceptance of the benefits hereof, agrees that it shall have no right individually to realize upon any
of the Collateral hereunder, it being understood and agreed by such Secured Party that all rights and remedies hereunder may be exercised solely by the Collateral Agent for the benefit of Secured Parties in accordance with the terms of this Section.
The provisions of the Credit Agreement relating to the Collateral Agent including, without limitation, the provisions relating to resignation or removal of the Collateral Agent and the powers and duties and immunities of the Collateral Agent are
incorporated herein by this reference and shall survive any termination of the Credit Agreement. 
 ARTICLE 11 

CONTINUING SECURITY INTEREST; TRANSFER OF LOANS

 This Agreement shall create a continuing security interest in the Collateral and shall remain in full force and effect until
the payment in full of all Secured 

  
 44 

 
Obligations, the cancellation or termination of the Commitments and the cancellation, expiration, posting of backstop letters of credit or cash collateralization of all outstanding Letters of
Credit satisfactory to the issuer(s) of such Letters of Credit, be binding upon each Grantor, its successors and assigns, and inure, together with the rights and remedies of the Collateral Agent hereunder, to the benefit of the Collateral Agent and
its successors, transferees and assigns. Without limiting the generality of the foregoing, but subject to the terms of the Credit Agreement, any Lender may assign or otherwise transfer any Loans held by it to any other Person, and such other Person
shall thereupon become vested with all the benefits in respect thereof granted to Lenders herein or otherwise. Upon the payment in full of all Secured Obligations, the cancellation or termination of the Commitments and the cancellation, expiration,
posting of backstop letters of credit or cash collateralization of all outstanding Letters of Credit satisfactory to the issuer(s) of such Letters of Credit, the security interest granted hereby shall automatically terminate hereunder and of record
and all rights to the Collateral shall revert to the Grantors. Upon any such termination the Collateral Agent shall, at the Grantors’ expense, execute and deliver to the Grantors or otherwise authorize the filing of such documents as the
Grantors shall reasonably request, including financing statement amendments to evidence such termination. Upon any disposition of property permitted by the Credit Agreement, the Liens granted herein on and with respect to such property shall be
deemed to be automatically released and such property shall automatically revert to the applicable Grantor with no further action on the part of any Person. The Collateral Agent shall, at the applicable Grantor’s expense, execute and deliver or
otherwise authorize the filing of such documents as such Grantor shall reasonably request, in form and substance reasonably satisfactory to the Collateral Agent, including financing statement amendments to evidence such release. 

ARTICLE 12 

STANDARD OF CARE; COLLATERAL AGENT MAY
PERFORM 
 The powers conferred on the Collateral Agent hereunder are solely to protect its interest in the
Collateral and shall not impose any duty upon it to exercise any such powers. Except for the exercise of reasonable care in the custody of any Collateral in its possession and the accounting for moneys actually received by it hereunder, the
Collateral Agent shall have no duty as to any Collateral or as to the taking of any necessary steps to preserve rights against prior parties or any other rights pertaining to any Collateral. The Collateral Agent shall be deemed to have exercised
reasonable care in the custody and preservation of Collateral in its possession if such Collateral is accorded treatment substantially equal to that which the Collateral Agent accords its own property. Neither the Collateral Agent nor any of its
directors, officers, employees or agents shall be liable for failure to demand, collect or realize upon all or any part of the Collateral or for any delay in doing so or shall be under any obligation to sell or otherwise dispose of any Collateral
upon the request of any Grantor or otherwise. If any 

  
 45 

 
Grantor fails to timely perform any agreement contained herein, the Collateral Agent may itself perform, or cause performance of, such agreement, and the expenses of the Collateral Agent incurred
in connection therewith shall be payable by each Grantor under Section 10.2 of the Credit Agreement. 
 ARTICLE 13

 MISCELLANEOUS 
 Any notice required or permitted to be given under this Agreement shall be given in accordance with Section 10.1 of the Credit Agreement. No failure or delay on the part of the Collateral Agent in
the exercise of any power, right or privilege hereunder or under any other Credit Document shall impair such power, right or privilege or be construed to be a waiver of any default or acquiescence therein, nor shall any single or partial exercise of
any such power, right or privilege preclude other or further exercise thereof or of any other power, right or privilege. All rights and remedies existing under this Agreement and the other Credit Documents are cumulative to, and not exclusive of,
any rights or remedies otherwise available. In case any provision in or obligation under this Agreement shall be invalid, illegal or unenforceable in any jurisdiction, the validity, legality and enforceability of the remaining provisions or
obligations, or of such provision or obligation in any other jurisdiction, shall not in any way be affected or impaired thereby. All covenants hereunder shall be given independent effect so that if a particular action or condition is not permitted
by any of such covenants, the fact that it would be permitted by an exception to, or would otherwise be within the limitations of, another covenant shall not avoid the occurrence of a Default or an Event of Default if such action is taken or
condition exists. This Agreement shall be binding upon and inure to the benefit of the Collateral Agent and the Grantors and their respective successors and assigns to the extent permitted by the Credit Agreement. No Grantor shall, without the prior
written consent of the Collateral Agent given in accordance with the Credit Agreement, assign any right, duty or obligation hereunder. This Agreement and the other Credit Documents embody the entire agreement and understanding between the Grantors
and the Collateral Agent and supersede all prior agreements and understandings between such parties relating to the subject matter hereof and thereof. Accordingly, the Credit Documents may not be contradicted by evidence of prior, contemporaneous or
subsequent oral agreements of the parties. There are no unwritten oral agreements between the parties. This Agreement may be executed in one or more counterparts and by different parties hereto in separate counterparts, each of which when so
executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument; signature pages may be detached from multiple separate counterparts and attached to a single counterpart so that
all signature pages are physically attached to the same document. 

  
 46 

 THIS AGREEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER (INCLUDING,
WITHOUT LIMITATION, ANY CLAIMS SOUNDING IN CONTRACT LAW OR TORT LAW ARISING OUT OF THE SUBJECT MATTER HEREOF) SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT
OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK (OTHER THAN ANY MANDATORY PROVISIONS OF THE UCC RELATING TO THE LAW GOVERNING PERFECTION AND THE EFFECT OF PERFECTION OF THE
SECURITY INTEREST). 
 THE PROVISIONS OF THE CREDIT AGREEMENT UNDER THE HEADINGS “CONSENT TO JURISDICTION” AND
“WAIVER OF JURY TRIAL” ARE INCORPORATED HEREIN BY THIS REFERENCE AND SUCH INCORPORATION SHALL SURVIVE ANY TERMINATION OF THE CREDIT AGREEMENT. 
 [Remainder of page intentionally left blank] 

  
 47 

 IN WITNESS WHEREOF, each Grantor and the Collateral Agent have caused this Agreement to be
duly executed and delivered by their respective officers thereunto duly authorized as of the date first written above. 
  

					
	HOLOGIC, INC., as Grantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Finance and Administration, Chief Financial Officer and Assistant Treasurer and Assistant Secretary

  

 
					
	 BIOLUCENT, LLC, as Grantor

	
	By: Hologic, Inc.,
	Its Sole Member and Manager
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Finance and Administration, Chief Financial Officer and Assistant Treasurer and Assistant Secretary
	
	 CRUISER, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 CYTYC CORPORATION, as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 CYTYC DEVELOPMENT COMPANY LLC, as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary

 
					
	 CYTYC INTERIM, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 CYTYC INTERNATIONAL, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 CYTYC LIMITED LIABILITY COMPANY, as Grantor

	
	By: Cytyc Corporation,
	Its Sole Member
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary

 
					
	 CYTYC PRENATAL PRODUCTS CORP., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 CYTYC SURGICAL PRODUCTS II, LIMITED PARTNERSHIP, as Grantor

	
	By: Cytyc Corporation,
	Its General Partner
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 CYTYC SURGICAL PRODUCTS III, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary

 
					
	 CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP, as Grantor

	
	 By: Cytyc Corporation,
 Its General Partner

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 DIRECT RADIOGRAPHY CORP., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 HOLOGIC LIMITED PARTNERSHIP, as Grantor

	
	 By: Cytyc Corporation,
 Its General Partner

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 INTERLACE MEDICAL, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary

 
					
	 SENTINELLE MEDICAL USA INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 SUROS SURGICAL SYSTEMS, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 SST MERGER CORP., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 THIRD WAVE AGBIO, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 THIRD WAVE TECHNOLOGIES, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary

 
					
	GEN-PROBE INCORPORATED, as Grantor
		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 GEN-PROBE SALES & SERVICE, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 GEN-PROBE INTERNATIONAL, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 GEN-PROBE HOLDINGS, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 GEN-PROBE TRANSPLANT DIAGNOSTICS, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary

 
					
	 GEN-PROBE GTI DIAGNOSTICS HOLDING COMPANY, as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 GEN-PROBE GTI DIAGNOSTICS, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 GEN-PROBE PRODESSE, INC., as Grantor

		
	By:	 	 /s/ Glenn P. Muir

		 	Name:	 	Glenn P. Muir
		 	Title:	 	Executive Vice President, Treasurer and Assistant Secretary
	
	 GOLDMAN SACHS BANK USA, as Collateral Agent

		
	By:	 	 /s/    Meredith
Mackey        

		 	Authorized Signatory

 EXHIBIT A 
 TO PLEDGE AND SECURITY AGREEMENT 
 PLEDGE SUPPLEMENT 

This PLEDGE SUPPLEMENT, dated [mm/dd/yy], is delivered by [NAME OF GRANTOR] a [NAME OF STATE OF ORGANIZATION] [TYPE OF
ENTITY] (the “Grantor”) pursuant to that certain Pledge and Security Agreement, dated as of August [1], 2012 (as it may be from time to time amended, restated, modified, or supplemented, the “Security
Agreement”), among Hologic, Inc., the other Grantors named therein, and Goldman Sachs Bank USA, as the Collateral Agent. Capitalized terms used herein not otherwise defined herein shall have the meanings ascribed thereto in the Security
Agreement. 
 Grantor hereby confirms the grant to the Collateral Agent set forth in the Security Agreement of, and does hereby
grant to the Collateral Agent, a security interest in all of Grantor’s right, title and interest in and to all Collateral to secure the Secured Obligations, in each case whether now or hereafter existing or in which Grantor now has or hereafter
acquires an interest and wherever the same may be located. The Grantor represents and warrants that the attached Supplements to Schedules accurately and completely set forth all additional information required to be provided pursuant to the Security
Agreement and hereby agrees that such Supplements to Schedules shall constitute part of the Schedules to the Security Agreement. 
 THIS PLEDGE SUPPLEMENT AND THE RIGHTS AND OBLIGATIONS OF THE PARTIES HEREUNDER (INCLUDING, WITHOUT LIMITATION, ANY CLAIMS SOUNDING IN CONTRACT LAW OR TORT LAW ARISING OUT OF THE SUBJECT MATTER HEREOF)
SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF
NEW YORK (OTHER THAN ANY MANDATORY PROVISIONS OF THE UCC RELATING TO THE LAW GOVERNING PERFECTION AND THE EFFECT OF PERFECTION OF THE SECURITY INTEREST). 
 IN WITNESS WHEREOF, the Grantor has caused this Pledge Supplement to be duly executed and delivered by its duly authorized officer as of [mm/dd/yy]. 

 

			
	[NAME OF GRANTOR]
		
	 By:
	 	  

		 	 Name:

		 	 Title:

  
 A-1

 SUPPLEMENT TO SCHEDULE 5.01 

TO PLEDGE AND SECURITY AGREEMENT 
 Additional Information: 
 GENERAL INFORMATION 

(A) Full Legal Name, Type of Organization, Jurisdiction of Organization, Chief Executive Office/Sole Place of Business (or Residence if
Grantor is a Natural Person) and Organizational Identification Number of each Grantor: 
  

									
	 Full Legal Name
	  	 Type of

Organization
	  	 Jurisdiction of
Organization
	  	
Chief Executive
Office/Sole Place of
Business (or

Residence if

Grantor is a

Natural Person)
	  	 Organization I.D.#

		  		  		  		  	

 (B) Other Names (including any Trade Name or Fictitious Business Name) under which each 

Grantor currently conducts business: 
  

					
	 Full Legal Name
	  	 	  	 Trade Name or Fictitious Business Name

		  		  	

 (C) Changes in Name, Jurisdiction of Organization, Chief Executive Office or Sole Place of Business (or
Principal Residence if Grantor is a Natural Person) and Corporate Structure within past five (5) years: 
  

					
	 Grantor
	  	 Date of Change
	  	 Description of Change

		  		  	

 (D) Agreements pursuant to which any Grantor is bound as debtor within past five (5) years:

  

					
	 Grantor
	  	 	  	 Description of Agreement

		  		  	

  
 A-2

 SUPPLEMENT TO SCHEDULE 5.02 

TO PLEDGE AND SECURITY AGREEMENT 
 COLLATERAL IDENTIFICATION 
  

	I.	INVESTMENT RELATED PROPERTY 

  

	 	(A)	Pledged Stock: 

  

															
	 Grantor
	 	 Stock

Issuer
	 	 Class of

Stock
	 	 Certificated

(Y/N)
	 	 Stock

Certificate

No.
	 	 Par Value
	 	 No. of

Pledged

Stock
	 	 Percentage

of

Outstanding
Stock of the
 Stock Issuer

		 		 		 		 		 		 		 	

 Pledged LLC Interests: 
  

											
	 Grantor
	 	 Limited

Liability

Company
	 	 Certificated

(Y/N)
	  	 Certificate No.

(if any)
	  	 No. of Pledged

Units
	  	 Percentage of

Outstanding

LLC Interests

of the Limited
 Liability
 Company

		 		 		  		  		  	

 Pledged Partnership Interests: 

 

											
	 Grantor
	 	 Partnership
	 	 Type of

Partnership

Interests (e.g.,
 general or
 limited)
	  	 Certificated

(Y/N)
	  	 Certificate No.

(if any)
	  	 Percentage of
Outstanding
Partnership
Interests of
the
Partnership

		 		 		  		  		  	

 Pledged Trust Interests: 

 

											
	 Grantor
	 	 Trust
	 	 Class of Trust

Interests
	  	 Certificated

(Y/N)
	  	 Certificate No.

(if any)
	  	 Percentage of
Outstanding

Trust Interests
 of the Trust

		 		 		  		  		  	

 Pledged Debt: 
  

											
	 Grantor
	 	 Issuer
	 	 Original

Principal

Amount
	  	 Outstanding
Principal

Balance
	  	 Issue Date
	  	 Maturity Date

		 		 		  		  		  	

  
 A-3

 Securities Account: 

 

							
	 Grantor
	 	 Share of Securities

Intermediary
	 	 Account Number
	  	 Account Name

		 		 		  	

 Deposit Accounts: 
  

							
	 Grantor
	 	 Name of

Depositary Bank
	 	 Account Number
	  	 Account Name

		 		 		  	

 Commodities Accounts: 
  

							
	 Grantor
	 	 Name of Commodities

Intermediary
	 	 Account Number
	  	 Account Name

		 		 		  	

 (B) 
  

					
	 Grantor
	 	 Date of Acquisition
	 	 Description of Acquisition

 

	II.	INTELLECTUAL PROPERTY 

  

	 	(A)	Copyrights 

  

							
	 Grantor
	 	 Description of Copyright
	 	 Registration Number
	  	 Registration Date

		 		 		  	

  

	 	(B)	Copyright Licenses 

  

							
	 Grantor
	 	 Description of

Copyright License
	 	 Registration Number

(if any) of underlying
 Copyright
	  	 Name of Licensor

		 		 		  	

  

	 	(C)	Patents 

  

							
	 Grantor
	 	 Title of Patent
	 	 Patent Number/

(Application Number)
	  	 Issue Date/ (Filing Date)

		 		 		  	

  
 A-4

	 	(D)	Patent Licenses 

  

							
	 Grantor
	 	 Description of

Patent License
	 	 Patent Number of

underlying Patent
	  	 Name of Licensor

		 		 		  	

  

	 	(E)	Trademarks 

  

							
	 Grantor
	 	 Trademark
	 	 Registration Number/

(Serial Number)
	  	 Registration Date/

(Filing Date)

  

	 	(F)	Trademark Licenses 

  

							
	 Grantor
	 	 Description of

Trademark License
	 	 Registration Number of

underlying Trademark
	  	 Name of Licensor

 

	 	(G)	Trade Secret Licenses 

  

	III.	COMMERCIAL TORT CLAIMS 

  

					
	 Grantor
	 	 	  	 Commercial Tort Claims

		 		  	

  

	IV.	LETTER-OF-CREDIT RIGHTS 

  

					
	 Grantor
	 	 	  	 Description of Letters of Credit

		 		  	

  

	V.	WAREHOUSEMAN, BAILEES AND OTHER THIRD PARTIES IN POSSESSION OF COLLATERAL 

 

					
	 Grantor
	 	 Description of Property
	 	 Name and Address of Third Party

		 		 	

  

	VI.	MATERIAL CONTRACTS 

  

					
	 Grantor
	 	 	  	 Description of Material Contract

		 		  	

  
 A-5

 SUPPLEMENT TO SCHEDULE 5.04 

TO PLEDGE AND SECURITY AGREEMENT 
 Financing Statements: 
  

			
	 Grantor
	 	 Filing Jurisdiction(s)

		 	
		 	
		 	
		 	
		 	
		 	
		 	

  
 A-6

 SUPPLEMENT TO SCHEDULE 5.05 

TO PLEDGE AND SECURITY AGREEMENT 
 Additional Information: 
  

			
	 Name of Grantor
	 	 Location of Equipment and Inventory

		 	
		 	
		 	
		 	
		 	

  
 A-7

 EXHIBIT B 
 TO PLEDGE AND SECURITY AGREEMENT 
 UNCERTIFICATED SECURITIES CONTROL
AGREEMENT 
 This Uncertificated Securities Control Agreement dated as of
[            ], 20[    ] among [            ] (the “Pledgor”), Goldman Sachs Bank USA, as
collateral agent for the Secured Parties (in such capacity as collateral agent, together with its successors and permitted assigns, the “Collateral Agent”) and
[            ], a [            ] [corporation] (the “Issuer”). Capitalized terms used but not defined herein
shall have the meaning assigned in that certain Pledge and Security Agreement dated as of August [1], 2012, among the Pledgor, the other Grantors party thereto and the Collateral Agent (as amended, restated, amended and restated, supplemented or
otherwise modified from time to time, the “Security Agreement”). All references herein to the “UCC” shall mean the Uniform Commercial Code as in effect in the State of New York. 

Section 1. Registered Ownership of Shares. The Issuer hereby confirms and agrees that as of the date hereof the Pledgor is
the registered owner of [            ] shares of the Issuer’s [common] stock (the “Pledged Shares”) and the Issuer shall not change the registered owner of the Pledged
Shares without the prior written consent of the Collateral Agent. 
 Section 2. Instructions. If at any time the
Issuer shall receive instructions originated by the Collateral Agent relating to the Pledged Shares, the Issuer shall comply with such instructions without further consent by the Pledgor or any other person. 

Section 3. Additional Representations and Warranties of the Issuer. The Issuer hereby represents and warrants to the
Collateral Agent: 
 (a) It has not entered into, and until the termination of this agreement will not enter into, any agreement
with any other person relating the Pledged Shares pursuant to which it has agreed to comply with instructions issued by such other person; and 
 (b) It has not entered into, and until the termination of this agreement will not enter into, any agreement with the Pledgor or the Collateral Agent purporting to limit or condition the obligation of the
Issuer to comply with Instructions as set forth in Section 2 hereof. 
 (c) Except for (i) the claims and interest of
the Collateral Agent and of the Pledgor in the Pledged Shares and/or (ii) Permitted Liens, the Issuer does not know of any claim to, or interest in, the Pledged Shares. If any person asserts any lien, encumbrance or adverse claim (including any
writ, garnishment, judgment, warrant of attachment, execution or similar process) against the Pledged Shares, the Issuer will promptly notify the Collateral Agent and the Pledgor thereof. 

(d) This Uncertificated Securities Control Agreement is the valid and legally binding obligation of the Issuer. 

  
 B-1

 Section 4. Choice of Law. THIS AGREEMENT (INCLUDING, WITHOUT LIMITATION,
ANY CLAIMS SOUNDING IN CONTRACT LAW OR TORT LAW ARISING OUT OF THE SUBJECT MATTER HEREOF) SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES
THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. 
 Section 5.
Conflict with Other Agreements. In the event of any conflict between this Agreement (or any portion thereof) and any other agreement now existing or hereafter entered into, the terms of this Agreement shall prevail. No amendment or
modification of this Agreement or waiver of any right hereunder shall be binding on any party hereto unless it is in writing and is signed by all of the parties hereto. 
 Section 6. Voting Rights. Until such time as the Collateral Agent shall otherwise instruct the Issuer in writing, the Pledgor shall have the right to vote the Pledged Shares. 

Section 7. Successors; Assignment. The terms of this Agreement shall be binding upon, and shall inure to the benefit of, the
parties hereto and their respective corporate successors or heirs and personal representatives who obtain such rights solely by operation of law. The Collateral Agent may assign its rights hereunder only with the express written consent of the
Issuer and by sending written notice of such assignment to the Pledgor. 
 Section 8. Indemnification of Issuer. The
Pledgor and the Collateral Agent hereby agree that (a) the Issuer is released from any and all liabilities to the Pledgor and the Collateral Agent arising from the terms of this Agreement and the compliance of the Issuer with the terms hereof,
except to the extent that such liabilities arise from the Issuer’s negligence and (b) the Pledgor, its successors and assigns shall at all times indemnify and save harmless the Issuer from and against any and all claims, actions and suits
of others arising out of the terms of this Agreement or the compliance of the Issuer with the terms hereof, except to the extent that such arises from the Issuer’s negligence, and from and against any and all liabilities, losses, damages,
costs, charges, counsel fees and other expenses of every nature and character arising by reason of the same, until the termination of this Agreement. 
 Section 9. Notices. Any notice, request or other communication required or permitted to be given under this Agreement shall be in writing and deemed to have been properly given when delivered
in person, or when sent by telecopy or other electronic means and electronic confirmation of error free receipt is received or two (2) days after being sent by certified or registered United States mail, return receipt requested, postage
prepaid, addressed to the party at the address set forth below. 
  

			
	Pledgor:	    	[Name of Pledgor]
		    	[c/o Hologic, Inc.]
		    	 35 Crosby Drive
 Bedford, MA
01730

		    	 Attention: Glenn P. Muir, Executive Vice President, Finance and Administration

Facsimile: +1 781 282-0669

  
 B-2

			
		    	with a copy to:
		
		    	Brown Rudnick LLP
		    	 One Financial Center, Boston MA 02111
 Attention: Philip J. Flink, Esq.

		    	Facsimile: +1 617 856-8201
		
	Collateral Agent:	    	Goldman Sachs Bank USA
		    	[Address of Collateral Agent]
		    	 Attention: [            ]

Telecopier: [            ]

		
		    	Issuer: [Name and Address of Issuer]
		    	Attention: [                    ]
		    	Telecopier: [                     ]

 Any party may change its address for notices in the manner set forth above. 

Section 10. Termination. The obligations of the Issuer to the Collateral Agent pursuant to this Control Agreement shall
continue in effect until the security interests of the Collateral Agent in the Pledged Shares have been terminated pursuant to the terms of the Security Agreement and the Collateral Agent has notified the Issuer or the Borrower of such termination
in writing. The Collateral Agent agrees to provide notice of such termination in substantially the form of Exhibit A hereto to the Issuer upon the request of the Pledgor on or after the termination of the Collateral Agent’s security interest in
the Pledged Shares pursuant to the terms of the Security Agreement. The termination of this Control Agreement shall not terminate the Pledged Shares or alter the obligations of the Issuer to the Pledgor pursuant to any other agreement with respect
to the Pledged Shares. 
 Section 11. Counterparts. This Agreement may be executed in any number of counterparts,
all of which shall constitute one and the same instrument, and any party hereto may execute this Agreement by signing and delivering one or more counterparts. 

  
 B-3

 IN WITNESS WHEREOF, the parties hereto have caused this Uncertificated Securities Control
Agreement to be executed as of the date first above written by their respective officers thereunto duly authorized. 
  

			
	 [NAME OF PLEDGOR], as Pledgor

		
	By:	 	  

		 	Name:
		 	Title:
	
	 GOLDMAN SACHS BANK USA, as Collateral Agent

		
	By:	 	  

		 	Authorized Signatory
	
	[NAME OF ISSUER], as Issuer
		
	By:	 	  

		 	Name:
		 	Title:

  
 B-4

 Exhibit A 
 Goldman Sachs Bank USA 
 [Address] 

[Date] 
 [Name and Address of
Issuer] 
 Attention: [            ] 

 

	Re:	Termination of Control Agreement 

 You are hereby notified that the Uncertificated Securities Control Agreement between you, [Name of Pledgor] (the “Pledgor”) and the undersigned (a copy of which is attached) is terminated
and you have no further obligations to the undersigned pursuant to such Agreement. Notwithstanding any previous instructions to you, you are hereby instructed to accept all future directions with respect to Pledged Shares (as defined in the
Uncertificated Control Agreement) from the Pledgor. This notice terminates any obligations you may have to the undersigned with respect to the Pledged Shares, however nothing contained in this notice shall alter any obligations which you may
otherwise owe to the Pledgor pursuant to any other agreement. 
 You are instructed to deliver a copy of this notice by
facsimile transmission to the Pledgor. 
  

			
	Very truly yours,
	
	 GOLDMAN SACHS BANK USA, as Collateral Agent

		
	By:	 	  

		 	Authorized Signatory

  
 B-5

 EXHIBIT C 
 TO PLEDGE AND SECURITY AGREEMENT 
 SECURITIES ACCOUNT CONTROL AGREEMENT

 This Securities Account Control Agreement dated as of
[            ], 20[    ] (this “Agreement”) among [            ] (the
“Debtor”), Goldman Sachs Bank USA, as collateral agent for the Secured Parties (in such capacity as collateral agent, together with its successors and permitted assigns, the “Collateral Agent”) and
[            ], in its capacity as a “securities intermediary” as defined in Section 8-102 of the UCC (in such capacity, the “Securities
Intermediary”). Capitalized terms used but not defined herein shall have the meaning assigned thereto in that certain Pledge and Security Agreement dated August [1], 2012 among the Debtor, the other Grantors party thereto and the Collateral
Agent (as amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Security Agreement”). All references herein to the “UCC” shall mean the Uniform Commercial Code as in
effect in the State of New York. 
 Section 1. Establishment of Securities Account. The Securities Intermediary
hereby confirms and agrees that: 
 (a) The Securities Intermediary has established account number [IDENTIFY ACCOUNT
NUMBER] in the name “[IDENTIFY EXACT TITLE OF ACCOUNT]” (such account and any successor account, the “Securities Account”) and the Securities Intermediary shall not change the name or account number of the
Securities Account without the prior written consent of the Collateral Agent; 
 (b) All securities or other property underlying
any financial assets credited to the Securities Account shall be registered in the name of the Securities Intermediary, indorsed to the Securities Intermediary or in blank or credited to another securities account maintained in the name of the
Securities Intermediary and in no case will any financial asset credited to the Securities Account be registered in the name of the Debtor, payable to the order of the Debtor or specially indorsed to the Debtor except to the extent the foregoing
have been specially indorsed to the Securities Intermediary or in blank; 
 (c) All property delivered to the Securities
Intermediary pursuant to the Security Agreement will be promptly credited to the Securities Account; and 
 (d) The Securities
Account is a “securities account” within the meaning of Section 8-501 of the UCC. 
 Section 2.
“Financial Assets” Election. The Securities Intermediary hereby agrees that each item of property (including, without limitation, any investment property, financial asset, security, instrument, general intangible or cash) credited
to the Securities Account shall be treated as a “financial asset” within the meaning of Section 8-102(a)(9) of the UCC. 

  
 C-1

 Section 3. Control of the Securities Account. If at any time the Securities
Intermediary shall receive any order from the Collateral Agent directing transfer or redemption of any financial asset relating to the Securities Account, the Securities Intermediary shall comply with such entitlement order without further consent
by the Debtor or any other person. If the Debtor is otherwise entitled to issue entitlement orders and such orders conflict with any entitlement order issued by the Collateral Agent, the Securities Intermediary shall follow the orders issued by the
Collateral Agent. 
 Section 4. Subordination of Lien; Waiver of Set-Off. In the event that the Securities
Intermediary has or subsequently obtains by agreement, by operation of law or otherwise a security interest in the Securities Account or any security entitlement credited thereto, the Securities Intermediary hereby agrees that such security interest
shall be subordinate to the security interest of the Collateral Agent. The financial assets and other items deposited to the Securities Account will not be subject to deduction, set-off, banker’s lien, or any other right in favor of any person
other than the Collateral Agent (except that the Securities Intermediary may set off (i) all amounts due to the Securities Intermediary in respect of customary fees and expenses for the routine maintenance and operation of the Securities
Account and (ii) the face amount of any checks which have been credited to such Securities Account but are subsequently returned unpaid because of uncollected or insufficient funds). 

Section 5. Choice of Law. THIS AGREEMENT AND THE SECURITIES ACCOUNT (INCLUDING, WITHOUT LIMITATION, ANY CLAIMS SOUNDING IN
CONTRACT LAW OR TORT LAW ARISING OUT OF THE SUBJECT MATTER HEREOF) SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD
RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. Regardless of any provision in any other agreement, for purposes of the UCC, New York shall be deemed to be the Securities Intermediary’s jurisdiction (within the
meaning of Section 8-110 of the UCC) and the Securities Account (as well as the securities entitlements related thereto) shall be governed by the laws of the State of New York. 

Section 6. Conflict with Other Agreements. 
 (a) In the event of any conflict between this Agreement (or any portion thereof) and any other agreement now existing or hereafter entered into, the terms of this Agreement shall prevail; 

(b) No amendment or modification of this Agreement or waiver of any right hereunder shall be binding on any party hereto unless it is in
writing and is signed by all of the parties hereto; 
 (c) The Securities Intermediary hereby confirms and agrees that:

 (i) There are no other control agreements entered into between the Securities Intermediary and the Debtor with
respect to the Securities Account; 

  
 C-2

 (ii) It has not entered into, and until the termination of this Agreement,
will not enter into, any agreement with any other person relating to the Securities Account and/or any financial assets credited thereto pursuant to which it has agreed to comply with entitlement orders (as defined in Section 8-102(a)(8) of the
UCC) of such other person; and 
 (iii) It has not entered into, and until the termination of this Agreement,
will not enter into, any agreement with the Debtor or the Collateral Agent purporting to limit or condition the obligation of the Securities Intermediary to comply with entitlement orders as set forth in Section 3 hereof. 

Section 7. Adverse Claims. Except for the claims and interest of the Collateral Agent and of the Debtor in the Securities
Account, the Securities Intermediary does not know of any claim to, or interest in, the Securities Account or in any “financial asset” (as defined in Section 8-102(a) of the UCC) credited thereto. If any person asserts any
lien, encumbrance or adverse claim (including any writ, garnishment, judgment, warrant of attachment, execution or similar process) against the Securities Account or in any financial asset carried therein, the Securities Intermediary will promptly
notify the Collateral Agent and the Debtor thereof. 
 Section 8. Maintenance of Securities Account. In addition to,
and not in lieu of, the obligation of the Securities Intermediary to honor entitlement orders as agreed in Section 3 hereof, the Securities Intermediary agrees to maintain the Securities Account as follows: 

(a) Notice of Sole Control. If at any time the Collateral Agent delivers to the Securities Intermediary a notice of sole control
in substantially the form set forth in Exhibit A hereto, the Securities Intermediary agrees that after receipt of such notice, it will take all instruction with respect to the Securities Account solely from the Collateral Agent. 

(b) Voting Rights. Until such time as the Securities Intermediary receives a Notice of Sole Control pursuant to subsection
(a) of this Section 8, the Debtor shall direct the Securities Intermediary with respect to the voting of any financial assets credited to the Securities Account. 
 (c) Permitted Investments. Until such time as the Securities Intermediary receives a Notice of Sole Control signed by the Collateral Agent, the Debtor shall direct the Securities Intermediary with
respect to the selection of investments to be made for the Securities Account; provided, however, that the Securities Intermediary shall not honor any instruction to purchase any investments other than investments of a type described
on Exhibit B hereto. 
 (d) Statements and Confirmations. The Securities Intermediary will promptly send copies of all
statements, confirmations and other correspondence concerning the Securities Account and/or any financial assets credited thereto simultaneously to each of the Debtor and the Collateral Agent at the address for each set forth in Section 12 of
this Agreement. 
 (e) Tax Reporting. All items of income, gain, expense and loss recognized in the Securities Account
shall be reported to the Internal Revenue Service and all state and local taxing authorities under the name and taxpayer identification number of the Debtor. 

  
 C-3

 Section 9. Representations, Warranties and Covenants of the Securities
Intermediary. The Securities Intermediary hereby makes the following representations, warranties and covenants: 
 (a) The
Securities Account has been established as set forth in Section 1 above and such Securities Account will be maintained in the manner set forth herein until termination of this Agreement; and 

(b) This Agreement is the valid and legally binding obligation of the Securities Intermediary. 

Section 10 Indemnification of Securities Intermediary. The Debtor and the Collateral Agent hereby agree that (a) the
Securities Intermediary is released from any and all liabilities to the Debtor and the Collateral Agent arising from the terms of this Agreement and the compliance of the Securities Intermediary with the terms hereof, except to the extent that such
liabilities arise from the Securities Intermediary’s negligence and (b) the Debtor, its successors and assigns shall at all times indemnify and save harmless the Securities Intermediary from and against any and all claims, actions and
suits of others arising out of the terms of this Agreement or the compliance of the Securities Intermediary with the terms hereof, except to the extent that such arises from the Securities Intermediary’s negligence, and from and against any and
all liabilities, losses, damages, costs, charges, counsel fees and other expenses of every nature and character arising by reason of the same, until the termination of this Agreement. 

Section 11. Successors; Assignment. The terms of this Agreement shall be binding upon, and shall inure to the benefit of, the
parties hereto and their respective corporate successors or heirs and personal representatives who obtain such rights solely by operation of law. The Collateral Agent may assign its rights hereunder only with the express written consent of the
Securities Intermediary and by sending written notice of such assignment to the Debtor. 
 Section 12. Notices. Any
notice, request or other communication required or permitted to be given under this Agreement shall be in writing and deemed to have been properly given when delivered in person, or when sent by telecopy or other electronic means and electronic
confirmation of error free receipt is received or two (2) days after being sent by certified or registered United States mail, return receipt requested, postage prepaid, addressed to the party at the address set forth below. 

 

			
	Debtor:	    	 [Name of Debtor] [c/o Hologic, Inc.]
 35 Crosby Drive
 Bedford, MA 01730

		    	Attention: Glenn P. Muir, Executive Vice President, Finance and Administration
		    	Facsimile: +1 781 282-0669
		
		    	with a copy to:
		
		    	 Brown Rudnick LLP
 One
Financial Center, Boston MA 02111
 Attention: Philip J. Flink, Esq.

		    	Facsimile: +1 617 856-8201

  
 C-4

			
	Collateral Agent:	    	 Goldman Sachs Bank USA

[Address of Collateral Agent]
 Attention:
[                    ]

		    	Telecopier: [                    ]
		
	Securities Intermediary:	    	[Name and Address of Securities Intermediary]
		    	Attention: [            ]
		    	Telecopier: [            ]

 Any party may change its address for notices in the manner set forth above. 

Section 13. Termination. The obligations of the Securities Intermediary to the Collateral Agent pursuant to this Agreement
shall continue in effect until the security interest of the Collateral Agent in the Securities Account has been terminated pursuant to the terms of the Security Agreement and the Collateral Agent has notified the Securities Intermediary of such
termination in writing. The Collateral Agent agrees to provide notice of termination in substantially the form of Exhibit C hereto to the Securities Intermediary upon the request of the Debtor on or after the termination of the Collateral
Agent’s security interest in the Securities Account pursuant to the terms of the Security Agreement. The termination of this Agreement shall not terminate the Securities Account or alter the obligations of the Securities Intermediary to the
Debtor pursuant to any other agreement with respect to the Securities Account. 
 Section 14. Counterparts. This
Agreement may be executed in any number of counterparts, all of which shall constitute one and the same instrument, and any party hereto may execute this Agreement by signing and delivering one or more counterparts. 

  
 C-5

 IN WITNESS WHEREOF, the parties hereto have caused this Securities Account Control Agreement
to be executed as of the date first above written by their respective officers thereunto duly authorized. 
  

			
	 [DEBTOR], as Debtor

		
	By:	 	  

	Name:	 	
	Title:	 	
	
	 GOLDMAN SACHS BANK USA, as Collateral Agent

		
	By:	 	  

		 	 Authorized Signature

	
	 [NAME OF SECURITIES INTERMEDIARY], as Securities Intermediary

		
	By:	 	  

	Name:	 	
	Title:	 	

  
 C-6

 EXHIBIT A 
 TO SECURITIES ACCOUNT CONTROL AGREEMENT 
 Goldman Sachs Bank USA 

[Address] 
 [Date]

 [Name and Address of Securities Intermediary] 
 Attention: [            ] 
 Re: Notice of Sole Control 
 Ladies and Gentlemen: 

As referenced in the Securities Account Control Agreement dated as of
[            ], 20[    ] among [Name of Debtor] (the “Debtor”), you and the undersigned (a copy of which is attached), we hereby give you notice of our
sole control over securities account number [            ] (the “Securities Account”) and all financial assets credited thereto. You are hereby instructed not to accept any
direction, instructions or entitlement orders with respect to the Securities Account or the financial assets credited thereto from any person other than the undersigned, unless otherwise ordered by a court of competent jurisdiction. 

You are instructed to deliver a copy of this notice by facsimile transmission to the Debtor. 

 

			
	Very truly yours,
	
	 GOLDMAN SACHS BANK USA, as Collateral Agent

		
	 By:
	 	  

		 	 Authorized Signatory

 cc: [Name of Debtor] 

  
 C-7

 EXHIBIT B 
 TO SECURITIES ACCOUNT CONTROL AGREEMENT 
 Permitted Investments

 Cash Equivalents and Investment Grade Securities, each as defined in the Credit and Guaranty Agreement dated as of August [1], 2012 (as
it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time) by and among Borrower, Guarantors, the Lenders party thereto from time to time, Goldman Sachs Bank USA, as Administrative Agent and
Collateral Agent thereunder. 

  
 C-8

 EXHIBIT C 
 TO SECURITIES ACCOUNT CONTROL AGREEMENT 
 Goldman Sachs Bank USA 

[Address] 
 [Date]

 [Name and Address of Securities Intermediary] 
 Attention: [                    ] 

Re: Termination of Securities Account Control Agreement 
 You are hereby notified that the Securities Account Control Agreement dated as of [            ], 20[    ] among you, [Name
of Debtor] (the “Debtor”) and the undersigned (a copy of which is attached) is terminated and you have no further obligations to the undersigned pursuant to such Agreement. Notwithstanding any previous instructions to you, you are
hereby instructed to accept all future directions with respect to account number(s) [            ] from the Debtor. This notice terminates any obligations you may have to the undersigned
with respect to such account, however nothing contained in this notice shall alter any obligations which you may otherwise owe to the Debtor pursuant to any other agreement. 
 You are instructed to deliver a copy of this notice by facsimile transmission to the Debtor. 
  

			
	Very truly yours,
	
	 GOLDMAN SACHS BANK USA, as Collateral Agent

		
	By:	 	  

		 	Authorized Signatory

  
 C-9

 EXHIBIT D 
 TO PLEDGE AND SECURITY AGREEMENT 
 DEPOSIT ACCOUNT CONTROL AGREEMENT

 This Deposit Account Control Agreement dated as of
[            ], 20[    ] (this “Agreement”) among
[                    ] (the “Debtor”), and Goldman Sachs Bank USA, as collateral agent for the Secured Parties (in
such capacity as collateral agent, together with its successors and permitted assigns, the “Collateral Agent”) and [            ], in its capacity as a
“bank” as defined in Section 9-102 of the UCC (in such capacity, the “Financial Institution”). Capitalized terms used but not defined herein shall have the meaning assigned thereto in that certain Pledge and
Security Agreement dated as of August [1], 2012 between the Debtor, the other Grantors party thereto and the Collateral Agent (as amended, restated, supplemented or otherwise modified from time to time, the “Security Agreement”).
All references herein to the “UCC” shall mean the Uniform Commercial Code as in effect in the State of New York. 
 Section 1. Establishment of Deposit Account. The Financial Institution hereby confirms and agrees that: 
 (a) The Financial Institution has established account number [IDENTIFY ACCOUNT NUMBER] in the name “[IDENTIFY EXACT TITLE OF ACCOUNT]” (such account and any successor account, the
“Deposit Account”) and the Financial Institution shall not change the name or account number of the Deposit Account without the prior written consent of the Collateral Agent and, prior to delivery of a notice of sole control in
substantially the form set forth in Exhibit A hereto, the Debtor; and 
 (b) The Deposit Account is a “deposit
account” within the meaning of Section 9-102(a)(29) of the UCC. 
 Section 2. Control of the Deposit
Account. If at any time the Financial Institution shall receive any instructions originated by the Collateral Agent directing the disposition of funds in the Deposit Account, the Financial Institution shall comply with such instructions without
further consent by the Debtor or any other person. The Financial Institution hereby acknowledges that it has received notice of the security interest of the Collateral Agent in the Deposit Account and hereby acknowledges and consents to such lien.
If the Debtor is otherwise entitled to issue instructions and such instructions conflict with any instructions issued the Collateral Agent, the Financial Institution shall follow the instructions issued by the Collateral Agent. 

Section 3. Subordination of Lien; Waiver of Set-Off. In the event that the Financial Institution has or subsequently obtains
by agreement, by operation of law or otherwise a security interest in the Deposit Account or any funds credited thereto, the Financial Institution hereby agrees that such security interest shall be subordinate to the security interest of the
Collateral Agent. Money and other items credited to the Deposit Account will not be subject to deduction, set-off, banker’s lien, or any other right in favor of any person other than the Collateral Agent (except that the Financial Institution
may set off (i) all amounts due to the Financial Institution in 

  
 D-1

 
respect of customary fees and expenses for the routine maintenance and operation of the Deposit Account and (ii) the face amount of any checks which have been credited to such Deposit
Account but are subsequently returned unpaid because of uncollected or insufficient funds). 
 Section 4. Choice of
Law. THIS AGREEMENT AND THE DEPOSIT ACCOUNT (INCLUDING, WITHOUT LIMITATION, ANY CLAIMS SOUNDING IN CONTRACT LAW OR TORT LAW ARISING OUT OF THE SUBJECT MATTER HEREOF) SHALL BE GOVERNED BY, AND SHALL BE CONSTRUED AND ENFORCED IN ACCORDANCE WITH,
THE LAWS OF THE STATE OF NEW YORK WITHOUT REGARD TO CONFLICT OF LAWS PRINCIPLES THEREOF THAT WOULD RESULT IN THE APPLICATION OF ANY LAW OTHER THAN THE LAW OF THE STATE OF NEW YORK. Regardless of any provision in any other agreement, for purposes of
the UCC, New York shall be deemed to be the Financial Institution’s jurisdiction (within the meaning of Section 9-304 of the UCC) and the Deposit Account shall be governed by the laws of the State of New York. 

Section 5. Conflict with Other Agreements. 
 (a) In the event of any conflict between this Agreement (or any portion thereof) and any other agreement now existing or hereafter entered into, the terms of this Agreement shall prevail; 

(b) No amendment or modification of this Agreement or waiver of any right hereunder shall be binding on any party hereto unless it is in
writing and is signed by all of the parties hereto; and 
 (c) The Financial Institution hereby confirms and agrees that:

 (i) There are no other agreements entered into between the Financial Institution and the Debtor with respect
to the Deposit Account [other than             ]; and 
 (ii) It has not entered into, and until the termination of this Agreement, will not enter into, any agreement with any other person relating the Deposit Account and/or any funds credited thereto pursuant
to which it has agreed to comply with instructions originated by such persons as contemplated by Section 9-104 of the UCC. 

Section 6. Adverse Claims. The Financial Institution does not know of any liens, claims or encumbrances relating to the
Deposit Account. If any person asserts any lien, encumbrance or adverse claim (including any writ, garnishment, judgment, warrant of attachment, execution or similar process) against the Deposit Account, the Financial Institution will promptly
notify the Collateral Agent and the Debtor thereof. 
 Section 7. Maintenance of Deposit Account. In addition to,
and not in lieu of, the obligation of the Financial Institution to honor instructions as set forth in Section 2 hereof, the Financial Institution agrees to maintain the Deposit Account as follows: 

(a) Notice of Sole Control. If at any time the Collateral Agent delivers to the Financial Institution a Notice of Sole Control in
substantially the form set forth in Exhibit A hereto, the Financial Institution agrees that after receipt of such notice, it will take all instruction with respect to the Deposit Account solely from the Collateral Agent. 

  
 D-2

 (b) Statements and Confirmations. The Financial Institution will promptly send copies
of all statements, confirmations and other correspondence concerning the Deposit Account simultaneously to each of the Debtor and the Collateral Agent at the address for each set forth in Section 11 of this Agreement; and 

(c) Tax Reporting. All interest, if any, relating to the Deposit Account, shall be reported to the Internal Revenue Service and
all state and local taxing authorities under the name and taxpayer identification number of the Debtor. 
 Section 8.
Representations, Warranties and Covenants of the Financial Institution. The Financial Institution hereby makes the following representations, warranties and covenants: 
 (a) The Deposit Account has been established as set forth in Section 1 and such Deposit Account will be maintained in the manner set forth herein until termination of this Agreement; and 

(b) This Agreement is the valid and legally binding obligation of the Financial Institution. 

Section 9. Indemnification of Financial Institution. The Debtor and the Collateral Agent hereby agree that (a) the
Financial Institution is released from any and all liabilities to the Debtor and the Collateral Agent arising from the terms of this Agreement and the compliance of the Financial Institution with the terms hereof, except to the extent that such
liabilities arise from the Financial Institution’s negligence and (b) the Debtor, its successors and assigns shall at all times indemnify and save harmless the Financial Institution from and against any and all claims, actions and suits of
others arising out of the terms of this Agreement or the compliance of the Financial Institution with the terms hereof, except to the extent that such arises from the Financial Institution’s negligence, and from and against any and all
liabilities, losses, damages, costs, charges, counsel fees and other expenses of every nature and character arising by reason of the same, until the termination of this Agreement. 

Section 10. Successors; Assignment. The terms of this Agreement shall be binding upon, and shall inure to the benefit of, the
parties hereto and their respective corporate successors or heirs and personal representatives who obtain such rights solely by operation of law. The Collateral Agent may assign its rights hereunder only with the express written consent of the
Financial Institution and by sending written notice of such assignment to the Debtor. 
 Section 11. Notices. Any
notice, request or other communication required or permitted to be given under this Agreement shall be in writing and deemed to have been properly given when delivered in person, or when sent by telecopy or other electronic means and electronic
confirmation of error free receipt is received or two (2) days after being sent by certified or registered United States mail, return receipt requested, postage prepaid, addressed to the party at the address set forth below. 

  
 D-3

			
	Debtor:	  	[Name of Debtor]
		  	[c/o Hologic, Inc.]
		  	 35 Crosby Drive
 Bedford, MA
01730
 Attention: Glenn P. Muir, Executive Vice President, Finance and Administration

		  	Facsimile: +1 781 282-0669
		
		  	with a copy to:
		
		  	 Brown Rudnick LLP
 One
Financial Center, Boston MA 02111
 Attention: Philip J. Flink, Esq.

		  	Facsimile: +1 617 856-8201
		
	Collateral Agent:	  	Goldman Sachs Bank USA
		  	[Address of Collateral Agent]
		  	 Attention:
[                    ]
 Telecopier:
[                    ]

		
	Financial Institution:	  	[Name and Address of Financial Institution]
		  	Attention: [    ] Telecopier:
[                    ]

 Any party may change its address for notices in the manner set forth above. 

Section 12. Termination. The obligations of the Financial Institution to the Collateral Agent pursuant to this Agreement
shall continue in effect until the security interest of the Collateral Agent in the Deposit Account has been terminated pursuant to the terms of the Security Agreement and the Collateral Agent has notified the Financial Institution of such
termination in writing. The Collateral Agent agrees to provide notice of termination in substantially the form of Exhibit B hereto to the Financial Institution upon the request of the Debtor on or after the termination of the Collateral Agent’s
security interest in the Deposit Account pursuant to the terms of the Security Agreement. The termination of this Agreement shall not terminate the Deposit Account or alter the obligations of the Financial Institution to the Debtor pursuant to any
other agreement with respect to the Deposit Account. 
 Section 13. Counterparts. This Agreement may be executed in
any number of counterparts, all of which shall constitute one and the same instrument, and any party hereto may execute this Agreement by signing and delivering one or more counterparts. 

  
 D-4

 IN WITNESS WHEREOF, the parties hereto have caused this Deposit Account Control Agreement to
be executed as of the date first above written by their respective officers thereunto duly authorized. 
  

			
	 [DEBTOR],
as Debtor

		
	 By:
	 	  

		 	 Name:

		 	 Title:

  

			
	 GOLDMAN SACHS BANK USA., as
Collateral Agent

		
	By:	 	  

		 	Authorized Signatory

  

			
	 [NAME OF FINANCIAL
INSTITUTION], as Financial
Institution

		
	By:	 	  

		 	Name:
		 	Title:

  

  
 D-5

 EXHIBIT A 
 TO DEPOSIT ACCOUNT CONTROL AGREEMENT 
 Goldman Sachs Bank USA 

[Address] 
 [Date]

 [Name and Address of Financial Institution] 
 Attention: [                    ] 

Re: Notice of Sole Control 

Ladies and Gentlemen: 
 As
referenced in the Deposit Account Control Agreement dated as of [            ], 20[    ] among [Name of Debtor] (the “Debtor”), you and the undersigned
(a copy of which is attached), we hereby give you notice of our sole control over deposit account number [            ] (the “Deposit Account”) and all financial assets
credited thereto. You are hereby instructed not to accept any direction, instructions or entitlement orders with respect to the Deposit Account or the financial assets credited thereto from any person other than the undersigned, unless otherwise
ordered by a court of competent jurisdiction. 
 You are instructed to deliver a copy of this notice by facsimile transmission
to the Debtor. 
  

			
	Very truly yours,
	
	 GOLDMAN SACHS BANK USA, as
 Collateral Agent

		
	By:	 	  

		 	Authorized Signatory

  

	cc:	[Name of Debtor] 

  
 D-6

 EXHIBIT B 
 TO DEPOSIT ACCOUNT CONTROL AGREEMENT 
 Goldman Sachs Bank USA 

[Address] 
 [Date]

 [Name and Address of Financial Institution] 
 Attention: [                    ] 

Re: Termination of Deposit Account Control Agreement 
 You are hereby notified that the Deposit Account Control Agreement dated as of [            ], 20[    ] among [Name of
Debtor] (the “Debtor”), you and the undersigned (a copy of which is attached) is terminated and you have no further obligations to the undersigned pursuant to such Agreement. Notwithstanding any previous instructions to you, you are
hereby instructed to accept all future directions with respect to account number(s) [            ] from the Debtor. This notice terminates any obligations you may have to the undersigned
with respect to such account, however nothing contained in this notice shall alter any obligations which you may otherwise owe to the Debtor pursuant to any other agreement. 
 You are instructed to deliver a copy of this notice by facsimile transmission to the Debtor. 
  

			
	Very truly yours,
	
	GOLDMAN SACHS BANK USA, as Collateral Agent
		
	By:	 	  

		 	Authorized Signatory

  
 D-7

 EXHIBIT E 
 TO PLEDGE AND SECURITY AGREEMENT 
 FORM OF TRADEMARK SECURITY AGREEMENT

 This Trademark Security Agreement dated as of [            ],
20[    ] (as it may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Trademark Security Agreement”) is made and entered into by and among each of the entities
identified on the signature pages hereto as a Grantor (each, a “Grantor” and, collectively, the “Grantors”) and Goldman Sachs Bank USA, in its capacity as collateral agent for the Secured Parties (together with any
successors and assigns thereto in such capacity, the “Collateral Agent”). 
 W I T N E S S E T H: 

WHEREAS, the Grantors are party to that certain Pledge and Security Agreement dated as of August [1], 2012 (as it may be amended,
restated, amended and restated, supplemented or otherwise modified from time to time, the “Pledge and Security Agreement”) by and among Hologic, Inc., a Delaware corporation (the “Borrower”), the Grantors, certain
other subsidiaries of the Borrower and the Collateral Agent, pursuant to which the Grantors are required to execute and deliver this Trademark Security Agreement; 
 NOW, THEREFORE, in consideration of the foregoing premises, the Grantors hereby agree with the Collateral Agent, as follows: 
 SECTION 1. Defined Terms. Unless otherwise defined herein, terms defined in the Pledge and Security Agreement and used herein have the meaning given to them in the Pledge and Security Agreement.

 SECTION 2. Grant of Security Interest in Trademark Collateral. 

2.1 Grant of Security. Each Grantor hereby grants to the Collateral Agent, for the benefit of the Secured Parties, a security
interest in and continuing lien on all of such Grantor’s right, title and interest in, to and under all trademarks registered in the United States (and/or all applications therefor), trade names, trade dress, corporate names, company names,
business names, fictitious business names, Internet domain names, service marks, certification marks, collective marks, logos, other source or business identifiers, designs and general intangibles of a like nature, whether or not registered, and
with respect to any and all of the foregoing: (i) all registrations and applications therefor, including, without limitation, the registrations and applications referred to or required to be referred to on Schedule I hereto, (ii) all
extensions or renewals of any of the foregoing, (iii) all of the goodwill of the business connected with the use of and symbolized by any of the foregoing, (iv) the right to sue or otherwise recover for past, present and future
infringement, dilution or other violation of any of the foregoing or for any injury to the related goodwill, (v) all Proceeds of the foregoing, including, without limitation, license fees, royalties, income payments, claims, damages and
proceeds of suit now or hereafter 

  
 E-1

 
due and/or payable with respect thereto, and (vi) all other rights of any kind accruing thereunder or pertaining thereto throughout the world (collectively, “Trademarks”),
in each case whether now owned or existing or hereafter acquired, created or arising and wherever located (collectively, the “Trademark Collateral”). 
 2.2 Certain Limited Exclusions. Notwithstanding anything herein to the contrary, in no event shall the Trademark Collateral include or the security interest granted under Section 2.1 hereof
attach to any “intent-to-use” application for Trademark registration filed pursuant to Section 1(b) of the Lanham Act, 15 U.S.C. §1051, prior to the filing under Section 1(c) or Section 1(d) of the Lanham Act of
a “Statement of Use” or an “Amendment to Allege Use” with respect thereto, solely to the extent, if any, that, and solely during the period, if any, in which, the grant of a security interest therein prior to such
filing would impair the validity or enforceability of any registration that issues from such intent-to-use Trademark application under applicable federal law. 
 SECTION 3. Security Agreement. The security interest granted pursuant to this Trademark Security Agreement is granted in conjunction with the security interest granted to the Collateral Agent for
the Secured Parties pursuant to the Pledge and Security Agreement, and the Grantors hereby acknowledge and affirm that the rights and remedies of the Collateral Agent with respect to the security interest in the Trademark Collateral made and granted
hereby are more fully set forth in the Pledge and Security Agreement, the terms and provisions of which are incorporated by reference herein as if fully set forth herein. In the event that any provision of this Trademark Security Agreement is deemed
to conflict with the Pledge and Security Agreement, the provisions of the Pledge and Security Agreement shall control. 

SECTION 4. Applicable Law. This Trademark Security Agreement and the rights and obligations of the parties hereunder shall be
governed by, and shall be construed and enforced in accordance with, the laws of the State of New York, without regard to its conflicts of law provisions (other than Section 5-1401 and Section 5-1402 of the New York General Obligation
Laws). 
 SECTION 5. Counterparts. This Trademark Security Agreement may be executed in any number of counterparts, each
of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument. 
 [Remainder of page intentionally left blank] 

  
 E-2

 IN WITNESS WHEREOF, each Grantor has caused this Trademark Security Agreement to be executed
and delivered by its duly authorized officer as of the date first set forth above. 
  

			
	 [NAME OF GRANTOR],

      as Grantor

		
	 By:
	 	  

		 	 Name:

		 	 Title:

  
 E-3

					
	STATE OF	  	                    )	 	
		  	                    :	 	ss
	COUNTY OF	  	                    )	 	

 On this      day of
            , before me personally appeared                     , proved to me on the
basis of satisfactory evidence to be the person who executed the foregoing instrument on behalf of                     , who being by me duly sworn
did depose and say that he/she is an authorized officer of said corporation, that the said instrument was signed on behalf of said corporation as authorized by its Board of Directors and that he/she acknowledged said instrument to be the free act
and deed of said corporation. 
  

	
	  

	Notary Public

  
 E-4

			
	 Accepted and Agreed:
  

GOLDMAN SACHS BANK USA., as Collateral Agent

 

	By:	 	  

		 	Authorized Signatory

  
 E-5

 SCHEDULE I 
 to 
 TRADEMARK SECURITY AGREEMENT 

TRADEMARK REGISTRATIONS AND APPLICATIONS 

  
 E-6

 EXHIBIT F 
 TO PLEDGE AND SECURITY AGREEMENT 
 FORM OF COPYRIGHT SECURITY AGREEMENT

 This Copyright Security Agreement dated as of [            ],
20[    ] (as it may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Copyright Security Agreement”) is made and entered into by and among each of the entities
identified on the signature pages hereto as a Grantor (each, a “Grantor” and, collectively, the “Grantors”) and Goldman Sachs Bank USA, in its capacity as collateral agent for the Secured Parties (together with any
successors and assigns thereto in such capacity, the “Collateral Agent”). 
 W I T N E S S E T H: 

WHEREAS, Grantors are party to that certain Pledge and Security Agreement dated as of August [1], 2012 (as it may be amended, restated,
amended and restated, supplemented or otherwise modified from time to time, the “Pledge and Security Agreement”) by and among Hologic, Inc., a Delaware corporation (the “Borrower”), the Grantors, certain other
subsidiaries of the Borrower and the Collateral Agent, pursuant to which the Grantors are required to execute and deliver this Copyright Security Agreement; 
 NOW, THEREFORE, in consideration of the foregoing premises, the Grantors hereby agree with the Collateral Agent, as follows: 
 SECTION 1. Defined Terms. Unless otherwise defined herein, terms defined in the Pledge and Security Agreement and used herein have the meaning given to them in the Pledge and Security Agreement.

 SECTION 2. Each Grantor hereby grants to the Collateral Agent, for the benefit of the Secured Parties, a security interest in
and continuing lien on all of such Grantor’s right, title and interest in, to and under the following, in each case whether now owned or existing or hereafter acquired, created or arising and wherever located (collectively, the
“Copyright Collateral”): 
 (a) all copyrights registered in the United States (and/or all applications
therefor), including but not limited to copyrights in software and all rights in and to databases, and all Mask Works (as defined under 17 U.S.C. 901 of the U.S. Copyright Act), whether registered or unregistered and whether or not the underlying
works of authorship have been published, moral rights, reversionary interests, termination rights, and, with respect to any and all of the foregoing: (i) all registrations and applications therefor including, without limitation, the
registrations and applications referred to on or required to be referred to Schedule I hereto, (ii) all extensions and renewals thereof, (iii) the right to sue or otherwise recover for past, present and future infringements thereof,
(iv) all Proceeds of the foregoing, including, without limitation, license fees, royalties, income, payments, claims, damages and proceeds of suit now or hereafter due and/or payable with respect thereto, and (v) all other rights of any
kind accruing thereunder or pertaining thereto throughout the world (collectively, “Copyrights”); and 

  
 F-1

 (b) any and all agreements, licenses and covenants granting to such Grantor any exclusive
right in or to any Copyrights including those referred to or required to be referred to on Schedule II hereto. 
 SECTION 3.
Security Agreement. The security interest granted pursuant to this Copyright Security Agreement is granted in conjunction with the security interest granted to the Collateral Agent for the Secured Parties pursuant to the Pledge and Security
Agreement, and the Grantors hereby acknowledge and affirm that the rights and remedies of the Collateral Agent with respect to the security interest in the Copyrights made and granted hereby are more fully set forth in the Pledge and Security
Agreement, the terms and provisions of which are incorporated by reference herein as if fully set forth herein. In the event that any provision of this Copyright Security Agreement is deemed to conflict with the Pledge and Security Agreement, the
provisions of the Pledge and Security Agreement shall control. 
 SECTION 4. Applicable Law. This Copyright Security
Agreement and the rights and obligations of the parties hereunder shall be governed by, and shall be construed and enforced in accordance with, the laws of the State of New York, without regard to its conflicts of law provisions (other than
Section 5-1401 and Section 5-1402 of the New York General Obligation Laws). 
 SECTION 5. Counterparts. This
Agreement may be executed in any number of counterparts, each of which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument. 

[Remainder of page intentionally left blank] 

  
 F-2

 IN WITNESS WHEREOF, each Grantor has caused this Copyright Security Agreement to be executed
and delivered by its duly authorized officer as of the date first set forth above. 
  

			
	 [NAME OF GRANTOR],
as Grantor

		
	By:	 	  

		 	Name:
		 	Title:

  
 F-3

					
	STATE OF	  	                    )	 	
		  	                    :	 	ss
	COUNTY OF	  	                    )	 	

 On this      day of
            , before me personally appeared                     , proved to me on the
basis of satisfactory evidence to be the person who executed the foregoing instrument on behalf of                     , who being by me duly sworn
did depose and say that he/she is an authorized officer of said corporation, that the said instrument was signed on behalf of said corporation as authorized by its Board of Directors and that he/she acknowledged said instrument to be the free act
and deed of said corporation. 
  

	
	  

	Notary Public

  
 F-4

			
	 Accepted and Agreed:
  

GOLDMAN SACHS BANK USA, as

Collateral Agent

		
	By:	 	  

		 	Authorized Signatory

  
 F-5

 SCHEDULE I 
 to 
 COPYRIGHT SECURITY AGREEMENT 

COPYRIGHT REGISTRATIONS AND APPLICATIONS 

  
 F-6

 SCHEDULE II 
 to 
 COPYRIGHT SECURITY AGREEMENT 

EXCLUSIVE COPYRIGHT LICENSES 

  
 F-7

 EXHIBIT G 
 TO PLEDGE AND SECURITY AGREEMENT 
 FORM OF PATENT SECURITY AGREEMENT

 This Patent Security Agreement dated as of [            ],
20[    ] (as it may be amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Patent Security Agreement”) is made and entered into by and among each of the entities
identified on the signature pages hereto as a Grantor (each, a “Grantor” and, collectively, the “Grantors”) and Goldman Sachs Bank USA, in its capacity as collateral agent for the Secured Parties (together with any
successors and assigns thereto in such capacity, the “Collateral Agent”). 
 W I T N E S S E T H: 

WHEREAS, Grantors are party to that certain Pledge and Security Agreement dated as of August [1], 2012 (as it may be amended, restated,
amended and restated, supplemented or otherwise modified from time to time, the “Pledge and Security Agreement”) by and among Hologic, Inc., a Delaware corporation (the “Borrower”), the Grantors, certain other
subsidiaries of the Borrower and the Collateral Agent, pursuant to which the Grantors are required to execute and deliver this Patent Security Agreement; 
 NOW, THEREFORE, in consideration of the foregoing premises, the Grantors hereby agree with the Collateral Agent, as follows: 
 SECTION 1. Defined Terms. Unless otherwise defined herein, terms defined in the Pledge and Security Agreement and used herein have the meaning given to them in the Pledge and Security Agreement.

 SECTION 2. Grant of Security Interest in Patent Collateral. Each Grantor hereby grants to the Collateral Agent, for
the benefit of the Secured Parties, a security interest in and continuing lien on all of such Grantor’s right, title and interest in, to and under all patents registered in the United States (and/or all applications therefor) and certificates
of invention, inventions or similar industrial property rights, and applications for any of the foregoing, including, but not limited to: (i) each patent and patent application referred to or required to be referred to on Schedule I hereto,
(ii) all reissues, divisions, continuations, continuations-in-part, extensions, renewals, and reexaminations thereof, (iii) all improvements thereto, (iv) the right to sue or otherwise recover for past, present and future
infringements or other violations thereof, (v) all Proceeds of the foregoing, including, without limitation, license fees, royalties, income, payments, claims, damages, and proceeds of suit now or hereafter due and/or payable with respect
thereto, and (vi) all other rights of any kind accruing thereunder or pertaining thereto throughout the world, in each case whether now owned or existing or hereafter acquired, created or arising and wherever located (collectively, the
“Patent Collateral”). 

  
 G-1

 SECTION 3. Security Agreement. The security interest granted pursuant to this Patent
Security Agreement is granted in conjunction with the security interest granted to the Collateral Agent for the Secured Parties pursuant to the Pledge and Security Agreement, and the Grantors hereby acknowledge and affirm that the rights and
remedies of the Collateral Agent with respect to the security interest in the Patent Collateral made and granted hereby are more fully set forth in the Pledge and Security Agreement, the terms and provisions of which are incorporated by reference
herein as if fully set forth herein. In the event that any provision of this Patent Security Agreement is deemed to conflict with the Pledge and Security Agreement, the provisions of the Pledge and Security Agreement shall control. 

SECTION 4. Applicable Law. This Patent Security Agreement and the rights and obligations of the parties hereunder shall be
governed by, and shall be construed and enforced in accordance with, the laws of the State of New York, without regard to its conflicts of law provisions (other than Section 5-1401 and Section 5-1402 of the New York General Obligation
Laws). 
 SECTION 5. Counterparts. This Patent Security Agreement may be executed in any number of counterparts, each of
which when so executed and delivered shall be deemed an original, but all such counterparts together shall constitute but one and the same instrument. 
 [Remainder of page intentionally left blank] 

  
 G-2

 IN WITNESS WHEREOF, each Grantor has caused this Patent Security Agreement to be executed
and delivered by its duly authorized officer as of the date first set forth above. 
  

			
	 [NAME OF GRANTOR],
as Grantor

		
	By:	 	  

		 	Name:
		 	Title:

  
 G-3

					
	STATE OF	  	                    )	 	
		  	                    :	 	ss
	COUNTY OF	  	                    )	 	

 On this      day of
            , before me personally appeared                     , proved to me on the
basis of satisfactory evidence to be the person who executed the foregoing instrument on behalf of                     , who being by me duly sworn
did depose and say that he/she is an authorized officer of said corporation, that the said instrument was signed on behalf of said corporation as authorized by its Board of Directors and that he/she acknowledged said instrument to be the free act
and deed of said corporation. 
  

	
	  

	Notary Public

  
 G-4

			
	 Accepted and Agreed:
  

GOLDMAN SACHS BANK USA, as
 Collateral
Agent

		
	By:	 	  

		 	Authorized Signatory

  
 G-5

 SCHEDULE I 
 to 
 PATENT SECURITY AGREEMENT 

PATENTS AND PATENT APPLICATIONS 

  
 G-6

 SCHEDULE I 
 to 
 PATENT SECURITY AGREEMENT 

PATENTS AND PATENT APPLICATIONS 

  
 G-7

 PLEDGE AND SECURITY AGREEMENT SCHEDULES 

The following Schedules (the “Schedules” or “Disclosure Schedules”) relate to the Pledge and Security
Agreement dated August 1, 2012 (as it may be refinanced, amended, restated, amended and restated, supplemented or otherwise modified from time to time, the “Pledge and Security Agreement”) between each of the Grantors thereto
and Goldman Sachs Bank USA. 
 Capitalized terms used but not defined herein shall have the same meanings ascribed to them in
the Pledge and Security Agreement. 
 The Disclosure Schedules are qualified in their entirety by reference to specific
provisions of the Pledge and Security Agreement, and are not intended to constitute, and shall not be construed as constituting, representations or warranties of any Grantor except and to the extent expressly provided in the Pledge and Security
Agreement. 
 The headings contained in the Disclosure Schedules are included for convenience only and are not intended to limit
the effect of the disclosures contained in the Disclosure Schedules or to expand the scope of the information required to be disclosed in the Disclosure Schedules. 
 The fact that any item or information is disclosed in the Disclosure Schedules shall not be construed to mean that such information is required to be disclosed by the Pledge and Security Agreement. The
inclusion of an item in the Disclosure Schedules as an exception to a representation or warranty will not be deemed an admission that such item represents a material exception or material fact, event or circumstance or that such item has had or
would reasonably be expected to have a Material Adverse Effect. 

  
 1 

 SCHEDULE 1.01A 
 TO PLEDGE AND SECURITY AGREEMENT 
 SPECIFIED CLOSING DATE MINORITY
INTERESTS 
  

									
	 Current Legal Entities Owned
	  	 Record Owner
	  	 Shares and/or Interest
	  	 Book Value
	 
	Roka Bioscience, Inc.	  	Gen-Probe Incorporated	  	10,726,289 shares of Series A preferred stock (voting); 1,403,235 shares of Series A-1 preferred stock (non-voting); and 3,003,668 shares of Series C preferred stock
(voting) (14.7%)	  	 	$4.7 million	  
	DiagnoCure, Inc.	  	Gen-Probe Incorporated	  	4,900,000 preferred shares (9.8%)	  	 	$5 million	  
	Pacific Biosciences of California, Inc.	  	Gen-Probe Incorporated	  	3,276,540 shares (4.8%)	  	 
 	$7.1 million (as of
7/16/2012)	  
  
	Qualigen, Inc.	  	Gen-Probe Incorporated	  	1,508,305 preferred voting shares and 643,511 non-voting shares (19.5%)	  	 	$5.4 million	  
	Cianna Medical, Inc.	  	Hologic, Inc.	  	1,000,000 Series A Preferred Shares, 6.56% fully-diluted ownership	  	 	$300,000	  
	New Leaf Ventures Partners Fund	  	Cytyc Corporation	  	1.4% of fund	  	 	$4.4 million	  
	Inspire Surgical Services, LLC	  	Hologic, Inc.	  	50% ownership, $500,000	  	 	$0.00	  
	Rubicor Medical, LLC (dba Encapsule Medical, LLC)	  	Hologic, Inc.	  	$750,000	  	 	$0.00	  
	Sunocine, Inc.	  	Hologic, Inc.	  	1,875,000 Series B Preferred Shares (contingent upon recruitment of additional investors’ funds in the amount of $2,000,000)	  	 	$0.00	  
	Combinent Biomedical Systems, Inc.	  	Cytyc Corporation	  	4,191,057 Common Shares	  	 	$0.00	  
	Windy Hill Medical, Inc.	  	Cytyc Corporation	  	966,568 Series A-2 Preferred Shares	  	 	$0.00	  
	Synarc Inc.	  	Hologic, Inc.	  	812,800 Common Shares, 4.78% ownership	  	 	cost basis $132,193	  
	Sierra Surgical Technologies, Inc.	  	Cytyc Corporation	  	2,100,000 Series A Preferred Shares	  	 	$0.00	  
	Collaborative Health Innovations, Inc.	  	Hologic, Inc.	  	$500,000 Convertible Note convertible into shares of Collaborative Health Innovations, Inc.	  	 
 
 
 
 
 
 	To be determined upon
conversion but in no
event will ownership
interest in
Collaborative Health
Innovations be greater
than
19.9%	  
  
  
  
  
  
  

  
 2 

 SCHEDULE 5.01 
 TO PLEDGE AND SECURITY AGREEMENT 
 GENERAL INFORMATION 

 

	(A)	Full Legal Name, Type of Organization, Jurisdiction of Organization, Chief Executive Office/Sole Place of Business (or Residence if Grantor is a Natural Person) and
Organizational Identification Number of each Grantor: 

  

									
	 Full Legal Name
	  	 Type of
Organization
	  	 Jurisdiction of
Organization
	  	 Chief Executive Office/Sole

Place of Business (or Residence

if Grantor is a Natural Person)
	  	 Organization I.D.#

	BioLucent, LLC	  	Limited Liability
Company	  	DE	  	250 Campus Drive, Marlborough, MA	  	4373762
	Cruiser, Inc.	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	3492272
	Cytyc Corporation	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	4350676
	Cytyc Development Company LLC	  	Limited Liability
Company	  	DE	  	250 Campus Drive, Marlborough, MA	  	3371780
	Cytyc Interim, Inc.	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	3413718
	Cytyc International, Inc.	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	3381869
	Cytyc Limited Liability Company	  	Limited Liability
Company	  	DE	  	250 Campus Drive, Marlborough, MA	  	3585822
	Cytyc Prenatal Products Corp.	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	2615867
	Cytyc Surgical Products, Limited Partnership	  	Limited
Partnership	  	MA	  	250 Campus Drive, Marlborough, MA	  	000954811
	Cytyc Surgical Products II, Limited Partnership	  	Limited
Partnership	  	MA	  	250 Campus Drive, Marlborough, MA	  	000954814
	Cytyc Surgical Products III, Inc.	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	2774404
	Direct Radiography Corp.	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	2590875
	Hologic, Inc.	  	Corporation	  	DE	  	35 Crosby Drive, Bedford, MA	  	2219600
	Hologic Limited Partnership	  	Limited
Partnership	  	MA	  	250 Campus Drive, Marlborough, MA	  	000828375
	Interlace Medical, Inc.	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	3994607
	Sentinelle Medical USA Inc.	  	Corporation	  	NV	  	250 Campus Drive, Marlborough, MA	  	E0485332007-5
	Suros Surgical Systems, Inc.	  	Corporation	  	DE	  	6100 Technology Center Drive,
Indianapolis, IN	  	3818261
	SST Merger Corp.	  	Corporation	  	DE	  	250 Campus Drive, Marlborough, MA	  	4391466
	Third Wave Agbio, Inc.	  	Corporation	  	DE	  	502 South Rosa Road, Madison, WI	  	2953247
	Third Wave Technologies, Inc.	  	Corporation	  	DE	  	502 South Rosa Road, Madison, WI	  	3275767

  
 3 

									
	 Full Legal Name
	  	 Type of
Organization
	  	 Jurisdiction of
Organization
	  	 Chief Executive Office/Sole

Place of Business (or Residence

if Grantor is a Natural Person)
	  	 Organization I.D.#

	Gen-Probe Incorporated	  	Corporation	  	DE	  	10210 Genetic Center Drive,
San Diego, CA 92121-4362	  	2133133
	Gen-Probe Sales & Service, Inc.	  	Corporation	  	DE	  	10210 Genetic Center Drive, San
Diego, CA 92121-4362	  	2777479
	Gen-Probe International, Inc.	  	Corporation	  	DE	  	10210 Genetic Center Drive, San
Diego, CA 92121-4362	  	4107840
	Gen-Probe Holdings, Inc.	  	Corporation	  	DE	  	550 West Avenue, Stamford, CT
06902	  	3708529
	Gen-Probe Transplant Diagnostics, Inc.	  	Corporation	  	DE	  	550 West Avenue, Stamford, CT 06902	  	3708528
	Gen-Probe GTI Diagnostics Holding Company	  	Corporation	  	DE	  	20925 Crossroads Circle, Waukesha,
WI 53186	  	4562580
	Gen-Probe GTI Diagnostics, Inc.	  	Corporation	  	WI	  	20925 Crossroads Circle, Waukesha,
WI 53186	  	1M22794
	Gen-Probe Prodesse, Inc.	  	Corporation	  	WI	  	20925 Crossroads Circle, Waukesha,
WI 53186	  	P029570

  

	(B)	Other Names (including any Trade Name or Fictitious Business Name) under which each Grantor (currently) commonly conducts business: 

 

			
	 Full Legal Name
	  	 Trade Name or Fictitious Business Name

	Hologic, Inc.	  	Hologic; Lorad; Fluoroscan
	Suros Surgical Systems, Inc.	  	Suros
	Direct Radiography Corp.	  	DRC
	Cytyc Corporation	  	Cytyc
	Cytyc Surgical Products II, Limited Partnership	  	Cytyc Surgical Products II; Cytyc Surgical Products, Inc.; Cytyc Surgical Products II, Inc.
	Cytyc Surgical Products III, Inc.	  	Adiana
	Cytyc Prenatal Products Corp.	  	Cytyc Prenatal Products; Adeza
	Third Wave Technologies, Inc.	  	Third Wave
	Third Wave Agbio, Inc.	  	Agbio
	Gen-Probe Holdings, Inc.	  	Tepnel North America Corporation
	Gen-Probe Transplant Diagnostics, Inc.	  	Tepnel Lifecodes Corporation; Gen-Probe Lifecodes; Tepnel Lifecodes; Lifecodes
	Gen-Probe GTI Diagnostics Holding Company	  	GTI Diagnostics Holding Company
	Gen-Probe GTI Diagnostics, Inc.	  	Genetic Testing Institute, Inc.; Genetic Testing Institute; GTI Diagnostics; GTI
	Gen-Probe Prodesse, Inc.	  	Prodesse, Inc.

  
 4 

	(C)	Changes in Name, Jurisdiction of Organization, Chief Executive Office or Sole Place of Business (or Principal Residence if Grantor is a Natural Person) and Corporate
Structure and has not commonly done business under any other name, in each case, within past five (5) years: 

  

					
	 Grantor
	  	Date of Change	  	 Description of Change

	Cytyc Corporation	  	10/22/2007	  	Cytyc Corporation was merged with and into Nor’easter Corp., with Nor’Easter Corp. being the surviving entity. Nor’easter Corp. changed its name to Cytyc
Corporation.
	BioLucent, LLC	  	9/19/2007	  	Merger of Bravo Transition, Inc., a wholly owned subsidiary of Hologic, Inc., with and into BioLucent, Inc. followed by merger of BioLucent, Inc. with and into Bravo Acquisition I,
LLC. Effective as of the merger, Bravo Acquisition I, LLC changed its name to BioLucent, LLC.
	Hologic Limited Partnership	  	10/31/2007	  	Name change from Cytyc Limited Partnership.
	Interlace Medical, Inc.	  	1/6/2011	  	Alpine Acquisition Corp. merged with and into Interlace Medical, Inc.
	Cytyc Surgical Products, Limited Partnership	  	6/27/2007	  	Cytyc Surgical Products, Inc. merged with and into Cytyc Surgical Products, Limited Partnership, a Massachusetts Limited Partnership, with Cytyc Surgical Products, Limited
Partnership being the surviving entity.
	Cytyc Surgical Products II, Limited Partnership	  	6/27/2007	  	Cytyc Surgical Products II, Inc., a Delaware Corporation, merged with and into Cytyc Surgical Products II, Limited Partnership, a Massachusetts Limited Partnership, with Cytyc
Surgical Products II, Limited Partnership being the surviving entity.
	Third Wave Technologies	  	7/24/2008	  	Thunder Tech Corp. merged with and into Third Wave Technologies, Inc.
	Gen-Probe Holdings, Inc.	  	5/1/2009	  	Name change from Tepnel North America Corporation
	Gen-Probe Transplant Diagnostics, Inc.	  	5/1/2009	  	Name change from Tepnel Lifecodes Corporation
	Gen-Probe GTI Diagnostics Holding Company	  	12/15/2010	  	Name change from GTI Diagnostics Holding Company
	Gen-Probe GTI Diagnostics, Inc.	  	12/15/2010	  	Name change from Genetic Testing Institute, Inc.
	Gen-Probe Prodesse, Inc.	  	10/21/2009	  	Name change from Prodesse, Inc.

  

	(D)	Security Agreements entered into by another Person pursuant to which any Grantor is bound as debtor within past five (5) years which has not been heretofore
terminated: 

 NONE 

  
 5 

 SCHEDULE 5.02 
 TO PLEDGE AND SECURITY AGREEMENT 
 COLLATERAL IDENTIFICATION

  

	I.	INVESTMENT RELATED PROPERTY 

  

	(1)	

	(A)	Pledged Stock: 

  

															
	 Grantor
	  	 Stock Issuer
	 	 Class of
Stock
	  	 Certificated
(Y/N)
	  	 Stock
Certificate
No.
	  	 Par Value
	  	 No. of
Pledged
Stock***
	  	 Percentage
of
Outstanding
Stock of the
Stock
Issuer
Pledged

	 Cytyc Corporation
	  	Cruiser, Inc.	 	Common	  	Y	  	1	  	$0.01	  	100	  	100%
	 Hologic, Inc.
	  	Cytyc
Corporation
(in the name
of Nor’easter
Corp.)	 	Common	  	Y	  	1	  	$0.01	  	2,000	  	100%
	 Cytyc International, Inc.
	  	Cytyc
Interim, Inc.	 	Common	  	Y	  	C-1	  	$0.01	  	100	  	100%
	 Cytyc Corporation
	  	Cytyc
International,
Inc.	 	Common	  	Y	  	C-1	  	$0.01	  	100	  	100%
	 Cytyc Corporation
	  	Cytyc
Prenatal
Products
Corp.	 	Common	  	Y	  	C-1	  	$0.001	  	1,000	  	100%
	 Cytyc Corporation
	  	Cytyc
Securities
Corporation	 	Common	  	Y	  	1	  	$0.01	  	250	  	100%
	 Cytyc Corporation
	  	Cytyc
Surgical
Products III,
Inc.	 	Common	  	Y	  	108	  	$0.01	  	100	  	100%
	 Hologic, Inc.
	  	Direct
Radiography
Corp.	 	Common	  	Y	  	4	  	$0.01	  	1,000	  	100%
		  		 	Series A
Preferred	  	Y
	  	P5
	  	$0.01
	  	1,000,000
	  	
	 Hologic, Inc.
	  	Hologic
Investment
Corp.	 	Common	  	Y	  	2	  	$0.01	  	100,000	  	100%
	 Hologic, Inc.
	  	Interlace
Medical, Inc.	 	Common	  	Y	  	1	  	$0.001	  	1	  	100%

  
 6 

															
	 Grantor
	  	 Stock Issuer
	 	 Class of
Stock
	  	 Certificated
(Y/N)
	  	 Stock
Certificate
No.
	  	 Par Value
	  	 No. of
Pledged
Stock***
	 	 Percentage
of
Outstanding
Stock of the
Stock
Issuer
Pledged

	 Cytyc Corporation
	  	SST Merger
Corp.	 	Common	  	Y	  	1	  	$0.01	  	100	 	100%
	 Hologic, Inc.
	  	Suros
Surgical
Systems, Inc.	 	Common	  	Y	  	1	  	$0.01	  	1	 	100%
	 Third Wave Technologies, Inc.
	  	Third Wave
Agbio, Inc.	 	Class A
Common	  	Y	  	A-105	  	$0.01	  	1,000 (Class
A Common)  
	 	100%
		  		 	Class B
Common	  		  	B-105	  	$0.01	  	20 (Class B
Common)  
	 	
		  		 	Series A
Preferred	  		  	AP-105	  	$0.01	  	1,000
(Series A
Preferred)	 	
	 Third Wave Technologies, Inc.
	  	Third Wave
Japan, Inc.	 	Series A-2	  	N	  	N/A	  	N/A	  	26,000	 	65%
	 Hologic, Inc.
	  	Third Wave
Technologies,
Inc.	 	Common	  	Y	  	1	  	$0.01	  	100	 	100%
	 Hologic, Inc.
	  	Gen-Probe
Incorporated	 	Common	  	Y	  	1	  	$0.001	  	100	 	100%
	 Cytyc Corporation
	  	Cytyc
Cayman
Limited	 	N/A	  	N	  	N/A	  	N/A	  	100	 	65%
	 Cytyc Interim, Inc.

Cytyc Corporation
	  	Hologic Asia
Pacific
Limited	 	N/A	  	Y	  	9	  	HK
$10.00	  	650	 	65%
	 Hologic, Inc.

Hologic Europer N.V.
	  	Hologic Asia
Limited	 	Ordinary	  	N	  	N/A	  	HKD
$1.00	  	65	 	65%
	 Cytyc Corporation
	  	Hologic
(Australia)
PTY Ltd.	 	Ordinary	  	Y	  	8	  	$1.00	  	347,750	 	65%

  
 7 

															
	 Grantor
	  	 Stock Issuer
	 	 Class of
Stock
	  	 Certificated
(Y/N)
	  	 Stock
Certificate
No.
	  	 Par Value
	  	 No. of
Pledged
Stock***
	  	 Percentage
of
Outstanding
Stock of the
Stock
Issuer
Pledged

	 Cytyc Corporation
	  	Hologic
Benelux
B.V.	 	N/A	  	N	  	N/A	  	1 EUR	  	50,000	  	65%
	 Cytyc Corporation
	  	Hologic
Canada
Limited	 	Common	  	Y	  	C-9	  	N/A	  	6,500	  	65%
	 Cytyc Corporation
	  	Hologic
Europe
Middle East
and Africa
S.A.	 	N/A	  	Y	  	1	  	CHF 1,000	  	65	  	65%
	 Cytyc Corporation
	  	Hologic
Iberia S.L.	 	N/A	  	N	  	N/A	  	N/A	  	3010 Euros	  	0%
	 Hologic, Inc.
	  	Hologic
International
Holdings
B.V.	 	N/A	  	N	  	N/A	  	Dfl. 100,---	  	400	  	65%
	 Cytyc Corporation
	  	Hologic
Italia S.r.l.	 	N/A	  	N	  	N/A	  	1 EUR	  	150,000	  	65%
	Hologic Surgical Products, Limited Partnership (fka Cytyc Surgical Products, Limited Partnership)	  	Hologic
Surgical
Products
Costa Rica
S.A.	 	Common	  	N	  	N/A	  	$1.00	  	100	  	0%
	 Cytyc Corporation
	  	Hologic
(UK)
Limited	 	Ordinary	  	Y	  	4	  	£1.00	  	6,500	  	65%
	 Hologic, Inc.
	  	R2
Technology
Canada, Inc.	 	Common	  	Y	  	C-5	  	$.01	  	715	  	65%
	 Hologic, Inc.
	  	Sentinelle	 	Common	  	Y	  	C-003	  	N/A	  	350,035	  	65%
	 Hologic, Inc.
	  	Medical Inc.
(fka 2247491
Ontario Inc.)	 		  		  	C-004	  		  	650.065	  	
	 Cytyc Corporation
	  	Hologic
France
SARL	 	N/A	  	N	  	N/A	  	N/A	  	319,682	  	65%

  
 8 

															
	 Grantor
	  	 Stock Issuer
	  	 Class of
Stock
	  	 Certificated
(Y/N)
	  	 Stock
Certificate
No.
	  	 Par Value
	  	 No. of Pledged
Stock***
	 	 Percentage
of
Outstanding
Stock of the
Stock
Issuer
Pledged

	Hologic, Inc.	  	Beijing
Healthcome
Technology
Co., Ltd.	  	N/A	  	N	  	N/A	  	N/A	  	100%	 	65%
	Hologic, Inc.	  	Navigation
Three
Limited	  	N/A	  	N	  	N/A	  	N/A	  	1,103,000,000	 	65%
	Hologic, Inc.	  	TCT
International
Co. Ltd.	  	Common	  	N	  	N/A	  	N/A	  	60,979,510
(Common)	 	65%
	Navigation Three Limited	  		  	Series A	  		  		  		  	10,796,220
(Series A)	 	
	Gen-Probe Incorporated	  	Gen-Probe
Sales &
Service, Inc.	  	Common	  	Y	  	1	  	$1.00	  	1,000	 	100%
	Gen-Probe Incorporated	  	Gen-Probe
International,
Inc.	  	Common	  	Y	  	C-2	  	$0.001	  	100	 	100%
	Gen-Probe Incorporated	  	Gen-Probe
Holdings,
Inc.	  	Common	  	Y	  	1	  	$0.01	  	100	 	100%
	Gen-Probe Holdings, Inc.	  	Gen-Probe
Transplant
Diagnostics,
Inc.	  	Common	  	Y	  	C-2	  	$0.01	  	100	 	100%
	Gen-Probe Incorporated	  	Gen-Probe
Prodesse,
Inc.	  	Common	  	Y	  	2	  	$0.001	  	100	 	100%
	Gen-Probe Incorporated	  	Gen-Probe
GTI
Diagnostics
Holdings
Company	  	Common	  	Y	  	7	  	$0.01	  	18,190	 	100%
	Gen-Probe GTI Diagnostics Holding Company	  	Gen-Probe
GTI
Diagnostics,
Inc.	  	Common	  	Y	  	9	  	$1.00	  	100	 	100%
	Gen-Probe Incorporated	  	Gen-Probe
UK Limited	  	Ordinary	  	Y	  	2	  	1.00 GBP	  	2,217,743	 	65%
	Gen-Probe Incorporated	  	Gen-Probe
Australia Pty
Ltd	  	Ordinary	  	Y	  	3	  	AUS $1.00	  	65	 	65%
	Gen-Probe Incorporated	  	Gen-Probe
Life Sciences
Ltd.	  	Ordinary	  	Y	  	3	  	0.01 GBP	  	482,451,088	 	65%

  
 9 

 SCHEDULE 5.02 
 TO PLEDGE AND SECURITY AGREEMENT 
 Pledged LLC Interests: 

 

											
	 Grantor
	  	 Limited Liability

Company
	  	 Certificated
(Y/N)
	  	 Certificate No.

(if any)
	  	 No. of

Pledged Units
	  	
Percentage of
Outstanding
LLC Interests
of the 
Limited
Liability
Company
Pledged

	Hologic, Inc.	  	BioLucent, LLC	  	Y	  	1	  	One unit representing 100% of the company’s membership interest	  	100%
	Cytyc Corporation	  	Cytyc Development Company LLC	  	Y	  	1	  	One unit representing 100% of the company’s membership interest	  	100%
	Cytyc Corporation	  	Cytyc Limited Liability Company	  	Y	  	1	  	One unit representing 100% of the company’s membership interest	  	100%
	Hologic, Inc.	  	Hologic Hitec-Imaging GmbH (formerly known as AEG Elektrofotografie GmbH)	  	N	  	N/A	  	3	  	65%
	Cytyc Corporation	  	Hologic Deutschland GmbH	  	N	  	N/A	  	1,000,000 Euros	  	65%
	Hologic, Inc.	  	Hologic (China) Enterprise Management Consulting Co., Ltd	  	N	  	N/A	  	Its 100% shareholder interest	  	65%
	Gen-Probe Incorporated	  	Gen-Probe Deutschland GmbH	  	N	  	N/A	  	16,250 Euros	  	65%
	Gen-Probe GTI Diagnostics, Inc.	  	GTI Diagnostics GmbH	  	N	  	N/A	  	16,250 Euros	  	65%

  
 10 

											
	 Grantor
	  	 Limited Liability

Company
	  	 Certificated
(Y/N)
	  	 Certificate No.

(if any)
	  	 No. of

Pledged Units
	  	
Percentage of
Outstanding
LLC Interests
of the 
Limited
Liability
Company
Pledged

	Gen-Probe Incorporated	  	Gen-Probe Sweden AB	  	Y	  	2, 3	  	32,500	  	65%
	Gen-Probe Incorporated	  	Gen-Probe Italia S.r.l.	  	N	  	N/A	  	32,500	  	65%
	Gen-Probe Incorporated	  	Gen-Probe Netherlands B.V.	  	N	  	N/A	  	58,500	  	65%
	Gen-Probe Incorporated	  	Gen-Probe France SAS	  	N	  	N/A	  	682,500	  	65%
	Gen-Probe Incorporated	  	Gen-Probe Denmark ApS	  	Y	  	2	  	52,065	  	65%
	Gen-Probe Incorporated	  	Gen-Probe Czech Republico s.r.o.	  	N	  	N/A	  	130,000	  	65%
	Gen-Probe Transplant Diagnostics, Inc.	  	Gen-Probe Belgium BVBA	  	N	  	N/A	  	12,084 Euros	  	65%
	Gen-Probe GTI Diagnostics, Inc.	  	Gen-Probe GTI Diagnostics K.K.	  	N	  	N/A	  	11,570	  	65%

  
 11 

 Pledged Partnership Interests: 

 

											
	 Grantor
	  	 Partnership
	  	 Type of

Partnership

Interests (e.g.,
 general or
 limited)
	  	Certificated (Y/N)	  	Certificate No. (if
any)	  	 Percentage of

Outstanding

Partnership

Interests of the
Partnership
 Pledged

	 Cytyc Corporation
 Cruiser,
Inc.
 Cytyc LLC
	  	Cytyc Surgical Products, Limited Partnership	  	General and Limited	  	Y	  	1
 2
 3
	  	 1% General Partner
 1% Limited
Partner
 98% Limited Partner

	 Cytyc Corporation
 Cruiser,
Inc.
 Cytyc LLC
	  	Cytyc Surgical Products II, Limited Partnerhsip	  	General and Limited	  	Y	  	1
 2
 3
	  	 1% General Partner
 1% Limited
Partner
 98% Limited Partner

	 Cytyc Corporation
 Cruiser,
Inc.
 Cytyc LLC
	  	Hologic Limited Partnership	  	General and Limited	  	Y	  	4
 5
 6
	  	 1% General Partner
 1%
Limited Partner
 98% Limited Partner

  
 12 

 Trust Interests or other Equity Interests not listed above: 

NONE 
 Minority Investments: 

Schedule 1.01A is hereby incorporated by reference. 
  

	2)	Pledged Debt: 

  

											
	 Grantor
	  	 Issuer
	  	 Original

Principal Amount
	  	 Outstanding

Principal Balance
	  	 Issue Date
	  	 Maturity Date

	Hologic LP	  	 Hologic Asia

Pacific Limited
 (Hong Kong)
	  	HKD 49,914,168	  	 HKD 40,914,168 as
 of July 18, 2012
	  	9/25/11	  	9/25/16
						
	 Gen-Probe

Incorporated
	  	 Gen-Probe Life

Sciences Ltd.
	  	GBP 3,300,000	  	 GBP 3,300,000 as of

July 16, 2012
	  	7/19/12	  	7/19/15

  

	3)	Securities Accounts, Securities Entitlements, Commodity Account and Commodity Contracts Securities Accounts: 

 

	A)	Security Accounts 

 See Schedule 14 on
Collateral Questionnaires. 
  

	(B)	Commodity Contracts and Commodities Accounts: 

NONE 
  

	(4)	Deposit Accounts: 

 See Schedule 14 on
Collateral Questionnaires. 

  
 13 

	II.	INTELLECTUAL PROPERTY 

  

	(5)	Patents, Trademarks and Copyrights constituting Material Intellectual Property 

 

	(A)	Patents 

  

									
	 Patent No.
	  	 Issued
	  	 Expiration
	  	 Owner
	  	 Title

	7590492	  	15-Sep-09	  	13-Jun-27	  	Cytyc Corporation	  	Method and System for Organizing Multiple Objects of Interest in Field of Interest
	7689038	  	30-Mar-10	  	21-Jul-28	  	Cytyc Corporation	  	A Method for Improved Image Segmentation
	6913881	  	5-Jul-05	  	28-Mar-17	  	Third Wave Technologies	  	METHODS AND COMPOSITIONS FOR DETECTING TARGET SEQUENCES
	7407782	  	5-Aug-08	  	2-Nov-16	  	Third Wave Technologies	  	NUCLEIC ACID DETECTION COMPOSITIONS
	7527948	  	5-May-09	  	4-May-25	  	Third Wave Technologies	  	DETECTION OF HPV
	7785852	  	31-Aug-10	  	31-Aug-14	  	Third Wave Technologies	  	CLEAVAGE OF NUCLEIC ACIDS
	6813520	  	2-Nov-04	  	12-Apr-16	  	Cytyc Corporation	  	Moisture Transport System for Contact Electrocoagulation
	7512445	  	31-Mar-09	  	19-Aug-17	  	Cytyc Corporation	  	Moisture Transport System for Contact Electrocoagulation (NATO)
	7604633	  	20-Oct-09	  	12-Apr-16	  	Cytyc Corporation	  	Moisture Transport System for Contact Electrocoagulation
	5432834	  	11-Jul-95	  	22-Nov-13	  	Hologic, Inc.	  	Whole-Body Dual-Energy Bone Densitometry Using a Naarrow Angle Fam Beam to Cover the Entire Body in Successive Scans
	6230036	  	8-May-01	  	8-May-18	  	Hologic, Inc.	  	SYSTEM FOR RADIOLOGICALLY SCANNING THE SPINE FOR MEASURING BONE DENSITY
	6135964	  	24-Oct-00	  	7-Jun-15	  	Hologic, Inc.	  	Ultrasonic Bone Testing Apparatus wth Repeatable Positioning and Repeatable Coupling
	7122803	  	17-Oct-06	  	29-Mar-25	  	Hologic, Inc.	  	Amorphous Selenium Flat Panel X-Ray Imager for Tomosynthesis and Static Imaging
	7233005	  	19-Jun-07	  	16-Feb-25	  	Hologic, Inc.	  	Amorphous Selenium Flat Panel X-Ray Imager for Tomosynthesis and Static Imaging
	7304308	  	4-Dec-07	  	13-Mar-25	  	Hologic, Inc.	  	Amorphous Selenium Flat Panel X-Ray Imager for Tomosynthesis and Static Imaging
	6350580	  	26-Feb-02	  	11-Oct-20	  	Hologic, Inc.	  	METHODS FOR DETECTION OF A TARGET NUCLEIC ACID USING A PROBE COMPRISING SECONDARY STRUCTURE
	7381532	  	3-Jun-08	  	5-Feb-20	  	Hologic, Inc.	  	COMPOSITIONS AND METHODS FOR THE DETECTION OF A NUCLEIC ACID USING A CLEAVAGE REACTION
	6001567	  	14-Dec-99	  	24-Jan-16	  	Third Wave Technologies	  	DETECTION OF NUCLEIC ACID SEQUENCES BY INVADER-DIRECTED CLEAVAGE
	6635463	  	21-Oct-03	  	24-May-20	  	Third Wave Technologies	  	ENZYMES FOR THE DETECTION OF NUCLEIC ACID SEQUENCES
	7577282	  	18-Aug-09	  	9-Aug-24	  	Hologic, Inc.	  	Image Handling and Display in X-Ray Mammography and Tomosynthesis
	7583786	  	1-Sep-09	  	11-Oct-25	  	Hologic, Inc.	  	X-Ray Mammography/Tomosynthesis of Patient’s Breast

  
 14 

									
	 Patent No.
	  	 Issued
	  	 Expiration
	  	 Owner
	  	 Title

	7616801	  	10-Nov-09	  	27-Nov-22	  	Hologic, Inc.	  	Image Handling and Display in X-Ray Mammography and Tomosynthesis
	7869563	  	11-Jan-11	  	23-Nov-25	  	Hologic, Inc.	  	Integrated Multi-Mode Mammography/Tomosynthesis X-Ray System and Method
	7970452	  	28-Jun-11	  	29-Apr-27	  	Hologic, Inc.	  	Open Architecture Imaging Apparatus and Coil System for Magnetic Resonance Imaging
	7988642	  	2-Aug-11	  	8-Feb-26	  	Hologic, Inc.	  	Vacuum Assisted Biopsy Device
	8048003	  	1-Nov-11	  	6-Dec-25	  	Suros Surgical Systems	  	Vacuum Assisted Biopsy Device

  
 15 

	(B)	Trademarks 

  

							
	 NAME OF

TRADEMARK
	  	 REGISTRATION AND/OR
APPLICATION NUMBER
	  	 COUNTRY
	  	 REGISTRATION

DATE

	HOLOGIC	  	3857248	  	US	  	10/5/2010
	HOLOGIC	  	006954069	  	CTM	  	7/28/2009
	SELENIA	  	3576103	  	US	  	2/17/2009
	SELENIA	  	007404941	  	CTM	  	1/20/2010
	NOVASURE	  	0884194	  	US	  	11/ 27/2001
	NOVASURE	  	004153243	  	CTM	  	11/30/2005
	THINPREP	  	1676316	  	US	  	2/18/1992
	THINPREP	  	2911395	  	US	  	12/14/2004
	THINPREP	  	2858447	  	US	  	06/29/2004
	THINPREP	  	000158949	  	CTM	  	07/08/1999
	THINPREP	  	002857100	  	CTM	  	04/03/2005
	INVADER	  	2304178	  	US	  	12/28/1999
	CLEAVASE	  	1920605	  	US	  	9/19/1995

  

	(C)	Copyrights 

 NONE 

  
 16 

	(6)	Patent Licenses, Trademark License, Trade Secret License and Copyright Licenses Constituting Material Intellectual Property 

 

	(A)	Patent Licenses 

  

			
	 License Agreement
	  	 Subject Matter

		
	 Non exclusive: License and Supply Agreement Between Third Wave and Epoch

Biosciences, Inc. (now Elitech, Inc.), dated June 25, 2004.
	  	Flourescent Dyes for Invader assays
		
	 Exclusive: License Agreement Between Cytyc Corp. and DEKA Products Limited, dated

March 22, 1993.
	  	Know-how for ThinPrep assay
		
	 License Agreement II between Arch Development Corp. (assignee of University of

Chicago patents) and R2, effective December 23, 1996, as amended on January 31, 2003,

as further amended on November 13, 2003, as further amended on March 23, 2005.
	  	Numberous patents, and technology used in R2 products.
		
	 License Agreement between University of Chicago and R2 Technology (licensee), dated

January 1, 2001.
	  	Numberous patents, and technology used in R2 products.
		
	 Exclusive: License Agreement between University of Chicago and R2 Technology

(licensee), dated July 27, 2003.
	  	Numberous patents, and technology used in R2 products.
		
	 Non Exclusive Agreement between University of Chicago and R2 Technology, dated

January 27, 2006.
	  	Numberous patents, and technology used in R2 products.
		
	 Exclusive License Agreement, October 1, 1993, and amended between Shih-Ping Bob
Wang
 and R2 Technology (licensee), dated June 16, 1997.
	  	Numberous patents, and technology used in R2 products.
		
	 Co-Exclusive License Agreement effective as of April 23, 1997 by and between
Gen-Probe
 Incorporated and The Board of Trustees of the Leland Stanford Junior University,
as
 amended (the “Stanford License”).
	  	Gen-Probe is the co-exclusive worldwide licensee of the Stanford nucleic acid amplification methods related to TMA.

  

	(B)	Trademark Licenses 

 NONE 

 

	(C)	Copyright Licenses 

 NONE 

 

	(D)	Trade Secret Licenses 

 NONE 

  
 17 

	(E)	Disputes: Schedule 5.7 is incorporated into this Schedule 5.2 by reference. 

 

	III.	COMMERCIAL TORT CLAIMS 

  

	(7)	Commercial Tort Claims 

  

			
	 Grantor    
	  	 Commercial Tort Claims

	 Hologic, Inc.        
	  	 On January 8, 2008, Hologic, Inc. filed a suit against SenoRx in the United States District Court for the District of Northern
California for infringement of U.S. Patent Nos. 5,913,813, 6,413,204 and 6,482,142. The complaint sought to enjoin SenoRx from infringing the patents, recovery of damages and costs, and sought a finding of willful infringement. On October 15, 2008,
the Markman claims construction hearing was held and a ruling was issued on February 18, 2009. A trial held in December 2009 resulted in a jury verdict in favor of SenoRx, finding the patents invalid. However, Hologic, Inc. appealed the matter to
the Court of Appeals for the Federal Court. On February 24, 2011, the Court of Appeals issued a ruling reversing the finding of invalidity by the District Court. The case has been remanded to the District Court for further proceedings consistent
with the Appeals Court’s ruling. The parties have proposed a tentative schedule which sets a trial date in February, 2013. On February 10, 2012, SenoRx, Inc. (“SenoRx”) filed a suit against Hologic in the United States District Court
of the District of Delaware. In the complaint, it is alleged that Hologic’s MammoSite product infringes SenoRx’s U.S. patents 8,079,946 and 8,075,469. The complaint seeks permanent injunctive relief and unspecified damages. Assuming the
parties do not settle the matter, in connection with the February, 2013 proceedings related to damages the District Court could award Hologic in excess of $5 million.

 

	 Gen-Probe

Incorporated
	  	 1.       Gen-Probe Incorporated v. Becton, Dickinson and
Company, in the United States District Court for the Southern District of California – Case No. 09 CV-2319 BEN(NLS), October 19, 2009.
  

2.       Gen-Probe Incorporated v. Becton, Dickinson and Company, in the
United States District Court for the Southern District of California – Case No. 10 CV-00602 JM-POR, March 23,
2010.1

 
 In October 2009, Gen-Probe filed a patent infringement action against Becton,
Dickinson and Company, or BD, in the United States District Court for the Southern District of California. The complaint alleges that BD’s ViperTM XTRTM testing system
infringes five of Gen-Probe’s U.S. patents covering automated processes for preparing, amplifying and detecting nucleic acid targets. The complaint also alleges that BD’s ProbeTecTM Female Endocervical and Male Urethral Specimen
Collection Kits for Amplified Chlamydia trachomatis/Neisseria gonorrhoeae (CT/GC) DNA assays used with the Viper XTR testing system infringe two of Gen-Probe’s U.S. patents covering penetrable caps for specimen collection tubes. The complaint
seeks monetary damages and injunctive relief. In March 2010, Gen-Probe filed a second complaint for patent infringement against BD in the United States District Court for the Southern District of California alleging that BD’s BD MAX SystemTM (formerly known as the HandyLab Jaguar system) infringes four of Gen Probe’s U.S. patents covering automated
processes for preparing, amplifying and detecting nucleic acid targets. The second complaint also seeks monetary damages and injunctive relief. In June 2010, these two actions were consolidated into a single legal proceeding.

  

	1 	This case was consolidated with Case No. 09 CV-2319 BEN(NLS) in June 2010. 

  
 18 

	IV.	LETTER OF CREDIT RIGHTS 

  

	(8)	Letters of Credit Rights 

 NONE 

  
 19 

	V.	WAREHOUSEMAN, BAILEES AND OTHER THIRD PARTIES IN POSSESSION OF COLLATERAL 

 

	(9)	Third Parties in Possession of Collateral 

  

									
	 Company
	  	 Name of Entity in
Possession of
Collateral/Capacity
of such
Entity
	  	 Address/Location
of Collateral
	  	 County
	  	 State

	 Gen-Probe Incorporated
	  	KMC Systems, Inc. (third party contract manufacturer of TIGRIS instruments)	  	220 Daniel Webster Highway Merrimack, NH 03054	  	Hillsborough	  	NH

  
 20 

	VI.	MATERIAL CONTRACTS 

  

	(10)	Material Contracts 

 Restated Agreement dated as
of July 24, 2009 by and between Gen-Probe Incorporated and Novartis Vaccines and Diagnostics, Inc. as modified by the Product Development Addendum for the Panther Instrument and Ultrio Elite Assay signed as of March 11, 2011 by and between
Gen-Probe Incorporated and Novartis Vaccines and Diagnostics, Inc. 
 Co-Exclusive License Agreement effective as of April 23, 1997 by and
between Gen-Probe Incorporated and The Board of Trustees of the Leland Stanford Junior University, as amended (the “Stanford License”). 
 Agreement and Plan of Merger dated April 29, 2012 by and among Hologic, Inc., Gold Acquisition Corp., and Gen-Probe Incorporated. 
 Indenture, dated as of December 10, 2007, by and between Wilmington Trust Company, as Trustee, and Hologic. 
 First Supplemental Indenture, dated December 10, 2007, by and between Wilmington Trust Company, as Trustee, and Hologic. 
 Second Supplemental Indenture, dated November 23, 2010, by and between Wilmington Trust Company, as Trustee, and Hologic. 
 Third Supplemental Indenture, dated March 5, 2012, by and between Wilmington Trust Company, as Trustee, and Hologic. 
 Indenture, dated as of August 1, 2012, by and between Wells Fargo Bank, National Association, as Trustee, and Hologic. 

  
 21 

 SCHEDULE 5.04 
 TO PLEDGE AND SECURITY AGREEMENT 
 FINANCING STATEMENTS: 

 

			
	 Grantor
	  	 Filing Jurisdiction(s)

	 BioLucent, LLC
	  	Office of the Secretary of State of the State of Delaware
	 Cruiser, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Cytyc Corporation
	  	Office of the Secretary of State of the State of Delaware
	 Cytyc Development Company LLC
	  	Office of the Secretary of State of the State of Delaware
	 Cytyc Interim, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Cytyc International, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Cytyc Limited Liability Company
	  	Office of the Secretary of State of the State of Delaware
	 Cytyc Prenatal Products Corp.
	  	Office of the Secretary of State of the State of Delaware
	 Cytyc Surgical Products, Limited Partnership
	  	Office of the Secretary of the Commonwealth of the Commonwealth of Massachusetts
	 Cytyc Surgical Products II, Limited Partnership
	  	Office of the Secretary of the Commonwealth of the Commonwealth of Massachusetts
	 Cytyc Surgical Products III, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Direct Radiography Corp.
	  	Office of the Secretary of State of the State of Delaware
	 Hologic, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Interlace Medical, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Suros Surgical Systems, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 SST Merger Corp.
	  	Office of the Secretary of State of the State of Delaware
	 Third Wave Agbio, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Third Wave Technologies, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Sentinelle Medical USA Inc.
	  	Office of the Secretary of State of the State of Nevada
	 Hologic Limited Partnership
	  	Office of the Secretary of the Commonwealth of the Commonwealth of Massachusetts
	 Gen-Probe Incorporated
	  	Office of the Secretary of State of the State of Delaware
	 Gen-Probe Sales & Service, Inc.
	  	Office of the Secretary of State of the State of Delaware

  
 22 

			
	 Grantor
	  	 Filing Jurisdiction(s)

	 Gen-Probe International, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Gen-Probe Holdings, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Gen-Probe Transplant Diagnostics, Inc.
	  	Office of the Secretary of State of the State of Delaware
	 Gen-Probe GTI Diagnostics Holding Company
	  	Office of the Secretary of State of the State of Delaware
	 Gen-Probe GTI Diagnostics, Inc.
	  	Office of the Secretary of State of the State of Wisconsin
	 Gen-Probe Prodesse, Inc.
	  	Office of the Secretary of State of the State of Wisconsin

  
 23 

 SCHEDULE 5.05 
 TO PLEDGE AND SECURITY AGREEMENT 
 FINANCING STATEMENTS: 

SCHEDULE 5.05(b) Government Receivables 

NONE 
 SCHEDULE 5.05(d) Location of
Collateral 
  

			
	 Grantor
	  	 Location of Equipment and Inventory

	 Hologic, Inc.

BioLucent, LLC
 Cruiser, Inc.
 Cytyc Corporation

Cytyc Development Company LLC

Cytyc Interim, Inc.

Cytyc International, Inc.

Cytyc Limited Liability Company

Cytyc Prenatal Products Corp.

Cytyc Securities Corporation

Cytyc Surgical Products II, Limited Partnership

Cytyc Surgical Products, Limited Partnership

Cytyc Surgical Products III, Inc.

Direct Radiography Corp.

Hologic Investment Corp.

Hologic Limited Partnership

Interlace Medical, Inc.

Sentinelle Medical USA Inc.

Suros Surgical Systems, Inc.

SST Merger Corp.
 Third Wave Agbio, Inc.
 Third Wave Technologies,
Inc.
	  	 250 Campus Drive
 Marlborough,
MA 01752

	 Hologic, Inc.

BioLucent, LLC
 Cruiser, Inc.
 Cytyc Corporation

Cytyc Development Company LLC

Cytyc Interim, Inc.

Cytyc International, Inc.

Cytyc Limited Liability Company

Cytyc Prenatal Products Corp.

Cytyc Securities Corporation

Cytyc Surgical Products II, Limited Partnership

Cytyc Surgical Products, Limited Partnership

Cytyc Surgical Products III, Inc.

Direct Radiography Corp.

Hologic Investment Corp.

Hologic Limited Partnership

Interlace Medical, Inc.

Sentinelle Medical USA Inc.

Suros Surgical Systems, Inc.
	  	 35 Crosby Drive
 Bedford, MA
01730

  
 24 

			
	 Grantor
	  	 Location of Equipment and Inventory

	 SST Merger Corp.

Third Wave Agbio, Inc.

Third Wave Technologies, Inc.
	  	
	 Suros Surgical Systems, Inc.

Hologic, Inc.
	  	 Northwest Technology Center

6100 (Building K)
 6110 (Building L)

6210 (Building J)
 Technology Center
Drive
 Indianapolis, IN 46278

	 Third Wave Agbio, Inc.

Third Wave Technologies, Inc.

Hologic, Inc.
	  	 502 South Rosa Road
 University
Research Park
 Madison, WI 53719

	 Hologic, Inc.
	  	 36 Apple Ridge Road
 Danbury,
CT 06810

	 Hologic, Inc.
	  	 37 Apple Ridge Road
 Danbury,
CT 06810

	 Hologic, Inc.
	  	 562 Parkway, Coyal Free Zone

El Coyol, Alajuela – Costa Rica
 PO Box
2481-4050, Alajuela

	 Cytyc Corporation

Hologic, Inc.
	  	 4 Navigator Road
 Londonderry,
NH 03053

	 Cytyc Corporation

Hologic, Inc.
	  	 445 Simarano Drive

Marlborough, MA 01752

	 Hologic, Inc.
	  	 #112-7100 Wonndbine Ave

Markham, Ontario L3R5J7

Canada

	 Cytyc Corporation

Hologic, Inc.
	  	 14 Agean Drive, Unit A

Methuen, MA

	 Hologic, Inc.
	  	 600 Technology Drive (including Building 600 &
 Building 400)
 Newark, DE 19702

	 Hologic, Inc.
	  	 2585 Augustine Drive
 Santa
Clara, CA 95054

	 Cytyc Corporation

Hologic, Inc.
	  	 1240 Elko Drive
 Sunnyvale, CA
94089

	 Hologic, Inc.
	  	 555 Richmond Street West
 Suite
800, PO Box 301
 Toronto, Ontario, Canada M5V 3B1

	 Hologic, Inc.
	  	 West Chester Corporate Center, 6929 Tylersville Road,
 West Chester, Butler County, Ohio

	 Cytyc Surgical Products, Limited Partnership

Hologic, Inc.
	  	301 East Evelyn Avenue, Mountain View, CA 94039
	 Gen-Probe Incorporated

Gen-Probe Sales & Service, Inc.

Gen-Probe International, Inc.

Gen-Probe Holdings, Inc.

Gen-Probe Transplant Diagnostics, Inc.
	  	 10210 Genetic Center Drive
 San
Diego, CA 92121-4362

  
 25 

			
	 Grantor
	  	 Location of Equipment and Inventory

	 Gen-Probe GTI Diagnostics Holding Company

Gen-Probe GTI Diagnostics, Inc.

Gen-Probe Prodesse, Inc
	  	
	 Gen-Probe Holdings, Inc.

Gen-Probe Transplant Diagnostics, Inc.
	  	 550 West Avenue
 Stamford, CT
06902

	 Gen-Probe GTI Diagnostics Holding Company

Gen-Probe GTI Diagnostics, Inc.

Gen-Probe Prodesse, Inc.
	  	 20925 Crossroads Circle

Waukesha, WI 53186

	 Gen-Probe Incorporated2
	  	 6333 Sequence Drive
 San Diego,
CA 92121-4362

	 Gen-Probe Incorporated
	  	 10808 Willow Court
 San Diego,
CA 92127

	 Gen-Probe Incorporated
	  	 Waterside Court
 Crewe
Road
 Manchester, M23 9BE
 United
Kingdom

  

	2 	Gen-Probe’s headquarters facility located in San Diego consists of the following two buildings, which are referred to as GCD1 (10210 Genetic Center Drive, San
Diego, CA 92121-4362) and GCD2 (6333 Sequence Drive, San Diego, CA 92121-4362). 

  
 26 

 SCHEDULE 5.06 
 TO PLEDGE AND SECURITY AGREEMENT 
 SCHEDULE 5.06(a) 

NONE 
 SCHEDULE 5.06(b) 

NONE 
 SCHEDULE 5.06(c) 

Schedule 5.02 (1) (A) is hereby incorporated by reference (other than Pledged Stock). 

  
 27 

 SCHEDULE 5.07 
 TO PLEDGE AND SECURITY AGREEMENT 
 SCHEDULE 5.07(a) 

NONE 
 SCHEDULE 5.07(b) 

NONE 
 SCHEDULE 5.07(c) 

NONE 
 SCHEDULE 5.07(d) 

NONE 
 SCHEDULE 5.07(h) 

Enzo Life Sciences, Inc. v. Hologic, Inc., Case No. 1:12-cv-00276-LPS (D. Del.). 
 On March 6, 2012, Enzo Life Sciences, Inc. (“Enzo”) filed a suit against Hologic in the United States District Court of Delaware. In the complaint, it is alleged that certain of our
molecular diagnostics products, including without limitation products based on our proprietary Invader chemistry such as Cervista HPV high risk and Cervista HPV 16/18, infringe Enzo’s U.S. patent 6,992,180. The complaint seeks permanent
injunctive relief and unspecified damages. Hologic was formally served with the complaint on July 3, 2012, but no hearing has been scheduled. 
 Smith & Nephew, Inc. v. Interlace Medical, Inc., Case No. 1:10-cv-10951-RWZ (D. Mass.) and Smith & Nephew, Inc. v. Hologic, Inc., Case No. 1:11-cv-12064-RWZ (D. Mass.).

 On July 16, 2010, Smith & Nephew, Inc. (“Smith & Nephew”) filed suit against Interlace, which Hologic
acquired on January 6, 2011, in the United States District Court for the District of Massachusetts. In the complaint, it is alleged that the Interlace MyoSure hysteroscopic tissue removal device infringes U.S. patent 7,226,459. The complaint
seeks permanent injunctive relief and unspecified damages. A Markman hearing was held November 9, 2010, and a ruling was issued on April 21, 2011. On November 22, 2011, Smith & Nephew, Inc. filed suit against Hologic in the
United States District Court for the District of Massachusetts. In the complaint, it is alleged that use of the MyoSure hysteroscopic tissue removal system infringes U.S. patent 8,061,359. The complaint seeks preliminary and permanent injunctive
relief and unspecified damages. On January 17, 2012, at a hearing on Smith & Nephew’s motion for preliminary injunction with respect to the suit filed November 22, 2011, the judge did not issue an injunction, consolidated the
two matters for a single trial and scheduled a trial on the merits for both claims for June 25, 2012. A case management conference held on February 14, 2012 resulted in the trial being rescheduled to begin on August 20, 2012. On
March 15, 2012, the Court heard summary 

  
 28 

 
judgment arguments related to the ‘459 patent and claim construction arguments related to the ‘359 patent. On June 5, 2012, the Court denied Smith & nephew’s request
for summary judgment of infringement, denied Smith & Nephew’s request for preliminary injunction, and denied Hologic’s requests for summary judgment of non-infringement and invalidity. The trial remains scheduled for
August 20, 2012. The purchase and sale agreement associated with the acquisition of Interlace includes an indemnification provision that provides for the reimbursement of a portion of legal expenses in defense of the Interlace intellectual
property. Hologic has the right to collect certain amounts set aside in escrow and, as applicable, offset contingent consideration payments of qualifying legal costs. Hologic has recorded legal fees incurred for this suit under the indemnification
provision net within accrued expenses. 
 SenoRx, Inc. v. Hologic, Inc., Case No. 1:12-cv-00173-LPS-CJB (D. Del.). 

On February 10, 2012, SenoRx, Inc. (“SenoRx”) filed a suit against Hologic in the United States District Court of the District of
Delaware. In the complaint, it is alleged that Hologic’s MammoSite product infringes SenoRx’s U.S. patents 8,079,946 and 8,075,469. The complaint seeks permanent injunctive relief and unspecified damages. 

Enzo Life Sciences Inc. v. Gen-Probe Incorporated, Case No. 1:12-cv-00104-LPS (D. Del.). 

In January 2012, Gen-Probe was sued by Enzo Life Sciences, Inc. (“Enzo”), in the United States District Court for the District of Delaware.
Enzo alleges that Gen-Probe has infringed United States patent number 6,992,180 through the manufacture and sale of molecular diagnostic assays that incorporate its patented HPA technology. The products alleged to infringe include Gen-Probe’s
APTIMA Combo 2 assay and APTIMA HPV assay. 
 Alere Mediation 
 During July 2011, Alere, Inc. (“Alere”) contacted Hologic and requested an audit of royalty payments due under a patent license agreement that had originally been entered into by and between
Adeza and Inverness Medical, Inc. (Inverness having been recently acquired by Alere). The patent license licensed certain Inverness patents to Hologic for the fetal fibronectin (fFn) product. On August 12, 2011, Alere sent a letter to Hologic
stating they believed that Hologic underpaid royalties by approximately $400K on its fFn product, and requested payment of $750,000.00 for Hologic’s sale of the Quikcheck fFn product. After review of the patents under agreement, Hologic
believes they do not cover the Quikcheck or fFn products. Hologic sent a letter to Alere on September 9, 2011, informing Alere that it did not intend to make further payments under the license and requested a meeting to seek a resolution.
Counsel for Hologic and Alere met on September 24, 2011 and exchanged names of business contacts. On November 29, 2011, Hologic met with Alere to discuss bases for Hologic’s position regarding the license agreement; no consensus was
reached. On December 12, 2011, Hologic contacted Alere with a proposed settlement involving royalty payments only on the QuikCheck product. On December 16, 2011, Alere’s counsel called to indicate that they would not consider the
settlement and intended to deliver a letter to Hologic in early January, officially notifying Hologic that they believed us in breach of our licensing agreement. On January 16, 2012, Alere forwarded a letter to Hologic, stating their belief
that Hologic is in breach of the license agreement, stating their 

  
 29 

 
belief that the fFn products are covered by an additional Alere patent, and providing an alternative settlement proposal, which includes royalties to the additional patent. On April 30,
2012, Hologic and Alere agreed to mediate the dispute. Mediation is currently scheduled for August 9, 2012. 
 SCHEDULE 5.07(j)

 Non-Assertion Agreement 
 Non-Assertion Agreement dated as of February 7, 1997 by and between Gen-Probe Incorporated and Organon Teknika B.V. to, among other things, avoid legal actions between themselves relating to each
other’s patent rights with respect to the Stanford License. 
 Covenant not to sue agreement between Hologic, Inc. and Siemens AG.

 Covenant not to sue agreement dated June 26, 2006, by and between Hologic, Inc. (“Hologic”) and
Siemens AG (“Siemens”) (collectively, the “Parties”). On September 29, 2005, Hologic consummated an acquisition of intellectual property and other assets of Fischer Imaging Corporation (“Fischer”), including
the intellectual property relating to Fischer’s prone stereotactic breast biopsy system, Mammotest (“Acquisition”). In order to resolve the alleged competitive harm that the United States Federal Trade Commission
(“FTC”) alleges has resulted or will result from the Acquisition in the alleged prone stereotactic breast biopsy system market, Hologic entered into an Agreement Containing Consent Order (“Consent Agreement”), which, if
accepted by the Commission, will require Hologic to enter into this Agreement with Siemens to effect the remedial purposes of the Commission’s Order to enable Siemens to develop, manufacture and market prone stereotactic breast biopsy systems
in order to compete effectively and independently in the market with Hologic. In order to further the purpose and comply with the terms of the Consent Agreement, or, when final, the FTC’s Decision and Order, Hologic and Siemens entered into
this Agreement. 
 Covenant not to sue agreement between Hologic, Inc. and Lunar Corporation. 

Covenant not to sue agreement dated September 26, 1995, by and between Hologic, Inc. (“Hologic”) and Lunar
Corporation (“Lunar”) (collectively, the “Parties”). Lunar and Hologic have been engaged in litigation in numerous forums, including in the United States District Court for the Western District of Wisconsin, Case
Number 94-C-0661-C, in which trial commenced before the Court on September 25, 1995. Lunar and Hologic reached an agreement to settle all of their disputes in all forums, worldwide, and the Parties entered into this settlement agreement which
provides that, inter alia, Lunar and Hologic will make a 10-year worldwide nonaggression pact with respect to all patent owned at any time by each party, which claim subject matter in the fields of x-ray bone densitometry and ultrasound bone
densitometry, worldwide, including but not limited to, an agreement not to engage the other party in disputes with respect to such patents including, without limitation, invalidity claims, unenforceability claims, infringement claims, or in patent
office oppositions, patent office protests, or patent office interferences. 

  
 30 

 SCHEDULE 5.08 
 TO PLEDGE AND SECURITY AGREEMENT 
  

					
	 MATERIAL CONTRACT
	  	 CONSENT REQUESTED
	  	 RESPONSE

	Restated Agreement dated as of July 24, 2009 by and between Gen-Probe Incorporated and Novartis Vaccines and Diagnostics, Inc. as modified by the Product Development Addendum
for the Panther Instrument and Ultrio Elite Assay signed as of March 11, 2011 by and between Gen-Probe Incorporated and Novartis Vaccines and Diagnostics, Inc. (the “Restated Agreement”).	  	 Gen-Probe Incorporated requested that Novartis vaccines and Diagnostics, Inc. (“Novartis”) consent to the collateral
assignment of the Restated Agreement to the Agent on August 22, 2012.
  

Novartis requested a copy of the Pledge and Security which Gen-Probe Incorporated made available to Novartis on August 24, 2012.

 
 Gen-Probe Incorporated followed-up by email on September 18, 2012 requesting a
response from Novartis. No response received to date.
  
	  	Novartis has not yet responded to the latest follow up communication from Gen-Probe Incorporated.
	Co-Exclusive License Agreement effective as of April 23, 1997 by and between Gen-Probe Incorporated and The Board of Trustees of the Leland Stanford Junior University, as
amended (the “Stanford License”)	  	Gen-Probe Incorporated requested that Stanford University consent to the collateral assignment of the Stanford License to the Agent on August 22, 2012 and August 28,
2012.	  	Because of Stanford’s obligation to insure the commercial availability of licensed products (for public use and benefit), it could not consent to the assignment of the license
to an entity that is not a qualified bio-tech company.

  
 31

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00208-of-00352.parquet"}]]